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Authors’ preface
Extensive world-wide studies in cancer epidemiology throughout most of 
this century have led to a generally accepted view that as much as 80-90% 
of all human cancer has its origins in environmental factors in our diet and 
lifestyle. Although in most cases several factors are likely to combine to 
produce a particular disease, the real significance of the above conclusion 
is its corrollary, that identification and elimination of these environmen­
tal factors should reduce the incidence of the disease. During this time 
period the incidence of most forms of cancer has remained essentially 
constant with one notable exception, lung cancer. Mortality from this 
disease has risen inexorably to its present epidemic proportions during 
the last seventy years and now accounts for the death of some 26000 men 
and 15 000 women each year in England and Wales alone. There is now no 
doubt that this is a direct result of cigarette smoking, and it is reliably 
predicted that abandonment of the habit would reduce this death rate 
ten-fold. The causes of other major forms of cancer, such as breast cancer 
in women and colon cancer in both sexes, have proved to be much more 
elusive. Their origins are probably complex and they are more difficult to 
study because there are no natural ‘controls’ as there are with lung cancer, 
where direct comparisons may be made between smokers and non- 
smokers. All possibilities for their causation are now under active 
consideration, and among them the influence of endogenous carcinogens 
generated by aberrant metabolism within the host is unknown, but cannot 
be discounted. It is now established that carcinogens of varied types are 
elaborated by both plants and microorganisms, and there seems to be no a 
priori reason why animals should not be similarly afflicted. Since most 
cancers are primarily diseases of old age it would seem unlikely that there 
would be strong evolutionary pressure against this happening. The idea 
that carcinogens, arising from steroids by incorrect metabolism, might be
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important in the induction of human cancer was a view commonly held in 
the past, but which has been neglected in recent times.
Over fifty years ago, at the very outset of research into chemical 
carcinogenesis, the potent polycyclic aromatic hydrocarbon carcinogen 
3-methylcholanthrene was prepared by simple chemicaljransformations 
from a bile acid derivative. The correct structures for the bile acids and 
sterols were themselves established at about the same time, and the 
synthesis of this carcinogen took on an exaggerated importance in the 
minds of scientists. The enduring idea that methylcholanthrene formed 
by incorrect bile acid or sterol metabolism in the body might prove to be a 
cause of human cancer led to numerous attempts to identify this 
carcinogen in tumours and other tissues, but without success. The reason 
for this failure now seems obvious because experience has shown that 
cyclization of the sterol side chain does not occur to provide a fifth fused 
ring. Instead this side-chain tends to be lost with migration of the angular 
methyl groups, leading to compounds of the simpler four-ring cyclo- 
penta[a]phenanthrene series. These compounds thus possess the same 
basic carbon ring system as the steroids, but lack the angular methyl 
groups which characterize the latter. They are therefore capable of 
complete dehydrogenation to fully aromatic phenanthrene derivatives, 
and compounds of this type do in fact occur widely in petroleum and in 
oil-bearing shales as well as in river and lake sediments; they are also 
found in cooking oils that have been overheated. Advances in our 
understanding of oestrogen biosynthesis and metabolism have moreover 
suggested a plausible route by which cyclopenta[a]phenanthrenes might 
be formed in the body, but so far no attempts have been made to test this 
possibility. The need for further investigations in this area using modern 
techniques is now apparent, because numerous cyclopenta[a]phenan- 
threne^ have since been synthesized and some have been shown to be 
strong carcinogens, similar in potency to the classical polycyclic 
hydrocarbon carcinogen benzo[a]pyrene.
This book is concerned with the occurrence, chemical synthesis, 
physical and chemical properties, and biological attributes of cyclo- 
penta[a]phenanthrenes. These are discussed in detail, as is their history 
which is intimately connected with the establishment of the correct 
structure of steroids. Interesting structure /carcinogenicity relationships, 
similar to those found among related polycyclic aromatic systems such as 
the chrysenes and benzo[a]anthracenes, are examined in relation to the 
metabolism of these compounds and the interactions of their metabolites 
with biological macromolecules. The book also lists physical data for 
nearly 350 cyclopenta[a]phenanthrene derivatives and contains exhaus­
Preface xvii
tive references to the original literature. It is hoped that it will provide a 
useful point of departure for those concerned with the possibility of the 
involvement of cyclopenta[a]phenanthrenes in the aetiology of human 
disease.
M .M .C .
T .S .B .
1Introduction
Six possible isomers can be formed by fusion of a cyclopentane ring with 
the angular tricyclic aromatic hydrocarbon phenanthrene, as shown in 
Fig. 1. Of these the [a] isomer occupies a special position because it 
possesses the same carbon ring system as members of the large and 
important group of natural products, the steroids. Indeed, cyclopen- 
ta[a]phenanthrenes became of importance during the elucidation of the 
structures of these natural products over 50 years ago. At about the same 
time it first became evident that carcinogenic properties were associated
Fig. 1
Phenanthrene
(a) (b) (c)
(d ,e , f ) ( i,k) (I)
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with many polycyclic aromatic hydrocarbons which result from incom­
plete combustion of most carbonaceous materials, and that the great 
majority of these could also be considered as derived from phenanthrene. 
The coincidence in time between the fruition of these two quite 
independent lines of research led many to feel that there might be a 
connection between them, and for a time there was considerable interest 
in the possible relationship between these two classes of compounds. 
Although most of the carcinogenic polycyclic aromatic hydrocarbons 
discovered at that time contained four or more fused benzene rings, the 
simpler cyclopenta[a]phenanthrenes with the same carbon skeleton as 
the C18 and C19 steroids (with the exception of the angular methyl groups 
in these steroids) were also examined, and these studies have continued 
until the present day.
In writing this monograph the purpose is to review the subject fully 
including both the earlier work as well as the more recent developments. 
A careful search has been made in Chemical Abstracts back to 1907, but a 
problem has been encountered in that the term ‘cyclopen- 
ta[a]phenanthrene’ includes numerous partially hydrogenated deriva­
tives which are better considered as steroids. In general we have neglec­
ted these if they include in their structure angular methyl groups, unless 
they have some direct relevance to the phenanthrene-derived compounds 
which are the main topic here. This work now spans more than half a 
century and in reviewing it almost inevitably some omissions will have 
occurred; the authors wish to apologize for these in advance. In the text 
individual compounds are assigned arabic numbers (in heavy type) 
sequentially so that they can be referred to without ambiguity, and the 
structures of most are shown in the figures. The latter and also the tables 
are numbered sequentially throughout the monograph, but literature 
references are collected at the end of each chapter in alphabetical and 
chronological order.
1.1 Nomenclature of cyclopenta[a]phenanthrenes
In common with many other polycyclic aromatic ring systems, 
the nomenclature of cyclopenta[a]phenanthrenes has undergone changes 
since the early work, and this will lead to confusion unless it is dealt with 
here. Originally compound (1) in Fig. 2 was named 1,2-cyclopen- 
tenophenanthrene and was numbered as shown 1(A). With the advent of 
the more facile method of designating the edge of each ring by a letter, 
as shown for phenanthrene in Fig. 1, the prefix denoting the fused 
five-membered ring becomes cyclopenta[a]; however, cyclopen- 
ta[a]phenanthrene itself now refers to the fully unsaturated hydrocarbon
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of which (2) is the 17i7-isomer. 15//-cyclopenta[a]phenanthrene is there­
fore compound (3), and the compound (1) containing only one double 
bond in the five-membered ring is correctly named 16,17-dihydro-15/f- 
cyclopenta[a]phenanthrene. In the older literature these two unsaturated 
hydrocarbons, (2) and (3), were named/dr(2) and zl2'(3’)-l,2-cyclopent- 
dienophenanthrene, respectively. When the position of the ‘extra’ 
hydrogen atom (on the carbon not doubly bonded) is fixed by a sub­
stituent, for example by the ketone oxygen atom in the ketone (4), its 
position need not be designated; e.g., the correct name for this ketone is 
15,16-dihydrocyclopenta[a]phenanthren-17-one or 15,16-dihydro-17- 
oxocyclopenta[a]phenanthrene. Numbering of the ring system follows 
the steroid convention as indicated on formula 1(B) in Fig. 2. The term 
cyclopenta[a]phenanthrene is therefore properly reserved for the fully 
unsaturated compounds containing a double bond in the five-membered 
ring. However, in this monograph it will be also used more loosely as a 
general term for compounds such as (l)-(4) of both types, except of 
course, in formal chemical names.
1.2 Cyclopenta[a]phenanthrenes, steroids, and carcinogenic
polycyclic hydrocarbons
Sterols isolated from plant and animal tissues and the bile acids 
from animal bile had been studied for over a century when in 1928 
Windaus and Wieland received the Nobel Prize for their outstanding 
work on these natural products. Extensive degradative experiments 
utilizing the classical methods of organic chemistry, purification by
4 Introduction
crystallization to a constant melting point or constant optical rotation and 
identification by elemental analysis, were unassisted by the chromato­
graphic and spectroscopic techniques so widely used today. By 1928 these 
experiments had culminated in the structures shown in Fig. 3 for the bile 
acid deoxycholic acid and the typical sterol cholesterol. However, in 1932 
these formulae were criticized on what at that time were quite esoteric 
grounds. In an X-ray crystallographic investigation of the vitamin D 
precursor ergosterol Bernal (1932b) determined its molecular dimen­
sions to be 7.2 x 5 x 17-20 A, and pointed out that these figures did not fit 
well with those ( 8 . 5 x 7 x 1 8 A) calculated for this sterol from the 
Wieland-Windaus structure. This supported a previous observation 
based on the results of experiments with surface films of sterols by Adam 
and Rosenheim (1929). Several years previously Diels et al. (1927) had 
obtained chrysene (5) and two other unidentified hydrocarbons by 
dehydrogenation of sterols by prolonged heating at 360°C with selenium, 
but it was at that time generally considered that these drastic conditions 
might well lead to deep-seated rearrangements within the molecule, so 
that the products would be of little use as indicators of structure. 
Discarding this view, Rosenheim and King (1932) proposed the novel 
structure (6a) for deoxycholic acid based on perhydrochrysene, and 
Bernal (1932a) calculated that an analogous structure for ergosterol 
would have the dimensions (7. 5 x 4 . 5 x 2 0  A), in good agreement with 
those found. Within a few months chemical considerations led to the 
revised structure (6b) for deoxycholic acid based on perhydrocyclopen- 
ta[a]phenanthrene; this formula has stood the test of time and is accepted
Fig. 3
HO
v j C 2 » 4
/ ch3
CH(CH2)3CH(CH3)2
12
6 7
Deoxycholic acid (1928)
OH
Cholesterol (1928) Chrysene
5
HO
6a 6b D iels’ hydrocarbon  
7D eoxycholic acid
(May ,1932) (Septem ber, 1932)
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today. In order to confirm this new structure for the bile acids and sterols 
the other hydrocarbons obtained by Diels, particularly the one melting at 
124-125°C, were reinvestigated. This hydrocarbon, which has since 
become known as Diels’ hydrocarbon, was originally obtained, together 
with chrysene and another hydrocarbon C25H24, by selenium dehydro­
genation of cholesterol and cholesteryl chloride; it was also isolated from 
the products of similar dehydrogenation of ergosterol and cholic acid. 
The following year Rosenheim and King (1933) proposed that Diels’ 
hydrocarbon was 16,17-dihydro-17-methyl-15Z/-cyclopenta[a]phenan- 
threne (7) on the basis of its ultraviolet spectrum, another use of a novel 
technique in those early days. The problem was taken up by several 
groups and all three (15-, 16-, and 17-methyl) hydrocarbons as well as the 
parent hydrocarbon 16,17-dihydro-15//-cyclopenta[a]phenanthrene (1) 
were synthesized. It was not, however, until 1935 that Diels’ hydrocarbon 
was finally and unambiguously assigned structure (7) by careful com­
parison with the synthetic specimen (Hillemann, 1935), thus finally 
confirming the steroid ring structure previously arrived at on quite 
different grounds.
At the same time momentous discoveries were being made in the field 
of carcinogenesis. Over 100 years ago occupational skin cancer was 
reported among oil and tar workers both in Germany (von Volkmann, 
1875) and in Scotland (Bell, 1876). Attempts to induce skin tumours in 
animals by topical application of these materials failed at first, but success 
was finally achieved by two Japanese workers, Yamagiwa and Ichikawa 
(1915). They succeeded where others had failed by persisting in their 
treatment, thus simulating human exposure; they found that tumours 
could be induced on the ears of rabbits by repeated, frequent applications 
of coal tar over a protracted period. It was then discovered that the dorsal 
skin of mice offered a more convenient test system, and using this 
technique a systematic search for the active carcinogenic agent in coal tar 
was initiated under the direction of Sir Ernest Kennaway at the Royal 
Cancer Hospital, London (for a short history of this work see Kennaway, 
1955). It was soon established that carcinogenic tars resulted from the 
pyrolysis of many carbon-containing materials as widely different as 
cholesterol, yeast, human hair and tissue, and even acetylene. It was also 
noted (Hieger, 1930) that all tars contained characteristic lines in their 
fluorescence spectra similar to those displayed by the polycyclic aromatic 
hydrocarbon benz[a]anthracene (Fig. 4), which is itself essentially non- 
carcinogenic. These lines, however, were of shorter wavelength in 
benz[a]anthracene, suggesting that the carcinogenic compound giving 
the characteristic lines was of similar type, but of higher molecular
Introduction
weight. The homologue dibenz[a,h]anthracene first prepared by Clar 
(1929) now holds the distinction of being the first pure chemical com­
pound to be shown to be carcinogenic, as demonstrated by Kennaway 
and Heiger (1930). The Royal Cancer Hospital group then undertook the 
fractionation of two tons of gas-works pitch and, using the fluorescence 
spectrum as a guide, eventually (Cook et al. , 1933) obtained seven grams 
of yellow crystals consisting mainly of benzo[a]pyrene. This polycyclic 
aromatic hydrocarbon was found to be a potent carcinogen in the mouse 
skin-painting test, more active than dibenz[a,h]anthracene and having a 
fluorescence spectrum closely similar to that previously observed to be 
associated with carcinogenicity in the crude tars. Later work established 
that most polycyclic aromatic carcinogens were derived from the angular 
system of phenanthrene, whereas its linear isomer anthracene did not 
generally give rise to biologically active derivatives.
In the same year another carcinogenic polycyclic aromatic hydro­
carbon was isolated, not from tar but from the products of pyrolysis of a 
steroid. During the elucidation of the structure of the cholic acids, the 
degradation product 12-ketocholanic acid (8) was found to undergo 
cyclization and decarboxylation at 330°C to yield dehydronorcholine (9). 
Dehydrogenation of this hydrocarbon with selenium led to loss of the two 
angular methyl groups and aromatization of the four six-membered rings 
to give 3-methylcholanthrene (Wieland and Dane, 1933) which was 
subsequently shown to be an even more potent carcinogen than 
benzo[a]pyrene (Cook and Hazelwood, 1933, 1934). This simple,
Fig. 4
10
3
2
4 5
benz[a]
anthracene
dibenz [a ,h i  
anthracene
benzo [a l 
pyrene
anthracene
HO
6 8 9 3-m ethylcholanthrene
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straightforward four-step transformation of a natural steroid into a 
potent carcinogen was important on several grounds. Firstly, selenium 
dehydrogenation was accompanied by the loss of the angular methyl 
groups, but the ring system remained intact. Thus it became more 
probable that the cyclopenta[a]phenanthrene skeleton of Diels’ hydro­
carbon correctly represented the steroid ring system. Secondly, the 
position of the carbon side chain was established at C-17 in cholic acids 
and thus through chemical correlations in all the sterols, as well as in 
other physiologically important steroids such as the progestogens and 
corticoids to be discovered later. Finally, this remarkable preparation of 
a carcinogen from a natural steroid for a time led to the feeling that an 
important and exciting breakthrough in our understanding of the origin 
of human cancer was at hand. For example, Fieser (1936) in his book 
Chemistry o f Natural Products Related to Phenanthrene wrote,
‘While proof is entirely lacking, it appears possible that many 
forms of cancer may originate in the metabolic production of 
methylcholanthrene or related substances from the bile acids, or 
perhaps from the sterols or sex hormones, of the body’.
Fifty years later we have to say that this possibility has not been realized, 
although it has not been disproved. There have been a number of new 
twists to the story among which the cyclopenta[a]phenanthrenes find an 
important place. The chemistry and biological attributes of these com­
pounds have been studied extensively partly because of their close 
relationship with the steroids, but also because of the attraction of this 
possibility of the endogenous formation of carcinogens from normal 
steroid hormones.
Early work on the synthesis of cyclopenta[a]phenanthrenes was largely 
aimed at proving, through the provision of pure synthetic specimens of 
known structure, the nature of the steroid dehydrogenation products. It 
was soon established that Diels’ hydrocarbon, its 15- and 16-methyl 
isomers, and the parent hydrocarbon (1) (Fig. 2) were not carcinogenic 
(Hartnell, 1951). Interest then centred on the possibility of the formation 
of cholanthrenes from steroids under conditions approximating to 
physiological (Inhoffen, 1953). The discovery of the C18 and C19 steroid 
hormones lacking a side chain at C-17, required to provide the extra 
carbon atoms for construction of the fifth ring, seemed to rule these out as 
precursors, although Fieser (1941) suggested that 17-ketones might 
condense with biological ketoacids to provide the necessary atoms. 
Parallel with this, work on the synthesis and testing of numerous poly­
cyclic aromatic hydrocarbons went on apace, and it rapidly became clear
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that nearly all these were based upon a phenanthrene ring system. 
Moreover, methyl substituents often had a dramatic effect in increasing 
the activity of weakly carcinogenic hydrocarbons. Thus the feeble car­
cinogenicity of chrysene (Fig. 3) is considerably enhanced by methyl 
substitution at C-5, whereas substitution at other ring positions has little 
effect (Dunlap and Warren, 1943). In the benz[a]anthracene (Fig. 4) 
series the hydrocarbon itself is essentially inactive, whilst carcinogenic 
activity of the monomethylbenz[a] anthracenes decreases in the order 
7-Me >  12-Me>  9-Me (Cook and Kennaway, 1938); 7,12-dimethyl- 
benz[a]anthracene (DMBA) is one of the most potent carcinogens 
known (Bachmann et al., 1938). It therefore became of importance to 
study the eight possible derivatives of 16,17-dihydro-15H-cyclopen- 
ta[a]phenanthrene (1) bearing methyl groups on the aromatic rings. 
Butenandt (1942) began by synthesizing the 6-methyl derivative from the 
androgen dehydroandrosterone (3-hydroxyandrost-5-en-17-one); during 
the following decade he and his group obtained the rest of the isomers by 
total synthesis and tested them for carcinogenicity in the mouse skin- 
painting test (Butenandt and Dannenberg, 1953). All were inactive with 
the exception of the 7- and 11-methyl hydrocarbons which were 
extremely weak carcinogens, thus strengthening the opinion held at that 
time that four aromatic rings were essential for high potency. In later 
work Dannenberg showed that introduction of a double bond into the 
five-membered D-ring also led to weak activity in the absence of methyl 
substitution. He found (Dannenberg, 1970) that dehydrogenation of 
sterols with high-potential quinones led to compounds of this class.
1.3 Oestrogens and cyclopenta[a]phenanthrenes
Continuing this short account of those exciting and eventful early 
years we turn to the female sex hormones, the oestrogens. A convenient 
and reliable assay for oestrogenic activity was devised by Allen and Doisy 
(1923) based on the ability of the test compound to induce oestrus in 
castrated female mice, as indicated by characteristic morphological 
changes in the cells lining the vagina. Using this test it was discovered that 
human pregnancy urine was a good source of oestrogenic activity, and six 
years later two groups led by Doisy (1929) in America and Butenandt 
(1929) in Germany isolated the main oestrogenic hormone, oestrone 
(Fig. 5). This hormone differs from most other steroids in possessing a 
phenolic A-ring and in lacking the angular methyl group at C-10. Soon 
afterwards a second, less active oestrogen, oestriol, was obtained from 
the same source by Marrian (1930) in England, while in France, Girard et 
al. (1932) using the water-solubilizing ketone reagent (trimethylamino-
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acetohydrazine hydrochloride) which now bears his name fractionated 
over 50 000 L of pregnant mares’ urine to isolate the naphtholic oestrogen 
equilenin.
During work aimed at establishing the structure of oestrone, the 
methyl ether of this hormone was submitted to Wolff-Kishner reduction 
to yield the 17-deoxy derivative (10) (Fig. 5) which on selenium dehydro­
genation yielded 16,17-dihydro-3-methoxy-15//-cyclopenta[a]phe- 
nanthrene (11) identical with a synthetic specimen (Cook and Girard, 
1934). Again selenium dehydrogenation led to elimination of the angular 
methyl group, but retention of the ring system. On the other hand, when 
oestrone methyl ether was treated with the methyl Grignard reagent and 
the resulting tertiary alcohol (12) was dehydrogenated the product was 
the 17,17-dimethyl derivative (14), not as expected the 17-monomethyl 
compound (17) or either of its 15- and 16-methyl isomers, all of which 
were synthesized for comparison (Cohen etal., 1935). Thus migration of 
the angular methyl group occurs during dehydrogenation and dehydra­
tion of this carbinol (12). The reason for this would appear to be the
Oestrone Oestriol Equilenin
CH3CH
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presence of the hydroxyl group vicinal to the quaternary carbon at C-13, 
because migration also occurs when oestradiol methyl ether (15) is 
similarly dehydrogenated to yield 16,17-dihydro-3-methoxy-17-methyl- 
15//-cyclopenta[a]phenanthrene (17). Migration also occurs when these 
alcohols are dehydrated under less drastic conditions to give the 17,17- 
dimethyl- and 17-methyl-18-nor-steroids (13) and (16), respectively. The 
structure of equilenin was also confirmed by selenium dehydrogenation 
of the tertiary alcohol derived from the methyl ether (analogous to 12) to 
furnish 15,16-dihydro-17,17-dimethyl-3-methoxycyclopenta[a]phenan- 
threne (14).
In the body oestrogens are biosynthesized from male sex hormones, 
the androgens. This was conclusively proved when it was shown that r e ­
labelled testosterone was converted into [14C] oestradiol (Heard et al., 
1955; Baggett et al., 1955). Aromatization of the A-ring in the androgen 
androst-4-ene-3,17-dione (18) (Fig. 6) requires the loss of the C-19 
methyl group together with two of the hydrogen atoms at C-l and C-2. 
Meyer (1955a) isolated the 19-hydroxy derivative (19) as a metabolite of 
this androgen, and showed that on incubation with enzyme preparations 
from the adrenal gland, the ovary, and the placenta it gave rise to 
oestrogens more readily than the original hormone (Meyer, 19556). It is 
now established that further oxidation at this carbon gives the 19- 
aldehyde (20) from which one hydrogen atom at C-2 is lost by enolization 
and the other at C-l by concerted oxidative elimination of the aldehyde 
group as formic acid to give the phenol oestrone as shown in Fig. 6 
(Stevenson et al., 1985). Working on human urinary oestrogen 
metabolites at Edinburgh, Marrian and his group isolated a new and 
unusual oestrone metabolite from pregnancy urine by partition 
chromatography on Celite. This compound was characterized (Loke et 
al., 1959) as 18-hydroxyoestrone (21) by its ready loss of formaldehyde 
when treated with dilute alkali, and by the formation of 18-noroestrone 
characterized as its methyl ether (22) identical with a synthetic sample 
(Loke et al., 1958) (Fig. 7). At that time compound (21) was unique, 
being the first instance of a steroid hydroxylated at C-18. Later, of course,
Fig. 6
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it was found that similar 18-hydroxylation occurs during the biosynthesis 
of the adrenocortical hormone aldosterone when the substrate is prob­
ably corticosterone (Eisenstein, 1967). Thus 18-hydroxylation is 
established as a normal adrenal function, at least for C21 steroids. After 
his move to London at about this time to take up the position of Director 
of Research at the Imperial Cancer Research Fund, Marrian pointed out 
to one of the present authors (M.C.) that should elimination of the 18- 
methyl group from oestrone occur in vivo, there would arise the possi­
bility of complete aromatization of the steroid to 15,16-dihydro-3- 
hydroxycyclopenta[a]phenanthren-17-one (23). An oestrogen, 
equilenin, was already known with both A- and B-rings aromatic, but 
aromatization of ring-C in this compound is normally blocked by the 
angular 18-methyl group. Furthermore, 3-deoxyequilenin (25) had been 
isolated from mares’ pregnancy urine by two groups (Marker and 
Rohrmann, 1939; Prelog and Fuhrer, 1945) under conditions which 
apparently precluded its formation as an artefact. The structure of this 
compound was later confirmed by its synthesis from equilenin (Bach- 
mann and Dreiding, 1950); they submitted the steroid to the Biicherer 
reaction to obtain its 3-amino analogue, the diazonium salt of which was 
reduced with hypophosphorous acid to give the 3-deoxy compound with 
properties identical with those of 3-deoxyequilenin isolated from natural 
sources. The biosynthesis of this compound is unknown, but if it is formed 
like normal 3-oxygenated steroids via lanosterol, presumably elimination 
of this oxygen must occur before the final aromatization step takes place. 
In yeast squalene cyclization first gives enzyme-bound lanosta-8,24-diene 
which is subsequently 3-hydroxylated (Barton and Moss, 1966). If the 
enzyme-bound, fully cyclized hydrocarbon became free before the final 
step it could conceivably give rise to 3-deoxy steroids. It is interesting that
Fig. 7
ch2oh
hoch2 o
21 22 aldosterone
R- H , 23  
R=CH3 , 24
25 4 26
12 Introduction
equilenin itself is apparently not derived from oestrone by further 
biological dehydrogenation (Gallagher et al., 1958). Non-oxidative 
cyclization of squalene to several triterpenes which lack oxygen at C-3 is 
well known, but has been little investigated (Manitto, 1981). Elimination 
of the 18-methyl group and C-ring aromatization in the 3-deoxy com­
pound (25) would furnish the parent ketone 15,16-dihydrocyclopen- 
ta[a]phenanthren-17-one (4).
It was therefore decided to synthesize both these cyclopen- 
ta[a]phenanthren-17-ones (4) and (23) in order to examine them for both 
oestrogenic and carcinogenic activity. In addition, preparation of the 
series of 17-ketones corresponding to Butenandt’s isomeric methyl 
hydrocarbons was also undertaken. When it was discovered that the 
11-methyl-17-ketone (26) (15,16-dihydro-ll-methylcyclopenta[a]- 
phenanthren-17-one) was a strong carcinogen (Coombs and Croft, 1966), 
much more potent than the corresponding hydrocarbon tested by 
Butenandt, interest in cyclopenta[a]phenanthrenes was renewed; work 
in this area has continued until the present day, and numerous related 17- 
oxocyclopenta[a]phenanthrenes have been synthesized and tested for 
mutagenic and carcinogenic activity. Recent work has been aimed at 
understanding the observed structure/activity relationships in terms of 
the metabolism of these compounds and their ability to modify biological 
macromolecules. In quite another sphere a number of cyclopenta[a]- 
phenanthrene derivatives have very recently been shown to occur 
naturally in petroleum and other mineral oils, as well as in river and lake 
sediments, thus again giving rise to renewed interest in this series of 
compounds.
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2Chemical synthesis of 
cyclopenta[a]phenanthrenes: hydrocarbons
2.1 Early synthesis of hydrocarbons in connection with steroids
As has already been outlined, syntheses of cyclopenta[a]phenan- 
threnes lacking oxygen substitution in ring-D were originally undertaken 
50 years ago to provide rigid structural proof for steroid dehydrogenation 
products. These syntheses were greatly assisted by previous investiga­
tions on the preparation of phenanthrene derivatives by Haworth and his 
school in connection with elucidation of the structures of the resin acids 
(Fieser, 1936). The parent hydrocarbon 16,17-dihydro-15i/-cyclopen- 
ta[a]phenanthrene (1) was obtained by both Kon (1933) and by Ruzicka 
et al. (1933) by essentially the same route, outlined in Fig. 8. Condensa­
tion of 2-(l-naphthyl)ethyl bromide with ethyl cyclopentanone-2-carbox- 
ylate gave the /?-keto-ester (40) which was decarboxylated, and the
Fig. 8
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resulting ketone was reduced to the secondary alcohol (41). This was 
cyclized to the tetracyclic compound (44), without isolation of the 
intermediate cyclopentene (42), by heating it with phosphorus pentox- 
ide, and the synthesis was completed by dehydrogenation with selenium. 
Ruzicka discovered that the final hydrocarbon (1) could be obtained 
directly by heating the keto-ester (40) with sulphuric acid. A somewhat 
different route was followed by Cook and Hewett (1933) who were 
interested in this compound in connection with their work on polycyclic 
aromatic hydrocarbon carcinogens. These workers first obtained the 
tertiary alcohol (43) by treating cyclopentanone with the Grignard 
reagent from 2-(l-naphthyl)-ethyl chloride, and this was cyclized directly 
to the final cyclopenta[a]phenanthrene with hot sulphuric and acetic 
acids. In both cases the unsaturated hydrocarbon (42) was probably an 
intermediate in these cyclizations because it could be formed from either 
of the alcohols (41) or (43) by dehydration under mild conditions. 
Presumably the sulphuric acid acts as an oxidizing agent in these reactions 
to remove the extra hydrogen atoms after dehydrating the alcohol and 
forming the carbonium ion. By employing the two isomeric 4-methyl and 
5-methyl homologues of ethyl cyclopentanone-2-carboxylate Ruzicka 
also synthesized the 15- and 16-methyl derivatives (45 and 46, respec­
tively) of the parent hydrocarbon; both proved to be distinctly different 
from Diels’ hydrocarbon (7) obtained from sterol dehydrogenations. In 
later work Cook and Hewett (1934) investigated the cyclization of the 
naphthylethylcyclopentene (42) with aluminium chloride and stannic 
chloride, isolating two spirans in addition to the expected product. The 
spiran rings in these two hydrocarbons were unstable to the high- 
temperature conditions during selenium dehydrogenation which arom­
atized them to chrysofluorene and 2-methylpyrene as shown in Fig. 9. 
Spiran formation was suppressed by placing a methyl group at the other
Fig. 9
Chrysofluorene
2- methylpyrene
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end of the double bond in (42). Thus in a synthesis of Diels’ hydrocarbon 
(7) (Harper et al., 1934) shown in Fig. 10, 2,5-dimethylcyclopentanone 
was treated with the Grignard reagent from 2-(l-naphthyl)ethyl bromide 
to give the tertiary carbinol (47), which on being heated with phosphorus 
pentoxide led to a good yield of the cyclized product (48). The angular 
methyl group was eliminated, but the 17-methyl group was retained on 
selenium dehydrogenation to yield Diels’ hydrocarbon (7). A year earlier 
Bergmann and Hillemann (1933) had obtained the same compound for 
the first time, from 2-acetylnaphthalene by way of a Reformatsky 
reaction with methyl bromoacetate, followed by reduction of the double 
bond, hydrolysis, ring closure, and Clemmensen reduction of the 15- 
ketone (49) (Fig. 10). Both samples melted at 125°C, like Diels’ hydro­
carbon itself, but for a time there was some confusion between this 
compound and the parent hydrocarbon (1), although the latter melted 
some 10 degrees higher. The two compounds cannot be distinguished 
readily from their elementary compositions:
Calculated for C18H16: C, 93.1; H, 6.9%
Calculated for C17H14: C, 93.5;H ,6.5%
owing to the limits of accuracy of combustion analysis (Ruzicka and 
Thomann, 1933); also mixed melting points failed to be helpful in this 
instance. In order to resolve this question, Hillemann (1935) prepared 
another sample of the hydrocarbon, this time by the method of Harper, 
and carefully compared the purified material with Diels’ hydrocarbon 
with which it proved to be identical. In particular the synthetic sample 
gave a characteristic nitroso compound, mp 238-239°C, identical with 
that given by Diels’ hydrocarbon, whereas the hydrocarbon (1) did not, 
as had been noted by Diels previously (Diels and Clar, 1934). Thus the 
structure of Diels’ hydrocarbon was settled at last.
Another synthesis of Diels’ hydrocarbon, together with its 17-ethyl and 
17-isopropyl derivatives, was described by Riegel etal. (1943) (Fig. 11).
Fig. 10
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The 3-acylphenanthrenes were converted in three steps into the propi­
onic acids which were cyclized to yield the 15-ketones (49 and 50). The 17- 
alkyl-16,17-dihydro-15//-cyclopenta[a]phenanthrenes (7, 52, and 53) 
were then obtained by reduction. The 17-ethyl hydrocarbon (52) was also 
isolated in 40% yield from selenium dehydrogenation of pregnanediol at 
300-350°C (Schontube and Janak, 1968). A similar synthesis of Diels’ 
hydrocarbon via its 15-ketone was reported by Tatta and Bardhan (1968). 
Condensation of diethyl 2-(l-naphthyl)-ethylmalonate with ethyl 
crotonate in the presence of base, followed by hydrolysis and decarbox­
ylation gave the di-acid (54). Ring closure was effected with 85% 
sulphuric acid, and the resulting ketone was reduced and aromatized by 
being heated with sulphur; the overall yield was over 70%. Cyclization of 
the acid chloride to give the 17-methyl-15-ketone (49) was accomplished 
with aluminium chloride in nitrobenzene; reduction of this ketone gave 
Diels’ hydrocarbon (7). The authors pointed out three advantages of this 
synthetic route: (i) the easy availability of starting materials; (ii) good 
yields throughout; and (iii) the avoidance of dehydrogenation in the final 
stage of the synthesis.
This first phase of cyclopenta[a]phenanthrene synthesis concluded 
with the synthesis of several methoxycyclopenta[a]phenanthrenes in 
connection with structural studies on the oestrogens, as discussed in 
Chapter 1. For the synthesis of 16,17-dihydro-3-methoxy-15//-cyclopen- 
ta[a]phenanthrene (11) (Fig. 12) the Grignard reagent, prepared from 
the chloride (55), itself secured in six steps from 2-naphthylamine, was 
added to 2-methylcyclopentanone; dehydration of the resulting alcohol 
gave the cyclopentene which was cyclized with aluminium chloride to the 
angular methyl compound (56). The angular methyl group was elimin­
Fig. 11
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ated as usual on selenium dehydrogenation to furnish the desired 3- 
methoxy hydrocarbon (11) (Cohen etal., 1935). The overall yield from 2- 
aminonaphthalene was only 0.02%, but the pure sample was identical 
with the sample prepared by selenium dehydrogenation of 17-deoxy- 
oestrone methyl ether. The 17,17-dimethyl derivative (14) was obtained 
in an analogous manner from 2,5,5-trimethylcyclopentanone, as was the 
17-methyl compound (17) from 2,5-dimethylpentanone. For the prepara­
tion of the 16- and 15- isomers (57 and 58) the bromide corresponding to 
(55) was condensed with ethyl 4-methyl- and 5-methylcyclopentanone-2- 
carboxylate, respectively, following the original synthesis shown in Fig. 
10. The 4- and 6-methoxy isomers (59), (61), and (62) were prepared by 
Kon and Ruzicka (1935) in an analogous manner from the corresponding 
methoxy-l-naphthylethyl bromides. The 3-methoxy hydrocarbon (11) 
was obtained in better yield by a different route (Chuang et al., 1939). 
Condensation of the acid chloride of the methoxynaphthylbutyric acid 
with the sodium salt of 2-acetyl-diethyl-succinate gave the diketo-diester 
(64) which on ring closure with sodium ethoxide and decarboxylation
Fig. 12
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yielded the 1,3-cyclopentanedione (65). Cyclization of the latter with 
phosphorus pentoxide then gave 3-methoxy-ll, 12,15,16-tetrahydro- 
cyclopenta[a]phenanthren-17-one (66), converted by Clemmensen 
reduction and selenium dehydrogenation to the desired 3-methoxy 
hydrocarbon (11). The 3-methoxy-17-methyl compound (17) was later 
obtained from the corresponding 17-ketone via a Grignard reaction 
(Coombs, 1966), and by dehydrogenation of a byproduct (63) isolated 
from the demethylation of oestrone methyl ether by fusion with 
pyridinium hydrochloride at 200°C (Hoffsommer etal. , 1966). The way in 
which these methoxycyclopenta[a]phenanthrenes were used to establish 
the structures of oestrone and equilenin have been discussed in Chapter 1 
(see Fig. 5).
2.2 Syntheses of the isomeric aryl methyl hydrocarbons
The next synthetic phase, in which all the possible monomethyl 
and several dimethyl derivatives of 16,17-dihydro-15//-cyclopen- 
ta[a]phenanthrene were prepared, led to the first detection of carcino­
genicity among compounds of this class. However, the first step in this 
direction was taken in connection with the structure of the cardiac
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aglycone strophanthidin. Like the sterols, this gave Diels’ hydrocarbon 
on selenium dehydrogenation, although a suggested formula for the 
aglycone should have led to its 6-methyl homologue (68) (Fig. 13). Both 
this cyclopenta[a]phenanthrene and the 6-monomethyl derivative (67) 
were synthesized by Gamble and Kon (1935) from l-(4-methyl-l-naph- 
thyl)-ethyl bromide and the requisite cyclopentanone following the 
general method of Harper (see Fig. 10) . Neither compound was identical. 
with Diels’ hydrocarbon and the suggested formula for strophanthidin 
had to be abandoned. The same two compounds together with the
6,17,17-trimethyl analogue (69) were later obtained by Butenandt and 
Suranyi (1942) from the androgen dehydroepiandrosterone (DHA, 3- 
hydroxy-androst-5-en-17-one). The 6-methyl group was introduced into 
the steroid by opening the 5,6-epoxide, prepared by oxidizing the 5(6)- 
double bond with perbenzoic acid, by means of methyl magnesium 
iodide. Introduction of the 17-methyl group was achieved by using the 
known propensity of the steroid 18-methyl group vicinal to a hydroxyl 
group to migrate to C-17 during selenium dehydrogenation. Diels’ 
hydrocarbon (7) was also synthesized by dehydrogenation of 3,17- 
dihydroxyandrost-5-ene, omitting the epoxidation step. Yet two more 
cyclopenta[a]phenanthrenes were synthesized while establishing the 
structure of the plant sapogenin, sarsasapogenin (Kon and Woolman, 
1939) (Fig. 14). To locate the hydroxyl group in this molecule the alcohol 
was oxidized to the ketone and the position of the oxygen was marked by 
converting it to the tertiary carbinol, methylsarsasapogenin, by treatment
Fig. 14
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with methyl magnesium iodide. Dehydrogenation gave a hydrocarbon 
thought to be 16,17-dihydro-3-methyl-15//-cyclopenta[a]phenanthrene 
(70), rather than the initially expected 3,17-dimethyl analogue (71). In 
order to confirm this, both these hydrocarbons were prepared as outlined 
in Fig. 14. 2-Acetyl-6-methylnaphthalene was transformed into 11- 
acetoxy-15,16-dihydro-3-methylcyclopenta[a]phenanthren-17-one (72) 
by Robinson’s method (discussed later in this chapter), and the derived 
methyl ether was treated with the methyl Grignard reagent to give 3,17- 
dimethyl-ll-methoxy-15//-cyclopenta[a]phenanthrene (73), dehydra­
tion of the intermediate tertiary carbinol having occurred readily during 
the reaction. Mild hydrogenation of this compound saturated the 16(17)- 
double bond yielding the dihydro derivative (74), while prolonged, 
vigorous catalytic reduction (Adams catalyst in acetic acid at 80-85°C for 
some days) of both the ll-acetoxy-17-ketone (72) and the 11-methoxy- 
16(17)-ene (73) removed the oxygen functions and partially reduced the 
aromatic rings. The crude reduction products were heated at 320°C with 
equal weights of 10% palladized charcoal, and the hydrocarbon fractions 
were isolated by percolation of petroleum extracts through columns of 
activated alumina. The 3-methyl hydrocarbon (70), which was obtained 
in about 20% yield, was found to be identical with the dehydrogenation 
product of methylsarsasapogenin, showing that migration of the 18- 
methyl group to C-17 does not always occur during dehydrogenation of 
steroids. The 3,17-dimethyl hydrocarbon (71) was obtained in a similar 
way from (73) by vigorous reduction followed by dehydrogenation, and 
was shown to be identical with a major product from dehydrogenation of 
3-methylcholestanol; a minor product appeared to be the 3-methyl 
hydrocarbon (70). During elucidation of the structure of the alkaloid 
cyclobuxine C25H42ON2, thought to possess the formula (75) shown in 
Fig. 14, selenium dehydrogenation yielded 15,16-dihydro-4,17-dimethyl- 
17-ethyl cyclopenta[a]phenanthrene (76) (Brown and Kupchan, 1962) 
thus confirming the nature of the carbon skeleton.
The rest of the methyl isomers and a number of dimethyl homologues 
were prepared by Butenandt and his co-workers by total synthesis over 
the next 10 years. For the synthesis of the 11-methyl and 11,12-dimethyl 
derivatives (83 and 87, respectively) use was made of a method for 
cyclopenta[a]phenanthrene synthesis elaborated by Robinson in his 
extensive work directed at the synthesis of steroids and which resulted in 
an early total synthesis of an equilenin stereoisomer. In number XXI of a 
remarkable series of papers from Oxford entitled ‘Experiments on the 
synthesis of substances related to the sterols’ published in the Journal o f 
the Chemical Society, Robinson (1938) adapted a little-known reaction
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discovered by Kehrer and Igler (1899) to the naphthalene series (Fig. 15). 
The furfurylidene derivative of 1-acetyl-naphthalene (77), obtained in 
high yield by base-catalysed condensation of 1-acetyl-naphthalene with 
furfuraldehyde, on being boiled with ethanolic hydrochloric acid yielded 
the diketoheptanoic acid (78). The mechanism of this intriguing reaction, 
in which the furan ring is opened by the formal addition of two molecules 
of water, is obscure; however, the acid is obtained reproducibly in about 
50% yield, the other product being a black insoluble tar. Intramolecular 
ring closure of the side chain brought about by hot 2% potassium 
hydroxide gave the naphthylcyclopentenone acetic acid (79) which 
was itself cyclized to yield ll-acetoxy-15,16-dihydrocyclopen- 
ta[a]phenanthren-17-one (80) by boiling it with acetic anhydride. Both 
these cyclizations occur essentially quantitatively and the whole sequence 
provides an elegant entry into the cyclopenta[a]phenanthrene series.
Butenandt et al. (1946a) modified this route by first converting the 
cyclopentenone (79) into the cyclopentane (81) by mild hydrogenation of 
the tetrasubstituted double bond (Koebner and Robinson, 1938), fol­
lowed by heating the derived semicarbazone with sodium ethoxide at 
180°C (Fig. 15). Cyclization in this acid is less facile because it is not 
favoured by the driving force provided by the creation of a new aromatic 
ring; it was achieved by treating the acid chloride of (81) with aluminium 
chloride to give the ketone (82) in about 50% yield. The 11-methyl group 
was introduced by a Grignard reaction with methyl magnesium iodide; 
dehydration and dehydrogenation with platinized charcoal at 300-310°C
Fig. 15
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then led to 16,17-dihydro-ll-methyl-15i/-cyclopenta[a]phenanthrene 
(83). Methylation at C-12 in the 11-ketone (82) was achieved in two ways; 
direct methylation with methyl iodide and potassium tert.-butoxide 
yielded a monomethyl derivative (85) of mp 85-86°C. Alternatively, 
condensation of the ketone (82) with dimethyloxalate in the presence of 
sodium methoxide, followed by pyrolysis of the glyoxalate (84) on glass 
powder at 180°C gave the 12-carboxylic ester (85); base-catalysed 
methylation of the latter with methyl iodide and decarboxylation of the 
intermediate led to a stereo-isomeric 12-methyl-ketone, mp 117-118°C, 
which could be converted into the lower-melting isomer with aqueous 
methanolic potassium hydroxide. Treatment of (86) with methyl lithium 
and dehydration-dehydrogenation of the intermediate tertiary carbinol 
finally yielded 16,17-dihydro-ll,12-dimethyl-15i7-cyclopenta[a]phenan- 
threne (87). The 12-methyl hydrocarbon was also prepared in low yield 
from the 12-methyl-11-ketone (86) by way of Clemmensen reduction, 
and proved to be identical with a specimen prepared by another route 
(see below).
This general synthetic route to cyclopenta[a]phenanthrenes was also 
employed for the synthesis of the 7-methyl isomer (Butenandt et al., 
1949a), starting from 2-acetyl-3-methyl-5,6,7,8-tetrahydronaphthalene 
(88) (Fig. 16). This was converted into the furfurylidene derivative (89) 
which underwent acid-catalysed furan ring opening to the heptanoic acid 
(90). However, on ring closure with dilute potassium hydroxide 
Butenandt reported that the cyclopentenone acetic acid (91) was 
accompanied by the furan propionic acid (95) (although in the 
experimental part of their paper, under the description of the acid (90) 
they state, ‘In manchen Ansatzen wurde ein Gemish der Dioxoheptan- 
saure und der nachstehend beschrieben Furan-propionsaure erhalten’). 
In connection with the synthesis of the 17-ketone corresponding to (94) 
Coombs and Jaitly (1971) repeated the acid treatment of the fur-
Fig. 16
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furylidene compound (89), obtaining similar amounts of the furan acid 
(95) and the required heptanoic acid (90); however, cyclization of the 
latter with dilute alkali led exclusively to (91). The reason for this 
apparent discrepancy is not known. The German preparation continued 
by vigorous catalytic reduction of (91), saturating the double bond and 
removing the ketone oxygen to yield the acid (92). Cyclization of the 
corresponding acid chloride with stannic chloride to the ketone (93) 
(70.5%), Clemmensen reduction of the latter, and dehydrogenation gave
16,17-dihydro-7-methyl-15//-cyclopenta[a]phenanthrene (94).
Another intermediate (96) discovered by Robinson during the early 
approaches to steroid synthesis was adopted by Butenandt for the 
preparation of several other cyclopenta[a]phenanthrenes (Fig. 17). This 
ketone was obtained by Hawthorne and Robinson (1936) by condensa­
tion of tetralone with acetylcyclopent-l-ene in the presence of sodium 
amide. Elimination of the ketone oxygen by heating the semicarbazone 
with sodium ethoxide and a trace of hydrazine hydrate, followed by 
dehydrogenation provided a new synthesis of 16,17-dihydro-15/7- 
cyclopenta[a]phenanthrene (1) (Butenandt etal., 1946c). Introduction of 
a methyl group at C-12 by treatment of the ketone (96) with methyl 
magnesium iodide, followed by dehydration and dehydrogenation gave 
the 12-methyl hydrocarbon (97). In a similar manner 7-methyltetralone
Fig. 17
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gave rise to the 2-methyl and 2,12-dimethyl compounds (98 and 99, 
respectively), while the 4-methyl (100) and 4,12-dimethyl (101) isomers 
were prepared from 5-methyltetralone (Butenandt et al., 19496).
Oxidation of the parent hydrocarbon (1) with chromic acid did not 
lead, as expected for a phenanthrene derivative, to the 6,7-quinone 
(Butenandt et al., 1946b). Instead oxidation occurred at the five-mem- 
bered ring to afford the 15-ketone (102) (Fig. 18) previously synthesized 
by Bachmann (1935). On the other hand, osmium tetroxide added across 
the 6,7-double bond in the hydrocarbon (1) to yield the 6,1-cis- 
dihydrodiol (103), mild oxidation of which with chromic acid in acetic 
acid solution gave the desired quinone (104). Reaction of this quinone 
with an excess of methyl magnesium iodide followed by heating the 
product with a mixture of zinc chloride and zinc dust then furnished
16,17-dihydro-6,7-dimethyl-15/7-cyclopenta[a]phenanthrene (105) in 
12.5% yield based on the quinone.
For the synthesis of the 1-methyl hydrocarbon (107) (Butenandt etal., 
1950) l-bromo-8-methylnaphthalene, obtained in several steps from 1,8- 
diaminonaphthalene (Fieser and Seligman, 1939), was treated with
Fig. 18
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phenyl lithium at — 10°C and ethylene oxide was added to yield the 
naphthylethyl alcohol (106). The scheme then followed the original 
method of Cook and Hewett (1933) shown in Fig. 8. In the final 
cyclization, addition of some acetic anhydride together with acetic and 
sulphuric acids was found markedly to improve the yield of 16,17- 
dihydro-l-methyl-15//-cyclopenta[a]phenanthrene (107). In its absence 
a second hydrocarbon, C18H20 having a naphthalene chromophore, was 
also isolated. 1-Methyl compounds are also obtainable from steroids by 
migration of the 19-methyl group to C-l by the dienonephenol rearrange­
ment (Kirk and Hartshorn, 1969). Thus l-methyl-19-norcholesta- 
1,3,5(10),6-tetraen-3-ol (108) is readily available from cholesta-1,4,6- 
trien-3-one by treatment with hot acid. Dehydrogenation of this com­
pound with selenium was accompanied, however, by loss of the 1-methyl 
group with formation of Diels’ hydrocarbon (7) (Butenandt etal., 1954). 
A dimethyl hydrocarbon thought to be 16,17-dihydro-l,17-dimethyl- 
15H-cyclopenta[a]phenanthrene was obtained earlier (Inhoffen et al., 
1949) by similar dehydrogenation of cholesta-l,4-dien-3-one or its 
rearrangement product, but was later shown to be the 4,17-isomer (110). 
Butenandt’s synthesis of the 1-methyl hydrocarbon concluded the 
acquisition of the 11 possible monomethyl hydrocarbons derived from
16,17-dihydro-15H-cyclopenta[a]phenanthrene. A number of 17-methyl 
hydrocarbons carrying in addition aryl methyl groups were later obtained 
from 17-ketones via the Grignard reaction; these are discussed in the next 
section.
Three syntheses of 16,17-dihydro-15H-cyclopenta[a]phenanthrenes 
have been described employing the Diels-Alder reaction to construct this 
ring system (Fig. 19). Sen Gupta and Bhattacharyya (1954) condensed 1- 
vinylnaphthalene with cyclopentane-l,2-dicarboxylic acid anhydride in 
boiling xylene to obtain a crystalline adduct thought to be (111). Treat­
ment with alkali or acid converted it to the naphthyl isomer (112) which 
resisted dehydrogenation with selenium. Conversion of this to its calcium 
salt followed by heating the latter with lime caused decarboxylation, and 
the crude product could then be dehydrogenated to the parent hydro­
carbon (1). In the second approach Tamayo and Martin (1952) formed 
ring-B by condensation of 4-vinylindan (113) with p-benzoquinone. The 
starting material was obtained from 4-chloroindan via the lithium deriva­
tive which reacted with ethylene oxide to yield 4-(2-hydroxyethyl)indan, 
readily dehydrated to (113). Condensation of this with p-benzoquinone 
at 100°C for 20 h gave the adduct (114) which was converted into the 
dihydroxy-tetrahydro compound (115) arid thence into 16,17-dihydro- 
l,4-dihydroxy-15H-cyclopenta[a]phenanthrene (116). In the third
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method (Blitz et al., 1940) the acetylene (117) was heated together with 
maleic anhydride at 130°C to yield the crystalline adduct (118), mp 249- 
251°C, which could be converted into the parent hydrocarbon (1) in low 
yield by dehydrogenation over palladium on charcoal at an elevated 
temperature.
Yet another way of constructing the cyclopenta[a]phenanthrene 
system by finally closing ring-C was devised by Birch and Robinson 
(1944) (Fig. 20). Condensation of the l-acetyl-3,4-dihydronaphthalenes 
(119 and 120) with lithium 2-isopropylcyclopentenone gave the diketones 
(121 and 122) which could be cyclized by sodium ethoxide to the 11-keto- 
12(13)-enes (123 and 124). Attempted methylation of (123) at the angular 
position (C-13) by addition of methyl magnesium iodide in the presence
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of cuprous bromide failed, giving instead the product of addition to the 
carbonyl group and dehydration (6,7,8,14,16,17-hexahydro-17- 
isopropyl-1 l-methyl-15//-cyclopenta[a]phenanthrene, 125). Direct 
dehydrogenation of (123) with palladium on charcoal gave the 11-phenol 
(126) whilst reduction of both (123) and (124) with sodium and ethanol 
followed by selenium dehydrogenation led to 16,17-dihydro-17- 
isopropyl-15//-cyclopenta[a]phenanthrene (53) and its 3-methoxy 
derivative (127).
2.3 Hydrocarbons containing an extra double bond in ring-D (15/Z­
and 17//-cyclopenta[a]phenanthrenes)
Although heating with either selenium or noble metal catalysts 
causes efficient dehydrogenation of the six-membered rings, a double 
bond is not introduced into the five-membered ring of the steroid or 
dihydrocyclopenta[a]phenanthrene systems by these reagents. This can, 
however, be readily accomplished starting from the ring-D ketones, the 
syntheses of which are described in Chapter 3. Thus treatment of 15,16- 
dihydrocyclopenta[a]phenanthren-15-one (102) and -17-one (4) with 
methyl magnesium iodide in boiling benzene, followed by chromatogra­
phy of the products on active alumina yielded 15-methyl-17/Z-cyclopen- 
ta[a]phenanthrene (128) and its 17-methyl-15// isomer (133), respect­
ively (Dannenberg et al., 1960) (Fig. 21). These compounds were found 
to be carcinogenic in the mouse skin-painting test, rather more active 
than the very weakly carcinogenic 7- and ll-methyl-16,17-dihydro-15//- 
derivatives previously tested, and the question arose as to whether 
carcinogenicity would be higher in molecules containing both these 
structural features (Dannenberg, 1960). This was later found to be the 
case by Coombs and Croft (1969) who investigated the series of six 17- 
methyl-16(17)-enes (133-138) prepared from the corresponding 17- 
ketones by the same method (Coombs, 1966). Dannenberg noted that the 
formation of (133) was accompanied by the appearance of a dimer 
C36H28, and suggested the structure (129) for this substance. This was 
confirmed by Coombs by a nuclear magnetic resonance study; he also 
reported that the yield of the monomer varied appreciably with the 
structure of the ketone used as substrate, as shown in Table 1. Dimeriza- 
tion apparently occurred during chromatography although neutral 
alumina was employed, for the yield of the ll-methoxy-17-methyl- 
16(17)-ene (138) was only 18% when it was obtained in this way, whereas 
it was 85% when it was isolated directly by crystallization before 
chromatography. The yield was also low for the 12-methyl (136) and 
11,12-dimethyl (137) compounds prepared by the general procedure.
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Hydrogenation of the D-ring double bond occurred readily to give the 
corresponding dihydro derivatives (7,17,139-142), but the correspond­
ing double bond in the dimer (129) was inert, as anticipated from its 
sterically hindered nature. Dannenberg also obtained the 17-methyl- 
16(17)-ene (133) when 15,16-dihydrocyclopenta[a]phenanthren-17-one
Fig. 21
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Table 1. Yields o f 17-methyl-15H- 
cyclopenta[a]phenanthrenes isolated after 
chromatography on alumina
Compound Yield (%)
unsubstituted (133) 60
3-methoxy (134) 55
12-methyl (136) 28
11-methyl (135) 74
11,12-dimethyl (137) 32
11-methoxy (138) 18
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(4) was treated with the methyl Wittig reagent. Coombs, however, 
isolated the expected 17-methylene derivative (143) without difficulty, 
but showed that it isomerized very readily to (133) in the presence of 
traces of acid.
Two isomers of the parent hydrocarbon cyclopenta[a]phenanthrene 
can exist (Fig. 22), depending upon whether the ring-D double bond is at
16,17- (i.e., 1577) (3) or at 15,16- (i.e., 17/7) (2). The theoretically 
possible third 16/7-isomer (144) is unknown, although intermediates with 
this quinoid bond structure seem to be involved in certain reactions at 
ring-D (Chapter 3). The 17/7-isomer, mp 164-165°C, was prepared by 
Badger et al. (1952) by elimination from the 15-benzoate (146) in boiling 
dimethylaniline and by Suss (1953) by decarboxylation of 17/7-cyclopen- 
ta[a]phenanthrene-17-carboxylic acid (148). In an attempt to prepare the 
then-unknown 15/7-isomer (3) Coombs (1966) reduced the 17-ketone (4) 
with sodium borohydride and converted the 17-alcohol into its p-toluene 
sulphonate (145). However, base-catalysed elimination from this ester in 
boiling collidine gave the 17/7-isomer (2) of mp 164-165°C; the structure 
of this compound was confirmed by preparing it in the same manner from 
the 15-tosylate (147). Since the 16(17)-ene (3) had presumably been 
formed initially from the 17-tosylate (145) and had subsequently under­
gone isomerization at 170dC in the reaction mixture, use was made of 
dimethylsulphoxide as solvent for this elimination (Nace, 1959). After 
30 min at 100°C in this solvent the hydrocarbon isolated in low yield by 
rapid chromatography on silica gel was different from (2); it was charac-
Fig. 22
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terized as the 16(17)-ene (3) by the similarity of its ultraviolet spectrum 
with that of 17-methyl-15/7-cyclopenta[a]phenanthrene (133). In particu­
lar it lacked the small maximum at 239 nm characteristic of the 15(16)-ene 
chromophore. It was rapidly isomerized at 180°C, and even at 100°C 
when the elimination in dimethyl sulphoxide was prolonged; it melted at 
the same temperature as its 17/7-isomer, no doubt due to the fact that it 
isomerized during heating up to 165°C. Kon (1933) had obtained an 
isomeric hydrocarbon, mp 182-183°C, by selenium dehydrogenation of 
the phosphoric acid cyclization product of the hydrocarbon (42) (Fig. 9) 
and thought it to be either 1577- or 17Z7-cyclopenta[a]phenanthrene, but 
this hydrocarbon was shown later to be chrysofluorene (Cook and 
Hewett, 1934). More recently Kotlyarevskii and Zanina (1961) isolated a 
compound of the same melting point and empirical formula from the 
products of pyrolysis of l-(l,2,3,4-tetrahydro-l-hydroxy-l-naphthyl)- 
2(l-hydroxycyclopentyl)-acetylene over a magnesia-chromia-alumina 
catalyst at 400-500°C. They claimed it to be a 1,2-cyclopen- 
tadienophenanthrene by reference to Kon’s paper, and by the fact that it 
consumed two atoms of hydrogen to yield 16,17-dihydro-1577-cyclopen- 
ta[a]phenarithrene. The structure of this compound is obscure, but it does 
not appear to be either 15/7- or 17/7-cyclopenta[a]phenanthrene. In a 
later study, Coombs and Hall (1973) treated 1577-cyclopen- 
ta[a]phenanthrene (3) with osmium tetroxide to obtain the ds-16,17-diol. 
Similar treatment of the 17/7-isomer (2), prepared by elimination from 
the 17-tosylate by boiling with collidine as described above, unexpectedly 
gave two diols, the anticipated ds-15,16-diol and in addition the cis-
16,17-diol identical with that obtained from the 7577-hydrocarbon. When 
17/7-cyclopenta[a]phenanthrene, prepared from the 15-tosylate by 
elimination by the more gentle method (in dimethyl sulphoxide at 100°C 
for 1 h), was similarly oxidized only the ds-15,16-diol was formed. It was 
therefore evident that the sample of the hydrocarbon previously thought 
to be the 1777-isomer was in fact a mixture of the 15/7- and 1777- 
hydrocarbons; the pure hydrocarbon differed from this mixture only in 
that the 239-nm band in its ultraviolet spectrum was somewhat more 
intense, and that it gave rise to only one diol. Dehydrogenation of 16, 
17-dihydro-15Z7-cyclopenta[a]phenanthrene with 2,3-dichloro-5,6- 
dicyanobenzoquinone in boiling benzene furnished a good yield of the 
mixture of 1577- and 17/7-hydrocarbons, as disclosed by the osmium 
tetroxide test. By contrast the tosylate derived from 16,17-dihydro-ll- 
methyl-1577-cyclopenta[a]phenanthren-17-ol (149) on being boiled with 
collidine, gave only the 1577-hydrocarbon (150), 11-methyl-15/7- 
cyclopenta[a]phenanthrene; it showed no ultraviolet absorption at
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239 nm and gave only one diol with osmium tetroxide. It therefore seems 
that an 11-methyl group stabilizes the 16(17)-double bond in the five- 
membered ring in this compound.
Introduction of a double bond into the five-membered D-ring of 15,16- 
dihydrocyclopenta[a]phenanthrenes cannot be accomplished directly by 
dehydrogenation by selenium or noble metal catalysts, but dehydrogena­
tion with high-potential quinones is successful in this respect. Dan­
nenberg et al. (1956) found that the ultraviolet spectra of a mixture of 
cyclopenta[a]phenanthrenes isolated from the products of dehydrogena­
tion of cholesterol with chloranil (tetrachloro-p-benzoquinone) in boiling 
xylene indicated the presence of compounds having an extra double bond 
in ring-D (Fig. 23). Under these conditions three new cyclopen- 
ta[a]phenanthrenes (151)-(153) were isolated in 32% yield. In all these 
the cholesterol side chain was retained, but the 18-methyl group had 
migrated to C-17 giving optically active products. In addition the 19- 
methyl group had been eliminated in the case of (151), but had migrated
cholesterol
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to C-l in (152) and C-4 in (153). The structures of these hydrocarbons 
were confirmed by their preparation by similar dehydrogenation of 19- 
norcholesterol (154), l-methyl-19-norcholesta-l,3,5(10),6-tetraene 
(155) (Dannenberg et al., 1964), and 4-methyl-19-norcholesta-l,3,5- 
triene (156) (Dannenberg and Neumann, 1961) in yields ranging between 
30 and 45%. The best yields and shortest reaction times were obtained 
with DDQ (2,3-dichloro-5,6-dicyanobenzoquinone) in boiling anisole. 
Quinone dehydrogenation reactions are known to involve a two-step 
ionic mechanism (Jackman, 1960). Abstraction of a hydride ion (H- ) 
from cholesta-3,5-diene (157) by the quinone is followed by loss of a 
proton (H+) or carbonium ion (C tT) with the formation of the 
hydroquinone and a double bond in the substrate (Fig. 23). Dannenberg 
(1970) proposed that this diene is first dehydrogenated to the 1,3,5-triene 
(158); addition of a proton then induces a diene-phenol type of 
rearrangement (symbolized by-0-*-) leading eventually to the 4- 
methylcyclopenta[a]phenanthrene (153). Hydride abstraction from C-7 
in this triene gives the carbonium ion (159) which undergoes another 
diene-phenol rearrangement to yield finally the 1-methyl hydrocarbon 
(152). Loss of a proton from (159) followed by hydride ion abstraction 
from C-9 in the 1,3,5,7-tetra-ene results in loss of the methyl group as a 
carbonium ion and formation of a naphthalene, finally converted to (151) 
by further dehydrogenations.
Dehydrogenation of 17/Lmethyl-zl9(11)-testosterone (160) (Fig. 24) with 
DDQ in boiling dioxan containing p-toluene sulphonic acid led to the
Fig. 24
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l,17,17-trimethyl-3-phenol (162) by way of the l,4,6,9(ll),16(17)-penta- 
ene (161) (Brown and Turner, 1971). Isolation of a 16(17)-ene from a 17- 
methyl-17-ol is unusual because dehydration is normally accompanied by 
Wagner-Meewein rearrangement of the 18-methyl group to C-17. In this 
case it was considered that relief of the usual 11/3-H, 18-methyl diaxial 
interaction of about 0.8 kcal/mol by the presence of the 9,11-double bond 
accounts for this. The final step, involving a diene-phenol rearrangement 
of the C-19 methyl group to C-l as well as rearrangement of the C-18 
methyl group to C-17, occurred simply by boiling the penta-ene (161) 
with acetic anhydride and p-toluene sulphonic acid, possibly by the 
mechanism shown, the last double bond being provided by aerial oxida­
tion. By contrast the l,4,6-trien-3-one (163) lacking the 9(ll)-double 
bond underwent the usual diene-phenol rearrangement to give the 
naphthol (164), dehydrogenation of which with DDQ yielded a mixture 
of (162) and the 15(16)-ene, 3-hydroxy-l,17,17-trimethylcyclopen- 
ta[a]phenanthrene (165), probably via the sequence shown. This com­
pound was not obtained from its 15,16-dihydro derivative (162) by 
treatment with DDQ.
Ring-D cleavage accompanied dehydrogenation of oestrone with 
chloranil in a mixture of boiling dioxan and tert. -butanol (Cross et al., 
1963) (Fig. 25). Dehydrogenation proceeded via the 9(ll)ene (166) to 
yield the dihydrophenanthrene acid ester (167); this was not formed in 
the absence of tert.-butanol. The 17,17-dicycloethylene ketal of oestrone
CHoCONH CH.CONH
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methyl ether gave a similar product in 77% yield under very mild 
conditions with an excess of DDQ in benzene at room temperature for 
5 min (Boots and Johnson, 1966). In the case of the 17/?-ol (168) cleavage 
occurred with the formation of the corresponding aldehyde (169) (Dan- 
nenberg, 1970). Quinone dehydrogenation is often accompanied by 
Diels-Alder addition to yield quinones, and sometimes by chlorination. 
Thus chloranil dehydrogenation of ergosterol gave, besides the expected 
product 17-methyl-17-(l,4,5-trimethyl-2-hexenyl)-cyclopenta[a]phenan- 
threne (170), also the product (171) of 7,15- addition of the quinone. 
Similar dehydrogenation of 3/?,17/3-dihydroxy-17a-methylandrost-5-ene 
gave 3-chloro-15,16-dihydro-17,17-dimethylcyclopenta[a]phenanthrene 
(172) (Dannenberg and Hebenbrock, 1966).
A novel route to cyclopenta[a]phenanthrenes has recently been des­
cribed by Lee-Ruff and co-workers based on the ready acid-catalysed ring 
cleavage of cyclobutanones and cyclobutanols. Thus condensation of 
cyclopentadiene with 1-naphthyl ketene, prepared in situ from 1-naph- 
thylacetyl chloride and triethylamine in boiling benzene, gave the 
cyclobutanone (173) (Fig. 26). Treatment of the latter with trifluoro- 
acetic acid then led to 11,12,13,14-tetrahydro-17i7-cyclopenta[a]phenan- 
thren-12-one (174) by way of the enol cation or cyclopropyl cation in 
about 75% yield (Lee-Ruff et al. , 1981). Reduction of the cyclobutanone 
to the cyclobutanol (175) and acid treatment gave phenyl-1-naphthyl- 
methane (60%), 13,14-dihydro-17i/-cyclopenta[a]phenanthrene (176) 
(25%), and 17J7-cyclopenta[a]phenanthrene (2) (5%) (Lee-Ruff et al., 
1982). Both the tetrahydroketone (174) and the dihydrohydrocarbon
(176) were converted into (2) by conventional means.
Fig. 26
175 176 2
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3Chemical synthesis of cyclopenta[a]- 
phenanthrenes: ring-D ketones
Early cyclopenta[a]phenanthrene syntheses were directed at the prepara­
tion of hydrocarbons and were not in the main readily adaptable to the 
synthesis of the corresponding ring-D ketones. However, parallel syn­
thetic endeavour at that time was also aimed at the synthesis of 17- 
ketosteroids such as equilenin. Thus Bardhan (1936) condensed 2-(l- 
naphthyl)ethyl bromide with dimethyl 2-ketoadipate to give the product
(177) which was cyclized with cold sulphuric acid to the 
dihydrophenanthrene (178) (Fig. 27). Formation of the five-membered 
ring by heating with acetic anhydride followed by decarboxylation at 
210°C gave 11,12,15,16-tetrahydrocyclopenta[a]phenanthren-17-one 
(179). The last step of dehydrogenation to give the corresponding 
phenanthrene was not undertaken, but the structure of (179) was 
established by converting it by way of Clemmensen reduction and 
selenium dehydrogenation into the known hydrocarbon (1). A similar 
synthesis was reported by Bachmann et al. (1943); in this the final 
cyclization of the di-acid (178) was brought about under Dieckmann 
conditions with sodium methoxide in dry benzene. Bachmann and 
Kloetzel (1937) obtained the parent 17-ketone (4), 15,16-dihydro- 
cyclopenta[a]phenanthren-17-one by cyclization of the acid chloride of 3- 
(l-phenanthyl)propionic acid (180) with aluminium chloride in 
nitrobenzene at 0°C, several other cyclization methods having failed. 
This ketone, mp 195-196°C, was isolated in very low yield, the major 
product being its isomer (181) in which cyclization had occurred in the 
opposite direction. The isomeric 15-ketone (102) (15,16-dihydro- 
cyclopenta[a]phenenathren-15-one), mp 183-184°C, was the only prod­
uct when the chloride of 3-(2-phenanthyl)propionic acid (182) was 
cyclized in nitrobenzene solution with stannic chloride at 80°C (Fig. 27). 
The structures of both these ketones were confirmed by reduction to the
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known hydrocarbon (1). Finally, the synthesis of the 15,17-diketone 
(185) was described by Fieser et al. (1936) who simply condensed 
dimethyl phenanthrene-l,2-dicarboxylate (183) with ethyl acetate in the 
presence of sodium, and hydrolysed and decarboxylated the product to 
give the pure diketone in 74% yield. 15,16-Dihydrocyclopen- 
ta[a]phenanthren-15,17-dione (185) melted at 240.5-241.5°C, and 
behaved as a typical diketone, dissolving in dilute alkali to give a red 
solution. It was recovered unchanged when the solution was immediately 
acidified, but on standing hydrolysis to a mixture of isomeric acetyl 
phenanthroic acids took place. 15,16-Dihydro-l,6-dimethoxy- 
cyclopenta[a]phenanthren-17-one (186) was also prepared in a similar 
manner (Fieser and Hershberg, 1936).
Two other syntheses of the ll,12-dihydro-17-ketone (179) have been 
described. Johnson and Petersen (1945) employed the Stobbe reaction to
Fig. 27
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add ring-D to 1,2,3,4-tetrahydrophenanthren-l-one (187) as shown in 
Fig. 28; the final ring closure was effected with anhydrous zinc chloride in 
acetic acid. This method was later used extensively by Coombs and his co­
workers for the preparation of methyl and other homologues. Bachmann 
and Holman (1951) used the same tetrahydrophenanthrene ketone (187) 
and its 3-methoxy derivative (188), but built up the three-carbon chain by 
a Reformatsky reaction with bromoacetic ester followed by Arndt- 
Eistert chain extension, and ring closure as before.
Robinson (1938) in searching for synthetic routes to 17-keto steroids 
devised the remarkable cyclopenta[a]phenanthrene synthesis already 
discussed in the previous chapter (see Fig. 29). In this reaction scheme 
closure of the six-membered ring-C in the precursors (79) and (189) 
(Robinson and Rydon, 1939) was brought about almost quantitatively by 
boiling them with acetic anhydride. The products (80) and (190),
Fig. 28
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however, contained a phenolic acetate group at C -ll, and methods for 
removing this without concomitant loss of the 17-oxygen function were 
unknown at that time. This problem was circumvented (Koebner and 
Robinson, 1938) by first reducing the 13(14)- double bond, then cyclizing 
the cyclopentanone acid (191) to give the 11,17-diketone (193). The two 
ketone groups in this compound differ markedly in reactivity, the 11- 
ketone being relatively inert owing to steric hindrance, and use was made 
of this property to eliminate the unwanted oxygen at C -ll. 
Unfortunately, neither the reduction nor the cyclization proceed 
smoothly in this case; the catalytic reduction of the tetra-substituted 
double bond over palladium on charcoal is sluggish and over-reduction 
with loss of the 17-oxygen is difficult to minimize. Ring closure proceeds 
with difficulty; most conventional methods fail, but yields of about 40% 
can be obtained under strictly controlled conditions (exposure to 
polyphosphoric acid at 125°C for 3 min) (Birch et al., 1945). The present 
authors experienced these difficulties when employing this route for the 
preparation of 17-ketones of the cyclopenta[a]phenanthrene series, but 
found that the diketone (193) was most valuable starting material for the 
synthesis of a number of compounds. Two recent developments have 
made this route potentially more attractive (Fig. 30). Cyclization of a 
closely related compound (195) to the diketone (196) was achieved in 
65% yield (75% based on the recovered starting material) by the use of
Fig. 30
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hydrogen fluoride in dry tetrahydrofuran (Posner et al., 1979). Also 
the diketone (193) has been obtained (Jung and Hudspeth, 1978) by 
a new method. The bicyclic enone (197), readily obtainable in 67% 
yield in several steps from vinyl acetate and dimethoxytetra- 
chlorocyclopentadiene, reacted with 1-naphthyl magnesium bromide 
to give a high yield of the exo-alcohol (198). Treatment of this in 
tetrahydrofuran with sodium amide caused a base-catalysed Cope 
rearrangement to the hexahydrocyclopenta[a]phenanthrene (199) in 
75% yield. This compound was readily converted by partial hydrogena­
tion, diketalization, and dehydrogenation into the diketone (193) via the 
decahydro compound (200). The C/D ring junction in this important 
diketone (193) is trans (Chinn et al., 1962), and it has been resolved into 
its optically active (+) and (—) forms making use of stereospecific 
reduction with Rhodotorula mucilaginosa (Siewinski et al., 1969). The 
diketone was first reduced to the diol with lithium aluminium hydride 
(Mejer and Kalinowska, 1969), then selectively oxidized back to the 17a- 
and 17/Miydroxy-l 1-ketones with chromium trioxide in pyridine. On 
fermentation of the 17a-hydroxy-ketone with this organism only half was 
reduced stereospecifically to the 17a, ll|3-diol, which on re-oxidation 
yielded (+) (193); re-oxidation of the residual ketoalcohol led to (—) 
(193) of opposite and equal specific rotation. The melting point of both 
these optical isomers was 138°C, 20 degrees higher than that of the 
racemic diketone ordinarily encountered.
Following Marrian’s suggestion regarding the possibility of aromatiza- 
tion of oestrone to its phenanthrene analogue already described in 
Chapter 1, a reappraisal of methods for the synthesis of 17-ketocyclopen- 
ta[a]phenanthrenes was undertaken. Robinson’s 11,17-diketone (193) 
was initially taken as a point of departure (Fig. 31) (Coombs, 1965), and it 
was found that by heating it with 2-methyl-2-ethyl-l ,3-dioxolan in the 
presence of a catalytic quantity of p-toluene sulphonic acid this diketone 
gave the oxo-ketal (201) in good yield. Prolonged heating led to the
11,17-diketal (203), but it was found that the benzylic ketal group in this 
compound was very sensitive to acid so that it could be readily converted 
back into the monoketal with a trace of hydrogen chloride in damp 
chloroform (Coombs, 1966). When this oxo-ketal (201) was reduced with 
sodium borohydride to the ll-o l and the latter was boiled with acetic acid 
containing hydrochloric acid in the presence of an excess of nitroben­
zene 15,16-dihydrocyclopenta[a]phenanthren-17-one (4) was obtained 
directly in 86% yield melting at 197°C; after recrystallization it formed 
very pale yellow needles, melting at 203-204°C. In a similar way the 3- 
methoxy-oxo-ketal (202) furnished the methyl ether of the phenanthrene
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analogue of oestrone, 15,16-dihydro-3-methoxycyclopenta[a]phen- 
anthren-17-one (24), in the same yield. In the absence of nitrobenzene 
the yield of (4) was halved and the tetrahydro derivative (205) was also 
formed. A detailed examination of the reaction led to the conclusion that 
it proceeds via the enol by abstraction of hydrogen from C-14 as shown 
in Fig. 31. Nitrobenzene had been employed previously by Koebner 
and Robinson (1941) to induce aromatization of ring-C. Thus when the
11,17-diketone (193) was treated with sodium hydroxide in the presence 
of nitrobenzene the phenol 15,16-dihydro-ll-hydroxycyclopenta[a] 
phenanthren-17-one (206) was formed directly, presumably via the enols 
by a similar mechanism. The tendency for dehydrogenation of ring-C to 
occur in suitable compounds was illustrated by these authors who found 
that the 16-benzylidene derivative of x-norequilenin methyl ether (207), 
dissolved in methanolic sodium hydroxide, on exposure to air for two 
days gave a bright yellow precipitate of 16-benzylidene-15,16-dihydro-3- 
methoxycyclopenta[a]phenanthren-17-one (208) by the formal loss of 
four hydrogen atoms from this ring.
In a similar manner (Fig. 32) treatment of the oxo-ketal (201) with 
methyl or ethyl magnesium iodide, or with n-butyl lithium (Coombs et al., 
1973), and submission of the products to acid in the presence of 
nitrobenzene led to good yields of the 11-methyl-, 11-ethyl-, and 11-n- 
butyl-derivatives (26, 211, and 212). Methylation of the oxo-ketal (201)
Fig. 31
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with methyl iodide in the presence of potassium tert. -butoxide gave a 
mixture of mono- and dimethyl derivatives (209) and (210), separated by 
column chromatography. Reduction of the 12-methyl-oxo-ketal (209) or 
treatment of it with methyl lithium followed by acid and nitrobenzene led 
to the 12-methyl- and ll,12-dimethyl-17-ketones (130 and 131), again in 
good yield. Treatment of the oxo-ketal (201) with the ylide from 
trimethylsulphonium iodide (Coombs et al., 1975) and acidification of the 
intermediate epoxide to pH 3 afforded the diol (213) which was 
acetylated and dehydrated with phosphoryl chloride in pyridine. 
Quinone dehydrogenation of the product (214) and removal of the 
protecting groups finally yielded 15,16-dihydro-ll-hydroxymethyl- 
cyclopenta[a]phenanthren-17-one (215). Condensation of the oxo-ketal 
(201) with ethyl formate in the presence of sodium ethoxide gave the 
bright yellow formyl-ketone (216) which was reduced to the diol with 
lithium aluminium hydride. When this diol was boiled with acetic acid 
containing hydrochloric acid and nitrobenzene, the 12-methyl-17-ketone 
(130) was formed together with the dimer (217).
Whilst this route was most successful for the preparations of 11- and 12- 
substituted-17-ketones, several difficulties beset its application to the
Fig. 32
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synthesis of 15,16-dihydro-7-methylcyclopenta[a]phenanthren-17-one 
(230) (Fig. 33). The furfurylidene derivative of 2-acetyl-3-methylnaph- 
thalene (218) gave not only the expected dioxoheptanoic acid (220) on 
acid hydrolysis, but the naphthylfuran propionic acid (223) was also 
formed in similar yield (Coombs and Jaitly, 1971). The analogous 
methoxy compound (219) obtained from 2-acetyl-3-methoxynaphthalene 
gave mostly the furan acid (224) with only a small quantity of the dioxo 
acid (221), whereas the unsubstituted compound (77) gave the dioxo acid 
(78) almost exclusively (Coombs and Vose, 1975). An nmr study con­
firmed the previous suggestions (Butenandt et al., 1949; Short and 
Rockwood, 1969) that a substitutent at C-3 in the naphthalene ring 
decreases conjugation between this ring system and the adjacent side 
chain by preventing co-planarity of these two systems. This in turn 
diminishes charge delocalization in the protonated intermediate (225) 
thereby promoting cyclization to the furan. The dioxo acid (220) under­
went smooth ring-closure in dilute alkali to the cyclopentenone (226) in 
which again the methyl group prevents co-planarity of the naphthalene 
and cyclopentone rings. Hydrogenation of this compound gave a mixture 
of at least six products, and was not pursued further. Cyclization of (226) 
with boiling acetic anhydride occurred normally to give ll-acetoxy-15,16- 
dihydro-7-methylcyclopenta[a]phenanthren-17-one (227) in good yield. 
After several failures it was discovered that reduction of the correspond­
ing diethylphosphate (229) with sodium in a mixture of tetrahydrofuran 
and liquid ammonia (Kenner and Williams, 1955) led to the desired 7- 
methyl-17-ketone (230), surprisingly in 47% yield. Presumably the
Fig. 33
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ketone is protected as the enol during this reduction. When this scheme 
was applied to the synthesis of the unsubstituted ketone (4), the yield in 
the reduction of the phosphate (228) was 27%; overall the yield from the 
cyclopentenone acid (79) was 18%, similar to that obtained in the longer 
synthesis from this intermediate previously described (see Figs. 29 and 
31). Desulphurization of the tosylate of 15,16-dihydro-ll-hydroxy- 
cyclopenta[a]phenanthren-17-one with Raney nickel to the correspond­
ing hydrocarbon was later reported (Kawarura et al., 1974), but this 
procedure, of course, also removes the 17-carboxyl group.
Another kind of difficulty arose when syntheses of 1,2,3,4,15,16- 
hexhydrocyclopenta[a]phenanthren-17-one (237) and its 11-methyl hom- 
ologue (238) were attempted using this general approach (Coombs and 
Bhatt, 1973) (Fig. 34). 6-Acetyl-l,2,3,4-tetrahydronaphthalene was con­
verted into its furfurylidene derivative which with hot acid yielded the 
corresponding dioxoheptanoic acid without difficulty, and ring closure of 
this to give the cyclopentenone acid (231) occurred smoothly under 
alkaline conditions. Over-reduction was difficult to avoid during the 
hydrogenation of the double bond in this compound, and a better method 
of obtaining the desired cyclopentanone acid (232) was by reduction with 
lithium in liquid ammonia. The difficulty arose in the next cyclization step 
because, lacking the strong directing influence of a naphthalene ring 
system, ring closure occurred in both directions leading to the angular 
(233) and linear (234) diketones in the ratio 1:4. Cyclization of the 
cyclopentenone acid (231) with boiling acetic anhydride gave a similar 
mixture of angular (235) and linear (236) acetoxy ketones. The angular 
diketone (233) was converted into its 17-ketal which on being either 
reduced or treated with the methyl Grignard reagent, followed by
Fig. 34
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aromatization with nitrobenzene and acid, yielded the tetrahydro-17- 
ketones (237) and (238).
The above-described synthetic scheme is not convenient for the 
preparation of certain other ring-substituted 17-oxocyclopen- 
ta[a]phenanthrenes owing to the difficulty of obtaining suitably sub­
stituted 2-acetyl naphthalenes. Attention was therefore directed towards 
the method of Johnson and Petersen (1945) utilizing the Stobbe reaction 
to build up the five-membered ring-D from suitable 1,2,3,4-tetra- 
hydrophenanthren-l-ones. This method was also used by Riegel et al. 
(1948) for the synthesis of 12-substituted derivatives (Fig. 35). These 
authors condensed 1-naphthyl magnesium chloride with ethylidene, 
propylidene, and isobutylidene malonic diester and hydrolysed and 
decarboxylated the products to furnish the 3-alkyl-4-(l-naphthyl)butyric 
acids (239-241). Cyclization of the latter (phosphorus pentachloride and 
stannic chloride) gave the required three-ring ketones (242-245) which 
were converted into the half-esters (246-248) by means of the Stobbe 
reaction with diethyl succinate in the presence of potassium tert. -butox- 
ide. Closure of the five-membered ring (zinc chloride in acetic acid) 
followed by hydrolysis and decarboxylation gave the tetrahydro ketones 
(249-251), from which the 12-alkyl-15,16-dihydrocyclopenta[a]- 
phenanthren-17-ones (130,253, and 254) were obtained on dehydrogena­
tion by heating with palladium on charcoal. Clemmensen reduction of 
these ketones gave the 12-alkyl hydrocarbons (97,255, and 256) in which 
they were interested. This sequence was also employed by Woodward et
Fig. 35
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al. (1953) to construct the 4,17-dimethyl hydrocarbon (110) from 5- 
methyl tetralone via 4-methyl-ll,12,15,16-tetrahydro-cyclopenta[a]- 
phenanthren-17-one (257).
For the synthesis of the 2-, 3-, 4-, and 6-methyl- and 6-methoxy-17- 
ketones (Coombs et al., 1970), the 2-methoxy-17-ketone (Coombs etal., 
1975), the 1-methyl, 7,11-dimethyl-, and l,ll-methano-17-ketones 
(Ribeiro etal., 1983), and l-methyl-4-hydroxy-17-ketone (Coombsetal., 
1985) the required 1,2,3,4-tetrahydrophenanthren-l-ones were prepared 
by several routes (Fig. 36). Thus reaction of Grignard reagents prepared
Fig. 36
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from the 1-bromonaphthalenes (258-260) with ethylene oxide gave the 
alcohols (261-263, X = OH), converted to the bromides (261-263, 
X = Br) with phosphorus tribromide and thence to the naphthyl butyric 
acids (264-266) by means of the malonic acid synthesis. Ring closure then 
gave the required tricyclic ketones (187, 267, and 268). In a second 
method the readily available 1-tetralones (269-273) reacted with methyl 
3-bromo-crotonate under Reformatsky conditions to form the 2,4- 
dienoic acids (274-278); isomerization to the naphthyl acids (279-283) was 
achieved with palladium black at 280-300°C, followed by saponification. 
Cyclization as before gave the ketones (187 and 284-287). 1,2,3,4- 
Tetrahydro-4-methylphenanthren-l-one (290) was obtained either from 
2-(l-naphthyl)-propionaldehyde (288) by condensation with malonic 
acid followed by decarboxylation and catalytic hydrogenation of the 
double bond and cyclization, or from methyl 2-(l-naphthyl)-propionate 
(289) by reduction to the alcohol, conversion of this into the bromide, and 
chain extension by the malonic acid route to yield the same naphthyl 
valeric acid. For the synthesis of 15,16-dihydro-l-methylcyclopen- 
ta[a]phenanthren-17-one (Ribeiro et al., 1983) the keto-ester (291) was 
converted by a Reformatsky reaction with methyl bromoacetate into the 
lactone (292), which underwent acid-catalysed hydrogenolysis to the acid 
ester (293). This was cyclized and the ketone was transformed in several 
steps into the naphthyl acetic ester (294), which was chain-extended and 
cyclized as before to yield the tricyclic ketone. In a similar manner 
Reformatsky reaction with 3-methyltetralone (296) and ethyl 2- 
bromopropionate led to the ester (297) from which 1,2,3,4-tetrahydro- 
4,10-dimethylphenanthren-l-one (298) was obtained as before. The 
tetracyclic ketone (300) was synthesized from 3-acenaphthyl acetic acid
(299) which was reduced to the alcohol, converted into the bromide with 
triphenylphosphine dibromide, and thence into the nitrile with potassium 
cyanide. Hydrolysis to the acid and cyclization gave the desired ketone
(300). 8-Methoxy-5-methyl-l ,2,3,4-tetrahydrophenanthren-l-one (301) 
was prepared from the corresponding tetralone by Reformatsky reaction 
with ethyl bromoacetate, followed by dehydration and aromatization to 
the naphthalene. The side chain was extended and cyclized as before.
These ketones were converted into 15,16-dihydrocyclopen- 
ta[a]phenanthren-17-ones by the sequence illustrated in Fig. 35. The 
Stobbe reaction proceeded in fair to good yield, except in the case of the 
dimethyl ketone (298) where the yield of half-ester was poor; presumably 
steric hindrance by the pen-7-methyl group accounts for this. Closure of 
the five-membered ring was satisfactory provided strictly anhydrous 
conditions were maintained by the use of freshly fused zinc chloride in a
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mixture of acetic acid and acetic anhydride. Dehydrogenation, the final 
step in this synthesis, was best achieved with DDQ in boiling benzene or 
(probably better) by palladium in boiling p-cymene. The former method 
fails with the 11-methyl compounds, probably because the 11-methyl 
group is axial in the 11,12-dihydro- derivative and therefore does not 
possess a pair of trans-diaxial protons required for quinone dehydrogena­
tion. Fifteen 17-ketones prepared in this way from 1,2,3,4-tetra- 
hydrophenanthren-l-ones are summarized in Table 2.
The 1-methyl-17-ketone (302) was also obtained in very low yield from 
testosterone as shown in Fig. 37. Initially A-ring aromatization of a 
suitable steroid via the dienone-phenol rearrangement appeared to
Table 2. 15,16-Dihydrocyclopenta[a]phenanthren-17-ones prepared by 
the Stobbe reaction
1,2,3,4-tetrahydro-
phenanthrene
15,16-dihydrocyclopenta[a]- 
phenanthren-17-one
unsubstituted (187) (4)
I-CH 3 (295) (302)
2 -CH3 (284) (303)
3 -CH3 (285) (304)
4 -CH3 (286) (305)
6 -CH3 (267) (306)
II-CH 3 (290) (26)
2 -OCH 3 (287) (307)
6 -OCH3 (268) (308)
7,11-(CH 3 ) 2 (298) (309)
1 ,1 1 -methano (300) (310)
I-CH 3 -4 -OCH3 (301) (311)
I 2 -CH3 (242) (130)
12-CH2 CH3 (243) (253)
12-CH(CH3 ) 2 (245) (254)
Fig. 37
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promise a convenient way of placing a methyl group at C-l in a cyclopen- 
ta[a]phenanthrene. Testosterone acetate was transformed in four steps 
by known methods (Burgess et al., 1962) into l-methyloestra-l,3,5(10)- 
trien-17-one (312). After having rejected several possible methods for 
the elimination of the 18-methyl group, the method devised by Cohen et 
al. (1971) for the removal of a 4-methyl group from a tetracyclic 
triterpene was selected, and investigated first with the readily available 
oestrone methyl ether. Abnormal Beckmann rearrangement of the 
oxime (314) in dimethylsulphoxide with dicyclohexylcarbodimide and 
trifluoroacetic acid gave the cyano-ene (315) which was epoxidized with 
m-chloroperbenzoic acid. Cyclization of the epoxide with boron 
trifluoride in boiling toluene then afforded 18-noroestrone methyl ether 
(22) in 12.5 % yield, from which both 13a and 13/3 epimers were isolated in 
the pure state (Coombs and Vose, 1974). When this reaction sequence 
was applied to the oxime of the steroid (312) its 18-nor derivative (313) 
was isolated in 14% yield, apparently as the single 13/1 epimer. 
Unfortunately, complete dehydrogenation of this compound with DDQ 
in boiling dioxan proceeded with difficulty, but a small amount of 15,16- 
dihydro-l-methylcyclopenta[a]phenanthren-17-one (302) identical with 
that prepared by total synthesis was isolated (Ribeiro et al., 1983). Of no 
use practically, this transformation again stresses the close relationship 
between steroids and cyclopenta[a]phenanthrenes.
Isotopically labelled 15,16-dihydrocyclopenta[a]phenanthren-17-ones 
required for biochemical and biological studies were prepared (Fig. 38) 
by adapting the various methods already described. A methyl group 
labelled with either carbon-14 or tritium was readily introduced at C -ll 
by means of a Grignard reaction between the oxo-ketal (201) and the 
appropriately labelled methyl magnesium iodide followed by the usual 
aromatization procedure. The five-membered ring was also labelled at C- 
15 and C-16 with carbon-14 by the use of diethyl [2,3-14C]succinate in the 
Stobbe reaction (Coombs etal., 1970). Reduction of the oxo-ketal (201) 
with tritiated sodium borohydride and removal of the easily exchange­
able tritium gave the [ ll-3H]alcohol (317) which yielded [11-3H]-15,16- 
dihydrocyclopenta[a]phenanthren-17-one without further loss of label, 
showing that as expected the 11-hydroxyl group is axial in this alcohol. 
Comparatively low to moderate specific activities were obtainable by 
these methods. For higher specific activities (in excess of 1 Curie per 
millimole) catalytic debromination of readily available 15-bromo-17- 
ketones such as (318) over palladium on calcium carbonate in tritium gas 
readily gave 15-[3H]-17-ketones at this activity. Even higher specific 
activities (5-30 Ci/mmol) were obtained by generally labelling with
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tritium by acid-catalysed exchange with [3H]acetic acid at 160°C over 
Adam’s catalyst (Coombs, 1979). All positions were similarly labelled by 
this method with the exception of the sterically hindered bay region (C-l 
and C -ll), as disclosed by tritium nuclear magnetic spectroscopy (see 
Table 3). Tritium is readily lost from C-16 in these compounds by acid- 
catalysed exchange via the enol, but is stable at other positions under 
normal conditions (Russell et al., 1985).
Badger et al. (1952) proposed an interesting route to 17-ketocyclopen- 
ta[a]phenanthrenes via ring-enlargement of the fluorenone (319) shown 
in Fig. 39. Treatment of this ketone with diazomethane in ether at room 
temperature, followed by addition of methanol and a trace of sodium 
carbonate gave the methoxyphenanthryl propionic ester in about 35% 
yield. Cyclization of the corresponding acid (320) with anhydrous hydro­
gen fluoride occurred, however, in the wrong direction to give the 
methoxy-ketone (321). In order to block this cyclization, the methoxy- 
phenanthrene (320) was chlorinated with phosphorus pentachloride to 
the o-chloro-methoxy acid which on ring closure with phosphorus pen­
tachloride and stannic chloride yielded 7-chloro-15,16-dihydro-6- 
methoxycyclopenta[a]phenanthren-17-one (322).
Fig. 38
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Another general method for the synthesis of cyclopenta[a]- 
phenanthrenes based on double acylation of naphthalenes has been 
described by Rahman and co-workers in several publications (Rahman 
and Perl, 1968; Rahman and Rodriguez, 1969, 1971; Rahman and 
Vuano, 1971). For example, ethyl 3-(2-naphthyl)propionate was 
acylated with succinic anhydride and aluminium chloride at C-6 to give 
the ketodiester (323) and was converted into the cyclopentafa]- 
phenanthrenes (324), (325), (326), and (1) by standard methods. An 
attractive feature of this route is the good yield at each step, as shown in 
Fig. 39; many adaptations of this method can be visualized. A straight­
forward preparation of 15,16-dihydro-15-phenyl-cyclopenta[a]phenan- 
thren-17-one (328) from 2-acetyl-naphthalene has also been reported 
(Shotter et a l., 1973). Conversion of the latter into the styryl ketone (327) 
in 91% yield was followed by cyclization with polyphosphoric acid at 
130°C (47% yield). Treatment of the phenanthylhydroxypropionic acid 
(329) with 97% sulphuric acid gave 17-methyl-16-phenylcyclopen- 
ta[a]phenanthren-15-one (330) (Mladenova-Orlinova e ta l., 1970).
A recent cyclopenta[a]phenanthren-17-one synthesis employs the 
Diels-Alder reaction to construct the C-ring (Corey and Estreicher, 
1981). Reaction of 3-nitro-2-cyclopentenone with the dimethoxy-diene 
(331) in boiling toluene gave the adduct which, without isolation, was 
treated with l,5-diazabicyclo-[4.3.0]non-5-ene forming 3,11-dimethoxy-
Table 3. Distribution o f  tritium in 15,16-dihydrocyclopenta[a]- 
phenanthren-17-ones generally labelled by catalytic exchange with 
[3H]acetic acid as disclosed by tritium nmr spectroscopy
Compound
Relative [3H] ------------------------------------------------------------------------------
"incorporation at: unsubstituted 11-methyl 12-methyl 11,12-dimethyl
C-15 14.2 15.3 8.4 15.1
C-16 12.3 16.6 47.0 17.9
C-2 I 06 0 7.3 7.8 7.2
C-3 r zo.y 7.3 7.9 7.1
C-4 9.7 5.7 8.4 8.0
C-6 13.1 8.3 7.4 7.7
C-7 10.4 6.4 1.9 4.0
C-12 4.1 4.5 — —
C-l 4.1 1.2 1.9 1.1
C -ll 5.2 — 0 —
11-CH3 — 27.4 — I 'X'X Q
I2-CH3 — — ‘ 9.3 r D i . y
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6,7,15,16-tetrahydrocyclopenta[a]phenanthren-17-one (332) in 51% 
yield. This approach clearly merits further attention.
(i)
Fig. 39
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4General chemistry of 
cyc!openta[a]phenanthrenes
All cyclopenta[a]phenanthrenes contain an aromatic phenanthrene ring 
system fused to a five-membered ring, and not unexpectedly chemical 
reactions due to both these structural moieties are observed. In the D- 
ring ketones the carbon-oxygen dipole induces electron withdrawal from 
the whole system, and often reactions at the five-membered ring tend to 
dominate the chemistry of these compounds.
Oxidation of the parent hydrocarbon (1) with chromic acid (Fig. 40) 
was found to give mainly the 15-ketone (102) (Hoch, 1938; Butenandt et 
al., 1946; Badger et al., 1952) together with a trace of the expected 6,7- 
quinone (104) (Badger et al., 1952). The 11-methyl hydrocarbon (83), 
conveniently prepared by hydrogenolysis of the ll-methyl-17-ketone 
(26) with Adam’s catalyst and palladium on charcoal in acetic acid 
containing hydrochloric acid, also gave the ll-methyl-15-ketone (334) in 
37% yield (Coombs, 1969). By contrast, the five-membered ring in the 
17-ketone, 15,16-dihydrocyclopenta[a]phenanthren-17-one (4), resisted 
further attack; oxidation with chromic acid in acetic acid led to a nearly 
quantitative yield of the bright yellow 6,7-quinone (335) (15,16-dihydro- 
cyclopenta[a]phenanthrene-6,7,17-trione). Similar oxidation of the 11- 
methyl-17-ketone (26) gave the corresponding ll-methyl-6,7,17-trione
(336) in 51% yield, together with unchanged starting material and small 
amounts of three other oxidation products. Butenandt et al. (1946) 
obtained the 6,7-quinone (104) from the parent hydrocarbon (1) 
indirectly by first treating it with osmium tetroxide to give the ds-6,7-diol 
(103) in good yield; this was then further oxidized to the quinone with 
chromic acid. Coombs found that the 17-ketones (4) and (26) also reacted 
smoothly with osmium tetroxide in pyridine to furnish the keto-diols
(337) and (338) which could be further oxidized with chromic acid to the 
quinones in high yield. The keto-diols were dehydrated when they were
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heated with 2.5-m sulphuric acid; the unsubstituted keto-diol (337) gave 
mainly the phenol 15,16-dihydro-6-hydroxycyclopenta[a]phenanthren- 
17-one (339) with a small amount of a second phenol, probably the 7- 
hydroxy isomer; this 6-phenol (339) was identical with the sample 
obtained from total synthesis (see Fig. 36). The 11-methyl keto-diol (338) 
was less readily dehydrated, and gave only the 6-phenol (340). Oxidation 
of the two 17-ketones with cerium (IV) ammonium nitrate in aqueous 
acetic acid at ambient temperature, conditions reported to oxidize the 
methyl group in 1-methyloestrone methyl ether to a formyl group in 90% 
yield (Laing and Sykes, 1968), led to mixtures containing the 6,7,17- 
triones and several other unidentified oxidation products in low to 
moderate yield.
Oxidation of the parent hydrocarbon (1) with lead tetraacetate gave 
the 15-acetoxy compound (333) (Badger et al., 1952). Similar oxidation of 
the two ketones (4) and (26) took a different course, leading to the 16-
OCOCH
,OCOCH;
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acetoxy derivatives, but better yields of the latter were obtained by 
similar oxidation of the enol acetates (341) and (342). These were readily 
prepared in high yield from the ketones with isopropenyl acetate, 
catalysed withp-toluene sulphonic acid. Oxidation with lead tetraacetate 
in a mixture and acetic acid and acetic anhydride with irradiation with 
visible light from a tungsten filament lamp then afforded the 17-keto-16- 
acetates (343) and (344) in excellent yield. Based on infrared evidence the 
initial oxidation products appeared to be the 16,17,17-triacetates, but 
these gave the 17-keto-16-acetates on recrystallization of the crude 
reaction products. The 17-ketone-16-ols (345) and (346) were readily 
obtained by acid hydrolysis; alkali caused decomposition.
Friedel-Crafts acylation of 16,17-dihydro-15/7-cyclopenta[a]- 
phenanthrene (1) (Dannenberg et al., 1965) in nitrobenzene with acetyl 
chloride in the presence of aluminium chloride led to substitution at C-12 
(Fig. 41). The 12-acetyl compound (347), obtained in 38% yield, was 
converted via Beckmann rearrangement of its oxime into the 12-amide 
(348) and thence into 12-amino-16,17-dihydro-15/f-cyclopenta[a]- 
phenanthrene (349). This amide (348) was synthesized independently 
from Robinson’s 12-ketone (96); the oxime (350) of this ketone was 
acetylated, then heated with acetic anhydride and acetyl chloride (Sem- 
mler-Wolff aromatization) to give the 6,7-dihydro-12-diacetylamino 
compound (351) in 60% yield. Treatment with potassium hydroxide 
followed by dehydrogenation with platinum on charcoal at 300°C 
furnished the same amide. Friedel-Crafts acylation of the naphthyl
Fig. 41
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compound (44) (ll,12,13,14,16,r7-hexahydro-15i7-cyclopenta[a]- 
phenanthrene), on the other hand, occurred at C-6 to give the 6-acetyl 
derivative (353), which was dehydrogenated and converted into the 
6-amide (354) as before. Electrophilic bromination of the 17-ketones (4) 
and (26) with bromine in chloroform or acetic acid, even in the absence of 
light or in the presence of silver nitrate and acid (Derbyshire and Waters, 
1950), conditions known to favour aryl bromination, did not lead to aryl 
substitution, but gave instead the 15-bromo (318) and (355) and 15,15- 
dibromo derivatives (356) and (357) (Fig. 42) by attack at the benzylic 
position in the five-membered ring (Coombs et al., 1973). With a large 
excess of bromine addition occurred at the 6,7-position of (4) to form the 
6,7-dihydro-6,7,15,15-tetrabromide (360), which on being heated lost 
hydrogen bromide to yield 15,16-dihydro-6(or 7),15,15-tribromo- 
cyclopenta[a]phenanthren-17-one (361) (Coombs, unpublished work). 
At no point did electrophilic bromination of the aromatic phenanthrene 
ring system occur, emphasizing the overriding effect of the carbonyl 
group at C-17 on the reactivity of the aromatic ring system. Free-radical
Fig. 42
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bromination of the ketones (4) and (26) with N-bromosuccinimide in 
carbon tetrachloride during irradiation with visible light furnished the 16- 
bromo-17-ketones (358) and (359) in high yield. Similar bromination of 
the 15-bromo-17-ketone led to 15,16-dibromo-15,16-dihydrocyclopen- 
ta[a]phenanthren-17-one (362), different from the dibromide obtained 
by direct bromination.
Dehydrobromination of 16-bromo-15,16-dihydrocyclopenta[a]- 
phenanthren-17-one (358) with triethylamine in tetrahydrofuran gave 
bright orange crystals of the fully unsaturated ketone, cyclopenta[a]- 
phenanthren-17-one (363). Debromination occurred readily, being com­
plete in a few minutes at room temperature, and could be followed 
conveniently by ultraviolet spectroscopy. The purification of this com­
pound was complicated by the ease with which it gave rise to insoluble 
material on attempted recrystallization. In this respect it resembled the 
analogous compound indenone which is known to undergo spontaneous 
polymerization (Marvel and Hinmann, 1954). 11-Methylcyclopen- 
ta[a]phenanthren-17-one (364), obtained from 16-bromo-15,16-dihydro- 
ll-methylcyclopenta[a]phenanthren-17-one (359) by the same method 
(Coombs et al., 1975), appeared to be somewhat more stable. Again by 
analogy with indenone (Lacey and Smith, 1971) acid-catalysed hydration 
of the 15(16)-double bond in the enone (363) using aqueous sulphuric 
acid in tetrahydrofuran, followed by acetylation, yielded the 15-acetoxy- 
17-ketone (365) from which the secondary alcohol (369) was obtained by 
acid hydrolysis. Hydration of the corresponding double bond in the 11- 
methyl homologue (364) proceeded more slowly, and recourse was made 
to sulphuric acid-catalysed addition of acetic acid which occurred much 
faster; the ll-methyl-15-acetoxy-17-ketone (366) was isolated directly by 
crystallization in 40% yield. As before the alcohol (370) was prepared by 
acid hydrolysis, alkali being detrimental. The 15-methoxy-17-ketones 
(367) and (368) were similarly made by acid-catalysed addition of 
methanol to the double bond (Bhatt et al., 1982).
In an effort to direct electrophilic bromination of these ketones to the 
aromatic phenanthrene rings, bromination in the presence of thallium 
triacetate (McKillop etal., 1972) was investigated (Coombs etal., 1973). 
Under these conditions (Fig. 43) with the parent, unsubstituted ketone
15,16-dihydrocyclopenta[a]phenanthren-17-one (4), the main product 
was a compound C19H140 3 devoid of bromine; this was identified as the 
15-acetoxy-17-ketone (365) already prepared as described above. It was 
not formed when either the 17-ketone (4) or its 15-bromo derivative (318) 
was treated with thallium triacetate in the absence of bromine, the best 
yield of the 15-acetate being secured when one equivalent of bromine was
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added to the original ketone and thallium triacetate in carbon 
tetrachloride at ambient temperature. A bromo derivative of thallium 
therefore appears to be involved, and it was proposed that esterification 
by it of the 17-enol to form the thallic ester (371) was followed by attack at 
C-15 by acetate, giving (318) as shown. This mechanism is similar to that 
proposed previously for the formation of 10^-trifiuoroacetoxy-19-noran- 
drosta-l,4-diene-3,17-dione (373) by the action of thallium trifluoro- 
acetate on oestrone via the phenolic thallic ester (372) (Coombs and 
Jones, 1972). The proposed intermediate (371) involves bond rearrange­
ment in the five-membered ring to a quinoid structure; this has been 
observed in other reactions involving substitution in ring-D. Thus 
attempted nucleophilic replacement of bromine in the 15-bromo-17- 
ketone (318) by acetate led smoothly not to the expected 15-acetate, but 
to the 16-acetoxy-17-ketone (343) identical with the specimen prepared 
by lead tetraacetate oxidation (Coombs et al., 1973). Also attempted 
demethylation of the 15-methoxy-17-ketone (367) with boron tribromide 
gave instead the 16-bromo-17-ketone (Coombs, unpublished work). In 
both these reactions quinoid intermediates (374) and (375), arising from 
nucleophilic attack at C-16 in the enol accompanied by bond migration, 
account reasonably for these unexpected results.
Reduction of the 16-hydroxy-17-ketones (345) and (346) with sodium 
borohydride (Fig. 44) readily furnished the 16,17-frans-diols (376) and
Fig. 43
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(377), whilst addition of osmium tetroxide to the D-ring double bond in 
15//-cyclopenta[a]phenanthrene (3) and its 11-methyl homologue (150) 
gave the 16,17-d.s-diols (378) and (379). In a similar way oxidation of 
17//-cyclopenta[a]phenanthrene (2) with osmium tetroxide led to the
15,16-ds-diol (382) (Coombs and Hall, 1973). On acid-catalysed 
dehydration all these diols gave rise to the previously unknown 16- 
ketones (380) and (381), analogous to the unconjugated ketone similarly 
formed on dehydration of indan-l,2-diol (Brooks and Young, 1956). 
These ketones are easily distinguished from their 15- and 17-isomers by 
their ultraviolet absorption spectra which are similar to those of the 
hydrocarbons, and by their infrared carbonyl stretching frequencies at 
1750 cm-1 as opposed to those of the conjugated ketones at 1690 cm-1. 
Presumably formation of 16-ketones occurs with gain in energy due to 
relief of strain in ring-D outweighing that which would have been gained 
by conjugation of the carbonyl group at either C-15 or C-17. Synthesis of 
partially hydrogenated 16-ketocyclopenta[a]phenanthrenes have been 
reported in two papers summarized in Fig. 44. Wilds (1942) brominated
Fig. 44
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1,2,3,4-tetrahydrophenanthren-l-one and condensed the 2-bromo-l- 
ketone with sodioacetoacetic ester to form the diketone (383). Treatment 
of the latter with dilute potassium hydroxide led to cyclization with the 
formation of 11,12,13,17-tetrahydro-16//-cyclopenta[a]phenanthren-16- 
one (384) in high yield. On Clemmensen reduction followed by dehydro­
genation with palladium on charcoal it was converted into the known 
hydrocarbon (1). In the second report (Turner, 1949) the same tricyclic 
ketone was transformed almost quantitatively into its furfurylidene 
derivative (385), which with hot acid yielded the diketo acid (386) by a 
reaction analogous to that reinvestigated by Robinson and described 
previously. Treatment of this diketone with dilute alkali caused ring 
closure to the 16-ketone (387) which had ultraviolet absorption very 
similar to that described by Wilds (1942) for (384).
Grignard reactions with the 17-ketone (4) (Fig. 45) yielded 17-methyl- 
and 17-isopropyl-15/7-cyclopenta[a]phenanthrenes (133) and (388) 
which on treatment with osmium tetroxide yielded the corresponding
16,17-ds-diols (389) and (400) (Dannenberg et al., 1960). Oxidation of 
the methyl-diol (389) with periodate cleaved ring-D to form the 
phenanthrene ketoaldehyde, whereas oxidation of this diol or of the 
precursor hydrocarbon (133) with chromic acid led to the corresponding 
ketoacid; 15-methyl-17i/-cyclopenta[a]phenanthrene (128) likewise 
gave the isomeric ketoacid on similar oxidation. The diol (401) resulted 
from ozonolysis of the 17-methyl-15//-hydrocarbon. Dehydration of the 
17-methyl-16,17-ds-diol (389) afforded the 17-methyl-16-ketone (402)
Fig. 45
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closely similar in properties to the parent 16-ketone (380). The 17- 
ketones also react normally in the Reformatsky reaction as first shown by 
Robinson and Slater (1941) who condensed the readily available 11- 
methoxy- and 3,ll-dimethoxy-17-ketones with ethyl bromoacetate in the 
presence of zinc to give the unsaturated esters (403) and (404) or their 
zl16(17) isomers (Fig. 46). In the course of the synthesis of cholanthrenes 
Dannenberg (1950) prepared the unsubstituted ester (405) and, by 
employing ethyl 2-bromopropionate, also the 20-methyl homologue 
(406) (Dannenberg and Dannenberg-von Dresler, 1964). The double 
bonds in these two esters were reduced by catalytic hydrogenation and 
the side chains in the products (407) and (408) were extended by means of 
the Arndt-Eistert reaction to (409) and (410) before cyclization at C-12 
and after further transformations to furnish the cholanthrenes (411) and 
(412). For the synthesis of the isomeric ring system 16,17-benzo-15/7- 
cyclopenta[a]phenanthrene [indeno(2' ,3': 1,2)phenanthrene] (416), 
derivatives of which have been isolated as minor products during
Fig. 46
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dehydrogenation of various sterols (Ruzicka and Goldberg, 1937), 
Nasipuri and Roy (1961) prepared the sodium salt of methyl 15,16- 
dihydro-17-oxo-cyclopenta[a]phenanthrene-16-carboxylate by Dieck- 
mann cyclization of the phenanthrene-1,2-diester (413). Acid hydrolysis 
of the 16-carboxylate led to 15,16-dihydrocyclopenta[a]phenanthren-17- 
one (4), mp 200-201°C, whilst condensation with the Mannich base 4- 
piperidinobutan-2-one methiodide or with l-chloropentan-3-one gave 
the diketo-esters (414) and (415), converted in several steps to the desired 
pentacyclic hydrocarbons (416) and (417). This ring system was also 
obtained (Buchta and Kraetzer, 196s) via Michael addition of ethyl vinyl 
ketone to the 16-hydroxymethylene-17-ketone (418) to form 15,16- 
dihydro-16-(3-oxopentyl)cyclopenta[a]phenanthren-17-one (419) which 
was cyclized and aromatized as before.
The 17-methylene group in cyclopenta[a]phenanthrenes, situated 
between two double bonds, is acidic. Thus the parent 11H- hydrocarbon 
(2) (Fig. 47) condensed readily with benzaldehyde and with p-dimethyl- 
aminobenzaldehyde in the presence of sodium hydroxide to yield the 
yellow 17-benzylidine compounds (420) and (421); hydrogenation of 
(420) gave the 17-benzyl derivatives (423) (Coombs, 1966). The yellow 
isopropylidene derivative (422) was similarly obtained by condensation 
with acetone in the presence of piperidine; in the presence of sodium 
hydroxide there was isolated a colourless isomer (424) in which the 
terminal double bond had rotated out of conjugation with the aromatic 
ring system, thereby presumably relieving the steric interaction between 
the side chain and hydrogen at C-12. Complete hydrogenation of this
Fig. 47
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diene readily gave 15,16-dihydro-17-isopropyl-17//-cyclopenta[a]- 
phenanthrene (53), but when hydrogenation was interrupted after 
two atom-equivalents had been absorbed, the starting material was 
recovered along with the fully reduced hydrocarbon (53) and both the 17- 
isopropyl-16(17)-ene (388) and its 15(16)-isomer (425), demonstrating 
that isomerization of the double bond in the five-membered ring from C- 
16(17) to C-15(16) had occurred in the course of the reduction. Partial 
reduction of the aromatic system in 17-ketocyclopenta[a]phenanthrenes 
cannot be conveniently accomplished by direct catalytic hydrogenation 
because the benzylic carbonyl group is eliminated comparatively readily 
(Robinson and Rydon, 1939). For example, reduction of the easily 
accessible 3,ll-dimethoxy-17-ketone (426) in acetic acid over Adam’s 
catalyst at 70°C gave 11,12,13,14,16,17-hexahydro-15//-ll-hydroxy-3- 
methoxy-cyclopenta[a]phenanthrene (427) among other products. In 
order to preserve the 17-carbonyl function, present in oestrogens and 
many C19 steroids, Robinson first opened the five-membered D-ring prior 
to hydrogenation as depicted in Fig. 48. The 16-hydroxymethylene 
derivative (429) was obtained by condensation of the dimethoxy-17- 
ketone with ethyl formate in pyridine, catalysed by sodium ethoxide; 
other methods gave more or less of the dimer (428). Conversion to the 
nitrile (430) was brought about with hydroxylamine in acetic acid, and 
without purification it was hydrolysed to the di-acid (431) with hot 
aqueous alcoholic potassium hydroxide. This di-acid was esterified and 
reduced catalytically as before; three partially hydrogenated products 
(432-434) were isolated from the reduction-product mixture. Re-forma- 
tion of the D-ring was achieved by heating the lead salts of these di­
acids in vacuo. In this way di-acid (432) gave 3,ll-dimethoxy-6,7,
15,16-tetrahydrocyclopenta[a]phenanthren-17-one (332) whilst 18- 
noroestrone methyl ether, 6,7,8,9,ll,12,13,14,15,16-decahydro-3- 
methoxycyclopenta[a]phenanthren-17-one (22) of unknown stereo­
chemistry was obtained from the di-acid (434); the isomeric di-acid (433) 
resisted cyclization by this method. Two years later Robinson and 
Slater (1941) approached this problem from a different angle. Starting 
with the readily available 12-ketones (96) and (437), reduction by the 
Pondorff procedure gave the corresponding alcohols (438) and (439), 
dehydration of which with potassium hydrogen sulphate yielded the 
required 9(ll),12(13)-dienes (440) and (441) together with the products 
of their further dehydrogenation, the 6,7,16,17-tetrahydro-15//- 
cyclopenta[a]phenanthrenes (442) and (443). The latter were the only 
products obtained when oxidation of the dienes to the corresponding 17- 
ketones with selenium dioxide was attempted. More recently Jacob et al.
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(1971) found that reduction of the 12-ketone (96) with lithium aluminium 
hydride gave, in addition to the diene (440) and triene (442) reported by 
Robinson, also the isomeric ll,12,13,14,16,17-hexahydro-15//-hydro- 
carbon (44) as well as the alcohol containing only one aromatic A-ring 
(444). Robinson and Slater also found that the Reformatsky product 
(405) already described, on vigorous reduction (with Raney nickel at 
200-220°C under 65 atm. pressure) was hydrogenated to the 18- 
noroestrogen derivative (445) with elimination of the 11-methoxy group.
In a recent study (Elvidge et al., 1985) the relative rates of proton 
exchange at C-16 in a series of 17-ketocyclopenta[a]phenanthrenes were 
measured. These compounds were labelled at C-16 specifically by acid-
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catalysed or hydroxide-catalysed exchange with tritiated water, and the 
position of the label in the product was checked by tritium nmr (<5 2.70- 
2.86 in deuterated chloroform). Hydroxide-catalysed detritiation in 9:1 
(v/v) water-dioxane was followed by measuring the radioactivity remain­
ing in aliquots of the substrate at fixed time intervals; the results are 
shown in Table 4. The rate constants for the unsubstituted 17-ketone (4) 
and its 1-methyl homologue (302) were essentially the same, but as 
expected methyl groups elsewhere in the molecule decreased this rate, 
the effect being greater the nearer the methyl group was to C-16. The rate 
for the 12-methyl isomer (130) was the lowest for the monomethyl 
compounds and was decreased further by introduction of a second methyl 
group at C -ll (131). The 7-methyl-17-ketone (230) was, however, 
anomalous because the rate was markedly increased, and this was true 
also of the other two 7-methyl derivatives (309) and (447). The 7-methyl 
group also had an effect on H-15 because in its nmr spectrum these 
protons were deshielded 0.42-0.46 ppm compared with the other isomers 
(see Table 4). These effects of 7-methyl substitution can be attributed to 
the strain it introduces into these molecules. This was indicated by the 
unexpected difficulties encountered in the synthesis of both the 7-methyl- 
and 7,11-dimethyl-17-ketones, and is fully confirmed by the results of X- 
ray crystallography discussed in Chapter 8.
Table 4. Hydroxide-catalysed second order rate constants (&oh‘) at 
298.2°K  for detritiation o f various [16-3H]-15,16-dihydrocyclopenta[a]- 
phenanthren-17-ones, and their nmr H-15 resonance signals (b) 
measured in ppm from tetramethylsilane
Compound KP&oh- mol-1 s-1 H-15 (6)
unsubstituted-17-ketone (4) 1.83±0.14 3.28
l-methyl-17-ketone (302) 1.85±0.05 3.25
3-methyl-17-ketone (304) 1.42±0.02 3.25
4-methyl-17-ketone (305) 1.47±0.19 3.26
6-methyl-17-ketone (306) 1.15±0.14 3.27
7-methyl-17-ketone (230) 3.17±0.08 3.70
ll-methyl-17-ketone (26) 1.47±0.06 3.24
12-methyl-17-ketone (130) 0.67±0.07 3.28
ll,12-dimethyl-17-ketone (131) 0.30±0.05 3.22
7,ll-dimethyl-17-ketone (309) 2.45±0.19 3.63
ll-hydroxy-17-ketone (206) 0.23±0.02 —
ll-methoxy-17-ketone (132) 2.06±0.06 3.22
7-methyl-ll-methoxy-17-ketone (447) 2.50±0.17 3.58
ll-ethyl-17-ketone (211) 1.58±0.03 —
l,ll-methano-17-ketone (310) 0.87±0.07 3.25
74 General chemistry
4.1 References
Badger, G .M ., Carruthers, W. & Cook, C. W. (1952). New derivatives of 
1,2-cyclopentenophenanthrene. J. Chem. Soc., 4996-5000.
Bhatt, T. S., Hadfield, S.T. & Coombs, M. M. (1982). Carcinogenicity and 
mutagenicity of some alkoxy cyclopenta[a]phenanthren-17-ones: effect of 
obstructing the bay region. Carcinogenesis, 3, 677-80.
Brooks, C. W. J. & Young, L. (1956). Biochemical studies of toxic agents. 9. 
The metabolic conversion of indene into cis- and trans- indane-l:2-diol. 
Biochem. J., 63, 264-9.
Buchta, E. & Kraetzer, H. (1962). Polycyclic compounds. X. 5-methyl- 
naphtho[2',r:l,2]fluorene. Ber., 95, 1820-5.
Butenandt, A ., Dannenberg, H. & von Dresler, D. (1946). Methylhomolage 
des 1,2-cyclopentenophenanthrens, III. Mitteilung: synthese des 9,10- 
dimethyl-l,2-cyclopentenophenanthrens. Z. Naturforsch., 1, 222-6.
Coombs, M. M. (1966). Potentially carcinogenic cyclopenta[a]phenanthrenes. 
Part II. Derivatives containing further unsaturation in ring-D. J. Chem.
Soc. (C), 963-8.
Coombs, M. M. (1969). Potentially carcinogenic cyclopenta[a]phenanthrenes. 
Part III. Oxidation studies. J. Chem. Soc. (C), 2484-8.
Coombs, M. M. & Hall, M. (1973). Potentially carcinogenic 
cyclopenta[a]phenanthrenes. Part VII. Ring-D diols and related 
compounds. J. Chem. Soc. Perkin Trans. I, 1255-8.
Coombs, M. M., Hall, M ., Siddle, V. A. & Vose, C. W. (1975). Potentially 
carcinogenic cyclopenta[a]phenanthrenes. Part X. Oxygenated derivatives 
of the carcinogen 15,16-dihydro-ll-methylcyclopenta[a]thren-17-one of 
metabolic interest. J. Chem. Soc. Perkin Trans. I, 265-70.
Coombs, M .M ., Hall, M. & Vose, C. W. (1973). Potentially carcinogenic 
cyclopenta[a]phenanthrenes. Part VIII. Bromination of 17-ketones. J.
Chem. Soc. Perkin Trans. I, 2236-40.
Coombs, M. M. & Jones, M. B. (1972). Oxidation of oestrone with thallium 
trifluoroacetate. Chem. Ind. (London), 169.
Dannenberg. H. (1950). Attempts to synthesise ‘Steranthrene’. I. 5-propyl-3- 
methylcholanthrene. Annalen, 568, 100-16.
Dannenberg, H. & Dannenberg-von Dresler, D. (1964). Relation between 
steroids and carcinogenic compounds. IV. Cholanthrene-5-acetic and 5- 
propionic acids, their synthesis and carcinogenic action. Z. Naturforsch., 
19B, 801-6.
Dannenberg, H ., Dannenberg-von Dresler, D. & Neumann, H.-G. (1960). 
Dehydrierung von Steroiden. III. l:2-cyclopentenphenanthrene. Annalen, 
636, 74-87.
Dannenberg, H ., Sonnenbichler, J. & Gross, H. J. (1965). 3-Amino and 9- 
acetamido-l,2-cyclopentenophenanthrene. Annalen, 684, 200-9.
Derbyshire, D. H. & Waters, W. A. (1950). The significance of the bromine 
cation in aromatic substitution. Part II. Preparative applicability. J. Chem. 
Soc., 575-7.
Elvidge, J. A ., Jones, J. R ., Russell, J. C., Wiseman, A. & Coombs, M.M. 
(1985). A  kinetic investigation of the hydroxide-catalysed detritiation of 
various [16-3H]-15,16-dihydrocyclopenta[a]phenanthren-17-ones and related 
compounds. J. Chem. Soc. Perkin Trans. II, 563-5.
Hoch, J. (1938). Substances with female hormone effect. The synthesis of 
two oxo-1,2-cyclopentenophenanthrenes. C. R. Hebd. Seances Acad. Sci., 
207, 921-3.
Jacob, G ., Cagniant, D. & Cagniant, P. (1971). Recherches dans le domaine
References 75
du dihydro-16,17-15H-cyclopenta[a]phenanthrene. C. R. Hebd. Seances 
Acad. Sci., Ser. C, 272, 650-2.
Lacey, P. H. & Smith, D. C. C. (1971). A convenient preparation of 
indenone. J. Chem. Soc. (C), 41-3.
Laing, S. B. & Sykes, P. J. (1968). Synthetic steroids. Part IX. A new route 
to 19-nor-steroids. J. Chem. Soc., 2915-18.
Marvel, C. S. & Hinmann, C. W. (1954). The synthesis of indone and some 
related compounds. J. Am. Chem. Soc., 76, 5435-7.
McKillop, A ., Bromley, D. & Taylor, E. C. (1972). Thallium in organic 
synthesis. XXV. Electrophilic aromatic bromination using bromine and 
thallium (III) acetate. J. Org. Chem., 37, 88-92.
Nasipuri, D. & Roy,.D.N . (1961). Polycyclic systems. Part IX. A new 
synthesis of indeno (2',3':l,2)phenanthrene. J. Chem. Soc., 3361-6.
Robinson, R. & Rydon, H. N. (1939). Experiments on the synthesis of 
substances related to the sterols. Part XXVII. The synthesis of x- 
noroestrone. J. Chem. Soc., 1394-1405.
Robinson, R. & Slater, S.N. (1941). Experiments on the synthesis of 
substances related to the sterols. Part XXIX. J. Chem. Soc., 376-85.
Ruzicka, L. & Goldberg, M. W. (1937). Polyterpene und polyterpenoide 
CXVII. Zur kenntnis der bedingungen und des mechanisms des 
dehydrierung der homologen sterine und des cholsaur. Helv. Chim. Acta, 
20, 1245-53.
Turner, D .L . (1949). Some aryl-substituted cyclopentenones; a new synthesis 
of the cyclopentenophenanthrene structure. J. Am. Chem. Soc., 71,
612-15.
Wilds, A. C. (1942). The synthesis of 2'-ketodihydro-l,2- 
cyclopentenophenanthrene and derivatives of phenanthro[l,2-b]furan. J. 
Am . Chem. Soc., 64, 1421-9.
5Physical and spectral properties of 
cyclopenta[a]phenanthrenes
Some 350 individual cyclopenta[a]phenanthrenes have so far been 
reported in the chemical literature, and at least some physical character­
istics of the majority of these have been described. In the earlier papers 
often only the melting point of the compound and possibly those of 
certain readily prepared derivatives were given. In somewhat later 
reports it is usual also to find ultraviolet absorption data, while in papers 
published during the last 25 years infrared, nuclear magnetic resonance, 
and mass spectra are frequently encountered. In this chapter melting 
points and spectroscopic data are summarized for the great majority of 
these cyclopenta[a]phenanthrenes, and this is followed by a separate 
section on the mass spectrometry of a few of these compounds. Con­
sideration of structural data derived from X-ray crystallographic studies 
appears in a separate chapter.
5.1 Melting points and spectral data
In the compilation which follows cyclopenta[a]phenanthrenes 
have been listed by molecular formula according to the convention 
adopted by Chemical Abstracts. The molecular formula is followed by 
the serial (arabic) number, when one has been assigned to it in the text, 
tables and figures, and by the complete chemical name. The Chemical 
Abstracts Registry Number [enclosed in square brackets] is also quoted 
when this is available. The compilation ends with a reverse index, relating 
serial number to molecular formula to assist location of individual 
compounds referred to elsewhere in the book. Melting points are quoted 
in degrees Centigrade, and ultraviolet spectra as Amax (log10£) where e is the 
molecular absorption coefficient, usually measured in ethanolic solution. 
Infrared absorption wavelengths (/un), especially of the strong aromatic 
bands in the 11-14/un region, are tabulated to provide an additional
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means of identification; measurements are for Nujol mulls unless 
otherwise specified. Nuclear magnetic (proton) resonance chemical shifts 
(6) measured in parts per million (ppm) relative to tetramethylsilane in 
deuterated chloroform are also quoted where available.
The ultraviolet absorption spectra of 16,17-dihydro-15//-cyclopen- 
ta[a]phenanthrene hydrocarbons were discussed by Dannenberg and 
Steidle (1954) who pointed out that these compounds, like simple 
phenanthrenes, possess four groups of absorption bands, shown in Fig. 49 
for Diels’ hydrocarbon. The most intensive band with a maximum around 
260 nm (log10e 4.7-4.8) was designated the/3-group, that with the shortest 
wavelength around 220 nm (log10e4.5) the /T-group, the three maxima 
between 280 and 310 nm (log10e 4.0-4.2) the p-group, and the three weak 
maxima between 320 and 360nm (log10e2.5-3.2) the a-group in 
accordance with the notation originated by Clar (1952). As expected 
addition of one or even two methyl groups to the five-membered ring has 
little effect on the chromophore, whereas substitution of one methyl 
group in the phenanthrene ring system causes a bathochromic shift of the 
/3-band of up to 7nm, depending upon the position of substitution. 
Substitution of a second methyl group causes a further shift in the same 
direction of 4-11 nm, from the parent hydrocarbon. By contrast the p- 
and a-band groups do not undergo this red shift to the same extent.
Fig. 49. Ultraviolet spectra recorded in ethanol of Diels’ hydrocarbon (7 )  
showing the /?', p and a bands, and of 15,16-dihydrocyclopenta[a]phenan- 
thren-17-one (4 )  and its borohydride reduction product, the 17-ol.
DIELS HYDROCARBON 17-ol
(xlO)
o< (x10)
250250 300 350 300 350
Wavelength (nm)
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Conjugation of a double bond at C-15 or C-17 in the five-membered ring 
also causes a bathochromic shift of the /3-band (10.0-14.5 nm); the 1777- 
hydrocarbons are readily distinguished by the presence of an additional 
absorption band at 239 nm absent in their 1577-isomers (Coombs, 1966b). 
Conjugation of an exocyclic carbon-carbon double bond at C-17 results 
in a similar shift of the /3-band, but conjugation of a carbonyl oxygen at 
this position has less effect. Thus 15,16-dihydrocyclopentaja]- 
phenanthren-17-one (4) absorbs at 265 nm; however, the a-bands are 
shifted 10-15 nm in the same direction (compared with the 16,17-dihydro 
hydrocarbon) whereas the p-bands are not and one of these 
(2max ~280 nm) is lost (see Fig. 49). Aryl methyl substitution is 
accompanied by the usual red shift in these 17-ketones. Surprisingly, 
conjugation of a carbonyl group at C-15 to give the isomeric ketone (102) 
causes a blue shift of the /3-band to 251.5 nm, and introduction of a 
C-15(16) double bond into the 17-ketone to yield cyclopen- 
ta[a]phenanthren-17-one (363) is also accompanied by a similar blue shift 
to 253 nm. In this compound the three maxima constituting the p-group 
are not greatly displaced, but the three weak a maxima are replaced by 
one broad maximum at 380-390 nm which imparts a yellow colour to this 
ketone and its 11-methyl homologue (364). The ultraviolet spectra of all 
these ketones become very similar to those of the corresponding hydro­
carbons after mild reduction in situ with sodium borohydride to the 
secondary alcohol as shown in Fig. 49. The spectra of the various 
tetrahydro, hexahydro, etc., hydrocarbons are generally similar to those 
of the analogous phenanthrene derivatives.
Little needs to be said about the infrared and nmr spectra of these 
compounds. In the former the conjugated carbonyl group in the 15- and 
17-ketones absorbs at about 5.92/un as expected and slightly lower in the
Table 5. Wavelength ranges associated with different aryl 
substitution patterns in 16,17-dihydro-15H- 
cyclopentafajphenanthrenes in carbon disulphide solution
Ring substitution pattern Wavelength range (um)
1,2 13.26-13.44
1,2,3 12.67-12.77
13.27-13.29
1,2,4 12.03-12.05
1,2,3,4 12.20-12.35
1,2,3,4,5 11.42-11.62
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D-ring bromo ketones, but at 5.71 pm  in the unconjugated 16-ketone 
(380). The strong out-of-plane deformation bands in the 11.0-14.0//m 
region are characteristic of each structure and give information regarding 
the substitution patterns. Dannenberg et al. (1953) discussed these 
absorption bands in the spectra of 16 variously substituted mono- and di­
methyl derivatives of 16,17-dihydro-15if-cyclopenta[a]phenanthrene 
measured in both the solid state (potassium bromide discs) and in 
solution in carbon disulphide. With few exceptions bands occurred within 
the wavelength ranges shown in Table 5 for the various ring-substitution 
patterns for spectra obtained in solution.
In the nmr spectra of the 15,16-dihydro-17-ketones the aromatic 
protons resonate between 6 7.3 and 7.8, but the bay-region protons at C-l 
and C -ll are deshielded by about lppm . The C-15 methylene group 
resonates as a multiplet at 6 3.24-3.28 for the unsubstituted 17-ketone (4) 
and all its isomeric arylmethyl derivatives with the exception of the 7- 
methyl compound (6 3.70), disclosing steric compression in this region of 
the molecule confirmed by X-ray crystallographic studies (Chapter 8).
5.2 Mass spectrometry of cyclopenta[a]phenanthrenes
The use of mass spectrometry for the determination of molecular 
weights of organic compounds including cyclopenta[a]phenanthrenes is 
commonplace, and it has recently led to the identification of several 
hydrocarbons of this series from a number of natural sources. Generally 
no difficulty is experienced with relatively simple aromatic compounds 
because often the molecular ion is also the most abundant ion in the 
spectrum. The technique is particularly valuable for the study of 
metabolites, usually obtainable only in very limited quantities. However, 
/raws-l ,2-dihydrodiols which commonly occur as metabolites derived 
from aromatic compounds often give problems because they undergo 
facile dehydration, so that the M+-18 ion is abundant and the molecular 
ion is weak or non-existent.
As a preliminary to employing mass spectrometric fragmentation 
patterns to assist in the elucidation of the structures of unknown 
metabolites of the carcinogen 15,16-dihydro-ll-methylcyclopen- 
ta[a]phenanthren-17-one (26) and related compounds, the mass spec­
trometry of several assorted synthetic compounds shown in Fig. 50 was 
studied in detail (Vose and Coombs, 1977). Table 6 shows the ions of 
abundance greater than 2% of the base peak produced from these 
compounds under comparable conditions (AEI MS-902 mass spec­
trometer with an ionizing potential of 70 eV; samples inserted directly 
into the source). The first four compounds, the parent 17-ketone (4), its
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11-methyl (26) and 11-hydroxymethyl (215) derivatives, and the 6-phenol 
(339) have the molecular ion as the base peak, behaviour characteristic of 
aromatic compounds. All show M+-28 ions arising from loss of the 
carbonyl group, and other ions which follow from the general degradative 
pathways proposed in Fig. 51. This is similar to the scheme reported by
Fig. 50. Synthetic cyclopenta[a]phenanthrenes studied by mass spectrometry 
(Vose and Coombs, 1977).
HOCH
OCOCH,II yococH,
OCOCH,
446
Fig. 51. Proposed origin of ions formed by fragmentation of ring-D in 15,16- 
dihydrocyclopenta[a]phenanthren-17-ones, and the loss of ketene involving a 
concerted six-membered hydrogen shift.
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Bowie (1966) for the related ketone indan-l-one. The 11-methyl and 11- 
hydroxymethyl ketones yield in addition weak ions at M+-15 and M+-31, 
respectively, indicating the loss of these substitutents from the molecular 
ion. By contrast the molecular ion is of low abundance with the other four 
cyclopenta[a]phenanthrenes. The M+-60 ion arising from the loss of 
acetic acid from the molecular ion is the base peak in the spectrum of the
16-acetoxy-17-ketone (343), with a less-abundant ion at M+-88 due to 
further loss of CO; the reverse is true for the isomeric 15-acetoxy-17- 
ketone (365). The ion at M+-42 in the spectrum of the latter is absent in 
that of its 16-isomer and a metastable ion (m* at 212.2) confirms that this 
ion arises by one-step loss of ketene from the molecular ion, probably by 
loss of the 17-carbonyl and 16-methylene groups. The ion at M+-42 
constitutes the base peak in the spectrum of the enol acetate (341); again 
it is shown to arise by one-step loss of ketene from the molecular ion by 
the presence of a metastable ion m* 196.5. This may occur via a concerted 
six-membered shift as shown in Fig. 51, leading to the molecular ion of 
the 17-ketone which then undergoes further fragmentation as already 
described. The enol acetate (341) is homologous with the M+-60 ion in 
the spectrum of the diacetate (446), and in this compound the base peak 
arises by loss of 42 mass units from the molecular ion, so that this 
rearrangement is probably general for compounds and ions of this series 
possessing or capable of forming an enol acetate structure.
The use of mass spectrometry in the identification of various 
metabolites is described in the chapter on the metabolism of cyclopen- 
ta[a]phenanthrenes. However, a rather unusual use of this technique is 
described here because it illustrates the power of this method to help 
solve otherwise intractable problems. After metabolic activation the 
carcinogen (26) binds covalently to DNA if it is added to the incubation 
mixture. As will be described later, reaction occurs mainly (~80%) with 
the guanine moieties to the extent of about one base in 104 bases in the 
DNA. From separate considerations it was thought that this reaction 
occurred between the exocyclic amino group in the deoxyguanine bases 
and a 3,4-dihydrodihydroxy-l,2-epoxide derived from the carcinogen to 
yield an adduct of the type shown as the ion of m/z447 in Fig. 52. When 
DNA treated in this way was submitted to pyrolysis electron-impact mass 
spectrometry without further derivatization (Wiebers et al., 1981), in 
addition to the usual ion products derived from the four common DNA 
component bases (adenosine, guanine, cytosine, and thymine) other 
peaks of low abundance (about one-hundredth of the peak heights of the 
normal components) were seen. It was readily possible, in view of the 
previous studies, to fit these into the postulated fragmentation scheme
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shown in which the numbers represent the masses of the ions observed. 
The structures proposed for the molecular ion and two fragment ions are 
also displayed in this figure. The most abundant ion m/z 368 was selected 
for further scrutiny by mass-analysed ion kinetic-energy spectrometry 
(MIKES), a technique which allows the further fragmentation of a single 
ion to be followed in detail. Ideally the molecular ion would be selected 
for this purpose, but in this case it was of extremely low abundance and it 
was felt that fragmentations leading to the relatively stable m/z 368 ion 
were reasonably well understood. Major daughter ions in the MIKE 
spectrum of this ion are shown in Table 7 and fully substantiate the 
structures proposed. In particular the ion at m/z 218 demonstrates loss of 
guanine (150 mass units), whilst the ion at m/z 233 (loss of 135 mass units) 
indicates that the entity of mass 218 derived from the carcinogen is 
attached to the NH of the exocyclic N2-amino group of this purine. This 
confirmation of the supposed structure of the major DNA adduct is
Fig. 52. Proposed molecular ion (m/z 447) formed from the DNA adduct,
and fragmentation pathways leading to the ions m/z 368 and 365.
m/z -  LL1 m /z-  368 m/z = 365
M+U 7
-HNC0
4.11 4 U  376 389
- c h 3 //  y c o  J - c o  J - h 2o  J - h 2o
396 383 386 358 371
- h20J
4.11 -CH3 /  365
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|  ~ H2 °  
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Table 7. Ions in the M IKE spectrum o f the major DNA adduct ion o f 
m/z 368
Daughter ion
Relative
intensity
Loss of parent 
ion m/z  368 
(C21H 14N50 2)
Composition of 
daughter ion
354 100.0 14(CH2) c 20h 12n 5o 2
351 77.0 17(OH) c 21h 13n 5o
340 52.3 28(C2H4) Ci9Hi0N5O2
325 38.3 43 (H NCO) c 20h 13n 4o
316 21.7 52(C4H4) ^17^10^5^2
289 31.8 77(C6H5) c 15h 9n 5o 2
267 25.0 101(C8H5) c 13h 9n 5o 2
254 32.0 114(C9H6) c 12h 8n 5o 2
233 31.8 135(C5H3N40 ) C16HnNO
218 57.0 150(C5H4N5O) c 16h 10o
206 41.0 162(C5H 10N5O) c 15h 10o
193 33.6 175(C7H5NsO) c 14h 9o
164 28.0 204(C8H6N5O2) c 13h 8
151 37.0 217(C9H7N50 2) c 12h 7
127 27.5 241(ChH7N50 2) c 10h 7
important because, owing to the extremely minute amount available, it is 
doubtful whether the information could have been obtained in any other 
way.
It has been known for a long time that during selenium dehydrogena­
tion of steroids at elevated temperatures the long sterol side chain at C-17 
is lost, although it is retained on quinone dehydrogenation at substan­
tially lower temperatures. It is therefore interesting to observe that in the 
mass spectra of cyclopenta[a]phenanthrenes bearing a sterol side chain 
the molecular ion is of very low abundance; the base peak is the ion 
formed by loss of this side chain (Ludwig et al., 1981).
5.3 Compilation of physical and spectroscopic data for most of the 
cyclopenta[a]phenanthrenes reported in the chemical literature 
up to 1985
C 17H 10B r 2 O
(356) 15,15-Dibromo-15,16-dihydrocyclopenta[a]phenanthren-17-one 
[50905-49-2] [74495-83-3]
MW 390; mp 213-213.5°C
2max 279 (4.70), 298 (4.24), 314.5 (4.18), 360 (3.30), 377 (3.27) nm 
vmax 5.85, 12.45, 14.0/an
6 4.69s (H-16) (Coombs et al., 1973a)
Ci7H10Br2O
(362) 15,16-Dibromo-15,16-dihydrocyclopenta[a]phenanthren-17-one 
[50905-50-5]
86 Physical and spectral properties  
MW 390; mp 179-180°C
Amax 283 (4.60), 311.5 (4.33), 361 (3.19), 380 (3.18) nm 
vmax 5.85, 12.04, 13.10//m
<5 5.05 (H-15), 6.10 (H-16) (Coombs et al., 1973a)
C17H10O (363) Cyclopenta[a]phenanthren-17-one [50905-54-9]
MW 230; Orange prisms, mp 202-208°C 
Amax 253, 286, 298, 310, 382 nm
vmax 5.85, 12.25, 12.80, 13.26/im (Coombs and Hall, 1973)
^17^10^2
(185) Cyclopenta[a]phenanthren-15,17-dione
MW 246; mp 240.5-241.5°C (Fieser et al., 1936)
Q 7H10O3
(335) 6,7,15,16-Tetrahydrocyclopenta[a]phenanthrene-6,7,17-trione 
MW 262; mp 245-247°C 
Amax 271-279 (4.03), 331 (3.31), 406 (3.21) nm 
vmax 5.84, 5.97, 6.30, 10.45, 11.63, 11.90, 12.90/im (Coombs, 1969) 
C17HnBrO
(318) 15-Bromo-15,16-dihydrocyclopenta[a]phenanthren-17-one 
[50905-48-1]
MW 311; mp 196-197°C
Amax 267 (4.78), 286.5 (4.41), 298.5 (4.36), 310 (4.13), 354 (3.32),
372 (3.31) nm
vmax 5.85, 12.26, 1 3 .2 5 ^
<3 4.83 (J 3,7) (15-H), 4.19 (J 18,7) and 3.68 (J 18,3) (H-16)
(Coombs et al., 1973a)
C17H nBrO
(358) 16-Bromo-15,16-dihydrocyclopenta[a]phenanthren-17-one 
[51013-72-0]
MW 311; Golden laths, mp 175°C (decomp.)
2max 230.5 (4.28), 273 (4.73), 300.5 (4.27), 335 (3.00), 354 (3.13),
371 (3.13) nm
vmax 5.88, 12.26, 13.25^m
6 3.20 (J 18,2) and 3.48 (J 18,6) (H-15), 5.96 (J 6,2) (H-16)
(Coombs et al. , 1973a)
Cj7H12 (3) 15i/-Cyclopenta[a]phenanthrene [219-07-8]
MW 216; mp 165-167°C
Amax 220 (4.45), 269 (4.79), 273 (4.81), 292 (4.23), 302 (4.17),
314 (3.96) nm
vmax (CS2) 12.48, 13.40, 14.50^m (Coombs, 19666)
C17H 12 (2) 17H-Cyclopenta[a]phenanthrene [219-08-9]
MW 216; mp 164-165°C (Coombs, 19966); 163-164°C (Badger et 
al., 1952)
2max 224 (4.41), 239 (4.24), 269 (4.72), 273.5 (4.70), 292 (4.17),
302.5 (4.16), 314.5 (4.04) nm
vmax (CS2) 12.49, 13.25, 13.30, 14.48//m (Coombs, 19666)
C17H 120  (102) 16,17-Dihydrocyclopenta[a]phenanthren-15-one [32425-83-5] 
MW 232; mp 184-186°C (Coombs, 19666); 183-184°C (Bachmann
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and Kloetzel, 1937); pale yellow needles, mp 183-184°C (Badger et 
al., 1952)
Amax 216 (4.41), 251.5 (4.58), 288 (4.06), 319 (4.08), 344 (3.65),
362 (3.49) nm
vmax 5-9> 10-32> 10-4> H -4> 11-76, 11.9, 12.26, 12.92, 13.2, 13.94/un
(Coombs, 1966b) 
C17H120  (380) 15,17-Dihydrocyclopenta[a]phenanthren-16-one 
MW 232; mp 172-174°C [42123-03-5]
Amax 258 (4.77), 269 (4.21), 278 (4.11), 300 (4.21), 319 (3.14),
335 (3.10), 350 (3.03) nm
vmax 5.88, 11.92, 12.49, 13.10, 13.30/un (Coombs and Hall, 1973) 
C17H 120  (4) 15,16-Dihydrocyclopenta[a]phenanthren-17-one [786-66-3] 
[74495-81-1] [74495-82-2]
MW 232; mp 203-204°C (Coombs et al., 1970); 200-201°C 
(Nasipuri and Roy, 1961)
2max 265 (4-89)> 284 (4 -52)> 296 (4 -38), 334 (3.24), 350 (3.40),
367 (3.44) nm
vmax 5.92, 11.48, 11.82, 12.40, 12.86, 13.22, 14.18/un
<5 3.28 (H-15), 2.70 (H-16) (Coombs, 1966a)
C 17H 120 2
(396) 15,16-Dihydro-2-hydroxycyclopenta[a]phenanthren-17-one 
[55651-45-1]
MW 248; mp 340°C (decomp.)
Amax 274.5 (4.74), 366 (3.40), 383 (3.45)
anion Amax 245 (4.59), 296 (4.62) (Coombs et al., 1975)
C 17H 1 2 ° 2
(23) 15,16-Dihydro-3-hydroxycyclopenta[a]phenanthren-17-one 
MW 248
Amax 278, 291, 324, 367 nm
anion Amax 234, 277, 288, 371 nm (Coombs, unpublished)
C 17H 120 2
(339) 15,16-Dihydro-6-hydroxycyclopenta[a]phenanthren-17-one 
[24684-45-5]
MW .248; mp 280°C
2max 270 (4-81)> 287 (4-48)> 302 (4.28), 361 (3.37), 378 (3.42) nm 
anion Amax 291, 350, 439 nm
vmax 3-20> 5-96> I!-34, 11.80, 12.18, 12.26, (Coombs, 1969)
C 17H 1 2 ° 2
(206) 15,16-Dihydro-ll-hydroxycyclopenta[a]phenanthren-17-one 
[83053-63-8]
MW 248; mp 310-315°C (Robinson, 1938); 306-310°C (Bhatt et al., 
1982)
Amax 261 (4.98), 293 (4.72), 368 (4.05), 387 (4.16)nm
(Bhatt et al., 1982)
C 17H 1 2 ° 2
(369) 15,16-Dihydro-15-hydroxycyclopenta[a]phenanthren-17-one 
[55081-28-2]
88 Physical and spectral properties
MW 248; Isolated as its acetate (365), mp 197-198°C (see 
C19H140 3) (Coombs et al., 1973a)
C 17H 120 2
(345) 15,16-Dihydro-16-hydroxycyclopenta[a]phenanthren-17-one 
[24684-54-6]
MW 248; mp 186-187°C, 197°C (decomp.)
Amax 265 (4.95), 284 (4.49), 296 (4.39), 335 (3.15), 351 (3.32),
369 (3.33) nm
vmax 2.96, 5.92, 12.16, 12.44, 13.30/an (Coombs, 1969)
Ci7h 12o 2
(104) 6,7 ,16,17-Tetrahydro-15//-cyclopenta[a]phenanthrene-6,7-
dione
MW 248; Bright red needles, mp 209-211°C (Badger et al., 1952); 
213°C (Butenandt et al., 1946b)
C 17H 13B r 0
c/s-16-Bromo-17-hydroxy-16,17-dihydro-15//-cyclopenta[a]- 
phenanthrene [50909-53-8]
MW 313
Amax 256.5, 278, 299 nm
vmax 3.01^m (Coombs et al., 1973a)
C17H14 (176) 13,14-Dihydro-17//-cyclopenta[a]phenanthrene [81396-17-0]
MW 218
vmax 3.22, 12.80, 13.25/im
<5 2.1-3.4 (m, 3H), 4.0 (m, 1H), 5.7 (m, 3H), 7.0-8.0 (m, 7H)
(Lee-Ruff et al. , 1982) 
C17H14 (1) 16,17-Dihydro-1577-cyclopenta[a]phenanthrene [482-66-6]
MW 218; mp 133-134°C (Kon, 1933); 134.5-135°C (Cook and 
Hewett, 1933); 132-133°C (Butz et al., 1940); 134-135°C (Coombs, 
19666)
Amax 216 (4.48), 259 (4.77), 280 (4.16), 288 (4.07), 300 (4.71)nm 
vmax (CS2) 12.32, 13.27pm  (Dannenberg et al., 1953) 
vmax 10.62, 11.56, 12.3, 12.95, 13.4, 14.08^m (Coombs, 19666) 
m/z  218 (100%), 219 (19%), 189 (28%), 188 (7%), 163 (6%)
(Chaffee and Jones, 1983) 
C17H 140  (38) 16,17-Dihydro-3-hydroxy-157/-cyclopenta[a]phenanthrene
MW 234; mp 184-188.5°C (Hoffelmer et al., 1964)
C17H 140  16,17-Dihydro-15//-cyclopenta[a]phenanthren-15-ol [42123-05-7]
MW 234; mp 166-167°C 
acetate, mp 127-128°C (Badger et al., 1952)
C17H 140  16,17-Dihydro-15i7-cyclopenta[a]phenanthren-ll-ol 
MW 234; mp 174-175°C
2max 228, 246, 279, 303, 349, 366 nm (Bhatt, unpublished data) 
C17H 140  16,17-Dihydro-15//-cyclopenta[a]phenanthren-17-ol 
MW 234; mp 183-184°C
2max 259 (4.77), 280 (4.09), 288 (3.98), 300 (4.12)nm 
vmax 3.15, 9.55, 11.50, 12.28, 12.92, 13.40, 13.85/nn
(Coombs, 19666)
C17H 140  (384) 11,12,13,17-Tetrahydro-167/-cyclopenta[a]phenanthren-16-one
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MW 234; mp 185-185.5°C 
oxime, mp 247-250°C (Wilds, 1942)
C17H140  (179) ll,12,15,16-Tetrahydro-cyclopenta[a]phenanthren-17-one
MW 234; Pale yellow scales, mp 210°C (Bardhan, 1936); colourless 
rhombohedral prisms, mp 214-216°C (Bachmann et al., 1943); pale 
yellow crystals, mp 219-221°C (Johnson and Peterson, 1945); 218- 
220°C (Coombs et al., 1970)
Amax 272 (4.61), 282 (4.70), 325 (3.18), 337 (3.21), 367 (2.97)nm 
vmax 11.50, 11.94, 12.14, 13.24, 13.85^m (Coombs et al., 1970) 
C17H 140  (174) ll,12,13,14-Tetrahydro-17H-cyclopenta[a]phenanthren-12-one 
[67279-07-6] [80299-44-1]
MW 234; mp 84-85°C (Lee-Ruff et al., 1981)
C17H140  13,14,15,16-Tetrahydrocyclopenta[a]phenanthren-17-one 
[7421-33-2] [5836-87-3]
MW 234; mp 95-96°C
'Lx 239 (4 -73)> 303 (3.88), 316 (4.01), 330 (3.88), 336 (3.86)nm 
vmax 5.75jum (Coombs, 1966a)
C^H^O
C 17H l A
c nH 14a
C 17H 1 4 ° 2
(116) 16,17-Dihydro-l,4-dihydroxy-15//-cyclopenta[a]phenanthrene 
MW 252; mp 210°C (Tamayo and Martin, 1952)
)
(382) 16,17-Dihydro-cw-15,16-dihydroxy-15//-cyclopenta[a]phenanthrene 
MW 250 (characterized as its diacetate (109) (see C21H ]g0 4)
(Coombs and Hall, 1973)
(378) 16,17-Dihydro-c/s-16,17-dihydroxy- 15H-cyclopenta[a]- 
phenanthrene [42122-94-1]
MW 250; mp 226-228°C
2max 250.5 (4.71), 257 (4.83), 279 (4.16), 287 (4.06), 299 (4.16),
320 (2.71), 327.5 (2.56), 334.5 (2.87), 343 (2.49), 350 (2.86)nm 
rmax 3.05, 12.15, 12.24, 13.33, 13.48//m (Coombs and Hall, 1973)
_>
(376) 16,17-Dihydro-tra«s-16,17-dihydroxy-15//-cyclopenta[a]- 
phenanthrene [42122-95-2]
MW 250; mp 277-278°C
Amax 250.5 (4.71), 257 (4.82), 279 (4.16), 287 (4.05), 299 (4.17),
320 (2.65), 327.5 (2.49), 335 (2.84), 343 (2.44), 350 (2.84) nm 
vmax 3-08, 12.10, 13.44^m (Coombs and Hall, 1973)
2
(324) l,2,3,4,16,17-Hexahydrocyclopenta[a]phenanthrene-l,15-dione 
MW 250; mp 173-175°C (Rahman and Rodriguez, 1969)
(± )  (193) ll,12,13,14,15,16-Hexahydrocyclopenta[a]phenanthrene-
11,17-dione [23462-83-1] [24808-98-8] [67530-16-9]
MW 250; Colourless needles, mp 115°C (Koebner and Robinson, 
1938); 120°C (Coombs, 1965)
2max 216 (4 -61), 248 (4.33), 315 (3.82)
vmax 5.98^m (Coombs, 1965)
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C 17H 1 4 ° 2
(+ )  (193) (+)-ll,12,13,14,15,16-Hexahydrocyclopenta[a]-
phenanthrene-11,17-dione
MW 250; mp 138°C, [a] 2S° +266° (CHC13)
Amax 248 (4.32), 314 (3.80)nm
vmax 5.75, 5.95pm  (Cagara and Siewinski, 1975)
-^'17^ 14^ 2
( —) (193) ( - ) - l  1,12,13,14,15,16-Hexahydrocyclopenta[a]-
phenanthrene-11,17-dione
MW 250; mp 138°C, [afS° -258° (CHC13)
Amax 248 (4.33), 314 (3.86) nm
vmax 5.75, 5.95pm  (Cagara and Siewinski, 1975)
^17^14^3
(337) 17-0x0-6,7,15,16-tetrahydrocyclopenta[a]phenanthrene-cw- 
6,7-diol
MW 266; mp 232-234°C 
Amax 245 (4.02), 309-317 (4.43) nm
vmax 2.86, 2.96, 5.78, 10.31, 11.91, 12.90, 13.51pm (Coombs, 1969) 
C17H 15N (349) 12-Amino-16,17-dihydro-15i7-cyclopenta[a]phenanthrene 
[3036-49-5]
MW 233; mp 250°C 
Amax 255.5 (4.64), 314 (3.98), 360 (3.11) 
vmax (KBr) 3.03, 3.47-4.41, 10.87, 12.20, 13.25pm  
C17H15N.HC1 [2960-80-7] (Dannenberg et al., 1965)
C17H16 (442) 6,7 ,16,17-Tetrahydro-15//-cyclopenta[a]phenanthrene
MW 220; mp 60°C (Jacob et al., 1971); 61-62°C (Robinson and 
Slater, 1941)
Amax 272 (4.30) nm
12-20> 13-07 pm
6 1 (m), 7.5 (m), 2.1 (m), 2.8 (m) (Jacob et al., 1971)
C17H 16 13,14,16,17-Tetrahydro-15/f-cyclopenta[a]phenanthrene [7421-32-1] 
[5836-83-9]
MW 220; mp 79-80°C
Amax 239 (4.76), 303 (3.84), 315 (3.91), 337 (3.63) nm 
vmax 10.55, 11.54, 12.15, 12.42, 13.25, 13.50, 13.80^m
(Coombs, 1966a)
C17H 160  (325) l,2,3,4,16,17-Hexahydrocyclopenta[a]phenanthren-15-one
MW 236 (Rahman and Rodriguez, 1969)
C17H 160  (237) l,2,3,4,15,16-Hexahydrocyclopenta[a]phenanthren-17-one 
MW 236; mp 145-146°C
Amax 256.5 (3.98), 282 (3.25), 292.5 (3.27), 333.5 (2.86), 348 (2.91)nm 
vmax 5.89, 9.55, 11.8, 12.1, 12.5,1ml (Coombs and Bhatt, 1973)
C17H 160  (82) ll,12,13,14,16,17-Hexahydro-15/7-cyclopenta[a]phenanthren-ll- 
one
MW 236; mp 119-120°C (Butenandt et al., 1946a)
C17H 160  (205) 11,12,13,14,15,16-Hexahydrocyclopenta[a]phenanthren-17-one 
[786-64-1]
MW 236; mp 114-114.5°C (Coombs, 1966a)
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C17H160  12-Hydroxy-ll,12,13,14-tetrahydro-17//-cyclopenta[a]phenanthrene 
[67279-08-7] [80299-45-2]
MW 236 (Dao et al. , 1978)
C17H160  13,14,16,17-Tetrahydro-15/f-cyclopenta[a]phenanthren-17-ol 
[788-65-2] [7421-34-3]
MW 236; mp 117-118°C
m^ax 239 (4.75), 301.5 (3.85), 315 (3.95), 330 (3.79), 336 (3.69)nm 
vmax 3-00, 9 3 5 p m  (Coombs, 1966a)
Q'7^16^2
(103) 6,7-dj,-Dihydroxy-6,7,16,17-tetrahydro-15//-cyclopenta[a]- 
phenanthrene
MW 252; mp 193°C (Butenandt et al., 1946b)
"^17^ 16^ 2
(115) l,4-Dihydroxy-6,7,16,17-tetrahydro-15//-cyclopenta[a]phenan- 
threne
MW 252 (Tamayo and Martin, 1952)
c 17h 16o 2
11.12.13.14.15.16-Hexahydro-l l-hydroxycyclopenta[a]phenanthren- 
17-one [23462-85-3] [23462-84-2]
(Mejer and Kalinowska, 1969)
^17^16^2
11,12,13,14,15, 16-Hexahydro-l la-hydroxycyclopenta[a]phenanthren- 
17-one [23462-84-2]
MW 252; mp 115°C 
Amax 229 (4.91), 278 (3.78) nm 
vmax (Nujol) 2.93, 5.15pm
vmax (CC14) 2.11 pm  (Mejer and Kalinowska, 1969)
^17^16^2
11.12.13.14.15.16-Hexahydro-l l/?-hydroxycyclopenta[a]phenanthren- 
17-one [23462-85-3]
MW 252; mp 201°C 
Amax 230 (4.96), 278 (3.84)nm 
vmax (Nujol) 2.88, 5.78^m
vmax (CC14) 2.11 pm  (Mejer and Kalinowska, 1969)
^17^16^2
11.12.13.14.16.17-Hexahydro-17a-hydroxy-15//-cyclopenta[a]- 
phenanthren-ll-one [23462-86-4]
MW 252; mp 119°C 
Amax 243 (4.35), 310 (3.88) 
v max (Nujol) 2.93, 6 m p m
vmax (CC14) 2.16pm  (Mejer and Kalinowska, 1969)
"^17^ 16^ 2
11.12.13.14.16.17-Hexahydro-17/3-hydroxy-15//-cyclopenta[a]- 
phenanthren-ll-one [23462-87-5]
MW 252; mp 132°C 
Amax 243 (4.35), 310 (3.93) nm 
vmax (Nujol) 2.93, 6 3 2 p m
vmax (CC14) 2.16pm  (Mejer and Kalinowska, 1969)
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CnH160 2
(+ )11 ,12,13,14,16,17-Hexahydro-17/3-hydroxy-15//-cyclopenta[a] - 
phenanthren-ll-one [23462-88-6]
MW 252; mp 111-112°C, [a] F - 13° (CHC13)
Spectra as for (± )  compound (Mejer and Kalinowska, 1969)
"^17^ 16^ 2
(114) 1,4,5,6,9 , 10, 16,17-Octahydro-15i/-cyclopenta[a]phenanthrene- 
1,4-dione
MW 252 (Tamayo and Martin, 1952)
C„H1S (326) 1,2,3,4 ,16,17-Hexahydro-157/-cyclopenta[a]phenanthrene
MW 222; mp 94-96°C (Rahman and Rodriguez, 1969)
C17H 18 (440) 6,7,8,14,16,17-Hexahydro-15//-cyclopenta[a]phenanthrene
MW 222; mp 79°C (Robinson & Slater, 1941); 78°C (Jacob et al., 
1971)
Amax 230 (3.78), 242 (3.75), 250 (3.66), 321 (4.09), 335 (4.15),
352 (3.97) nm 
v max 13.25/nn
<5 8(m), 7.4(m), 6.76(d), 6.15(d), 3.2(m), 2.2(m) (Jacob et al., 1971) 
C17H 18 (44) 11,12,13,14,16,17-Hexahydro-15H-cyclopenta[a]phenanthrene
[31301-56-1]
MW 222; mp 91-92°C (Coombs, 1966a); 85-87°C (Buchta and 
Ziemer, 1956)
Amax 230 (4.28), 275 (3.63), 285 (3.76), 292 (3.54)nm
(Coombs, 1966a)
C„Hi80  (96) 6,7,8 ,12,13,14,16,17-Octahydro-15//-cyclopenta[a]phenanthren- 
12-one
MW 238; mp 171°C (Robinson and Slater, 1941); 173°C (Jacob et 
al., 1971); 169-170°C (Hawthorne and Robinson, 1936)
Amax 295 (4.20) nm 
Vmax 5.99^m
(5 7.7(m), 7.2(s), 6.5(s), 1.8(m) (Jacob et al., 1971)
^17^18^2
lla,17a-Dihydroxy-ll,12,13,14,16,17-hexahydro-15H-cyclopenta[a]- 
phenanthrene [23462-89-7]
MW 254; mp 164°C 
Amax 229 (5.12), 279 (3.86) nm
v max (CC14) 2-77 and 290//m (Mejer and Kalinowska, 1969)
^17^18^2
ll/?,17a-Dihydroxy-ll,12,13,14,16,17-hexahydro-15H-cyclopenta[a]- 
phenanthrene [23462-92-2]
MW 254; mp 192°C 
Amax 229 (5.11), 279 (3.81) nm
vmax (CC14) 2.11 pm. (Mejer and Kalinowska, 1969)
"^17^ 18^ 2
(±)ll,17/J-Dihydroxy-ll,12,13,14,16,17-hexahydro-15/7-
cyclopenta[a]phenanthrene
MW 254; mp 115°C [23462-90-0]
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Amax 229 (5.03), 278 (3.79)nm
vmax (CC14) 2.11 pm  (Mejer and Kalinowska, 1969)
c 17h 18o 2
(+)ll,17/?-Dihydroxy-ll,12,13,14,16,17-hexahydro-15//- 
cyclopenta[a]phenanthrene [23462-91-1]
MW 254; mp 170-175°C, [ a } ¥  +63° (EtOH)
2max 299 (5.08), 279 (3.87) nm
vmax (CHClj) 2.77pm  (Mejer and Kalinowska, 1969)
^17^18^2
(233) l,2,3,4,ll,12,13,14,15,16-Decahydrocyclopenta[a]-
phenanthrene-11,17-dione
MW 254; mp 111-113°C
2max 200 (4.25), 257 (3.91), 308 (3.33) nm
vm3X 5.75, 5.95, 10.1, 10.7, \ \ . 9 p m  (Coombs and Bhatt, 1973)
C17H20O (438) 12-Hydroxy-6,7,8,12,13,14,16,17-octahydro-15//-cyclopenta[a]- 
phenanthrene
MW 240; mp 131-132°C (Robinson and Slater, 1941)
C17H220  (444) 6,7,8,9,ll,12,13,14,16,17-Decahydro-12-hydroxy-15H- 
cyclopenta[a]phenanthrene 
MW 242; mp 165°C 
2max 265 (2.71) nm 
Vmax 2'97> 13.70/im
6 7.2(m), 1.5(s), 3.2(m) (Jacob et al., 1971)
C 18H 12B r 2 0
(357) 15,15-Dibromo-15,16-dihydro-ll-methyl-cyclopenta[a]- 
phenanthren-17-one [50905-51-6] [74495-85-5]
MW 234; Orange crystals, mp 206-207°C
'Lx 267-5 (4-68), 302.5 (4.32), 315 (4.12), 369 (3.29), 384 (3.31) nm
vmax 5.84, 12.15, 13.44, 13.93, 14.12^m
6 4.69 (H-16) (Coombs et al., 1973a)
ClgH120  (310)15,16-Dihydro-l,ll-methanocyclopenta[a]phenanthren-17-one 
MW 244; mp 195°C
2max 266.5 (4.77), 277 (4.76), 303 (3.34), 348 (3.03), 365.5 (2.86)nm 
V m a x  5.94, 6.12, 7 .14, 7.74, 12.20, 12.42/fm
62.8 (H-16), 3.25 (H-15), 4.2 (bridge CH2) (Ribeiro et al., 1983)
C18H120  (364) ll-Methylcyclopenta[a]phenanthren-17-one 
MW 244 [55651-29-1]
2max 256, 288, 298, 312, 389nm (Coombs et al., 1975)
1^8-^ 12^ 2
(148) 17//-Cyclopenta[a]phenanthrene-17-carboxylic acid
MW 260; mp 250-270°C (Siiss, 1953)
c 18Hi2o 2
(418) 15,16-Dihydro-16-formylcyclopenta[a]phenanthren-17-one 
MW 260; mp 197-198°C (Buchta and Kraetzer, 1962)
"^18^ 12
(336) 1 l-Methyl-6,7,15,16-tetrahydrocyclopenta[a]phenanthrene-
6,7,17-trione
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MW 276; mp 230°C
Amax 263 (4.15), 345 (3.44), 410 (2.94)nm
vmax 5.80, 6.00, 6.24, 10.30, 11.91, 12.08, 13.70, 13.86jim
(Coombs, 1969)
C 18H 13B r 0
(355) 15-Bromo-15,16-dihydro-l l-methylcyclopenta[a]phenanthren- 
17-one [50905-52-7]
MW 325; mp 211.5-212°C
Amax 267.5 (4.68), 290 (4.37), 303 (4.29), 363 (3.31), 381 (3.35)nm 
vmax 5.88, 12.20, 13.18, 13.85, 14.29pm  
d 4.85 (J 7,3) (H-15), 3.72 (J 18,3) and 4.23 (J 18,7) (H-16)
(Coombs et al. , 1973a)
C18H13BrO
(359) 16-Bromo-15,16-dihydro-ll-methylcyclopenta[a]phenanthren- 
17-one [55651-28-0]
X 215A,  359, 377nmmax " “
vmax 5.81, 11.49, 12.09, 12.50, 12.99, 13.19, lA M p m  
6 5.94 (J 2,6) (H-16), 3.49 (J 6,20) and 3.30 (J 2,20) (H-15)
(Coombs et al., 1975)
-^'18-^ 13 C102
(322) 7-Chloro-15,16-dihydro-6-methoxycyclopenta[a]phenanthren- 
17-one
MW 296.5; mp 220°C (Badger et al., 1952)
C18H14 (143) 15,16-Dihydro-17-methylenecyclopenta[a]phenanthrene
[5837-17-2]
MW 230; mp 217-218°C
2max 215 (4.22), 273.5 (4.69), 287 (4.44), 299 (4.34), 307 (4.09),
333 (3.08), 349 (3.28), 367 (3.34) nm
vmax 3.25, 6.18, 10.62, 11.6, 12.04, 12.42, 13.42, 13.9^tm
6 5.56 and 5.13 (olefinic protons), 3.25 and 3.05 (methylene protons)
(Coombs, 1966b)
C18H14 '(150) ll-Methyl-15//-cyclopenta[a]phenanthrene [42122-99-6]
MW 230; mp 87-89°C
Xmsx 221.5 (4.47), 267 (4.65), 274 (4.65), 294 (4.08), 306 (4.08),
317 (2.83), 348 (2.85), 364 (2.74) nm
vmax 12.27, 13.32, 14.27pm  (Coombs and Hall, 1973)
C18H 14 (128) 15-Methyl-17//-cyclopenta[a]phenanthrene
MW 230; mp 135°C
Amax 221 (4.68), 241 (4.45), 267.5 (4.60), 293 (4.02), 305 (4.17),
317.5 (4.15), 344 (3.08), 361 (2.99) nm
vmax (KBr) 12.29, 12.40, 13.24, 1 3 .4 1 ^  (Dannenberg et al., 1960) 
C18H 14 (133) 17-Methyl-15H-cyclopenta[a]phenanthrene [3353-08-0]
MW 230; Cream needles, mp 209-212°C
Amax 223 (4.30), 270 (4.70), 276 (4.73), 293 (4.14), 316 (3.74),
331 (2.71), 348 (2.69), 366 (2.46) nm
vmax 11.0, 11.55, 12.0, 12.3, 12.8, 13.4, 13.82^m (Coombs, 1966b) 
ClgH uO (302) 15,16-Dihydro-l-methylcyclopenta[a]phenanthren-17-one 
[85616-38-2]
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MW 246; mp 189-190°C
2max 266 (4.84), 288 (4.53), 303 (4.30), 359 (3.77), 375 (3.77) nm 
vmax 5.92, 12.09, 12.99^m
6 2.73 (H-16), 3.08 (methyl), 3.38 (H-15) (Ribeiro et al., 1983) 
C18H140  (303) 15,16-Dihydro-2-methylcyclopenta[a]phenanthren-17-one 
[27343-46-0]
MW 246; mp 221-222°C
Amax 267 (5.05), 284 (4.22), 298 (4.12), 336 (3.11), 352 (3.34),
370 (3.27) nm
vmax 5.85, 11.72, 11.90, 12.10, 12.50, 12.95, 14.08/«n
(Coombs et al., 1970) 
ClgH140  (304) 15,16-Dihydro-3-methylcyclopenta[a]phenanthren-17-one 
[27363-65-1]
MW 246; mp 203-204°C
2max 267 (5.02), 285 (4.67), 298 (4.41), 344 (3.28), 366 (3.25) nm 
vmax 5.88, 11.10, 11.60, 11.90, 12.36, 13.05, 13.90, 14.10^m
(Coombs et al. , 1970) 
C18H 140  (305) 15,16-Dihydro-4-methylcyclopenta[a]phenanthren-17-one 
[27343-45-9]
MW 246; mp 265-266°C
Amax 266 (4.98), 284 (4.67), 300 (4.36), 336 (3.06), 352 (3.22),
370 (3.23) nm
vmax 5.92, 11.10, 11.88, 12.05, 12.34, 12.60, 13.85, 14.15/«n
(Coombs et al. , 1970) 
C18H 140  (306) 15,16-Dihydro-6-methylcyclopenta[a]phenanthren-17-one 
[27343-44-8]
MW 246; mp 210.5-212°C
2max 266 (5.06), 284 (4.69), 298 (4.45), 336 (3.10), 352 (3.32),
370 (3.33) nm
vmax 5.86, 11.44, 12.12, 13.00, 14.25pm  (Coombs et al., 1970)
C18H 140  (230) 15,16-Dihydro-7-methylcyclopenta[a]phenanthren-17-one 
[30835-65-5]
MW 246; mp 198-199°C
2max 268 (4.79), 286 (4.42), 301 (4.28), 343 (3.23), 360 (3.41),
378 (3.42) nm
vmax 5.91, 11.3, 11.98, 12.92, 13.34/«n
<5 2.72 (H-15), 2.92 (methyl), 3.70 (H-16) (Coombs and Jaitly, 1971) 
C18H140  (381) 15,17-Dihydro-ll-methylcyclopenta[a]phenanthren-16-one 
[42123-04-6]
MW 246; mp 152.5-153°C
Amax 256.5 (4.77), 282 (4.06), 295 (4.08), 307 (4.16), 324 (2.99),
339 (306), 355 (3.04) nm
vmax 5.75, 12.08, 12.58, 13.46/im (Coombs and Hall, 1973)
C18H140  (26) 15,16-Dihydro-ll-methylcyclopenta[a]phenanthren-17-one 
[892-17-1] [74495-84-4] [74524-21-3]
MW 246; mp 171-172°C
Amax 222 (4.11), 264 (4.83), 288 (4.49), 301 (4.32), 342 (3.11),
358 (3.38), 376 (3.43) nm
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vmm 5.92, 11.40, 12.28, 13.34, 14.00, 14.52/im  
6 2.68 (H-16), 3.00 (methyl), 3.23 (H-15) (Coombs, 19666)
C18H 140  (130) 15,16-Dihydro-12-methylcyclopenta[a]phenanthren-17-one 
[789-46-8]
MW 245; mp 233°C (Coombs, 19666; Riegel et al., 1948)
Amax 219 (4.18), 268 (4.85), 286 (4.42), 299 (4.36), 340 (2.96),
355 (3.22), 373 (3.28)nm
vmax 5.92, 11.36, 12.32, 12.70, 13.20^m
6 2.70 (H-16), 2.82 (methyl), 3.28 (H-15) (Coombs, 19666)
C18H 140  (49) 16,17-Dihydro-17-methylcyclopenta[a]phenanthren-15-one
MW 246; mp 138-139°C (Tatta and Bardhan, 1968)
C18H140  (402) 15,17-Dihydro-17-methylcyclopenta[a]phenanthren-16-one 
[42123-02-4]
MW 246; mp 231-233°C (Dannenberg et al. , 1960)
C18H 140  (334) 16,17-Dihydro-ll-methylcyclopenta[a]phenanthren-15-one 
[24684-42-2]
MW 246; mp 182-183°C
2max 217 (4.57), 253 (4.63), 284 (4.15), 323 (4.14), 363 (3.41)nm 
vmax 5.94, 11.60, 12.22, 13.28, 13.72, 14.02^m (Coombs, 1969)
c 18h 14o 2
(458) 15,16-Dihydro-4-hydroxy-l-methylcyclopenta[a]phenanthren- 
17-one
MW 262.0994; found, 262.0992 
Amax 270, 305 nm
2max (anion) 260, sh 284, 325nm (Coombs et al., 1985)
C 18H 140 2
(340) 15,16-Dihydro-6-hydroxy-ll-methylcyclopenta[a]phenanthren- 
17-one [24684-47-7]
MW 262; Golden yellow needles, mp 335°C
Amax 265 (4.76), 289 (4.51), 306 (4.27), 368 (3.37), 384 (3.41)nm
vmax 3.08, 5.95, 11.46, 12.05, 12.86, 13.04, 13.74, 14.50/an
(Coombs, 1969)
c 18h 14o 2
(215) 15,16-Dihydro-ll-hydroxymethylcyclopenta[a]phenanthren-17- 
one [55651-36-0]
MW 262; mp 190-192°C
Amax 264.5 (4.85), 285 (4.51), 300 (4.32), 356 (3.29), 372.5 (3.41)nm 
m/z  262; (M+, 100%), 234 (M+-CO, 20%), 235 (M+-CHO, 45%),
233 (M+-CH2OH, 18%) (Coombs et al., 1975)
^18^14^2
15,16-Dihydro-ll-hydroxy-7-methylcyclopenta[a]phenanthren-17-one
[30835-60-0]
MW 262; mp 335-340°C 
acetate, mp 243-244°C 
Amax 230.5 (4.24), 267 (4.79), 295.5 (4.38), 360 (3.47), 378 (3.77),
398 (3.86) nm (Coombs and Jaitly, 1971)
C 18H 1 4 ° 2
(370) 15,16-Dihydro-15-hydroxy-ll-methylcyclopenta[a]phenanthren- 
17-one [55651-31-5]
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MW 262
2max 265 (4.84), 300 (4.53), 356 (3.29), 374 (3.21) nm
(Coombs et al. , 1975)
c 18h 14o 2
(346) 15,16-Dihydro-16-hydroxy-ll-methylcyclopenta[a]phenanthren- 
17-one [24684-56-8]
MW 262; mp 205-207°C
Amax 264 (4.88), 288 (4.52), 301 (4.35), 345 (3.14), 361 (3.36),
379 (3.39) nm
vmax 3.00, 5.92, 11.44, 11.62, 12.06, 12.28, 12.55, 12.80, 13.56, 
14.10/im (Coombs, 1969)
c 18h 14o 2
(307) 15,16-Dihydro-2-methoxycyclopenta[a]phenanthren-17-one 
[55651-43-9]
MW 262; mp 180-180.5°C
2max 271 (4.81), 360 (3.45), 377 (3.51) nm
vmax 5.87-5.95, 9.59, 10.47, 12.14, 12.66, 13.16, 13.89^m
(Coombs et al., 1975)
C 18H 1 4 ° 2
(24) 15,16-Dihydro-3-methoxycyclopenta[a]phenanthren-17-one 
MW 262; mp 209 and 230°C
2max 218-220 (4.21), 269 (4.78), 277 (4.83), 319 (4.22), 347 (3.62),
366 (3.28) nm
vmax 5.92, 11.42, 12.38, 13.04/an (Coombs, 1966b)
C 18H 140 2
(308) 15,16-Dihydro-6-methoxycyclopenta[a]phenanthren-17-one 
[24684-46-6]
MW 262; mp 196-197°C
2max 270 (4.98), 287 (4.69), 302 (4.37), 361 (3.36), 378 (3.33)nm 
vmax 5.90, 11.86, 12.24, 12.76, 13.04, 13.78, 14.12pm
(Coombs et al., 1970)
C 18H 140 2
(132) 15,16-Dihydro-ll-methoxycyclopenta[a]phenanthrene-17-one 
[5836-85-1]
MW 262; mp 179°C (Robinson, 1938); 184°C (Coombs, 1966b)
2max 214 (4.21), 261 (4.86), 292 (4.42), 303 (4.29), 346 (3.42),
363 (3.72), 381 (3.82) nm
vm3X 5.88, 11.30, 12.30, 13.32pm (Coombs, 1966b)
C 18H 140 2
(367) 15,16-Dihydro-15-methoxycyclopenta[a]phenanthren-17-one 
[83053-56-9]
MW 262; mp 155°C
2max 268, 297, 352, 369nm (Bhatt et al., 1982)
C 18H 140 3
(465) 15,16-Dihydro-2,15-dihydroxycyclopenta[a]phenanthren-17-one 
[55081-26-0]
MW 278; Yellow solid, mp 278°C 
2max 276; anion 250, 300 nm
(Coombs and Crawley, 1974)
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C18HlA
15.16-Dihydro-ll-hydroxy-3-methoxycyclopenta[a]phenanthren-17- 
one
MW 278; mp 293-299°C (Robinson, 1938)
c 18h 14o 4
(463) 8,9-Epoxy-2,15-dihydroxy-ll-methyl-8,9-secogona-
1,3,5,7,9,11,13-heptaen-17-one
MW 294; mp 280-282°C
Amax 278 (4.55); anion 255 (4.50), 299 (4.50)nm
(Coombs and Crawley, 1974)
c 18h 15n o
16.17-Dihydro-17-methyl-157/-cyclopenta[a]phenanthren-15-one, 
oxime [17981-86-1]
MW 261; mp 169-171°C (Tatta and Bardhan, 1968)
C18H 16 (107) 16,17-Dihydro-l-methyl-15//-cyclopenta[a]phenanthrene
[63020-74-6]
MW 232; mp 75-76°C (Butenandt et al., 1950)
Amax 256 (4.80), 285 (4.05), 297 (4.03), 306 (4.11), 323 (2.68),
339 (2.69), 355 (2.54) nm (Dannenberg and Steidle, 1954) 
vmax (CS2) 12.22, 12.77, 13.28/im (Dannenberg et al., 1953)
C18H16 (98) 16,17-Dihydro-2-methyl-15i/-cyclopenta[a]phenanthrene
[3988-20-3]
MW 232; mp 106-107°C (Butenandt et al., 1946c)
Amax 261 (4.81), 282 (4.16), 291 (4.07), 303 (4.16), 323 (2.85),
338 (3.08), 354 (3.10) nm (Dannenberg and Steidle, 1954)
vmax (CS2) 12.03, 12.20/un (Dannenberg et al., 1953)
C18H 16 (70) 16,17-Dihydro-3-methyl-15//-cyclopenta[a]phenanthrene
MW 232; mp 132°C (Kon and Woolman, 1939)
C18H16 (100) 16,17-Dihydroi4-methyl-15if-cyclopenta[a]phenanthrene
[63020-75-7]
MW 232; mp 151-152°C (Butenandt et al., 1949a)
2max 255 (4.69), 263 (4.78), 283.5 (4.14), 294.5 (4.12), 306.5 (4.22), 
324 (2.80), 339 (2.85), 355 (2.73) nm (Dannenberg and Steidle,
1954)
vmax (CS2) 12.33, 12.72, 13.29/^m (Dannenberg et al., 1953)
C]8Hj6 (67) 16,17-Dihydro-6-methyl-15i/-cyclopenta[a]phenanthrene 
[63020-26-8]
MW 232; mp 109-110°C (Gamble and Kon, 1935); 98-101°C 
(Butenandt and Suranyi, 1942)
Amax 262 (4.80), 282 (4.16), 290 (4.06), 303.5 (4.09), 322 (2.83),
337 (2.92), 354 (2.87)nm (Dannenberg and Steidle, 1954) 
vmax (CS2) 11.52, 12.26, 13.21jum (Dannenberg et al., 1953)
C18H 16 (94) 16,17-Dihydro-7-methyl-15//-cyclopenta[a]phenanthrene
[63020-76-8]
MW 232; mp 106-108°C (Butenandt et al., 1949a)
2max 261 (4.77), 281 (4.24), 291 (4.06), 304 (4.08), 323.5 (2.91),
339 (3.15), 355 (3.19) nm (Dannenberg and Steidle, 1954)
vmax 11-42, 12.22, 13.44^m (Dannenberg et al., 1953)
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ClgH16 (83) 16,17-Dihydro-ll-methyl-15//-cyclopenta[a]phenanthrene 
[24684-41-1]
MW 232; mp 80-81°C (Butenandt et al., 1946a); 81-82°C (Coombs, 
1969)
/lmax 256 (4.81), 285 (4.05), 297 (4.03), 306 (4.10), 323.5 (2.91),
340 (3.05), 356 (3.07) nm (Dannenberg and Steidle, 1954) 
vmax (CS2) 11.58, 12.28, 13.43/zm (Dannenberg et al., 1953)
C18H16 (97) 16,17-Dihydro-12-methyl-15//-cyclopenta[a]phenanthrene
[63020-73-5]
MW 232; mp 86-87°C (Butenandt et al., 1946a); 85-86°C (Riegel et 
al., 1948)
2max 261 (4.79), 282 (4.16), 291 (4.05), 303 (4.15), 321 (2.70),
337 (2.70), 353 (2.56) nm (Dannenberg and Steidle, 1954) 
vmax (CS2) 11.53, 12.27, 13.39/an (Dannenberg et al., 1953)
Trinitro deriv., mp 196-197°C (Riegel et al., 1948)
C18H16 (45) 16,17-Dihydro-15-methyl-15//-cyclopenta[a]phenanthrene
MW 232; mp 76-77°C (Ruzicka et al. , 1933)
Trinitrobenzene deriv., mp 143-144°C 
C18H 16 (46) 16,17-Dihydro-16-methyl-15//-cyclopenta[a]phenanthrene
MW 232; mp 106-107°C; bp 160-170°C/0.3 mm (Ruzicka et al. , 
1933)
Trinitrobenzene deriv., mp 140-141°C 
0 18H16 (7) Diels’ hydrocarbon [549-38-2]
16,17-Dihydro-17-methyl-15//-cyclopenta[a]phenanthrene 
MW 232; mp 125-126°C (Diels and Gadke, 1927; Diels and 
Rickert, 1935; Bergmann and Hillemann, 1933); 126-127°C (Riegel 
etal.,  1942); 125.5-126°C (Tatta and Bardhan, 1968); 126.5-127.5°C 
(Coombs, 1966b)
2max 259 (4.80), 280 (4.14), 288.5 (4.04), 300.5 (4.11), 321 (2.74),
336 (2.94), 351.5 (2.33) nm (Dannenberg and Steidle, 1954) 
vmax 11.6, 12.06, 12.36, 13.06, 13.4, 13.9/nn
(Coombs, 1966b)
C18H 160  (11) 16,17-Dihydro-3-methoxy-15//-cyclopenta[a]phenanthrene 
MW 248; mp 76-77°C (Cook and Girard, 1934)
Orange picrate, mp 135-136.5°C 
Trinitrobenzene deriv., mp 160-161°C 
C18H1sO (59) 16,17-Dihydro-4-methoxy-15/7-cyclopenta[a]phenanthrene 
MW 248; mp 153°C 
picrate, mp 160°C (Kon and Ruzicka, 1935)
C18H 160  (61) 16,17-Dihydro-6-methoxy-15//-cyclopenta[a]phenanthrene
MW 248; mp 129°C (Kon and Ruzicka, 1935)
C18H 160  16,17-Dihydro-ll-methoxy-15i7-cyclopenta[a]phenanthrene 
MW 248; mp 106-107°C 
2max 229, 248, 254, 278, 300, 332, 348, 364 nm
(Bhatt, unpublished data) 
C16H 160  (448) 16,17-Dihydro-ll-methyl-1577-cyclopenta[a]phenanthren-17-ol 
[40951-13-1]
MW 248; mp 140-141°C
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Amax 227 (4.22), 255 (4.78), 281 (4.02), 293 (4.02), 304.5 (4.10),
323 (2.79), 338.5 (2.96), 354 (2.98) ran
vmax 3.08, 12.12, 12.24, 13.33^m (Coombs and Hall, 1973)
ClgH 160  1-Methyl-l 1,12,15,16-tetrahydrocyclopenta[a]phenanthren-17-one 
[85616-49-5]
MW 248; mp 138-140°C
Amax 276 (4.55), 286 (4.62), 330 (4.09), 343 (4.11), 376 (3.87)nm 
vmax 5.94, 6.06/im (Ribeiro et al., 1983)
ClgH 160  2-Methyl-l 1,12,15,16-tetrahydrocyclopenta[a]phenanthren-17-one 
[27343-51-7]
MW 248; mp 139-140°C
Amax 272.5 (4.56), 283 (4.68), 327 (3.29), 338 (3.31), 370 (2.94) nm 
vmax 10.25, 11.80, 12.10/im (Coombs et al., 1970)
ClgH 160  3-Methyl-l 1,12,15,16-tetrahydrocyclopenta[a]phenanthren-17-one 
MW 248; mp 222-223°C
Amax 272 (4.61), 283 (4.70), 327 (3.25), 340 (3.31), 368 (3.12)nm 
vmax 11.16, 12.24, 12.98, 13.78, 14.10^m (Coombs et al., 1970) 
ClgHI60  (257) 4-Methyl-l 1,12,15,16-tetrahydrocyclopenta[a]phenanthren-17- 
one [27343-34-6]
MW 248; mp 237.5-241.3°C (Woodward et al. , 1953); 245-246°C 
(Coombs et al., 1970)
Amax 276 (4.50), 288 (4.59), 327 (3.07), 242 (3.11), 372 (2.89)nm 
vmax 12.20, 12.44, 13.18/zm (Coombs et al., 1970)
ClgH160  6-Methyl-l 1,12,15,16-tetrahydrocyclopenta[a]phenanthren- 17-one 
[27343-49-3]
MW 248; mp 180.5-181.5°C
Amax 276 (4.50), 287 (4.65), 327 (3.06), 342 (3.12), 375 (2.99)nm 
vmax 11.42, 12.15, 13.10,um (Coombs et al., 1970)
Ci8H 160  (252) 11-Methyl-l 1,12,15,16-tetrahydrocyclopenta[a]phenanthren-17- 
one [27343-48-2]
MW 248; mp 177-178°C
Amax 271 (4.58), 282 (4.68), 327 (3.14), 341 (3.19), 368 (3.00)nm 
vmax 11.52, 12.10, 12.28, 13.26Jam (Coombs et al., 1970)
ClgH 160  (249) 12-M ethyl-ll,12,15,16-tetrahydrocyclopenta[a]phenanthren- 
17-one
MW 248; mp 156.5-157°C (Riegel et al., 1948)
c 16h I6o 2
2-Methoxy-l 1,12,15,16-tetrahydrocyclopenta[a]phenanthren-17-one 
[55651-42-8]
MW 264; mp 154-154.5°.C
A 273.5 (4.39), 284 (4.44), 328 (4.30)nm (Coombs et al., 1975)
c 18h 16o 2 max
(66) 3-M ethoxy-ll, 12,15,16-tetrahydrocyclopenta[a]phenanthren-
17-one
MW 264; mp 210-211°C (Chuang et al., 1939)
Colourless plates, mp 211-212°C (Bachmann and Holman, 1951)
c 18h 16o 2
6-Methoxy-ll,12,15,16-tetrahydrocyclopenta[a]phenanthren-17-one
[27343-47-1]
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MW 264; mp 175-176°C
'Lax 280 (4 -53)> 290 (4 -64)> 327 (2-92)> 342 (2-94)> 375 (2.99)nm 
vmax H -70, 12.20, 13.15/zm (Coombs et al., 1970)
^ '18-^ 1 6 ^ 2
(379) 16,17-Dihydro-cw-16,17-dihydroxy-ll-methyl-15//-cyclopen- 
ta[a]phenanthrene [42123-00-2]
MW 264; mp 181-182°C
Amax 227 (4.19), 255 (4.83), 281 (4.07), 292.5 (4.03), 305 (4.11),
323.5 (2.80), 338.5 (2.96), 354 (2.94) nm
vmax 3.02, 9.11, 12.20, 13.46^m (Coombs and Hall, 1973)
(377) 16,17-Dihydro-fra/z5-16,17-dihydroxy-ll-methyl-15H-
cyclopenta[a]phenanthrene
MW 264; mp 224-226°C [42123-09-1]
2max 227 (4.22), 256 (4.85), 281 (4.07), 292.5 (4.04), 305 (4.13),
323 (2.82), 338.5 (2.97), 354 (2.98) nm
vm3X 3.05, 9.36, 12.12, 13.42/on (Coombs and Hall, 1973)
(389) 16,17-Dihydro-cw-16,17-dihydroxy-17-methyl-15i/-cyclopen- 
ta[a]phenanthrene [42202-82-4]
MW 264; mp 171-172°C
Amax 215 (4.56), 251 (4.73), 257.5 (4.84), 279 (4.18), 287.5 (4.08),
299 (4.19), 320 (2.65), 334 (2.84), 351 (2.82) nm 
vmax (KBr) 2.94, 8.56, 8.63, 8.95, 9.30, 12.15, 13.30//m
(Dannenberg et al., 1960)
^ 18^ 1 6 ^ 3
(194) 11,12,13,14,15,16-Hexahydro-3-methoxycyclopenta[a]- 
phenanthrene-11,17-dione
MW 250; mp 126-127°C (Koebner and Robinson, 1938)
c18H16o3
(338) ll-Methyl-17-oxo-6,7,15,16-tetrahydrocyclopenta[a]-
phenanthrene-c/s-6,7-diol
MW 280; mp 244-245°C
2max 232 (4.13), 308-314 (4.22)nm
vmax 2.90, 3.05, 5.96, 10.20, 10.38, 11.14, 12.04, 12.78, 13.10, 13.40, 
13.80, 14.46//m (Coombs, 1969)
-^"18^ 1 6 ^ 3
(457) 3a,4/J-Dihydroxy-ll-methyl-3,4,15,16-tetrahydrocyclopenta[a]- 
phenanthren-17-one
MW 280 (see Chap. 7 for spectral data) (Coombs et al., 1979; 1980)
^■18^ 1 6 ^ 3
(459) la,2/?-Dihydroxy-l 1-methyl-l ,2,15,16-tetrahydrocyclopenta[a]- 
phenanthren-17-one
MW 280 (see Chap. 7 for spectral data) (Coombs et al., 1979; 1980)
-^"18^ 1 6 ^ 4
(454) 11-Methyl-1,2,15,16-tetrahydro- l a ,2j3,15-trihydroxy-
cyclopenta[a]phenanthren-17-one
MW 296 (see Chap. 7 for spectral data)
(Coombs and Crawley, 1974; Coombs et al., 1980)
Physical and spectral properties
Ci8H160 4
(456) 11-Methyl-3,4,15,16-tetrahydro-3 a  ,4/?, 16-trihydroxy- 
cyclopenta[a]phenanthren-17-one
MW 296 (see Chap. 7 for spectral data) (Coombs et al., 1980)
^18^16^4
(455) 1 l-Methyl-3,4,15,16-tetrahydro-3a ,4/3,15-trihydroxy- 
cyclopentaja] phenanthren-17-one
MW 296 (see Chap. 7 for spectral data) (Coombs et al., 1980)
-^■18^ 16^ 5
(460) 8,9-Epoxy-la ,2/3,15-trihydroxy-11 -methyl-8,9-secogona-
3,5,7,9,ll,13-hexaen-17-one
MW 312; mp 120°C (decomp.), [ a } ¥ -214° (c. 0.134, EtOH)
Amax 267 (4.57), 320 (4.03), 332 (4.04), 352 (3.67), 370 (3.61) nm 
vmax 2.94-3.16, 5.91, 6.23, 9.62, 9.95^m
<3 H -l, 5.85 (J12 2); H-2, 4.36 (J12 2, J23 6); H-3, 6.30 (J23 6, J34 9); 
H-4, 6.85 (J34 9); H-6, 7.52 (J67 9); H-7, 8.48 (J67 9); H-12, 7.52; 
H-15, 5.76 (j15>16 2, J15>16 6); H -i6, 3.19 (J15>16 6, J1616 19); H-16,
2.60 (J1516 2, J1616 19); 11-CH3, 3.22 (Coombs and Crawley, 1974) 
C18H 180  (443) 3-Methoxy-6,7,16,17-tetrahydro-15/7-cyclopenta[a]phenan- 
threne
MW 250; mp 101-102°C (Robinson and Slater, 1941)
ClgH lgO (238) l,2,3,4,15,16-Hexahydro-ll-methylcyclopenta[a]phenanthren- 
17-one
MW 250; mp 150-152°C
2max 223 (4.23), 261 (4.77), 287 (3.97), 297.5 (4.02), 308 (3.87),
344 (3.69), 354 (3.74) nm 
vmax 5.95, 11.5, 12.45/im  
m/z  250.13574 (M+), 235, 222, 207, 194, 179
(Coombs and Bhatt, 1973) 
ClgHlgO (86) 11,12,13,14,16,17-Hexahydro-12-methyl-15/7-cyclopenta[a]- 
phenanthren-11-one 
MW 250 
12/3-methyl, mp 85-86°C
12a-methyl, mp 117-118°C (Butenandt et al., 1946a)
c 18h 18o 4
(462) l,2,3,4,15,16-Hexahydro-la,2/J,15-trihydroxy-ll-
methylcyclopenta[a]phenanthren-17-one
MW 298; mp 225-227°C
2max 260 (4.70), 285 (3.89), 295 (3.94), 342 (3.46), 354 (3.49)nm
(Coombs and Crawley, 1974) 
C18H20O (441) 6,7,8,14,16,17-Hexahydro-3-methoxy-15H-cyclopenta[a]- 
phenanthrene
MW 252; mp 82-85°C (Robinson and Slater, 1941)
C18H20O2
(427) 11,12,13,14,16,17-Hexahydro-l l-hydroxy-3-methoxy-15H- 
cyclopenta[a]phenanthrene
MW 268; mp 141—142°C (Robinson and Rydon, 1939)
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C 18H 20O 2
(437) 3-Methoxy-6,7,8,12,13,14,16,17-octahydro-15//-cyclopenta[a]- 
phenanthren-12-one
MW 268; mp 192°C (Robinson and Slater, 1941)
-^"18^ 20^ 2
3-Methoxy-6,7,8,12,13,14,15,16-octahydrocyclopenta[a]phenanthren- 
15-one
MW 268; mp 142°C (Nazarov et al., 1953)
"^18^ 20^ 2
3-Methoxy-6,7,8,12,13,14,15, 16-octahydrocyclopenta[a]phenanthren- 
17-one
MW 268; bp 210-215°C/0.5mm (Nazarov et al., 1953)
ClgH220  (313) 6,7,8,9,ll,12,13,14,15,16-Decahydro-l-methylcyclopenta[a]- 
phenanthren-17-one
MW 254; mp 85-88°C (Coombs and Vose, 1974)
ClgH220  (93) l,2,3,4,ll,12,13,14,16,17-Decahydro-7-methyl-15i7- 
cyclopenta[a]phenanthren-l 1-one 
MW 254; mp 102-103°C (Butenandt et al., 1949a)
•^max 261, 311 nm
CjgHjjOj
(22) 6,7,8,9,11,12,13,14,15, 16-Decahydro-3-methoxycyclopenta[a]-
phenanthren-17-one
MW 270
mp 13/S, 149-150°C; 13a, 120-121°C (Loke et al., 1958)
mp 13/S, 161-163°C; 13a, 121-122°C (Johns, 1958)
mp 13/S, 163-164°C; 13a, 120-122°C (Coombs and Vose, 1974)
C H O
(439) 12-Hydroxy-3-methoxy-6,7,8,12,13,14,16,17-octahydro-15i7- 
cyclopenta[a]phenanthrene
MW 270; mp 157-161°C (Robinson and Slater, 1941)
C18H220 2
3-Methoxy-6,7,8,9,ll,12,13,14,15,16-decahydrocyclopenta[a]-
phenanthren-15-one
MW 270; two isomers, mp 160-160.3°C and 116-117°C
(Nazarov et al., 1953)
c 19h 14o 2
(341) 17-Acetoxy-1577-cyclopenta[a]phenanthrene [24684-52-4]
MW 274; mp 210-211°C
2max 222 (4.48), 269 (4.91), 273 (4.92), 291 (4.28), 312 (3.89),
329 (2.91), 345 (2.83), 363 (2.66) nm
Vmax 5.72, 8.24, 11.00, 12.02, 12.28, 12.85, 13.34, 13.88/mi
(Coombs, 1969)
c 19HiA
(397) 2-Acetoxy-15,16-dihydrocyclopenta[a]phenanthren-17-one 
[55651-44-0]
MW 290; mp 248-249°C
2max 265.5 (5.84), 282.5 (4.46), 296 (4.36), 352 (3.37), 369 (3.39) nm
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vmax 5.70 (acetate), 5.90 (aryl CO), 9.85, 10.75^ 111 
(5 3.44 (15-H2), 2.83 (16-H2), 2.39 (acetate Me)
(Coombs et al., 1975)
c 19h 14o 3
(80) ll-Acetoxy-15,16-dihydrocyclopenta[a]phenanthren-17-one 
[24684-58-0]
MW 290; mp 207°C (Robinson, 1938)
c19H14o3
(343) 16-Acetoxy-15,16-dihydrocyclopenta[a]phenanthren-17-one 
[24684-53-5]
MW 290; mp 178°C
K™ 266 (4 -92)> 2§4 (4.50), 297 (4.39), 352 (3.31), 370 (3.32)nm 
V m a x  5.70, 8.16, 5.81, 12.14, 12.40, 12.92, 13.16/on (Coombs, 1969) 
d 3.25 (J 4,17) and 4.3 (J 7.5,17) (H-15), 5.63 (J 4,7.5)
(Coombs et al. , 1973a)
C 1 9 H 1 4 O 3
(365) 15-Acetoxy-15,16-dihydrocyclopenta[a]phenanthren-17-one 
[50905-55-0]
MW 290; mp 197-198°C
2max 269 (4 -76)> 297 (4-26), 330 (3.10), 349 (3.09), 366 (3.07) nm 
vmax 5.74, 5.84, 9.78, 11.69, 12.19, 13.20/im
(Coombs et al., 1973a)
c19H14o4
(186) l,6-Dimethoxy-cyclopenta[a]phenanthrene-15,17-dione 
MW 306; Deep yellow needles, mp 281-283°C
(Fieser and Hershberg, 1936) 
C19H16 (135) ll,17-Dimethyl-15H-cyclopenta[a]phenanthrene [5831-10-7]
MW 244; mp 149-150°C
Amax 222 (4.32), 270 (4.70), 276.5 (4.81), 295 (4.13), 306 (4.13),
317 (3.69), 350 (2.93), 368 (2.83)nm
vmax 10.90, 11.52, 12.20, 13.06, 13.32, 13.86/im (Coombs, 1966b)
C19H16 (136) 12,17-Dimethyl-15//-cyclopenta[a]phenanthrene [5831-09-4]
MW 244; mp 161-162°C
2max 222.5 (4.38), 272 (4.81), 276 (4.81), 290 (4.27), 318 (3.88),
349 (2.71), 367 (2.43) nm
vma* 10-96, 11.44, 12.28, 12.34, 13.15, 13.34 pm  (Coombs, 1966b)
C19H160  (347) 12-Acetyl-16,17-dihydro-15/7-cyclopenta[a]phenanthrene 
[2960-75-0]
MW 260; mp 128°C
Amax 242 (4.50), 262 (4.66), 290.5 (4.03), 320.5 (4.16), 350 (3.50),
369 (3.43) nm
vmax 5.99, 11.45, 12.20, 13.30/mi
<5 (CC14) 2.68 (3H, methyl), 2.0-3.5 (6H ), 7.4-7.9 (5H, aromatic), 
8.4-8.9 (2H, aromatic) (Dannenberg et al., 1965)
C19H160  (309) 15,16-Dihydro-7,ll-dimethylcyclopenta[a]phenanthren-17-one 
[85616-56-4]
MW 260; mp 208-210°C
Amax 275 (4.76), 293 (4.48), 307 (4.29), 368 (3.46), 389 (3.51)nm 
vmax 5.96/im
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6 2.65 (H-16), 2.82 and 2.98 (methyls), 3.63 (H-15)
(Ribeiro et al. , 1983)
C19H 160  (131) 15,16-Dihydro-ll,12-dimethylcyclopenta[a]phenanthren-17-one 
[894-52-0]
MW 260; mp 149-150°C
Amax 218 (4.09), 264 (4.88), 292 (4.45), 304 (4.32), 349 (3.05),
366 (3.34), 383 (3.40)nm
Vmax 5.94, 11.40, 12.38, 13.26, 14.00^m
d 2.70 (H-16), 2.75 (methyls), 3.17 (H-15) (Coombs, 1966a)
C19H 160  (211) 15,16-Dihydro-ll-ethylcyclopenta[a]phenanthren-17-one 
[42028-27-3]
MW 260; mp 129-130°C
Amax 264.5 (4.91), 289 (4.47), 302 (4.33), 360 (3.51), 378 (3.54)nm 
vmax 5.88, 12.38, 13.36, 13.90, 14.54/mi (Coombs et al., 1973b) 
C19H 160  (253) 15,16-Dihydro-12-ethylcyclopenta[a]phenanthren-17-one
MW 260; mp 206.5-207°C (Riegel et al., 1948)
C19H 160  (50) 16,17-Dihydro-17-ethylcyclopenta[a]phenanthren-15-one 
MW 260; mp 110-111.2°C (Riegel et a l ,  1943)
Oxime, mp 169-170.8°C 
C19H 160  (134) 3-Methoxy-17-methyl-15//-cyclopenta[a]phenanthrene 
MW 260; mp 204-205°C
Amax 223 (4.28), 273 (4.84), 294 (4.22), 304 (4.16), 318 (4.10),
338 (2.92), 355 (3.04), 374 (3.03) nm
vmax 10.94, 11.64, 12.22, 13.10, 13.82/mi (Coombs, 1966b)
C19H 160  (138) ll-Methoxy-17-methyl-157/-cyclopenta[a]phenanthrene 
[5831-12-9]
MW 260; mp 159-160°C
Amax 221 (4.37), 272 (4.70), 280 (4.74), 287 (4.63), 324 (3.69),
339 (3.29), 356 (3.49), 374 (3.57)nm
vmax 10.92, 11.95, 12.10, 12.20, 12.55, 13.10, 13.35, 13.90^m
(Coombs, 1966b)
c 19h 16o 2
(333) 15-Acetoxy-16,17-dihydro-15//-cyclopenta[a]phenanthrene 
MW 276; mp 127-128°C (Badger et al., 1952)
C 19H 1 6 ° 2
(390) 15,16-Dihydro-ll-ethoxycyclopenta[a]phenanthren-17-one 
[83053-57-0]
MW 276; mp 191-193°C
Amax 261 (4.91),291 (4.54), 362(3.98),381 (4.00) nm (Bhatt et al., 1982)
^19^16^2
(311) 15,16-Dihydro-4-methoxy-l-methylcyclopenta[a]phenanthren- 
17-one
MW 276; mp 199-200°C 
Amax 262, 302, 366, 384 nm
<5 2.80 (H-16), 3.07 (methyl), 3.40 (H-15), 4.03 (O-methyl)
(Coombs et al. , 1985)
C 19H 1 6 ° 2
(468) 15,16-Dihydro-6-methoxy-ll-methylcyclopenta[a]phenanthren- 
17-one [24684-49-9]
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MW 276; mp 203-205°C
vmax 5.86, 12.26, 13.18, 13.78/im (Coombs, 1969)
c 19h 16o 2
(447) 15,16-Dihydro-ll-methoxy-7-methylcyclopenta[a]phenanthren- 
17-one [30835-61-1]
MW 276; mp 215-216°C
Amax 267 (4.81), 293.5 (4.37), 321 (3.92), 355 (3.44), 373 (3.74),
393 (3.81) nm (Coombs and Jaitly, 1971)
c 19h 16o 2
(368) 15,16-Dihydro-15-methoxy-ll-methylcyclopenta[a]- 
phenanthren-17-one [83053-62-7]
MW 276; mp 158°C
Amax 265, 299.5, 355, 373 nm (Bhatt et al., 1982)
c19H16o2
(407) 17-(16,17-Dihydro-15//-cyclopenta[a]phenanthryl)-acetic acid 
MW 276; mp 164-166°C
Amax 215 (4.56), 259 (4.74), 280 (4.19), 288 (4.10), 300 (4.10),
320 (2.65), 327.5 (2.47), 333 (2.83), 342.5 (2.41), 351 (2.83)nm 
vmax 3.32, 3.75, 3.85, 5.87, 12.35, 1 3 .3 7 ^
(Dannenberg and Dannenberg-von Dresler, 1964)
c19H16o3
(111) 8 , 12,13,14,16,17-Hexahydro-15i7-cyclopenta[a]phenanthrene-
13.14-dicarboxylic acid anhydride
MW 292; mp 172-173°C (Sen Gupta and Bhattacharyya, 1954)
c 19h 16o 3
(112) ll,12,13,14,16,17-Hexahydro-15H-cyclopenta[a]phenanthrene-
13.14-dicarboxylic acid anhydride
MW 292; Flakes, mp 183°C (Sen Gupta and Bhattacharyya, 1954)
c 19h 160 3
(426) 15,16-Dihydro-3,1 l-dimethoxycyclopenta[a]phenanthren- 
17-one
MW 292; mp 200-201°C (Robinson, 1938)
c 19h I6o 3
(387) 15-(16-O xo-ll,12,13,17-tetrahydro-16/f-cyclopenta[a]- 
phenanthryl)-acetic acid
MW 292; mp 221-223°C (Turner, 1949)
C19H 17C1
(172) 3-Chloro-15,17-dihydro-17,17-dimethylcyclopenta[a]- 
phenanthrene [13914-44-8]
MW 280.5; mp 134°C
Amax 220 (4.66), 224 (4.67), 255 (4.78), 261 (4.84), 283 (4.24),
292 (4.18), 304 (4.26), 323 (2.99), 331 (2.74), 338 (3.24), 347 (2.75), 
355 (3.31) nm
vmax (KBr) 11.10, 11.62, 11.94,12.09^m
(Dannenberg and Hebenbrock, 1966)
c 19h 17n o
(354) 6-Acetamido-16,17-dihydro-15//-cyclopenta[a]phenanthrene 
[2960-73-8]
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MW 275; mp 273°C
2max 262 (4.68), 291 (3.97), 304 (4.02), 338 (2.96), 350 (2.81)nm 
vmax 3.09, 6.05, 6.51, 11.55, 12.35, 13.25pm
(Dannenberg et al., 1965)
c 19h 17n o
(348) 12-Acetamido-16,17-dihydro-15//-cyclopenta[a]phenanthrene 
[2960-79-4]
MW 275; mp 248°C
Amax 222.5 (4.48), 242.5 (4.49), 262.5 (4.81), 303 (4.17), 312 (4.03) nm
vmax 3.05, 6.01, 6.46, 11.52, 12.26, 13.45.am
<3 2.0-3.5, 7.3-8.0 (5H, aromatic), 8.0-8 .6 (2H, aromatic),
8.1 (singlet) (Dannenberg et al., 1965)
C19H18 (99) 16,17-Dihydro-2,12-dimethyl-15//-cyclopenta[a]phenanthrene
[3974-81-0]
MW 246; mp 136-137°C (Butenandt et al., 1946c)
Xmsx 264 (4.71), 284 (4.10), 292 (3.98), 305 (4.08), 322 (2.75),
339 (2.87), 355 (2.84) nm (Dannenberg and Steidle, 1954) 
vmax (CS2) 11.60, 12.05/«n (Dannenberg et al., 1953)
C19Hlg (71) 16,17-Dihydro-3,17-dimethyl-15//-cyclopenta[a]phenanthrene
MW 246; mp 139-140°C (Kon and Woolman, 1939)
C19Hlg (101) 16,17-Dihydro-4,12-dimethyl-15//-cyclopenta[a]phenanthrene 
[63020-70-2]
MW 246; mp 106-107°C (Butenandt et al., 1949b)
Amax 250 (4.59), 264 (4.70), 286 (4.03), 296.5 (4.02), 308.5 (4.13),
339.5 (2.63), 356 (2.24) nm (Dannenberg and Steidle, 1954)
vmax (CS2) 11.62, 12.35, 13.27/cm (Dannenberg et al., 1953)
C19H 18 (110).16,17-Dihydro-4,17-dimethyl-15//-cyclopenta[a]phenanthrene 
[63020-71-3]
MW 246; mp 130-131°C (Inhoffen et al., 1949); 134.5-136°C 
(Woodward et al. , 1953)
Amax 216 (4.58), 255 (4.72), 262.5 (4.80), 283 (4.18), 293 (4.16),
306 (4.27), 322.5 (2.77), 338 (2.84), 254 (2.73)nm (Dannenberg and 
Neumann, 1961a)
vmax (CS2) 12.34, 12.67jum (Dannenberg et al., 1953)
C19H18 (68) 16,17-Dihydro-6,17-dimethyl-15//-cyclopenta[a]phenanthrene
MW 246; mp 80°C (Gamble and Kon, 1935); 78-78.5°C 
(Butenandt and Suranyi, 1942)
2max 271 (4.82), 282 (4.18), 290 (4.06), 303.5 (4.10), 323 (2.75),
337 (2.88), 354 (2.84) nm (Dannenberg and Steidle, 1954) 
vmax (CS2) 11.47, 12.22, 13.27/cm (Dannenberg et al., 1953)
C19HI8 (105) 16,17-Dihydro-6,7-dimethyl-15T/-cyclopenta[a]phenanthrene 
[63020-72-4]
MW 246; mp 98-99°C (Butenandt et al., 1946a)
Amax 263.5 (4.78), 286 (4.15), 296.5 (4.04), 307 (3.95), 327 (2.86),
342 (3.02), 358 (3.12) nm (Dannenberg and Steidle, 1954) 
vmax (CS2) 12.25, 13.00, 13.31/*m (Dannenberg et al., 1953)
C19H18 (87) 16,17-Dihydro-ll,12-dimethyl-157/-cyclopenta[a]phenanthrene
[63020-69-9] MW 246; mp 105-106°C (Butenandt et al., 1946a)
108 Physical and spectral properties
Amax 261 (4.73), 288 (3.96), 300 (3.98), 311 (4.01), 343 (2.83),
360 (2.72) nm 
vmm 12.32, 13.37^/m
(Dannenberg and Steidle, 1954) 
(Dannenberg et al. , 1953)
C19H18 (139) 16,17-Dihydro-l 1,17-dimethyl-15/f-cyclopenta[a]phenanthrene
[5831-16-3]
MW 246; mp 65°C
Amax 219 (4.45), 227 (4.19), 257 (4.80), 294 (4.02), 306 (4.07),
324 (2.85), 339 (3.00), 355 (3.03) nm
rmax 11.40, 12.02, 12.24, 13.28, 13.40, 13.94, 14.60.um
C19H18 (140) 16,17-Dihydro-12,17-dimethyl-15H-cyclopenta[a]phenanthrene
[5831-15-2]
MW 246; mp 56-57°C
Amax 217 (4.63), 261 (4.83), 290 (4.06), 303 (4.13), 321 (2.57),
337 (2.64), 353 (2.41) nm
vmax 11.50, 12.22, 13.42.um (Coombs, 1966b)
C19H 18 (255) 16,17 Dihydro-12-ethyl-15//-cyclopenta[a]phenanthrene
[7478-25-3]
MW 246; mp 64.5-65°C (Riegel et al., 1948)
C19H18 (52) 16,17-Dihydro-17-ethyl-15//-cyclopenta[a]phenanthrene
[17290-34-5]
MW 246; Irregular platelets, mp 85-86°C (Riegel et al., 1943); 78- 
79°C (Schontube and Janak, 1968)
Picrate, mp 94.8-96.4°C  
C19H lgO (58) 16,17-Dihydro-3-methoxy-15-methyl-15i/-cyclopenta[a]phenan-
C19H lgO 12,12-Dimethyl-11,12,15,16-tetrahydrocyclopenta[a]phenanthren-17- 
one [5837-18-3]
MW 262; mp 186-187°C
Amax 219 (4.87), 241 (4.11), 251 (4.16), 262 (4.57), 270 (4.89),
281 (5.00), 324 (4.48), 336 (4.51), 362 (4.25)nm
vmax 5-90> 10-10’ 12-30> 12-78> 13.22.um
<5 1.32 (6H,s,two geminal methyls), 314 (2H ,s,C -ll methylene),
2.90 (2H,m,C-15 methylene), 2.7 (2H,m,C-16 methylene)
(Coombs, 1966a)
C19H 180  (57) 16,17-Dihydro-3-methoxy-16-methyl-15//-cyclopenta[a]phenan- 
threne
MW 262; mp 136.5-137.5°C (Cohen et al., 1935)
C19H lgO (17) 16,17-Dihydro-3-methoxy-17-methyl-15//-cyclopenta[a]phenan- 
threne
MW 262; mp 147.5-148.5°C (Cohen et al., 1935); 149-150°C 
(Coombs, 1966b)
Amax 212 (4.42), 225 (4.30), 236 (4.36), 261 (4.82), 282 (4.20),
291 (4.12), 302 (3.95), 326 (2.83), 341 (3.16), 358 (3.28) nm 
vmax 11.64, 12.28, 12.45, 13.80.um (Coombs, 1966b)
C19H180  (62) 16,17-Dihydro-6-methoxy-17-methyl-15//-cyclopenta[a]phenan- 
threne
(Coombs, 1966b)
threne
MW 262; mp 97.5-98°C (Cohen et al., 1935)
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MW 262; mp 111°C (Kon and Ruzicka, 1935)
C19H180  (142) 16,17-Dihydro-ll-methoxy-17-methyl-15H-cyclopenta[a]- 
phenanthrene
MW 262; Viscous syrup, bp 80°C/10~3 mm 
2max 218-220 (4.42), 228 (4.45), 246.5 (4.60), 252.5 (4.59), 276 (4.44), 
298 (3.95), 330 (3.25), 345 (3.55), 362 (3.65) nm 
vmax 11-92, 12.26, 12.56, 13.30, 13.96/mi (Coombs, 1966b)
C19HlgO 7,ll-Dimethyl-ll,12,15,16-tetrahydrocyclopenta[a]phenanthren-17- 
one [85616-55-3]
MW 262; mp 145-146°C
Amax 265 (4.47), 274 (4.75), 285 (4.84), 335 (4.39) nm 
v max 5.94, 6.13, 6.20/an
d 1.06 (3H,d,J 7 Hz, CUMe),  2.68 (3H,s,aryl methyl)
(Ribeiro et al. , 1983) 
C19H18 O (250) 12-Ethyl-l 1,12,15,16-tetrahydrocyclopenta[a]phenanthren- 
17-one
MW 262; mp 102-103°C (Riegel et al., 1948)
CjgHjgOj
(332) 3,1 l-Dimethoxy-6,7,15,16-tetrahydrocyclopenta[a]phenanthren- 
17-one
MW 294; mp 143°C (Robinson and Rydon, 1939); 142-143°C 
(Corey and Estreicher, 1981) 
dinitrophenylhydrazone, mp 242-243°C
(Robinson and Rydon, 1939)
Ci9h 18o 3
(235) ll-Acetoxy-l,2,3,4,15,16-hexahydrocyclopenta[a]phenanthren- 
17-one
MW 294; mp 207-208°C
222 (4.27), 257.5 (4.84), 286 (4.00), 296 (4.04), 307 (3.91),
340 (3.72), 352 (3.81) nm
vmax 5.69, 5.89, 8.30, 9.60, 10.50, 12.40/mi
(Coombs and Bhatt, 1973)
1^9-^ 18^ 3
(201) 17,17-Ethylenedioxy-l 1,12,13,14,15,16-hexahydrocyclopen- 
ta[a]phenanthren-l 1-one 
MW 294; mp 98°C 
2max 216.5, 244, 310nm
vmax 6.05/«n (Coombs, 1965)
C19Hlg03
(85) 12-Carbomethyoxy-l 1,12,13,14,16,17-hexahydro-15//-cyclopen- 
ta[a]phenanthren-l 1-one
MW 294; mp 149-150°C (Butenandt et al., 1946a)
C19H20O (353) 6-Acetyl-11,12,13,14,16,17-hexahydro-15//-cyclopenta[a]- 
phenanthrene [2960-76-1]
MW 264; mp 73°C
Amax 228 (4.64), 312 (3.84), 333 (3.78) nm 
vmax 5.96, 11.30, 13.08//m
<5 2.73, 3.24, 7.1-7.9, 8.65 (Dannenberg et al., 1965)
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C 1 9 H 2 0 O 3
(199) 17,17-Dimethoxy-8,9,11,12,13, 14-hexahydrocyclopenta[a]- 
phenanthren-ll-one
MW 296 
vmax 5.85
<5 6.9-7.3 (4H,m), 5.8-6.3 (4H,m), 3.17 (3H,s), 3.09 (3H,s),
2.3-3.5 (6H,m)
m/z  296 (M+), 264 (M+ -M eOH), 262 (M+ -MeOH-H2)
(Jung and Hudspeth, 1978) 
C19H22 (48) ll,12,13,14,16,17-Hexahydro-14,17-dimethyl-15/7-cyclopenta[a]-
phenanthrene
MW 250; bp 160°C/0.4mm, nD 1.60681 (Harper et al., 1934)
C19H220  (56) 11,12,13,14,16,17-Hexahydro-3-methoxy- 14-methyl-15/7- 
cyclopenta[a]phenanthrene
MW 266; Thick yellowish gum which refused to crystallize 
Nitrobenzene derivative scarlet needles, mp 110-110.5°C
(Cohen et al. , 1935) 
C]9H220  (63) ll,12,13,14,16,17-Hexahydro-3-methoxy-17-methyl-15H- 
cyclopenta[a]phenanthrene
MW 266; mp 13-1TC  (Hoffsomner et al., 1966)
C19H240  (16) 3-Methoxy-17-methyl-6,7,8,9,ll,12,14,15-octahydro-16H- 
cyclopenta[a]phenanthrene
MW 268; mp 141-146°C (Cohen et al., 1935)
C H O
(200) 17,17-Dimethoxy-6,7,8,9,ll,12,13,14,16,17-decahydro-15if- 
cyclopenta[a]phenanthren-11-one
MW 300
d 3.95 (2H,d,Jg9 10 Hz) (Jung and Hudspeth, 1978)
c 20h 15n o 3
(430) 15,16-Dihydro-3,ll-dimethoxy-16-cyanocyclopenta[a]- 
phenanthren-17-one
MW 317 (Robinson and Rydon, 1939)
C20Hi6 (422) 17-Isopropylidenecyclopenta[a]phenanthrene [5830-65-9]
MW 256: Bright yellow leaflets, mp 188-189°C
2max 214 (4.44), 228 (4.50), 270 (4.63), 302 (4.67), 310 (4.77),
347 (3.61), 366 (3.50) nm
vmax 6.10, 11.66, 12.00, 12.14, 12.50, 13.20/im (Coombs, 19666) 
C20H 16 (424) 17-(2-Propenyl)-15//-cyclopenta[a]phenanthrene [5837-12-7]
MW 256: Colourless needles, mp 255°C
2max 223 (4.40), 271 (4.74), 276 (4.75), 295 (4.30), 3.16 (3.40)nm 
vmax 10.20, 10.90, 12.08, 12.38, 12.86, 13.48, 1 4 .6 0 ^
(Coombs, 19666)
c 20h 16o 2
(342) 17-Acetoxy-ll-methyl-157/-cyclopenta[a]phenanthrene 
MW 288 (Coombs, 1969)
^20^16^3
(469) 6-Acetoxy-15,16-dihydro-ll-methylcyclopenta[a]phenanthren- 
17-one [24684-48-8]
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MW 304; mp 225-227°C (Coombs, 1969)
^ 2 o H l 6 ^ 3
(227) 1 l-Acetoxy-15,16-dihydro-7-methylcyclopenta[a]phenanthren- 
17-one
MW 304; mp 243-244°C
5 2.92 (3H,s,aryl methyl), 2.49 (3H,s,acetate), 2.80 (2H,m,
C-16 methylene), 3.76 (2H,m,C-15 methylene)
(Coombs and Jaitly, 1971)
^ 2 o H l 6 ^ 3
(72) ll-Acetoxy-15,16-dihydro-3-methylcyclopenta[a]phenanthren- 
17-one
MW 304; mp 224°C (Kon and Woolman, 1939)
^ 2 o H l 6 ® 3
(366) 15-Acetoxy-15,16-dihydro-ll-methylcyclopenta[a]phenanthren- 
17-one [55651-30-4]
MW 304; mp 209-210°C
Amax266 (4.81), 301 (4.30), 356 (3.11), 374 (3.19) nm
(Coombs et al., 1975)
^ 2 o H l 6 ® 3
(344) 16-Acetoxy-15,16-dihydro-ll-methylcyclopenta[a]phenanthren- 
17-one [24684-55-7]
MW 304; mp 156-157°C
263 (4.87), 288 (4.52), 301 (4.35), 342 (3.12), 357 (3.37),
375 (3.42) nm
vmsx 5.72, 5.81, 8.10, 12.02, 12.14, 12.90, 13.18, 13.30, 13.96/«n
(Coombs, 1969)
Q o H i 6 ® 3
ll-Acetoxymethyl-15,16-dihydrocyclopenta[a]phenanthren-17-one
[55651-35-9]
MW 304; mp 175-176°C
l maj 265 (4.88), 285 (4.50), 300.5 (4.36), 356 (3.32), 373 (3.44) nm 
<5 (CD3SOCD3), 2.08 (s,acetate), 2.82 (m,16-H2), 3.12 (m,15-H2),
5.32 (s,11-CH2)
m/z 304 (M+, 100%), 245 (M+-CH3C 0 2, 20%), 231 
(M+-CH2C 0 2CH3, 30%) (Coombs et al. , 1975)
C 20H 1 6 ° 4
(190) ll-Acetoxy-15,16-dihydro-3-methoxycyclopenta[a]phenanthren- 
17-one
MW 320; mp 241-242°C (Robinson and Rydon, 1939)
C 20H 16O 4
(429) 15,16-Dihydro-3 ,ll-dimethoxy-16-formylcyclopenta[a]- 
phenanthren-17-one
MW 320; mp 195°C (decomp.) (Robinson and Rydon, 1939)
C20Hlg 17-Ethyl-17-methylcyclopenta[a]phenanthrene 
MW 258;. mp 117°C, [ a ] F -63 .8° (ethanol)
'Lx 221 (4 -78), 242 (4 -51)> 265-5 (4 -63)> 295 (4.01), 307 (4.16),
319 (4.15), 345 (3.03), 361 (2.62)nm
(Dannenberg and Neumann, 1961b)
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C20H18 (388) 17-Isopropyl-15//-cyclopenta[a]phenanthrene
MW 258; mp 153°C (Coombs, 1966b); 154-156°C (Dannenberg et 
a l ,  I960)
Amax 224 (4.31), 271 (4.70), 275 (4.71), 316 (4.02) nm 
vmax 10.26, 10.90, 11.50, 12.22, 12.90, 13.34, 13.66/im
(Coombs, 1966b)
C20H18 (425) 17-Isopropyl-17//-cyclopenta[a]phenanthrene [5830-63-7]
MW 258; mp 106-107°C
2max 221 (4.66), 240 (4.33), 269 (4.65), 274 (4.60), 292.5 (4.07),
303 (4.08), 317 (3.95)nm
vmax 10.30, 10.52, 10.76, 10.90, 11.50, 12.30, 13.00, 13.26, 13.65,
14.00/an (Coombs, 1966b)
C20H18 (137) ll,12,17-Trimethyl-15//-cyclopenta[a]phenanthrene [5831-11-8]
MW 258; mp 126-126.5°C 
Amax 219 (4.35), 280 (4.93), 311 (4.14), 355 (2.78)nm 
vmax 10.90, 12.30, 13.18, 13.34, 13.64, 14.90/nn (Coombs, 1966b) 
C20H18O (254) 15,16-Dihydro-12-isopropylcyclopenta[a]phenanthren-17-one
MW 274; mp 183.5-184°C (Riegel et al., 1948)
C20H 18O (73) 3 ,17-Dimethyl-ll-methoxy-15if-cyclopenta[a]phenanthrene 
[5831-18-5]
MW 274; mp 130-131°C (Kon and Woolman, 1939)
C20H 18O (51) 16,17-Dihydro-17-isopropylcyclopenta[a]phenanthren-15-one 
MW 274; mp 143.6-144.4°C (Riegel et al. , 1943) 
oxime, mp 205-211°C 
C20H 18O (165) 3-Hydroxy-l,17,17-trimethylcyclopenta[a]phenanthrene 
[isolated as its acetate C22H20O2:
MW 316; mp 121-122°C 
Xmax 263, 297, 310, 322 
vmax 5-65> 8-13/an
6 1.42 (s,17-gem-diMe), 2.38 (s,3-OAc), 3.15 (s,l-M e),
6.75 (d,J 6, 16-H), 7.2-8.8 (m, olefinic and Ar H) 
m/z 316 (44%, M+), 275 (23%), 274 (100%, M+-CH2CO),
259 (29%), 244 (15%), 215 (15%)] (Brown and Turner, 1971)
^20^18^2
(391) 15,16-Dihydro-ll-n-propoxycyclopenta[a]phenanthren-17-one 
[83053-58-1]
MW 290; mp 181-182°C
Amax 262.5 (4.92), 292 (4.66), 363 (4.05), 382 (4.12) nm
(Bhatt et al., 1982)
^20^18^2
(392) 15,16-Dihydro-ll-isopropoxycyclopenta[a]phenanthren-17-one 
[83053-59-2]
MW 290; mp 172-173°C
Amax 261 (4.78), 292 (4.41), 364 (4.01), 384 (4.05) nm
(Bhatt et a l ,  1982)
-^"20^ 18^ 2
(408) 17-(16,17-Dihydro-15//-cyclopenta[a]phenanthyl)-2-propionic 
acid
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MW 290; mp 235-240°C
Amax 256 nm (Dannenberg, 1950)
-^"20^ 18^ 2
(409) 17-(16,17-Dihydro-15/7-cyclopenta[a]phenanthyl)-3-propionic 
acid
MW 290; mp 187-190°C
kmsx 215 (4.54), 259 (4.80), 280 (4.18), 288 (4.08), 300 (4.06),
320 (278), 327.5 (2.58), 335 (2.94), 342.5 (2.50), 350 (2.88)nm 
vmax 3-00> 3.80-3.85, 5.78, 13.20, 13.24^m
(Dannenberg and Dannenberg-von Dressier, 1964)
"^20^ 18^ 4
(84) 11,12,13,14,16,17-Hexahydro-12-methoxyoxalyl-15//-cyclopen- 
ta[a]phenanthren-l 1-one
MW 322; mp 157-158°C (Butenandt et al. , 1946a)
•^20^ 18^ 4
(216) 17,17-Ethylenedioxy-12-formyl-ll,12,13,14,15,16-hexahydro-
cyclopenta[a]phenanthren-l 1-one
MW 322; Large yellow prisms, mp 144-145°C
2max 218 (4.54), 254.5 (4.13), 362 (3.87) nm
vmax 6-24, 6.30,am (Coombs, 1966a)
C20H20 (36) 15,16-Dihydro-17-ethyl-17-methylcyclopenta[a]phenanthrene
[3750-94-5] [81943-50-2]
MW 260; mp 94-96°C, [a]D-2 8 °  (Bharucha et al., 1962); 97-98.5°C, 
[a]D—28.5° (Chinn and Mihina, 1965)
2max 216 (4.50), 220 (4.46), 253 (4.69), 280 (4.15), 287 (4.05),
300 (4.14), 319 (2.73), 326 (2.53), 334 (2.96), 340 (2.47),
350 (3.00) nm
vmax (CS2) 11-63, 12.28, 13.37, 13.96/jm (Bharucha et al., 1962)
C20H20 (467) 16,17-Dihydro-17-n-propyl-15//-cyclopenta[a]phenanthrene
MW 260; mp 88-89°C
vmax (CS2) 12.33, 13.39/*m (Dannenberg et al., 1953)
C20H20 (256) 16,17-Dihydro-12-isopropyl-15//-cyclopenta[a]phenanthrene
MW 260; mp 88.5-89°C (Riegel et al., 1948)
C20H20 (53) 16,17-Dihydro-17-isopropyl-15//-cyclopenta[a]phenanthrene
[5830-64-8]
MW 260; Thin plates, mp 97.6-98.4°C (Riegel et al., 1943); 85°, 
93°C (Coombs, 1966b)
Picrate, mp 108-113°C (Riegel et al., 1943)
C20H20 (69) 16,17-Dihydro-6,17,17-trimethyl-15//-cyclopenta[a]phenanthrene
[63642-51-3]
MW 260; mp 96-97°C (Butenandt and Suranyi, 1942)
2max 262 (4.82), 282 (4.18), 290 (4.06), 303.5 (4.10), 323 (2.76),
337 (2.87), 354 (2.80) nm (Dannenberg and Steidle,
1954)
vmax (CS2) 11.47, 12.22, 13.26pm  (Dannenberg et al., 1953)
C20H20 (141) 16,17-Dihydro-l 1,12,17-trimethyl-15//-cyclopenta[a]-
phenanthrene [5831-17-4]
MW 260; mp 75-77°C
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Amax 218 (4.33), 224.9 (4.26), 261 (4.71), 287 (3.98), 301 (3.97),
312 (4.01), 343 (3.17), 360 (3.07) nm
vmax 11.50, 12.12, 12.56, 13.30, 13.86/mr (Coombs, 19666)
C20H20O (74) 16,17-Dihydro-3,17-dimethyl-ll-methoxy-15//-cyclopenta[a]- 
phenanthrene
MW 276; mp 83-84°C (Kon and Woolman, 1939)
C20H20O (162) 15,16-Dihydro-3-hydroxy-l,17,17-trimethylcyclopenta[a]- 
phenanthrene 
MW 276; mp 142-144°C
Amax 263 (4.83), 285 (4.09), 295 (4.01), 306 (3.94), 344 (3.11),
362 (3.11) nm
vmax 3.01, 6.17, 10.00, 11.56, 12.27/mi (Brown and Turner, 1971) 
C » H » 0 ( 1 4 )
15,16-Dihydro-17,17-dimethyl-3-methoxycyclopenta[a]phenanthrene 
MW 276; mp 166-167°C (Cohen et al., 1935)
C20H20O (126) 16,17-Dihydro-ll-hydroxy-17-isopropyl-15//-cyclopenta[a]- 
phenanthrene
MW 276; mp 162°C (Birch and Robinson, 1944)
C20H20O (251) 12-Isopropyl-l 1, 12,15,16-tetrahydrocyclopenta[a]phenanthren- 
17-one
MW 276; mp 115-116°C (Riegel et al., 1948)
-^'20-^ 2 0 ^ 2
(400) 16,17-Dihydro-ds-16,17-dihydroxy-17-isopropyl-15//-
cyclopenta[a]phenanthrene
MW 292; mp 183°C
Amax 215 (4.56), 251 (4.75), 258 (4.87), 279 (4.21), 287 (4.10),
299 (4.21), 320 (2.67), 334 (2.86), 350 (2.85)nm
vmax 2.99, 9.22, 8.70, 12.30, 13.33,1ml (Dannenberg et al., 1960)
^ 20^ 2 0 ^ 3
(209) 17,17-Ethylenedioxy-l 1,12,13,14,15,16-hexahydro-12-
methylcyclopenta[a]phenanthren-ll-one
MW 308; mp 123-124°C
Amax 217 (4.61), 240 (4.32), 310 (3.81)nm
vmax 6.00/mi (Coombs, 1966a)
^ 20^ 2 0 ^ 4
(202) 17,17-E thylenedioxy-11,12,13,14,15,16-hexahydro-3 -methoxy-
cyclopenta[a]phenanthren-ll-one
MW 324; mp 114°C
Amax 221 (4.65), 246 (4.49), 310 (3.76)nm
vmax 6.00/mi (Coombs, 1966a)
-^"20^ 2 2 ^ 4
(213) 17,17-Ethylenedioxy-l 1,12,13,14,15,16-hexahydro-l 1-hydroxy-
ll-hydroxymethylcyclopenta[a]phenanthrene
MW 326; needles, mp 168-170.5°C
Amax 230.5 (4.92), 272.5 (3.74), 282 (3.76), 291 (3.62) nm
d 3.85 (lH ,d , J 11.5, H aCHbOH), 4.33 (lH ,d, J 11.5, HBCHAOH),
3.96 (4H,s,OCH2CH20 )
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m/z  326.1511 (M+, 35%), 380 (M+-H20 ,  20%), 295 
(M+-CH2OH, 100%), 99 (acetal ion, 89%) (Coombs et al., 1975) 
C20H24O (164) 3-H ydroxy-ll,12,13,14,15,16-hexahydro-l,17,17- 
trimethylcyclopenta[a]phenanthrene 
MW 280; mp 158-160°C 
2max 263, 283, 294, 307nm
V ra a x  3.13/^m
d 0.90 (s, methyl), 1.10 (s, methyl), 2.88 (s, 1-methyl), 6.80-
7.75 (4H, aromatic) (Brown and Turner, 1971)
C20H24O (123) 17-Isopropyl-6,7,8,9,ll,14,16,17-octahydro-15/7-cyclopenta[a]- 
phenanthren-11-one
MW 280; bp 193-195°C/0.08nm (Birch and Robinson, 1944) 
C20H26O (13) 17,17-Dimethyl-3-methoxy-6,7,8,9,ll,12,15,16-octahydrocyclo- 
penta[a]phenanthrene
MW 282; mp 58-60°C (Cohen et al., 1935)
C20H28O 6,7,8,9,11,12,13,14,15, 16-Decahydro-17a-ethyl-17-methylcyclopen- 
ta[a]phenanthren-3-ol 
MW 284; mp 152-153.5°C, [a]D-17°
2max 279.5, 286nm
vmax (KBr) 3.07, 6.22, 6.32jum (Chinn and Mihina, 1965)
C21H14 (416) 16,17-Benzo-15//-cyclopenta[a]phenanthrene
MW 266; mp 331-332°C
(Nasipuri and Roy, 1961; Ruzicka and Goldberg, 1937)
^ 2 1 ^ 1 8 ^ 2
(405) Ethyl 17-(cyclopenta[a]phenanthrylidene)-acetate 
MW 302; mp 183-184°C
m^ax 215 (4-34)> 274 (4-68), 285 (4.63), 299 (4.67), 314-324 (4.53),
355 (3.85), 373 (3.80) nm
vmax (KBr) 5.88, 6.13, 8.5-8.7, 9.63, 9.74, 11.65, 12.12, 12.43, 12.89, 
13.28/mi (Dannenberg et al., 1964)
c 21Hi8o 4
(109) cw-15,16-Diacetoxy-16,17-dihydro-15H-cyclopenta[a]- 
phenanthrene [42122-92-9]
MW 334; mp 189-191 °C
2max 223 (4-29), 255 (4.76), 279 (4.13), 287.5 (4.06), 299.5 (4.11),
319 (2.58), 325.5 (2.49), 334 (2.59), 340 (2.35), 350 (2.23) nm 
vmax 5.90, 12.26, 13.25/im (Coombs and Hall, 1973)
C 21H 1 8 ° 4
cis-16,17-Diacetoxy-16,17-dihydro-15H-cyclopenta[a]phenanthrene 
[42122-93-0]
MW 344; mp 173-175°C
2 m a x  249.5 (4.74), 256.5 (4.87), 278.5 (4.20), 286 (4.09), 298 (4.18),
319.5 (2.63), 327.5 (2.48), 333.5 (2.82), 343 (2.43), 350 (2.82) nm 
vmax 5.75, 12.24, 13.26/«n
d Ha-15, 3.42 (J 16,5); HB-15, 3.70 (J 16,7); H-16, 4.28 m;
H-17, 6.42 d (J 6) (Coombs and Hall, 1973)
C21H20 l,17-Dimethyl-17-ethylcyclopenta[a]phenanthrene
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MW 272; mp 123-124°C, [a]ly  -5 6 .2  (alcohol)
Amax 224 (4.70), 244 (4.40), 266 (4.64), 297.5 (4.01), 309 (4.32),
322 (4.23), 347 (2.91), 364 (2.63) nm
(Dannenberg and Neumann, 1961b) 
C21H20O (212) ll-n-Butyl-15,16-dihydrocyclopenta[a]phenanthren-17-one 
[63642-51-3]
MW 288; mp 113-114°C
Amax 264.5 (4.90), 289.5 (4.45), 302 (4.32), 360 (3.41), 377 (3.46)nm 
vmax 5.90, 11.44, 12.72, 13.40, 14.08pm  (Coombs et al., 1973b)
C2\H20O2
(393) ll-n-Butoxy-15,16-dihydrocyclopenta[a]phenanthren-17-one 
[83053-60-5]
MW 304; mp 156-157°C
Amax 261.5 (4.87), 292 (4.44), 363.5 (3.76), 382 (3.82) nm
(Bhatt et al. , 1982)
C2iH20O2
(410) 17-(16,17-Dihydro-15//-cyclopenta[a]phenanthryl)-3-butyric 
acid
MW 304; mp 157-159°C
Amax 257 (4.79) nm (Dannenberg, 1950)
C2iH20O6
(118) l,2,3,4,5,6,7,ll,12,13,16,17-Dodecahydro-15H-cyclopen- 
ta[a]phenanthrene-6,7,11,12-tetracarboxylic-acid-6,7,11,12-dian­
hydride
MW 368; mp 249-251°C
Amax 255.5 (4.28) nm (Butz et al., 1940)
c 21h 21n o 2
(351) 12-Diacetylamino-6,7,16,17-tetrahydro-15//-cyclopenta[a]-
phenanthrene
MW 319; mp 151°C
Amax 211 (4.77), 273 (4.31), 284 (4.18), 301 (3.55) nm 
vmax 5-85> 13.03/an
<5 2.3 (10 aliphatic), 7.15-7.35 (5 aromatic)
(Dannenberg et al., 1965)
c 21h 21o 5p
(228) 15,16-Dihydro-17-oxocyclopenta[a]phenanthren-ll-ol diethyl- 
phosphate [30835-59-7]
Amax 262 (4.83), 288.5 (4.48), 302 (4.32), 340 (3.27), 357 (3.52),
375 (3.59) nm
vmax 5.90, 7.9, 9.Spm  (Coombs and Jaitly, 1971)
C2iH 22 (76) 15,16-Dihydro-4,17-dimethyl-17-ethylcyclopenta[a]phenanthrene 
MW 274; mp 145-147°C (Brown and Kupchan, 1962)
C21H22 (37) 16,17-Dihydro-15-isopropyl-4-methyl-15//-cyclopenta[a]-
phenanthrene [72814-88-1] [77327-08-3]
MW 272 (Laflamme and Hites, 1979)
C21H220  (127) 16,17-Dihydro-17-isopropyl-3-methoxy-15/f-cyclopenta[a]- 
phenanthrene
MW 290; mp 129°C (Birch and Robinson, 1944)
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C21H22O3
(210) 17,17-Ethylenedioxy-12,12-dimethyl-l 1,12,13,14,15, 16-hexa- 
hydrocyclopenta[a]phenanthren-ll-one 
MW 322; mp 167°C 
Amax 217 (4.35), 244 (4.14), 306 (3.59)nm
vmax 5.95/im (Coombs, 1966a)
c 21h 22o 4
(203) 11,11:17,17-Bis(ethylenedioxy)-l 1,12,13,14,15,16- 
hexahydrocyclopenta[a]phenanthrene
MW 338; mp 170°C (Coombs, 1966a)
C21H26 (125) 6,7 ,8,14,16,17-Hexahydro- 17-isopropyl-l l-methyl-15H-
cyclopenta[a]phenanthrene 
MW 278; Colourless oil, bp 190°C/0.1 mm
(Birch and Robinson, 1944)
^21^26^2
^22^18^5
(124) 17-Isopropyl-3-methoxy-6,7,8,9,ll,14,16,17-octahydro-15//-
cyclopenta[a]phenanthren-l 1-one
MW 310; Yellow glass, bp 128-134°C/0.15mm
(Birch and Robinson, 1944)
(466) 2,15-Diacetoxy-15,16-dihydrocyclopenta[a]phenanthren-17-one 
[55081-27-1]
MW 362 
Amax 267 nm
vmaX 5.76, 5.81, 5.88//m (Coombs and Crawley, 1974)
c 22h 18o 6
(464) 2,15-Diacetoxy-8,9-epoxy-ll-methyl-8,9-secogona-
l,3,5,7,9,ll,13-heptaen-17-one 
MW 378; mp 208-210°C 
Amax 267, 298sh, 356, 374 nm
vmax 5.68, 5.76, 5.83/an (Coombs and Crawley, 1974)
^ 22^ 20^ 2
C22H20O2
C22H20O3
^22^20^4
(406) Ethyl 17-(cyclopenta[a]phenanthrylidene)-2-propionate 
MW 316; mp 92-93°C (Dannenberg, 1950)
)
(419) 15,16-Dihydro-16-(3-oxopentyl)cyclopenta[a]phenanthren- 
17-one
MW 316; mp 165-166°C (Buchta and Kraetzer, 1962)
i
(403) Ethyl 17-(ll-methoxycyclopenta[a]phenanthrylidene)-acetate 
MW 332; mp 144°C (Robinson and Slater, 1941)
1
(446) 16,17-Dihydro-ll-methyl-15if-cyclopenta[a]phenanthrene-cw-
16,17-diacetate [42123-07-9]
MW 348; mp 192.5-193°C
Amax 226 (4.15), 254.5 (4.88), 281 (4.11), 292 (4.06), 303.5 (4.14),
323.5 (2.81), 338.5 (2.97), 354 (2.98) nm 
vmax 5.75, 7.97, 8.08, 12.23pm
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C22H20O4
c 22h 22o 2
d H-15, 3.35 (J 16,4); H-15, 3.64 (J 16,6); H-16, 5.69;
H-17, d 6.39 (J 6) (Coombs and Hall, 1973)
i
16.17-Dihydro-ll-methyl-15H-cyclopenta[a]phenanthrene-fra/w-
16.17-diacetate [42123-08-0] [63780-58-5]
MW 348; mp 156-157°C
Amax 224 (4.14), 254 (4.88), 280.5 (4.09), 292 (4.05), 304 (4.15),
323 (2.80), 338 (2.97), 354 (2.97) nm
vmax 5.79, 7.95, 8.07pm
d Ha-15, 3.16 (J 17,4); HB-15, 3.90 (J 17,8); H-16, 5.58;
H-17, d 6.42 (J 4) (Coombs and Hall, 1973)
)
(394) 15,16-Dihydro-ll-n-pentoxycyclopenta[a]phenanthren-17-one 
[83053-61-6]
MW 318; mp 138-138.5°C
Amax 262 (4.88), 293 (4.52), 363 (4.09), 382 (4.13)nm
(Bhatt et al. , 1982)
c 22h 22o 4
(214) 1 l-Acetoxymethyl-17,17-ethylenedioxy-13,14,15,16-
tetrahydrocyclopenta[a]phenanthrene
MW 350
Amax 237.5 (4.81), 303 (3.88), 315 (3.87), 336 (3.59) nm
(Coombs et al., 1975)
c 22h 23o 5p
(229) 15,16-Dihydro-7-methyl-17-oxocyclopenta[a]phenanthren-ll-ol 
diethylphosphate [30835-64-4]
MW 397; Brown crystals, mp 140-142°C 
Amax 266, 291, 305, 350, 368, 396nm
vmax 5.88, 7.82, 9.10pm  (Coombs and Jaitly, 1971)
C22H24 (39) 16,17-Dihydro-17-isopentyl-15H-cyclopenta[a]phenanthrene
[21549-34-8]
MW 288; mp 115°C (Wilk and Taupp, 1969)
C22H240 5
(204) 11,11:17,17-Bis(ethylenedioxy)-l 1,12,13,14,15,16-hexahydro-3- 
methoxycyclopenta[a]phenanthrene
MW 368; mp 174°C (Coombs, 1966a)
^22^30^3
(445) Ethyl 17-(6,7,8,9,11,12,13,14,16,17-decahydro-3-methoxy- 15H- 
cyclopenta[a]phenanthryl)acetate
MW 342; bp 208-215°C/0.4mm (Robinson and Slater, 1941)
C23H 160  (328) 15,16-Dihydro-15-phenylcyclopenta[a]phenanthren-17-one 
[50558-60-6]
MW 308; White needles, mp 222°C 
vmax 5.87, 12.05^m
6 1.25-3.10 (13H, aromatic), 5.05 (q,CH), 6.46-7.57 [H-15 and 
H-16, 2q, J1516 (trans) 7.7, J1516 (cis) 2.6, J1616 19.2]
(Shotter et al. , 1973)
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C 23H 20O 4
(414) Methyl 15,16-dihydro-17-oxo-16-(3-oxobutyl)cyclopenta[a]- 
phenanthrene-16-carboxylate
MW 360; mp 170°C (Nasipuri and Roy, 1961)
^23^22^4
(404) Ethyl 17-(3,ll-dimethoxycyclopenta[a]phenanthrylidene)- 
acetate
MW 362; mp 192°C (Robinson and Slater, 1941)
^23^24^2
(395) 15,16-Dihydro-l l-«-hexoxycyclopenta[a]phenanthren-17-one
MW 332; mp 136-137°C
Amax 246 (4.96), 279 (4.78), 303 (4.30), 349 (4.07)
(Bhatt, unpublished data)
c 24h 15n o 3
ll-Benzoxazol-2-yloxy-15,16-dihydrocyclopenta[a]phenanthren-17- 
one [30835-62-2]
MW 365; mp 237-238°C
Amax 229, 263, 285, 300, 338, 355, 373 nm (Coombs and Jaitly, 1971) 
C24H16 (420) 17-Benzylidenecyclopenta[a]phenanthrene [5830-62-6]
MW 292; Orange needles, mp 262-263°C 
Amax 249 (4.52), 328 (4.65), 384 (4.07) nm
vmax 12.05, 12.47, 13.12, 13.38, 14.44^m (Coombs, 1966b)
C24H 160  (330) 17-Methyl-16-phenylcyclopenta[a]phenanthren-15-one 
[27983-36-4]
MW 320 (Mladenova-Olinova et al., 1970)
^24^18^2
(146) 16,17-Dihydro-15-hydroxy-15//-cyclopenta[a]phenanthrene 
benzoate
MW 338; mp 176-177°C (Badger et al., 1952)
C 24H 1 8 ° 4 S
ll-Hydroxy-17-oxo-cyclopenta[a]phenanthrene tosylate [54206-57-4]
(Kawarura et al., 1974) 
C24H20 (423) 17-Benzyl-16,17-dihydro-15//-cyclopenta[a]phenanthrene
[5830-61-5]
MW 260; mp 156-157°C
Amax 216 (4.46), 260 (4.81), 281 (4.20), 289 (4.08), 301 (4.14),
320 (2.77), 336 (2.98), 352 (3.00) nm
vmax 12.10, 12.36, 12.96, 13.30, 13.48, 14.28/mi (Coombs, 1966b)
C 24H 20O 3 S
(147) 16,17-Dihydro-15-hydroxy-15//-cyclopenta[a]phenanthrene 
tosylate
MW 388 (Coombs and Hall, 1973)
C 24H 20O 3 S
(145) 16,17-Dihydro-17-hydroxy-15H-cyclopenta[a]phenanthrene 
tosylate [5837-15-0]
MW 388; Leaflets, mp 178-179°C
Amax 220 (4.48), 259 (4.83), 279 (4.23), 288 (4.09), 300 (4.15) nm
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vmax 11.40, 12.24, 12.80, 12.95, 14.00, 14.30, 14.68.um
(Coombs, 1966b)
^24^22^4
(415) Methyl 15,16-dihydro-17-oxo-16-(3-oxopentyl)cyclopenta[a]- 
phenanthrene-16-carboxylate
MW 374; mp 157°C (Nasipuri and Roy, 1961)
C24H22O7
(461) la,2/3,15-Triacetoxy-l,2,15,16-tetrahydro-ll-methylcyclopen-
ta[a]phenanthren-17-one
MW 422; mp 170-171°C
2max 268 (4.64), 322 (4.05), 333 (4.07), 370 (3.50)nm 
vmax 5.75, 5.85, 9.80/mi
d H -l, 7.11 (J12 2); H-2, 5.47 (J12 2, J23 6); H-3, 6.28 (J23 5, J34 9); 
H-4, 6.95 (J34 9); H-6, 7.55 (J67 9); H-7, 8.11 (J67 9); H-12, 7.56; 
H-15, 6.70 (J15jl6 1.5, J15>16 6); H-16, 3.28 (J15>16 6, ’j 16,16 19);
H-16, 2.62 (J15>16 1.5, J1616 19); 11-CH3, 2.93
(Coombs and Crawley, 1974)
c 25h 18o 2
(208) 16-Benzylidene-15,16-dihydro-3-methoxycyclopenta[a]- 
phenanthr en- 17-one
MW 350; Yellow needles, mp 223-224°C
(Koebner and Robinson, 1941)
^25^22^2
(207) 16-Benzylidene-l 1,12,13,14,15,16-hexahydro-3-methoxy- 
cyclopenta[a]phenanthren-17-one
MW 354 (Koebner and Robinson, 1941)
c 25h 22o 3s
(149) 16,17-Dihydro-17-hydroxy-ll-methyl-15H-cyclopenta[a]- 
phenanthrene tosylate 
MW 402
vmax 9.71, 9.90/mi (Coombs and Hall, 1973)
C26H21N (421) 17-p-Dimethylaminobenzylidenecyclopenta[a]phenanthrene 
[5831-06-1]
MW 347; Yellow crystals, mp 248-250°C 
Amax 371 (4.18), 434 (4.58) nm
vmax 12.15, 12.32, 12.58, 13.24, 13.50/mi (Coombs, 1966b)
C26H30 (151) 17-Methyl-17-[2(6-methyl)-heptyl]-cyclopenta[a]phenanthrene
MW 342; mp 138-139°C, [ a ] F -15°  (CHC13)
Amax 221 (4.83), 241.5 (4.56), 265 (4.66), 294.5 (4.05), 306.5 (4.18),
319.5 (4.18), 345 (3.07), 362 (2.98) nm 
vmax (KBr) 12- i8, 1.2.63, 13.24/^m 
d 0.59 (d,J 6.5), 0.88 (d,J 6.0), 1.38(s), 6.4-8.8(m)
(Dannenberg et al., 1964)
C26H32 (27) 15,16-Dihydro-17-methyl-17-[2(6-methyl)-heptyl]-cyclopenta[a]-
phenanthrene [80382-29-2]
MW 344
<3 0.74 (3H,d,J 6.5), 0.88 (6H,d,J 6.5), 1.33 (3H,s), 2.29 (2H,m), 
3.23 (2H,m), 7.43-8.58 (8H,m)
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m/z  344 (M+, 4%), 231 (M+-C8H 17, 100%),
216 (M+-C8H17-CH3, 8%) (Ludwig et al., 1981)
C„H,n (170) 17-Methyl-17-[2(5,6-dimethyl)hept-3-enyl]-cyclopen- 
* ta[a]phenanthrene [13914-42-6]
MW 354; mp 131°C
2max 222 (4.84), 242.5 (4.58), 267.5 (4.67), 295 (4.06), 307 (4.19),
320 (4.18), 346 (3.08) nm 
vmax (KBr) 12.17, 12.61, 13.21/an
(Dannenberg and Hebenbrock, 1966) 
C27H32 (152)1 ,17-Dimethyl-17-[2(6-methyl)-heptyl]-cyclopenta[a]phenan- 
threne
MW 356; oil, [a] F  -75 .7° (CHC13)
Amax 224 (4.74), 245 (4.46), 264 (4.69), 297 (4.06), 309 (4.25),
322 (4.25), 347 (2.94), 364 (2.70) nm 
vmax 12.14, 13.27/un
d 6 .4-8 .8 (aromatic and olefinic protons), 3.12 (1-methyl),
1.38 (17-methyl) (Dannenberg et al., 1964)
C27H32 (153)4 , 17-Dimethyl- 17-[2(6-methyl)-heptyl]-cyclopenta[a]- 
phenanthrene [26231-18-5]
MW 356; mp 152°C, [ a ] F  -57 .8° (CHC13)
Amax 224 (4.75), 237 (4.43), 244 (4.56), 272.5 (4.59), 280 (4.46),
298 (4.06), 310 (4.24), 323 (4.23), 347 (3.01), 364 (2.79) nm
(Dannenberg and Neumann, 1961ft) 
C27H34 (30) 15,16-Dihydro-l,17-dimethyl-17-[2-(6-methyl)-heptyl]-cyclopen-
ta[a]phenanthrene [80382-27-0]
MW 358; oil, [ a ] F  -22 .4° (CHC13)
Amax 213 (4.45), 226.5 (4.25), 257 (4.89), 282 (4.13), 293 (4.08),
305.5 (4.18), 337 (2.70), 353 (2.60), 364 (2.64) nm
vmax (CS2) 12.19, 13.23, 13.96/an (Dannenberg et al., 1964)
6 0.78 (3H,d,J 6.8), 0.91 (6H,d,J 6.8), 1.38 (3H,s), 2.34 (2H,m),
3.17 (3H,s), 392. (2H,m), 7.50-8.72 (7H,m) 
m/z 358 (M+, 4%), 245 (M+-C8H 17, 100%), 230 (M+-C8H 17-CH3, 
10%), 215 (M+-CgH17-2CH3, 10%) (Ludwig et al., 1981)
C27H34 (33) 15,16-Dihydro-4,17-dimethyl-17-[2(6-methyl)-heptyl]cyclopen-
ta[a]phenanthrene [80382-25-8]
MW 358; mp 140°C, [a] F  -1 1 .8  (CHC13)
2max 216 (4.58), 255 (4.71), 263 (4.79), 283.5 (4.13), 294 (4.10),
306 (4.22), 322 (2.76), 337.5 (2.81), 354 (2.69) nm (Dannenberg and 
Neumann, 1961ft)
<5 0.73 (3H,d,J 6.8), 0.87 (6H,d,J 6.5), 1.34 (3H,s), 2.31 (2H,m),
2.75 (3H,s), 3.29 (2H,m), 7.50-8.57 (7H,m)
m/z  358 (M+, 4%), 245 (M+-C8H I7, 100%), 230 (M+-C8H17-CH3,
8%), 215 (M+-C8H 17-2CH3, 8%) (Ludwig et al., 1981)
c27H34o,
15,16-Dihydro-15,16-dihydroxy-4,17-dimethyl-17-[2(6-methyl)- 
heptyl] cyclopenta[a]phenanthrene 
MW 390; mp 87°C
Amax 216 (4.53), 229 (4.23), 253 (4.72), 261 (4.80), 282 (4.16),
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292.5 (4.13), 305 (4.23), 320 (2.76), 336 (2.74), 352 (2.42)nm 
vmax (KBr) 2.96, 9.40/zm (Dannenberg and Neumann, 1961a)
C29H38 (32) 15,16-Dihydro-l,17-dimethyl-17-[2-(5-ethyl-6-methyl)-
heptyl]cyclopenta[a]phenanthrene [80382-28-1]
MW 386
<5 0.75 (3H,d,J 6.8), 0.84 (6H,d,J 6.8), 0.86 (3H,t,J 7.6),
1.35 (3H,s), 2.31 (2H,m), 3.13 (3H,s), 3.28 (2H,m),
7.44-8.78 (7H,m)
m/z  386 (M+, 3%), 245 (M+-C10H21, 100%), 230 (M+-C10H21-CH3, 
7%), 215 (M+-C10H21 -2CH3, 7%) (Ludwig et al., 1981)
C29H38 (35) 15,16-Dihydro-4,17-dimethyl-17-[2-(5-ethyl-6-
methyl)heptyl]cyclopenta[a]phenanthrene 
MW 386
<3 0.75 (3H,d,J 6.5), 0.86 (3H,t,J 6.5), 0.87 (6H,d,J 6.5),
1.33 (3H,s), 2.72 (3H,s), 3.30 (2H,m), L30-8.25 (7H,m)
m/z  386 (M+, 4%), 245 (M+-C10H21, 100%), 230 (M+-C10H21-CH3,
7%), 215 (M+-C10H21-2CH3, 7%) (Ludwig et al., 1981)
^31^38^4
15,16-Diacetoxy-15,16-dihydro-4,17-dimethyl-17-[2(6-methyl)- 
heptyl] cyclopentaf a] phenanthrene 
MW 474; [a] F  +29° (ethanol)
2max 216 (4.58), 221 (4.40), 253 (4.73), 261 (4.80), 282.5 (4.20),
293 (4.17), 305.5 (4.25), 320 (2.94), 336 (2.93), 352 (2.83) nm 
vmax 5.76, 8.10, 9.5, 12.17, 12.55, 13.10,um
(Dannenberg and Neumann, 1961a)
c 36h 26o 3
(217) Bis(15,16-dihydro-17-oxocyclopenta[a]phenanthr-12-ylmethyl) 
ether [5837-22-0]
MW 506; mp 229-233°C
Amax 219, 267.5, 286, 298, 338, 353, 371 nm
vmax 5.92, 12.32, 13.36, 13.68, 1 4 .5 0 ^  (Coombs, 1966a)
C36H28 (129) 16-[17-(16,17-Dihydro-17-methyl-15//-cyclopenta[a]-
phenanthryl)]-17-methyl-15i7-cyclopenta[a]phenanthrene 
2max 261.5 (4.76), 273 (4.80), 283.5 (4.92), 300.5 (4.44), 324 (4.13)nm 
vmax 11.60, 12.32, 13.40, 13.88/mi (Coombs, 1966ft)
^39^30^6
(428) 16,16'-Di(17-oxo-3,ll-dimethoxycyclopenta[a]phenanthryl)- 
methine
MW 594; mp 301-302°C (Robinson and Rydon, 1939)
5.4 Index relating serial numbers assigned to cyclopenta[a]-
phenanthrenes appearing in the text, tables, and figures to 
their molecular formulae
Serial Molecular Serial Molecular Serial Molecular
No. formula No. formula No. formula
1 C17H 14 3 C17H12 7 C18H16
2 C17H12 4 C17H 120  11 C18H 160
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erial Molecular Serial Molecular Serial Molecular
No. formula No. formula No. formula
13 ^20^ 26^ 76 c 21h 22 136 Q9H16
14 C20H20O 80 Ci9H1403 137 C20H i8
16 Ci9H 240 82 c 17h 16o 138 c 19h 16o
17 C19H18° 83 ^18-^16 139 CjgHjg
22 ClgH2202 84 -^"20^ 18^4 140 Ci9H 18
23 C17H1202 85 ^19^ 18^3 141 2^0^ 20
24 ^18^ 14^2 86 ^18^ 18^ 142 c 19h 18o
26 ^18^ 14^ 87 C19H18 143 ^18^14
27 ^26^32 93 Ci8H 220 145 C24H20O3S
30 C27H34 94 ^18^16 146 "^24^ 18^2
32 r  u29 38 96 ^17^ 18® 147 C24H20O3S
33 ^27^34 97 c 18h 16 148 -^"18^-12^2
35 P  PT29 38 98 ^18^16 149 c 25h 22o 3s
36 2^0^ 20 99 Ci9Hi8 150 ^18^14
37 C21H22 100 Qb 1^6 151 ^26^30
38 c 17h 14o 101 CjgHig 152 P  H27 32
39 C22H24 102 c 17H i2o 153 "^"27^32
44 ^17^18 103 C17H16°2 162 c 20h 20o
45 ^18^16 104 c 17H i2o 2 164 c 20h 24o
46 c 18h 16 105 CjgHig 165 c 20h 18o
48 P  XJ19 22 107 ^18-^16 170 "^"27^30
49 ^18^ 14® 109 "^21^ 18^4 172 C19H17C1
50 CigHjgO 110 CjgHjg 174 c 17h 14o
51 ^20^ 18® 111 ^19^ 16^3 176 c 17h I4
52 C19H18 112 ^19^ 16^3 179 c 17h 14o
53 2^0^ -20 114 C17H16°2 185 ^17^ 10^2
56 Ci9H 220 115 ^17^ 16^2 186 c 19h 14o 4
57 CjgHjgO 116 ^17^14^2 190 c 20h 16o 4
58 C19H180 118 Q i^ 20^6 193 c 17H 14o 2
59 Q8^ 16® 123 C20H 24O 194 c 18h 16o 3
61 ^18^ 16® 124 Q l^ 26^2 199 Ci9H 20O 3
62 CjjHjgO 125 ^21^26 200 ^19^ 24^3
63 C19H22° 126 c 20h 20o 201 CjgHjgOj
66 ^18^ 16^2 127 C2iH 22° 202 "^20^ 20^4
67 ^18^16 128 ^18^14 203 c 21h 22o 4
68 C19H j8 129 ^36^28 204 c 22H 24o 5
69 2^0^ 20 130 ^18^ 14^ 205 c 17h 16o
70 ^18^16 131 ^ 19^ 16® 206 c „ h 12o 2
71 C19Hlg 132 C18H14°2 207 ^25^ 22^2
72 ^20^ 16^3 133 ^18^14 208 "^25^ 18^2
73 C20H18O 134 ^19^ 16^ 209 ^20^ 20^3
74 "^20^ 20® 135 ^19^16 210 c 21h 22o 3
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No. formula
211 C19H 16°
2 12 C2iH 20O
213 c 20h 22o 4
214 C22H 22O 4
215 ^18^14^2
216 ^"20^18^4
217 ^36^26^3
227 ^20^16^3
228 C21H 210 5P
229 -^"22^ 23 ^ 5 P
230 ^"18^14®
233 C17H 18°2
235 Ci9Hig0 3
237 c 17h 16o
238 Cj8H igO
249 C 18H 16°
250 C19H 18°
251 ^ 20^ 20®
252 ^18^16®
253 C19H 16°
254 ^20^18
255 C19H 18
256 P TT20 20
257 ^18^16^
302 ^18^14®
303 C 18H 140
304 c 18h 14o
305 ^18^14^
306 C 18H 14°
307 ^•18^14^2
308 C 18H 14°2
309 ^19^16^
310 ^18^12®
311 C 19H 16°2
313 ^18^22^
318 C 17H uBrO
322 ^18^13^®2
324 C 17H 1402
325 c 17h 16o
326 ^17^18
328 C23H 160
330 c 24h 16o
Serial Molecular
No. formula
332 Ci9H1803
333 ^19^ 16^2
334 C18H14°
335 Ci7H 10O 3
336 C18H1203
337 C17H14°3
338 "^18^ 16^3
339 ^17^12 0 2
340 ^18^ 14^2
341 CigH^Oj
342 ^20^ 16^2
343 c 19h 14o 3
344 C20H16°3
345 Q7H12O2
346 ^18^ 14^2
347 ^19^ 16^
348 c 19h 17n o
349 c 17h 15n
351 c 21h 21n o 2
353 C 19H 2oO
354 c 19h 17n o
355 C18H13Br0
356 C17H10Br2°
357 C18H12Br2°
358 C17H nBrO
359 C18H13Br°
362 Ci7HioBr 2 0
363 c ,7h 10o
364 C18H120
365 C 19H 1 4 0 3
366 -^"20^ 16^3
367 C18H14°2
368 C19H16°2
369 C17H12°2
370 C18H14°2
376 ^17^14 0 2
377 C18H16°2
378 ^17^14 0 2
379 C18H 16°2
380 c 17h 12o
381 C18H140
382 Q 7H 14O 2
Serial Molecular
No. formula
384 c 17h 14o
387 Q 9H 1603
388 C 20H 18
389 ^ 1 6 ^ 1 6 ^ 2
390 ^ " 1 9 ^ 1 6 ^ 2
391 ^ 2 0 ^ 1 8 ^ 2
392 C 20H 18O 2
393 C21H 20O 2
394 C22H 2202
395 C 23H 240 2
396 C 17H 1 2 ° 2
397 C 19H 14O 3
400 ^ 2 0 ^ 2 0 ^ 2
402 C 18H 1 4 °
403 C22H 20 O3
404 C 23H 2 2 P 4
405 ^ - " 2 1 ^ 1 8 ^ 2
406 C 22H 20O 2
407 ^ 1 9 ^ 1 6 ^ 2
408 C 20H 1 8 ° 2
409 ^ " 2 0 ^ 1 8 ^ 2
410 C21H 20O 2
414 C 23H 20O 4
415 C24H 22O 4
416 c 21h 14
418 ^ 1 8 ^ 1 2 ^ 2
419 p  i j  n22 20 2
420 ^ 2 4 ^ 1 6
421 c 26h 21n
422 Q o-^ -16
423 C 24H 20
424 ^ " 2 0 ^ 1 6
425 C 20H 18
426 ^ 1 9 - ^ 1 6 ^ 3
427 C 18H 2 0 ° 2
428 ^ 3 9 ^ 3 0 ^ 6
429 Q o ^ 160 4
430 CmH jjN O j
437 C 18H 20O 2
438 c ,7h 20o
439 Cl8H220 2
440 Q 7H 18
References 125
Serial Molecular Serial Molecular Serial Molecular
No. formula No. formula No. formula
441 ^18^20^ 454 ^18^16^4 462 ^18^18^4
442 ^17^16 455 ■^18^ 16^ 4 463 Q b-^14^4
443 ^18^18 456 ^18^16^4 464 ^22^18^6
444 c „h 22o 457 ■^18^ 16^ 3 465 ^18^14^3
445 c 22h 30o 3 458 ^18^14^2 466 c 22h 18o 5
446 "^22^ 20^ 4 459 ^18^16^3 467 ^20^20
447 ^19^16^2 460 ^18^16^5 468 c19H16o2
448 ^18^16^ 461 -^"24^ 22^ 7 469 c 20h 16o 3
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6Carcinogenicity and mutagenicity of 
cyclopenta[a]phenanthrenes
6.1 Structure/carcinogenic activity relationships
As has been discussed in Chapter 1, simple cyclopenta[a]- 
phenanthrene hydrocarbons became of interest during the establishment 
of the correct structure of the sterols in the 1930s. This coincided with the 
isolation of benzo[a]pyrene from coal tar in 1933, and the intense interest 
in carcinogenic polycyclic hydrocarbons which followed soon showed 
that their structures were based mainly upon the phenanthrene ring 
system extended with one or more fused aromatic ring(s). Diels’ hydro­
carbon (16,17-dihydro-17-methyl-15/7-cyclopenta[a]phenanthrene,7) 
was shown to be inactive as a carcinogen (Craciun et al. , 1939; Butenandt 
and Suranyi, 1942), and this reinforced the idea that additional fused 
benzo rings, as for example in the benz[a]anthracenes, were essential for 
carcinogenic activity. However, it also became apparent that correct 
methyl substitution can have dramatic effects on activity; thus whilst 
benz[a]anthracene is essentially inactive, its 7,12-dimethyl derivative is 
one of the most potent carcinogens known. This prompted Butenandt to 
synthesize the aryl methyl isomers of Diels’ hydrocarbon and to test 
them, together with six dimethyl and trimethyl homologues, for carcino­
genicity in the mouse (Butenandt and Dannenberg, 1953) both by skin 
painting and injection experiments. For the former, mice of the B1.H1. 
strain of known cancer incidence (Kaufmann et al. , 1942) as well as mice 
of mixed strain from a commercial source were employed. The animals 
received two drops of a 0.4% solution of the test compound in benzene 
twice weekly on their dorsal skin, and the experiments lasted from 275 to 
714 days with the results shown in Table 8. Only compounds bearing 
methyl groups at C-7 or C -ll were carcinogens; the 7-methyl (94) and 11- 
methyl (83) isomers were of similar activity with tumour incidences of 
14.3 and 15.4%, respectively, whereas the 11,12-dimethyl hydrocarbon
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(87) was less active (tumour incidence 10%). No latent periods were 
given and the use of two different strains of mice complicates interpreta­
tion, but it is evident that these hydrocarbons are only weakly carcino­
genic. This was supported by the observation that no local tumours were 
induced by injection of these compounds into B1.H1. mice (5 mg in oil).
Three cyclopenta[a]phenanthrenes containing a conjugated double 
bond in ring-D, namely 17-methyl-15//- (133), 17-isopropyl-15if- (388), 
and 15-methyl-17//-cyclopenta[a]phenanthrene (128) (Table 9), were 
also tested for carcinogenicity in mice of mixed strain and Swiss mice with 
low spontaneous tumour incidence (Dannenberg, 1960) by the methods 
already described. Introduction of a conjugated D-ring double bond was 
accompanied by the appearance of weak carcinogenicity; all three com­
pounds were active by topical application, although their activity was low 
as judged by their long mean latent periods. The least active was the 
isopropyl hydrocarbon, and this failed to induce tumours on injection. 
Quinone dehydrogenation of sterols (Dannenberg et al., 1956) leads to 
this type of hydrocarbon, and Dannenberg felt that their carcinogenicity 
might be connected with the possibility of the reactive D-ring double 
bond behaving as a ‘K-region’. Thus two independent structural factors 
give rise to carcinogenicity in the cyclopenta[a]phenanthrene series, 
namely methyl substitution at C-7 or C -ll and extension of the conjuga­
tion of the phenanthrene ring system into the D-ring. However, it was not 
established whether these two influences were additive.
A chance came to test this using a series of 17-ketones which were 
originally synthesized for another purpose (see below). As shown in Fig. 
21 these were converted by means of the Grignard reaction into the 
corresponding 17-methyl-15i/-cyclopenta[a]phenanthrenes which were 
further reduced catalytically to their 16,17-dihydro derivatives. The 12 
compounds thus obtained, together with three related hydrocarbons 
(Fig. 53), were tested for carcinogenicity (Coombs and Croft, 1966, 
1969). A standardized method was set up employing Swiss mice of the 
T.O. (Theiler’s Original) strain outbred within a closed colony in the 
laboratories of the Imperial Cancer Research Fund for many years. They 
were housed 10 to a cage on sawdust bedding and had free access to a 
standard solid laboratory diet and water at all times. At the beginning of 
the experiment they were three months old, and they were used in 
formally randomized groups of 20 (10 male and 10 female) for each 
compound. One drop of a toluene solution (0.5% w/v) of the compound 
was applied to the shaved dorsal skin (1 drop = 6juL = 30 jug = 120 nmol) 
twice weekly for one year. The mice were observed for a second year and 
experiments were terminated at two years (~730 days). Survival was
136 Carcinogenicity and mutagenicity
excellent; more than 40% of the animals were still alive at this time in the 
untreated and solvent control groups, and 90% survived to 18 months. 
No skin tumours were seen on any mice painted with toluene alone and 
their survival was the same as those of the untreated group. The date of 
appearance, position, and size of all skin tumours were recorded both 
when the animals were painted during the first year, and once a week 
during the second year. The times of appearance of the first skin tumours 
were used to calculate mean latent periods; at this time the tumour was 
less than 1 mm in diameter, but it was scored only if it persisted and grew 
in size. When the tumour exceeded 1 cm in diameter the animal was killed 
and autopsied, as were all the mice remaining at the end of the experi­
ment. Occasionally seriously sick animals were killed and autopsied to 
avoid loss of the tumour material. All skin tumours and surrounding 
tissue were examined by routine histology and classified as papillomas 
unless there was evidence of penetration of the panniculus carnosus 
muscle, when they were classed as carcinomas.
Table 10 summarizes the results of this experiment. The last column 
lists Iball indices calculated for these compounds from the observed mean 
latent periods and tumour incidences as follows:
IL i, . , percentage of animals with tumour* „Iball index = - --------- :----------------------------------- x 100mean latent period m days
* based on the number of animals alive at the time of the 
appearance of the first skin tumour in that group
Fig. 53. Cyclopenta[a]phenanthrenes tested for carcinogenicity by skin 
painting (Coombs and Croft, 1969).
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For this index ‘tumours’ include both papillomas and carcinomas at the 
site of application, and the latent period is the time elapsed between the 
beginning of the treatment and the first appearance of the first skin 
tumour on each mouse. The mean latent period is the average latent 
period for all the animals in that group. This index is a better measure of 
carcinogenicity than tumour incidence alone because it also takes latent 
periods into account, although, of course, it does not include other 
important parameters such as the total number of tumours per animal, 
the carcinoma/papilloma ratio, or the rate of tumour growth. However, it 
has the merit of allowing comparisons to be made readily, and is probably 
a valid procedure for a series of closely related compounds such as the one 
at present under discussion because these compounds all have very 
similar physical properties, especially solubility.
Substitution of a methyl group at C-17 in 16,17-dihydro-15i7-cyclopen- 
ta[a]phenanthrene does not lead to activity because Diels’ hydrocarbon 
(7) fails to induce skin tumours, as others have found. In agreement with 
Butenandt and Dannenberg, introduction of a methyl group at C -ll into 
Diels’ hydrocarbon leads to weak carcinogenicity (compounds 139 and 
141) whereas introduction of this group at C-12 does not (compound 
140). A methoxy group at the biologically important C-3 position is 
ineffective, but again it is weakly activating at C -ll. Also in agreement 
with the latter author (Dannenberg, 1960), introduction of a 16(17)- 
double bond into Diels’ hydrocarbon to yield 17-methyl-15H-cyclopen- 
ta[a]phenanthrene (133) is accompanied by the appearance of weak 
activity; the tumour incidence of this compound reached 30%, but its 
mean latent period was very long resulting in a low Iball index. The 
isomeric 17-methylene hydrocarbon (143) was of similar activity, but as it 
is known to isomerize readily to the 16(17)-isomer (133) the meaning of 
this is unclear. 17/7-Cyclopenta[a]phenanthrene (2) lacking a D-ring 
methyl group was inactive as was the isopropylidene hydrocarbon (422). 
However, introduction of a methyl group at C -ll in these unsaturated 
ring-D compounds dramatically enhanced activity; thus 11,17-dimethyl- 
15/7-cyclopenta[a]phenanthrene (135) and its 11,12,17-trimethyl homol- 
ogue (137) were moderately strong carcinogens. It is interesting that in 
this series a methoxy group at C -ll has only a marginally activating effect, 
while at C-3 it appears to cause deactivation. Thus it is clear that ring-D 
unsaturation and 11-methyl group substitution are additive vis-a-vis 
induction of carcinogenicity in this series.
The 17-ketones corresponding to these hydrocarbons were also tested 
in this experiment to determine whether conjugation by a carbonyl group 
at C-17 would have an enhancing effect similar to that shown by a 16(17)-
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double bond. A carbonyl group at this position is, of course, a feature of 
many naturally occurring steroids. The results of this test are shown in 
Table 11. It is immediately obvious that conjugation of a carbonyl group 
has a considerable enhancing effect on carcinogenicity. In fact 15,16- 
dihydro-ll-methylcyclopenta[a]phenanthren-17-one (26) was the most 
potent carcinogen to be tested, and was more active than the analogous 
ring-D unsaturated hydrocarbon (135). The 11,12-dimethyl and 11- 
methoxy ketone (131 and 132) were also strong carcinogens whilst the 
unsubstituted ketone (4) and its 12-methyl (130) and 3-methoxy (24) 
derivatives were devoid of activity. The ll-acetoxy-17-ketone (80) 
appeared to be marginally active, but the 11-phenol (206) was too 
insoluble to be tested in this way. The high activity of the ll-methyl-17- 
ketones was unexpected because introduction of oxygen substituents into 
poly cyclic aromatic hydrocarbons often has the reverse effect. This series 
also differs from the 16(17)-ene series in that the parent 17-ketone (4) is 
inactive, as are its 12-methyl and 3-methoxy derivatives, whilst the 11- 
methoxy derivative is considerably more carcinogenic than the cor­
responding hydrocarbon derivative (138).
The high activity of the ll-methyl-17-ketone (26) prompted a much 
more thorough study of the structure/carcinogenicity relationships in this 
series of 17-ketones. All the aryl methyl isomers were synthesized and 
tested, as were a range of related compounds listed in Table 12 which 
shows the results of testing these compounds by the standard method 
(Coombs et al., 1973, 1979; Hadfield et al., 1984; Kashino et al., 1986). 
The ll-methyl-17-ketone (26), used as a positive control, was again 
shown to be a potent carcinogen, whereas the 2-, 3-, 4-, and 6-methyl
Table 11. Skin tumour induction with some 15,16-dihydrocyclo- 
penta[a]phenanthren-l 7-ones
Compound
No. of mice with 
skin tumours at site 
of application Percentage
Iball
indexpapillomas carcinomas
- tumour 
incidence
unsubstituted (4) 0 0 0 _
11-methyl (26) 1 13 70 36
12-methyl (130) 0 0 0 —
11,12-dimethyl (131) 2 11 65 30
3-methoxy (24) 0 0 0 —
11-methoxy (132) 2 9 55 25
11-acetoxy (80) 1 1 10 3
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isomers were inactive. The l-methyl-17-ketone (302) appeared to possess 
marginal carcinogenic activity because one mouse developed a papilloma 
at the site of application; this has never been observed with mice in 
control groups treated repeatedly with the vehicle (toluene) alone. The 7- 
methyl-17-ketone (230) was moderately active, so that these structure/ 
activity relationships resemble those found by Butenandt and Dan­
nenberg for the corresponding hydrocarbons, with the exception that in 
the ketone series the 11-methyl compound is much more active than its 7- 
methyl isomer. The ll-ethyl-17-ketone (211) was much less carcinogenic 
than its methyl homologue, and the ll-n-butyl-17-ketone (212) was 
inactive. This order of decreasing carcinogenicity with increasing carbon 
chain length in a bay-region substituent has been observed in several 
Other series of polycyclic aromatic hydrocarbons. As anticipated, the 
7,ll-dimethyl-17-ketone (309) proved to be a powerful carcinogen, 
probably more active than its 11-methyl homologue. Unfortunately, 
owing to shortage of material repeated applications of this dimethyl 
ketone were continued for only 10 weeks instead of the 50 weeks in the 
standard regime, but this, nevertheless, resulted in 30 skin tumours, a 
third of which were malignant, in 13/20 mice with a short mean latent 
period of 19 weeks. There is little doubt that both the number of tumours 
and the tumour incidence would have been higher if topical applications 
had been continued as usual for one year. Introduction of a 6-methoxy 
group into the 11-methyl ketone to give compound (468) considerably 
diminished its activity, whereas introduction of an 11-methoxy group into 
the 7-methyl-17-ketone to give compound (447) led to an increase in 
activity, although not to the extent that might have been predicted.
Interruption of conjugation in the phenanthrene ring system abolished 
carcinogenicity; thus neither the ll,12-dihydro-ll-methyl-17-ketone 
(252) nor the 1,2,3,4-tetrahydro derivative (238) were active. It is, 
therefore, probable that an intact phenanthrene system is the smallest 
polycyclic aromatic ring system that can give rise to carcinogenicity upon 
correct substitution. Transposition of the 17-carbonyl group to C-15 
(compound 334) markedly reduced activity; in fact this ketone was a 
weak carcinogen, like the corresponding saturated D-ring hydrocarbon 
(139). This is surprising because Dannenberg (1960) demonstrated that in 
the unsaturated D-ring hydrocarbon series both 15-methyl-17/f- and 17- 
methyl-15T7-cyclopenta[a]phenanthrenes were carcinogenic and of com­
parable activity. As expected the unsubstituted -15-ketone (102) was 
inactive. Linkage of the C-l and C -ll positions by a methylene bridge did 
not destroy activity, for 15,16-dihydro-l,ll-methanocyclopen- 
ta[a]phenanthren-17-one (310) is moderately carcinogenic, although it
Carcinogenicity and mutagenicity
does not possess a bay-region. Expansion of the five-membered ring by 
one carbon atom to yield ll-methyl-l,2,3,4-tetrahydrochrysen-l-one 
(450) retained activity unchanged; thus the Iball indices of this ketone 
and of 15,16-dihydro-ll-methylcyclopenta[a]phenanthren-17-one (26) 
were essentially the same. The unsubstituted 1,2,3,4-tetrahydrochrysen- 
1-one (449) was inactive.
The unexpectedly high activity of this chrysenone (450) was further 
investigated by converting it into a series of hydrocarbons including 1,11- 
dimethylchrysene (453) by means of the Grignard reaction followed by 
dehydration, dehydrogenation, or reduction as outlined in Fig. 54. These 
compounds were then tested for carcinogenicity by the standard pro­
cedure (Coombs et al., 1974) with the results shown in Table 13. The 
ketone (450) was by far the most active, and the least active was the 
tetrahydrohydrocarbon (452); the Iball indices of both were similar to 
those of the analogous cyclopenta[a]phenanthrenes. However, the 3,4- 
dihydro hydrocarbon (451) was distinctly less carcinogenic than the 
corresponding ll,17-dimethyl-15//-cyclopenta[a]phenanthrene (135), 
and in fact it was the fully aromatic 1,11-dimethylchrysene (453) that 
possessed activity similar to that of (135) (see Table 10). This tetrahydro 
ketone (450) is therefore markedly more active than the corresponding 
aromatic hydrocarbon containing four condensed benzene rings.
The tests so far described all involved repeated application of the test 
compound and therefore each test with 20 mice required about 100 mg of 
sample. While this was usually readily possible with synthetic com­
pounds, testing of metabolites, obtained by in vitro metabolism and 
separation by high-pressure liquid chromatography, posed a problem in 
this respect. Tests by repeated application measure ‘complete carcino­
genicity’, i.e ., the sum total of the initiation and promotion caused by the 
test compound, but it is possible to test for initiation alone using a two- 
stage initiation-promotion regime. With an initiating dose of 1.6jumo\
Fig. 54
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(400/ig) applied once, followed by twice-weekly promotion of the 
treated area of skin by the application of 10 pL  of a 1% v/v solution of 
croton oil in toluene, it was established that the carcinogen 15,16- 
dihydro-ll-methylcyclopenta[a]phenanthren-17-one (26) produced a 
tumour incidence and mean latent period similar to those produced by 
the standard repeated-application method. However, the two-stage 
method used less than one-tenth of the amount of sample required by the 
latter, and proved to be useful for studies with metabolites. It was also 
employed to determine the initiating activity of a range of synthetic 
compounds (Coombs and Bhatt, 1978; Coombs et al., 1979; Bhatt et al., 
1982; Hadfield et al., 1984; Kashino et al., 1986) shown in Table 14.
As was to be expected, the ll-methyl-17-ketone (26) and its 7,11- 
dimethyl homologue (309) proved to be potent tumour initiators whilst 
the parent unsubstituted ketone (4) and its 3-methyl derivative (304) 
were inactive. In line with the results from repeated application of these 
compounds, the dimethyl compound appeared to be the more active as 
shown by its shorter mean latent period, and consequently its higher Iball 
index. Of course, these indices cannot be compared directly with those 
derived from repeated-application experiments, but they serve the same 
purpose of providing a convenient guide to the relative initiating poten­
tial of a series of closely related compounds. Predictably the 11-methyl- 
chrysenone (450) was also a very active tumour initiator whereas the 
unsubstituted chrysenone (449) was inactive. The l,ll-methano-17- 
ketone (310) was a moderately active initiator, and again the 1-methyl- 
17-ketone (302) appeared to be marginally active. However, occasionally 
a papilloma is induced in uninitiated control mice painted with croton oil, 
so that the meaning of a low Iball index in this system is questionable. 
Among the ll-alkoxy-17-ketones the methoxy compound (132) was the 
most active, followed by the ll-ethoxy-17-ketone (390) which was 
somewhat less so, whilst the n-pentoxy, and n-hexoxy derivatives were 
not tumour initiators. Unexpectedly, both the 11-isopropoxy and 11-n- 
butoxy-17-ketones appeared to be very weak tumour initiators, but again 
these low indices are questionable. The 15-methoxy-17-ketone (367) was 
not an initiator, but its 11-methyl derivative (368) was active. In this 
Table the three hydroxy derivatives and the parent 11-methyl-17-ketone 
used as a positive control are placed together separately. The reason for 
this is that they were tested together in a separate experiment (Coombs 
and Bhatt, 1982) in which for solubility reasons acetone-toluene (1:1 v/v) 
was employed in place of toluene to administer the initiating dose of these 
compounds. This led to the unexpected result of effectively increasing the 
initiating activity of this carcinogen, as can be seen from the increased
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Iball index. However, within this small group it is clear that the 16- 
hydroxy derivative is almost as active as the original carcinogen whereas 
the 15-hydroxy and 11-hydroxymethyl derivatives are much less active. 
These hydroxy derivatives are of interest because they also occur as 
metabolites of this ll-methyl-17-ketone.
In summary it is clear that in the 17-ketone series carcinogenicity is 
favoured by small electron-releasing groups at C -ll and to a lesser degree 
at C-7, but not elsewhere in the molecule. On these grounds the 11- 
phenol (15,16-dihydro-l l-hydroxycyclopenta[a]phenanthren-17-one,
206) was expected to be carcinogenic, but it was not possible to test it by 
topical application as usual because it was very sparingly soluble in most 
organic solvents. It was therefore finely ground and suspended in olive oil 
for subcutaneous injection into T.O. mice at 10mg/animal. Subsequent 
promotion of the dorsal skin remote from the site of injection (shoulder) 
with 1% v/v croton oil in toluene then led, in two separate but identical 
experiments, to tumour incidences of 60 and 65% with mean latent 
periods of 25 and 30 weeks, respectively. Under these conditions of 
systemic initiation the ll-methyl-17-ketone used as a positive control was 
very active, giving a 95% dorsal skin tumour incidence with a short mean 
latent period of 21 weeks.
6.2 The carcinogenicity of 15,16-dihydro-ll-methylcyclopenta[a]-
phenanthr en-17-one
From the foregoing it is apparent that this ll-methyl-17-ketone 
(26) is a potent carcinogen in T.O. mice. This was further studied in two 
dose/response studies and direct comparisons with the classical polycyclic 
aromatic hydrocarbon carcinogen benzo[a]pyrene. In the first (Coombs 
et al., 1979) this ketone was painted on to the dorsal skin twice weekly, 
using groups of 20 T.O. mice as usual, at doses of 50,25,10, and 5^g per 
mouse. A further group was treated in the same way with benzo[a]pyrene 
(5/^g/mouse), and the last group received the ll-methyl-17-ketone at this 
dosage together with 15 jug of the aryl hydrocarbon hydroxylase inhibitor 
7,8-benzoflavone (Kinoshita and Gelboin, 1972). The results of this 
comparison are displayed in Table 15 and Fig. 55. Comparison of the 11- 
methyl-17-ketone and benzo[a]pyrene at the same twice-weekly dose 
(5 pg = 20 nmol) showed that these two compounds are of comparable 
potency as complete carcinogens on T.O. mouse skin. The figure also 
shows the curves formed by plotting the time of first appearance of the 
tumours, and the best line for points given by plotting mean latent periods 
(Lp) against the logarithms of the doses (d) using the well-known 
relationship
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Lp = a -  b (log10 d + c)
(Bryan and Shimkin, 1941) where a, b, and c are constants. In this case 
the data fit the equation
Lp = 29.40 -  10.803 (log10 d -  1.199)
where Lp is in weeks and d in pig\ the correlation coefficient is 0.96. Also 
shown are the tumours induced by this carcinogen administered together 
with 7,8-benzoflavone. As found previously (Coombs et al., 1975) this 
flavone markedly decreased the tumour incidence and increased the 
mean latent period. When the latter (36.1 weeks) was fitted to this line, it 
was found that this inhibitor effectively reduced the dose to about half of 
that administered.
In the second dose/response experiments (Coombs and Bhatt, 1982) 
single applications of the carcinogen (26) were made at doses of 1600, 
400, and 200 nmol/mouse to groups of 20 animals which were then 
promoted with croton oil-toluene twice weekly as usual, with the results 
shown in Fig. 56. Even at the lowest dose (200 nmol = 50/^g) tumour 
incidence was 50%; at the highest dose (1600 nmol = 400/^g) both the 
tumour incidence and mean latent period were similar to those observed 
on repeated application of 100-200 nmol of this compound twice weekly.
Fig. 55. Induction of skin tumours in T.O. mice by twice-weekly application 
of benzo[a]pyrene (BaP) (-1— (-), the ll-methyl-17-ketone (26) (o— o), and 
the relationship between mean latent period and dose for the latter. The 
solid circles ( • — •)  represent tumours produced by this carcinogen when 
administered together with the aryl hydrocarbon hydroxylase inhibitor 7,8- 
benzoflavone (BF).
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A very similar result was obtained in a previous experiment (Coombs et 
al., 1979) in which the 11-methyl-17-ketone (26) was again compared 
with benzo[a]pyrene in the two-stage system, with both compounds at a 
dose of 1600nmol and subsequent twice-weekly promotion. The effects 
of the aryl hydrocarbon hydroxylase inhibitor 7,8-benzoflavone and the 
epoxide hydratase inhibitor 1,1,1-trichloropropene oxide (TCPO) on 
tumour induction by (26) under these conditions were also studied (Table 
16). It is apparent that benzo[a]pyrene is somewhat less active as a 
tumour initiator than the cyclopenta[a]phenanthrene (26) in this system. 
Unexpectedly, co-administration of 7,8-benzoflavone together with the 
initiating dose of (26) had little effect on either tumour incidence or latent 
period, in marked contrast to its effect upon repeated twice-weekly 
applications already discussed. It seems probable that the reason for this 
may reside in the comparatively high initiating dose (1600 nmol) used, in 
comparison with the twice-weekly dose (20 nmol) employed before (see 
Fig. 55). In a preliminary experiment (Coombs et al., 1975) it was found 
that this inhibitor had less effect at a higher dose of (26) even though the 
same ratio of carcinogen: inhibitor was maintained. Appreciable 
shortening of the mean latent period was,obtained when the epoxide 
hydratase inhibitor TCPO was given with the initiating dose of the
Fig. 56. Appearance of first skin tumours in T.O. mice (groups of 20) treated 
with a single dose of the carcinogen (as shown) followed by promotion with 
croton oil applied twice weekly.
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carcinogen (26). Similar effects have been observed with 3-methyl- 
cholanthrene (Berry et al., 1977; Burki et al., 1974) and benzo[a]pyrene 
(Berry et al., 1977). With the latter the inhibitor prevents hydration of the 
initial 7,8-oxide to the 7,8-diol (Selkirk et al., 1974), but the ultimate 
carcinogen, the 7,8-dihydroxy-9,10-epoxide is not a substrate for this 
enzyme (Wood et al., 1976). This suggests that the ll-methyl-17-ketone 
(26) may be activated in a similar manner, via its 
3,4-hydroxy-1,2-epoxide.
This ketone (26) also behaved like benzo[a]pyrene when croton oil was 
used as a co-carcinogen. The latter is defined as ‘all forms of augmen­
tation of tumour induction, usually brought about by concurrent 
administrations of the carcinogen and the added factor’ (Berenblum, 
1969). As shown in Table 17, T.O. mice in the usual groups of 20 were 
treated topically twice weekly with 20 or 200 nmol of the ll-methyl-17- 
ketone (26) or 20 nmol of benzo[a]pyrene dissolved in either toluene or 
toluene-croton oil (99:1 v/v). At both dose levels of (26) 1% croton oil in 
the solvent markedly reduced the mean latent periods, the difference 
again being the larger with the lower dose of the carcinogen (26). 
Benzo[a]pyrene behaved in a similar manner, but again appeared to be 
rather less active than the cyclopenta[a]phenanthrene (26) on the basis of 
tumour incidence, although not on mean latent period (Vose etal., 1981).
In the work described so far skin tumours induced with the 11-methyl- 
17-ketone (26) at the site of application were studied after topical 
application to the dorsal skin. The first experiment (Table 11) was 
supported by a small injection experiment shown in Table 18, employing 
T.O. mice (Coombs and Croft, 1969). Of the three compounds tested, 
the unsubstituted 17-ketone (4) gave no tumours in line with its lack of 
activity after topical application. The ll-methyl-17-ketone (26) was the 
only compound to yield local sarcomas at the site of injection, although 
the dose required was high. Both this compound and its 11,12-dimethyl 
homologue (131) gave rise to both papillomas and carcinomas on the skin 
remote from the site of injection, mainly on the ventral surfaces, without 
apparent promotion. Ventral skin is thicker and contains considerably 
more fat than dorsal skin, and it seems probable that this may retard the 
loss of this lipophilic ketone, thereby allowing it to act over a prolonged 
period at this site. It is interesting that the more lipophilic benzo[a]pyrene 
[which dissolves in hexane -  the cyclopenta[a]phenanthrenone (26) does 
not], like other polycyclic aromatic hydrocarbons, readily gives rise to 
local sarcomas after subcutaneous injection. It has already been men­
tioned, in connection with testing the 11-phenol (206), that the 11- 
methyl-17-ketone acts as a potent systemic initiator after subcutaneous
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154 Carcinogenicity and mutagenicity
injection of 10mg of this compound in olive oil, giving a high yield of 
dorsal skin tumours after promotion of this site remote from the site of 
injection with croton oil. In order to carry out the long-term experiment 
to be described (Coombs et al., 1979) it was necessary to avoid the 
induction of local sarcomas. This was easily achieved by reducing the 
injected dose to 3 mg; subsequent twice-weekly dorsal promotion with 
croton oil then led to dorsal skin tumours at the site of promotion in 65% 
of the animals (see Table 19), but no local sarcomas. The mean latent 
period for these skin tumours was 33 weeks; no dorsal skin tumours were 
observed in the absence of croton oil promotion of this area. When mice 
were injected but otherwise left untreated for six months before the usual 
promotion was begun, a tumour incidence of 45% was still obtained with 
the shorter mean latent period of 24 weeks. Iball indices calculated from 
these tumour incidences and mean latent periods (from the start of 
promotion) were almost identical (28 for immediate promotion and 27 for 
delayed promotion), indicating that initiation with this carcinogen is a 
permanent and irreversible state. These injected animals also developed 
a number of other tumours, whether they were promoted or not. The 
eyelids were particularly affected, and head and ventral surface tumours 
were also noted. This useful property of the carcinogen (26) of initiating 
skin effectively after subcutaneous injection without the induction of 
local sarcomas has been put to use in two other experiments. In the first 
(Bhatt et al., 1984), concerned with demonstrating that silica fibre 
isolated from the seeds of the grass Phalaris canariensis can act as a 
tumour promoter in T.O. mice, among a total of 70 mice injected there 
were 10 with eyelid and 22 with ventral trunk tumours. It has also made 
possible skin-transplantation experiments in Balb C mice, which are 
highly susceptible to the carcinogenicity of this ketone (J. Cox, private 
communication). Also Abbott (1983) demonstrated that this compound 
induced skin tumours in C57B1 mice, but not DBA/2 mice, in both the 
repeated-application (200 nmol twice weekly) and two-stage (1600 nmol 
once, followed by twice-weekly promotion) regimes. The resistance of 
DBA/2 mice is difficult to understand because for all three strains (T .O ., 
C57B1, and DBA/2) total DNA adducts in the treated skin, as well as the 
pattern of adducts as disclosed by high-pressure liquid chromatography 
of the derived nucleosides, were very similar. Moreover, the persistences 
of these DNA adducts in vivo were also similar for all three strains. It 
would be interesting to investigate whether DBA/2 mice lack an onco­
gene which is possessed in common by T .O ., C57B1, and Balb C mice, 
making them susceptible to cancer.
Little work has been carried out with cyclopenta[a]phenanthrenes in
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animals other than mice. However, intragastric instillation of 15,16- 
dihydro-l l-methylcyclopenta[a]phenanthren-17-one (26) into 27 virgin 
female Sprague-Dawley rats (30 mg/rat) induced mammary adeno­
carcinomas in six of them, as shown in Table 20 (Coombs et al., 1979). 
Mammary tumours were detected during the 18th week after treatment, 
but a single spontaneous adenocarcinoma did not appear among control 
rats until the 42nd week. Differences in tumour incidence between the 
two groups were significant at 30 weeks and highly significant at 50 weeks 
as indicated by the P values calculated by the exact method of Yates 
(Fisher, 1954). By contrast, benign fibroadenomas occurred later and to a 
similar extent in both the carcinogen-treated and the untreated control 
groups. In its ability to induce mammary carcinomas after a single 
intragastric instillation this compound resembles other potent known 
carcinogens such as 3-methylcholanthrene (Shay et al., 1949) and 7,12- 
dimethylbenz[a]anthracene (Huggins, 1961). However, it is less potent 
than either of the latter in this regard and also in its ability to induce skin 
tumours in mice after topical application (Coombs and Croft, 1969). The 
suggestion that the carcinogenicity of aromatic hydrocarbons increases as 
their structure approaches that of steroids (Yang et al., 1961) is there­
fore not substantiated. Interperitoneal injection of the cyclopenta[a]- 
phenanthrenone into 57 male Sprague-Dawley rats (10 mg/rat, in oil) did 
not induce local sarcomas in any of these animals. In this behaviour it 
differs markedly from polycyclic aromatic hydrocarbons such as 
benzo[a]pyrene (Flesher, 1976). However, a third of these animals later 
developed leukaemia; this disease is caused in rats by hydrocarbons such 
as 7,12-dimethylbenz[a]anthracene only after injection directly into the 
bloodstream via the caudal vein (Huggins etal., 1978). In addition 25% 
also suffered liver degeneration, while 50% developed cirrhosis of the 
kidney including one animal with a reticulosarcoma of this organ (Bhatt, 
1986).
6.3 The mutagenicity of cyclopenta[a]phenanthrenes
Over the last decade there has been a great deal of interest shown 
in the relationship between carcinogenicity and mutagenicity, chiefly in 
search of short-term tests for carcinogenicity that could supplant the 
tedious and expensive animal experiments of the type already described. 
During the intervening period it has become apparent that there is in fact 
a good correspondence between these two types of biological activity 
(Ames et al., 1973; Purchase et al., 1976). However, previously this was 
not obvious, and it then seemed of interest to re-test the 36 cyclopen- 
ta[a]phenanthrenes and two chrysenes listed in Table 21 for mutagenicity
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160 Carcinogenicity and mutagenicity
since there existed approximately quantitative data on the relative 
potency of these compounds as carcinogens in mice of a single strain. 
Initially, it was found that the compounds were not mutagenic in Ames’ 
original Salmonella typhimurium strains TA1535 and TA1538, but when 
these bacteria became available carrying the R-factor plasmid (pKMlOl) 
as TA98 and TA100 (McCann et al., 1975), making the bacteria more 
sensitive to polycyclic aromatic hydrocarbons, experiments became poss­
ible with cyclopenta[a]phenanthrenes. It was soon found that the carcino­
genic 11-methyl-17-ketone (26) was readily detected using TA100 and a 
standard homogenate obtained from the livers of rats induced with the 
chlorinated biphenyl mixture Aroclor 1254, but it was less readily 
detected with TA98. Thereafter, Salmonella typhimurium TA100 was 
used exclusively (Coombs et al., 1976; Bhatt et al., 1982; Hadfield et al., 
1984) in a standardized protocol. Each compound was first tested with 
three concentrations of the enzyme preparation (homogenate) to 
ascertain the concentration needed to give the highest mutation rate. As 
can be seen for the 7-methyl-17-ketone (230) in Fig. 57,20pL  or 50pL  of 
homogenate give the same initial slope of the dose/response curve, but 
this slope is less steep with 100/^L, although the maximum number of 
revertant colonies is larger at a higher dose. The compound was then re­
tested, at least in triplicate, using the optimum enzyme concentration and 
at 1, 5, 10, 50, and 100/^g/plate; the mutagenicity was expressed as the
Fig. 57. Induction of his+ mutations in Salmonella typhimurium TA100 with
15,16-dihydro-7-methylcyclopenta[a]phenanthren-17-one (230) at increasing
doses and at three levels of enzyme («L of homogenate).
2000 0
pg of compound / plate
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number of revertant colonies/nmol calculated from the initially straight 
part of the dose/response curve where cytotoxicity is minimal. Com­
pounds exhibiting less than 0.2 colony/nmol were considered non-muta- 
genic; this number is approximately equivalent to the spontaneous 
mutation rate of these bacteria under these conditions. Also collected in 
this Table are Iball indices of carcinogenicity for skin tumours induced in 
T.O. mice under the standard repeated-application (120 nmol twice 
weekly) and two-stage (1600 nmol once, twice-weekly promotion with 
croton oil) procedures, as already outlined. Compounds for which this 
index is <1 were not carcinogenic in these tests, i.e., the tumour 
incidence was less than 5% (<1 in 20 animals) in 700 days.
In this study all the carcinogens were mutagenic with the possible 
exception of the l-methyl-17-ketone (302) and the ll-n-butoxy-17- 
ketone (393); the former may possess marginal carcinogenicity whilst the 
latter appears to be a very weak carcinogen. However, the reverse was 
not true, for out of the 15 non-carcinogens six (marked with asterisks) 
were mutagenic. Also there was no consistent relationship between 
carcinogenic and mutagenic potency, although several strong carcino­
gens were also strong mutagens, giving dose/response curves similar to 
that shown in Fig. 58 for the ll-methyl-17-ketone (26). The dramatic
Fig. 58. Dose/response showing the effect of the increasing toxicity of the 
carcinogenic ll-methyl-17-ketone (26) above 10/rg/plate, and the inhibitory 
effect of a constant amount (30,ng) of 7,8-benzoflavone (BF) on mutation 
induction.
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decrease in the number of mutant colonies observed with doses above 
20/zg/plate probably reflects the considerable toxicity of this compound. 
This figure also demonstrates the effect of adding 7,8-benzoflavone 
(300^g) to the plate; in agreement with its inhibitory effect on tumour 
induction, this flavone also considerably reduced the apparent mutageni­
city of this compound, presumably by blocking metabolism. It is notice­
able that of the six mutagenic non-carcinogens, five are parent unsub­
stituted compounds which become carcinogens upon 11-methyl 
substitution. Of these 15,16-dihydrocyclopenta[a]phenanthren-17-one 
(4) is of particular interest for it has been tested side-by-side with its 11- 
methyl homologue (26) on many occasions, but has never been found to 
give tumours.
In order to carry this investigation a little further, these two compounds 
were also tested for mutagenicity in a mammalian cell culture system 
(Bhatt et al., 1983), using V79 Chinese hamster cells and scoring for 
mutations conferring 6-thioguanine resistance (Huberman and Sachs, 
1974). It was unexpectedly discovered that hamster embryo cells, used by 
these authors metabolically to activate polycyclic aromatic hydrocarbon 
carcinogens, did not appear to activate the cyclopenta[a]phenanthrenone 
(26). The method of Diamond et al. (1980) was therefore employed, 
making use of human hepatoma cells (HepG2) to cause activation. 
Under these conditions the ll-methyl-17-ketone (26) and its strongly 
carcinogenic chrysenone analogue (450) were both potent mutagens 
whilst the 2- and 3-methyl-17-ketones (303 and 304, respectively, both 
non-carcinogens) were inert. However, the non-carcinogenic parent 
ketone (4) was still moderately mutagenic in this system (Table 22). 
Again substantial toxicity was encountered with the carcinogen (26) in 
these cells, the cloning efficiency being reduced 50% at a dose of lpg! 
mL, at which the highest mutation frequency was observed (Fig. 59). 
These two cyclopenta[a]phenanthrenes (4) and (26) were also compared 
for their ability to increase the frequency of sister chromatid exchanges in 
human lymphocytes, again using Hep G2 cells to cause biological activa­
tion (Lindahl-Kiessling et al., 1984). In this case it was found that the 
carcinogen (26) was able consistently to increase this frequency whereas 
the non-carcinogen (4) was not.
Several of these compounds have also been tested in yeast (Kelly, 1983; 
Kelly and Parry, 1983). Gene conversion at the trp5 locus was measured 
in Saccharomyces cerevisiae strain JD1, whilst strain D6 was used to 
detect mitotic aneuploidy. The experiments were carried out in ignorance 
of the identities of the compounds until completion of the series. Results 
are summarized in Table 23 in which a positive response (+) denotes at
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least a two-fold increase over control levels in white, cycloheximide 
resistant, monosomic colonies in strain D6 or trp+ prototrophs in strain 
JD1. For reference carcinogenicity is displayed alongside, again either 
positive or negative, without any indication of potency. There is a 
remarkably good correlation between genetic activity and carcinogeni­
city in both strains of this yeast. Of the carcinogens only the 11-phenol 
(206) was not detected; this compound is almost insoluble in water and 
most organic solvents, so that a sufficient concentration was probably not 
achieved in the incubation medium. The ll-isopropoxy-17-ketone (392) 
was active in D6, but not in JD1 thus confirming its apparent very weak 
carcinogenicity, whereas the ll-n-butoxy-17-ketone, also a very weak 
carcinogen, was active in both, although it was not detected in the Ames’ 
test. All the non-carcinogens were inactive in both D6 and JD1, including 
the unsubstituted parent ketone (4) which was mutagenic in both the 
Ames’ test and in V79 cells in culture. The l-methyl-17-ketone (302) was 
not mutagenic in any of these tests, thus throwing further doubt on its 
questionable carcinogenicity. Sensitivity for these compounds was poor,
Fig! 59. Toxicity (reduction in plating efficiency) and mutagenicity (induction 
of 6 -thioguanine-resistant colonies) with the carcinogenic ll-methyl-17- 
ketone (26) in V79 cells mediated by human Hep G2 liver cells.
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the maximum increase in genetic activity over background never reaching 
more than three-fold, and there was little indication of potency. Addition 
of rat liver homogenate to the plates generally increased the observed 
frequency of mitogenic conversion and aneuploidy events, but the yeasts 
were to some extent capable of activating these compounds themselves, 
especially when they had been grown on low glucose (0.5%) to the 
exponential phase and then transferred to high glucose (20%) to suppress 
mitochondrial function. Under these conditions a marked increase in the 
P450/448 content of the yeast could be demonstrated.
Of these methods for measuring genetic toxicity the Ames’ test is to be 
preferred on grounds of operational simplicity as well as sensitivity. In 
this cyclopenta[a]phenanthrene series the test is capable of detecting 
virtually all the carcinogens, but suffers chiefly from being too sensitive in 
that it also detects some non-carcinogens as mutagens. This is of little 
consequence when the test is used to distinguish the biologically active 
metabolites of these compounds among the many separable by hplc, as is 
described in Chapter 7.
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7Metabolic activation of cyclopenta[a]- 
phenanthrenes and their interaction with 
DNA
7.1 Activation of 15,16-dihydro-ll-
methyIcyclopenta[a]phenanthren-17-one
In the various mutation tests described in the last chapter, 
without exception none of the cyclopenta[a]phenanthrenes was active in 
the absence of an added source of metabolism. Since there is a good 
parallelism between mutagenicity and carcinogenicity in this series, it 
seemed reasonable to suppose that metabolism was required before these 
compounds could act to cause tumours in animals. Dannenberg (1960) 
found that introduction of a double bond between C-16 and C-17 in Diels’ 
hydrocarbon (7) to give 17-methyl-15//-cyclopenta[a]phenanthrene 
(133) led to weak carcinogenicity (see Table 9). He noted that this double 
bond was the most chemically reactive in the molecule, adding, for 
example, to osmium tetroxide to give the 16,17-as-diol in preference to 
the K-region 6,7-double bond, and he suggested that the carcinogenicity 
of this hydrocarbon and its 15-methyl-17i/-isomer (128) might be due to 
the reactivity of these double bonds in the five-membered ring-D. It has 
already been shown that some of the 17-ketones of this series, lacking a 
carbon-carbon double bond in the ring-D, are more active than the 
corresponding unsaturated ring-D hydrocarbons (see Tables 10 and 11), 
and in these ketones the most chemically reactive double bond is between 
C-6 and C-7 (i.e., in the K-region). Metabolism of cyclopentaja]- 
phenanthrene hydrocarbons such as (128) and (133) does not appear to 
have been studied yet, although structure/activity relationships 
established since Dannenberg’s suggestion do indicate interesting dif­
ferences between the two series (see Table 24). Thus comparing the Iball 
indices obtained under the same standard conditions for several identi­
cally substituted pairs of 17-methyl-16,17-enes and 15,16-dihydro-17- 
ketones it is clear that carcinogenicity among the latter is confined to 11-
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substituted derivatives, whereas all the hydrocarbons appear to be active 
to some extent. Analogously substituted 17-ketones are more active than 
the corresponding hydrocarbons, particularly in the case of the 11- 
methoxy derivatives.
At the outset the ll-methyl-17-ketone (26) was chosen for metabolic 
study because it was at that time the most carcinogenic cyclopen- 
ta[a]phenanthrene known; in many experiments the inactive unsub­
stituted parent 17-ketone (4) was examined alongside. An indication that 
simple metabolic experiments employing the microsomal fraction from 
rat liver in incubations in phosphate buffer containing an excess of 
NADPH in air would yield meaningful results came from an early 
experiment (Coombs et al., 1975). In this it was established that the aryl 
hydrocarbon hydroxylase inhibitor 7,8-benzoflavone not only inhibited 
tumour production with this 11-methyl ketone (26), but also considerably 
diminished the binding of this 3H-labelled carcinogen to calf thymus 
DNA under these in vitro metabolic conditions (Table 25). The carcino­
gen administered twice weekly at a total dose of 60/zg/week gave the 
expected skin tumour incidence (85%) and mean latent period (29 
weeks). At one-tenth of this weekly dose, in two identical experiments 
the tumour incidence was approximately halved, and the mean latent 
period increased about 50%; these results illustrate the good reprodu­
cibility achievable in this type of tumour-induction experiment. No skin 
tumours were produced at one-hundredth of the original weekly dose. 
When a mixture of the carcinogen at the highest weekly dose was painted 
together with 7,8-benzoflavone at three times this dose, tumour incidence 
was reduced to 70% and the mean latent period was prolonged by almost 
30%, but when both were repeatedly administered together at one-tenth
Table 24. Comparison o f Iball indices (T.O. mice, repeated 
application) o f 17-methyl-15H-cyclopenta[a]phenanthrene 
hydrocarbons with the corresponding 15,16-dihydrocyclo- 
penta[a]phenanthren-l 7-ones
Substitution
Iball index (see Table 21)
17-methyl-16,17-ene 17-ketone
unsubstituted (133) 6 (4) <1
11-methyl (135) 27 (26) 46
12-methyl (136) 7 (130) <1
11,12-dimethyl (137) 23 (131) 30
11-methoxy (138) 11 (132) 25
3-methoxy (134) 2 (24) <1
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of these amounts no skin tumours were observed. Thus this inhibitor is 
relatively more active at lower doses of the carcinogen as has been noted 
already. Administration of a nine-fold quantity of the non-carcinogenic 
parent ketone (4) together with the carcinogen (26) had no effect on the 
tumour induction by the latter. This carcinogen (26) bound covalently to 
calf thymus DNA added to the in vitro metabolic incubation, but this was 
largely prevented by inclusion of the inhibitor in the incubation mixture. 
No DNA binding occurred in the absence of the microsomal preparation, 
or if the enzyme was deactivated by heat treatment (2 min at 100°C) prior 
to incubation with the substrate and DNA. This whole experiment clearly 
supports the view that metabolism is involved in tumour induction with 
this carcinogen, and that this simple metabolic system is a valid model for 
its study:
Under similar in vitro metabolic conditions in the absence of added 
DNA and using microsomes isolated from the livers of uninduced 
Sprague-Dawley rats (Coombs et al., 1976), the main metabolites ex­
tracted from the incubation mixture with ethyl acetate appeared to be 
mono-ols on examination by thin-layer chromatography (tic). These 
were readily identified as the 15-ols (369 and 370) and 16-ols (345 and 
346), from the unsubstituted -17-ketone (4) and its carcinogenic 11- 
methyl homologue (26), respectively, by direct comparison of R ? values 
and ultraviolet spectra of material recovered from the plates with those of 
the synthetic compounds. When 3H-labelled compounds were used these 
identities were confirmed by dilution analysis of the derived acetates. The 
carcinogen also gave a small amount of its 11-hydroxy-methyl derivative 
(215) identified in the same way, and by the fact that as expected it 
retained only about 65% of the radioactivity of the original compound 
when the latter was labelled with tritium in the 11-methyl group. Other 
more polar metabolites were also detected by tic, and these were 
increased relative to the mono-ols when the rats were induced by 
injection with 3-methylcholanthrene or phenobarbitone before sacrifice. 
While tlfc gave a good separation of these metabolites and the overall 
structures of some could be tentatively deduced from their relative R ? 
values and their ultraviolet spectra, particularly after in situ reduction of 
the carbonyl group with sodium borohydride, not enough could be 
obtained in this way for further examination. Moreover, it was difficult to 
avoid aerial oxidation using this technique.
Rapid progress was made when high-pressure liquid chromatography 
(hplc) was introduced because it overcame both of these difficulties. Also 
developments in high-held Fourier transform nuclear magnetic 
resonance (nmr) spectroscopy at this time greatly increased the sen­
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sitivity of this analytical technique so that it became applicable to the 
amounts of metabolites obtainable by hplc. Finally, the renewed interest 
in the metabolism of polycyclic aromatic hydrocarbons had led to the 
identification of a bay-region diol-epoxide as the active form of 
benzo[a]pyrene (Sims etaL, 1974), and it was subsequently demonstrated 
that a number of other phenanthrene-derived hydrocarbons followed a 
similar activation route (Jerina et al., 1978). It seemed probable that the 
carcinogenic 15,16-dihydro-ll-methylcyclopenta[a]phenanthren-17-one 
(26) might undergo analogous metabolism, and this was reinvestigated 
using these new techniques with this in mind.
Figure 60 shows a typical hplc separation of in vitro metabolites of this 
compound (26) extracted with ethyl acetate after incubation with 
NADPH and a microsomal preparation obtained from the livers of male 
Sprague-Dawley rats previously injected with 3-methylcholanthrene 
(Coombs et al., 1980). Under these conditions most of the conjugating 
enzymes normally present in the supernatant are absent, thus largely 
preserving the products of primary metabolism. After being shaken in the 
presence of atmospheric oxygen for 30 min at 37°C, extraction with ethyl 
acetate routinely led to recovery of about 80% of the material incubated, 
as determined by recovered radioactivity when a labelled substrate was 
metabolized. A reverse-phase column was employed to separate the 
complex mixture formed using a gradient of aqueous methanol increasing 
in methanol concentration, so that the more polar metabolites eluted first 
and last peak to emerge was the unreacted substrate (26). The profile 
shown in the figure was monitored continuously at 254 nm, but the profile 
of eluted radioactivity was very similar. The properties and the structures
Fig. 60. Profile of in vitro metabolites of the carcinogen (26) separated by 
reverse-phase hplc and monitored by their ultraviolet absorption at 254 nm; 
the first peak m is of microsomal origin, and the last is the unchanged 
substrate (26).
m
Retention time (min )
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deduced for the main metabolites (a-g) are listed in Table 26 (Coombs et 
al., 1980). The peak denoted M, of microsomal origin, was always 
present and acted as a useful chromatographic marker. Molecular form­
ulae were based on molecular weights obtained from mass spectrometry; 
the patterns of fragment ions were in all cases those expected from 
previous work with synthetic compounds (see Chapter 5). With the
Table 26. Structures and properties o f the main metabolites a-g (Fig. 60) 
of the carcinogen 15,16-dihydro-ll-methylcyclopenta[a]phenanthren-l 7- 
one (26)
Metabolite Structure
(a) 11-methyl-1,2,15,16-tetrahydro-1,2,15-trihydroxycyclo- 
penta[a]phenanthren-17-one (454) C18H160 4
Found: M+ 296.1043; Calculated 296.1049
Amax 265 (4.60), 322 (4.10), 334 (4.14), 354 (3.71), 373 (3.68)nm
Xmm (reduced) 259 (4.65), 267 (4.69), 320 (3.80) nm
(b) 1 l-methyl-3,4,15,16-tetrahydro-3,4, 15-trihydroxycyclo- 
penta[a]phenanthren-17-one (455)
ClgH 160 4 Found: M+ 296; Calculated 296
273 (4.70), 327sh (3.83), 335 (3.84), 370sh (3.54) nm 
Xmax (reduced) 248 (4.74), 327 (3.97), 347 (3.85) nm
(c) 1 l-methyl-3,4,15,16-tetrahydro-3,4,16-trihydroxycyclo- 
penta[a]phenanthren-17-one (456)
C18H160 4 Found: M+ 296; Calculated 296
Xmax 272 (4.70), 327sh (3.89), 333 (3.90), 370sh (3.61) nm
Amax (reduced) 248 (4.76), 326 (4.03), 347 (3.90)nm
(d) 15,16-dihydro-15-hydroxy-ll-hydroxymethylcyclopenta[a]- 
phenanthren-17-one C18H 140 3
Found: M+ 278.0948; Calculated 278.0943
Amax 269 (4.78), 300 (4.27), 358 (3.26), 376 (3.24) nm
Xm3X (reduced) 255 (4.82), 279 (4.09), 290 (4.05), 301 (4.09), 334
(4.06), 350 (2.93)nm
(e) 3,4-dihydroxy-11 -methyl-3,4,15,16-tetrahydrocyclopenta[a] - 
phenanthren-17-one (457)
C18H 160 3 Found: M+ 280.1109; Calculated 280.1100 
Xmax 273 (4.71), 332sh (3.84), 357 (3.57), 371 (3.55) nm 
Amax (reduced) 250 (4.70), 306 (3.58), 330 (3.63), 349 (3.59) nm
(f) 15,16-dihydro-15-hydroxy-l l-methylcyclopenta[a]phenanthreri- 
17-one
(370)
Identified by reference to the synthetic compound (see Chapter 5 
for physical data)
(g) 15,16-dihydro-16-hydroxy-l l-methylcyclopenta[a]phenanthren- 
17-one
(346)
Identified by reference to the synthetic compound (see Chapter 5 
for physical data)
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vicinal trans-dihydro diols the molecular ions were weak, but the M+-18 
ions (loss of water) were prominent, and ions due to the ready loss of 
carbon monoxide (28 mass units) from ring-D confirmed the retention of 
this double-bonded oxygen atom in these metabolites. The ultraviolet 
spectra of these cyclopenta[a]phenanthrene derivatives after mild reduc­
tion of this conjugated double bond with sodium borohydride resembled 
those of the corresponding known phenanthrene derivatives, and 
allowed assignment of the points of saturation and hence the position of 
the trans-dihydrodiol systems. This was further checked by dehydration 
of these diols by heating them with 50% sulphuric acid for 30 min, 
and examining the resulting phenols (Table 27). Metabolites (b), (c), and 
(e) gave 4-phenols with almost identical ultraviolet spectra, similar 
to those of synthetic 15,16-dihydro-4-hydroxy-l-methylcyclopen- 
ta[a]phenanthren-17-one (458), whereas the 2-phenol from metabolite a 
resembled synthetic 15,16-dihydro-2-hydroxycyclopenta[a]phen- 
anthren-17-one (396). The inter-relationships between these various 
metabolites are shown in Fig. 61. The mono-ols (215), (346, g), (370, f), 
and the A-ring diols (459) and (457, e) suffer further conversion into the 
triols (454, a), (455, b) (456, c), and the diol (d). This was con­
firmed by similar metabolism of the synthetic mono-ols which gave 
rise to these further-hydroxylated derivatives as expected. The minor
Table 27. Ultraviolet spectra o f phenols obtained by acid-catalysed 
dehydration o f the metabolites (a), (b), (c), and (e) in comparison with 
those o f two synthetic phenols
Phenol
^  Oogio e) 
Neutral Alkaline
Derived from (a) 278 (4.71) 250 (4.53),
301 (4.55)
15,16-dihydro-2-hydroxycyclopen- 274.5(4.74) 245 (4.59),
ta[a]phenanthren-17-one (396) 296 (4.62)
Derived from (b) 269 (4.61), 261 (4.70),
274 (4.62), 327 (4.37)
301.5 (4.48)
Derived from (c) 269 (4.68), 262 (4.76),
274 (4.67), 328 (4.46)
301 (4.57)
Derived from (e) 271 (4.66), 261 (4.64),
301 (4.45) 325 (4.32)
15,16-dihydro-4-hydroxy-l- 270, 305 260, 325
methylcyclopenta[a]phenanthren-17-
one (458)
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metabolites (215) and (459) were not resolved with a 10-^m reverse- 
phase column, but using a similar 5-/mi column the 11-hydroxymethyl- 
17-ketone (215) ran as a small peak just ahead of the 15-ol (370), whilst 
the 1,2-diol (459) appeared just before the 3,4,15-triol (455) and pos­
sessed ultraviolet characteristics almost identical with those of the 1,2,15- 
triol (454). Thus the 1,2-diols are noticeably more polar than the 
corresponding 3,4-diols; it later appeared that this was due to the fact that 
the 1,2-diols were diaxial, whereas the 3,4-diols were diequatorial. It 
therefore seems that this ketone (26) suffered oxidative metabolic attack 
at rings -A and -D and at the methyl group, but not elsewhere in the 
molecule. In particular the 6,7-double bond, the most reactive chemi­
cally, was unaffected.
The kinetics of the formation of certain of these various metabolites 
were investigated, chiefly in order to optimize the amount of the 3,4- 
dihydrodiol since this was required for further study. Aliquots were 
withdrawn from an in vitro incubation of the 14C-labelled carcinogen at 
intervals, immediately cooled in ice and extracted with ethyl acetate. 
Separation of the metabolites by hplc and quantitation were carried out
Fig. 61. Structures proposed for the main metabolites formed in vitro from
the carcinogen (26).
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as usual to generate the curves shown in Fig. 62. About 75% of the 
substrate was consumed, but at a decreasing rate during 45 min, by 
shaking in air at 37°C. The 3,4-dihydrodiol increased in amount up to 
about 15 min and then remained fairly constant, decreasing somewhat 
only at times after 30 min. Presumably this plateau resulted from the rate 
of its formation just matching its loss by further metabolism until the 
amount of substrate was diminished substantially. The 15-ol, on the other 
hand, increased rapidly in amount at first, reaching a maximum account­
ing for about 25% of the substrate at 10min, but thereafter decreased 
sharply. Conversely, the 1,2,15-triol after a sluggish start increased in 
amount roughly linearly up to about 30 min, confirming that it was 
formed largely from the 15-ol by further metabolic attack in ring-A. 
Subsequently, incubations were generally maintained for 30 min to allow 
consumption of about 70% of the substrate and to maximize the quantity 
of the 3,4-dihydrodiol under these conditions of substrate and enzyme 
concentration.
Identification of the biologically active metabolite(s) of this carcinogen 
(26) was tackled in two ways -  by measuring the ability of metabolite 
fractions (a-g) to bind to calf thymus DNA in vitro after further 
metabolism, and by investigating their mutagenicity in the Ames’ test. It 
has already been mentioned (Table 25) that after metabolism this 
compound binds covalently to DNA added to the incubation mixture.
Fig. 62. Kinetics of the formation of certain metabolites of the carcinogen
(26) on in vitro incubation.
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When DNA exposed in this way to the 14C-labelled ll-methyl-17-ketone 
(26) was isolated, purified, hydrolysed enzymatically to its constituent 
nucleosides, and the latter were separated by chromatography on a 
column of Sephadex LH20 (hydroxypropyl cellulose) using a water- 
methanol gradient, two radioactive peaks A and B eluted following the 
natural nucleosides (detected by their ultraviolet absorption) as shown in 
Fig. 63. This carcinogen, generally labelled with tritium at very high 
specific activity (13.9 Ci/mmol), was also applied to mouse skin in vivo as 
in a tumour-initiation experiment; 24 h later the mice were killed and the 
treated skin was removed. Isolation of the DNA was achieved by initial 
digestion of the skin with proteinase K according to the method of Blin 
and Stafford (1976). After purification and enzymatic hydrolysis, the 
constituent nucleosides were separated as before by LH20 chromatog­
raphy to give radioactive peaks A and B with the same retention times as 
those obtained from calf thymus DNA in vitro. In this experiment the 
amount of peak A relative to peak B was less, and owing to the lability of 
the tritium due to metabolism, the normal nucleosides also became
Fig. 63. Sephadex LH20 profiles of DNA hydrolysates: (a) profile from calf 
thymus DNA treated in vitro with the 14C-labelled carcinogen (26) (the 
dotted line represents ultraviolet absorption of the eluate continuously 
monitored at 254nm and the solid line radioactivity); (b) similar profile from 
DNA isolated from the skin of mice treated topically in vivo with the 3H- 
labelled carcinogen (26); (c) co-chromatography of the in vitro 14C-adduct B 
and in vivo 3H-adduct B, establishing their identity.
'C dpm
in vitro
1 0 0 0 -
3H dpm 
2 0 0 0 -
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labelled to some extent. When the main adduct peak B, labelled with14C 
from the first in vitro experiment, was co-chromatographed on LH20 with 
the 3H-labelled adduct peak B from the in vivo experiment they co-eluted 
together precisely. Thus it seemed that the simple in vitro model 
adequately represented the in vivo situation in mouse skin. The binding 
of the 14C-labelled metabolic fractions (a-f) to DNA was next studied in 
vitro using hepatic microsomes and calf thymus DNA as before. In each 
case the recovered DNA was degraded to its constituent nucleosides 
which were separated by LH20 chromatography, and the radioactivity in 
peaks A and B from each was measured. The results obtained from this 
experiment are displayed in Table 28 which also lists the mutagenicity of 
these fractions a-f in the Ames’ test. In both tests the metabolite (e) (3,4- 
dihydrodiol) was by far the most active, being two and a half times more 
mutagenic and binding to DNA nearly four times as much as the original 
carcinogen (26). It was also the only metabolite to yield adduct B ; the fact 
that it also gave some adduct A proved that it underwent further 
hydroxylation to metabolites (b) or (c). Adduct A is formed from the
3,4,15- and 3,4,16-triols (b and c); the mono-ols (g) and (f) also gave this 
adduct, no doubt after their conversion into (b) and (c). The 1,2,15-triol 
(a) and the ll-hydroxymethyl-15-ol (d) were inactive in both tests. Thus 
the primary metabolite responsible for the biological activity of the 
carcinogen (26) is its 3,4-dihydrodiol (457, e). That this was also mainly 
responsible for its carcinogenicity was investigated in a direct, straight­
forward manner (Coombs and Bhatt, 1982). Repeated large-scale 
(10/unol) in vitro incubation of this carcinogen and separation of the
Table 28. Mutagenicity and in vitro DNA binding o f metabolites a-g 
(Fig. 60) o f the carcinogen 15,16-dihydro-ll-methylcyclopenta[a]~ 
phenanthren-17-one (26)
DNA-binding index (//mol of
Mutagenicity metabolite/mol of DNA phosphorus)
(revertants/
Metabolite nmol) Adduct A  Adduct B Total
(a)
(b)
(c)
(d)
(e)
(f)
(g)
Carcinogen (26)
0 0 0 0
8.9 347 0 347
14.8 74 0 74
0 0 0 0
45.6 56 541 597
6.6 58 0 58
13.6 31 0 31
17.5 30 127 157
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metabolites produced by hplc gave enough of these main metabolites ( a -  
g) for them to be tested for carcinogenicity in the standard two-stage 
initiation/promotion experiment with T.O. mice. Groups of 20 mice were 
employed as usual, and each received a topical dose of 100nmol [in 
toluene-acetone (1:1 v/v) because this solvent was known to enhance the 
carcinogenicity of (26)]; twice-weekly promotion with 1% croton oil in 
toluene then led to the result illustrated in Fig. 64. Again the 3,4-diol 
(457) was more active than the original carcinogen both in respect to 
higher skin tumour incidence and to a shorter mean latent period. The
3,4,15- and 3,4,16-triols (455 and 456) were much less active as tumour 
initiators, and the 1,2,15-triol (454) and ll-hydroxymethyl-15-ol were 
inactive. This firmly established that 3,4-dihydroxy-ll-methyl-3,4,15,16- 
tetrahydrocyclopenta[a]phenanthren-17-one is the main proximate form 
of the carcinogen (26).
The nature of the adduct peaks A and B was further investigated by 
hplc (Abbott and Coombs, 1981). When the total radioactive DNA 
adducts (peaks A and B) derived from mouse skin treated in vivo with the 
carcinogen (26) as already described were chromatographed on a 10-//m 
reverse-phase column in water-methanol (9:1 v/v) six discrete peaks 
were seen (Fig. 65). By chromatographing peaks A and B separately it
Fig. 64. First appearance of skin tumours in groups of 20 mice after a single 
topical ( 1 0 0  nmol) application of the carcinogen (26) and its metabolites 
(455)-(457), followed by twice-weekly promotion with croton oil.
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was found that A gave rise to I, II, and III, while peak B separated into 
IV, V, and VI. The DNA recovered from an in vitro binding experiment 
gave a similar result, and the origin of the individual peaks was 
determined by incubating each of the main metabolites (b ,  c, e, g) and (f) 
with DNA in the presence of rat liver microsomes in vitro. In this way it 
became clear that the proximate carcinogen (metabolite e) gave rise to 
the main adduct V accounting for over 80% of the total adducts, as well as 
the minor adduct IV, while the other peaks arose from the triols (b )  and 
(c). By incubating DNA labelled with tritiated deoxyguanosine with the 
14C-labelled carcinogen (26) it was readily established that the major 
adduct V as well as II (probably the 16-hydroxy derivative of V) both 
involved binding to this base. By using poly(deoxyadenosine-thymidine) 
labelled with tritiated deoxyadenosine it was likewise shown that adduct 
VI (and possibly I) involved binding to adenosine. Thus it appears that
Fig. 65. hplc Profile of DNA adducts derived from the skin of mice treated
topically with the 3H-labelled carcinogen.
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over 85% of the DNA binding observed with this carcinogen is to 
deoxyguanosine. Thus in this respect, as well as its activation via the
3.4-dihydrodiol, this ll-methyl-17-ketone closely resembled 
benzo[a]pyrene.
Since further metabolism was required before the 3,4-dihydrodiol 
(457, e) bound to DNA in vitro or caused mutations in bacteria it was 
tempting to assume that this, like benzo[a]pyrene, was mediated via a 
bay-region diol-epoxide. However, this was difficult to prove in the 
absence of the synthetic diol epoxide, although two separate pieces of 
evidence pointed in this direction. As has already been discussed in 
Chapter 5, a detailed and extensive mass spectral study of DNA treated in 
vitro with the carcinogen (26) established that a 2,3,4-trihydroxy deriva­
tive was bound to deoxyguanosine via its exocyclic N2-amino group 
(Wiebers et al., 1981). The other evidence comes from LH20 elution 
volume data with the nucleoside peak B, which as we have seen, consists 
mainly (>80%) of this deoxyguanosine adduct. In Tris buffer at pH 8.7 
this adduct has an elution volume of about 250 mL, whereas in borate 
buffer of the same pH and ionic strength it elutes earlier, with an elution 
volume of about 200mL (Coombs et al., 1979). This is consistent only 
with an intermediate twfr‘-l,2-epoxy-fra«.s-3,4-dihydrodiol, nucleophilic 
opening of which would yield a 2,3,4-trihydroxy derivative in which the 
vicinal C-2 and C-3 hydroxy groups are cis with respect to one another, 
and therefore are able to complex with the borate. A sy«-l,2-epoxy- 
?rara'-3,4-dihydrodiol would give rise to an al\-trans arrangement unable 
to form a complex, and thus elute earlier (Fig. 66). The absolute 
stereochemistry was based on an nmr and circular dichroism study of the
3.4-diol (457, e) (Hadfield et al., 1984b). Chemical shifts (d values) and 
coupling constants for the ring-A protons in this 1 l-methyl-3,4- 
dihydroxy-3,4-dihydro-17-ketone and its unsubstituted homologue, both 
obtained from metabolism of (26) and (4) in vitro, together with the 
borohydride reduction product of the latter diol are shown in Table 29. 
From the large coupling constants between H-3 and H-4 in these com-
Fig. 6 6 . Nucleophilic opening of 3,4-dihydro-3,4-dihydroxy-anti- and syn- 1,2- 
oxides at C-l; only the anti-oxide can give a vicinal ds-diol which can 
complex with borate.
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pounds it is clear that the 3,4-diol system is trans and diequatorial. Both
3,4-dihydroxy-17-ketones had similar circular dichroism curves of the 
same sign; the unsubstituted 3,4,17-triol had a circular dichroism curve 
similar to and of the same sign as that of trans-lR,2R-dihydroxy-l,2- 
dihydrophenanthrene. Taken together these findings point to [3R,4R]- 
dihydroxy-3,4,15,16-tetrahydrocyclopenta[a]phenanthren-17-one as the 
structure of the proximate carcinogen (457) which is further oxidized at 
C-l, C-2 and then interacts with DNA mainly as illustrated in Fig. 67.
The in vitro metabolism of this carcinogen (26) has also been studied 
with the human hepatoma cell line HepG2 (Bhatt, 1986) in connection 
with the ability of these cells to activate this compound to a mutagen in 
the V79 Chinese hamster cell system as described in Chapter 6. These 
cells are highly induceable (Dawson et al., 1985) and after pretreatment 
with benzanthracene or Arochlor microsomes prepared from them gave 
the range of metabolites seen with rat liver microsomes, including a large 
amount of the proximate carcinogen (457). However, in addition prod­
ucts from enzymatic reduction of the 17-ketone function were also 
observed. Thus with uninduced microsomes the major metabolite was 
the 17-alcohol (16,17-dihydro-ll-methyl-15i/-cyclopenta[a]phenan- 
thren-17-ol, 448), while with induced microsomes the 16,17-diol and a 
phenol, probably the 4,15,17-triol, were also identified. The reductase 
responsible for 17-ketone reduction appeared to be largely present in the 
supernatant for when the microsomes were carefully washed these 
products were minimized. After exposure to these cells the carcinogen 
(26) bound to added DNA to give the adduct peaks A and B on LH20 
chromatography, apparently identical with those found after activation 
with rat liver preparations. Little metabolism was seen when hamster 
embryo cells were used, whether they were induced or not, and this
Fig. 67. Proposed metabolic route leading to the ultimate carcinogen and its
main deoxyguanosine adduct.
OH o OH
dR= 2-deoxyrib ose
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explains why these cells fail to activate this carcinogen to a mutagen in 
V79 cells. In this respect this carcinogenic cyclopenta[a]phenanthrenone 
appears to differ from hydrocarbons such as benzo[a]pyrene, but the 
reason for this is not clear at present.
Mouse embryo cells derived from T.O. mice also activate this carcino­
gen (26). In a study of the binding of a number of polycyclic hydrocarbon 
carcinogens to nuclear and mitochondrial DNA (Allen, 1979; Allen and 
Coombs, 1980) in these cells, the familiar patterns of adduct peaks were 
again observed. However, the mitochondrial DNA binding index (//mol 
of compound bound per mol of DNA phosphorus) was over 500 times 
higher than was this index for the nuclear DNA. This was found to be 
common also for the other carcinogens, where the ratio ranged between 
50-fold and 250-fold.
7.2 In vivo metabolism of 15,16-dihydro-ll-methylcyclopenta[a]-
phenanthren-17-one in the rat
Prior to the work on in vitro metabolism just described urinary 
metabolites of this carcinogen (26) and its inactive parent ketone (15,16- 
dihydrocyclopenta[a]phenanthren-17-one (4) were investigated in the 
rat. Adult Sprague-Dawley males were injected (100 mg/animal) 
intraperitoneally with these compounds, labelled with14C or tritium, and 
urine was collected for three days when excretion of radioactivity was 
largely completed. It was found advantageous to extract the metabolites 
from the crude urine by first absorbing them on to neutral charcoal, from 
which they could be recovered by elution with methanol containing 
ammonia. The extract was then evaporated to a syrup which was mixed 
with water and re-extracted with ethyl acetate. This work was, of course, 
carried out before the advent of hplc, and the metabolites obtained in this 
way were compared by careful semiquantitative tic on silica gel-coated 
glass plates. Each compound gave over a dozen metabolites which 
formed discrete bands on the plate, and could be located by their 
radioactivity (after autoradiography on X-ray film), their fluorescence, 
and by various colour reactions. By removal of the material comprising 
these bands from the plate, and eluting it with ethanol ultraviolet spectra 
could be obtained. The result of this survey is shown in Table 30. The 
most noticeable feature is the remarkable similarity between the patterns 
of urinary metabolites of these two ketones. In most cases this similarity 
extended to a number of colour reactions (not shown) carried out by 
spraying the plates. The amounts in the bands, as judged by their 
radioactivity, were also similar for each pair with the exceptions shown in 
the second column. With the two pairs of phenols (bands 4 and 5) in each
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case 3-4 times as much was obtained from the parent ketone (4) as from 
its 11-methyl homologue (26), accounting for 30-40% of the total 
radioactivity for the former. By contrast the amounts of the similar 
metabolites in band 10 differed greatly; only a trace was obtained from 
(4), whereas it was a major metabolite from (26), accounting for about 
50% of the total. The structure of this metabolite was therefore 
determined since this difference between the carcinogen and its inactive 
parent seemed possibly of significance.
To this end a total of 20 g of the ll-methyl-17-ketone (26) labelled with 
tracer amounts of tritium were injected into rats, and metabolites were 
isolated from their urine as already described. The mixture was then 
chromatographed on silica gel columns, finally to give the band-10 
metabolite, after further purification by recrystallization, as 120mg of 
pale fawn needles, mp 120°C decomp. It was optically active, [a] n 6 ° — 214° 
(c. 0.134, ethanol), and its ultraviolet characteristics, 2max 267 (4.57), 
320 (4.03), 332 (4.04), 352 (3.67), 370 (3.61) nm, were very similar 
to those of ll-methyl-l,2,15,16-tetrahydro-l,2,15-trihydroxy-cyclo- 
penta[a]phenanthren-17-one (454, metabolite a, Table 26) later 
isolated from in vitro metabolism of (26). Combustion analysis estab­
lished the formula C18H160 5 (see Fig. 68); the mass spectrum was 
informative, although the molecular ion was absent:
m/z % abundance Derivation
c 18h 14o 4 294.0892 — —
requires
Found 294.0893 6 m +-h 2o
278 34 m +-h 2o -o
260 21 M+-2H20 - 0
232 50 M+-2H20 - 0
Fig. 6 8 . The structure (460) of the main urinary metabolite of the carcinogen 
(26) in the rat, and some of its chemically derived products.
C18Hi,°t[(COCH3g C18H16°5
Activation o f l ,  ll-methano-17-ketone 189
The fifth ‘non-functional’ oxygen atom was therefore thermally labile; it 
was also eliminated on acetylation with acetic anhydride in pyridine at 
room temperature, giving the triacetate C24H220 7 (461) and on mild 
hydrogenation yielding the dihydro-deoxy derivative C18H180 4 (462). 
Surprisingly, it was, however, retained when the metabolite was submit­
ted to acid-catalysed dehydration (2 .5-m sulphuric acid at 100°C for 1 h) to 
give the phenol C18H 140 4 (463). A full nmr study finally established the 
structures shown in Fig. 68 for these compounds (Coombs and Crawley, 
1974,1975) (see Chapter 5 under the appropriate molecular formula for 
details). Precedents exist in the chemical literature both for loss of the 
bridge oxygen in oxepins of this type (460) both thermally and on 
hydrogenation as well as its retention in strongly acidic media, but not for 
its loss on mild acetylation; the mechanism by which this occurs remains a 
mystery. The occurrence of a structure such as (460) as a metabolite of a 
poly cyclic aromatic compound is, to the best of our knowledge, unique. 
Its structure is closely related to that of the major metabolite (454) 
encountered during in vitro metabolism with hepatic preparations, and it 
is tempting to postulate that it is formed from this metabolite by further 
microbiological oxidation in the gut. It has not been tested for carcino­
genicity, but in view of its close relationship to (454) which is itself 
inactive, and the fact that the epoxide-oxepin structure appears to be 
stable enough to withstand the long and complicated extraction and 
purification procedures used in its isolation, it seems unlikely that it 
would prove to be active.
7.3 Biological activation of 15,16-dihydro-l,ll-methanocycIo-
penta[a]phenanthren-17-one
It has been known for 40 years that nearly all carcinogenic 
polycyclic aromatic hydrocarbons are related to the angular hydrocarbon 
phenanthrene rather than the linear hydrocarbon anthracene, but the 
reason for this has become apparent only recently. It now seems that for 
activity the hydrocarbon needs a ‘bay region’ (the extramolecular area 
bounded by C-l, C-10, C-9, and C -ll in a cyclopenta[a]phenanthrene) in 
order to allow metabolic formation of a bay-region diol-epoxide of the 
type already discussed. This is the ultimate carcinogenic species and it is 
perhaps hardly surprising that the 1-, 2-, 3-, and 4-methyl derivatives are 
inactive, because these A-ring substituents would be expected to inter­
fere with the formation of the 3,4-diol-l,2-oxide. However, on these 
grounds it is less clear why the unsubstituted structure is inactive and 
becomes carcinogenic only on substitution at C-7 or C -ll; an analogous 
situation also exists in the related chrysene and benzja]anthracene series.
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It was reasoned that the 1,11-methano compound (310), in which C-l is 
joined covalently to C -ll by a methylene group, should not be carcino­
genic for although it has a small substituent at C -ll favouring activity, the 
substituent at C-l was expected to obstruct the formation of a bay-region 
diol-epoxide. The first indication that this reasoning was not sound came 
when it was discovered that this compound was weakly mutagenic 
towards Salmonella typhimurium TA100. It was therefore tested more 
thoroughly than usual for carcinogenicity, and in two identical initiation/ 
promotion experiments appeared to possess initiating activity approach­
ing that of its ll-methyl-17-ketone analogue (26), although it proved to 
be only moderately active as a complete carcinogen in two repeated- 
application experiments. An investigation into the metabolism of this 
compound (310) was therefore undertaken in an attempt to account for 
this unexpected result (Coombs et al., 1982; Hadfield et al., 1984a). The 
same strategy and tactics were employed as those that successfully 
unravelled the activation of the 11-methyl-17-ketone (26). After in vitro 
metabolism of the generally labelled [3H]-l,ll-methano-17-ketone (310) 
metabolites were separated by hplc (Fig. 69) and the fractions (i)-(x) 
were assayed for mutagenicity in the Ames’ test. This ketone is only 
weakly active in this test with TA100, giving under optimum conditions 
from two to three times the background number of revertants; neverthe­
less, the results of this comparison were clear (Table 31). Only fraction 
(iv) elicited a higher reversion rate than the starting material which was
Fig. 69. hplc Separation of in vitro metabolites of 15,16-dihydro-l,ll- 
methanocyclopenta[a]phenanthren-17-one (310); equimolar amounts of 
fractions (i)-(x) were tested for mutagenicity (see Table 31).
310
VII
R eten tion  tim e  (min)
Activation o f l ,  ll-methano-17-ketone 191
eluted in fraction (x). The structure of metabolite (b) contained in this 
fraction and purified to homogeneity by hplc was therefore studied, as 
were those of the other metabolites (a-g) obtained pure in sufficient 
quantity. Molecular formulae based on their mass spectra are shown in 
Table 32 together with selected ions of diagnostic value. All metabolites 
gave molecular ions except metabolite (b) which was, however, known to 
be a vicinal diol from other evidence (see below), and gave an abundant 
[M+-H20] ion; the analogous ion was in fact the base peak in the 
spectrum of the diol (a). Both metabolites also gave abundant ions due to
Table 31. Relative mutagenic response from equimolar 
amounts(a) o f metabolites contained in fractions (i)-(x) 
(Fig. 69)
Fraction
Relative mutagenicity 
(as percentage of fraction x)
(i) 18
(ii) 24
(iii) 23
(iv) 160
(v) 44
(Vi) 28
(vii) 80
(vm) 59
(ix) 43
( x ) (310) 100
a, based on radioactivity.
Table 32. Molecular formulae o f metabolites (a-g) and selected mass 
spectral ions o f diagnostic value
Selected diagnostic ions 
Metabolite [observed (calculated) (relative abundance, %)]
(a) C18H140 3 M+ 278.0954 (278.0943) (69.2%);
M-H20  (100%); M+-H20-C 2H20  (80.7%)
(b) C18H140 3 M+-H20  260.0711 (260.0837) (58.6%);
M+-H20-C 2H20  (58.6%)
(c) ClgH 120 3 M+ 276.07940 (276.07864) (62%); M+-H 20  (100%)
(d) C18H10O2 M+258 (33%); M+-CHO (17%)
(e) C,8H120 2 M+ 260 (100%); M+-C2H20  (70%)
(f) C18H 120 2 M+260 (100%)
(g)C ,8H.n0 2 M+ 258.06808 (258.06770) (100%);
M+-CO (28%), M+-2(CO) (91%)
(310) C18H120  M+ 244 (57.3%); M+-C2H20  (100%)
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further loss of 42 mass units, as did the original l,ll-methano-17-ketone 
(310). This is not a common degradative pathway in 17-ketocyclopen- 
ta[a]phenanthrenes, nor was it seen with 4,5-methylenephenanthrene 
itself. The loss seems to be due to the formal elimination of ketene from 
the five-membered ring, and appears to be characteristic of this ring 
lacking further substitution in these 1,11-methano compounds. Although 
the ultraviolet spectrum of the l,ll-methano-17-ketone (310) [Amax 266.5 
(4.77), 277 (4.76) nm] differs appreciably from that of (say) the 11- 
methyl-17-ketone (26) [2max 264 (4.83) nm], the spectra of metabolites (a) 
and (b) strongly resembled those of, respectively, the 1,2- and 3,4- 
dihydrodiols of the latter, and this was fully confirmed by their nmr 
spectra listed in Table 33. The structures of the other metabolites were 
deduced from similar combinations of mass and ultraviolet spectral 
information. For example, the mono-ol (e) had a strong M+-42 ion 
(unsubstituted 17-keto D-ring) and ultraviolet spectrum similar to that of 
the original ketone (310); after borohydride reduction the spectra of (e) 
and the diketone (g) were identical. These are therefore both 18- 
substituted-17-ketones. The ultraviolet spectrum of (d) differed from all 
the others in that it was altered on addition of alkali (enolizable /?- 
diketone). The two hydroxyl groups in the diol (c) (ultraviolet spectrum 
similar to the original ketone) were at C-15 and C-18 because this diol had 
an intense M+-H20  ion, a characteristic of the 15-hydroxy-, but not 16- 
hydroxy-ll-methyl-17-ketone. The proposed structures of all these 
metabolites are illustrated in Fig. 70. Thus again with this compound 
(310) the most mutagenic metabolite was a fra«s-3,4-dihydrodiol, but 
here the coupling constant, 5.5 Hz, was smaller than that associated with 
frwis-3,4-dihydrodiols from other cyclopenta[a]phenanthren-17-ones 
(10-12 Hz) indicating that it possessed a conformation mid-way between 
diaxial and diequatorial. After metabolic activation in vitro (rat liver 
microsomes) the l,ll-methano-17-ketone (310) bound to added DNA 
which, after isolation and enzymatic hydrolysis, gave essentially a single 
nucleoside adduct. An identical result was obtained with DNA isolated 
from the skin of mice treated topically with this compound in vivo. As 
with the main adduct from the ll-methyl-17-ketone (26), this eluted from 
an LH20 column after the common nucleosides, and appeared signifi­
cantly earlier in the presence of borate. This strongly suggests that the
3,4-dihydrodiol (metabolite b) is the proximate carcinogen, and that it is 
further converted by metabolism into an fl«fr'-3,4-dihydroxy-l,2-oxide. 
That the 1,2-double bond in (310) is capable of metabolism via a 1,2- 
oxide is proved by the isolation of the 1,2-dihydrodiol (metabolite a).
The bay region in the l,ll-methano-17-ketone (310) is obstructed
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mainly within the plane of the molecule. The bridge methylene protons 
are magnetically equivalent because they resonate as a singlet, and this 
part of the molecule is therefore essentially flat (as will be described later, 
this was also proved by X-ray crystallography). It therefore seems that 
the active oxygen species is inserted into the 1,2-double bond of this 
molecule from either above or below this plane in the active site of the 
oxidase. This helps to account for the rapid fall-off in carcinogenic 
activity with chain length at C -ll observed in both the alkyl and alkoxy 
series because these substituents would not be confined to this plane. The 
carcinogenicity of (310) further emphasizes the role of small substituents 
at C -ll in endowing cyclopenta[a]phenanthrenes with biological activity. 
In retrospect it is not entirely surprising that this compound is a carcino­
gen because as long ago as 1946 it was shown that the corresponding 
bridged analogue of 7,12-dimethylbenz[a]anthracene, namely 1,12- 
methano-7-methylbenz[a]anthracene, yielded tumours in mice after 
injection (Dunlap and Warren, 1946). Much more recently metabolic 
oxidation at methyl-substituted double bonds in both 7-methyl- 
benzo[a]pyrene (Kinoshita et al. , 1982) and 8-methylbenz[a]anthracene 
(Yang et al., 1981) has been reported.
Fig. 70. Structures proposed for the in vitro metabolites of the 1,11-methano-
17-ketone (310).
O
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7.4 Comparative in vitro metabolism of 15,16-dihydrocyclo-
penta[a]phenanthren-17-one and some of its methyl homologues
The marked structure/biological activity relationships among 
cyclopenta[a]phenanthrenes are, of course, mirrored in other poly cyclic 
aromatic systems. For example, in both the chrysene and benz[a]anthra- 
cene series methyl substitution at the bay region in the position other than 
on the terminal benzo ring leads to a considerable enhancement in 
carcinogenicity, but there does not yet seem to be any general agreement 
on the reason for this. In the series of 17-keto-cyclopenta[a]- 
phenanthrenes the isomers are very similar to one another in most of 
their physical properties, including solubility which is likely to be of 
importance in their pharmacodynamics. Unlike polycyclic aromatic 
hydrocarbons these polycyclic ketones are not appreciably soluble in 
hexane; they are, however, reasonably soluble in aromatic hydrocarbons 
and in alcohols, and are readily soluble in dipolar solvents such as 
chloroform and dimethylsulphoxide. Their solubility in water is less than 
O.S^g/mL, but is increased somewhat by the presence of protein as, for 
example, in tissue culture media. No quantitative comparison of their 
solubility has been made, but the virtual identity of their chromato­
graphic properties in a number of solvent systems suggests that this is 
closely similar for the isomeric members of this series, and probably their 
tissue distribution in animals will not therefore be dissimilar. In their 
chemistry, too, the inactive 15,16-dihydrocyclopenta[a]phenanthren-17- 
one (4) and its carcinogenic 11-methyl homologue show close similarity 
(see Chapter 4). However, an apparent major difference in the urinary 
metabolites of these two ketones has already been noted, and made a 
comparative study of the in vitro metabolism of compounds of this series 
imperative since it was evident that metabolism was intimately connected 
with the expression of their biological effects. In contemplating this it 
seemed initially that the 1-, 2-, 3-, and 4-methyl derivatives could be 
excluded, for it appeared likely that these ring-A substituents would 
block diol-epoxide formation. However, when it was discovered that 
the C-l methylene group in 15,16-dihydro-l,ll-methanocyclopenta[a]- 
phenanthren-17-one (310) was unable to do this it was decided to include 
in the study the l-methyl-17-ketone (302), especially as the cancer tests 
with this compound were not convincingly negative. The unsubstituted 
parent ketone (4) and its 6- and 12-methyl derivatives (306 and 130), all 
non-carcinogens, and the carcinogenic 7- and ll-methyl-17-ketones (230 
and 26) and the ll,12-dimethyl-17-ketone (131) have also been investi­
gated using the in vitro method with hepatic microsomes from 3-methyl- 
cholanthrene-induced rats as already described.
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As was anticipated from earlier tic work it was found (Hadfield et al., 
1984#) that the main metabolites of the unsubstituted ketone (4) were 
analogous to those of its 11-methyl derivative already described. Lacking 
the methyl group they were somewhat more polar, eluting about five 
minutes earlier from the reverse-phase hplc column than their 11-methyl 
counterparts. They were readily identified by their ultraviolet spectra 
(Table 34) which were very similar to those of the metabolites derived 
from the carcinogen (26). The most polar (Fig. 71) was again the 1,2,15- 
trihydroxy-17-ketone (a) followed by the 1,2-diol (b); the latter was 
formed in larger amount from this compound (4) than from its 11-methyl 
derivative (26), possibly because the methyl group in the latter partially 
hinders approach of the active site in the enzyme to the 1,2-double bond. 
After removal of the extra conjugation by reduction of the ketone to the 
secondary alcohol, the circular dichroism spectrum of the product had the 
same sign as phenanthrene-[lR,2R]-diol (Fig. 72); the absolute 
stereochemistry of this metabolite is therefore also [1R,2R] or l a ,2/? as
Fig. 71. hplc Profiles of the in vitro metabolites formed from the 
unsubstituted 17-ketone (4) and its 11-methyl (26) and 12-methyl (130) 
derivatives.
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198 Metabolism and DNA interactions
shown. Next in order of decreasing polarity were the two 3,4,15- and 
3,4,16-triols (c and d), followed by the 3,4-dihydrodiol (e) shown by its 
nmr spectrum (Table 29) to be diequatorial and by its circular dichroism 
spectrum (after borohydride reduction) to be [3R,4R] or 3a,4)5. It was 
further characterized by its mass spectrum which showed a molecular ion 
(M+ found 266.09379; C17H140 3 requires 266.09429) (81.4%), and inter 
alia ions at 248 (M+-H20 , 100%), 200 (M+-H20-CO , 72.8%). Finally a 
large amount of the 15-ol (f, 369) and a smaller quantity of the 16-ol (g, 
345) were eluted, and characterized by comparison with the synthetic 
materials.
The 12-methyl-17-ketone (130) yielded a similar range of in vitro 
metabolites (Fig. 71), and the 3,4-dihydrodiol (e) was again conspicuous. 
It was characterized by its ultraviolet spectrum and elution time (both 
virtually identical to those of its 11-methyl isomer) and its mass spectrum 
(M+ found 280.10949; C18H 160 3 requires 280.10994, 8.6%; M+-H20 ,  
100%; M+-H20-CO , 16.5%). Its nmr spectrum shown in Table 35 
demonstrated that this diol was frans-diequatorial, and again the circular 
dichroism spectrum showed that it was [3R,4R] or 3a,4)5. The additional 
methyl group in the ll,12-dimethyl-17-ketone (131) led to further reten­
tion on the reverse-phase column so that this ketone and its metabolites 
were eluted about five minutes later than the 11- or 12-methyl-17-ketone 
and their analogous metabolites. The range of major metabolites formed 
was the same as those (a-f) obtained from the other compounds, but the
Fig. 72. Circular dichroism spectra of phenanthrene-[lR,2R]-dihydrodiol and 
of the borohydride reduction product of the 1 ,2 -dihydro-l,2 -dihydroxy 
metabolite of (4).
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200 Metabolism and DNA interactions
extra methyl group also caused the expected bathochromic shift in the 
ultraviolet maxima observed (see Table 34). From its elution time the 3,4- 
dihydrodiol formed from the 11,12-dimethyl compound (i.e., metabolite 
e) was trans-diequatorial, and its absolute stereochemistry was in all 
probability [3R,4R] like all the others. Under identical conditions of 
incubation, extraction, and chromatographic separation, the four 17- 
ketones gave these metabolites in the relative amounts shown in Table 
36. Thus at very similar total percentage conversion, all four compounds 
(two carcinogens, and two non-carcinogens) yielded commensurate 
amounts of 3,4-dihydrodiols, which appeared to be trans and of the same 
conformation and absolute stereochemistry. Thus metabolism cannot 
account for the lack of carcinogenicity of the ketones (4) and (130).
The 6- and 7-methyl-17-ketones (306 and 230, respectively) have not 
been studied in such detail (Coombs et al., 1981), but examination of the 
hplc profiles of their in vitro metabolites showed a marked difference. 
Whereas the 6-methyl compound gave just three main metabolites, the 7- 
methyl ketone yielded many metabolites, all in small amounts. Amongst 
these was a trans-3,4-dihydrodiol with retention time and ultraviolet 
characteristics similar to those of the analogous ll-methyl-17-ketone-3,4- 
diol. It was further characterized by its mass spectrum: M+, 280 (31.5%); 
M+-H20 , 262 (100%); M+-H20-CO , 234 (14%). After metabolic activa­
tion in vitro the 7-methyl-17-ketone (230) bound to calf thymus DNA 
added to the incubation to about half the extent of the 11-methyl isomer; 
this seems to account satisfactorily for its weaker carcinogenicity. The 6- 
methyl-17-ketone (306), on the other hand, failed to exhibit appreciable 
binding to DNA in vitro or in vivo (mouse skin) in line with its failure to
Table 36. Relative amounts o f major metabolites formed from the 
unsubstituted -17-ketone (4), its 11-methyl (26), 12-methyl (130), and 
11,12-dimethyl (131) derivatives under identical incubation conditions in 
vitro
(Compound) amount of metabolite as percentage 
Metabolite of the total ethyl acetate extractable radioactivity
(4) (26) (130) (131)
(a) 11.2 8.0 5.2 0.9
(c) 9.2 5.7 12.1 6.3
(d) 4.2 4.0 6.6 5.3
(e) 11.6 9.2 7.7 11.1
(f) 4.3 10.8 1.7 9.2
Other metabolites 35.7 38.1 39.1 42.1
Unchanged compound 23.8 24.2 27.6 25.1
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evoke tumours in mice. Nevertheless, the major metabolite of this 
ketone, accounting for about 30% of the material in the extract, was a 
*ra«s-3,4-dihydrodiol, 2max 271.5, 309, 322.5, 358, 373 nm. However, the 
total lack of magnetic coupling between H-3 and H-4 in its nmr spectrum 
(Table 35; see also Fig. 73) demonstrated that the bonds connecting these 
protons to C-3 and C-4 in this metabolite were at right angles to one 
another, and consequently the diol hydroxyl groups were diaxial. This 
was also confirmed by the polarity of this diol which eluted about 10 
minutes earlier than the diequatorial 3,4-dihydrodiols formed by the 
other compounds. Further microsomal metabolism of this diol led to 
several more polar metabolites with ultraviolet spectra characteristic of
1,2,3,4-tetrahydro derivatives. However, if a 3,4-diol-l,2-epoxide was 
involved its half-life must have been exceedingly short because the 6- 
methyl- 17-ketone did not bind significantly to DNA added to the incuba­
tion medium. Introduction of a methoxy group at C-6 in the 11-methyl- 
17-ketone-(26) to yield (468) diminished its carcinogenicity drastically 
(Iball indices 46 and 14, respectively -  see Table 12), again demonstrating 
the inhibitory effect of a peri substituent. In the hydrocarbon series 16,17- 
dihydro-7-methylcyclopenta[a]phenanthrene (94) is a weak carcinogen, 
but its 6,7-dimethyl analogue (105) is inactive (see Table 7). Also 5,12- 
dimethylchrysene (which has methyl groups in the bay region and the peri
Fig. 73. nmr Signals due to H-3 and H-4 of the metabolically derived 3,4-
dihydrodiol of 15,16-dihydro-6-methylcyclopenta[a]phenanthren-17-one (306).
H-4
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positions equivalent to C -ll and C-6 in a cyclopenta[a]phenanthrene) is 
much less carcinogenic than 5-methylchrysene itself (Hecht et al., 1979). 
Probably any bulky group at the peri position (C-6 in cyclopen- 
ta[a]phenanthrenes) would force an adjacent 3,4-diol into the diaxial 
conformation, and this appears to have a deleterious effect on 
carcinogenicity.
The in vitro metabolism of the l-methyl-17-ketone (302) has also been 
examined recently (Coombs et al., 1985) for the reasons already given. 
The profiles of metabolites (Fig. 74) obtained in the usual way, although 
not separated in quite the same way as shown in Fig. 71, did not bear 
much resemblance to those of the other isomers. In particular no less than 
six metabolites (hatched in the figure) were phenolic, whereas only traces 
of phenols were found before. Phenolic metabolites, even if their struc­
ture is unknown, are easy to identify because addition of a little alkali to 
the methanolic solution in the cuvette generates the anion with its own 
characteristic ultraviolet absorption spectrum. As can be seen from Table 
37 three of these phenols (q, r, and x) were extremely similar, and the 
latter (x) was positively identified as 15,16-dihydro-4-hydroxy-l- 
methylcyclopenta[a]phenanthren-17-one (458) by comparison of its elu­
tion time and ultraviolet spectra (neutral, anion, and reduced) with those 
of the synthetic compound which had been completely characterized. 
The spectra of the other phenolic metabolites (n, s, and t) also shared 
some similarities with this compound. It therefore appears that a major 
pathway in the metabolism of the l-methyl-17-ketone (302) involves 
epoxidation of the 3,4-double bond followed by rapid isomerization of
3,4-epoxide to the 4-phenol (metabolite x), rather than enzymatic open­
ing to give a 3,4-dihydrodiol as observed with all the other compounds.
Fig. 74. hplc Profile of the in vitro metabolites of 15,16-dihydro-l- 
methylcyclopenta[a]phenanthren-17-one (302); the hatched peaks are 
phenolic.
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204 Metabolism and DNA interactions
Further hydroxylation of this metabolite then leads to the other, more 
polar, phenols. Presumably isomerization is promoted by electron 
release by the p-methyl group for the reverse, stabilization of epoxides 
towards isomerization, is known to be favoured by electron withdrawal 
(Chiasson and Berchtold, 1977). Another six metabolites (designated 
ccp-diol, etc. in the Table) appeared to be hydroxylated derivatives 
retaining the intact phenanthrene chromophore; their extents of hydrox­
ylation can be guessed from their relative elution times, but an extensive 
nmr and mass spectral investigation would be needed to establish their 
exact structures. Only two metabolites, (k) and (1), had spectra suggest­
ing partial unsaturation. Metabolite (1) was obviously a 1,2-dihydrodiol 
from the characteristic splitting of the ultraviolet maximum into two 
peaks of similar intensity (Amax 258, 267 nm) on borohydride reduction; 
from its polarity it was probably further hydroxylated at C-15, C-16, or at 
the methyl group. Thus again there is evidence for enzymatic attack at the 
carbon-substituted double bond at C -l,2. The spectra of metabolite (k) 
were those typical of a l,2,3,4-tetrahydro-17-ketone; this compound may 
therefore be a 1,2,3,4-tetrahydro-tetraol formed either by further 
hydroxylation of 1,2-diol or of a 3,4-diol. The former seems the more 
likely because there is no evidence of a 3,4-dihydro-diol, and this seems to 
account adequately for the l-methyl-17-ketone (302) being essentially 
inactive as a carcinogen and mutagen.
Thus to summarize, metabolic studies have shown that the carcino­
genic 11-methyl-, 7-methyl-, and ll,12-dimethyl-17-ketones all yield 
tram'-diequatorial 3,4-dihydrodiols, presumably capable of further trans­
formation to diol-epoxides since they bind to DNA after metabolism. 
The 1-methyl and 6-methyl-17-ketones are non-carcinogens because, for 
different reasons, they do not form diol-epoxides of this sort. This leaves 
the unsubstituted and 12-methyl-17-ketones which are anomalous 
because they form tams'-[3R,4R]diequatorial diols and yet are not 
carcinogens.
7.5 Formation of DNA adducts, and their persistence
Further progress in understanding these structure/activity rela­
tionships came from examining the binding of some of these compounds 
to DNA. The unsubstituted-17-ketone (4) is a bacterial mutagen 
although it is not carcinogenic. After in vitro metabolic activation it 
bound to added DNA, albeit to a lesser extent than the 11-methyl ketone. 
The pattern of nucleoside adducts separated by Sephadex chromatogra­
phy was similar to those given by the latter (see Fig. 63). Originally (Table 
21) the 12-methyl-17-ketone was classed as a non-mutagen; however, a
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more recent study (Hadfield, 1983) disclosed weak activity with 
Salmonella typhimurium TA100. After metabolic activation in vitro this 
compound also bound to added DNA, but to only about 15% of the 
extent of the 11-methyl isomer (Russell et al., 1985). It yielded the 
familiar pattern of nucleosides except that peak A was almost the same 
size as peak B. When the binding of these compounds to mouse skin 
DNA was measured in vivo as before the following results were obtained, 
where DNA binding is quoted as nmol of compound/mol of DNA 
phosphorus in peaks A and B:
Thus the unsubstituted-17-ketone essentially failed to bind covalently to 
DNA in vivo in the target tissue, and this seems to explain its failure to act 
as a carcinogen. The 12-methyl-17-ketone, however, bound to DNA in 
vivo to about one-third of the extent of the 11-methyl isomer, i.e., to a 
greater extent than it did in vitro. When in each case the major adduct B 
was chromatographed on Sephadex LH20 using borate buffer (Hadfield 
et al., 1984a), the 12-methyl adduct showed the usual early elution 
expected if it were derived from an a«f/-diol-epoxide. By contrast the 
adduct from the unsubstituted ketone showed no such effect (Fig. 75). 
This experiment was repeated several times, always with the same result, 
and on the face of it seems to indicate that this adduct is derived from a 
i'yw-diol-epoxide as outlined in Fig. 66. However, further experiments 
are needed to confirm this surprising result. By analogy with 
benzo[a]pyrene only the anft’-diol-epoxides might be expected to exhibit 
carcinogenicity (Levin et al., 1977; Buening et al., 1978) although syn- 
diol-epoxides are mutagenic to bacteria (Wood et al., 1977).
This still left the lack of carcinogenicity of the 12-methyl-17-ketone 
unexplained for at the topical dose of 1000 nmol on mouse skin this 
compound gave a DNA binding ratio equivalent to that given by about 
340 nmol of its 11-methyl isomer, and at this dose on mouse skin the latter 
is strongly carcinogenic (Russell et al., 1985). However, an interesting 
result was obtained when the persistence of these DNA adducts was 
investigated.
The rate of formation and persistence of DNA adducts of the carcino­
genic 11-methyl-17-ketone was studied by Abbott and Crew (1981). They 
found that after topical application (400pg per mouse, to the dorsal skin)
DNA binding
unsubstituted-17-ketone (4)
11-methyl-17-ketone (26)
12-methyl-17-ketone (130) 
ll,12-dimethyl-17-ketone (131)
19
458
155
974
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or intramuscular injection (3 jug per mouse, into the shoulder) binding to 
the DNA of skin, lung, and liver reached a maximum at 1-2 days, and 
then declined. The half-life in skin and lung, targets for this carcinogen, 
was about 7 days, whereas it was only 2.5 days for liver which is not a 
target (Fig. 76). By labelling the skin with tritiated thymidine it was 
shown that labelled DNA was lost from this tissue with a half-life of about 
6 days. Hence there is little evidence for active repair of the 11-methyl 
lesions in skin whereas they are rapidly eliminated from liver. When this 
type of experiment was extended to the 12-methyl- (Russell et al., 1985) 
and 11,12-dimethyl-17-ketones (Furn, personal communication, 1985) 
(1000 nmol/mouse, topical), maximum binding was again found at about 
2 days, but loss of adducts from the skin occurred with a half-life of 3.5
Fig. 75. Elution of the main DNA adducts formed by the unsubstituted (4) 
and 12-methyl-17-ketones (130) from Sephadex LH20 columns with Tris and 
borate buffers of the same pH and molarity.
0 05M Tris pH 8.7 
0.05M Borate pH87
130
0.05M Tris 
pH 8 7
10-0 5 M 
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days for the former while it was about 7 days for the latter, like the result 
for the ll-methyl-17-ketone. Thus it appears the 12-methyl-17-ketone is 
not carcinogenic because the DNA damage it causes in skin is largely 
repaired before cell division occurs. This is another unexpected result 
that needs confirmation.
7.6 Summary
Carcinogens of the 17-oxocyclopenta[a]phenanthrene series are 
not mutagenic in the absence of prior metabolism. This suggests that the 
observed carcinogenicity/chemical structure relationships might, at least 
in part, be related to the correct metabolic activation of these molecules 
and, as has been outlined above, this indeed proves to be the case. These 
compounds are biologically activated like polycyclic aromatic hydro­
carbons, through benzo-ring oxidation. Specifically, epoxidation of the
3,4-double bond followed by enzyme-induced hydrolylic ring opening to 
give a diequatorial tram,-3a,4/3-dihydrodiol is required. This metabolite 
must then be further oxidized at C -l,2 to an anti-3a,4j3-dio\-la,2a- 
epoxide, which must be stable enough to avoid reaction with the 
nucleophiles such as water present in the environment in which it is
Fig. 76. Loss of 3H-labeIled DNA adducts of the carcinogen (26) from mouse 
skin, lung, and liver; total amounts of the adducts were estimated from the 
adduct peaks A and B eluting from Sephadex columns (see Fig. 63). The half 
lives (/j) were not adjusted for the rate of DNA turnover in these tissues, 
about six days for skin and lung, and much longer for liver (Abbott and 
Crew, 1981).
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produced. It must also survive transport through the nuclear membrane 
and into the cell’s genetic material in the nucleus. There it must be 
capable of reacting covalently with specific nucleoside bases to give 
adducts that resist removal by the efficient DNA repair enzymes, and be 
able to cause mutations that ultimately lead to abnormal and uncon­
trolled cell division, possibly by activation of a cellular oncogene. All 
these requirements must be met in turn, and it is consequently clear why 
most of the methyl isomers (for instance) are inactive. On the other hand, 
this information does not help us to understand why 7- and 11-methyl 
substitution are uniquely able to lead to diol-epoxides which fulfil all 
these requirements. This problem, which applies also to other polycyclic 
aromatic systems and has recently been discussed (DiGiovanni et al., 
1983), will be mentioned again in Chapter 8.
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8X-ray crystallography of some cyclopenta[a]- 
phenanthrenes: an apparent correlation 
between molecular strain and carcinogenicity
8.1 Early work
We usually think of X-ray crystallography as being a technique 
which has been developed to its present high state of sophistication over 
the last 25 years. However, its origins go back much further, and in fact 
one of its earliest uses was to help establish the structure of sterols. In 
1932 Bernal studied the X-ray diffraction patterns of crystals of several 
sterols, and from their experimentally established cell dimensions 
deduced that these molecules were 17-20 A long, 7-8 A wide, and 5 A 
thick. The original Windaus formula (Chapter 1, Fig. 3) would have 
required these dimensions to be approximately 18.0 X 7.0 X 8.5 A, mak­
ing the molecules too thick to fit into the unit cell derived from the X-ray 
diffraction data. The same conclusion was also reached from a study of 
the molecular cross-section sizes derived from the surface area of 
monolayer films by Adam (1930). Diels’ hydrocarbon had, of course, 
previously been isolated from the products of selenium dehydrogenation 
of cholesterol and other sterols and its identification as a cyclopen- 
ta[a]phenanthrene had strengthened this evidence for a revised steroid 
structure. However, at that time uncertainty still existed as to whether 
this hydrocarbon was 16,17-dihydro-15//-cyclopenta[a]phenanthrene (1) 
or its 17-methyl homologue (7) (Fig. 77), and Bernal set out to examine
Fig. 77. The two cyclopenta[a]phenanthrene hydrocarbons studied by X-ray
crystallography in 1935.
C H 3
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this question by X-ray crystallography (Bernal and Crowfoot, 1935). For 
comparison the synthetic parent hydrocarbon (1) and Diels’ hydrocarbon 
prepared by dehydrogenation of cholesterol (Diels etal., 1927), as well as 
the two specimens of the 17-methyl hydrocarbon synthesized by different 
methods by Bergmann and Hillemann (1933) and by Harper et al. (1934) 
were available. Suitable crystals were obtained by crystallization from the 
melt by the hot-wire method (Bernal and Crowfoot, 1933) because in 
many cases the crystals which separated from solution were too small and 
imperfect for X-ray examination.
All four crystal samples were found to consist of ‘lath-shaped mol­
ecules of width approximately 6 A and thickness 4 A packed together in 
parallel bundles’. Two characteristic crystalline forms were observed: 
monoclinic in which the planes of the rings were inclined to the basal 
plane, and orthorhombic with them approximately parallel to it. The 
parent hydrocarbon (1) crystallized in both forms and both were 
examined, while all three samples of the 17-methyl homologue formed 
only monoclinic crystals and appeared to be crystallographically identical 
with one another within the limits of the experimental method (Table 38). 
It was therefore concluded that Diels’ hydrocarbon was definitely not the 
parent compound (1), and it was observed (correctly) that the small 
differences in melting points and crystal habit found between the three 
samples of the 17-methyl derivative were probably due ‘to the presence of 
impurities, possibly in very small quantities’. For this compound the unit 
cell had a density = 1.185 ± 0.005 g/cm3 indicating that it contained four 
molecules of molecular weight 232 ± 3 (C18H 16 requires 232); the molec­
ules were arranged in the crystal as shown in Fig. 78.
The parent hydrocarbon (1) was also studied by Iball (1935) who 
pointed out that the X-ray intensities found were remarkably similar to 
those observed for crystals of chrysene, and proposed the structure of the
Table 38. Crystal data for 16,17-dihydro-15H-cyclopenta[a]- 
phenanthrene (1) and Diels’ hydrocarbon (7)
Cell dimensions (A) Probable 
molecular 
length (A)Hydrocarbon
Space
group a b c
(1)C17H14
(stable)
(1) c 17h 14
(metastable)
( V  c18H16 
B2,/a
Aba
Aba
18.2 6.05 21.2 11.6
8.10
8.50
6.4 22.8 11.4
6.25 24.3 12.1
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former on this basis. However, it was not until 20 years later that the 
positions of the carbon atoms could be located in this structure using the 
Fourier transformation (Entwhistle et al., 1954) which, because of the 
extensive computation required, became practicable only after the 
introduction of electronic digital computers. The definitive paper did not 
appear for another seven years (Entwhistle and Iball, 1961) and in the 
meantime another X-ray structure for this compound had been published 
(Basak and Basak, 1959). Iball’s structure was based on Fourier synthesis 
with 50 terms and subsequent refinement of the atomic co-ordinates by 
four cycles of least-squares calculations, reducing the reliability factor 
finally to R = 0.108. The reliability factor (discrepancy index) is an 
estimate of the agreement between the measured diffraction pattern 
intensities and those calculated for a particular model of arrangement of 
atoms in the repeat unit; values of 0.06-0.02 are considered good for 
present-day structural determinations (Glusker and Trueblood, 1985). 
Basaks’ results were obtained from a study restricted to Fourier synthesis
Fig. 78. Arrangement of the molecules of 16,17-dihydro-15//-
cyclopenta[a]phenanthrene (1 ) in the orthorhombic and monoclinic crystals
(Bernal and Crowfoot, 1935).
a
b
Orthorhombic Monoclinic
214 X-ray crystallography
in two zones with no refinement of the co-ordinates (R = 0.28) and in 
many instances the bond lengths differed appreciably from those of Iball, 
although the overall structure was the same (see Table 39). The K-region 
C-C bond C(6)-C(7) was short, as found for other aromatic compounds 
containing a phenanthrene nucleus. The bonds joining the five-mem- 
bered ring to the aromatic system C(14)-C(15) and C(17)-C(13) were 
intermediate in length between a single aliphatic single bond and an 
aromatic bond, whereas the other cyclopentene bonds C(15)-C(16) and 
C(16)-C(17) were rather longer than a normal aliphatic single bond. The 
aromatic rings in this molecule were essentially flat, but carbon atoms 
C(15) and C(17) bonded to them were 0.1 A below the plane while C(16) 
was 0.18 A above. Bond angles are shown in Table 40. The exocyclic 
angle at C(9) is unusually large, no doubt relieving the interaction 
between the protons H (l) and H (ll)  in the bay region. No other X-ray 
crystallographic studies of cyclopenta[a]phenanthrenes seem to have 
been published since 1961 until the recent work on the 17-ketones 
described below.
Table 39. Carbon-carbon bond lengths for 16,17- 
dihydro-15H-cyclopenta[a]phenanthrene (1) 
obtained from X-ray crystallography 
measurements
Bond
Bond length (A)
Iball Basak
C(l)-C(2) 1.39 1.38
C(2)-C(3) 1.34 1.40
C(3)-C(4) 1.40 1.42
C(4)-C(5) 1.40 1.37
C(5)-C(6) 1.45 1.42
C(6)-C(7) 1.36 1.39
C(7)-C(8) 1.44 1.41
C(8)-C(9) 1.45 —
C(9)-C(10) 1.43 1.40
C(10)-C(5) 1.45 —
C (9)-C (ll) 1.41 1.40
C (ll)-C (12) 1.41 1.41
C(12)-C(13) 1.44 1.42
C(13)-C(14) 1.36 —
C(14)-C(15) 1.52 1.48
C(15)-C(16) 1.55 1.52
C(16)-C(17) 1.57 1.53
C(17)-C(13) 1.51 1.46
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Table 40. Carbon-carbon bond angles 
(°) in 16,17-dihydro-15H-cyclopen- 
ta[a]phenanthrene (1)
Endocyclic angles
C (10)-C(l)-C(2) 120
C(l)-C (2)-C (3) 121
C(2)-C(3)-C(4) 122
C(3)-C(4)-C(5) 120
C(4)-C(5)-C(10) 118
C(5)-C(6)-C(7) 118
C(6)-C(5)-C(10) 121
C(6)-C(7)-C(8) 124
C(7)-C(8)-C(9) 118
C(8)-C(9)-C(10) 118
C (8)-C (9)-C (ll) 119
C (9)-C (ll)-C (12) 124
C (ll)-C (12)-C(13) 116
C(12)-C(13)-C(14) 123
C(13)-C(14)-C(8) 121
C(13)-C(14)-C(15) 112
C(14)-C(15)-C(16) 102
C(15)-C(16)-C(17) 101
C(16)-C(17)-C(13) 101
C(17)-C(13)-C( 14). 113
Exocyclic angles
C(4)-C(5)-C(6) 121
C(7)-C(8)-C(14) 123
C(8)-C( 14)-C(15) 127
C(l)-C(10)-C(9) 121
C(10)-C (9)-C (ll) 124
C(12)-C(13)-C(17) 124
8.2 The molecular structures of thirteen 15,16-dihydro-17-ketones
derived from X-ray crystallography: the shapes of the molecules
As part of an in-depth study of 15,16-dihydrocyclopen- 
ta[a]phenanthren-17-one and its isomeric methyl homologues aimed at 
improving understanding of the structure/carcinogenicity relationships 
found among them, thirteen 17-ketones have been studied by X-ray 
crystallography. The compounds, chosen to cover the widest possible 
range of biological activities from inactive compounds to the strongest 
carcinogen, are shown in Fig. 79. Two quite separate investigations have 
been made; in the first (Clayton etal., 1983) the ll-methyl-17-ketone (26) 
and the six ketones shown in the top half of the figure were studied at the 
Northern Polytechnic, London, under the supervision of Dr Mary 
McPartlin using Cu-Ka radiation for (4) and Mo-Ka radiation for the rest. 
The six compounds shown in the bottom half of this figure, together with
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ketone (26), were later investigated in the laboratory of Dr Jenny 
Glusker at the Institute for Cancer Research, Fox Chase, Philadelphia, 
using Mo-Ka radiation for the 11,12-dihydro compound (252) and Cu-Ka 
radiation for all the rest (Kashino et al., 1986). The carcinogen (26) 
(15,16-dihydro-ll-methylcyclopenta[a]phenanthren-17-one) was there­
fore common to both groups and was studied using both types of 
radiation. The sample used at Fox Chase was synthesized there by a 
variation of the published method, and the structure of the compound 
was solved independently in the two laboratories without prior know­
ledge of one another’s results. It is satisfying to observe close agreement 
between the two sets of data; for example, the average differences 
between C-C distances and angles were within ±0.002 A and ±0.11°, less 
than the quoted experimental errors. For this reason the two sets of
Fig. 79. The 13 cyclopenta[a]phenanthrenes studied by X-ray crystallography
(Clayton et al., 1983; Kashino et al., 1986).
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results are considered together for the purpose of the discussion which 
follows. Some fundamental crystal data for the thirteen 17-ketones 
shown in Fig. 79 are presented in Table 41. The structures were refined by 
full matrix least squares, and in all cases the final reliability factors were 
between 0.051 and 0.084. These, and the complete agreement between 
the two structures independently derived for the 11-methyl-17-ketone 
(2«), give us reason to believe that the differences in bond lengths and 
angles calculated from the X-ray data are meaningful. They lead to an 
interesting correlation.
Carbon-carbon and carbon-oxygen bond lengths for the 13 com­
pounds are listed in Table 42 together with estimated standard deviations 
in parentheses; Table 43 similarly displays the bond angles. It is notice­
able that equivalent C-C bonds in these molecules differ from the 
average values by not more than 0.03 A. This applies equally to the 1,11- 
methano compound (310) although it is obviously strained owing to the 
five-membered ring fused in the bay region. All have long (1.418-1.470 A) 
C(9)-C(10) bay-region bonds, and short (1.320-1.371 A) C(6)-C(7) K- 
region bonds, very similar to those observed in the hydrocarbon (1), 
1.433 and 1.355 A (Entwhistle and Iball, 1961) and in phenanthrene 
itself, 1.460 and 1.352A, respectively (Kay et al., 1971). In the 11,12- 
dihydro derivative (252) C(ll)-C(12) is a single bond (1.538 A) while 
C (9)-C (ll) and C(13)-C(14) fall within the range of the aryl-methyl 
bond lengths (1.503-1.531 A). The aryl-methylene C(l)-C(18) and 
C(ll)-C(18) bond lengths in the 1,11-methylene compound (310) are 
similar. In contrast to the bond lengths, the bond angles show more 
variability among these 17-oxocyclopenta[a]phenanthrenes. For exam­
ple, the endocyclic angles in six-membered rings (120.0° for a regular 
hexagon) vary between 115.8° and 128.1°. With two exceptions (the 7- 
methyl and 1,11-methano compounds, 230 and 310) the exocyclic bay- 
region angles C(l)-C(10)-C(9) and C(10)-C(9)-C(ll) are greater than 
120° (range 120.5-126.0°); this is particularly marked in compounds with 
substituents at C-l or C -ll in the bay region. The 1,11-bridged compound 
(310) is quite anomalous in that these two angles are only 110.7° and 
109.9°, resulting in considerable distortion from the normal pattern. This 
can readily be seen by superimposing it upon the parent molecule 15,16- 
dihydrocyclopenta[a]phenanthren-17-one (4) as shown in Fig. 80. To 
compensate for these small bay-region angles, the angles at the other side 
of the molecule, C(4)-C(5)-C(6) and C(7)-C(8)-C(14), are exception­
ally large, 129.5° and 131.2°. The perturbing effect this distortion has on 
the electronic distribution in this molecule is demonstrated by comparing 
their ultraviolet absorption spectra. That of the unsubstituted compound
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(4) (dotted line) is characteristic of all its methyl homologues, and 
different from that of the l,ll-methano-17-ketone (310) (solid line). In 
the compounds lacking substituents in the bay region the long C (9)-C (ll) 
bond and large bay-region bond angles help to minimize the repulsive 
interaction between H (l) and H (ll) . However, this is still marked as can 
be seen from their proton magnetic resonance spectra in which these 
hydrogens are deshielded by about l ppm compared with the other 
aromatic protons in these molecules. As was previously found by Ent-
Fig. 80. Superimposed plan views of 15,16-dihydrocyclopenta[a]phenanthren- 
17-one (4) (dotted lines) and its 1,11-methano derivative (310) (solid lines) 
and their ultraviolet absorption spectra.
350250 300
-1-5 0-3-
■10 ^  0 2 -
0-1
Table 44. Dihedral angles between planes o f rings
Compound
Dihedral angle (°) between rings
A/B B/C A/C
unsubstituted (4) 1.5 1.1 2.6
1-methyl (302) 2.4 2.5 4.9
2-methyl (303) 2.2 3.3 4.2
6-methyl (306) 0.9 0.7 1.5
7-methyl (230) 2.5 1.4 3.9
11-methyl (26) 7.0 5.5 12.5
12-methyl (130) 1.0 1.3 2.6
7,11-dimethyl (309) 9.7 11.1 20.6
11,12-dimethyl (131) 7.9 5.7 13.6
11-ethyl (211) 4.0 3.8 7.3
11-methoxy (132) 1.3 1.9 1.9
1,11-methano (310) 1.3 2.7 3.9
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whistle and Iball (1961) for the parent hydrocarbon 16,17-dihydro-15//- 
cyclopenta[a]phenanthrene (1), these 17-ketones are essentially planar. 
The exceptions are the compounds with methyl or ethyl groups in the bay- 
region, particularly at C-11. This is best demonstrated by consideration of 
the dihedral angles observed between the planes of the aryl rings listed in 
Table 44 [the dihydro derivative (252) is obviously not comparable and is 
omitted from this Table]. The angle between rings -A and -C is roughly 
the sum of those between rings -A and -B and rings -B and -C. Thus 
severe steric interactions in the bay region in those compounds bearing a 
methyl or ethyl group at C (ll)  are avoided by considerable out-of-plane 
deformation, as illustrated by side views of these molecules (Fig. 81). In 
the 11-methyl-11,12-dihydro-17-ketone (252) the methyl group is axial, 
with the bond joining it to C (ll)  at right angles to the plane of the rings 
(Fig. 82). This compound is not dehydrogenated by quinones which 
require the substrate to possess a trans-diaxial arrangement of the 
protons to be abstracted, and this axial methyl conformation had 
previously been correctly assigned to it (Coombs et al., 1970) on these 
grounds. The approximate planarity of the 1,11-methano-17-ketone 
(310) was suggested by its nmr spectrum in which the bridge methylene 
protons are equivalent, resonating as a singlet (Ribeiro et al., 1983).
The effects these factors have on the geometry of the bay region are 
summarized in Table 45, in which the distances are in A and the interbond 
and torsion angles are given in degrees. The torsion angle C(l)-C(10)- 
C(9)-C (ll) is defined as the angle between the bonds C(l)-C(10) and 
C (9)-C (ll), looking along the central bond C(10)-C(9). A carbon 
substituent at C (ll)  causes the molecule to twist about the central ring so 
that this substituent and the proton at C(l) are not in the same plane, thus 
minimizing their interaction. When the substituent is a methyl group this 
leads to a bay-region torsion angle of 13.5-20.5° and all these 17-ketones 
are strong carcinogens. In the benz[a]anthracene and chrysene series 
7,12-dimethylbenz[a]anthracene and 5,6-dimethylchrysene, both potent 
carcinogens, have torsion angles of this order. The weakly carcinogenic 
ll-ethyl-17-ketone (211) has a smaller torsion angle (8.9°) whilst the 
inactive compounds range between 6.8° (2-methyl) to 0.1° (12-methyl). 
Interestingly, a methyl group at the other bay-region position, at C(l), 
does not have this effect; the torsion angle is only 5.2°. However, the 
C(10)-C(l)-C(2) angle in this compound is narrowed by comparison with 
that in the other compounds, and the associated bonds C(l)-C(2) and 
C(l)-C(10) are longer than average. In plan view these molecules closely 
resemble steroids; for example, as is shown in Fig. 83 in which the 11- 
methyl-17-ketone (26) is superimposed on oestrone. However, this
X-ray crystallography
Fig. 81 (i) and (ii). Views of structures of twelve 15,16- 
dihydrocyclopenta[a]phenanthren-17-ones calculated from X-ray 
crystallography data; all are shown as plan and side views, and tilted at 30°
Unsubs-)7-ketone (4)
l-Methyl-17-ketone (302)
2-Methyl-17 -ketone (303)
6-Methyl-17-ketone (306)
7-Methyl-17-ketone (230)
(i)
1)-Methyl-17-ketone (26)
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12-M ethyl-)7-ketone ^130)
7,11-D im ethyH 7-ketone (309)
U f12-D im ethyH 7-ketone (131)
11-EthyH7-ketone (211)
11-M ethoxy-l7-ketone 032)
1,ll-M ethano-17-ketone (310)
(ii)
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Fig. 82. Three views (as in Fig. 81) of 11-methyl-ll, 12,15,16- 
tetrahydrocyclopenta[a]phenanthren-17-one (252).
11,12 -  Dihydro - 1 1-m ethyl- 17-ketone (252)
Fig. 83. Plan and side views of oestrone (dotted lines) superimposed on 
15,16-dihydro-ll-methylcyclopenta[a]phenanthren-17-one (26) (solid lines).
similarity in two dimensions is lost in the third dimension because rings -C 
and -D in the steroid are not quasi planar.
8.3 An apparent correlation between carcinogenicity and molecular
strain
Thus there seems to be a rough correlation between out-of-plane 
deformation and carcinogenicity, but in this respect the 7-methyl-17- 
ketone (230) is anomalous since it is essentially flat. Molecular strain is, 
however, introduced also into this structure by the 7-methyl group which 
is locked in the plane of the ring system. Non-bonding distances between 
the two C(15) hydrogen atoms and one of the 7-methyl hydrogens are 
exceptionally short (1.82 and 1.84 A), even shorter than those found for
228 X-ray crystallography
the two hydrogen atoms in the bay region (1.94 A ). Moreover, movement 
of the methyl group out of the plane of the rings would further decrease 
one of these. This leads to several consequences; for example, the bay- 
region angle C(10)-C(9)-C(ll) is 119.0°, 3° less than the average for the 
compounds lacking a bay-region substituent, and results in the H (l) to 
H (ll)  non-bonding distance being the shortest observed (Table 46). In 
the five-membered ring the protons at C(15) are deshielded by 0.42- 
0.46 ppm, and the rate of proton exchange at C(16) is approximately
Table 46. N on -bon din g  H ( l)  . . .  H ( l l )  distances, rate constants fo r  
detritiation at C(16), an d  n m r chem ical shifts at C(15) fo r  six 17-ketones
Compound
H ( l ) . . .  H ( ll)  
distance (A)
Rate constant 
(102^ q H-  nmoh1 s_1)
Chemical 
shift (<5)
unsubstituted (4) 1.999 1.83 ±0 .14 3.28
2-methyl (303) 2.019 (not measured) 3.25
6-methyl (306) 1.973 1.15 ± 0 .14 3.27
7-methyl (230) 1.942 3.17 ± 0 .08 3.70
11-methyl (26) — 1.47 ± 0 .06 3.24
12-methyl (130) 2.004 0.67 ±  0.07 3.28
Table 47. M olecular strain and carcinogenicity
Iball
Compound General state of molecule index(o)
unsubstituted (4) planar, unstrained <1
1-methyl (302) essentially planar, some bond and angle 1
distortion in ring-A
2-methyl (303) essentially planar, unstrained <1
6-methyl (306) planar, unstrained <1
7-methyl (230) essentially planar, evidence of strain in bay 10
region and ring-D
11-methyl (26) out-of-plane deformation, bay-region 46
torsion angle 13.5°
12-methyl (130) planar, unstrained <1
7,11-dimethyl (309) out-of-plane deformation, bay-region >49(6)
torsion angle 20.5°
11,12-dimethyl (131) out-of-plane deformation, bay-region 30
torsion angle 13.8°
11-ethyl (211) some out-of-plane deformation, bay-region 8
torsion angle 8.9°
11-methoxy (132) planar, unstrained 25
1,11-methano (310) planar, but severe bond angle distortions 16
a, Figure for repeated application of the compound twice weekly for one year.
b, Twice-weekly applications for 10 weeks only.
Carcinogenicity and molecular strain 229
doubled compared with the other five compounds. This strain built into 
the 7-methyl-17-ketone (230) was reflected originally in the difficulty 
experienced in the synthesis of this structure.
The general condition of 12 compounds examined by X-ray crystal­
lography and shown in Fig. 79 (neglecting the 11,12-dihydro compound 
(252) which is not comparable) are summarized in Table 47 alongside 
their potencies as skin carcinogens in T.O. mice, as indicated by their 
Iball indices taken from Tables 11 and 12. It is evident that there is (with 
one exception) a direct correlation between molecular strain and carcino­
genicity among these 17-oxocyclopenta[a]phenanthrenes. Newman 
(1983), of course, has also noted a similar relationship in the 
benz[a]anthracene series, but the way in which these two properties are 
connected is quite obscure at the present time. There is one exception to 
this general rule among the compounds studied by X-ray crystallography; 
the ll-methoxy-17-ketone (132) is a fairly strong carcinogen although it is 
planar and its bond angles are quite normal. Unlike the carbon sub­
stituents at C (ll) , the ether oxygen at C (ll)  is in the molecular plane and 
only 1.98 A from the hydrogen at C (l), suggesting that this contact is 
attractive. This is reflected in its nmr spectrum in which H (l) is further 
deshielded, resonating at <5 9.8 compared with d 8.8 for the ll-methyl-17- 
ketone (26) (Abraham and Loftus, 1978). There is a marked difference 
between the 11-alkoxy and 11-alkyl series in regard to their ability to 
induce skin tumours, summarized in Table 48. This comparison is
Table 48. Comparison o f  Iball indices o f  11-alky I- and 11-alkoxy -15,16- 
dihydrocyclopenta[a]phenanthren-17-ones
Compound
Iball index
Repeated
application
Initiation/
promotion
11-Alkyl series
11-methyl (26) 46 57
11-ethyl (211) 8 —
11-n-butyl (212) >1 —
7,11-dimethyl (309) 49(«) 66
11-Alkoxy series
11-methoxy (132) 25 38
11-ethoxy (390) — 28
11-n-butoxy (393) — 5
7-methyl-ll-methoxy (447) 17 —
a, Incomplete treatment, see Table 47.
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somewhat confused because two methods of skin painting have been 
employed, giving rise to two series of Iball indices (see Chapter 6 for a 
discussion of this), and not all the compounds have been tested by both 
methods. However, it is obvious that in the alkyl series carcinogenic 
activity falls off rapidly with increase in alkyl chain length so that the ethyl 
derivative is only weakly active and the butyl homologue is inactive. In 
the 11-alkoxy series, on the other hand, the ethoxy compound is not much 
less active than its methoxy homologue, and even the «-butoxy com­
pound is a weak carcinogen. Moreover, whereas introduction of a 7- 
methyl group into the 11-methyl compound to give the 7,ll-dimethyl-17- 
ketone (309) increases its potency so that this ketone is the most active so 
far encountered in this series, the 7-methyl-ll-methoxy-17-ketone (447) 
is appreciably less carcinogenic than the 11-methoxy analogue (132). It 
therefore seems probable that the way in which 11-alkyl and 11-alkoxy 
groups endow the parent molecule with carcinogenic potential may be 
fundamentally different.
8.4 Investigation of the diol-epoxides of 15,16-dihydrocyclopenta[a]-
phenanthren-17-ones by computer modelling
The enhancing effect of methyl substitution at the non-benzo 
bay-region position (the ‘bay-region methyl effect’) is, of course, well 
known among several polycyclic aromatic hydrocarbon systems, and has 
been noted by many authors (DiGiovanni etal., 1983; Hecht etal., 1979; 
Iyer et al., 1980). However, no really satisfactory explanation for this 
effect has been advanced. With this large amount of exact X-ray data to 
hand it seemed worth while investigating the effects of the methyl group 
on the structures of the diol-epoxides of the strongly carcinogenic 11- 
methyl-17-ketone (26) by computer construction (Kashino et al., 1986). 
These metabolites have not been synthesized, but they are known to be 
concerned in the expression of biological activity; it is probable that they 
are very reactive and this would further complicate their study by X-ray 
crystallography, although the diol-epoxides of benzo[a]pyrene have been 
studied in this way (Neidle et al., 1980; Neidle and Cutbush, 1983).
An interesting result which follows from the dihedral angle of 12.5° 
between rings -A and -C in the ll-methyl-17-ketone (26) is that this 
molecule can exist in right- and left-handed mirror-image forms, and as 
normally prepared consists of the racemate. This can be seen in the 
crystal structure disclosed by X-ray analysis and is illustrated in Fig. 84, in 
which both forms are clearly visible. The energy required to flip one form 
to the other is not known and cannot be reliably calculated, so that it is 
unclear whether the two forms exist as stable conformers in solution. A
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study of the temperature factors from the X-ray structure (Table 49) 
indicates that the atoms having the lowest temperature factors, and hence 
least motion in the crystalline state, are those in the bay region. That is, 
there is no disorder of the 11-methyl group in the crystal, and no evidence 
for interconversion of the two forms in the crystalline state.
In constructing the diol-epoxides this has therefore been borne in 
mind, and the four structures, two syn and two anti, shown in Fig. 85 have 
been considered although as described in Chapter 7 the biologically 
derived diol-epoxide appears to be exclusively anti, with the diol system 
[3R,4R] (i.e., 3a, 4/3). These four structures were obtained by 
superimposing the X-ray co-ordinates of the syn- and anft'-diol-epoxides 
of benzo[a]pyrene on those of the two conformers of 15,16-dihydro-ll- 
methylcyclopenta[a]phenanthren-17-one (26). Four further [3S,4S] 
optical isomers are possible, and are precise mirrpr images of those 
shown. The diol-epoxides of 15,16-dihydro-ll-methoxycyclopenta[a]- 
phenanthren-17-one (132) were similarly constructed although here, of
Fig. 84. Mirror-image forms of the ll-methyl-17-ketone (26) disclosed by X- 
ray crystallography; the two forms have been superimposed with the bond 
joining C(13) to C(14) in common.
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course, only one conformer exists because the oxygen at C (ll)  is in the 
plane of the flat aromatic rings. Selected interatomic distances measured 
from these computer-simulated diol-epoxides are shown in Table 50. 
Some of these distances are unacceptably short, as indicated, and this 
leads to the conclusion that the most likely structure for the diol-epoxide 
of the ll-methyl-17-ketone (26) is an anti structure with the epoxide 
oxygen and 11-methyl group on the same side of the molecular plane [(a) 
in Fig. 85]. Neither syn conformers would appear to be likely. This 
therefore confirms the same conclusion previously drawn from entirely 
different reasoning. In the absence of the 11-methyl group either diol- 
epoxide may be formed without generating unacceptably short non­
bonding distances; in practice only the syn-diol-epoxide is observed for
Table 49. Temperature factors (B) for the oxygen and 
carbon atoms in 15,16-dihydro-ll-methylcyclopen- 
ta[a]phenanthren-17-one
Atom B Atom B
0 7.3 C(9) 4.0
C(l) 6.3 C(10) 4.6
C(2) 7.7 C (ll) 4.1
C(3) 7.7 C(12) 4.4
C(4) 6.7 C(13) 4.3
C(5) 5.2 C(14) 4.2
C(6) 5.8 C(15) 5.4
C(7) 5.0 C(16) 6.3
C(8) 4.1 C(17) 5.3
Fig. 85. The two anti- and two syn-diol epoxides of the ll-methyl-17-ketone 
(26) studied by computer construction.
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Table 50. Interatomic distances (A) in models o f diol-epoxides
Diol-epoxides o f 15,16-dihydro-l 1 -methylcyclopenta[a]phenanthren-l 7-one (26)
O(epoxide)----- H(ll-m ethyl) anti (a) 3.06
(b) 3.74
syn (c) 2.89
(d) 2.38 (rather short)
H (l)(epoxide)--------H(ll-m ethyl) i anti (a) 1.85
(b) 1.56 (too short)
syn (c) 1.31 (too short)
(d) 1.83
Diol-epoxides o f 15,16-dihydro-ll ■ methoxycyclopenta[aJphenanthren-17-one
(132)
O(epoxide)--------O(methyl) anti 3.81
syn 3.07
H (l)(epoxide)--------O(methyl) anti 1.76
syn 1.77
the parent unsubstituted 17-ketone (4) (Hadfield etal., 1984). In the case 
of the ll-methoxy-17-ketone (132) the computer model indicates that 
there is little differentiation between syn- and anft'-diol-epoxides except 
for a rather short O  O distance in the syn-isomer.
8.5 Molecular orbital calculations
Ground-state molecular orbital wave functions have been cal­
culated by the CNDO/2 all valence approximation (Pople et al., 1965; 
Pople and Segal, 1966) for the seven structures examined in London 
(Clayton, 1982). Bond indices, defined as the number of electrons 
statistically localized between a pair of atomic centres (Wiberg, 1968), 
are shown in Table 51. The values for aromatic C-C bonds vary consider­
ably from that for benzene, 1.425e (Ibata et al., 1975), from the highest 
values (1.660—1.720e) for C(6)-C(7) to the lowest (1.14-1.20e) for the 
adjacent C(5)-C(6) bond. The sum of the bond indices for each aromatic 
ring (Table 52) is less than that for benzene owing to migration of 
electronic charge to the carbon-oxygen dipole at C(17). As a conse­
quence of this aromatic bromination, for example, occurs at C(15) and 
not at aromatic carbon in these ketones (see Chapter 4). There are three 
other notable features apparent in this Table. Firstly, the sum of bond 
indices for rings -A and -C are in all cases greater than for ring-B. Thus 
this ring acts as an electron donor towards the two outer aromatic rings; a 
similar pattern is also observed in phenanthrene (Dixon et al., 1978). 
Secondly, the sum of the bond indices for ring-A is always greater than 
that for ring-C, emphasizing the electron-acceptor characteristics of the
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adjacent five-membered ring. Finally, the sum of the bond indices for any 
ring with a methyl or methano substituent is less than that for the 
corresponding unsubstituted ring. Thus the methyl groups show electron- 
acceptor character, and this is reflected in the aryl C-CH3 bond indices 
which average 1.033 for these ketones. This somewhat surprising feature 
has been observed previously for benzene-toluene by Libit and Hoff­
mann (1974) who concluded that the ‘classic’ electron-donor character of 
the methyl group is realized through a polarization mechanism resulting 
in a decrease and increase in electron density at the ipso and ortho carbon 
atoms, respectively. The expected changes in charge distribution are 
evident in the molecular fragments surrounding the methyl group in these 
substituted ketones. For example, the bond indices for C(l)-C(2) and 
C(2)-C(3) in the 2-methyl-17-ketone (303) are less than those in the 
unsubstituted compound (4), whilst the reverse is true for C(3)-C(4).
Orbital energies of the three highest occupied molecular orbitals 
(HOMO) and three lowest unoccupied molecular orbitals (LUMO) of 
these seven ketones are listed in Table 53. Two important features are 
apparent. Firstly, LUMO and LUMO + 1  orbitals are energetically 
similar and well separated from the remaining unoccupied orbitals, with 
energy differences between LUMO + 1  and LUMO + 2 of 67.0- 
80.0 au X 10-3. Energy differences between the highest occupied orbitals 
are smaller, the differences between HOMO and HOMO-1 varying 
between 22.5 and 31.0 au x 10~3. Secondly, the introduction of a methyl 
or methano group slightly increases the energy of HOMO and decreases 
that of LUMO. This is consistent with the dual character of the methyl 
group, as an electron acceptor and as electron donor via an hyperconju- 
gative mechanism. Pure electron donors increase the energy of both 
HOMO and LUMO, whereas pure conjugative groups increase the
Table 52. Sum o f bond indices for each aromatic ring in seven 
17-oxocyclopenta[aJphenanthrenes
Compound Ring-A Ring-B Ring-C
unsubstituted (4) 8.390 7.865 8.250
2-methyl (303) 8.315 7.865 8.275
6-methyl (306) 8.395 7.805 8.255
7-methyl (230) 8.365 7.825 8.225
11-methyl (26) 8.365 7.880 8.185
12-methyl (130) 8.380 7.815 8.190
11,12-methano (31) 8.260 7.900 8.175
[benzene, 8.550e (Ibata et al., 1975)].
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energy of HOMO while they decrease the energy of LUMO (Fleming, 
1976).
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9Conclusion
9.1 The occurrence of cyclopenta[a]phenanthrenes
From the beginning cyclopenta[a]phenanthrenes have been 
associated on the one hand with sterols and steroids, and on the other 
with polycyclic aromatic hydrocarbons. Related to this is the possibility of 
their occurrence in nature, particularly in animal tissues as a result of 
aberrant steroid metabolism. This idea was raised at an early stage 
(Cook, 1933) and has reappeared periodically on a number of occasions 
since (Steiner, 1943; Inhoffen, 1953; Haddow, 1958; Dannenberg, 1960; 
Bischoff, 1969; Coombs and Croft, 1969; Wilk and Taupp, 1969; Coombs 
etal., 1973). However, to the best of the present authors’ knowledge no 
definitive report of a cyclopenta[a]phenanthrene (i.e., a steroid deriva­
tive lacking both angular methyl groups) arising from such a source has 
yet appeared.
In contrast to this, recent studies indicate that cyclopenta[a]- 
phenanthrene hydrocarbons are widely distributed in several natural 
environments where they have probably arisen from sterols by microbio­
logical dehydrogenation. This unexpected discovery has come to light as 
a result of the use of modern sophisticated analytical techniques such as 
gas chromatography-mass spectrometry with computer-assisted peak 
sorting. Nevertheless, Diels’ hydrocarbon (7) was first identified in 
petroleum over 20 years ago (Mair and Martinez-Pico, 1962). In recent 
work (Ludwig et al., 1981) aromatic components of shale oil were 
separated into classes containing 1,2,3. . .  aromatic rings, and these 
fractions were further separated by hplc. The nine cyclopen- 
ta[a]phenanthrenes shown in Fig. 86 were identified on the basis of their 
mass spectra, and the identity of five of them (27, 30, 32, 33, 35) was 
confirmed by comparison with authentic samples prepared from sterols 
by the method of Dannenberg, namely chloranil dehydrogenation to the
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17//-cyclopenta[a]phenanthrene followed by catalytic hydrogenation to 
its 15,16-dihydro derivative. These hydrocarbons appear to be wide­
spread constituents of petroleum-bearing sediments where they are 
formed by long-term degradation of sterols in the subsurface; they do not 
appear to occur in recent sediments. In an investigation of the hydro­
carbons present in samples of Toarcian shales at different sites in the Paris 
basin, Mackenzie et al. (1981) identified the cyclopenta[a]phenan- 
threne (33) and also 15,16-dihydro-17-ethyl-17-methylcyclopenta[a]- 
phenanthrene (36), again by comparison with authentic specimens. The 
methyl ethyl hydrocarbon (36) has also been reported to occur in Chinese 
shales (Shi et al., 1982). Mackenzie et al. found that the extent of steroid 
aromatization increased with burial depth, and therefore with maturity of 
the sample. The extent of carbon-carbon bond cracking in the side chain 
was found to be small in the shallow samples, and became significant only 
in the deepest specimens. It was suggested that these two reactions -  
aromatization and side-chain cracking -  probably occur during petroleum 
formation and that steroid hydrocarbon distribution might serve as a 
useful indication of maturity in exploration studies. The parent hydro­
carbon 16,17-dihydro-15i7-cyclopenta[a]phenanthrene (1) has recently 
been identified in Australian brown coal where it was obtained as a minor 
component of the triaromatic hydrocarbon fraction separated by hplc. Its 
occurrence together with numerous other tetra- and pentacyclic hydro­
carbons derived from phenanthrene establishes its probable origin from 
triterpene precursors (Chaffee and Johns, 1983).
A different cyclopenta[a]phenanthrene hydrocarbon, namely 16,17- 
dihydro-15-isopropyl-4-methyl-15//-cyclopenta[a]phenanthrene (37), 
has been identified by several groups in river and lake sediments. 
Wakeham et al. (1980) examined cores of recent sediment from Lake 
Lucerne, Lake Zurich and Grieifensee (Switzerland), and Lake 
Washington (north-west U.S.A.). Aromatic components were separated 
by hplc into groups according to the number of aromatic rings and these 
were subsequently analysed by gas chromatography-mass spectrometry; 
the cyclopenta[a]phenanthrene (37) was identified in the phenanthrene 
fraction. These authors considered that the variety of phenanthrenes and
Fig. 8 6 . Cyclopenta[a]phenanthrenes which occur naturally in mineral oils.
Occurrence o f cyclopenta[a]phenanthrenes 241
chrysenes found pointed to short-term alteration of biogenic precursors 
and could in no way be linked to anthropogenic combustion or pyrolysis 
processes. It was proposed that the hydrocarbon probably arose as a 
result of dehydrogenation of sterols or triterpenes mediated by 
microorganisms The same cyclopenta[a]phenanthrene was also identi­
fied in sediment cores collected from two Adirondack lakes in New York 
state, remote from industrial activities (Tan and Heit, 1981), and from 
the Amazon river and Cariaco Trench (Laflamme and Hites, 1979). 
These authors suggested that it could be formed from a pentacyclic 
triterpene such as lupeol via cleavage of the oxygenated A-ring, followed 
by aromatization of the remaining six-membered rings, together with 
migration and loss of the angular methyl groups as shown in Fig. 87.
Whereas these cyclopenta[a]phenanthrenes can be considered as 
naturally occurring, others occur in edible oils which have been over­
heated. Heating above 200°C causes the formation of a small amount of 
fluorescent material, arising from aromatization of sterols which are 
always present naturally in both animal and vegetable fats. Schmid (1962) 
and Schmid and Waitz (1963) heated the potential sterol precursors, 
cholesterol, phytosterol, and ergosterol, at 400°C in a slow stream of 
nitrogen, and isolated from the products 16,17-dihydro-15/7-cyclopen- 
ta[a]phenanthrene (1) and Diels’ hydrocarbon (7) among other 
phenanthrene and chrysene derivatives. Pyrolysis of ergosterol (Hof- 
felner, Lisbet and Schmid, 1964) gave in addition 16,17-dihydro-3- 
hydroxy-15H-cyclopenta[a]phenanthrene (38). All these cyclopen- 
ta[a]phenanthrenes were obtained in the crystalline state and fully
Fig. 87. Suggested derivation of the cyclopenta[a]phenanthrene (37) found 
naturally in river and lake sediments from the triterpenoid lupeol. The 
phenol (38) was isolated from the products formed by heating sterols at 
400°C in nitrogen, while the hydrocarbon (39) was obtained by exposing 
cholesterol adsorbed on silica gel to iodine vapour at ambient temperature.
37Lupeol
38 39
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characterized. Earlier Falk et al. (1949) had studied the products 
obtained from heating cholesterol in air at 360°C, in connection with the 
report of Hieger (1947) that commercially obtained samples of this sterol 
were weakly carcinogenic. The products were separated chemically into 
acidic, basic, ketonic neutral, and non-ketonic neutral fractions, the last 
two fractions accounting for 23% and 75% of the whole, respectively. 
The non-ketonic neutral fraction was further separated by column 
chromatography, and the individual substances were identified by their 
ultraviolet absorption spectra. The phenanthrene derivative of 
cholesterol (33) and Diels’ hydrocarbon (7) occurred in the fluorescent 
fractions from the column, but no trace of 3-methylcholanthrene was 
observed. The latter was carefully sought because theoretically it could 
have arisen through cyclization of the cholesteryl side chain; instead this 
side chain was apparently lost to yield Diels’ hydrocarbon (7). Com­
pounds (7) and (33) are not carcinogens, and Fieser considered that 
cholesterol itself, so widely distributed in nature, was most unlikely to be 
active. He therefore sought carcinogenic activity among the many known 
oxidation products of this sterol, eventually discovering definite activity 
in the 6/3-hydroperoxy derivative of cholest-4-en-3-one (Fieser et al., 
1955).
The methods for producing cyclopenta[a]phenanthrenes from sterols 
all involve pyrolysis or quinone oxidation at elevated temperatures, 
conditions far removed from those encountered in living systems. It is 
therefore of considerable interest and possible significance that Wilk and 
Taupp (1969) found that 16,17-dihydro-17-isopentyl-15H-cyclopen- 
ta[a]phenanthrene (39), obtainable from cholesterol by selenium 
dehydrogenation at 350°C, was also formed when this sterol was adsor­
bed on silica gel and exposed to iodine vapour at room temperature for 
20 h. The authors considered that the oxidation potential required in the 
adsorbed state was substantially lower than that normally required for 
dehydrogenation, and that this might be a model for biological dehydro­
genation of steroids by naturally occurring quinones found in the cell.
A considerable amount of data has now been accumulated on the 
relationship between chemical structure and carcinogenicity among 
cyclopenta[a]phenanthrenes. On this basis it seems unlikely that any of 
the hydrocarbons so far identified from natural sources or as pyrolysis 
products would be active. However, the recently discovered widespread 
occurrence of cyclopenta[a]phenanthrenes indicates that this class of 
compound is rather prone to arise from sterols and steroids under a 
variety of conditions, and this again raises the unresolved question of
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whether they occur in animal tissues as a result of incorrect steroid 
biosynthesis or metabolism.
9.2 Do cyclopenta[a]phenanthrenes occur as a result of aberrant
steroid metabolism in animals?
It is now well established that carcinogens are produced by a 
variety of microorganisms and plants, and there seems no a priori reason 
why animals should not also possess similar capabilities. The incidences 
of most common forms of cancer rise steeply with age, and in Great 
Britain about one in five people eventually die from one of the many 
forms of this disease. We now have extensive knowledge of the long 
latent periods encountered in animal experiments with weak carcino­
gens, or with very low doses of more potent carcinogens, and it seems 
entirely possible that at least some of this human disease might result 
from the prolonged action of minute amounts of an endogenous carcino­
gen formed in the body by aberrant steroid metabolism. The amount 
needed might only be small, and the potency not particularly high to 
produce this high cancer incidence observed in elderly people. This view, 
fashionable 40 years ago, led to experiments that failed to detect such a 
carcinogen, but in retrospect two reasons can now be advanced to 
account for this failure. The first has to do with the experimental methods 
available then. Quite astonishing advances have been made in analytical 
procedures in the intervening years, and as we have seen these are now 
beginning to disclose a whole range of unexpected cyclopen- 
ta[a]phenanthrenes in natural sources. The application of these new 
sensitive methods to animal tissues and extracts has not yet been under­
taken. The second reason is undoubtedly connected with the history of 
this subject. As has already been pointed out, the straightforward 
synthesis in 1933 of the extremely potent carcinogen 3-methyl- 
cholanthrene from a simple derivative of cholic acid, coupled with the 
observations that Diels’ hydrocarbon and other simple cyclopen- 
ta[a]phenanthrenes were inactive, for two decades strongly directed 
interest away from cyclopenta[a]phenanthrenes and towards the 
cholanthrenes. However, it now seems to be firmly established that sterol 
dehydrogenation does not lead to compounds of the latter class, but 
instead side-chain cleavage occurs to generate a variety of cyclopen- 
ta[a]phenanthrenes. The discovery of potent carcinogens among this 
class of sterol degradation products inevitably redirects attention to the 
possibility of the endogenous formation of carcinogenic cyclopen- 
ta[a]phenanthrenes by incorrect steroid metabolism in mammals.
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In the older literature, reviewed by Steiner in 1943, there are a number 
of reports on the production of tumours in animals with various crude 
tissue extracts. Activity was generally found in association with lipids, 
and in most instances with the unsaponifiable fraction of these lipids. 
Crude extracts reported to be active were prepared from human cancer 
tissues, bile, urine, lung, and liver, but it was the latter source that was 
studied in greatest detail. Later, in an extensive comparison of extracts of 
human liver and other human and animal organs (Steiner et al., 1947), 
considerable carcinogenic potential was detected with extracts of human 
liver from both normal and cancer patients. Extracts of the minced, 
frozen tissue were made by alkaline hydrolysis followed by extraction 
with ethylene dichloride; after removal of the solvent the unsaponifiable 
lipid was dissolved in warm tricaprylin and injected into C57B1 mice in 
groups of about 50. Sarcomas were induced at the site of injection in up to 
half the animals treated with some, but not all, of these liver extracts from 
both normal and cancer patients. Extracts prepared in the same way from 
human spleen, and even from livers of stillborn infants also gave some 
sarcomas, although fewer in number. It was felt these two sources 
reduced the possibility that all the carcinogenic activity was due to 
extrinsic, dietary carcinogens. Hieger (1946) also successfully induced 
sarcomas in mice with unsaponifiable lipid material from human liver, 
and from pooled lung, kidney, and muscle. He fractionated this lipid and 
determined that the most active fraction was the crystalline material 
obtained which consisted largely (85%) of cholesterol. The latent periods 
for these tumours were long (14-24 months) and he suggested that the 
carcinogen was probably of low potency. Bischoff (1963), in a thorough 
review of sterol carcinogenesis, pointed out that the cholesterol oxidation 
products 5a,6a-epoxy-3/?-cholesterol and 6/Miydroperoxycholest-4-en-3- 
one were known to produce local sarcomas on injection into mice. He felt 
that this should be taken into account when considering Hieger’s results. 
With this in mind Higginson et al. (1964) attempted to reproduce the 
experiments of Des Ligneris (1940) who had found that non-saponifiable 
extracts obtained from the livers of Bantu subjects, both with and without 
primary liver cancer, were more carcinogenic in mice than similar 
extracts from white subjects. The extracts were prepared by the former 
authors by saponification of the livers in alcohol with potassium hydrox­
ide, followed by extraction of the non-saponifiable lipid with peroxide- 
free ether, and care was taken to avoid aerial oxidation by carrying out 
the whole procedure under nitrogen. An extract was prepared from 
pooled mouse liver in the same way. None of these extracts yielded 
tumours when mice were repeatedly painted with them, but after injec-
A  result o f aberrant steroid metabolism? 245
tion all gave a low incidence of fibrosarcomas at the injection site, and this 
was not seen with the solvent (sesame oil or tricaprylin) alone. The 
authors concluded that while this experiment confirmed the existence of 
low-grade carcinogens in non-saponifiable extracts from human and 
mouse liver, it did not support the racial difference claimed by Des 
Ligneris. Deliberate exposure of these extracts to air and light for 
prolonged periods to produce peroxides, the presence of which was 
confirmed by analysis, did not increase this low sarcoma incidence, thus 
casting doubt on Bischoff’s suggestion. It remains difficult to understand 
the reason for these results, but they cannot be ignored because they are 
the outcome of quite extensive experiments conducted by serious, 
capable workers. A whole battery of powerful methods is now available 
that could be employed to determine whether these crude extracts 
contain true endogenous carcinogens, or whether the activity is a result of 
artefacts, either exogenous carcinogens or carcinogens produced under 
the drastic conditions used in the extraction processes. For example, 
bacterial mutation assays could be used rapidly to pinpoint active frac­
tions which could then be investigated by gas chromatography-mass 
spectrometry, a technique which has recently had spectacular success in 
identifying small molecules, including cyclopenta[a]phenanthrenes, in a 
variety of natural sources.
The net result of the various structure/carcinogenicity studies among 
cyclopenta[a]phenanthrenes outlined in this book can be readily sum­
marized as follows:
(i) carcinogenicity is conferred on the parent hydrocarbon 16,17- 
dihydro- 15Z/-cyclopenta[a]phenanthrene (1) by methyl substitu­
tion at C-7, and especially at C -ll;
(ii) potency is increased by extending conjugation of the 
phenanthrene nucleus into the five-membered D-ring, either as 
an endocyclic carbon-carbon double bond or as an exocyclic 
carbon-oxygen double bond at C-17;
(iii) the 11-methyl group can be replaced by a methoxy group without 
marked loss of carcinogenicity, but longer side chains at this 
position reduce or abolish activity.
In contemplating possible structures for a hypothetical carcinogenic 
cyclopenta[a]phenanthrene which might be derived from a steroid in 
vivo, a difficulty is apparent. Whilst a 17-carbonyl group is a common 
feature of both androgens and oestrogens, rearrangements leading to an 
11-methyl or 11-methoxy structure are without precedent; in all known 
examples rearrangement of the C-19 methyl group in steroids leads to 1-
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or 4-methyl derivatives. It is therefore of considerable interest that 
introduction of an 11-hydroxy group was also found to lead to carcino­
genicity in a cyclopenta[a]phenanthrene. Injection of the sparingly 
soluble phenol 15,16-dihydro-ll-hydroxycyclopenta[a]phenanthren-17- 
one (206) suspended in olive oil into mice followed by repeated appli­
cation of croton oil to their dorsal skin caused the appearance of skin 
tumours, both carcinomas and papillomas, at the site of promotion 
(Bhatt et al., 1982), thus proving that this phenol is capable of systemic 
initiation. This compound was less potent than its 11-methyl analogue, 
but essentially the same result was obtained in two identical experiments 
separated in time by about a year. 11-Hydroxy steroids are, of course, 
well known and arise mainly if not entirely from the adrenal cortex. As we 
have already seen the 3-deoxy steroid androsta-3,5-dien-17-one has been 
isolated from the urine of both male and female patients with adrenal 
tumours (Burrows et al., 1937; Wolfe et al., 1941). This is important 
because the 3-hydroxy group present in the vast majority of steroids 
would probably inhibit activity in a cyclopenta[a]phenanthrene since the 
analogous synthetic phenol derived from 3-methylcholanthrene is not a 
carcinogen (Shear and Leiter, 1941). In this connection Marker and 
Rohrmann (1939) in their study which disclosed the presence of 3-deoxy 
equilenin in mares’ pregnancy urine, also described a diketone ^18^16^2 > 
mp 214°C. This compound was isolated from the non-crystalline carbinol 
fraction after mild oxidation with chromic acid and formed only a 
monosemicarbazone, from which the 11,17-diketone structure (see Fig. 
88) was proposed for it. The close relationship between this 3-deoxy 
steroid and the carcinogenic cyclopenta[a]phenanthrene phenol (206) is 
apparent especially when one considers that the adrenal cortex is not only 
the centre of steroid 11-hydroxylation, but also of oxygenation at C-18, as 
in aldosterone biosynthesis. C-18 hydroxylation of this 11,17-diketone 
could lead to the loss of the angular methyl group and conversion to the 
11-phenol (206). Whether this or any other cyclopenta[a]phenanthrene 
occurs in adrenal tissue or in tumours of this organ is, of course, at present 
unknown. Adrenal extracts were studied intensively during the isolation
Fig. 8 8 .
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of the cortical hormones 40 years ago, but in almost all of this work only 
the more polar fractions were examined (Fieser and Fieser, 1959). In this 
work finely chopped frozen tissue was extracted with acetone, the latter 
was removed by evaporation, and the aqueous residue was extracted with 
petroleum ether to leave the adrenocortical hormone in the aqueous 
phase (Cartland and Kuizenga, 1936). Hieger (1946) tested adrenal 
extracts (prepared by the saponification and solvent extraction method 
used for liver) for carcinogenicity, but failed to induce sarcomas. It seems 
unlikely that either of these extraction methods would have isolated the 
phenol (206), although the petroleum extract might have contained 
cyclopenta[a]phenanthrene hydrocarbons, if they were present.
Modern cancer research is beginning to uncover the cause of some 
human tumours. By far the most important discovery is that cigarette 
smoking is causally related to the tragic increase in lung cancer observed 
during this century, a disease that now claims some 30000 men each year 
in this country alone. Several other minor forms of cancer have been 
traced to industrial exposure to carcinogens. For example, bladder 
cancer is associated with exposure to aromatic amines previously used as 
dyestuff intermediates and as antioxidants in the manufacture of rubber. 
However, it still remains true that the cause of the majority of human 
tumours remains completely unknown. The case for the initiation of at 
least some of these by endogenous carcinogens formed in the body from 
steroids now seems as strong as it did 50 years ago. It is clear that a fresh 
approach to this whole question now needs to be made, fully utilizing 
both the splendid new analytical techniques and our deeper understand­
ing of steroid biochemistry.
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General index
Throughout this Index the word ‘cyclopenta[a]phenanthren(e)’ is abbreviated 
to ‘cpp’, but is indexed as the full word. The prefixes cis, trans, syn, anti, and 
n (=  normal) are ignored for the purpose of indexing. Besides more general 
entries, the index also contains the chemical names of approximately 350 
cpps, of which over 280 bear the serial numbers (in bold type) assigned to 
them in the text, tables, and figures. There is a brief guide to cpp nomencla­
ture on pages 2-3 of this book, but in case of difficulty look up the serial 
number in the serial number-molecular formula index (pp. 122-5). Then 
using the molecular formula find the compound in the physical and spectral 
data compilation (pp. 85-122) which is arranged according to the Chemical 
Abstracts system and also contains the full chemical name used here. Author 
indexes are to be found at the end of each chapter.
Abbreviations 
journal titles, (ix), (x) 
other common, (xi) 
6-Acetamido-16,17-dihydro-15//-cpp 
(354), 63-4, 106-7 
12-Acetamido-16,17-dihydro-15//-cpp 
(348), 63, 107
2-Acetoxy-15,16-dihydro-cpp-17-one 
(397), 103-4
ll-Acetoxy-15,16-dihydro-cpp-17-one 
(80), 23, 43, 48, 104 
carcinogenicity of, 139
15-Acetoxy-15,16-dihydro-cpp-17-one 
(365), 64-6, 80-3, 104
16-Acetoxy-15,16-dihydro-cpp-17-one 
(343), 62, 63, 6 6 , 80-3, 104
15-Acetoxy-16,17-dihydro-15/i-cpp (333), 
62, 105
11 - Acetoxy-15,16-dihydro-3-methoxy-cpp- 
17-one (190), 43, 111 
6 - Acetoxy-15,16-dihydro-ll-methyl-cpp- 
17-one (469), 110-11
11 - Acetoxy-15,16-dihydro-3-methyl-cpp- 
17-one (72), 21-2, 111
ll-Acetoxy-15,16-dihydro-7-methyl-cpp- 
17-one (227), 48, 111
15-Acetoxy-15,16-dihydro-ll-methyl-cpp- 
17-one (366), 64-5, 111
16-Acetoxy-15,16-dihydro-l 1 -methyl-cpp- 
17-one (344), 62-3, 111
17-Acetoxy-15//-cpp (341), 62-3, 80-3, 103
1 l-A cetoxym ethyl-15,16-dihydro-cpp-17-one, 
111
ll-A cetoxym ethyl-17,17-ethylenedioxy-
13,14,15,16-tetrahydro-cpp (214), 47,
118
11-A cetoxy-l,2,3,4,15,16-hexahydro-cpp- 
17-one (235), 49, 109
17-Acetoxy-ll-methyl-15//-cpp (342), 62- 
3, 110
12-A cetyl-16,17-dihydro-15//-cpp (347),
63, 104
6-A cetyl-11 ,12,13,14,16,17-hexahydro- 
15/i-cpp (353), 6 3 -4 ,1 0 9
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Adenocarcinomas, in rats, 156-7 
Adrenal cortex, 246 
Adrenal tumours, isolation of 3-deoxy 
steroids from, 246
11-Alkoxy-15,16-dihydro-cpp-17-ones, 
comparison of carcinogenicity with 
17-alkyl analogues, 229-30
Ames’ test 
determination of mutagenicity of cpps, 
158-61, 163 
metabolic activation, need for in 
detection of cpps, 160, 178 
Salmonella typhimurium, strains 
TA1535, TA1538, TA98 and TA100, 
160
spontaneous mutation rate in strain 
TA100, 161 
toxicity and dose response, 161, 163 
use in identification of biologically 
active metabolites, 178, 180
12-Amino-16,17-dihydro-15//-cpp (349), 
63, 90
Androgens, cpps from, 20-1, 33-4 
Androsta-3,5-dien-17-one, isolation from 
adrenal tumours, 246 
Aneuploidy, in yeast induced by cpps, 
163-6 
Anthracene, 6
Bay region 
carcinogenicity, decrease in with 
increase in size of substituent at, 194 
obstruction of, 190, 194 
torsion angle, definition, 223 
Beckmann reaction, abnormal, 54 
Benz[a]anthracene, 6 , 189 
carcinogenicity of methyl derivatives, 8  
fluorescence spectrum, 5
7,8-Benzoflavone 
carcinogenicity, inhibition of, 146-50, 
171-2
DNA binding, inhibition of, 171-3 
mutagenicity, inhibition of, 161, 163
16,17-Benzo-15//-cpp (416), 69-70, 115 
Benzo[a]pyrene, 6 , 157, 183 
bay-region diol-epoxide, 174, 183 
isolation from coal tar, 5-6 
use as a positive control, 146-52 
1 1  -Benzoxazol-2-yloxy-15,16-dihydro- 
cpp-17-one, 119 
17-Benzyl-16,17-dihydro-15//-cpp (423), 
70, 119
16-Benzylidene-15,16-dihydro-3-methoxy- 
cpp-17-one (208), 46, 120
17-Benzylidene-cpp (429), 70, 119
16-Benzylidene-ll,12,13,14,15,
16-hexhydro-3-methoxy-cpp- 17-one 
(207), 46, 120 
Bile acids, see Sterols and bile acids
Bis(15,16-dihydro-17-oxocyclopenta- 
[a]phenanthr-12-yl)ether (217),
47, 122
11,11:17,17-Bis(ethylenedioxy)-ll, 12, 13, 
14, 15, 16-hexahydro-cpp (203), 45, 
46, 117
ll,ll:17,17-Bis(ethylenedioxy)-ll,12,13,
14,15,16-hexahydr o-3-methoxy-cpp
(205), 46, 118
Bladder cancer and aromatic amines, 247
15-Bromo-15,16-dihydro-cpp-17-one 
(318), 54-5, 64-6, 8 6
16-Bromo-15,16-dihydro-cpp-17-one 
(358), 64-6, 8 6
15-Bromo-15,16-dihydro-ll-methyl-cpp- 
17-one (355), 64, 94
16-Bromo-15,16-dihydro-l 1-methyl-cpp- 
17-one (359), 64-5, 94
"ds-16-Bromo-17-hydroxy-16,17-dihydro- 
15/7-cpp, 8 8
ll-n-Butoxy-15,16-dihydro-cpp-17-one
(393), 116, 229 
genetic activity in yeasts, 165 
mutagenicity, lack of in Ames’ test,
159, 161 
weak initiating activity of, 144-5
11-n-Butyl-15,16-dihydro-cpp-17-one 
(212), 46-7, 116, 229
carcinogenicity of, lack of, 140-1 
mutagenicity, lack of, in Ames’ test,
159
12-Carbomethoxy-ll,12,13,14,16,17- 
hexahydro-15//-cpp-ll-one (85),
23-4, 109
Carbon-14 labelled cpps, 54-5, 179, 186
Carcinogenicity of cpps, 132-57 
correlation with molecular strain, 227-9 
enhancing effect of ring-D conjugation 
(C=C or C = 0 ) on, 138-9, 141 
of 39 cpp derivatives, comparison with 
their mutagenicity in Ames’ test, 
158-9
structure/activity relationships, 132-46
Carcinogenicity of 15,16-dihydro-ll- 
methyl-cpp-17-one (26), 146-57 
co-carcinogenicity (with croton oil), 
151-2
complete carcinogenicity on TO mouse 
skin, 139-40, 146-8 
dose response (complete 
carcinogenicity), 146-8, 171-2 
dose response (initiation/promotion) 
146-50
in C57B1 and Balb C mice, 154 
inhibition with 7,8-benzoflavone, 146- 
50, 171-3 
initiating activity of, 144-5, 181 
lack of, in DBA/2 mice, 154
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leukaemia in rats, 157 
local sarcomas, lack of after injection 
of, 154, 157 
mammary tumours in rats, 156-7 
remote skin tumours after injection in 
TO mice, 151, 154-6 
Carcinogenicity testing, 
method with TO mice by repeated 
application, 135-6, 138 
initiation/promotion, 142, 144-6 
Carcinoma, classification of skin tumours 
as, 136
Charcoal, for extraction of metabolites 
from rat urine, 186 
Chemical Abstracts registry numbers, 76- 
122
Chinese hamster V79 cells, 186 
cloning efficiency of, 163-4 
mutations in, with cpps, 162-4 
Cholanthrenes from cpps, 69 
3-Chloro-15,l 6-dihydro-17,17-dimethyl- 
cpp (172), 35-6, 106
7-Chloro-15,16-dihydro-6-methoxy-cpp- 
17-one (322), 55, 57, 94 
Chrysene, 4, 189
Chrysenes, carcinogenicity compared with 
analogous cpps, 142-3 
Chrysofluorene, 16 
Circular dichroism data, 185, 197-8 
Combustion analysis, limits of accuracy, 
17
Conjugation, effect on carcinogenicity, 
135, 138-9, 141 
Contents (vii)-(viii)
Cope rearrangement, in synthesis of 
(193), 44-5 
Croton oil 
as a co-carcinogen, 151-2 
as a tumour promoter, 144-6, 148-51, 
181
Cyclobuxine, selenium dehydrogenation 
of, 2 1 - 2  
Cyclization 
with anhydrous hydrogen fluoride, 44-5 
with polyphosphoric acid, 44 
Cpp-15,17-dione (185), 42, 8 6  
Cyclopentaphenanthrenes, isomeric, 1 
Cyclopenta[a]phenanthrene synthesis 
Diels’-Alder route, 27-8, 56-7 
double acylation of naphthalene, 56-7 
elimination of 18-methyl group during, 
53-4
final closure of ring C, 15-17, 19, 23-4,
28-9, 43-5, 49 
final closure of ring D, 18-19, 41-3, 
50-4, 56-7, 67-72 
linear vs. angular cyclization of ring C, 
49
of D-ring ketones, 41-57
Robinson’s route, 22-4, 43-4, 48-9 
route via cyclobutanones, 36 
Stobbe route, 50-3
Cyclopenta[a]phenanthrenes 
and steroids, 3-12, 20-1 
carcinogenicity and molecular strain in,
227-30
computer modelling of diol epoxides 
of, 227-30 
in Chemical Abstracts, 2 
isotopically labelled, 54-5 
mass spectrometry of, 79-85, 188, 191 
metabolism of, 170-210 
molecular orbital calculations on, 233-6 
nomenclature and ring numbering of,
2-3
occurrence, see Occurrence of cpps 
physical and spectral properties of, 76- 
130
ring-D cleavage in, 71-2 
synthesis of, in connection with steroid 
structures, 15-20 
X-ray crystallography of, 211-33
Cpp-17-one (363), 64-5, 78, 8 6  
acid-catalysed additions to the 15(16)- 
double bond, 64-5 
reaction with thallium (III) triacetate, 
66
1.2.3.4.11.12.13.14.15.16-Decahydro- 
cpp-ll,17-dione (233), 49, 93
6.7.8.9.11.12.13.14.15.16-Decahydro- 
17a-ethyl-17-methyl-cpp-3-ol, 115
6.7.8.9.11.12.13.14.16.17-Decahydro-
12-hydroxy-15//-cpp (444), 72, 93
6.7.8.9.11.12.13.14.15.16-Decahydro-3- 
methoxy-cpp-17-one (22), 10,11,
53-4, 71-2, 103
6.7.8.9.11.12.13.14.15.16-Decahydro-l- 
methyl-cpp-17-one (313), 53-4, 103
1.2.3.4.11.12.13.14.16.17-Decahydro-7- 
methyl-15/7-cpp-ll-one (93), 24-5, 
103
Deoxycholic acid (6 ), 4, 6  
3-Deoxyequilenin (25), 11, 246 
3-Deoxy-ll-oxoequilenin, 246 
3-Deoxy steroids 
isolation from adrenal tumours, 246 
possible biosynthetic pathways to, 1 1 -  
12
2,15-Diacetoxy-15,16-dihydro-cpp-17-one 
(466), 117 
cis-16,17-Diacetoxy-16,17-dihydro-15//- 
cpp, 115
15,16-Diacetoxy-15,16-dihydro-4,17- 
dimethyl-17-[2(6-methyl)heptyl]-cpp, 
122
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2.15-Diacetoxy-8,9-epoxy-ll-methyl-8,9- 
secogona-I,3,5,7,9,ll,13-heptaen-17- 
one (464), 117
12-Diacetylamino-6,7,16,17-tetrahydro- 
15/7-cpp (351), 63, 116
Dibenz[a,h]anthracene, first chemical 
carcinogen, 6
15.15-Dibromo-15,16-dihydro-cpp-17-one 
(356), 64, 85
15.16-Dibromo-15,16-dihydro-cpp-17-one 
(362), 64-5, 85
15.15-Dibromo-15,16-dihydro-l 1-methyl- 
cpp-17-one (357), 64, 93
2,3-Dichloro-5,6-dicyanobenzoquinone, 
see Quinone dehydrogenation
Diels’ hydrocarbon (7) 
carcinogenicity, lack of, 7, 132-3, 136- 
8 , 245
crystal data from X-ray study, 212 
from dehydrogenation of sterols and 
bile acids, 4-5, 26-7, 241-2 
from DHA, 20-1
mutagenicity of, in Ames’ test, 158 
occurrence of, 239, 241-2 
properties of, 99 
ring-D isomers of, 15-16 
synthesis of, 17—18, 30 
uncertainty of formula of, 17 
uv spectrum of, 77 
X-ray structure of, 211-12
Dienonephenol rearrangement of 
steroids, 27, 53
16.17-Dihydro-cpp-15-one (1 0 2 ), 26, 29, 
41-2, 61-2, 86-7
carcinogenicity, lack of, 140-1 
mutagenicity of, in Ames’ test, 159 
uv spectrum of, 78
15.17-Dihydro-cpp-16-one (380), 67, 69, 
79, 87
15.16-Dihydro-cpp-17-one (4), 1 1 , 29, 31, 
171
bay-region, geometry of, 226 
binding to DNA, 200, 205 
bond indices and orbital energies 
(calculated), 233-6 
bond lengths and angles from X-ray 
data, 218-23 
bromination of, 64-5 
carcinogenicity, lack of, 139, 151, 153, 
200
crystal data for, 217 
dihedral angles between rings in, 2 2 2 - 3  
syn-diol epoxide from, 205-6 
genetic activity, lack of in yeasts, 163-5 
Grignard reactions with, 30-1, 6 8  
initiating activity, lack of, 144-5 
lack of effect on carcinogenicity of its
11-methyl homologue (26), 173 
mass spectrum of, 79-82
methyl homologues, solubility of, 195 
microsomal metabolism of, 173, 195-7, 
200, 204 
molecular strain, lack of, 228 
molecular structure of, 224 
mutagenicity in Ames’ test, 158 
mutagenicity in V79 cells, 162-3 
nomenclature of, 3 
oxidation of, 61-2 
properties of, 87
radio-labelled (14C or 3H), 54-6, 173, 
186
rate of proton exchange at C-16 in, 73 
synthesis of, 41-2, 45-6, 48-9, 53, 69- 
70
urinary metabolites in the rat, 186-8 
uv spectra of metabolites, 196 
uv spectrum of, 77-8 
X-ray crystallography of, 215-33
15.16-Dihydro-2,15-dihydroxy-cpp-17-one 
(465), 97
15.16-Dihydro-15,16-dihydroxy-4,17- 
dimethyl-17-[2(6-methyl)-heptyl]-cpp, 
121-2
16.17-Dihydro-l,4-dihydroxy-15//-cpp 
(116), 27-8, 89
16.17-Dihydro-c«-15,16-dihydroxy-15/f- 
cpp (382), 67, 89
16.17-Dihydro-os-16,17-dihydroxy-15//- 
cpp (378), 67, 89
16.17-Dihydro-trans-16,17-dihydroxy-15 H- 
cpp (376), 66-7, 89
16.17-Dihydro-ds-16,17-dihydroxy-17- 
isopropyl-15//-cpp (400), 6 8 , 114
16.17-Dihydro-c/s-16,17-dihydroxy-l 1- 
methyl-15tf-cpp (379), 67, 101
16.17-Dihydro-ds-16,17-dihydroxy-17- 
methyl-15tf-cpp (389), 6 8 , 101
16.17-dihydro-tram,-16,17-dihydroxy-ll- 
methyl-1577-cpp (377), 67, 101
15.16-Dihydro-3,ll-dimethoxy-cpp-17-one 
(426), 71-2, 106
15.16-Dihydro-3,1 l-dimethoxy-16-cyano- 
cpp-17-one (430), 71-2, 110
15.16-Dihydro-3,1 l-dimethoxy-16-formyl- 
cpp-17-one (429), 71-2, 111
15.16-Dihydro-7,ll-dimethyl-cpp-17-one
(309), 52-3, 104-5
bay-region geometry of, 226 
bond angles and lengths from X-ray 
data, 218-23 
complete carcinogenicity of, 140-1 
crystal data for, 217 
dihedral angles between rings, 2 2 2  
initiating activity of, 144-5 
molecular strain in, 228 
molecular structure of, 225 
rate of proton exchange at C-16, 73 
X-ray crystallography of, 216-30
Index 255
15.16-Dihydro-ll,12-dimethyl-cpp-17-one
(131), 29-30, 47, 105 
bay-region geometry of, 226 
binding to mouse skin DNA, 205 
bond angles and lengths from X-ray 
data, 218-23 
complete carcinogenicity of, 139, 141 
crystal data for, 217 
dihedral angles between rings in, 222-3 
genetic activity in yeasts, 165 
half-life of DNA adducts in vivo, 206 
in vitro metabolism of, 195-8, 204 
molecular strain in, 228 
molecular structure of, 225 
mutagenicity in Ames’ test, 159 
rate of proton exchange at C-16, 73 
tumours produced by injection of, 151-3 
uv spectra of metabolites of, 196 
X-ray crystallography of, 215-33
15.16-Dihydro-4,17-dimethyl-17-ethyl-cpp 
(76), 21-2, 116
15.16-Dihydro-l,17-dimethyl-17- 
[2(5-ethyl-6-methyl)-heptyl]-cpp (32), 
122, 239
15.16-Dihydro-4,17-dimethyl-17-[2(5- 
ethyl-6 -methyl)heptyl]-cpp (35),
122, 239
16.17-Dihydro-3,17-dimethyl-15H-cpp 
(71), 21-2, 107
16.17-Dihydro-6,7-dimethyl-15//-cpp 
(105), 26, 107
lack of carcinogenicity of, 132-3, 201
16.17-Dihydro-6,17-dimethyl-15//-cpp
(6 8 ), 20-1, 107
16.17-Dihydro-2,12-dimethyl-15/7-cpp 
(99), 25-6, 107
lack of carcinogenicity of, 132-3
16.17-Dihydro-4,12-dimethyl-15//-cpp 
(101), 25-6, 107
lack of carcinogenicity of, 132-3
16.17-Dihydro-4,17-dimethyl-15//-cpp 
(110), 26-7, 50, 107
lack of carcinogenicity of, 132-3
16.17-Dihydro-ll,17-dimethyl-15//-cpp
(139), 29-30, 108 
carcinogenicity of, 136-8, 141 
mutagenicity of, in Ames’ test, 158
16.17-Dihydro-l 1,12-dimethyl-15//-cpp 
(87), 22-4, 107-8
carcinogenicity of, 132-3
16.17-Dihydro-12,17-dimethyl-15//-cpp
(140), 29-30, 108
lack of carcinogenicity of, 136-8
15.16-Dihydro-17,17-dimethyl-3-methoxy- 
cpp (14), 9-10, 19, 114
16.17-Dihydro-3,17-dimethyl-ll-methoxy- 
15i7-cpp (74), 21-2, 114
15,16-Dihydro-l,17-dimethyl-17-[2(5,6- 
dimethyl)heptyl]-cpp (31), 239-40
15.16-Dihydro-4,17-dimethyl-17[2(5,6- 
dimethyl)heptyl]-cpp (34), 239-40
15.16-Dihydro-l,17-dimethyl-17-[2-(6- 
methyl)-heptyl]-cpp (30), 121, 239-40
15.16-Dihydro-4,17-dimethyl-17[2(6- 
methyl)-heptyl]-cpp (33), 121,
239-40, 242
15.16-Dihydro-ll-ethoxy-cpp-17-one
(390), 105, 229
initiating activity of, 144-5 
genetic activity in yeasts, 165 
mutagenicity in Ames’ test, 159
15.16-Dihydro-ll-ethyl-cpp-17-one (211), 
46-7, 73, 105
bay-region geometry of, 226 
bond angles and lengths from X-ray 
data, 218—23 
carcinogenicity of, 140 
crystal data for, 217 
dihedral angles between rings, 222-3 
molecular strain in, 228 
molecular structure of, 225 
mutagenicity in Ames’ test, 159 
X-ray crystallography of, 215-33
16.17-Dihydro-17-ethyl-cpp-15-one (50),
18, 105
15.16-Dihydro-12-ethyl-cpp-17-one (253), 
50, 53, 105
16.17-Dihydro-12-ethyl-15//-cpp (255),
50, 108
16.17-Dihydro-17-ethyl-15H-cpp (52), 18,
19, 108
15.16-Dihydro-17-ethyl-17-methyl-cpp 
(36), 113, 240
15.16-Dihydro-16-formyl-cpp-17-one 
(418), 69-70, 93
13,14-Dihydro-17/f-cpp (176), 36,
88
16.17-Dihydro-157/-cpp (1 ) 
carbon-carbon bond angles, 215 
carbon-carbon bond lengths, 214 
carcinogenicity lack of, 132-3 
crystal data, 2 1 2
crystal structures of orthorhombic and 
monoclinic forms, 213 
from pyrolysis of sterols, 241 
Friedel-Crafts acylation of, 63 
nomenclature of, 3 
occurrence, in brown coal, 240 
oxidation of, 26, 61-2 
properties, 8 8
synthesis, 15-16, 25, 41-2, 56-7, 6 8  
X-ray structure of, 211-15, 218, 223
16.17-Dihydro-15//-cpp-ll-ol, 8 8
16.17-Dihydro-15//-cpp-15-ol, 8 8
16.17-Dihydro-15//-cpp-17-ol, 77, 8 8
17-(16,17-Dihydro-15//-
cyclopenta[a]phenanthryl)-acetic 
acid (407), 69, 106
256 Index
17-(16,17-Dihydro-1577-
cyclopenta[a]phenanthryl)-3-butyric 
acid (410), 69, 116
17-(16,17-Dihydro-1577-
cyclopenta[a]phenanthryl)-2 - 
propionic acid (408), 69, 112-13
17-(16,17-Dihydro-1577-
cyclopenta[a]phenanthryl)-3- 
propionic acid (409), 69, 113
15.16-Dihydro-ll-n-hexoxy-cpp-17-one
(395), 119, 144-5
15.16-Dihydro-2-hydroxy-cpp-17-one
(396), 87, 176
15.16-Dihydro-3-hydoxy-cpp-17-one (23), 
11, 87
15.16-Dihydro-6-hydroxy-cpp-17-one 
(339), 62, 80-2, 87
15.16-Dihydro-ll-hydroxy-cpp-17-one
(206), 46, 87, 139
as a possible in vivo oestrogen 
metabolite, 246-7 
genetic activity, lack of in yeast, 164-5 
low solubility of, 146, 164 
rate of proton exchange at C-16 in, 73 
systemic initiation by, 146, 164
15.16-Dihydro-15-hydroxy-cpp-17-one 
(369), 64-5, 87-8
as a microsomal metabolite, 173, 198 
mass spectrometry of, 198
15.16-Dihydro-16-hydroxy-cpp- 17-one 
(345), 62-3, 66-7, 88
as a microsomal metabolite, 173, 198 
mass spectrometry of, 198
16.17-Dihydro-3-hydroxy-1577-cpp (38), 
8 8 , 241.
16.17-Dihydro-15-hydroxy-1577-cpp 
benzoate (146), 31, 119
16.17-Dihydro-15-hydroxy-1577-cpp 
tosylate (147), 31-2, 119
16.17-Dihydro- 17-hydroxy-1577-cpp 
tosylate (145), 31-2, 119-20
16.17-Dihydro-l 1 -hydroxy- 17-isopropyl- 
1577-cpp (126), 28-9, 114
15.16-Dihydro-l l-hydroxy-3-methoxy- 
cpp-17-one, 98
15.16-Dihydro-4-hydroxy-1 -methyl-cpp- 
17-one (458), 96, 176, 202-3
15.16-Dihydro-6-hydroxy-11 -methyl-cpp- 
17-one (340), 62, 96
15.16-Dihydro-11 -hydroxymethyl-cpp- 17- 
one (215), 47, 96
as a microsomal metabolite, 173-7 
initiating activity of, 144-5 
mass spectrometry of, 80-2
15.16-Dihydro-l l-hydroxy-7-methyl-cpp- 
17-one, 96
15.16-Dihydro-15-hydroxy-ll-methyl-cpp- 
17-one (370), 64-5 , 96-7
as a microsomal metabolite, 173-8
binding to DNA in vitro, 182 
initiating activity of, 144-5
15.16-Dihydro-16-hydroxy-11-me thyl-cpp- 
17-one (346), 62-3, 66-7, 97
as a microsomal metabolite, 173-7 
binding to DNA in vitro, 182 
initiating activity of, 144-5 
mutagenicity of, in Ames’ test, 159
16.17-Dihydro-l 7-hydroxy-11 -methyl-1577- 
cpp tosylate (149), 31-3, 120
15.16-Dihydro-3-hydroxy-l,17,17- 
trimethyl-cpp (162), 34-5, 114
16.17-Dihydro- 17-isopentyl-1577-cpp (39), 
118, 241
15.16-Dihydro-ll-isopropoxy-cpp-17-one 
(392), 112
genetic activity in D 6  yeast, 164-5 
mutagenicity in Ames’ test, 159 
weak initiating activity of, 144-5
15.16-Dihydro-12-isopropyl-cpp- 17-one 
(254), 50, 53, 112
16.17-Dihydro-17-isopropyl-cpp-15-one 
(51), 112
16.17-Dihydro-12-isopropyl-1577-cpp 
(256), 50, 113
16.17-Dihydro-17-isopropyl-1577-cpp (53), 
18, 28-9, 70-1, 113
16.17-Dihydro-17-isopropyl-3-methoxy- 
1577-cpp (127), 28-9, 116
16.17-Dihydro-15-isopropyl-4-methyl- 
1577-cpp (37), 116, 240-1
15,16-Dihydro-l,ll-methano-cpp-17-one
(310)
bay-region, geometry of, 226 
binding to DNA in vitro and in vivo, 
193
bond indicies and orbital energies 
(calculated), 233-6 
bond lengths and angles, 218-23 
complete carcinogenicity of, 140-1, 190 
crystal data for, 217 
dihedral angles between rings, 222-3 
evidence for an anti-diol epoxide from, 
193
genetic activity in yeasts, 165 
initiating activity of, 144-5, 190 
ketene, loss of in mass spectra, 193 
mass spectrometry of metabolites, 191 
metabolism in vitro of, 189-94 
molecular strain in, 2 2 2 , 228 
molecular structure of, 225 
mutagenicity of, in Ames’ test, 159, 190 
mutagenicity of metabolites of, 190-1 
nmr spectra of metabolites of, 192 
properties of, 93
rate of proton exchange at C-16 in, 73 
structures of metabolites, 193-4 
synthesis of, 51-3 
uv spectrum of, 2 2 2
Index 257
X-ray crystallography of, 215-33
15, 16-Dihydro-2-methoxy-cpp-17-one
(307), 52-3, 97
15.16-Dihydro-3-methoxy-cpp-17-one 
(24), 11, 30, 46, 97
carcinogenicity, lack of, 139, 141, 171 
mutagenicity, lack of in Ames’ test, 159
15.16-Dihydro-6-methoxy-cpp-17-one
(308), 52-3, 97
15.16-Dihydro-ll-methoxy-cpp-17-one
(132), 29-30, 69, 97
bay region geometry of, 226 
bond lengths and angles from X-ray 
data, 215-33 
carcinogenicity of, 139, 141 
crystal data for, 217 
dihedral angles between rings, 222-3 
genetic activity in yeasts, 165 
initiating activity of, 144-5 
molecular strain, lack of, 228 
molecular structure of, 225 
mutagenicity in Ames’ test, 159 
nmr chemical shift at C(l) in, 229 
rate of proton exchange at C-16, 73 
X-ray crystallography of, 215-33
15.16-Dihydro-15-methoxy-cpp-17-one 
(367), 64-6, 97
demethylation with boron tribromide, 
66
initiating activity of, 144-5
16.17-Dihydro-3-methoxy-15//-cpp (11),
9, 18-20, 99
16.17-Dihydro-4-methoxy-15/f-cpp (59), 
19, 99
16.17-Dihydro-6-methoxy-15/f-cpp (61), 
19, 99
16.17-Dihydro-ll-methoxy-15//-cpp, 99
16.17-Dihydro-3-methoxy-15-methyl-15//- 
cpp (58), 19, 108
16.17-Dihydro-3-methoxy-16-methyl-15i/- 
cpp (57), 19, 108
16.17-Dihydro-3-methoxy-17-methyl-15//- 
cpp (17), 9, 20, 30, 108
carcinogenicity, lack of, 136-7 
mutagenicity, lack of in Ames’ test, 158
15.16-Dihydro-4-methoxy-l-methyl-cpp- 
17-one (311), 52-3, 105
15.16-Dihydro-6-methoxy-l 1-methyl-cpp- 
17-one (468), 105-6, 201
carcinogenicity of, 140 
mutagenicity in Ames’ test, 159
16.17-Dihydro-6-methoxy-17-methyl-15/7- 
cpp (62), 19, 108-9
15.16-Dihydro-l l-methoxy-7-methyl- 
cpp-17-one (447), 73, 106
carcinogenicity of, 140-1, 229-30 
mutagenicity in Ames’ test, 159
16.17-Dihydro-l l-methoxy-17-methyl- 
15//-cpp (142), 29-30, 109
carcinogenicity of, 136-7
15.16-Dihydro-15-methoxy-ll-methyl-cpp- 
17-one (368), 64-5, 106
initiating activity of, 144-5
15.16-Dihydro-l-methyl-cpp-17-one (302) 
bay-region, geometry of, 226
bond angles and lengths, 218-23
crystal data for, 217
dihedral angles between rings in, 222-3
from testosterone, 53
genetic activity, lack of in yeasts, 164-5
in vitro metabolism of, 195, 202-4
lack of evidence for a 3,4-diol, 204
molecular strain in, 228
molecular structure of, 224
mutagenicity, lack of in Ames’ test,
158, 161 
phenolic metabolites from, 2 0 2  
properties of, 94-5
questionable carcinogenicity of, 140-1, 
144-5
rate of proton exchange at C-16, 73,
228
synthesis of, 53
uv spectra of metabolites of, 203 
X-ray crystallography of, 215-33
15.16-Dihydro-2-methyl-cpp-17-one (303) 
bay-region geometry in, 226
bond angles and lengths, 218-23 
bond indices and orbital energies 
(calculated) 233-6 
carcinogenicity, lack of, 140 
crystal data for, 217 
dihedral angles between rings, 222-3 
genetic activity in yeasts, lack of, 164-5 
molecular strain, lack of, 228 
mutagenicity, lack of, 158, 162-3 
properties of, 95 
synthesis of, 53
X-ray crystallography of, 215-33
15.16-Dihydro-3-methyl-cpp-17-one (304) 
carcinogenicity, lack of, 140, 144—5 
genetic activity, lack of in yeasts, 164-5 
mutagenicity, lack of, 158, 162-3 
properties of, 95
rate of proton exchange at C-16, 73 
synthesis of, 53
15.16-Dihydro-4-methyl-cpp-17-one (305),
53-95
carcinogenicity, lack of, 140
mutagenicity, lack of, 158
rate of proton exchange at C-16, 73
15.16-Dihydro-6-methyl-cpp-17-one (306) 
bay region, geometry of, 226 
binding to DNA, lack of, 201
bond angles and lengths, 218-23 
bond indices and orbital energies 
(calculated), 233-6 
carcinogenicity, lack of, 140
258 Index
15.16-Dihydro-6-methyl-cpp-17-one 
(cont)
crystal data for, 217 
dihedral angles between rings, 222-3 
in vitro metabolism of, 195, 199-202 
molecular strain, lack of, 228 
molecular structure, 224 
mutagenicity, lack of in Ames’ test, 158 
properties of, 95
rate of proton exchange at C-16, 73,
228
synthesis of, 53
X-ray crystallography of, 215-33
15.16-Dihydro-7-methyl-cpp-17-one (230) 
bay-region geometry of, 226 
binding to DNA, 200
bond angles and lengths, 218-33 
bond indices and orbital energies 
(calculated) 233-6 
carcinogenity of, 140 
crystal data for, 217 
dihedral angles between rings, 222-3 
genetic activity in yeasts, 165 
in vitro metabolism of, 195, 200 
molecular strain in, 227-9 
molecular structure of, 224 
mutagenicity in Ames’ test, 158, 160 
properties of, 95
rate of proton exchange at C-16, 73, 
228
synthesis of, 48
X-ray crystallography of, 216-33
16.17-Dihydro-l l-methyl-cpp-15-one
(334), 61-2, 96
carcinogenicity of, 140-1 
mutagenicity of, in Ames’ test, 159
15.17-Dihydro-l l-methyl-cpp-16-one 
(381), 67-8, 95
15,16-Dihydro-ll-methyl-cpp-17-one (26),
11-12, 30 
bay-region, geometry of, 226 
bond angles and lengths in, 218-23 
bond indices and orbital energies 
(calculated), 233-6 
bromination of, 64-5 
carcinogenicity of, see Carcinogenicity 
of 15,16-dihydro-ll-methyl-cpp-17- 
one
chiral form disclosed by X-ray 
crystallography, 230-1 
computer modelling of diol-epoxides 
of, 230-3 
crystal data for, 217 
dihedral angles between rings in, 2 2 2 - 3  
genetic activity of, in yeasts, 164-5 
hydrogenolysis of, 61 
molecular strain in, 228 
metabolism of, see Metabolism of
15,16-dihydro-ll-methyl-cpp-17-one
molecular structure of, 224 
mutagenicity in Ames’ test, 159-61 
mutagenicity in mammalian V79 cells, 
162-3 
oxidation of, 61-3 
properties of, 95-6
radiolabelled (14C and 3H), 54-6, 171, 
179, 182
rate of proton exchange at C-16, 73,
228
structure compared with that of 
oestrone, 227 
synthesis of, 46-7, 53 
X-ray crystallography of, 215-33
15.16-Dihydro-12-methyl-cpp-17-one 
(130)
bay region, geometry of, 226 
binding to DNA in vitro and in vivo, 
205 .
bond angles and lengths, 218-23 
bond indices and orbital energies 
(calculated) 233-6 
carcinogenicity, lack of, 139, 200 
crystal data for, 217 
dihedral angle between rings in, 222-3 
anti-diol epoxide from, 205-6 
half life of DNA adducts in vivo, 206-7 
in vitro metabolism of, 195-200 
molecular strain, lack of, 228 
molecular structure of, 225 
mutagenicity of, 159, 204-5 
properties of, 96
rate of proton exchange at C-16, 73, 
228
synthesis of, 29-30, 47, 50, 53 
uv spectra of metabolites, 196 
X-ray crystallography of, 215-33
16.17-Dihydro-17-methyl-cpp-15-one (49), 
17-18, 96; oxime, 98
15.17-Dihydro-17-methyl-cpp-16-one 
(402), 6 8 , 96
15.16-Dihydro-17-methyl-17[2-(5,6- 
dimethyl)heptyl]-cpp (28), 239-40
15.16-Dihydro-17-methylene-cpp (143), 
29-31, 94
carcinogenicity of, 136-8
15.16-Dihydro-17-methyl-17[2-(5-ethyl-6- 
methyl)heptyl]-cpp (29), 239-40
16.17-Dihydro-l-methyl-157/-cpp (107), 
26, 98
lack of carcinogenicity of, 132-3
16.17-Dihydro-2-methyl-15//-cpp (98), 
25-6, 98
lack of carcinogenicity of, 132-3
16.17-Dihydro-3-methyl-15//-cpp (70),
21-2, 98
lack of carcinogenicity of, 132—3
16.17-Dihydro-4-methyl-15/7-cpp (100), 
25-6, 98
Index 259
lack of carcinogenicity of, 132-3
16.17-Dihydro-6-methyl-15//;cpp (67), 
20-1, 98
lack of carcinogenicity of, 132-3
16.17-Dihydro-7-methyl-15/7-cpp (94),
24-5, 98, 201
carcinogenicity of, 132-3
16.17-Dihydro-l l-methyl-15//-cpp (83),
22-4, 61-2, 99
carcinogenicity of, 132-3
16.17-Dihydro-12-methyl-15//-cpp (97), 
25, 50, 99
lack of carcinogenicity of, 132-3
16.17-Dihydro-15-methyl-157/-cpp (45), 
15-16, 99
lack of carcinogenicity of, 132-3
16.17-Dihydro-l l-methyl-15//-cpp-cw-
16.17-diacetate (446), 80-3, 117
16.17-Dihydro-11-methyl-15//-cpp-rrans-
16.17-diacetate, 118
16.17-Dihydro-16-methyl-15//-cpp (46), 
15-16, 99
lack of carcinogenicity of, 132-3
16.17-Dihydro-17-methyl-15//-cpp (7), see 
Diels’ hydrocarbon
16.17-Dihydro-l l-methyl-15//-cpp-17-ol 
(448), 99-100, 140, 185
16-[17-(16,17-Dihydro-17-methyl-15//-cpp- 
yl)]-17-methyl-15//-cpp (129), 29-30, 
122
15.16-Dihydro-17-methyl-17-[2(6- 
methyl)heptyl)]-cpp (27), 120, 239-40
15.16-Dihydro-7-methyl-17-oxo-cpp-ll-ol 
die'thylphosphate (229), 48, 118
15.16-Dihydro-16-(3-oxopentyl)-cpp-17- 
one (419), 69-70, 117
15.16-Dihydro-17-oxo-cpp-il-ol 
diethylphosphate (228), 48-9, 116
15.16-Dihydro-11 -n-pentoxy-cpp- 17-one
(394), 118
genetic activity, lack of, in yeasts, 165 
initiating activity, lack of, 144-5 
mutagenicity, lack of, in Ames’ test,
159
15.16-Dihydro-15-phenyl-cpp-17-one 
(328), 56-7, 118
15.16-Dihydro-l l-n-propoxy-cpp-17-one
(391), 112
genetic activity, lack of, in yeasts, 165 
initiating activity, lack of, 144-5 
weak mutagenicity in Ames’ test, 159
16.17-Dihydro-17-«-propyl-15//-cpp (467), 
113
15.16-Dihydro-6(or 7),15,15-tribromo- 
cpp-17-one (361), 64
16.17-Dihydro-6,l7,17-trimethyl-15//-cpp
(69), 20-1, 113
lack of carcinogenicity of, 132-3
16.17-Dihydro-l 1,12,17-trimethyl-15//-cpp
(141), 29-30, 113-14, 171 
carcinogenicity of, 136-8 
trans- lR,2R-Dihydroxy-l ,2-
dihydrophenanthrene, circular 
dichroism of, 185, 197-8
11.17-Dihydroxy-ll,12,13,14,16,17- 
hexahydro-15//-cpp, 92-3
trans-1,2-Dihydroxy-l ,11-methano-
1.2.15.16-tetrahydro-cpp- 17-one, 
191-4
trans-3,4-Dihydroxy-1,11-methano-
3.4.15.16-tetrahydro-cpp-17-one, 
191-4
1 a ,2 /?-Dihydroxy- 1 1  -me thyl-1,2,15,16- 
tetrahydro-cpp-17-one (459), 101, 177 
trans-3,4-Dihydroxy-6-methyl-3,4,15,16- 
tetrahydro-cpp-17-one, 201, 204 
diaxial conformation from nmr and 
polarity data, 2 0 1  
3a,4^-Dihydroxy-7-methyl-3,4,15,16- 
tetrahydro-cpp-17-one, 200, 204 
3a ,4/?-Dihydroxy-l l-methyl-3,4,15,16- 
tetrahydro-cpp-17-one (457), 101, 175 
binding to DNA in vitro, 180, 182 
conformation of from circular 
dichroism data, 185 
high initiating activity of, 181 
mutagenicity in Ames’ test, 180 
nmr data for A-ring protons in, 184 
occurrence as a microsomal metabolite, 
174-8
phenol drived from, uv spectrum of,
176
3a ,4/?-Dihydroxy-12-methyl-3,4,15,16- 
tetrahydro-cpp-17-one, 198, 199, 204 
3a ,4/?-Dihydroxy-3,4, 15,16-tetrahydro- 
cpp-17-one 
conformation from circular dichroism 
data, 185, 198 
mass spectrum of, 198 
nmr data for A-ring protons in, 184
1,4-Dihydroxy-6,7,16,17-tetrahydro-15//- 
cpp (115), 27-8, 91 
6,7-m-Dihydroxy-6,7,16,17-tetrahydro- 
1577-cpp (103), 26, 61-2, 91
11.17-Dimethyl-1577-cpp (135), 29-30,104 
carcinogenicity of, 136-9 
carcinogenicity compared with that of
1,11-dimethylchrysene, 142 
mutagenicity of, in Ames’ test, 158
12.17-Dimethyl-15//-cpp (136), 29-30,
104
carcinogenicity of, 136-8, 171 
mutagenicity of, in Ames’ test, 158 
l,6-Dimethoxy-cpp-15,17-dione (186), 42, 
104
17.17-Dimethoxy-6,7,8,9,ll,12,13,14,16, 
17-decahydro-15//-cpp-ll-one (200), 
44-5, 110
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17.17-Dimethoxy-8,9,ll,12,13,14- 
hexahydro-cpp-ll-one (199), 44-5, 
110
3.11-Dimethoxy-6,7,8,12,13,14,15,16- 
octahydro-14-nitro-cpp-17-one, 56-7
3,1 l-Dimethoxy-6,7,15, 16-tetrahydro-cpp- 
17-one (332), 56-7, 71-2, 109
17-p-Dimethylaminobenzylidene-cpp 
(421), 70, 120
7.12-Dimethylbenz[a]anthracene, 8 , 157
1.11-Dimethylchrysene (453), (=  5,7- 
dimethylchrysene), 142-3
1,11 -Dimethyl-3,4-dihydrochrysene (451), 
142-3
1.17-Dimethyl-17-ethyl-cpp, 115-16
3 .17-Dimethyl-l l-methoxy-15//-cpp (73), 
21-2, 112
17.17-Dimethyl-3-methoxy-
6,7,8,9,11,12,15,16-octahydro-cpp 
(13), 9,115
1.17-Dimethyl-17-[2(6-methyl)-heptyl]-cpp
(152), 33-4, 121
4.17-Dimethyl-17-[2(6-methyl)heptyl]-cpp
(153), 33-4, 121
1.11-Dimethyl-l ,2,3,4-tetrahydrochrysene 
(452), 142-3
7.11-Dimethyl-ll,12,15,16-tetrahydro- 
cpp-17-one, 109
12.12-Dimethyl-ll,12,15,16-tetrahydro- 
cpp-17-one, 108
1.2.3.4.5.6.7.11.12.13.16.17- 
Dodecahydro-157/-cpp-6,7,ll,12- 
tetracarboxylic acid-6 ,7,1 1 ,1 2 - 
dianhydride (118), 28, 116
16,16'-Di(17-oxo-3,ll-
dimethoxycyclopenta[a]phenanthryl)- 
methine (428), 71-2, 122
Discrepancy index, see Reliability factor
DNA adducts 
identity of in vitro and mouse skin 
adducts derived from the 1 1 -methyl- 
17-ketone (26), 179 
isolation of, from mouse skin, 179 
pattern of adducts from T.O., C57B1, 
and DBA/2 mouse skin, 154 
persistence of, 204-7 
Sephadex LH20 chromatography of, 
179-81
5a,6a-Epoxy-3/?-cholesterol, a
carcinogenic oxidation product of 
cholesterol, 244
8,9-Epoxy-2,15-diacetoxy-l l-methyl-8 ,9- 
secogona-l,3,5,7,9,ll,13-heptaen-17- 
one(464), 117
Equilenin 
biosynthesis of, 1 2
isolation from mare’s pregnancy urine,
8-9
selenium dehydrogenation of, 1 0  
Electrophilic substitution, effect of 17- 
carbonyl group on position of, 64 
Enzyme induction 
effect on metabolic profile, 173 
with Aroclor 1254, 160, 185 
with benzanthracene, 185 
with phenobarbitone, 173 
with 20-methylcholanthrene, 173
8.9-Epoxy-2,15-dihydroxy-ll-methyl-8,9- 
secogona-l,3,5,7,9,ll,13-heptaen-17- 
one (463), 98, 188-9
8 .9-Epoxy-1 a ,2/3,15-trihydroxy- 11 -methyl-
8,9-secogona-3,5,6,9,11,13-hexaen- 
17-one (460), 102
loss of oxepin oxygen on hydrogenation 
and acetylation, 189 
occurrence as a major urinary 
metabolite in the rat, 188-9 
Ethyl 17-(cyclopenta[a]phenanthrylidene)- 
acetate (405), 69, 72, 115 
Ethyl 17-(cyclopenta[a]phenanthrylidene)-
2-propionate (406), 69, 117 
Ethyl 17-(6,7,8,9,11,12,13,14,16,17- 
decahydro-3-methoxy-15//- 
cyclopenta[a]phenanthryl)-acetate 
(445), 72, 118 
Ethyl 17-(3,1 l-dimethoxycyclopenta[a]- 
phenanthrylidene)-acetate (404),
69, 119
17.17-Ethylenedioxy-11,12,13,14,15,16- 
hexahydro-cpp-ll-one (201), 45-7,
54-5, 109
17.17-Ethylenedioxy-12,12-dimethyl-
11.12.13.14.15.16-hexahydro-cpp-ll- 
one (210), 47, 117
17.17-Ethylenedioxy- 1 2 -formyl-
11.12.13.14.15.16-hexahydro-cpp-ll- 
one (216), 47, 113
17.17-Ethylenedioxy-ll,12,13,14,15,16- 
hexahydro-1 1 -hydroxy-l 1 -hydroxy- 
methyl-cpp (213), 47, 114
17.17-Ethylenedioxy- [ 11 -3H]-11 -hydroxy-
11.12.13.14.15.16-hexahydro-cpp 
(317), 54-5
17.17-Ethylenedioxy-ll,12,13,14,15,16- 
hexahydro-3-methoxy-cpp-l 1-one 
(202), 45-6, 114
17.17-Ethylenedioxy-ll,12,13,14,15,16- 
hexahydro-1 2 -methyl-cpp-ll-one 
(209), 47, 114
Ethyl l7-(ll-methoxycyclopenta[a]- 
phenanthrylidene)-acetate (403),
69, 117 
17-Ethyl-l7-methyl-cpp, 111
12-Ethyl-ll, 12,15,16-tetrahydro-cpp-17- 
one (250), 50, 109
Fibroadenomas, in rats,-155-7
Index 261
Fieser, L .F . ,7
Gene conversion, in yeast induced by 
cpps, 163-6 
Girard reagent (for ketones), 8
15/Z-Cpp (3) 
base-catalysed condensations, 70 
nomenclature, 3
oxidation of, with osmium tetroxide, 67 
properties of, 8 6
quinone dehydrogenation of 16,17- 
dihydro-15//-cpp, 32 
synthesis of, 31
thermal isomerization of, 31-2 
17//-Cpp (2) 
carcinogenicity, lack of, 136-8 
mutagenicity of, in Ames’ test, 158 
nomenclature, 3 
properties of, 8 6
quinone dehydrogenation of 16,17- 
dihydro-15//-cpp, from, 32 
synthesis of, 31—2, 36 
thermal isomerization of, 31-2 
17//-Cpp-17-carboxylic acid (148), 31-2, 
93
15H- and 17//-
Cyclopenta[a]phenanthrenes 
dimers from, 29-30 
16//-isomer (144), postulated, 31 
ring-D cleavage in, 68-9 
ring-D double bond and K region, 170 
synthesis of, 29-35 
uv spectra, differences in, 32 
Hamster embryo cells, failure to activate 
cpps, 163 
Hep G2 cells 
activation of cpps by, 163 
inducibility of, 185
metabolism of the ll-methyl-17-ketone 
(26) by, 183 
reductase in supernatant from, 185
1.2.3.4.16.17-Hexahydro-cpp-l, 15-dione
(324), 56-7, 89
11.12.13.14.15.16-Hexahydro-cpp-ll,17- 
dione (193), 43-5, 89-90
optical resolution of, 45
1.2.3.4.16.17-Hexahydro-cpp-15-one
(325), 56-7, 90
1.2.3.4.15.16-Hexahydro-cpp-17-one 
(237), 49-50, 90
11.12.13.14.15.16-Hexahydro-cpp-17-one 
(205), 46, 90
11.12.13.14.16.17-Hexahydro-14,17- 
dimethyl-15//-cpp (48), 17, 110
1.2.3.4.16.17-Hexahydro-15//-cpp (326), 
56-7, 92
6.7.8.14.16.17-Hexahydro- 15//-cpp (440), 
71-2, 92
8.12.13.14.16.17-Hexahydro-15//-cpp-
13.14-dicarboxylic anhydride (111),
27-8, 106
11.12.13.14.16.17-Hexahydro-15//-cpp 
(44), 15-16, 63-4, 72, 92
11.12.13.14.16.17-Hexahydro-15//-cpp-
13.14-dicarboxylic acid anhydride 
(112), 27-8, 106
11.12.13.14.16.17-Hexahydro-15//-cpp-ll- 
one (82), 23-4, 90
11.12.13.14.15.16-Hexahydro-11 -hydroxy- 
cpp-17-one, 11a- and ll/?-isomers, 91
11.12.13.14.16.17-Hexahydro-17-hydroxy- 
15//-cpp-ll-one, 91-2
11.12.13.14.16.17-Hexahydro-ll-hydroxy- 
3-methoxy-15//-cpp (427), 71-2, 102
6.7.8.14.16.17-Hexahydro-17-isopropyl-
ll-methyl-15/7-cpp (125), 28-9,
117
11.12.13.14.15.16-Hexahydro-3-methoxy- 
cpp-ll,17-dione (194), 43, 101
6.7.8.14.16.17-Hexahydro-3-methoxy- 
15//-cpp (441), 71-2, 102
11.12.13.14.16.17-Hexahydro-3-methoxy-
14-methyl-15//-cpp (56), 18-19, 110
11.12.13.14.16.17-Hexahydro-3-methoxy- 
17-methyl-15//-cpp (63), 19,20, 110
11.12.13.14.16.17-Hexahydro-12-methoxy- 
oxalyl-15/7-cpp-ll-one (84),
23-4, 113
1.2.3.4.15.16-Hexahydro-ll-methyl-cpp-
17-one (238), 49-50, 102
lack of carcinogenicity of, 140-1
11.12.13.14.16.17-Hexahydro-12-methyl- 
15//-cpp-ll-one (8 6 ), 23-4, 102
1.2.3.4.15.16-Hexahydro-la,2/?,15- 
trihydroxy-ll-methyl-cpp-17-one 
(462), 102, 188, 189
High-pressure liquid chromatography 
(hplc) separation 
of microsomal metabolites, 173-7 
of nucleoside-carcinogen adducts, 181— 
2
Human hepatoma cells, see Hep G2 cells
Human liver extracts, carcinogenicity of, 
244-5
Human lymphocytes, sister chromatid 
exchanges in, induced by cpps, 163
6/J-Hydroperoxycholest-4-en-3-one, a 
carcinogenic oxidation product of 
cholesterol, 244
Hydrogenolysis, of oxygen functions at 
C -ll and C-17 in cpps, 22, 48-9,
61-2
12-Hydroxy-ll,12,13,14-tetrahydro-17//- 
cpp, 91
3-Hydroxy-l 1,12,13,14,15,16-hexahydro-
1,17,17-trimethyl-cpp (164), 34-5,
115
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12-Hydroxy-3-methoxy-
6.7.8.12.13.14.16.17-octahydro-15H- 
cpp (439), 71-2, 103
12-Hydroxy-6,7,8,12,13,14,16,17- 
octahydro-15//-cpp (438), 72, 93
18-Hydroxyoestrone (21), 10—11
11-Hydroxy-17-oxo-cpp tosylate, 119 
3-Hydroxy-l, 17,17-trimethyl-cpp (165),
34-5, (acetate) 112
Iball index, 138, 139, 140, 158-9 
comparison for selected pairs of 17- 
methyl-16,17-enes and 17-ketones, 
170-1 
definition of, 136 
inapplicability to comparison of 
different test methods, 144 
of 11-alkyl and ll-alkoxy-17-ketones, 
229
relationship to molecular strain, 228-9 
Indan-l-one, 83
Indeno(2' ,3': 1,2)phenanthrenes (416, 
417), 69-70, see also 16,17-Benzo- 
15//-cpp
Infrared spectral data, 67, 76-122 
Initiation/promotion 
as a test method, 142-3 
economy with test samples, 143 
of cpps, 144-6 
17-Isopropyl-15//-cpp (388), 6 8 , 70-1, 1 1 2  
carcinogenicity of, 134-5 
17-Isopropyl-17//-cpp (425), 70-1, 112 
17-Isopropylidene-cpp (422), 70, 110 
lack of carcinogenicity of, 136-8
17-Isopropyl-3-methoxy-
6.7.8.9.11.14.16.17-octahydro-cpp-ll- 
one (124), 28-9, 117
17-Isopropyl-6,7,8,9,ll,14,16,17- 
octahydro-15/f-cpp-ll-one (123),
28-9, 115
12-Isopropyl-ll,12,15,l 6 -te trahydro-cpp-
17-one (251), 50, 114
Kinetics of formation of in vitro 
metabolites, 177-8
Latent period, 135, 136, 243 
mean latent period, definition of, 136 
shortening of, with 1 ,1 ,1 - 
trichloropropene oxide, 148-50 
relationship with dose, 146, 148 
use of acetone as solvent, 144-6, 181 
Lead tetraacetate oxidation, 62-3 
Leukaemia, in rats, 157 
Lung cancer and cigarette smoking, 247
Marrian, G. F., 8 , 10 
discoverer of oestriol, 8  
suggested route to cpps from
oestrogens, 1 1  
Mass-analysed ion kinetic-energy 
spectrometry (MIKES), 84-5 
Mass spectrometry of cpps, 79-85, 188,
191
fragmentation of a DNA-adduct, 83-5 
fragmentation of ring-D in 17-ketenes, 
82
loss of carbon monoxide, 82, 175-6 
loss of guanine, 84-5 
loss of ketene, 82, 193 
loss of water, 79, 175-6 
loss of sterol side chain, 85 
typical fragmentation patterns, 80-1 
use in identification of metabolites,
173-6, 188, 191, 193, 200 
Melting points of cpps, 76-131 
Metabolic activation of cpps, 170-2i0 
Metabolism of 15,16-dihydro-ll-methyl- 
cpp-17-one (26) 
activation of, 170—86 
binding to DNA in vitro, 171-3 
binding to mitochondrial versus nuclear 
DNA, 186 
binding to mouse skin DNA, 205 
by Hep G2 cells, 185 
by mouse embryo cells, 186 
comparative in vitro, of methyl 
homologues of 15,16-dihydro-cpp-17- 
one, 195-204, 207-8 
diol-epoxides of, by computer 
modelling, 230-3 
anrf-diol-epoxide, evidence for, 185 
half-life of DNA adducts of, in mouse 
skin, lung, and liver, 205-8 
identification of main nucleoside adduct 
involving deoxyguanosine, 83-5, 182 
identity of in vitro and in vivo mouse 
skin DNA adduct patterns, 179 
major difference in urinary metabolites, 
188-9
microsomal metabolites of, 173-8, 196— 
9
separation of metabolites by hplc, 174 
structure of main nucleoside adduct,
185
urinary metabolites from the rat, 186-9 
urinary metabolites, separation by tic, 
186-8
1,12-Methano-7-methylbenz[a] anthracene, 
194
3-Methoxy-6,7,8,9,ll,12,13,14,15,16- 
decahydro-cpp-15-one, 103 
3-Methoxy-6,7,8,12,13,14,16,17-octa- 
hydro-15H-cpp-12-one (437), 71-2, 
103
3-Methoxy-17-methyl-15Z/-cpp (134),
29-30, 105 
carcinogenicity of, 136-8, 171
Index 263
mutagenicity of, in Ames’ test, 158 
ll-Methoxy-17-methyl-15//-cpp (138),
29-30, 105 
carcinogenicity of, 136-9, 171 
mutagenicity of, in Ames’ test, 158 
3-Methoxy-6,7,8,12,13,14,15,16- 
octahydro-cpp-15-one, 103 
3-Methoxy-6,7,8,12,13,14,15,16- 
octahydro-cpp-17-one, 103 
3-Methoxy-17-methyl-6,7,8,9,ll,12,14,15- 
octahydro-16//-cpp (16), 9-10, 110
2-Methoxy-11, 12,15,16-tetrahydro-cpp-17- 
one, 1 0 0
3-Methoxy-11,12,15,16-tetrahydro-cpp-17 - 
one (6 6 ), 19-20, 43, 100
6 -Methoxy-l 1, 12,15,16-tetrahydro-cpp-17- 
one, 1 0 0 - 1
3-Methoxy-6,7,16,17-tetrahydro-15H-cpp 
(443), 71-2, 102
3-Methylcholanthrene, 6 , 157 
from bile acid by selenium 
dehydrogenation, 6  
lack of formation on pyrolysis of 
sterols, 242-3 
possibility of metabolic formation from 
steroids, 7 
ll-Methyl-cpp-17-one (364), 64-5, 78,
93
Methyl 15,16-dihydro-17-oxo-cpp-16- 
carboxylate, 69-70 
Methyl 15,16-dihydro-17-oxo-16-(3- 
oxobutyl)-cpp-16-carboxylate (414), 
69-70, 119 
Methyl 15,16-dihydro-17-oxo-16-(3-
oxopentyl)-cpp-16-carboxylate (415), 
69-70, 120
17-Methyl-17-[2(5,6-dimethyl)hept-3- 
enyl]-cpp (170), 35-6, 121 
Methyl groups 
chemical elimination of C-18, 53 
electron donor character of, 235 
enhancement of carcinogenicity by, 7- 
8 , 195
lack of migration during 
dehydrogenation, 2 2  
migration of 18-methyl group, 9, 10 
migration of 19-methyl group, 245-6 
11 -Methyl-15H-cpp (150), 31-3, 67, 94
15-Methyl-17H-cpp (128), 29-30, 94 
carcinogenicity of, 134-5, 170 
oxidation of, 6 8
17-Methyl-15H-cpp (133), 29-30, 94 
carcinogenicity of, 134-8, 170-1 
mutagenicity of, in Ames’ test, 158 
oxidation of, 6 8
17-Methyl-17-[2(6-methyl)heptyl]-cpp 
(151), 33-4, 120
ll-Methyl-17-oxo-6,7,15,16-tetrahydro- 
cpp-m-6,7-diol (338), 61-2, 101
17-Methyl- 16-phenyl-cpp- 15-one (330), 
56-7, 119
2-Methylpyrene, 16
11-Methyl-l,2,3,4,-tetrahydrochrysen-1- 
one (450) 
complete carcinogenicity of, 140-3 
genetic activity of, in yeasts, 165 
initiating activity of, 144-5 
mutagenicity of, in Ames’ test, 159 
mutagenicity of, in mammalian V79 
cells, 162-3
1-Methyl-ll,12,15,16-tetrahydro-cpp-17- 
one , 1 0 0
2-M ethyl-ll,12,15,16-tetrahydro-cpp-17- 
one , 1 0 0
3-M ethyl-ll,12,15,16-tetrahydro-cpp-17- 
one , 1 0 0
4-M ethyl-ll,12,15,16-tetrahydro-cpp-17- 
one (257), 50-1, 100
6-m ethyl-ll,12,15,16-tetrahydro-cpp-17- 
one , 1 0 0
11-Methyl-l 1,12,15,16-tetrahydro-cpp-17- 
one (252), 100 
axial methyl group in, 223 
bond angles and lengths in, from X-ray 
data, 218-23 
carcinogenicity, lack of, 140-1 
crystal data for, 217 
molecular structure of, 227 
mutagenicity, lack of in Ames’ test, 159 
X-ray crystallography of, 215-33
11-Methyl-6,7,15,16-tetrahydro-cpp-
6,7,17-trione (336), 61-2, 93-4
12-Methyl-l 1,12,15,16-tetrahydro-cpp-17- 
one (249), 50, 100
11-Methyl-l ,2,15,16-tetrahydro-la, 2/3,15- 
trihydroxy-cpp-17-one (454), 101,
175, 188-9 
binding to DNA, lack of, 180 
initiating activity, lack of, 181 
mutagenicity, lack of in Ames’ test, 180 
occurrence as a microsomal metabolite, 
174-8
phenol derived from, 176
1 l-Methyl-3,4, 15,16-tetrahydro-3a ,4/3,15- 
trihydroxy-cpp-17-one (455), 102, 175 
binding to DNA in vitro, 180, 182 
initiating activity of, 181 
mutagenicity in Ames’ test, 180 
occurrence as a microsomal metabolite, 
174-8
phenol derived from, uv spectrum of, 
176
ll-Methyl-3,4,15,16-tetrahydro-3a,4/3,
16-trihydroxy-cpp-17-one (456), 102, 
175
binding to DNA in vitro, 180, 182 
initiating activity of, 181 
mutagenicity in Ames’ test, 180
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1 l-Methyi-3,4,15,16-tetrahydro-3a,4/3, 
cont.
occurrence as a microsomal metabolite,
174-8
phenol derived from, uv spectrum of, 
176
Mitochondrial DNA, 186 
Molecular orbital calculations, 233-6 
Mouse 
Balb C, 154 
Bl. HI. strain, 132-5 
C57B1, 154 
DBA/2, 154 
embryo cells (TO), 186 
‘mixed’ strain, 132-5 
Swiss, 135
Theiler’s Original (TO), 133-55, 181 
Mutagenicity of cpps, 157-66 
comparison of 39 cpp derivatives by the 
Ames’ test, 158-63 
lack of correspondence between 
mutagenic and carcinogenic 
potencies, 161 
mutagenic ‘non-carcinogens’, 159, 161 
see also Ames’ test 
Mutation rate, variation with oxidative 
enzyme concentration, 160
Naphthalene, double acylation of, 56-7 
Nitrobenzene, use in aromatization of 
ring-C, 45-6
18-Noroestrone methyl ether (22), see
6,7,8,9,11,12,13,14,15,16-Decahydro-
3-methoxy-cpp-17-one 
Nuclear magnetic resonance data, 77-122 
and non-bonding distances, 228-9 
of metabolites, 175, 184, 192-4, 199, 
201
Occurrence of cpps, 239-47 
from cholesterol with iodine vapour in 
the adsorbed state, 242 
in brown coal, 240 
in edible oils, 241-2 
in lake and river sediments, 240-1 
in petroleum, 239-40 
possibility of, from steroids by aberrant 
metabolism, 239, 243-6
1.4.5.6.9.10.16.17-Octahydro-15//-cpp-
1,4-dione (114), 27-8, 92
6.7.8.12.13.14.16.17-Octahydro-15//-cpp-
12-one (96), 25, 63, 71-2, 92,
(oxime) 63
Oestriol, 8 , 9 
Oestrone, 8-10 
reaction with 
thallium(III)trifluoracetate and 
bromine, 6 6  
Welff-Kishner reduction of, 9
Oestrogens 
and cpps, 8 - 1 2
biosynthesis from androgens, 1 0  
discovery of, 8
migration of angular methyl groups in,
9-10
selenium dehydrogenation of, 9 
test for, 8  
Oxepins, stability to acid, 189 
Osmium tetroxide oxidation, 61, 67
17-Oxo-6,7,15,16-tetrahydro-cpp-cw-6,7 - 
diol (337), 61-2, 90 
15-(16-Oxo-ll,12,13,17-tetrahydro-16H- 
cyclopentafalphenanthryl)-acetic acid 
(387), 67-8, 106
Papilloma, classification of skin tumours 
as, 136
Peri-substituent at C -6 , inhibitory effect 
on carcinogenicity, 2 0 1 - 2  
Physical data (melting points, optical 
rotations, etc.), 76-131
17-(2-Propenyl)-15H-cpp (424), 70, 110 
Proton exchange, rate of at C-16, 73,
228-9
Quinoid ring-D structures, postulated for 
reaction intermediates (371, 374,
375), 6 6  
Quinone dehydrogenation, 
chlorination, during (with DDQ), 35-6 
Diels-Alder adduct with DDQ, 35-6 
migration of methyl groups during, 33- 
5
of cholesterol, mechanism of, 33-4 
of 17/3-methyl-zl9(11)-testosterone, 34-5 
ring-D cleavage during, 35-6
Rat
induction of leukaemia in, 157 
urinary metabolism of (26) in, 186-9 
induction of mammary adenocarcino­
mas in, 156-7 
Reduction with lithium in liquid ammo­
nia, 49
Reformatsky reaction, 51-2, 69 
Reliability factor (discrepancy index), 213
Sarsasopogenin, dehydrogenation of its 3- 
methyl derivative, 2 1 - 2  
Selenium dehydrogenation 
loss of angular methyl groups during, 6 , 
7, 9
loss of 1-methyl group during, 26-7 
migration of angular methyl groups 
during, 9-10, 22, 245-6 
of cyclobuxine, 2 1 - 2  
of 12-ketocholanic acid, 3-methylcho- 
lanthrene from, 6
Index 265
of oestrogens, 19 
of strophanthidin, 2 1  
Sephadex LH20 chromatography of nuc- 
leoside-carcinogen adducts, 179-81, 
206
use of borate buffer to distinguish be­
tween cis- and trans-diols, 183, 205-6 
Sister chromatid exchanges, induced in 
human lymphocytes by cpps, 163 
Skin cancer, 5 
Skin painting, 132-54 
test method with TO mice, 135-6, 138 
Skin tumours 
classification as papillomas or carcino­
mas, 136 
eyelid, 154-5
produced by delayed promotion, 154 
ventral skin, 151, 154-5 
Spectral properties of cpps (ultraviolet, 
infrared, and nmr), 76-131 
Spiran formation, I suppression of during 
cpp synthesis, 16—17 
Squalene cyclization, 11-12 
Steric hindrance to conjugation, 48, 52 
Steroid, 18-hydroxylation, 11 
Sterols and bile acids, 
chrysene (5), from, 4 
Diels’ hydrocarbon (7), from, 4, 241-2 
dimensions from X-ray analysis, 4, 211 
long term degradation in subsurface of, 
240
revised formula for, 4 
side-chain cracking in, 240 
Wieland-Windaus formulae for, 4 
Stobbe reaction, 42-3, 50-3 
with [2,3-C14]diethyl succinate, 55 
Strophanthidin, selenium dehydrogena­
tion of, 2 1  
Structure-carcinogenicity relationships, 
among 16,17-dihydro-157/-cpps, 132-5 
among 15,16-dihydro-17-ketones, 139— 
46
among 15H- and 17/7-cpps, 134, 135, 
137-8
correlation with molecular strain, 227-9 
DNA adduct formation and persistence 
and, 207-8 (summary) 
metabolism and, 207-8 (summary) 
of cpps, 245 (summary)
Testosterone, cpps from, 53-4
6,7,15,15-Tetrabromo-6,7,15,16- 
tetrahydro-cpp-17-one (360), 64
I,2 ,3 ,4-Tetrahydrochrysen-l-one (449) 
lack of carcinogenicity of, 140-2, 144—5 
mutagenicity of, in Ames’ test, 159
13,14,15,16-Tetrahydro-cpp-17-one, 89
II,12,15,16-Tetrahydro-cpp-17-one (179), 
41-3, 89
6.7.15.16-Tetrahydro-cpp-6,7,17-trione
(335), 61-2, 8 6
6.7.16.17-Tetrahydro-1577-cpp (442), 71- 
2, 90
13.14.16.17-Tetrahydro-1577-cpp, 90
6.7.16.17-Tetrahydro-15//-cpp-6,7-dione 
(104), 26, 61-2, 8 8
13.14.16.17-Tetrahydro-15/f-cpp-17-ol, 91
ll,12,13,14-Tetrahydro-17//-cpp-12-one
(174), 36, 89
11.12.13.17-Tetrahydro-16//-cpp-16-one 
(384), 67-8, 88-9
1.2.3.4-Tetrahydrophenanthren-l-one, 
67-8
1.2.3.4-Tetrahydrophenanthren-l-ones, 
syntheses of, 50-3
Thallium (III) triacetate, effect on 
bromination, 65-6
3.4.16.17-Tetrahydro-3a,4/3,17-trihydroxy- 
157/-cpp
conformation from circular dichroism 
data, 185 
nmr data for A-ring protons in, 184 
Theiler’s Original (TO) mice, 
survival of, 136
use in carcinogenicity testing, 135-55 
Thin-layer chromatography, 173, 186-7 
Torsion angles, definition of, 223 
1,1,1-Trichloropropene oxide (TCPO), 
shortening of mean latent period by, 
149-50
10/?-Trifluoroacetoxy-19-norandrosta-l,4- 
diene-3,17-dione (373), 6 6  
la,2/3,15-Triacetoxy-l,2,15,16-tetrahydro-
ll-methyl-cpp-17-one (461), 120, 
188-9
11.12.17-Trimethyl-15//-cpp (137), 29-30, 
112
carcinogenicity of, 135-8, 171 
mutagenicity of, in Ames’ test, 158 
Tritium 
acid-catalysed exchange, 55-6 
labelled cpps, 54-5, 171, 173, 186 
position of labelling from nmr 
spectroscopy, 56 
rate of exchange at C-16, 73, 228
Ultraviolet spectral data, 76-122, 187,
196, 222
difference beteen spectra of 1577- and 
177/-cpps, 32
V79 cells, see Chinese hamster V79 cells
Wieland-Windaus formula for deoxycholic 
acid and cholesterol, 4, 211 
Wittig reaction, with 17-ketones, 31
266 Index
X-ray crystallography of
cyclopenta[a]phenanthrenes, 211-33 
reliability factor (discrepancy index), 
213
Yeasts
increase in P450/448 content in, 166 
Saccharomyces cerevisiae strains JD1 
and D6, 163-6
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D.Sc. Presentation
I wish to base my presentation for the degree of Doctor of Science on my work in 
the general area of chemical carcinogenesis over the last 25 years (please see 1959-1987 
section (viii) in my Curriculum Vitae). This research is largely summarised in a recent book 
entitled "Cyclopenta[a]phenanthrenes" published last year by Cambridge University Press, 
and which I now include as the main part of my submission. It is supported by 24 scientific 
papers and reviews, of which I am author or co-author, which seem to me to provide a fair 
overview of my interests and endeavours in this field. These together represent about a 
quarter of my publications which are listed in full in my c.v. Those now submitted consist of:-
(i) Parts 1-11 of a series entitled "Potentially carcinogenic cyclopenta[a]- 
phenanthrenes" mostly describing synthetic organic chemistry, published in the Journal of 
the Chemical Society;
(ii) a review on chemical carcinogenesis commissioned by the Journal of Pathology 
in 1980, and a chapter written by invitation for the book "Target Organ Toxicity" published in 
1987;
(iii) 11 assorted papers on carcinogen metabolism, mutagenicity and carcinogenicity 
testing, and chemical structure/carcinogenicity relationships, published mainly in cancer 
research journals.
I am the sole author of the first few of these papers, but later, as head of the Chemistry 
Laboratory in the Imperial Cancer Research Fund, I had the benefit of collaboration with a 
series of excellent postdoctoral research fellows, postgraduate Ph.D. students, and senior 
technical staff whose names appear in the various publications. I directed all the research 
described in these papers and had a substantial personal inolvement at the practical level in all 
of it. Although most of the animal work was carried out by my colleague, Dr. T.S. Bhatt, I 
possessed a Home Office animal licence until I moved to Surrey a year ago.
M.M. Coombs 
September, 1988
CAMBRIDGE UNIVERSITY PRESS
Announcing a new series 
CAMBRIDGE MONOGRAPHS ON CANCER RESEARCH
Chemical Carcinogens
The right o f  the  
University o f  Cambridge  
to  prin t and  sell a ll 
m anner o f  books was granted  
by  H enry V III  in 
R oyal Letters Patent 
o f  20 Ju ly  1534
Scientific Editors: Dr. Maurice M. Coombs, Imperial Cancer Research Fund 
Laboratories, London; Dr. John Ashby, Imperial Chemical Industries Pic, Cheshire; 
Professor R Marian Flicks, United Biscuits (UK) Ltd, R. & D. Centre, High Wycombe, 
formerly at the Middlesex Hospital Medical School, London.
Executive Editor: Herbert Baxter, formerly at the Laboratory of the Government 
Chemist, London.
This major series will examine in detail the mechanisms of carcinogenesis. Initially the 
series has concentrated on chemical (environmental) carcinogenesis, where there is a 
great quantity of data which is in need of presentation in a coherent and systematic 
format. The series is now broadening to include other aspects of carcinogenesis, such 
as cell and molecular biology.
An understanding of the chemistry and metabolism of chemical carcinogens will help to 
provide valuable insight into this area, as well as pointing the way for more effective 
safety measures. The series has therefore been initiated with a number of 
monographs on the chemistry and biological effects of chemical carcinogens. The 
monographs will be in-depth studies that bring together and evaluate the published 
data, and present a coherent, integrated account of the cited literature. Volumes of 
approximately 200-300 pages are envisaged, each involving the following subject 
areas:
Nomenclature and structure 
Occurrence; Synthesis
Industrial preparation and use (for compounds used commercially)
Physical and spectral properties (including X-ray studies)
Analysis
General chemistry (and synthesis if not included above)
Metabolism, including identification of metabolites
Interaction of the compounds, and their metabolites, with biological
macromolecules
Toxic, mutagenic and carcinogenic properties.
In a series of this nature it is not easy to define areas precisely, and it is recognized that 
authors will require a certain amount of latitude in their approach to both the style and 
content of these volumes. Since the subject matter of the books covers a range of 
scientific disciplines, some of the books may require more than one author.
We think that the series will be popular as it will provide comprehensive and integrated 
reviews of the chosen topics to both chemists and biologists. The appearance of the 
series is timely because of the high current interest in the role of environmental factors, 
including chemical pollution, in the aetiology of human cancer.
V  ___________________________________ J
Published titles: i  '
M. Osborne & N. Crosby: Benzopyrenes
M.M. Coombs & T.S. Bhatt: Cyclopenta(a)phenanthrenes
M. Newman, S. Veeraraghavan & B. Tierney: Chemistry and biology o f 
benz(a)anthracenes
The following titles are now in preparation for the series:
J . Jacob: Sulphur analogues of polycyclic aromatic hydrocarbons
M.J.E. Hewlins & J.C. Phillips: Nitrogen analogues o f polycyclic aromatic hydrocarbons
W.F. Karcher: Dibenzanthracenes
J. Jacob & W.F. Karcher: Benzofluoranthenes and fluoranthene 
C.W. Vose and S.T. Hadfield: Cholanthrenes
H. Rosenkranz & P. Floward: Nitrated polycyclic aromatic hydrocarbons
S.K. Yang: Chrysenes
W. Lijinsky: Chemistry and biology o f N-nitroso compounds
R.G. Plarvey: Polycyclic aromatic hydrocarbons: chemistry and carcinogenesis
T. Sugimura & S. Takayama: Heterocyclic amines: mutagens and carcinogens in 
cooked and pyrolysed foods
J.P. Glusker: Structural studies in cancer research
J. Fiigginson et a l\ The epidemiology and causes o f human cancer
B.M. Wagner & R.M. Leader: Animal models o f carcinogenesis
R.W. Tennant: Biological aspects o f identifying chemical carcinogens
G.B. Leslie, C. Joseph & F.J.C. Roe: Hormones, diet and cancer
G. H. Pigott: Solid state carcinogenesis
A.R. Kinsella: Colorectal carcinoma: a scientific perspective
CAMBRIDGE UNIVERSITY PRESS
CAMBRIDGE MONOGRAPHS ON CANCER RESEARCH
More than twenty books in this series are in preparation and the first three are now published. The 
series originated with books on chemical carcinogenesis, and from the beginning authors have been 
encouraged to write in depth about fields in which they have been personally involved and have a 
special interest. About ten volumes covering various classes of polycyclic aromatic hydrocarbons 
and their heterocyclic analogues, N-nitroso compounds, and aromatic nitro compounds, are being 
written. More recently the series has widened in scope and more general monographs, for 
example on animal models in carcinogen testing, biological aspects of short-term tests, the effects 
of diet and hormones on human cancer incidence, and modem perspectives in cancer aetiology, are 
now under contract.
Organ-specific carcinogenesis
W e wish now to propose further monographs on the separate diseases which are loosely classed 
together as cancer, seen primarily from the scientific viewpoint. For example, bladder cancer, 
leukaemia, and cancer of the colon, breast and lung are distinct, common human diseases which 
immediately spring to mind. There is clearly scope for a number of useful volumes of this type, 
and with these we suggest that the following points, among others, should be considered:
Occurrence of the particular human disease and what is 
known of its causes through epidemiology, etc.
A short review of its salient pathology, and a brief 
indication of methods used in its treatment including 
a realistic view of what is achievable by these means.
This will include inter alia a concise discussion of the 
anatomy and physiology of the organ in question for the 
benefit of non-medical readers.
Animal models for the disease, induction o f the disease 
with particular carcinogens, possibly with a resume of 
what is known about the mechanism o f action of the 
carcinogen at the molecular level; effects seen 
experimentally in the use of promoters and tumour 
inhibitors in these situations, with particular respect 
to possible human exposure to these and similar agents.
Like the earlier volumes of this series, these new monographs of about 300 pages 
will be aimed largely at graduates who need to obtain an authoritative, up-to-date review of the 
present situation in these areas.
Cambridge University Press is taking much care in presenting these books 
attractively in hard-back edition at an affordable price and we hope that the series will become 
established world-wide in many medical and scientific libraries. Of course we realise that 
individual authors will want to approach their subject in their own way and may want to involve 
colleagues in view of the wide range of subject matter to be covered. However we hope that each 
volume will be a well-integrated, in-depth study of the disease in question with adequate references 
to the original literature for those who want to delve further. The editors would welcome 
suggestions for subject areas, with or without synopses, and any other comments on this proposed 
new venture.
John Ashby Scientific
Maurice Coombs Editors
Marian Hicks
The right o f  the 
U niversity o f  Cambridge 
to  p rin t a nd  sell all 
m anner o f  books was granted  
by H enry V III in 
R oval Letters Patent 
o f  20 Ju ly  1534
Herbert. Baxter Executive Editor
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C H E M IC A L  C A R C IN O G E N E S IS :  A V IE W  A T  T H E  E N D  
O F  T H E  F IR S T  H A L F -C E N T U R Y *
M. M. C o o m b s
Chemistry Laboratory, Imperial Cancer Research Fund, London
R e v i e w s  of chemical carcinogenesis commonly begin with the London 
surgeon Sir Percival Pott, who in 1775 concluded that the high incidence o f 
epithelioma of the scrotum among chimney sweeps was due to the soot to which 
they were daily exposed from ah early age. In his “ Chirurgical Observations ” 
he wrote “  It is a disease which always makes its first attack on, and its first 
appearance in the inferior part of the scrotum ; where it produces a superficial, 
painful, ragged, ill-looking sore with hard and rising edges. The trade call it 
soot-wart. . . .  The disease, in these people, seems to  derive its origin from  a 
lodgement o f soot in the rugae of the scrotum.” Probably the first preventive 
measure against chemically induced cancer was taken in 1778 when the Danish 
chimney-sweeps’ guild urged its members to  bathe daily (Clemmesen, 1951). 
A hundred years later the same disease occurred among workers in the Lanca­
shire cotton spinning industry where it became known as “ mule spinner’s 
cancer ” . A bout this time occupational skin cancer among oil and tar workers 
was reported by von Volkmann (1875) in Germany and by Bell (1876) in 
Scotland, and it was suspected that prolonged contact o f the spinners with 
clothes impregnated with mineral oil used to  lubricate their machines was 
responsible for the disease. Towards the end o f the century attempts were 
made to  produce skin cancer experimentally in animals by topical application 
o f these oils and tars. Success was finally achieved in 1915 by two Japanese 
workers, Yamagiwa and Ichikawa, who induced tumours on the ears o f rabbits 
by repeated application of coal ta r; they succeeded where others had failed by 
persisting with their treatment, thus imitating the hum an exposure. Using the 
dorsal skin of mice as a more convenient test system, Sir Ernest Kennaway and 
his associates at the Royal Cancer Hospital in London soon showed that 
strongly carcinogenic tars resulted from pyrolysis o f many carbonaceous 
materials such as cholesterol, yeast, and hum an hair, skin, and muscle, as well 
as non-carcinogenic oils and even acetylene (HC =  CH) (Kennaway, 1955). 
Examination o f these tars revealed that they all possess characteristic lines in 
their fluorescence spectra, similar to  those displayed by the polycyclic arom atic 
hydrocarbon benz[a]anthracene (1 : 2 -benzanthracene, 1 , fig. 1), itself essentially 
non-carcinogenic. In  1929 Clar synthesised a derivative, dibenz[a,h]anthracene 
(1 : 2 :  5 : 6 -dibenzanthracene, 2), which has the distinction o f being the first 
pure chemical compound to  be shown to be carcinogenic (Kennaway and 
Hieger, 1930).
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The study of chemical carcinogenesis can therefore be considered to  begin 
with these momentous discoveries. It is the purpose of this review to outline 
briefly the progress which has been made in our understanding of this important 
subject during the intervening half-century. The viewpoint is o f necessity that 
of an organic chemist whose interest is focused on this area.
Over 3000 pure chemical compounds are now known to be carcinogenic, 
in experimental animals and it seems certain that this number will increase since 
at present about 200,000 new  organic compounds are reported yearly (Arcos,
1978). Chemical carcinogens are now known to belong to  widely diverse 
structural types and include a number of natural products, thus dispelling the 
idea current some years ago that carcinogenic activity would be found only 
among “ artificial ”  compounds for which detoxifying enzymes had not been
F ig . 1.—Polycyclic hydrocarbons: benz[a]anthracene (1), dibenz[a,h]anthracene (2), and benzo[a]-
pyrene (3).
developed during the course o f evolution. In this section the various types 
o f chemical carcinogens will be discussed and the bearing they have on human 
disease will be noted.
Using the characteristic fluorescence spectrum as a guide, Kennaway and 
his associates fractionated 2  tons o f gas-works pitch, eventually to obtain 7 
grams of yellow crystals consisting mainly o f benzo[a]pyrene (BaP, 3 :4 - 
benzpyrene, 3, fig. 1). This compound is strongly carcinogenic and it is now 
known to  be very widely distributed because it is formed whenever organic 
m atter undergoes incomplete combustion. It is present in urban air in 
measurable quantities; in fact it is estimated that in America no less than 1300 
tons o f benzo[a]pyrene is emitted into the atmosphere each year. Even so, 
Shubik (1972) has suggested that the lower incidence o f lung cancer in the USA 
compared with this country, when allowance is made for the different smoking 
habits, m ay be due to  the 12,000-fold higher content o f benzo[a]pyrene in the 
coal ta r used in road-making here in  Britain, compared with the petroleum 
asphalts used for this purpose in the USA. Benzo[a]pyrene is also detectable 
in everyday materials such as charcoal-broiled steak, whisky, and tobacco 
smoke (Nagao and Sugimura, 1978). Compounds 1-3 belong to  a  group o f
Types o f  chemical compounds having carcinogenic properties
2 3
(BaP)
P olycyclic  hydrocarbons
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polycyclic compounds, structurally related to phenanthrene (4), many o f which 
are carcinogenic (fig. 2).
Phenanthrene itself is inactive, but a relative, 7,12-dimethylbenz[a]anthra- 
cene (DMBA, 9 : 10-dimethyl-1 : 2-benzanthracene, 5), is one o f the most potent 
carcinogens known. Topical application of micrograms of this compound is 
sufficient to induce skin tumours in the mouse. Simpler compounds of the 
cyclopenta[a]phenanthrene series structurally related to steroids are active; 
for example the ketone (6) studied by ourselves is similar in activity to benzo- 
[ajpyrene as a carcinogen (Coombs, Bhatt and Croft, 1973). 3-Methyl- 
cholanthrene (7), another “ classical ” carcinogen, was first produced by 
pyrolysis o f a  bile acid derivative (Cook and Haslewood, 1933; W ieland and 
Dane, 1933). A t one time there was a suspicion that such compounds might 
arise in the body by aberrant steroid metabolism (Inhoffen, 1953); however, 
no evidence has come to light to  support this idea. M any synthetic heterocyclic
5
(DMBA)
F ig. 2.—Polycyclic compounds; all are carcinogenic except phenanthrene (4). Hydrocarbons (5) 
and (7) are the “ classical ” carcinogens 7,12-dimethylbenz[a]anthracene (DMBA) and 
3-methylcholanthrene (MCA).
analogues o f these polycyclic aromatic hydrocarbons made by Buu-Hoi and 
his associates (Lacassagne, Buu-Hoi, Dandel and Zajdela, 1956; Buu-Hoi, 
1964) are also strong carcinogens.
Aromatic amines and azo compounds (fig. 3)
Another large group of related compounds comes under this heading. The 
greatly elevated incidence o f bladder cancer formerly found among workers in 
dyestuff factories (Wignall, 1929) was traced to  their daily contact with arom atic 
amines such as benzidine (8 ) and 2-naphthylamine (jS-naphthylamine, 9), 
produced as intermediates in dye-stuff manufacture (Case, Hosker, M cDonald 
and Pearson, 1954). Benzidine, o f course, was commonly employed in medical 
laboratories as a test for occult blood. Bladder cancer was also a  health 
problem in sections o f the rubber industry where arom atic amines were used as 
anti-oxidants (Case and Hosker, 1954). The manufacture and use o f these 
materials is now prohibited in this country under the Carcinogenic Substances 
Regulations, 1967, No. 879. Another aromatic amine which has achieved 
considerable importance in experimental cancer research is 2 -acetamidofluorene 
(AAF, 10). This compound was proposed as an insecticide during the 1939-45
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war, but luckily it was tested (Wilson, De Eds and Cox. 1941) before it was 
employed on a large scale., ii is a powerful carcinogen, producing a variety o f 
tumours in rooents, including those of the liver, external acoustic meatus, and
mammary glands. Very recently Sugimnra and co-workers (1977) in Japan, 
investigating the mutagenicity of pw hv  charmd fish and meat, made the 
important discovery that pyrolysis o f  the -acid tryp tophan  led to
compounds of the type ( 11) . superficially i t  0 o AAF. Compound 11,
3-amino-1 -mct:liyl-5H-pyrido[4,3-b]}ndole, was intensely m utagenic for bacteria 
and transformed cells m  cuiiurc; it would, therefore be expected to be
carcinogenic in animals when proper an  , xoj completed.
Closely related to the aromatic a .m u  are the aromatic azo compounds 
which are important as dyes. Some, sw p o-aminoazotoiuene (12), give liver 
tumours on prolonged feeding to r ah- t  -Raida, 1934V), Of this class the most
Nifo
10
■‘ AAF
COCH3 £
NN W^V'fsf^ ^ rNH2 
» N
CH,
Q - n = n- ( ~ /M
C H 3 ~ C N 3
12
c h !
13
F ig .  3 ,— C a rcin o g en ic  a ro m a tic  am in es  and a z o  c o m p o u n d s; (11) is  th e recently  d iscovered  p ro lys is
p rod u ct o f  th e  a m in o  ac id  tryp top h an .
notorious is butter yellow (13), (Yosliida, 19346; Kinoshita, 1936) so called 
because up to about 1935 it was used to colour margarine yellow, like butter.
Many food colouring agents are azo compounds, but today they are submitted 
to extensive animal tests before they are certified safe for use in food.
AT~Nitroso compounds (fig. 4)
Nitrosamines and nifrosamides, long familiar to organic chemists as 
synthetic intermediates, form another large and more recently discovered group
of potent carcinogens (Magee and Swann, 1969). Formulae of typical nitro­
samines are shown in the figure; the common structural feature associated 
with carcinogenicity seems to be the possession of the moiety CH-N(NO)R 
(Lijinsky, 1977).
Diraethylnitrosaraine, (CH3)2N"NO, was formerly used as an industrial 
solvent, and it was the observation of liver cirrhosis in exposed workers that led 
Magee and Barnes (1954) to investigate it in animals. It proved to be highly 
toxic, and in chronic experiments in rats it gave 100 per cent, incidence o f liver
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cancer. O f over 100 nitrosamines tested, 90 per cent, are carcinogens, and 
many display remarkable organotropic properties. Thus while the liver is the 
main target, followed by lung and kidney with the majority o f the compounds, 
certain derivatives reproducibly give rise to  cancer o f the oesphagus, fore­
stomach, and nasal cavity (Druckrey, 1975). Another notable feature o f 
nitrosamine carcinogenesis is that it has been shown to  occur in each o f the 16 
species in which tests have been made—in fish, birds, and mammals, including 
guinea-pigs which are resistant to  most chemical carcinogens, and in monkeys. 
It can hardly be doubted that m an is also susceptible.
In  contrast to  the nitrosamines and the other types of carcinogens so far 
discussed, nitrosamides such as N-methyl-N-nitrosourea (M N U 14) and the 
related N-methyl-N-nitrosourethane (M NUT, 15) and N-m ethyl-N ^nitro-N- 
nitrosoguanidine (M NNG, 16) are direct acting carcinogens, i.e., they do not
R’= R*=alkyl (CH3,C2H5,etc.)
R2/N-N=0 R = alkyl, R = phenyl, etc.
2R
r’= R = cycloalkyl
0  r u  0  CH NH r u
h2N‘ ^ 'n'm n c 2h 5o -c -n ' 3 no2-n h -c -n ;c h 3 2 N=0 2 5 N=0 2 'n *0
14 15 16
(MNU) (MNUT) (MNNT)
Fig. 4.—Carcinogenic nitroso compounds.
require biological activation before they can exert their biological potential, 
although tissue thiols markedly enhance the rate o f methylation o f D N A  by 
M N N G  (Lawley and Thatcher, 1970). Like the nitrosamines, they elicit 
tumours at several sites (Druckrey, 1975). Oral administration o f M N N G  to 
guinea-pigs produced squamous-cell carcinomas o f the forestomach while 
M N U T gave adenocarcinomas o f the pancreas and gastric carcinomas 
resembling hum an stomach cancer. Intravenous injection o f M N U  into rats, 
dogs, and rabbits yielded neural tumours o f the brain and spinal cord. The 
latter were induced in young rats after treating their mothers with ethylnitro- 
sourea a t the 15th day o f gestation; transplacental carcinogenesis was also 
observed with other nitroso compounds.
Nitrosamines are readily formed by interaction o f amines with nitrous acid 
(HNO 2) a t acid pH  (Walters, 1977). Suitable amines, o f course, occur widely 
in foodstuffs, particularly meat and fish. A part from  atmospheric nitrogen, the 
most widespread form of this element is nitrate, bu t m any bacteria and some 
fungi and plants are capable o f reducing this to  nitrite; a  nitrate reducing 
enzyme is also present in  hum an saliva (Tannenbaum et al., 1977). Sodium 
nitrate is widely used as a  preservative in cured meat and fish, bacon, cheese, etc.
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I t is therefore not surprising that trace amounts of nitrosamines can be detected 
in samples o f these foods; levels of 100 /xg/kg o f dimethylnitrosamine have been 
observed consistently in fried bacon (Scanlan, 1975). No hum an disease is yet 
definitely associated with nitrosamines, but the presence o f nitrosamines, 
including a new compound N-l-methylacetonyl-N-3-methylbutyl nitrosamine, 
in corn bread inoculated with common fungi o f the Fusarium, Geotrichan, and 
Aspergillus species and encountered as food in the Henan province of China, 
has recently been discussed with reference to the high incidence o f oesophageal 
cancer in this area (Shixin, Mingxin, Chuan, Mingyao, Yinglin, and Liang,
1979). A t present it is impossible to judge the effects o f exposure o f hum an 
beings to  trace levels o f carcinogens, for it is not certain whether we may
Fig. 5.—Biological alkylating agents, and the important industrial chemical vinyl chloride (24).
extrapolate from animal experiments or whether there is a  low threshold dose 
below which no effect is found (Cornfield, 1977). However, it has been pointed 
out (Walters, 1977) that the steady decline in gastric cancer in the western world 
may be due to  the use o f refrigeration to  store nitrate-containing vegetables, 
thus inhibiting its enzymatic conversion to nitrite. I t  is clearly essential to  aim 
a t  minimisation o f the amounts of these versatile carcinogenic nitroso compounds 
in the environment.
Nitrosamines and nitrosamides are alkylating agents, but here we consider 
other types which like the latter (but not the former) are direct acting carcino­
gens. 2,2'-Dichlorodiethyl sulphide (17), used as the vesicant m ustard gas in 
the 1914-18 war, causes cancer o f the bronchus, larynx and nasal sinuses (Doll, 
1977a). Replacement o f the sulphur atom  by nitrogen gives a  nitrogen m ustard
s X H 2CH2Cl
' ch2ch2ci
17 18 19
20
CHjCHjCI CH2CH20 S 0 2CHj
'CHjCHjCI CHj CHjOSOj CHj
21
CHjSOjOCH,
22
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CH-OO2
23
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Biological alkylating agents (fig. 5)
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(18), the progenitor of hundreds of anti-cancer drugs such as cyclophosphamide
(19), chlornaphazin (20), and the more distantly related myleran (21).
Many of these drugs have been shown to be weak to  moderately strong 
carcinogens in animal tests, and there is evidence for the involvement o f some 
in the induction o f human tumours. Chlornaphazin, for example, caused 
bladder cancer in patients with other forms o f cancer treated with it and its use 
has been discontinued (Thiede, Chieritz and Christenson, 1964); treatm ent 
with cyclophosphamide is associated with the induction o f leukaemia. 
Medically unim portant monofunctional alkylating agents, such as methyl 
methanesulphonate (19), jS-propiolactone (20) used in fumigation, and vinyl 
chloride (21) are also carcinogens. The last, produced industrially on a vast 
scale in the manufacture of polyvinylchloride (PVC), produces a  rare type o f 
liver tum our (angiosarcoma) in workers exposed to it (Waxweiler et al., 1976).
OH
OR1 CH.OCOR2 r ^ V 0C H 3
CH.CH=CH
U l
CH ,CH,
kHCO(CH2),CH=CHCH 
26  . 'CH,27 
0  
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F ig . 6.—Some naturally occurring carcinogens.
Fortunately PVC itself appears to be safe, but there has been considerable 
concern about the possible release o f occluded monomer from this plastic 
which is used in food packaging.
Carcinogenic natural products (fig. 6)
One o f the newer aspects o f chemical carcinogenesis is the lengthening list 
o f naturally occurring compounds which have been shown to  be active. These 
include the weak liver carcinogens safrole (25), present in oil o f  sassafras, 
pyrrolizidine alkaloids (26) which occur in senecio leaves used in Africa to  
prepare a  medicinal tea, and capsaicin (27), a  constituent o f chili peppers.
The aflatoxins such as aflatoxin B1 (28) are a  family o f complex lactones 
produced by the common yellow mould Aspergillus flavus which contaminates 
peanuts and certain grains. This compound (28) is perhaps the m ost potent 
carcinogen known, producing liver tomours in  rats fed with 1 /zg per day, and 
local sarcomas in mice after subcutaneous injection o f 10 pg  (Butler, Greenblat 
and Lijinsky, 1969). I t  is also extremely toxic and was, in fact, discovered as a
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result of the investigation in 1960 o f the death o f a  large num ber of young 
turkeys fed on contaminated peanut meal (Lancaster et al., 1961). The 
aflatoxins are widely distributed especially in hot, humid parts o f the world 
such as central Africa and South East Asia where it is thought that they may 
be implicated in the abnormally high incidence of primary liver cancer found in 
these areas (Linsell and Peers, 1977). Another carcinogenic natural product is 
the glycoside cycasin (29a) present in cycad nuts, used as a foodstuff in Guam. 
I t is hydrolysed by the intestinal flora to the aglycone methylazoxymethanol 
(29b) which behaves as a  methylating agent like the methylnitrosamines, causing 
liver and kidney tumours in experimental animals (Lacqueur, 1964). Bracken 
ferns, common in Great Britain, contain an unidentified carcinogenic principle 
(Evans and Mason, 1965) which may account for the frequent observation of 
stomach tumours in cattle in certain parts of Scotland. Young bracken fronds 
are eaten as a  vegetable in Japan.
.OH
30 31
Fig. 7.—Oestrogens: oestrone (30) and stilboestrol (31).
Steroids (fig. 7)
In 1932 Lacassagne induced mammary cancer by injection o f oestrone (30) 
into male mice of a strain in which only the females normally develop this 
tumour. This natural sex hormone, which is essential for the full development 
o f all female animals, was therefore the first naturally occurring compound 
whose administration appeared to cause cancer.
At about this time the newly discovered carcinogenic hydrocarbon 
benzo[a]pyrene was found to possess weak oestrogenic activity. Dodds (1947), 
in extensive work aimed at investigating the connection between these two 
biological activities, synthesised the compound stilboestrol (31) which has 
exceptional oestrogenic potency, surpassing even that o f the natural hormone. 
This compound has since gained importance as a  drug, and commercially as an 
aid in fattening of cattle for slaughter. Used therapeutically to control prostatic 
cancer, it no t unexpectedly causes breast development with a  risk of breast 
cancer in the men treated. It is now evident that the use o f large doses o f 
stilboestrol to  avert threatened abortion has resulted in vaginal cancer in some 
o f  the daughters o f the woman treated 15-20 years previously (Bibbo, Gill and 
Azizi, 1977). The more recent treatm ent o f menopausal symptoms by hormone 
replacement therapy using oestrogens has led to  the development o f endometrial 
cancer (Smith, 1975).
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The bile acids, too, have been under suspicion as carcinogens ever since the 
early pyrolytic conversion into 3-methylcholanthrene. M ore recently Hill 
(1975) has proposed that they may be involved through anaerobic metabolism 
by intestinal flora, in the causation o f colon cancer.
The preceding sections mentioned the main classes of chemical carcinogens 
without, o f course, being exhaustive. There are many other compounds which 
do not fall into these categories; a few of these of particular interest are 
mentioned here.
Colon cancer has until recently been difficult to  study experimentally due to 
the lack of an animal model for the disease, but now colon tumours are readily
obtainable in rodents by gastric instillation o f 1,2-dimethylhydrazine (33) 
(Newberne and Rogers, 1973). A nother! powerful, direct-acting carcinogen 
which has found much use in research is 4-nitroquinoline-N-oxide (32) 
(Nakahara, Fukuoka and Sugimura, 1957). The drugs isoniazid (34), im portant 
in the treatment of tuberculosis (Toth and Shubik, 1966), and the useful 
trichomonacide metronidazole (35) (Rustia and Shubik, 1972), increase the 
incidence of lung adenomas in mice, although there is no evidence that they are 
active in man (Goldman, Ingelfiner and Friedman, 1977). Urethane (C2H 5O . 
CONH2) previously employed as a  hypnotic, is more active, giving occasional 
liver tumours as well as lung adenomas (Tannenbaum and Silverstone, 1958). 
Hycanthone (36), widely used as a schistosomicide, is a weak liver carcinogen 
in mice, and is interesting because it probably represents the first instance where 
a  bacterial mutagen was subsequently found to  be carcinogenic (Hartm an and
Miscellaneous organic compounds (fig. 8)
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Fig. 8.—Miscellaneous organic compounds and drugs (34-36) which are carcinogenic,
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Hulbert, 1975). Ethionine (37), a  synthetic homologue of the natural amino- 
acid methionine, is a hepatocarcinogen in the rat. Several common solvents 
are active on chronic exposure. Carbon tetrachloride previously used in dry- 
cleaning is a weak liver carcinogen, as is chloroform employed at one time as an 
anaesthetic and commonly as an ingredient in cough syrups. Dioxan, a widely 
used solvent, induces tumours in the liver in rodents at relatively high doses 
(Argus, Arcos and Hoch-Ligeti, 1965).
Inorganic carcinogens
Chemical carcinogens are not confined to organic compounds. A  number 
o f metallic elements are known to be active in producing various types of 
tumours in m an and in animals, either as the pure metal or in the form of its 
salts or oxide (Hemberg, 1977). Thus it has been known for a  long time that 
workers in the chromate and nickel industry suffer from a high incidence of 
lung cancer, while beryllium salts cause this disease in animals of several species, 
including primates. Injections of cadmium or its salts, or cobalt powder, induce 
sarcomas at the site o f injection, and kidney tumours follow renal degeneration 
caused by lead poisoning in experimental animals. Arsenic is interesting 
because whereas lung and skin cancer has resulted from its therapeutic use in 
humans, its carcinogenicity has not been confirmed in animal studies (Ott, 
Holder and Gordon, 1974).
By far the most im portant inorganic carcinogen is asbestos; o f the various 
forms o f this mineral crocidolite (blue asbestos) is apparently the most active 
(Doll, 1955). Asbestos has been used widely in construction, insulation, etc., 
and an im portant use is as a component in brake linings. Blue asbestos is no 
longer imported, but it is still encountered during the demolition of older 
buildings. W orkers in those industries where exposure to  asbestos dust occurs 
(Selikoff, 1977) suffer from a rare tumour, mesothelioma, which appears to  be 
caused by the ability o f the extremely thin mineral fibres to penetrate into the 
pleura. Mesothelioma can be induced in rats by implantation o f asbestos or 
even glass fibres o f comparable dimensions in the pleura (Stanton and Wrench, 
1972). A n elevated incidence of bronchial carcinoma also occurs among these 
asbestos workers. In addition there appears to be a  synergistic relationship 
between asbestos inhalation and cigarette smoking, because the incidence of 
lung cancer among asbestos workers who smoke is higher than that expected 
if  the two exposures were purely additive (Saracci, 1977). The carcinogenicity 
o f asbestos seems to be related to its physical shape and  size, rather than to 
its physiochemical properties and therefore comes into the province of physical 
carcinogenesis, rather than chemical carcinogenesis.
Metabolic activation and the somatic mutation theory o f  cancer
The bewildering variety o f chemical compounds outlined above leads us to 
ask what the underlying reason is for their special ability to  cause cancer. 
Subtle factors are involved because frequently delicate structure/activity 
relationships are observed. To quote one example, with one exception the
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positional methyl isomers o f the strongly carcinogenic ketone (6) are all inactive 
(Coombs, Bhatt, and Croft, 1973). Although it is true that for many compounds 
we are still unable to  answer the above question in detail, important conceptual 
and practical advances have been made in this area during the last two decades.
-  In order to  understand these it is first necessary to discuss the somatic m utation 
theory o f cancer.
Sixty-five years ago Boveri (1914) suggested that cancer might arise as a 
result of mutations in somatic cells. This theory accounts for the most 
characteristic feature o f cancer, namely that tumour cells give rise to  daughter 
tumour cells with identical properties, distinct from those of the norm al tissue 
cells from which the tum our has developed. Altered genetic information is 
inherited, so that tumours seldom regress. The theory also readily explains the 
wide variety of tumours found in animals and man, and that most tumours 
appear to  be clonal in origin (Fialkow, 1976). M ore recently it has been 
supported by investigations o f the hereditary disease xeroderma pigmentosum 
which occurs about once in 250,000 births (Arlett and Lehmann, 1978). The 
skin o f sufferers with this affliction is susceptible to damage by sunlight and 
artificial sources o f ultraviolet light; irregular pigmented lesions appear early, 
followed by moles and later by malignant epithelial skin tumours. Those 
affected seldom survive long into adulthood. The disease is caused by a 
genetically controlled lack o f the enzymes which normally repair D N A  damage 
caused by ultraviolet light, thus demonstrating a clear relationship between 
induced DNA damage and cancer. Analysis of hum an cancer incidences, 
which mostly increase steeply with age, suggests that mutations in several (four 
to five) genes are necessary to transform a normal into a tum our cell (Cairns, 
1975). Spontaneous mutations occur at random  throughout life, thus providing 
a reason for the long latent period often seen between the application o f a 
carcinogen and the appearance of a tumour.
If  cancer is caused in general by somatic mutation, it follows that all chemical 
carcinogens should also be mutagens. I t  was the apparent failure o f the potent 
classical carcinogens to act as mutagens in the standard bacterial test systems 
that previously discredited the somatic m utation theory. The reason for this 
failure is easy to see in retrospect; no allowance was made for the crucial 
role played by mammalian metabolism in mutagenesis and carcinogenesis. 
Traditionally, metabolism of compounds foreign to  the body was looked upon 
purely as the method by which the animal disposed o f this material by rendering 
it water soluble prior to  excretion. The notion that this process might involve 
reactive intermediates which can react covalently with D N A  and thereby cause 
mutations did not take root easily. Nevertheless, the essential correctness o f 
this idea is readily demonstrated experimentally by adding a  source o f oxidative 
enzymes, such as that contained in freshly prepared ra t liver homogenate 
containing the correct co-factors, to  the bacterial test system. U nder these 
conditions the classical carcinogens are strong mutagens. The key to  m odem  
work on mutagenesis and carcinogenesis is therefore biological activation.
It is now difficult to  see why it took so long for this concept to gain general 
acceptance. Already in 1947 Boyland stressed the importance o f metabolism
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in carcinogenesis with polycyclic hydrocarbons, and the covalent interaction of 
carcinogens with proteins of target tissues had been noted (Miller and Miller, 
1952). Demonstration o f the binding o f the nitrogen m ustard (18, fig. 5) to 
nucleic acids (Wheeler and Skipper, 1957) was followed by Brookes and Lawley 
(1964), who in a  classical paper showed that the carcinogenic potency o f five 
polycyclic hydrocerbons correlated with their extents o f binding to  the DNA, 
but not to the RN A or ptotein o f mouse skin in vivo. A clear demonstration of 
the part played by metabolism in the activation of the carcinogenic aromatic 
amine, 2-acetamido fluorene (AAF, 10), was provided by the pioneering work 
o f J. and E. Miller (Miller, 1970). They found (fig. 9) that AAF, which after
H OH OCOCHj
O C 0 NCoai  o  "
AAF /  38 39
dG, pH 740
proximate CH.0H
OH
ultimate
Fig. 9.—Biological activation of the carcinogen 2-acetaminofluorene (AAF). Enzymatic hydroxy- 
lation at nitrogen is followed by conversion to the sulphate ester (40) which is the proximate 
carcinogen. The latter decomposes to yield the electrophilic ultimate form (41) which reacts, for 
example, with deoxyguanosine (dG), to form the major adduct (42). Compound (39) is a 
synthetic ester which is also a proximate carcinogen.
injection gives rise to  distant liver tumours in most species except the guinea- 
pig, undergoes biological N-hydroxylation to N-hydroxy-AAF in the liver (38). 
This metabolite which is more carcinogenic than AA F particularly a t the site o f 
injection, and is also active in guinea-pigs, is termed the “ proximate carcinogen.” 
It is not itself capable o f reacting spontaneously with biological macromolecules 
(proteins and nucleic acids), whereas simple synthetic esters such as the acetate 
(39) have this property. In  the intact animal the ester probably involved is the 
sulphate (40) formed through esterification of (38) by the enzyme PAPS 
(3'-phosphoadenine-5'-phosphosulphate). Breakdown o f this sulphate ester by 
cleavage o f the N-0 bond (with acquisition o f the two electrons it contains by 
the oxygen atom, as symbolised by the curved arrow) generates the electrophilic 
species (41). The latter, which is electron deficient, readily attacks electron-rich 
(nucleophilic) centres in molecules forming, for example with deoxyguanosine,
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the covalent adduct (42) in neutral, aqueous solution. The net result is that the 
carcinogen AA F becomes chemically bound to the purine base a t C -8 through 
its nitrogen atom, providing a model for the way in which AA F reacts with
The concept of the reactive form (“ ultimate carcinogen ”) as an electro­
philic reagent has proved to be fruitful (Miller and Miller, 1971). It is applicable 
to direct acting carcinogens, such as the nitrogen m ustard (15) (fig. 10) which 
does not require metabolic activation, and by cleavage o f a C-Cl bond gives the 
electrophilic species (43). Dimethylnitrosamine (44) undergoes biological 
C-hydroxylation with subsequent loss of this carbon atom to give the azo
Fig. 10.—Activation of a nitrogen mustard (spontaneous), a nitrosamine (44, through biological 
hydroxylation to a proximate carcinogen), and a nitrosamide (14, spontaneous) to ultimate 
electrophilic carcinogens.
compound (45) which acts as a  source o f the electrophilic methylating group 
[CH3+]. The second part of this pathway is shared by M N U  which does not 
need intermediate metabolic activation (Druckrey, 1975).
The first chemical carcinogens to  be discovered, the polycyclic arom atic 
hydrocarbons, are currently the last in which the pathway o f biological acti­
vation has been delineated (fig. 11). Following the original suggestion by 
Boyland (1950) that epoxides might be im portant in  the metabolism o f arom atic 
compounds, Sims (1974) a t the Chester Beatty Research Institute in  London 
showed that the proximate form of benzo[a]pyrene (3) is its 7,8-trans-diol (46), 
and that this is further metabolised to the ultimate carcinogen, the bay-region 
diol-epoxide (47). The strained epoxide ring in this metabolite acts as an 
electrophilic reagent. It combines for example with the electron-rich exocyclic 
amino group o f deoxyguanosine to  give the adduct (48) in which a  trihydroxy 
derivative o f the hydrocarbon is covalently linked to  deoxyguanosine through
DNA.
carcinogen proximate ultimate carcinogen 
carcinogen
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C-10 of the benzo ring (Weinstein, 1976). Since 1974 there has been intense 
interest in this field, particularly in the USA, and no less than eight phenan- 
threne-related polycyclic carcinogens including the ketone (6) (Coombs, 
Kissonerghis, Allen, and Vose, 1979) are now known to be activated in an 
analogous manner.
The extremely potent carcinogen aflatoxin Bi (28) is also activated through 
an epoxide formed at the double bond in the terminal furan ring, with subse­
quent opening to give an electrophilic form that substitutes N-7 in deoxyguano­
sine (Swenson et al., 1977). It seems very probable that when the metabolism 
of other types o f carcinogens is studied it will be found that these, too, give rise 
to reactive forms that are electrophilic reagents.
Fig. 11.—Biological activation of benzo[a]pyrene (BaP) to its proximate (46) and ultimate (47) forms, 
and the main adduct the latter forms with deoxyguanosine. (Peripheral atoms joined by solid 
lines are above, and [those joined by dotted lines are below the plane of the rings, which is the 
plane of the paper.)
The enzymes that carry out these oxidations occur in the microsomal 
fraction of tissues as members of the “ mixed function oxidase ” system. This 
is a complex o f numerous mono-oxygenases which require N A DPH and 
molecular oxygen, and which carry out aromatic ring oxidation, aliphatic 
hydroxylation, oxidative demethylation, N-hydroxylation, etc., on a great 
variety of organic compounds (Gillette, 1969). Relatively high levels of these 
enzymes are present in liver, and they are detectable in most other tissues. 
Enzyme levels are capable of being raised by prior administration of many 
types o f compound, including polycyclic hydrocarbons and drugs such as 
phenobarbital, by a process known as enzyme induction. Responsiveness to 
the induction o f the enzymes which oxidise aromatic double bonds (aryl 
hydrocarbon hydroxylase, AHH) is under strict genetic control in mice (Nebert, 
Robinson, Niwa, Kumaki, and Poland, 1975), and mice o f inducible strains are
1-deoxyribose
HO"
OH
48
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more susceptible to carcinogenesis by polycyclic hydrocarbons than mice of 
non-inducible strains (Nebert and Felton, 1975). In humans it seems probable 
that the variation in the outcome of exposure to  chemical carcinogens, for 
example among smokers exposed to roughly the same carcinogenic dose, may 
be due to this phenomenon. Thus it has been shown that the induced levels of 
AH H in the placenta o f women who smoke varies considerably between 
individuals (Nebert, Winkler, and Gelboin, 1969). Moreover, there is now 
strong evidence that there is a greater proportion o f high inducers among 
patients with squamous-cell lung cancer than among matched patients with 
other forms of cancer, or among healthy controls (Emery, Danford, Arrand, 
Duncan, and Paton, 1978). The biological role o f the mixed function oxidase 
system is to provide detoxification o f compounds foreign to  the anim al; 
hydroxylation increases the polarity o f these lipid soluble materials, thus 
facilitating their excretion. All aromatic compounds appear to be metabolised 
by the same process involving these reactive electrophilic intermediates, yet 
only a few are carcinogens. Evidently the latter must generate intermediates 
with some special property, the nature o f which is no t clear at present. This 
may be no more than the correct degree o f stability to allow the intermediate 
to survive the aqueous medium within the cell for long enough for it to  migrate 
from its site of formation in the cytoplasm into the nucleus, and  there react 
with the DNA.
Animal tests
Animal tests for carcinogens are still of great importance. They do not 
differ fundamentally from the methods originally used; the need for persistence 
in treatment and patience in observation are still param ount. Tum ours a t 
most sites have been induced in animals o f many species, using practically every 
route o f administration (Argus, Arcos, and Wolf, 1968).
Skin “ painting ” using mice is still a  method o f choice for locally-acting 
carcinogens such as polycyclic hydrocarbons. Skin tumours (papillomas) can 
readily be detected at an early stage so that this method naturally lends itself to  
the study o f dose-response relationships. The latent period (i.e., the time which 
elapses between the first dose of the carcinogen and the appearance o f the 
tumour) is as definite a parameter o f carcinogencity as tum our incidence, and 
a useful index o f activity includes both factors:
_  „  . . percentage tum our incidenceIball index =  -—  ----- r - ^ —-=----------
latent period m days
The mean latent period (L) o f a particular carcinogen is related to  the dose '(d) 
by an equation o f the type: L  =  a —b (logio d + c ), where a, b, and c are 
constants characteristic o f that carcinogen (Bryan and Shimkin, 1941). 
Relatively simple theoretical mathematical models have been proposed which 
account for this relationship (Brodsky, 1979). Quantitative experiments are 
obviously difficult when internal tumours are used as the end point, bu t similar 
data can be obtained; for example Druckrey (1967) obtained good quantitative
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data for the induction of malignant tumours in rats given different doses of 
diethylnitrosamine in their drinking water.
Skin painting tests usually involve repeated, twice or thrice weekly, applica­
tions of the carcinogen at a fairly low dose. Berenblum (1941) made a discovery 
o f fundamental importance when he found that skin tumours could be ind uced 
equally well with one topical dose of the carcinogen, itself ineffective, when this 
was followed by repeated treatments with a “ promoting ag en t” . The most 
important promoter is croton oil, obtained from the seeds of the tropical plant 
Euphorbiacea Croton tiglium. However, phenols especially anthranil (1,8,9- 
trihydroxyanthrancene) (Bock and Bums, 1963), long chain hydrocarbons such 
as w-dodecane (Shubik et al., 1956), and certain other compounds are also 
active. Structure/promoter activity relationships nevertheless are precise. 
Thus Hecker (1971) isolated numerous derivatives of the diterpene phorbol 
(49a) (fig. 12) from croton oil and has synthesised others. Promoting activity
OR1
'CHCH
i S a ,  R1=R^H 
b, R’=R=CO(CH2)3CH3 
c , r1=co(cHj)12ch3 , rIc o c h ,
Fig. 12.—The naturally occurring phorbol (49a) isolated from croton oil, and synthetic (49b) and 
natural (49c) diesters which are promoting agents.
ranges from the inert parent, phorbol, through the weakly active 12,13- 
dibutyrate (49b), to the 12-myristate, 13-acetate (49c) which is the most potent 
promoter known.
The importance o f Berenblum’s discovery is that it establishes that tumour 
induction is a  two- or multi-stage process, consisting o f “ initiation ” and 
“  promotion ” (Berenblum, 1975). It has been shown by appropriate experi­
ments that initiation is a rapid and irreversible process, being completed within 
a  few hours o f the administration o f the single dose of carcinogen. The modern 
view is that this time is an indication of the time taken fo r the carcinogen to 
reach its target, undergo metabolism to its ultimate form, and cause specific 
DNA damage essential for the eventual appearance of the tumour. Promotion, 
on the contrary, is a prolonged and less understood concept. On the practical 
level, the two-stage test has advantages: it uses much less test compound, an 
im portant consideration when valuable natural products and metabolites are 
to  be evaluated, and experiments are less hazardous because they avoid the 
repeated handling o f the carcinogen.
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Subcutaneous injection o f locally-acting carcinogens yields sarcomas at the 
site of injection, often together with other tumours at distant sites, such as the 
ear ducts where these lipophilic compounds can accumulate and undergo 
metabolism over a prolonged period. In this connection Huggins (1961) made 
the observation that mammary cancer can be induced regularly and quickly by 
gastric instillation o f strong carcinogens into virgin female rats 50 days o f age; 
presumably a similar mechanism operates through accumulation in the mammary 
fat pads, although here the hormonal status o f the animals also is o f importance. 
Chronic feeding experiments are necessary to induce liver tumours, for example, 
with aromatic amines (Yoshida, 1934).
Whatever the experiment, work with animals suffers from a num ber of 
inherent drawbacks. The long latent period for tum our induction means that 
the animals may have to be kept for most or the whole o f their lifespan, ranging 
from 2 years for mice, 3-4 years for rats, to  about 10-15 years for dogs. To 
make matters worse, even if  rather large groups o f animals are employed the 
test will still be comparatively insensitive. A  chemical would be generally 
agreed to be non-carcinogenic if  it failed to increase the low spontaneous 
tum our incidence in several hundred test animals o f two or more species over 
their entire lifespan. However, if  this chemical is subsequently used, as a  food 
additive for example, millions o f human beings would be exposed to it for 
prolonged periods. The shere difference in the size o f the groups a t risk 
makes adequate testing virtually impossible and certainly extremely expensive.
It is therefore understandable that over the last few years great efforts have 
been made to  devise rapid, simple, and economic bioassays to  supplement 
animal tests. This work has led to  im portant practical advances, and a t the 
same time has greatly strengthened the somatic m utation hypothesis.
Carcinogenicity and mutagenicity
The realisation that metabolism is essential for the activation o f the m ajority 
of chemical carcinogens, together with the increasingly likely hypothesis that 
DN A damage is involved in tum our initiation, has led many people to  re­
examine mutagenesis by carcinogens in microbiological and cell culture 
systems. As a result o f this work, so-called short-term tests for carcinogenicity 
(Bridges, 1976) have been proposed which employ a wide range o f organisms, 
from bacteriophage and  bacteria, through yeasts and insects, to m ammalian 
cells in culture. The great attraction of these methods is that they circumvent 
the two main drawbacks to  animal tests; the long latent period is avoided, and 
the statistics are readily improved because it is easy to grow millions o f individual 
bacteria or cells on a  single petri dish. Bioassays have been devised (A nderson/ 
1978), that involve not only mutagenesis (Ames et al., 1973), bu t also look at 
the damaging effects o f carcinogens on D N A  by other means, such as chrom o­
some aberrations including sister chromatid exchange (Perry and Evans, 1975), 
D N A  fragmentation (Heddle, 1973), and D N A  repair (Scan and Stich, 1975). 
The main objection to  all these tests is that they are even further removed from  
the hum an situation than  the animal tests they are designed to  supplement.
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Probably the most important results have come from the study of bacterial 
mutation brought about by chemical carcinogens. In these tests the rationale 
is invariably the same: the organism is exposed to  the test compound, if 
necessary together with an appropriate system for biological activation, and the 
progeny is subsequently examined for some inherited alteration. Biological 
activation is provided in vitro by the inclusion of mammalian (usually rat liver) 
microsomes, which are a good source o f oxidative enzymes, plus NADPH. 
Originally “ host mediated ” assays were devised in which the micro-organisms 
were incubated within the animal treated with the test compound; metabolism 
was provided by the tissues of the host, and later the organisms were recovered, 
plated out, and examined for mutants (Garridge and Legator, 1969). M uta­
genesis is also investigated in mammilian cells (Arlett, 1977) in culture; here 
the cells themselves may be capable o f the necessary metabolism for biological 
activation, or this may be provided by a “ feeder-layer” o f irradiated, but 
metabolically competent rat cells. M utation is usually detected as a  change in 
growth requirements; e.g., Chinese hamster cells are screened for the ability of 
test compounds to  produce resistance to the lethal effect o f azaguanine by a 
forward m utation (Chu and  Mailing, 1968). Observed m utations are of two 
main types, frameshift and point mutations (base-pair substitution); while both 
occur through alterations in the normal nucleotide base sequence in the DNA, 
different mechanisms are involved (Streisinger et al., 1966). Both usually lead 
to loss o f a protein or impairment o f its function. M utants which have lost an 
essential function can also be used to look for back mutations to sensitivity of 
the wild type. Here the m utation causes restoration o f a functional protein, 
although only rarely will this be chemically identical with the protein having 
the same function in the wild type.
The principle of back mutation has been employed extensively by Ames 
(McCann and Ames, 1977) in California, whose influence in this area has been 
considerable. Using a strain of Salmonella typhimurium unable to synthesise 
the amino acid histidine, compounds are tested for their capacity to cause 
reversion to histidine non-requirement by a back m utation. Sensitivity is 
achieved by selecting his_bacteria which further are unable to repair D N A  
damage (uvr- ), and which lack the usual lipopolysaccharide coat thus improving 
their permeability to the test chemical (Ames, Lee and Durston, 1973). In tro­
duction of a bacterial plasmid (R-factor) carrying an ampicillin resistance 
m arker enhances the sensitivity of some strains to reversion by particular 
classes of mutagens (McCann, Springarn, Kobori and Ames, 1975). The most 
im portant tester strains a re :
Strain Type o f  mutation causing reversion
TA 1535 base-pair substitution
TA 1537 frameshift (-C-C-C-C-)
TA 1538 frameshift (-C-G-C-G-C-G-)
TA 98 -f-R factor, as for 1538
TA 100 + R  factor, as for 1535
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Thus TA 1535 and TA 100 detect reversions caused by base-pair substitutions 
while the rest are reverted by frameshift mutations specific for tracts in the 
DN A composed o f repeated deoxycytosine (C) or deoxycytosine-deoxyguano- 
sine (C-G) units. Standard bacteriological techniques are employed and a test 
is complete within 3 days.
Examination o f almost 300 compounds, about half of which were known 
carcinogens, by these methods showed that 90 per cent, o f the carcinogens were 
mutagenic while 87 per cent, o f the non-carcinogens were inactive (McCann, 
Choi, Yamasaki and Ames, 1975; McCann and Ames, 1976). Essentially the 
same result was obtained with a different 120 chemicals at the I.C.I. Central 
Toxicology Laboratory during extensive work carried out there to find reliable 
short-term assays (Purchase et al., 1976). The conlcusion drawn from this 
work was that the Ames’ test, together with a cell transformation test, are able 
to detect a high percentage o f a wide range o f carcinogens, while generating a
C0NH2 
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F ig. 13.—A hair dye (50), a flame retardant (51), and a food preservative (52) which are mutagens
and carcinogens.
low level o f false positives. This cell transformation test (Styles, 1977) involves 
exposure o f BHK21/C13 hamster cells to the test compound in tissue culture 
medium, followed by selection of the transformed cells by their ability to  form 
colonies when grown in semi-solid agar under strictly specified conditions. N o 
claim is made that the transformed colonies are composed o f tum our cells; 
however it is claimed that transformation correlates about as well as m uta­
genesis does in the Ames’ system with carcinogenicity. These tests are now in 
everyday use for screening new chemicals. Among 54 closely related polycyclic 
compounds tested against TA 100, we found that without exception all 38 
carcinogens were mutagenic, but that in addition there were seven mutagens 
that seem not to  be carcinogenic (Coombs, Dixon and Kissonerghis, 1976).
It is clear from these and many similar results that the various tests using 
Salmonella typhimurium are invaluable as primary screens when looking for 
carcinogens among compounds o f unknown biological propensity (fig. 13). 
Ames et al., (1975) tested 169 permanent hair dyes commercially available in 
the USA, and found that 89 per cent, o f them were mutagenic. 2,4-Diamino- 
toluene (50) is mutagenic; formerly used as a  hair dye, it was banned on account 
o f its carcinogenicity in rats, but it is still used in the synthesis o f  hair dyes. 
The flame retardant tris(2,3-dibromopropyl) phosphate (51), widely used as a 
textile additive, particularly in  children’s pyjamas, is mutagenic (Blum and 
Ames, 1977) and has recently been shown to be carcinogenic (Gold, Blum and
NH2
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Ames, 1978). The food additive AF-2 (furylfuramide, 52) was used in Japan 
from 1965 as a food preservative until it was found to be mutagenic in bacterial 
tests including TA 98 and TA 100 (Yahagi et al., 1967). It had previously 
failed to  produce tumours, but on re-testing it was shown to be carcinogenic in 
mice, rats, and hamsters (Nagao, Sugimura and Matsushima, 1978). Many 
cancer chemotherapeutic drugs are mutagenic in this test system (Benedict 
et al., 1977).
These short-term tests are rapid, relatively cheap, and easy to carry out. 
They will be used increasingly, but o f course they cannot displace the animal 
tests. On the theoretical side this recent correlation o f mutagenicity and 
carcinogenicity seems to  put the somatic m utation theory into an unassailable 
position.
DNA repair and carcinogenesis
From the foregoing it is clear that there is abundant proof that carcinogens 
react chemically with DNA. If  animals are treated with a chemical carcinogen 
which is labelled with a radioactive isotope so that its fate can be followed, it is 
usually found that binding of the carcinogen to D N A  in the target cells (e.g., 
liver cells for a  nitrosamine or aromatic amine, skin cells for a  polycyclic 
compound) reaches a maximum within the first 24 hr. The am ount bound per 
unit of DNA then decreases, rapidly at first then more slowly, and often binding 
can be demonstrated even after several weeks have elapsed. It is thought that 
this rapid decrease is due to excision repair brought about by repair enzymes 
essentially similar to those that remove thymidine dimers from u.v.-irradiated 
DNA. This process is best understood in bacteria, such as Escherichia coli 
(Lehmann and Bridges, 1977). An exonuclease first cuts the D N A  at a point 
adjacent to the bound molecule, and an endonuclease then removes the altered 
base together with a tract of several adjacent bases. This tract is then re­
synthesised by a D N A  polymerase, and the completed chain is finally joined by 
a ligase. Repair by this multi-enzyme system is usually error-free. A second 
type o f repair, often termed post-replication repair, operates when the excision 
enzymes are unable to  remove the blocking adduct, and probably also when the 
excision repair system is overwhelmed. In this type o f repair replication of the 
damaged D N A  occurs, but gaps are left corresponding to the altered bases. 
These gaps are later filled, but this process is prone to error leading to mispairing 
o f bases, and to  mutations. It seems to be the lack o f one or more enzymes of 
the excision repair complex by xeroderma pigmentosum patients and the 
operation of the second type of repair that leads to their u.v. light-induced skin 
lesions.
Most o f the work in animals has so far been carried out with nitrosamines 
because they alkylate D N A  to a greater extent than these other types o f carcino­
gens. Dimethylnitrosamine gives rise mainly to N-7-methyldeoxyguanosine 
(53) with smaller amounts of 0-6-methyldeoxyguanosine (54) and N-3-methyl- 
deoxyguanosine (55) (fig. 14). O f these the 0-6-methyl nucleoside (54) miscodes 
(Lawley and M artin, 1975) and is thought to  be responsible for the carcino­
genicity o f dimethylnitrosamine (Loveless, 1969). A recent and unexpected
CHEMICAL CARCINOGENESIS 137
development has been the discovery o f yet a  third type o f DN A repair process 
which is relatively error-free and is inducible by low doses of methylating agents. 
First found in bacteria (Samson and Cairns, 1977), this inducible repair system 
appears to be active also in the liver o f rats treated with dimethylnitrosamine 
(Montesano, Bresil, and M argison, 1979). The precise mechanism of this type 
o f repair is not yet clear; it appears to differ from the previous two types not 
only in that it is inducible, but also in that it involves in-situ alteration of the 
06-methylguanine residues (Karran, Lindahl, and Griffin, 1979; Robins and 
Cairns, 1979).
As we have already seen, A A F attaches itself mainly to the C-8 position o f 
deoxyguanosine (adduct 42, fig. 9), but this adduct is lost rapidly by repair. It
Fig. 14.—The three methylation products (53-55) of deoxyguanosine, and the minor adduct it forms
is the minor adduct (56, fig. 14), in which deoxyguanosine is linked through its 
exocyclic nitrogen to C-3 of A A F that persists and may be involved in carcino­
genesis (Westra, Kriek, and Hittenhausen, 1976). Benzo[a]pyrene also attaches 
to  the exocyclic amino group of deoxyguanosine (adduct 48, fig. 11), but it is 
no t known a t present whether it is this or one o f the minor adducts (Jeanette 
et al., 1977) which persists. I t  is well established on the basis o f the total dose 
required to produce tumours that polycyclic hydrocarbons like benzo[a]pyrene 
are in general more active than aromatic amines such as AAF. Perhaps it is 
o f significance that binding through the exocyclic amino group o f deoxyguano­
sine appears to  give rise to the major product formed from benzo[a]pyrene, bu t 
the m inor adduct from AA F (56). It has been shown by Yamasaki et al. (1977) 
that the latter does not cause local denaturation, in contrast to  the m ajor adduct 
(42) which does; it is thought that it is the recognition o f denaturation by the 
endonuclease that initiates excision repair.
OCH 0 CH3 NHj
53
R R CH3 R
54 55
R= 1-deoxyribose
COCH30
56
with AAF (56).
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It is evident that there is a great deal to be discovered concerning the precise 
types o f lesions in the DNA that are important, and research in this area is in 
progress in many laboratories. The much more important problem of which 
mutations are related to carcinogenesis has yet to be approached in depth. 
From the practical point of view of cancer prevention this research, essential 
for our understanding o f the process of tum our initiation, may be irrelevant 
because we now have convenient short-term tests which for the first time make 
screening the environment for potential carcinogens feasible. Coupled with 
detailed statistical knowledge of cancer incidences throughout the world, this 
promises to  allow us to identify the cause of several types of cancer, and we 
hope, to eradicate them by prevention. Prevention is always better than cure, 
and this is never more true than for the diseases known as cancer.
Cancer as an environmental and social disease
A most im portant development in cancer research has been the gradual 
realisation as a  result o f epidemiology that much cancer appears to be of 
environmental origin, and therefore in theory largely preventable. The first 
director of research o f the Imperial Cancer Research Fund, E. F. Bashford, in 
a “  Draft of Scheme for Enquiring into the Nature, Cause, Prevention, and 
Treatment o f Cancer ”  written in 1902 and published in 1908 proposed that 
statistics of incidence should be collected both for general causes and for special 
groups. These proposals have been realised to  an extent that Bashford could 
not have envisaged. We have already seen that cancers among numerous 
occupational and “ special groups ” have been investigated, causes identified, 
and prevention instituted. However, these constitute only a small proportion 
o f all cancer cases, and it is true that with the exception o f lung cancer, the 
causes o f the other m ajor cancers remain unknown. However, the first steps 
towards their discovery have been taken, so that today we have a great wealth 
o f detailed information on the incidence of various forms o f cancer for most of 
the countries throughout the world (Doll, 1911b).
In this country cancer accounts for one death in five, and o f these deaths 
about 50 per cent, occur as a result o f one o f the three major diseases, cancer of 
the lung, colon, or breast. When appropriate adjustments are made for the 
changing age structure o f the population, it is found that mortality from most 
forms of cancer has remained fairly constant during this century, with two 
exceptions. As already mentioned cancer of the stomach has shown a slow, 
but steady decline, whereas lung cancer has increased enormously, almost 
100-fold in men since 1910. The latter is now the most common cancer in m an 
and it is becoming increasingly common in women among whom smoking 
became socially acceptable only in the 1930’s. The evidence that this disease is 
associated with smoking tobacco, especially cigarettes, is now overwhelming 
and so well known (Doll, \911b) that it need not be reiterated here. However, 
it must be mentioned that although this evidence has been common knowledge 
for almost 20  years, negligible impact has been made on prevention by effectively 
discouraging the habit.
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It is when we look at world-wide cancer incidences that marked differences 
become discernible. For example the incidence of lung cancer among American 
men is about half that found among British men, despite similar smoking 
habits. Breast cancer is much less common among Japanese women than 
among British or American women. In northern Iran  cancer of the oesphagus 
is very common; about 20 per cent, of people over the age o f 50 die from this 
disease. The incidence is also abnormally high in certain areas o f France where 
it is associated with the consumption o f cider-based liqueurs (Doll, 1977b). 
Primary liver tumours are much more frequent in underdeveloped parts o f the 
world than in Western Europe and the USA, whereas the reverse is true o f 
cancer of the colon. Worldwide incidence o f the latter is closely correlated 
with meat consumption (Wynder and Reddy, 1975), although since this in turn 
is a good indicator o f relative affluence, it is not at all certain what factor is 
involved here. In Japan meat consumption is low and so is colon cancer, but 
cancer o f the stomach is very high although the incidence of this disease is 
declining there also. The incidence o f both colon and stomach cancer among 
Japanese who have emigrated to California tends towards that o f the white 
population, particularly in the second and third generations. This indicates 
that whilst these diseases probably have environmental causes, these are 
connected with cultural differences rather than general factors to  which the 
whole population is exposed.
Consideration o f epidemiological data o f this nature led Sir Richard Doll 
(1977b) to conlcude that most cancers have environmental causes, and if  these 
were known and were prevented incidence rates should drop by 80-90 per cent. 
For example, in 1976 there were over 33,000 deaths from lung cancer in England 
and Wales (Mortality Statistics, 1976); o f these about 30,000 would have been 
avoided if  smoking had not become a widespread habit. The economic 
consequences o f stopping smoking have been estimated by the Departm ent o f 
Health and Social Security (1972). A t first the increase in the population, 
coupled with the decrease in absence from work and the amount o f health 
Care required, would increase the gross national product. However, within 
two decades this would be cancelled by the large num ber o f old people who 
would require support, but who would not contribute to  the production o f 
national wealth. It seems inevitable that considerations such as these must 
influence government’s attitude to cigarette sales. Diet is implicated in large 
bowel cancer, and in particular the consumption o f animal fat is under suspicion 
(Hill, 1977). The presence o f a mutagen in the faeces o f individuals on a full 
Western diet is now established (Bruce et ah, 1977), and would seem to  give 
hope that the cause o f this disease, which killed nearly 11,000 people in England 
and Wales in 1976, will be found. Dietary fat is also correlated with breast 
cancer in women (Armstrong and Doll, 1975), but here other factors are also 
important. About half the 12,000 deaths (in England and Wales in 1976) would 
have been avoided if these women had had their first pregnancy soon after 
puberty (Stoll, 1976). The reason for this is not understood a t present, bu t it 
suggests lines o f research which may ultimately lead to  preventative measures.
Although great advances have been made in the treatm ent o f clinical cancer,
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further improvements in therapy are becoming more and more difficult to 
achieve. In the field of chemotherapy the drugs employed, with a few exceptions, 
are designed to kill dividing cells by causing massive DN A damage. Not 
unexpectedly many of these agents can be shown to be carcinogenic in animals, 
and in fact Haddow (1945) postulated that substances which inhibit tumour 
growth may be expected to be also carcinogenic, and vice versa. Soon after our 
discovery in 1966 of the strong carcinogenicity of the cyclopenta[a]phenanthrene 
(6) it was, at Professor Haddow’s suggestion, tested at the Chester Beatty 
Research Institute for its capacity to inhibit the growth o f the Walker 256 
tum our in rats. In agreement with his postulate it was found that 6  was active 
in this respect whereas the homologue of 6  lacking the methyl group, which is 
not a carcinogen in mice and rats (Coombs and Croft, 1969), was without 
tumour-inhibiting activity (personal communication). Despite this well-known 
relationship a number o f carcinogenic anti-cancer agents are currently in use 
not only in the alleviation of terminal disease, but also in treatments designed 
to effect long-term “ cures ” . Thus a growing number of apparent cures of 
childhood leukaemia have been claimed for various combinations o f intensive 
chemotherapy using them over the last 10 years. Undoubtedly it is right to  use 
even known carcinogens to save life, but there must be misgivings about the 
ultimate outcome of this treatment. All our experience with animals tells us 
that carcinogens always have a latent period which is frequently a significant 
proportion of the animal’s lifespan; only time will disclose whether the 
treatm ent received by these patients will give rise to other cancers. An entirely 
new approach to cancer chemotherapy is clearly needed. Agents must be 
discovered which can control the growth and invasive properties o f tumours 
without damaging cells. This, after all, is a natural process. After fertilisation, 
the zygote produces trophoblastic cells which temporarily resemble malignant 
tum our cells (Manes, 1974); they multiply vigorously and invade the uterine 
wall, implanting the ovum. Having completed this task, these cells lose their 
invasive quality and become part of the fetus. Almost nothing is at present 
known o f the factors controlling this process, but it is encouraging that an 
active interest is now being shown in chemical agents which can trigger off 
differentiation (Marks et al., 1978). However, no useful drugs have so far been 
described which utilise this idea.
In contrast to  the severe problems facing improvements in the chemotherapy 
o f cancer, the chances of dramatically improving cancer prevention have never 
seemed brighter. It seems entirely possible, given the investment o f adequate 
funds and facilities throughout the world, that the cause o f several of the major 
forms of cancer may now be established within the foreseeable future. The 
real problems of prevention may then be tackled. These will undoubtedly be 
formidable, for judging from the difficulty experienced in trying to change 
smoking habits it will be extremely difficult to change dietary or other cultural 
factors, if these are finally implicated. Already lung cancer must be considered 
as a major social disease of this century and every effort must be sustained to 
reduce its incidence.
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1. INTRODUCTION
The origin of (he study of cancer induction by chemicals is often ascribed to the London 
surgeon Sir Pcrcival Pott.' who over 200 years ago postulated that the high incidence of 
epithelioma of the scrotum among chimney sweeps was due to their excessive exposure to 
soot. The same disease made its appearance again in England 100 years later, among the 
Lancashire cotton spinners, who called it “ mule spinner’s cancer” .2 At about this time other 
forms of skin cancer were making their appearance following industrialization as it became 
established in northern Europe. Thus, occupational skin cancer among oil and tar workers 
was commented upon by Volkmann' in Germany as early as 1875. and it became apparent 
(hat exposure to mineral oil was the cause of both their and the mule spinners’ disease. The 
latter used oil liberally to lubricate their machines* so much so that their clothes became 
impregnated with it. However, many attempts to produce skin tumors in animals by exposing 
them to tar and oils did not meet with success until 1915. when two Japanese workers, 
Yamagiwa and Ichikawa,4 simulated Human exposure by persisting in their treatment. They 
found that skin tumors could be produced on the cars of rabbits by frequently repeating 
applications of coal tar oyer several months. It was soon discovered that the dorsal skin of 
mice was also sensitive to tumor induction by similar treatment with coal tar, and offered 
a more convenient test system. Using this test, Kcnnaway and his associates in London 
identified aromatic materials as the carcinogenic component of these tars,' culminating in 
1930 in the demonstration of the carcinogenicity of dibcnz|a,/i]anthraccne/’ the first pure, 
synthetic organic compound shown to be active. This was soon followed by the isolation 
of a few grams of benzo[u]pyrene by fractionation of two tons of gas-works pitch.7 The 
study of chemical carcinogenesis was then well under way, and it continues at an ever- 
increasing spate today.
However, already a new form of occupational cancer was appearing, namely bladder 
cancer among workers in dyestuff factories.* It later transpired that certain dyestuff inter­
mediates, particularly aromatic amines such as 2-naphthylamine and benzidine, were to 
blame for this disease. Some workers were heavily exposed; bladder cancer incidences 
approaching 100% appeared among men who had previously been engaged in (he large- 
scale purification of these compounds by distillation, and an elevated incidence was found 
even among office staff employed in these factories.9 This problem also later turned up in 
the rubber industry where these aromatic amines were used as anti-oxidants.10
Thus, at the very outset it was obvious, unfortunately as a result of human exposure, that 
chemical carcinogens are markedly organ specific. The great mass of animal data subse­
quently generated during the 50 years following these early observations has shown this to 
be a general rule among nearly all classes of chemical carcinogens. This work has moreover 
demonstrated that many carcinogens are, in addition, species specific, and that in some cases 
the type of cancer induced is dependent upon the route of administration. These compli­
cations, together with the fact that cancer induction is usually a protracted process often 
occupying a substantial proportion of the animal’s normal life span, make the testing of new 
compounds for carcinogenicity difficult. A recent review of comparisons of carcinogenicity 
o f 250 chemicals in two species," in most cases rats and mice, revealed that 38% were 
noncarcinogenic, and 44% were carcinogenic, in both species; 8% were active in mice only 
and 7% in rats only. Moreover, only 64% of the carcinogens produced cancer at the same 
site in the two species. Animals of more than one species must therefore be employed, in 
sufficient numbers to give the tests statistical significance, and treatment must be continued 
indefinitely. Mice live about 2 years, rats 3 to 4, and other test animals even longer, so that 
thorough testing of a new chemical for its capacity to produce tumors is a very expensive 
operation, frequently by far the most expensive part of the complete toxicological exam i­
nation. Furthermore, the routes of administration will probably have been chosen with regard
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to previous experience with other compounds of the type under study, and this can itself 
lead to errors of omission.
For all these reasons knowledge of organ and species specificity in carcinogenesis is for 
(he most part fragmentary and unsatisfactory for many carcinogens. Humans are for obvious 
reasons the least studied, virtually all the information coming from retrospective epide­
miology. and of course this makes risk assessment for a new chemical particularly difficult 
to evaluate. Nevertheless, the broad outlines of the subject arc now clear and in this chapter 
we will explore these phenomena in a general way. always bearing in mind the limitations 
already mentioned. The main types of chemical compounds which tend to give rise to 
carcinogens (aromatic hydrocarbons, arylamines, nitroso compounds, alkylating agents) will 
be discussed separately, and these will be followed by some miscellaneous and inorganic 
carcinogens, and carcinogenic natural products. Suggested reasons for specificity, usually 
depending upon differential tissue distribution and metabolism, will be discussed where 
appropriate. Two recent publications review this subject in detail and are recommended for 
further reading; the first is a report'2 of a symposium on organ and species specificity in 
carcinogenesis held at Raleigh, N.C. in 1981, and the second is a computer-generated 
compilation" of-the target organ specificity of 811 selected chemical compounds. These 
include many chemicals of industrial and medicinal importance, and no less than 97 organ 
sites arc considered; much recent mutagenic and other gcnotoxic data is also tabulated. This 
publication is particularly useful because it contains an enormous amount of data in an easily 
accessible form together with over 750 references to the original literature. Other extensive 
sources of data are the International Agency for Research on Cancer (IARC) monographs 
on the evaluation of carcinogenic risk of chemicals to m an" and the National Cancer 
Institute's Survey o f  Compounds Which Have Been Tested fo r Carcinogenic Activity. 15
II. POLYCYCLIC HYDROCARBONS
Following from the early work on the production of cancer by oils and tars, the chemistry 
and biology of polycyclic aromatic hydrocarbons has become a major part of the study o f 
chemical carcinogenesis. O f some 350 polycyclic hydrocarbons and simple heterocyclic 
analogues tested just over 50% show evidence of carcinogenicity.16 Most, but not all, o f 
the active compounds contain four or more fused aromatic rings, three of which are fused 
in an angular configuration as in phenanthrene (Figure I (1)). This hydrocarbon is itself 
inactive although its 1,2,4-trimethyl derivative is a weak carcinogen; by contrast the cyclo- 
penta[a]phenanthrene ketone (Figure 1 (2)), which is a 1,2,4-trisubstituted phenanthrene 
derivative formally related in structure to the steroids, is a potent carcinogen with an activity 
similar to that o f benzofajpyrene (Figure 1 (3)) on mouse skin.17 Benz[a]anthracene with 
four fused rings gives rise to many strong carcinogens such as 7 ,12-d im ethy l- 
benz[n]anthracene (DMBA, Figure 1 (4)) and 3-methylcholanthrene, both of which have 
been studied extensively. Benzofajpyrene, of course, is a widespread pollutant, occurring 
whenever organic materials undergo incomplete combustion and for this reason it has been 
intensively studied over the last decade.1"
Carcinogens of this class are effective locally, and have often been tested by the classical 
method of skin painting using mice. They are activated19 by metabolism to bay-region diol 
epoxides, as shown here for benzofaJpyrene. The 7,8-double bond in this hydrocarbon is 
enzymatically oxidized to the epoxide which is rapidly and stereospecifically opened by 
another enzyme, epoxide hydrase, to yield the (7R,8R]-//w!j-diol (Figure 1 (6)). The olefinic 
9,10-double bond in the latter is further oxidized, mainly to the anti-diol epoxide (Figure 1
(7)), which acts as an electrophilic reagent, reacting inter alia with nucleophilic sites in 
DNA such as the exocyclic amino group in deoxyguanosine to yield the adduct (Figure I
(8)). These oxidations are brought about by microsomal monooxygenases (aryl hydrocarbon
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HGURE I,. Polycyclic aromatic carcinogens derived from phenanthrene (I): 15.16-dihydro-1 l-mcth- 
ylcyclopenta|o|-phcnanthrcn-17-onc (2). hcnzo|«]pyrcnc (3). 7,l2-dim elhylbcnz|a)anthracenc (4). and 
3-mcthylcholanthrcnc (5). These compounds are biologically activated by oxidation o f their terminal 
benzo-ring. as shown for bcnzo[o|pyrcne (3). first to the non-bay region diol (6). followed by formation 
of the diol-cpoxidc (7) which then attacks the exocyclic amino group in deoxyguanosine in DNA to 
form trihydroxy adducts of type (K).
hydroxylases) and it is not clear whether different oxidative enzymes are active in epoxidizing 
these two different double bonds. Thus, at least two enzymes (epoxide hydrase and a 
monooxygenase) are involved in the activation o f this hydrocarbon; in addition other enzymes 
such as UDP-glucuronosyl transferases, glutathione-S-epoxide transferases and sulfotrans- 
ferases are involved in benzo(oJpyrene mctabo!ism.,, Aryl hydrocarbon hydroxylase is pres­
ent in most tissues including skin, although its level is highest in liver, and it is inducible 
by a variety of compounds including polycyclic aromatic hydrocarbons, flavones, and pol­
ychlorinated biphenyls. Both its constitutive and induced levels are genetically regulated, 
and differ between animals of different species, between tissues of the same species, and 
even between individuals of the same species. The latter is particularly noticeable for hu­
mans.20 Consequently, observed organ and species differences in chemical carcinogenesis 
with polycyclic hydrocarbons are at least partly dependent upon these factors.
Polycyclic aromatic hydrocarbons as a class act locally, i.e ., tumors arise at the site of 
application. Mouse skin is particularly sensitive to these agents, papillomas, and later car­
cinomas developing on the treated areas after topical application. Initially this gave rise to 
a sensitive test for carcinogens of this class, and the reproducibility of the test made possible 
the establishment of the two-stage nature of cancer induction.21 To illustrate, we will take 
examples from our own work with the cyclopenta[a]phenanthrene ketone (Figure 1 (2)). 
Although this compound is not a simple hydrocarbon, it is metabolized to a /ra/t5[3R,4R]- 
diol-a/i//-l ,2-epoxide22 which reacts predominantly with deoxyguanosine in DNA2-1 in pre­
cisely the same manner as benzo(a]pyrene, a typical polycyclic aromatic hydrocarbon. This 
ketone efficiently induces skin tumors in mice; at a topical dose of 50 p,g given twice weekly 
to T.O. (Theiler’s Original, derived from Swiss) mice 90% of the animals develop skin 
tumors with a short mean latent period of about 25 weeks. Essentially the same result is 
obtained if a single initial topical dose of 400 p.g is followed twice weekly by topical doses 
of the promoter croton o il. Note that this dose is only 16% of the cumulative dose administered
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over 25 weeks in the first experiment: if it is not followed by repeated treatments with the 
promoter it is ineffective, producing skin tumors in only 15% of the mice with a long mean 
latent period of 65 weeks.24 No tumors arc found on repeated topical treatment of the mice 
with the promoter in the absence of the initiating dose of carcinogen. The two-stage ex­
periment can also be carried out by giving the initiating dose by injection; a larger dose (10 
mg) is administered in oil by subcutaneous injection and this is followed twice weekly by 
the promoter applied topically to the dorsal skin, remote from the injection site. Tumors 
appear on the treated skin in 95% of the mice with a mean latent period of 21 weeks, 
whereas no dorsal skin tumors occur in animals injected with the carcinogen, but not 
promoted.2'  Thus, a single dose of this carcinogen applied topically or systemically initiates 
the skin; moreover, this initiation persists, for even if promotion with croton oil is delayed 
for 6 months similar tumor incidences and latent periods arc observed when promotion is 
eventually begun.17 Histologically the skin tumors arc diagnosed as a mixture of papillomas 
and carcinomas, the proportion of (he latter usually being higher when repeated applications 
of the carcinogen are used. In all these respects this cyclopcnta[a]phenanthrene (Figure 1 
(2)) behaves like a classical polycyclic aromatic hydrocarbon, but it is less potent than either 
DMBA (Figure 1 (4)) or 3-methylchoIanthrenc (Figure 1 (5)). Like them26-27 it induces 
mammary adenocarcinomas in virgin Spraguc-Dawley rats after a single intragastric 
instillation.17
In general, rat skin is not susceptible to carcinoma induction with polycyclic aromatic 
hydrocarbons/howcver, injection of either rats or mice with compounds of this class usually 
gives rise to sarcomas at the injection site. In the latter respect, the carcinogenic polycyclic 
ketone (Figure I (2)) differs because local sarcomas are not frequently observed in mice28 
or rats. In an ongoing experiment similarly injected Sprague-Dawley rats have given no 
local sarcomas, but a number have developed leukemia and skin tumors on the face and 
trunk.196 These experiments perhaps provide a clue as to the importance of tissue distribution 
in polycyclic hydrocarbon carcinogenesis. This ketone is less lipophilic than hydrocarbons 
such as (3) to (5) of Figure I ; for example, it is almost insoluble in aliphatic hydrocarbon 
solvents such as hexane that readily dissolve the latter. It is therefore probably more rapidly 
cleared from the injection site than these hydrocarbons, especially when oil is used as the 
vehicle. On the other hand, it is moderately lipophilic, as shown by the fact that after 
intraperitonea! injection into Balb/C mice traces of the unchanged compound can still be 
detected I month later in dorsal skin, especially in the fatty dermal layer. Mice so initiated 
are highly susceptible to promotion with phorbol esters.197
Benzo[a]pyrene (Figure 1 (3)) can be considered as a typical polycyclic hydrocarbon 
carcinogen; it has been studied extensively29 and sensitive methods for its detection and 
analysis10 in the environment have been developed. It is always found when other polycyclic 
aromatic hydrocarbons are present, and has often been used as an indicator of their presence. 
It has been tested in nine species (mouse, rat, hamster, rabbit, guinea pig, duck, newt, dog, 
and monkey) and found to be carcinogenic in each.29 Besides skin tumors already discussed, 
it induces malignant tumors of the forestomach in mice,11 rats,12 and hamsters”  after oral 
administration. After subcutaneous or intramuscular injection local sarcomas have been 
observed in m ice,14 rats,1'  ham sters,16 guinea pigs,17 and in the primates, tree shrews,18 and 
cottontail marmosets.19 There are very little data concerning the effects of benzo[a]pyrene 
itself in man; in two reports40-41 topical exposure caused warts which later regressed, and 
in another a squamous epithelioma developed in a man while carrying out an animal ex­
periment with this carcinogen.42
Polycyclic aromatic hydrocarbons are suspected of being involved in one major human 
disease, namely lung cancer. Large amounts of these compounds find their way into the 
atmosphere as a result of industrialization, especially power generation utilizing the com ­
bustion of fossil fuels. This may account for the higher incidence of this disease generally
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observed for urban compared with rural areas. Much more striking is the very high incidence 
of lung cancer among heavy cigarette smokers.4' Cigarette consumption and lung cancer 
mortality have increased steadily year by year since the early part of this century, and only 
recently has this increase been checked. It is thought that this is due to the considerable 
reduction of tar yield achieved with many brands of cigarettes within the last few years.44 
Cigarette tar contains many polycyclic aromatic compounds, including benzo[alpyrcnc in 
amount (1.6 p.g/100 cigarettes) insufficient by itself to account for the disease. It is thought 
that other active compounds in the tar. carcinogens, promoters, and co-carcinogens, may 
account for this discrepancy. In this connection it is known that heavy smokers employed 
in the asbestos industry arc at particularly high risk,45 and that alcohol consumption increases 
the risk of cancer of the mouth and esophagus46 in this group. Attempts to induce lung 
cancer in animals by intratracheal administration of benzofi/jpyrene were unsuccessful until 
the carcinogen was given together with a dust such as hematite that could fix it in the lung,47 
or by using the carcinogen in a particulate form.48 Lung tumors in dogs, similar to human 
lung tumors, have been induced by fixation of the carcinogen in the bronchial wall.49
In summary, polycyclic aromatic hydrocarbons appear to be carcinogenic to most species 
and most tissues where they can accumulate and act over a prolonged period. The one notable 
exception is liver; there arc almost no reports of liver tumors induced with these agents. 
Possibly the high level of many enzymes, including the conjugating enzymes, in this tissue 
ensures that carcinogens arc rapidly metabolized to harmless excretion products. Moreover, 
in a comparison of the binding of the carcinogenic cyclopentafajphenanthrcne (Figure 1 (2)) 
to the DNA of mouse skin, lung, and liver, loss of adducts from the former two could not 
be measured above the normal rate of DNA turnover, whereas adducts were removed rapidly 
from liver, with a half-life of 2.5 days.*’ This suggests that liver may possess a specially 
active DNA repair system to help protect it from damage by the multitude of foreign chemicals 
it has to metabolize.
That differential tissue distribution and metabolism, or even DNA repair are not always 
the determining factors in carcinogenesis by polycyclic aromatic compounds is shown by 
the following recent experim ent.'1 The carcinogen (Figure 1 (2)) was applied topically to 
mice of the T .O ., C57BL, and DBA/2 strains in an identical manner. In both repeated 
application and initiation-promotion experiments, a high incidence of skin tumors was in­
duced in T.O . and C57BL mice, although the mean latent period for the latter was longer 
in each case. By contrast, in both types of experiment, the DBA/2 mice were completely 
resistant to tumor induction, although metabolism of the carcinogen was similar in terms of 
the total DNA adducts isolated from the treated skin of mice of all three strains, and in the 
pattern of individual adducts. In addition, the rate of removal of these adducts from the skin 
DNA was not different for the three strains. It therefore appears that in this case, strain 
specificity is related to a step(s) in the promotional stage common to both the carcinogen 
and to the phorbol ester used in the repeated application and initiation-promotion experiments, 
respectively.
III. ARYLAMINES
The history of synthetic dycstuffs goes back to the beginnings of organic chemistry as 
we know it today. Perkin’s early synthesis of the violet dye mauveine by the oxidation of 
impure aniline was soon followed by the discovery of diazonium coupling of aromatic amines, 
and the chemistry of aromatic systems was rationalized by Kekule by his proposal for the 
ring structure of benzene in 1863. Within a few years commercial manufacture o f synthetic 
dyestuffs began in Germany, and 25 years later, Rehn'2 first noted three cases of bladder 
cancer among chemists in a dyestuff works. Reporting a further 23 cases a few years later, 
he suggested that “  . . . aniline, its derivatives, and related compounds such as naphthy-
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FIGURE 2. fjuman bladder carcinogens 2-naphthylamine (9). benzidine (10). and 4-aminobiphcnyl 
( I I ) .  and the strong carcinogen 2-acctamidofluorene (AAF. 12). Aromatic amines arc enzymatically 
activated as shown here for AAF; A/-hydroxylation to (13) followed by estcrification gives the active 
ester (O-acetate 14. or O-sulfate 15). which undergoes fission to the resonance-stabilized clcctrophile 
(16). Reaction o f this through nitrogen with C-8 o f deoxyguanosine. or through carbon with the exocyclic 
amino group leads to the DNA adducts (17) and (18). respectively.
lamine . . . ”  might have been responsible for this disease.'3 However, it was not until 
1938 that bladder cancer was produced in an animal model, the dog.54 Human bladder cancer 
is a comparatively rare disease so that cases caused by occupational exposure arc more 
readily identified, and many case reports appeared during the first half of this century. In 
1947, a thorough epidemiological survey o f the chemical industry in the U.K. was initiated; 
it established that 2-naphthylamine (Figure 2 (9)) and benzidine (Figure 2 (10)) were as­
sociated with the disease, whereas aniline and 1-naphthylamine were not.55 During the course 
of this investigation, a new source of bladder cancer was discovered in the rubber industry, 
where a complex of the two naphthylamines with acetaldehyde was used as a compounding 
ingredient.10 Subsequently 4-aminobiphenyl (Figure 2 (11)) was also identified as a potent 
human bladder carcinogen.56
Extensive animal studies with aromatic amines have since been carried out and many new 
structures and analogues have been tested. Among these, one o f the most studied is 2- 
acetamidofluorene (Figure 2 (12)). This compound, originally proposed as an insecticide, 
was found to produce several types of tumors in rats,57 and has subsequently achieved a 
prominent place in cancer research, although, unlike amines (9) to (1 1) of Figure 2, it has 
never become an important intermediate manufactured on a large scale. In general, poly- 
nuclear aromatic amines are more active than single-ring arylamines, and ortho-methyl or 
-methoxy substituents often increase carcinogenicity of the parent amine, usually also di­
versifying its organ selectivity. N-Acetyl derivatives are equally or sometimes more active 
than the parent amines. Numerous metabolic studies with various carcinogens of this type 
point to N-hydroxylation as being implicated in their activation.58 This was first established 
for 2-acetamidofIuorene (Figure 2 (I I ) ) ;59 like most aromatic compounds this amide is 
extensively ring-hydroxylated, and the resulting phenols are excreted largely as their sulfate 
and glucuronide conjugates. In addition, most species excrete AMiydroxy-AAF (Figure 2 
(13)), except the guinea pig which is also resistant to the induction of distant liver tumors
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by administration of this carcinogen. AMlydroxy-AAF is also carcinogenic, but gives tumors 
at the site of injection and is active in the guinea pig. This metabolite was therefore termed 
the “ proximate carcinogen" by the Millers. However, it docs not itself react spontaneously 
with biological macromolcculcs such as proteins and nucleic acids, whereas simple esters 
such as the () acetate (Figure 2 (14)) possess this capability. In the intact animal, probably 
the 6>-sulfatc (Figure 2 (15)) is the active species although W.O-acyltransferascs present in 
many tissues catalyze the transfer of the /V-acctyl group to form the O-acctate which may 
also be involved in binding to DNA.6*' Hcterolytic fission of the N -0  bond in (Figure 2(15)) 
yields the resonance-stabilized clectrophile (Figure 2 (16)) which reacts with nuclcophilic 
centers, including both C-8 and the cxocyclic amino group of deoxyguanosine in DNA. to 
yield the adducts (17)6' and (18).62 both found in Figure 2.
In man. exposure to the aromatic amines (9) to ( I I )  of Figure 2 during manufacture 
(among others) was probably mostly via skin absorption and ingestion, and led to bladder 
cancer. Apparently monkeys are also susceptible to induction of bladder tumors with 2- 
naphthylamine, but not with 2-acetamidofluorenc,6’ the activity of which in man is unknown. 
This disease may be induced in dogs, and more conveniently in hamsters; certain strains of 
rats and mice are also susceptible.64 Most animal tests have been carried out by feeding 
these arylamincs over prolonged periods, and tumors of the liver and ear duct are commonly 
observed in addition to those of the bladder. Mammary tumors occur in females of certain 
hamster strains.6'  Skin, tumors arc not usually observed, although repeated treatment of the 
skin of mice with croton oil after feeding the animals with AAF (Figure 2(12)) was successful 
in this respect.66 Prior feeding with AMiydroxy-AAF (Figure 2 (13)) produced fewer skin 
tumors, suggesting that a different form of activation might be involved in skin.
While arylamincs have proved to be carcinogenic in all species in which they have been 
tested, with the exception of the guinea pig and steplemming,67 marked organ specificity 
exists among closely related members of this class. Thus, 2-naphthylamine induces mainly 
liver and bladder tumors, whereas 3-methyI-2-naphthylamine yields tumors of the large 
intestine in certain rat strains,68 and in hamsters suffering from intestinal enteritis.69 The 
latter is interesting as a possible model for the human disease colon cancer, for which 
ulcerative colitis is a predisposing condition. 3-Nitro-2-naphthylamine gives rise to mammary 
and forestomach tumors.70 Again, 2-acetamidofluorene induces mainly liver cancer in rats, 
while 2,7-diacctamidofiuorene reliably induces carcinomas of the glandular stomach.71 Higher 
homologues, such as 2-aminoanthracene and 4-amino- and 4-dimethylaminostilbene give 
mainly ear duct tumors and mammary tumors in young adult female rats.72 Similar results 
were obtained with 3-acetamidophenanthrene, but the 2-acetamido isomer in addition induced 
leukemia.72
Closely related to these polycyclic amines are several heterocyclic amines (Figure 3 (19 
to 21)). These occur in charred parts of cooked fish and meat, and were first detected by 
their high mutagenic activity in bacterial tests. Trp-P-1 (Figure 3 (19)) and Trp-P-2 (Figure 
3 (20)) were isolated from pyrolysates of DL-tryptophan, as was Glu-P-1 (Figure 3 (21)) 
from glutamic acid. Fibrosarcomas were obtained in rats and hamsters after injection of Trp- 
P-1,74 and feeding both Trp-P-1 and Trp-P-2 induced hepatomas in mice.75 These results 
are of importance because these amino acids occur commonly in cooked food.
As already mentioned aniline was exonerated from blame for occupational bladder cancer 
and proved inactive in animal tests. Recent interest in single-ring arylamines has arisen 
because Ames et a l.76 discovered that many hair dyes are mutagenic in tests with Salmonella 
typhimurium. Apparently some 40% of adult women in the U.S. regularly use hair dyes, 
and concern was felt because aromatic diamines are commonly used in these preparations 
together with an oxidizing agent such as hydrogen peroxide. Long-term feeding experiments77 
in both rats and mice established that 2,4-diaminotoluene, 2,4-diaminoanisole, and o-phen- 
ylenediamine were carcinogenic in both species, inducing mostly bladder and liver cancer;
Volume 11 189
22 23
FIGURE 3. Carcinogenic hclerocyclic amines (19— 21) formed by the pyrolysis 
o f amino acids in charred food, and two azo-dyc carcinogens, butter yellow (22) 
and aminoazotoluene (23).
the anisole also gave a high incidence of thyroid tumors.™ Recently, chronically high-level 
intakes of aniline itself have given rise to hemangiosarcomas in the spleens of male rats; it 
has been suggested67 that prolonged stress by aniline on the hematopoietic system may have 
indirectly caused these tumors.
On the whole there is still little understanding of the reasons for the observed organ and 
species selectivity in carcinogenesis by aromatic amines.”  Undoubtedly, tissue distribution 
must play a role, but this seems to have been little studied. The /V-hydroxylation mechanism 
of activation already discussed accounts satisfactorily for a number of observations; thus, 
animals in which /V-hydroxylation is low, such as the guinea pig, are generally resistant to 
arylamine carcinogenesis. Also, compounds in which the amino group is ortho to a second 
aromatic ring, such as 1-naphthylamine and I-AAF, do not undergo N-hydroxylation and 
are not carcinogens.
Related to the aromatic amines are the azo dyes which originated the interest in this area 
of chemical carcinogenesis. These are large in number, and have been widely studied in the 
past.80 Feeding dyes such as butter yellow (Figure 3 (22)),81 so called because it was formerly 
added to margarine to color it yellow like butter, and o-aminoazotoluene (Figure 3 (23)) to 
rats induced hepatomas in good yield with a relatively short latent period.82 Related com ­
pounds cause a variety of tumors (bladder and liver in the dog,83 ear duct, intestine, and 
skin in the rat84) similar to those seen with arylamines. Azo dyes appear to be activated by 
/V-hydroxylation, after metabolic loss of an /V-methyl substituent if necessary, followed by 
formation of the sulfate ester.85 Enzymatic cleavage of azo bonds may in some cases lead 
to detoxification by giving single ring fragments, but in others it may lead to activation.86
IV. NITROSAMINES AND NITROSAMIDES
Nitrosamines (R2N -N =0) have long been familiar to organic chemists as useful and 
versatile intermediates, but it was not until 1956 that their carcinogenicity was first dem ­
onstrated. Following up studies on the toxic effects of dimethylnitrosamine among workers 
exposed to it during its manufacture as a solvent. Magee and Barnes87 showed 19/20 rats 
fed on a diet containing 50 ppm of this nitrosamine developed liver tumors within 26 to 40 
weeks. At higher doses severe liver damage was observed. Since then interest in this class 
of carcinogens has increased year by year, and the last 5 years have witnessed a veritable 
explosion in research and publications on this subject. Some 1400 papers now appear annually 
on all aspects of nitrosamines and the related nitrosamides (R .CO .N H .N =0), and no fewer
t x <  i t  * r K ' i ' i  i  i ' U (  i l \
than 8 monographs'"1 M' on this subject have been published by the International Agency for 
Research on Cancer since 1972. Several recent reviews'*1 00 also summarize this field from 
berth the biological and chemical angles. There are a number of reasons for this intense 
interest; many nitrosamines and nitrosamides are potent carcinogens with remarkably or­
ganotrophic properties; certain of them occur naturally in the environment, and the possibility 
of their in vivo formation from dietary amines is all too apparent.
At the present time about 3(H) nitroso compounds have been tested for carcinogenicity, 
and about 909r have proved to be active.0'  These compounds include symmetrical, unsym- 
metrical, and cyclic nitrosamines, nitrosoureas, nitrosonitroguanidines, and nitrosourcthanes. 
They arc carcinogenic in 39 species belonging to 36 genera, 25 families, 17 orders, and 5 
classes of animals ranging from fish to primates.0' 100 Sites at which tumors appear include 
brain and nervous system, oral cavity, esophagus, stomach, gut, liver, kidney, urinary 
bladder, pancreas, haematopoietic system, heart, and skin. There is still no unequivocal 
evidence for their carcinogenicity in man. although there can be little doubt that he, too, is 
susceptible. Two cases of acute noniymphocytic leukemia in brain cancer patients treated 
with the cytostatic A-nitrosourca derivatives, Ar-/V'-(6/.i-2-chloroclhyl)-/V-nitrosourca and N- 
cyclohcxyl-;V-2-chlorocthyl-A,-nitrosourea have been reported,,<u and both these drugs were 
subsequently shown to be carcinogenic in the rat.102 Severe liver damage and cirrhosis leading 
to death occurred recently in a victim of criminal poisoning with dimethylnitrosamine;"*' 
almost identical toxic symptoms were previously seen in laboratory rodents after high doses 
of nitrosamines'."*4 Also, similar DNA methylation patterns occur in human liver after 
dimethylnitrosamine poisoning as occur in rat liver after exposure to this carcinogen.10'
Nitrosamines (unlike nitrosamides) are not direct-acting carcinogens, and must be met - 
abolically activated. It now appears that this is achieved by a-hydroxylation as shown in 
Figure 4 for the two resonance extremes (24) and (25) of dimethylnitrosamine. Both lead, 
via a-hydroxylation followed by fragmentation of a six-membered, partially hydrogen- 
bonded transition state, ultimately to methyl diazonium hydroxide (Figure 4 (26)), which is 
a powerful electrophile, readily methylating nucleophilic sites in DNA and other biological 
macromolecules.00 On the other hand, the nitrosamide, N-nitroso-N-methylurea (Figure 4 
(27)), is already hydrogen-bonded for spontaneous fragmentation to yield the diazohydroxide 
hydroxide; it docs not therefore need biological activation and consequently behaves as a 
direct-acting carcinogen. Breakdown of the corresponding nitrosourethane (Figure 4 (28)), 
in which hydrogen bonding is absent, is considerably enhanced by thiol compounds by 
formation of the thio-half-acetal (Figure 4 (29)) as an intermediate,"*6 although the nitro­
sourethane is usually considered as a direct-acting carcinogen.
Probably no group of carcinogens has been more widely tested than these nitroso com­
pounds. Diethylnitrosamine has received the most attention, having proved to be active in 
all 25 species in which it has been tested. Dimethylnitrosamine and A-nitroso-/V-methylurea 
are likewise carcinogenic in each of the 16 species tested.100 Organ specificity in nitrosamine 
and nitrosamide carcinogenesis depends mainly on the chemical structure of the carcinogen, 
although the animal species, route of application, and duration of treatment often play a 
part.
As Magee and Barnes87 were the first to show, dimethylnitrosamine induces primary liver 
tumors in rats after chronic feeding for some months. However, the same authors found that 
after a single high dose of this carcinogen malignant kidney tumors were observed exclu­
sively.107 Inhalation (100 ppm in air for 30 min twice weekly) induced tumors of the nasal 
cavity in rats,108 with no liver cancer, indicating that the enzyme system responsible for a -  
hydroxylation is present also in this tissue. In feeding experiments this carcinogen induced 
liver cancer in Syrian hamsters,100 but in mice it gave rise mainly to lung cancer,"0 pre­
sumably due to its high volatility.
Diethylnitrosamine was found to be a potent liver carcinogen in the rat,1"  but after low
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FIGURE 4. Biological activation o f dimethylnitrosamine (resonance extremes 24 and 25) occurs by 
a-hydroxylation; the 6-membered hydrogen-bonded intermediates fragment to yield methyldiazonium 
hydroxide (26), which is a powerful electrophile. The same product is formed by spontaneous frag­
mentation of methylnitrosourea (27), while thiols enhance fragmentation o f methylnitrosourethane (28) 
via formation o f the intermediate thiohemiacetal (29).
oral doses carcinomas of the esophagus occurred in addition. Liver cancer was induced also 
in guinea pigs, mice, rabb its,"2 and m onkeys."3 In mice carcinomas of the forestomach 
and esophagus occurred together with liver tum ors,"4 whereas hamsters suffered from lung 
cancer after oral adm inistration."5 In a recent report"6 of 18 different species treated with 
diethylnitrosamine by various routes, liver was the target in the great majority of cases, 
together with forestomach, esophagus, and respiratory tract in a few cases.
In an extensive comparison o f over 65 different nitroso compounds in BD rats, Druckrey 
et a l.108 reached the following conclusions regarding the relationship be*ween chemical 
structure and organ specificity of nitrosamines. Symmetrically substituted dialkylnitrosa- 
mines produced liver cancer, the exceptions being di-n-butylnitrosamine which caused blad­
der tumors and diamylnitrosamine which selectively induced lung cancer. Unsymmetrical 
dialkylnitrosamines, especially methyl amyl-, cyclohexy!-, phenyl-, benzyl-, or phenylethyl- 
nitrosamines selectively produced carcinomas of the esophagus. However, methylallylnitro- 
samine gave malignant tumors of the kidney. Nitrosamines in which a-hydroxylation is 
impaired (ethyl /m -butyl-, dibenzyl-, dicyclohexyl-) or is impossible (diphenyl, diallyl-) 
are not carcinogenic.
In a recent review, Lijinsky91* has given species and target organ data for 2 homologous 
series of nitrosamines as shown in Tables I and 2. The interesting differences between 
straight chain nitrosamines with odd and even numbers of carbon atoms may be due to 
omega oxidation followed by successive beta oxidations, leading to different final products.
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Table I
CARCINO G ENICITY OF A SERIES OF ALIPHATIC  
NITRO SAM INES C H ^ C H A N fC H JN O  IN THE RAT
n T a r i f f  o rgan
1 Liver
2 Esophagus
3 Esophagus
4 Esophagus
5 Esophagus, liver
6 Liver, lung
7 Liver, bladder
8 Liver
9 Bladder
10 Liver, lung
11 Bladder
13 , Bladder
Table 2
C A RCINO G ENICITY OF A SERIES OF ALICYCLIC  
NITRO SAM INES (CH 2)„N-NO IN TH REE SPECIES
T arget organ
n Rat M ouse H am ster
3 Liver Lung None
4 Liver Lung Trachea
5 Liver Liver Trachea
Esophagus Esophagus
Nasal cavity Forestomach
6 Liver Lung Trachea
Esophagus
7 Lung — Forcstomach
Esophagus Nasal cavity
Trachea
8 Lung — —
Esophagus
N i trosomorphol i nc Lung Lung Trachea
Nasal cavity
Di n i trosopi perazi ne Esophagus Liver —
Nasal cavity Lung
Among the cyclic nitrosamines differences in target organ are accompanied by large dif­
ferences in potency, e .g ., the compound in which n = 4 is a much weaker carcinogen than 
the one in which n =  6. They are also unusual in that they bind to DNA in vivo much less 
than their aliphatic counterparts.
In another publication117 Lijinsky compared the carcinogenicity of three cyclic nitrosamines 
in four species, again with marked organotropic results (Table 3). The cumulative oral doses 
administered over 6 months or more needed to induce these tumors in 50% or more of the 
animals ranged between 0.5 and 8 g/kg. Lijinsky suggested that these profound differences 
between species might be explained “ by large differences in metabolism or by kinetic 
differences in the balance of various pathways of metabolism".
In contrast to the dependence upon metabolism displayed by nitrosamines, nitrosamides 
(Figure 5) decompose spontaneously to give alkylating intermediates and are therefore direct- 
acting carcinogens. 4n line with this idea, subcutaneous injections of nitrosamides into rats
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Table 3
CARC IN O G EN IC ITY  OK THREE CYCLIC NITROSAM INES IN 
ANIM ALS OF FOUR SPECIES
Species, and organs bearing  tum ors
C om pound
2.6-Dimcthylnitrosomorpholinc
2.6-Dimethyldinitrosopipera/.inc 
Nitrosohcptamethylenciminc
Rat
Esophagus
Esophagus
Lung
Esophagus
Syrian
ham ste r
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FIGURE 5. Direct-acting carcinogenic nitroso compounds; nitrosamides (30), nitrosourethanes 
(31), nitrosoureas (32). nitrosobiurets (33), and nitrosonitroguanidines (34).
produced local sarcomas,11" while topical application of A/-nitroso-/V-methylurea to mice led 
to skin tum ors."9 As is to be expected, the potency of these carcinogens roughly parallels 
their chemical reactivity (Figure 5); most active are alkylnitrosocarboxamides (30), followed 
in order by urethanes (31), ureas (32), biurets (33), and nitroguanidines (34).120 Mainly 
tumors of the forestomach were obtained after oral administration o f these nitrosamides to 
rats121123 and to ham sters,124 but gastric carcinomas occurred in the guinea p ig .12'  /V-methyl- 
/V'-nitro-yV-nitrosoguanidine (MNNG) (34) was found, in rats126 and dogs,127 to be particularly 
suitable for the induction of gastric tumors which resemble human stomach tumors, and 
now provide an important model for this disease. On intravenous injection into rats methyl- 
nitrose urethane (MNUT) (Figure 5 (31)) produced lung carcinomas exclusively, whereas 
ethylnitrosourethane gave carcinomas of the forestomach.10" Unexpectedly A-methyl-A/-ni- 
trosourea (MNU) (Figure 5 (32)) gave neither, but led to a high yield of neurogenic tumors 
of the brain and spinal cord;128 similar results were obtained in rabbits129 and in do g s.130 
Higher alkyl homologues of MNU tended to give fewer neurogenic tumors, but induced 
other types of cancer, particularly of the digestive tract12'  and leukemia.131 In the hamster 
fl-propyl-nitrosourea gave tumors of the spleen, forestomach, duodenum, and vagina.132
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/V-Nitroso compounds have also been shown to cause cancer transplacentally;w dimethyl- 
and dicthylnitrosamincs given to pregnant rats led to the appearance of a variety of tumors 
in their offspring. However, cthylnitrosourca, a carcinogen that exerts its effects independ­
ently of metabolism, afforded the most interesting results; administration of a single dose 
on the 15th day of gestation produced malignant and mostly multiple tumors of the brain, 
spinal cord, trigeminal nerves, and peripheral nervous system in all the offspring.'" No 
tumors were observed when the carcinogen was administered before the 12th day of gestation, 
indicating that a certain degree of differentiation is required before tumor induction can 
become effective. Administration to the progeny 30 days after birth led to fewer neurogenic 
and an increasing proportion of kidney and female genital tumors.
Reasons for the remarkable organotrophy shown by nitroso compounds arc for the most 
part obscure, but are usually attributed to organ-specific metabolic effects as far as the 
nitrosamines arc concerned. With the direct-acting nitrosamides, the route of application is 
more important, and organotrophy depends in a more understandable way on the relative 
stability of the carcinogen. Thus, by the oral route the reactive A-nitrosomethylurethane 
gives tumors of the forestomach, while the more stable MNNG (Figure 5 (34)) induces 
gastric cancer. Also, the very reactive acetoxymethyl-methylnitrosamine induces local tumors 
after oral, subcutaneous, intravenous, and intrarcctal application to rats;"4 systemic admin­
istration also led to tumors of the heart, a most unusual site. The great variety of animal 
tumors now available by the use of specific nitroso compounds has opened up new areas of 
cancer research, and ultimately may help to improve treatment for the analogous human 
diseases.
On the other side of the coin, however, the ready formation of nitrosamines by the simple 
reaction of amines with nitrous acid means that these compounds arc ubiquitous in our 
environment. The development over the last 15 years of extremely sensitive methods94 for 
the detection of nitrosamines in household and environmental materials has brought this 
problem into focus. Nitrosamines are present in trace amounts in many foodstuffs, being 
particularly high in preserved meat and fish where no doubt they form by reaction of the 
constituent secondary and tertiary amines with sodium nitrite used as the preservative. 
Probably more important is the formation of nitrosamines in vivo, particularly in the Stomach 
where the acid conditions are ideal for their rapid production. Many animal experiments 
have been carried out in which several types of tumor have been induced by deliberately 
feeding various amines and sodium nitrite.113 It is very difficult to gauge the extent o f human 
exposure, although the recent method of measuring the amount of the noncarcinogenic N- 
nitrosoproline formed from orally administered proline should help in the future.116 Unfor­
tunately, there is also a lack of animal data on the effects of chronic feeding with very low 
doses of nitrosamines, as might be expected to occur in the human situation, because in the 
past most experiments have been designed to produce tumors in a relatively short time. For 
the rat the minimum dose for tumor induction seems to be about I ppm in the d ie t." 7 There 
has recently been much interest in nitrosamine levels in various parts o f the world, especially 
those such as northern Iran and areas in China where there is known to be an abnormally 
high incidence of esophageal cancer. However, so far it has not been proved possible to 
implicate nitrosamines in human disease with certainty, although clearly it is prudent to 
ensure that human exposure to these agents is always as low as is practicable.
V. ALKYLATING AGENTS
Although nitrosamines and nitrosamides are alkylating agents of a particular type, some 
halogenated hydrocarbon derivatives and similar compounds that readily undergo nucleo- 
philic displacement can also alkylate biological macromolecules, and many are carcinogenic. 
These compounds are, o f course, direct acting carcinogens, tending to give local tumors at
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FIGURE 6. Carcinogenic antitumor drugs; cyclophosphamide (35). chloma- 
phazin (36). and chlorambucil (37). and the fumigant P-propiolactonc (38).
(he site o f application.1'* The group is large, including a number of industrial intermediates 
and the medically important class of anticancer agents known as the nitrogen mustards.
Soldiers exposed to the vesicant mustard gas (2.2'-dichloroethyl sulfide, S(CH2CH2C1)2) 
in World War I later suffered from cancer of the bronchus, larynx, and nasal sinuscs.,3v 
Replacement of the sulfur atom in this compound by nitrogen gives the nitrogen mustard 
NH(CH2CH2Cl)2, the simplest member of a series of hundreds of anticancer drugs such as 
cyclophosphamide (35), chlomaphazin (36), and chlorambucil (37) (Figure 6). These agents 
have in common the ability to kill dividing cells by incapacitating their DNA; from the 
present vantage point of understanding the general correlation between DNA damage and 
carcinogenesis it is not surprising that many have been shown to be weak to moderately 
strong carcinogens in animal tests. In man cyclophosphamide has apparently induced a whole 
range of cancers (reticulum cell sarcoma, chronic lymphocytic leukemia, Hodgkin’s disease, 
cervical cancer, malignant melanoma, astrocytoma, glioblastoma, and bladder cancer.)140 
Bladder cancer was also noted in patients with other forms of cancer treated with chloma- - 
phazin.141 Chlorambucil produces lymphomas in rats, and lymphosarcomas and ovarian and 
lung cancer in mice after intraperitoneal injection.142 Several case reports have implicated 
this drug in the induction of leukemia and other cancers in man.
The reactive compound fc/5(chloromethyl)cther {0(CH2C1)2] is a powerful carcinogen, 
producing skin tumors in m ice,135 after skin painting and lung and nasal tumors in rats after 
inhalation.144 (3-PropioIactone (Figure 6 (38)), previously used as a medical sterilant, is 
similarly active in mice, rats, hamsters, and guinea pigs.145 Vinyl chloride (CH2=CHC1), 
produced on a huge scale in the manufacture of polyvinylchloride (PVC), is toxic to animals 
and man. In mice, rats, hamsters, and rabbits exposure to this compound in air leads to 
angiosarcomas (malignant tumors affecting blood vessel walls) of the liver and other organs 
together with tumors of the lung, intestines, kidney, skin, mammary gland, and forestomach. 
Liver angiosarcomas have also been diagnosed in a number of PVC workers exposed on an 
average of 20 years previously to vinyl chloride at high concentrations in a ir.146
VI. SOME NATURAL PRODUCTS
At one time it was felt that naturally occurring compounds would not be carcinogenic 
because animals would have evolved efficient means to deal with these threats to their 
existence. We now know that is not true, and in fact certain enzyme systems designed for 
this purpose can act to the detriment of the animal, causing biological activation. The 
lengthening list o f carcinogenic natural products includes a few of the more important 
compounds discussed below (Figure 7).
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FIGURE 7. Naturally occurring carcinogens: aflatoxin Bl (39), slerigmatocystin (40). patulin (41), 
chloramphcrficol (42). cycasin (45a). and a senccio alkaloid o f the pyrrolidine group (43). These alkaloids 
are enzymatically dehydrogenated to (44) which yields an elcctrophilc by fission o f the ester as shown.
The estrogens estrone (46) and stilbestrol (47) cause cancer only under unusual circumstances, and 
probably not by the same mechanism as most other carcinogens.
Aflatoxin B, (Figure 7 (39))'47 is one of a number of complex lactones formed by the 
yellow mold Aspergillus flavus  which widely contaminates foodstuffs in warm, humid parts 
of the world. It was, in fact, discovered in 1960 as a result of an investigation into the death 
of a number of turkeys fed contaminated peanut m eal.14* Fed to rats at 1 pg/kg in the diet, 
liver cell carcinomas occurred in 10% of the animals, while all the animals succumbed to 
this tumor at 100 times this dose .'4V Aflatoxin B, is therefore one of the most potent liver 
carcinogens known. Low dietary doses induced liver cancer in trout, salmon, guppies, and 
ducks, and in rhesus monkeys, marmosets, and tree shrews.147 Administered to rats in 
dimethylsulfoxide solution either by stomach tube or by intraperitoneal injection, it induced 
hepatocellular carcinomas; similar results were also obtained with rhesus m onkeys.'50-151 
There is convincing circumstantial evidence that primary liver cancer in man may be caused 
by this agent.'52 Aflatoxins are activated153 by epoxidation of the terminal furanoid double 
bond, and it is interesting that like the hydrocarbons which are also activated in a similar 
manner local sarcomas result after injection of aflatoxin B, (Figure 7 (39)) in oil into both 
mice and rats. However, the similarity stops here, because aflatoxins are powerful liver 
carcinogens, whereas hydrocarbons almost never cause tumors at this site.
Aflatoxins are members of a group of mycotoxins, many of which are mutagenic and 
teratogenic.154 A related structure, sterigmatocystin (Figure 7 (40)), also produces liver 
tumors in rats'55 and lung tumors in mice156 after oral administration. Patulin (Figure 7 (41)), 
another cyclic lactone antibiotic, induces sarcomas at the site o f injection in ra ts .157 Chlor­
amphenicol (Figure 7 (42)), an antibiotic metabolite of Streptomyces venezuelae used clin­
ically for various infectious diseases, has caused severe bone marrow depression in patients 
followed by leukem ia.'58
Liver and other tumors have been induced in rodents also with several alkaloids of the 
pyrrolizidine group, of general structure (Figure 7 (43)).l5<, These undergo enzymic dehy­
drogenation in the liver to yield highly reactive alkylating agents (Figure 7 (44)) which are 
probably the proximate carcinogens. These alkaloids are found in senecio leaves used in
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FIGURE 8. 4-Nitroquinoline-W-oxidc (48). a powerful carcinogen, is activated 
by reduction to the oxime (49); acylation o f the latter gives a reactive ester, fission 
o f which leads to an electrophile. Thiouracil (51). an antithyroid substance, is 
carcinogenic, as are the antibacterial nitrofurans (52 and 53).
various parts of Africa to prepare medicinal tea. The glycoside cycasin (Figure 7 (45)) occurs 
as a constituent of cycad nuts used as a foodstuff in Guam. Hydrolysis by intestinal flora 
yields the aglycone methylazomethanol (Figure 7 (45b)), which behaves as a methylating 
agent like the mcthylnitrosamines. Similarly, cycasin produces a variety of malignant tumors 
mainly of the liver, kidney, and intestine in rats, hamsters, guinea pigs, rabbits, and fish .'60
Carcinogenicity associated with the natural and synthetic estrogens, estrone (Figure 7 
(46)) and diethylstilbestrol (Figure 7 (47)), is probably not due to their conversion to elec- 
trophilic agents as seems to be the case for most carcinogens. Lacasagne161 was the First to 
use estrone to induce breast cancer in male mice of a strain in which only the females 
normally developed this tumor; this sex hormone was therefore probably the First natural 
product shown to be carcinogenic. Stilbestrol, synthesized by Dodds in 1947, has exceptional 
estrogenic potency surpassing that of the natural hormone, and has found importance both 
as a drug and commercially as an aid to fattening cattle for slaughter. Large doses used 
formerly to prevent threatened abortions unfortunately led to vaginal tumors in some of the 
daughters of women treated 15 to 20 years previously.162 More recently, treatment of older 
women for the alleviation of menopausal symptoms by estrogen replacement therapy has 
given rise to endometrial cancer.163 Today there is concern lest the prolonged use of con­
traceptives containing estrogens should raise the incidence of breast cancer among the women 
taking them. The estrogens are extremely powerful hormones and their use in unnatural 
situations presumably upsets the delicate balance controlling tissue growth and replacement. 
However, the detailed mechanism by which this leads to cancer is still obscure.
The preceding sections have catalogued the main types of chemical carcinogens without, 
of course, being in any way exhaustive. There are still many other miscellaneous organic 
compounds which are carcinogenic, and here we shall mention just a few of these which 
are interesting for various particular reasons (Figure 8).
Colon cancer has until recently been difficult to study experimentally due to the lack of 
an adequate animal model. Now 1,2-dimethylhydrazine (CH3NH.NHCH3) is found readily 
to induce adenocarcinomas of the colon and rectum when fed to rats; at low doses liver
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tumors are obscrved.,,v4 Ora! administration to mice and hamsters give high incidences of 
angiosarcomas mainly localized in muscle, liver, lung, heart, and pancreas. However, after 
subcutaneous injection colon carcinomas were found in mice as well as rats, but in hamsters 
hepatocellular carcinomas were seen in addition.1'’' Dimethylhydrazine probably acts as a 
methylating agent since azoxymcthane. a possible metabolite, also gave a high incidence of 
colon and rectal carcinomas in rats and m ice.IM’
4-Nitroquinolinc-A-oxidc (Figure 8 (48)) is a powerful synthetic carcinogen which has 
found much use in cancer research. Enzyme systems necessary for its activation occur in 
most prokaryotic and eukaryotic cells and for this reason it tends to act locally. Thus, unlike 
most carcinogens it frequently induces tumors of the mouth, tongue, and salivary glands in 
mice, rats, and hamsters when given orally; however, tumors of the esophagus, forestomach. 
stomach, and lung have also been observed in these animals and in rabbits. In skin painting 
experiments it has been shown to induce skin tumors in mice, hamsters, and guinea pigs. 
Biological activation involves reduction of the nitro group to yield the oximc (Figure 8 (49)). 
followed by acylation of the latter forming the ester (Figure 8 (50)) which acts as a potent 
electrophile.167
It has been known for a long time that thyroid tumors can be induced by low iodine diets. 
Unavailability of inorganic iodide suppresses the synthesis of thyroxine resulting in a hor­
monal imbalance of the hypothalamo-pituitary-thyroid system, and leads to thyroid cancer 
by an indirect mechanism, as is probably also the case of cancer caused by the female sex 
hormones. Antithyroid substances such as thiourea (S=C(NH,): ) and thiouracil (Figure 8 
(51)) not unexpectedly arc carcinogenic in this situation. Thus, thiourea produced liver, 
thyroid, and Zymbal gland tumors in rats both by oral administration and by intrapcritoneal 
injection; mice, however, were resistant. Similarly, oral thiouracil also produced thyroid 
tumors in several strains of rats.1™
The 5-nitrofurans have been widely used as food preservatives and clinically as antibac­
terial agents since 5-nitro-2-fura!dehyde semicarbazone (Figure 8 (52)) was shown to be 
active in 1944.169 A large number of related compounds have been synthesized and many 
show antibacterial activity; some also appear to be carcinogenic. Thus, (Figure 8 (52)) 
produced benign mammary tumors in a high proportion of female rats after feeding it in 
their d ie t.170 A similar compound AF-2, furylfuramide (Figure 8 (53)), was used in Japan 
as a food additive until it was found to be strongly mutagenic in bacterial tests.171 It had 
previously failed to produce tumors in an animal test, but on subsequent retesting was shown 
to be carcinogenic in mice, rats, and hamsters.172
Finally, a number of chlorinated hydrocarbons of great technical and industrial importance 
appear to be weakly carcinogenic in animal tests. Both chloroform (CHCl,) and carbon 
tetrachloride (C C D  g‘ve rise to liver tumors in rodents; chloroform, once a constituent o f 
cough syrups, also induced malignant kidney tumors in male rats and thyroid tumors in 
females. Tetrachlorethylene (C12C:CC12), used mainly in dry cleaning, also produced he­
patocellular carcinomas in m ice.173
VIII. INORGANIC CARCINOGENS
Carcinogens are by no means confined to organic compounds; carcinogenicity is associated 
with the elements arsenic, beryllium, cadmium, chromium, nickel, and lead in the form of 
the pure metals or more usually their salts or oxides. Several forms of the mineral asbestos 
(complex fibrous magnesium and iron silicates) are also known to be carcinogenic in man 
and in animals. Much of the information regarding the carcinogenicity of these materials 
comes from human epidemiology because they are all of considerable industrial importance, 
and exposure to them has occurred during their mining, refinement, and use.174
Arsenic is of particular interest because in the past numerous attempts to demonstrate its 
carcinogenicity in a number of animal species (mice, rats, rabbits, and dogs) have met with
Volume II 199
failure, although more recently intratracheal instillation of a pesticide containing calcium 
arsenate has heen shown to induce lung tumors in ra ts .'7'  Its activity in man is. of course, 
well established.” '’ Human exposure has occurred through the medicinal use of Fowler's 
solution (potassium arsenitc) for a variety of ailments including skin diseases such as pso­
riasis, leading to chronic arsenicism (peripheral neuropathy) and skin cancer. The tumors 
often appear at unusual sites such as the palms and soles, different from the skin tumors 
induced by other known carcinogens; ingested arsenic is known to concentrate in the skin 
and hair. Epidemiology shows the occurrence of an excess of respiratory cancer among 
workers engaged in the manufacture of arsenical pesticides and those engaged in smelting 
copper, lead, and zinc, metals which in the crude state contain arsenic.
Beryllium and its compounds find technical application mostly in electrical equipment, 
and in the nuclear industry; the use of beryllium in fluorescent tubes has been discontinued. 
Beryllium compounds arc carcinogenic in rats, rabbits, and monkeys; lung tumors result 
from inhalation or intratracheal instillation, and ostcocarcinomas from intravenous or in- 
traosseus administration (rabbits). There is limited epidemiological evidence that exposure 
to beryllium and its compounds may lead to an increased lung cancer risk in m an.177 Cadmium 
and a few of its salts arc used mainly in electroplating, although they are important in a 
number of other technical applications. In the rat they give rise to sarcomas at the injection 
site, and testicular tumors of interstitial-cell origin follow testicular atrophy in both the rat 
and mouse. There is a suggestion that heavy industrial exposure to cadmium oxide may 
cause prostate cancer in m an.178
Chromium is used widely in the metallurgical industry, particularly in the production of 
ferrochromium alloys and stainless steel, and in electroplating. It is also employed in the 
manufacture of refractory materials, and many highly colored chromatcs are used as pig­
ments. A number of Cr(VI) compounds (chromates, chromium trioxide) produce sarcomas 
at their sites of subcutaneous, intramuscular, and intrapleural administration in the rat. Lead 
chromate, the main component of the pigment chrome yellow used widely in paints and 
printing inks, also induced renal carcinomas after intramuscular injection in rats.179 Numerous 
worldwide epidemiological studies have firmly implicated Cr(VI) compounds in the causation 
of occupational lung cancer among chromate production workers; increased risk of other 
forms of cancer (esophagus, prostate, maxillary sinus) has also been reported."*0
The transition metal, nickel, also finds many uses in the modem industrial world. In the 
past, human exposure occurred mainly in nickel refineries where cancer of the lung and 
nasal cavities was found to be, respectively, 5 to 10 times and 100 to 900 times higher than 
that expected from the average national rates.181 Nickel carbonyl, involved in one refining 
process, may not have been to blame because similarly increased risks were associated with 
refineries using the electrolytic process. Suspicion falls upon nickel oxide and subsulfide 
present in the crude nickel ore, the dust o f which leads to heavy exposure to these compounds 
during the early parts of the refining process. Nickel subsulfide and oxide produced local 
and rhabdomyosarcomas after intramuscular injection into rats and mice; other nickel com­
pounds were also active by this route.182 Inhalation of nickel carbonyl produced the occasional 
lung tumor in rats, while after intravenous injection it gave rise to a range of malignant 
tumors (liver, kidney, breast, lymphomas, and leukemia).183 Extensive experiments on the 
carcinogenicity of nickel subsulfide in mice, rats, rabbits, and hamsters of several strains 
has recently been reviewed.184
Lead is one of the oldest metals known and has many uses: in electrical storage batteries, 
solders, alloys (brass and bronze), as tetraethyl lead as an anti-knock additive for motor 
fuels, as the oxides in paint, etc. Lead acetate and phosphate produced kidney tumors in 
rats and mice after oral or parenteral administration.183 Subcutaneous administration of 
tetraethyl lead in tricaprylin to neonatal mice induced lymphomas in 5/41 females, but not 
in the m ales.186 O f three epidemiological studies of workers who were exposed to lead and
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inorganic lead compounds and to tetraethyl lead, two indicated slight, but not significant 
increases in deaths from cancer of the digestive and respiratory systems, and of the skin 
(tetraethyl lead workers).""
Suspicion of an association Ik  tween the disease asbestosis and lung cancer among industrial 
asbestos workers was voiced in 1935.187 First reports of pleural and peritoneal tumors 
appeared 10 years later, but the occurrence of mesotheliomas in these workers was not 
recognized until 1963."*" Mesothelioma is a rare tumor in the general population, and this 
has aided epidemiological surveys of asbestos-linked cancer. Worldwide surveys have con­
firmed the original findings, and all industrially important forms of asbestos have been shown 
to induce mesotheliomas in rats following intrapleural administration."*9 Mesotheliomas have 
also been induced in hamsters19*’ and rabbits.191 The long latent periods observed in these 
experiments are in agreement with the average of 40 years estimated for the production of 
these tumors in humans. Risk of carcinoma of the lung in asbestos workers is greatly increased 
in those who smoke cigarettes,43 whereas risk of mesothelioma is not.192 Fiber dimensions 
appear to be important with regard to the latter disease, and in fact glass fibers of the same 
optimum dimensions also induce mesotheliomas.19’ This suggests that the aerodynamic 
properties of these fibers are critical in ensuring that they reach their target, but the mechanism 
by which they cause cancer is still unknown. Asbestos is, of course, an important commercial 
material, used mainly in the building industry for insulation; it is also an essential constituent 
of brake linings and clutch plates. It is, therefore, widely distributed and the cause of concern 
today.194
IX. CONCLUSION
Perhaps the most striking feature disclosed by a review of this sort is the remarkable 
organ specificity shown by many carcinogens. Thus, in general polycyclic hydrocarbons 
tend to produce skin cancer, whereas many aromatic amines induce bladder tumors; in 
humans asbestos causes mesotheliomas while vinyl chloride exposure is associated with 
angiosarcomas. Frequently, organ specificity differs between animals of different species; 
for example 2-aminonaphthalene gives liver tumors in mice, but is a bladder carcinogen in 
man.
Where they have been examined sufficiently it is often clear that several factors combined 
to give rise to the observed species or organ specificity. Tissue distribution is obviously 
important, and is sufficient to explain the effects of very reactive direct-acting carcinogens. 
The alkylating agent 6/j(chloromethyl)ether induces skin tumors when applied topically, but 
tumors o f the lung and nasal cavities when inhaled. Nitrosomethylurea, a chemically more 
stable direct-acting carcinogen capable of being distributed intact throughout the body, gives 
a variety of tumors (kidney, intestine, stomach, lung, brain) after intravenous injection, as 
well as local tumors o f the blood vessels; skin tumors again result from topical application 
of this compound. The clearest correlation between DNA damage induced in specific tissues 
- and subsequent tumor formation, comes, however, from the study of radiation carcinogen­
esis. Both UV light and ionizing radiation possess wavelengths associated with sufficient 
energy to break most chemical bonds, and not unexpectedly are known to cause macroscopic 
chromosome damage and to be mutagenic. UV radiation is the less energetic and is incapable 
of penetrating far into tissue; in agreement with this it is found to give rise to skin cancer. 
X- and y-rays are much more energetic; they can penetrate tissue and deliver their energy 
internally. Leukemia developed in certain of those (atomic bomb survivors, patients irradiated 
for diseases such as ankylosing spondylitis) who suffered general irradiation. Radioactive 
metals such as strontium-90 and plutonium, on the other hand, become incorporated into 
bone where their intense local irradiation gives rise to osteosarcomas.
The majority of chemical carcinogens require metabolic activation before they can act.
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and this leads to a second important factor; not only has the carcinogen to reach the target 
organ, hut there it must undergo the correct metabolic transformation. Activation of several 
major classes of carcinogens, such as polycylic hydrocarbons and aromatic amines, requires 
more than one metabolic step; moreover, a number of detoxifying enzymes compete with 
this process. A further complication is that at least some of the enzymes involved are capable 
of being induced by a variety of substances. Since relatively little is known concerning tissue 
distribution and inducibility of these enzymes it is usually not possible to predict the target 
organ(s) for these carcinogens, except by analogy. However, there docs appear to be a 
positive correlation between high aryl hydrocarbon hydroxylase activity in primary lung 
cancer patients compared with patients with other pulmonary disease, as would be expected 
if polycyclic aromatic hydrocarbons were the cause of their cancer.195
Other important considerations also apply to the determination of species and organ 
specificity in chemical carcinogenesis. Different tumors proliferate at different rates; a par­
ticularly rapidly growing tumor may therefore kill the animal before other tumors become 
visible. This can sometimes be disclosed by varying the dose; thus, chronic feeding of rats 
with dimethylnitrosamine leads to liver cancer, whereas a single, high dose gives rise to 
kidney tumors. Clbsely related to this is simply the adequacy of the experimental obser­
vations; it is easy to overlook or neglect small tumors when the postmortem examination is 
focused on large tumors at an expected site. Also related is the question of dormant cells. 
A great mass of animal data firmly establishes that tumor induction occurs in two or more 
distinct steps; at subthreshold doses animals treated with a variety of careinogcns show no 
signs of cancer until subsequently treated with a promoting agent. Tumor promoters are 
themselves organ specific so this must add to organ specificity in carcinogenesis. Finally, 
DNA repair is clearly of importance and this, too, is reviewed in Chapter 9, this volume.
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Metabolites of 15,16-dihydrocyclopenta[a]phenanthren- 
17-one and its 1- and 12-methyl homologues (all non­
carcinogens) along with those from the 11-methyl and
ll,12-dimethyl-17-ketones (carcinogens), produced in vitro by 
hepatic microsomes from methylcholanthrene induced rats, 
were separated by reverse phase h.p J.c. Identifications of in­
dividual metabolites were based upon elution times, u.v. spec­
tra, and in some cases by mass spectrometry, circular 
dichroism, and identity with synthetic derivatives. All five 
compounds were biologically oxidised at their terminal A and 
D rings to yield 1,2-dihydrodiols and 15- and 16- ols; with 
the exception of the 1-methyl compound, all also gave similar 
amounts of 3, 4-dihydrodiols. The 1-methyl compound by 
contrast failed to produce this metabolite, furnishing instead 
the 4-phenol and five other, probably related phenolic deriva­
tives. Previous work has established that for the ll-methyl-17- 
ketone, the 3,4-dihydrodiol is the proximate carcinogen. Thus, 
whereas lack of biological activity with the 1-methyl com­
pound can be ascribed to its failure to produce a 3,4-dihydro­
diol, in the case of the unsubstituted parent ketone and its 
12-methyl derivative other determining factors must come into 
play.
Introduction
Derivatives of 15,16-dihydrocyclopenta[a]phenanthrene (I Figure
1) which are related structurally to both steroids and polycyclic 
hydrocarbons provide an interesting series for the study of the 
correlation between carcinogenicity and chemical structure (1). 
Thus, whilst the 11-methyl derivative (HI) is a potent carcinogen, 
similar in its behaviour to benzo[a]pyrene on mouse skin (2), 
its 7-methyl isomer is less active and the 1-, 2-, 3-, 4-, 6- and 
12-methyl isomers are not carcinogenic (3,4). The 11,12-dimethyl 
compound (V) is also strongly active and the 7,11-dimethyl ana­
logue (15 ,16-dihydro-7,11 -dimethylcyclopenta[a]phenanthren- 
17-one) is the most carcinogenic member of this series so far 
tested. The Iball indices for these compounds, tested by repeated 
application to the dorsal skin of mice, are listed in Table I. The 
activating effect o f a bay region methyl group [at C (l l)  in the 
cyclopenta[a]phenanthrene series] is well known in similar poly­
cyclic hydrocarbons, but the reason for this is still not clear.
It is now firmly established that metabolism is involved in the 
activation of the 11-methyl ketone (III). Thus, this compound 
is not mutagenic towards Salmonella typhimurium TA 100 in the 
Ames test, and fails to bind covalently to DNA in vitro unless
it is first exposed to biological oxidation. Under these conditions 
the major nucleoside adduct formed with DNA added to the in­
cubation is identical to that isolated from the DNA of mouse skin 
after topical application of (III), as in a tumour induction experi­
ment (5). Detailed examination of the metabolites of (III), isolated 
by ethyl acetate extraction after incubation in vitro with rat liver 
microsomes and NADPH, demonstrates that this molecule is 
metabolically oxidised in ring A to form both 1,2- and 3,4-di- 
hydrodiols; oxidation occurs in addition at the methyl group and 
at both methylene groups at C(15) and C(16) to give mono-ols. 
Metabolites derived from oxidation in both ring A and ring D 
are also observed, but enzymic attack does not apparently occur 
at C(6), C(7) or C( 12) in this molecule (6). O f the in vitro meta­
bolites the 3,4-dihydrodiol is the most carcinogenic, being about 
10 times more active than the original compound (III) (7). More­
over, after further metabolism in vitro this metabolite binds to 
exogenous DNA to form the same adduct, via further oxidation 
to the [R,R]trans-3,4-dihydro-3,4-dihydroxy-a«ft- 1,2-epoxide, 
analogous to the most potent diol epoxide stereoisomer of 
benzo[a]pyrene (8).
More recently examination of in vitro metabolism has been 
extended to the unsubstituted parent ketone (I) and its 12-methyl 
derivative (IV), both non-carcinogens (8). It was found that both 
compounds give rise to [R,R]tra«5-3,4-dihydrodiols analogous 
to the proximate carcinogen from (III). The present report ex­
tends this work in that it attempts to identify other metabolites 
of these two non-carcinogens. In addition the 1 -methyl-(II) and
11,12-dimethyl-17-ketone (V) are examined in a similar man­
ner for the first time.
Materials and methods
Chemistry
The compounds (I) — (V) were prepared previously in this laboratory (9,10) and 
their purity was established by standard methods. For the quantitative comparison 
they were generally labelled with tritium by Pt-catalysed exchange with tritiated 
water, and repurified by column chromatography (1 1 ).
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Fig. 1. Cyclopenta[a]phenanthrenes referred to in the text.
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Table I. Iball indices of cyclopent[a]phenanthren-17-ones mentioned in the 
text
Compound Iball index3
Unsubstituted (I)
1-methyl (II)
2 -methyl
3-methyl
4-methyl 
6 -methyl
11-methyl (III)
12-methyl (IV)
11,12-dimethyl (V)
7,11-dimethyl
aIball index = ^  x Percentage tumour incidence 
mean latent period in days 
b2 0  applications of 2 0 0  nmol during 1 0  weeks; all the rest had 1 0 0  applica­
tions during 50 weeks. Theiler’s Original (derived from Swiss) mice were 
used in groups of twenty; standard conditions were employed throughout, 
and all experiments were continued for 2  years (1).
For the synthesis of 15,16-dihydro-4-hydroxy-l-methylcyclopenta[a]phenan- 
thren-17-one (VI, Figure 1) the phenolic function was protected throughout as 
its methyl ether, and the multi-step route followed that used previously (1 0 ) as 
outlined in Figure 2. 5-Methoxy-8-methyltetralone (12) was converted in five 
steps (i—v) to the tricyclic ketone, itself transformed by three further steps (vi—viii) 
into 15,16-dihydro-4-methoxy-l-methylcyclopenta[a]phenanthren-17-one, m.p.
199 —200°C; \ max 262,302,366,384; after reduction with NaBH4, 
250,282,307,319,344,360 nm n.m.r. (CDC13), 5 2.80 (2H, multiplet, 16-CH2), 
3.07 (3H, singlet, 1-methyl), 3.40 (2H, multiplet, 15-CH2), 4.03 (3H, singlet, 
O-methyl), 6 .8-9.0 (6 H, aromatic protons); Found, C, 82.2; H, 5.6%; M+ 
276.1148. C19H160 2 requires C, 82.6; H, 5.8%; M+ 276.1150. Demethylation 
with sodium ethane mercaptide (reagent ix) was preferable to the more conve­
nient phosphorous tribromide in that it gave more consistently good yields of 
15,16-dihydro-4-hydroxy-l-methylcyclopenta[a]phenanthren-17-one (VI) as a pale 
yellow solid, Xmax (methanol) 270,305; after addition of NaOH, 260,284sh, 325; 
after reduction of a neutral solution with NaBH4, 251,285 nm. Found, M+ 
262.0992. Ci8H140 2 requires M+ 262.0994. Other intermediates in this synthesis 
also had spectral characteristics consistent with their expected structures.
Chemicals and solvents used were from various commercial sources. Ethyl 
acetate and methanol used in the metabolic work were from Fison’s Ltd., Lough­
borough, and NADPH was purchased from BDH Chemicals Ltd., Poole.
Metabolism
Incubation were carried out using microsomes derived from the livers of male 
Sprague Dawley rats induced by i.p. injection of methylcholanthrene 24 h before 
sacrifice, essentially as previously described (6 ). Briefly, the compound (1 /tmol) 
dissolved in dimethylsulphoxide (50 /d) was added to 0.1 M Tris buffer (3 ml, 
pH 7.2) containing NADPH (20 mg), followed by microsomes equivalent to 5 
mg of protein suspended in Tris buffer (1 ml). The mixture was shaken gently 
in air at 37°C for 30 min, after which it was cooled in ice and extracted six times 
with an equal volume of ice-cold ethyl acetate. The extracts were dried over 
anhydrous sodium sulphate, evaporated to dryness in an atmosphere of nitrogen, 
and finally redissolved in methanol (100 /d). Separation was achieved by h.p.l.c. 
using a Whatman Partisil M9 10/50 reverse phase ODS column (Whatman, Ltd., 
Maidstone, Kent) and a Waters h.p.l.c. system (Waters Associates, MA, USA). 
A solvent gradient, 15% v/v methanol/water changing to pure methanol over 
80 min at a flow rate of 4 ml/min, was usually employed; other conditions are 
as described in the text. Metabolites were detected by continuous u.v. monitor­
ing at 254 nm, collected as appropriate in clean glass vials, and stored at —20°C 
until utilised, usually within a few hours.
Examination by u.v. spectroscopy
The u.v. spectra of peaks isolated by h.p.l.c. were examined using a Perkin- 
Elmer Coleman 572 recording spectrophotometer over the wavelength range
200 — 400 nm, adjusting the water/methanol ratio in the reference cell to match 
approximately that of the sample. Reduction of the ketone to the corresponding 
alcohol was achieved by adding a few mg of sodium borohydride in situ and 
recording the reduced spectrum after 15—20 min. When phenols were suspected, 
the u.v. spectrum of the anion was produced by adding one drop of N sodium 
hydroxide to the original solution in the cell.
CH, 0
och3
Fig. 2. Synthesis of 4-hydroxy-l-methyl-15,16-dihydrocyclopenta[a]phen- 
anthren-17-one (VI). Reactions (i) Reformatsky reaction (ethyl bromoacetate, 
zinc) followed by aromatisation by heating the product with sulphur; (ii) 
Reduction with lithium aluminium hydride; (iii) Bromination of the resulting 
alcohol with triphenylphosphine dibromide; (iv) Malonate conversion to the 
homologous carboxylic acid; (v) Cyclisation with phosphorous pentachloride 
and stannic chloride; (vi) Stobbe reaction of the tricyclic ketone with diethyl 
succinate in the presence of potassium terr-butoxide; (vii) Cyclisation with 
acetic anhydride and zinc chloride, followed by alkaline hydrolysis and 
decarboxylation; (viii) Dehydrogenation at C (ll), C(12) by heating with 
palladium on charcoal catalyst; (ix) Demethylation with sodium ethane 
mercaptide in refluxing dimethyl formamide.
Examination by mass spectrometry
In certain cases mass spectra were obtained from fractions pooled from large 
scale (5 —10 ftmol) incubations, and further purified by h.p.l.c. The final material 
was dissolved in a small volume of methanol, introduced into a hard glass micro­
tube, evaporated to dryness in a vacuum desiccator, and the tube was sealed prior 
to submission. Mass spectra were recorded at 70 eV on an A.E.l. MS 902 in­
strument at Queen Mary College, University of London.
Examination of metabolite lb by circular dichroism
A solution of metabolite (lb) (Figure 3) in methanol was reduced by the addition 
of sodium borohydride. The solvent was removed in vacuo, and the residue was 
extracted with ethyl acetate which was washed with water, dried over anhydrous 
sodium sulphate, and evaporated to dryness under nitrogen. H.p.l.c. of the residue, 
redissolved in methanol ( 1 0 0  /d), disclosed equal amounts of two reduction pro­
ducts with identical u.v. spectra (Xmax257,265 nm), and absence of (lb). The two 
fractions were combined for the circular dichroism measurement. Phenanthrene- 
[3R,4R]-dihydrodiol was obtained by metabolism of phenanthrene using the method 
described above, followed by h.p.l.c. separation. C.d. spectra were recorded in 
methanol with 1 cm path length cells using a JASCO J40 Cs spectrometer at 
King’s College, University of London.
Results and discussion
Figure 3 illustrates the h.p.l.c. profiles of the ethyl acetate solu­
ble metabolites obtained from in vitro incubations of the un­
substituted (I), 12-methyl (IV) and 11,12-dimethyl (V) 
compounds. On this reverse phase column the most polar 
metabolites elute first, and the last major peak to appear is the 
unchanged starting material. Allowing for the increased 
lipophilicity following the introduction of one or two methyl 
groups into the molecule, indicated by the increasing elution times 
for the unchanged ketones, the metabolic profiles for these three 
compounds show general similarity. On the other hand the pro­
file for the 1-methyl-17-ketone (II) shows many differences 
(Figure 5, where the h.p.l.c. conditions were 30—100% 
MeOH/water over 3 h at 4 ml/min, although this was also a linear 
gradient).
Table II lists the u.v. spectra of the metabolites derived from 
compounds (I), (IV) and (V) together with data previously ob­
tained for metabolites of the ll-methyl-17-ketone (III), the struc­
tures of which have been confirmed by mass spectrometry (5,6). 
Elution times of these were very similar to those shown here for 
the 12-methyl compound. The simple u.v. maxima shown in 
Table II do not do justice to the wealth of information contained 
in the actual peak shapes which were very similar to those pre­
viously published for the 11-methyl ketone, and in practice it 
was easy to assign structures to metabolites on their basis of their 
u.v. spectra and elution times. The ability to obtain a second,
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Fig. 3. H.p.l.c. profiles of the products of in vitro metabolism of 
compounds (I), (IV) and (V); u.v. trace monitored at 254 nm. For u.v. 
maxima of peaks see Table II. Linear gradient, 15—100% methanol in 
water, over 80 min at 4 ml/min. M represents a peak of microsomal origin.
independent spectrum for each compound by in situ reduction 
of the ketone group also greatly facilitates identification. The 
structure of the 3,4-diols (Ie) and (IVe) have in addition been 
established already by n.m.r. and mass spectrometry (8), while 
the structures of (If) and (Ig) follow from their identity with syn­
thetic samples of the 15-ol and 16-ol of (I) (13). Mass spectra 
of selected metabolites of compounds (I) and (TV) (Table HI) con­
firm these assignments.
In each case the first major peak (M) to emerge from the col­
umn is of microsomal origin since it contains no radioactivity 
when tritiated compounds are employed. The next peak (a) con­
sists of trans-1,2-dihydrodiols further hydroxylated in ring D, 
probably largely at C(15). As with bay-region vicinal diols of 
polycyclic hydrocarbons, the 1,2-diol system in these metabolites 
is diaxial, thus accounting for their polarity. Other minor 
metabolites eluting before (b) have 1,2,3,4-tetrahydro chromo- 
phores (Xmax 260, and 240 nm after reduction to the 17-alcohol) 
and are therefore tetra-ols and penta-ols derived from metabolic 
saturation of ring A. Peaks (b) represent the mms-1,2-dihydro- 
diols, again diaxial and much more polar than the isomeric quasi- 
diequational trans-3,4-dihydrodiols (e). Circular dichroism was 
used to establish the absolute stereochemistry of the unsubstituted 
1,2-diol (lb). Reduction of this metabolite with sodium borohyd­
ride in methanol gave an equimolar mixture of epimeric 17a- 
and 17-/5 alcohols, separable by h.p.l.c. It has recently been 
shown for the corresponding 3,4-dihydro-3,4-dihydroxy-17-one 
that the epimeric 17-ols have similar c.d. spectra of the same 
sign, demonstrating that, as expected, the 17-ols has little effect 
on the chiral dihydrophenanthrene chromophore (8). Figure 4 
shows that the mixture of epimeric 1,2,17a and 1,2,17/5-triols 
derived from (I) has a c.d. spectrum similar to, and of the same 
sign as that of phenanthrene-[3R,4R]-dihydrodiol isolated as a 
metabolite of phenanthrene using hepatic microsomes from 
methylcholanthrene-induced rats (14). The 1,2-diol system in 
metabolite (lb) is therefore also [1R,2R], (i.e., la ,2(3 as shown).
The u.v. spectra of the 3,4-dihydrodiols (e) are very similar 
to those of metabolites (c) and (d) which are 3,4-diols further 
hydroxylated at ring D, and possibly also at the methyl groups 
for (IV) and (V). In the mass spectrometer the 3,4-dihydrodiols 
undergo facile dehydration and molecular ions are not always
Table II. U.v. spectra of metabolites of compounds (I) and (III) —(V)
Compound Xmax (nm) of metabolites a —f (see Figure 3)
a b c d e f
11-methyl (III) 3 265,322,334, 262,306,319,332 273,327sh,333 272,327sh,333 273,332sh,357 265,300,359
373 370sh 370sh 371 374
(259,267,320)b (259,267,305) (248,327,347) (250,326,347) (250,306,330,349) (256,280,291,303,337,
352)
Unsubstituted (I) 266,320,332, 266,272,316,328 267,317,327, 278,330sh,360sh, 269,350sh,368 268,280sh,297,352,
366 345sh,365 345sh,365 376 369
(255,264,310, (257,265) (243,264,320) (253,312,328) (243,300,309,321,341) (248,256,278,281,298)
347)
12-methyl (IV) 268,321,333, 261,303,315,327 269,325sh,360, 268,362,374 270,355,375 270,308,358,375
355sh,375 372sh
(257,266,310) (257,266) (245,308sh,322) (246,322) (248,3 lOsh,323,342) (259,281,303)
11,12-dimethyl (V) 273,323,336, - 276,320sh,338sh, 275,320sh,338sh, 275,321sh,336,370 268,291sh,303,363,
366,386 372 372 383
(261,270,328) (252,332,349) (254,320,334,350) (256,274,321,337) (259,296,332,356)
aRefs. 6  and 7.
bThe figures in brackets represent the u.v. maxima after reduction of the 17-carboxyl group with sodium borohydride in situ. The peaks of highest intensity 
are underlined; sh indicates a well-defined shoulder.
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observed (6), the ion of highest mass often being the [M-H20] + 
ion. Ions due to the loss of CO, CO + H20 , and 2H20  (from
15-hydroxy-A-ring diols) are also commonly observed (15). 
Metabolite (Vic) decomposed further, but the ions at m/z 170, 
155 and 127 in its mass spectrum occur also in the more normal 
spectrum of the related 3,4-diol (VId). The mass spectrum of 
metabolite (IVf), which retains the phenanthrene chromophore, 
is notable in having the molecular ion as the base peak, as has 
been observed previously for other D-ring mono-ols of this series
(1). The metabolites (IVf) and (Vf), and (IVg) and (Vg) having 
u.v. spectra similar to (If) and (Ig), respectively, are assigned
15-ol and 16-ol structures by analogy. Peaks labelled (h), (i), 
and (j) in the figure all have u.v. spectra which closely resemble 
those of metabolites (f) and (g); from their elution times these 
appear to be 15,16-diols and/or hydroxy methyl-ring D monools.
Table III. Mass spectra of selected metabolites of compounds (I) and (IV) 
shown in Figure 3
Metabolite .Molecular formula m/z (relative abundance)
(la) C17H140 4 Found M+, 282.0894; calc. 282.0892,
282 (32,M+), 264 (53, M-H20), 254 
(20, M-CO), 246 (12, M-2H20), 236 
(41, M-CO-HzO)
(lb) C17H140 3 Found M+, 266.0943, calc. 266.0943,
266 (13, M+), 248 (60, M-H20), 220 
(25, M-CO-HzO)
(Ic) C17H140 4 Found M+, 282.0891; calc. 282.0892,
282 (65, M+), 264 (57, M-H20), 246 
(35, M-H20), 236 (21, M-CO-H20) 
(IVa) C18H160 4 296 (6 , M+), 278 (14, M-H20), 262
(11), 260 (9, M-2H20), 170 (50)
(IVc) C18H160 4 223 (8 ), 170 (67), 155 (100), 127 (79)
(IVd) C18H160 4 278 (13, M-H20), 263 (10), 262 (18),
260 (20, M-2H20), 232 (M-2H20-C0), 
170 (65), 155 (100), 127 (58)
(IVf) C18H140 2 263 (23), 262 (100, M+), 245 (11, M-
OH), 244 (13, M-H20), 233 (14), 216 
(23, M-H20-CO), 215 (28), 203 (23), 
202 (35)
Of the six possibilities for the dimethyl compound (V) at least 
three (Vh, i, j) appear to occur.
An attempt was made to compare the amounts of the main 
metabolites (a) — (f) quantitatively using compounds (I) and (III)- 
(V) labelled with tritium. The compounds were incubated under 
identical conditions using microsomes from the same prepara­
tion, and the amounts of the various metabolites were estimated 
from the radioactivity found in the appropriate h.p.l.c. peaks. 
Table IV summarises the average of two experiments. Recovery 
of tritium in the ethyl acetate extracts was in all cases better than 
80%, the remainder presumably representing water-soluble meta­
bolites and tritiated water formed by exchange. All four com­
pounds were metabolised to similar extents and, more 
significantly, they all gave 3,4-dihydrodiols (e) in not dissimilar 
amounts. Since (Hie) is the proximate form of the carcinogen 
(III) (5), lack of this metabolic step is not the reason for the non­
carcinogenicity of compounds (I) and (IV).
It is evident from Figure 5 that the profile of metabolites from 
the l-methyl-17-ketone (II) bears little resemblance to those from 
compounds (I) and (III) — (V), although the in vitro metabolism 
of all these compounds was carried out under similar conditions. 
No fewer than six of the peaks (n, q —t, x) proved to be phenolic, 
wheras phenols are not found as metabolites of the other com­
pounds. Table V lists the u.v. maxima of peaks (k) — (x) together 
with tentative structural assignments. Of the non-phenolic peaks
Table IV. Relative amounts of major metabolites formed from compounds 
(I) and (III) — (V) under identical incubation conditions in vitro
Metabolite Compound (% of total ethyl acetate soluble
tritium)
(I) (III) (IV) (V)
(a) 1 1 .2 8 . 0 5.2 0.9
(c) 9.2 5.7 1 2 .1 6.3
(d) 4.2 4.0 6 . 6 5.3
(e) 1 1 .6 9.2 7.7 9.2
(f) 4.3 1 0 .8 1.7 1 1 .1
Unchanged compound 23.8 24.2 27.6 25.1
Other metabolites 35.7 38.1 39.1 42.1
OH
OH
HOHO
A OD
260
Wavelength (nm)
Fig. 4. Circular dichroism spectra of phenanthrene-[ 1R,2R]-dihydrOdiol (............. ) and the borohydride reduction product of metabolite lb (—).
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Fig. 5. H.p.l.c. profile of in vitro metabolism of compound (II); u.v. trace monitored at 254 nm. The hatched peaks represent phenolic metabolites; for u.v. 
maxima of peaks k —x see Table V. Linear gradient, 30—100% methanol in water, over 3 h at 4 ml/min. M represents a peak of microsomal origin.
Table V. U.v. spectra of metabolites (k) —(x) derived from the 1-methyl-17-ketone (II). (Xmax, nm; peaks of highest intensity underlined)
Peak Neutral NaBH4 Alkaline Tentative assignment
k 259,277,290,301 236,259 — 1,2,3,4-tetraol
1 269,304shb,331,337,368 258,267,305 - l,2,15(or 16) triol
m 268,279sh,298 257,266,282sh,294,303 - phenan-triol3
n 264,297 248,267,273,284,293 258,293 phenol
0 270,302,359,376 259,282,292,304 - phenan-diol
P 268,302,369 259,303,363 - phenan-diol
q 254,278,303 249,282,296sh,318sh,346,365 261,290,324 phenol
r 253,277,301 249,255sh,281,344,361 262,291,325 phenol
s 243,267,293 248,258sh,281,291 262,291 phenol
t 252,276,299 247,258,266sh,292sh 268,290sh,301sh phenol
u 266,284sh,302,357,375 258,281sh,292sh,304 - phenan-ol
V 270,285sh,303sh,358,375 256,281,292,303 - phenan-ol
w 268,290sh,303sh 256,282,292,305 - phenan-ol
X 270,305 250,285,300sh,320,349,365 260,284sh,324 4-phenol (VI)
aPhenan- denotes an intact phenathrene chromophore. 
bsh denotes a shoulder.
another six (m, o, p, u —w) retain chromophores indicating an 
intact phenanthrene conjugated to a 17-carbonyl group. The three 
peaks (u —w) have retention times expected for mono-ols; these 
therefore probably represent the 15- and 16-hydroxy and the
1-hydroxymethyl derivatives of (II), although it is not possible 
to specify which is which. The two very similar peaks (o) and 
(p) appear to be diols from their polarity, and there are at least 
three other minor metabolites which may be other isomers in 
this region. Peak (m) has the mobility of a triol, and may conse­
quently be the 15,16-dihydroxy-1-hydroxymethyl derivative of
(II). Peak (1) is also a triol, but from its u.v. spectrum is quite 
clearly a 1,2-dihydro diol further hydroxylated in ring D; split­
ting of the main peak at 269 nm into two peaks of similar inten­
sity at 258 and 267 nm on reduction of the carbonyl group is 
most characteristic of the 1,2-diol system (see Table II). This 
metabolite (1) thus corresponds to metabolite (a) from compounds
(I) and (III) — (V). However it is less polar than the latter because 
the diol system is gwast-diequatorial, the 1-methyl group taking 
up a quasi-sudal conformation. A precedent exists (16) for ox­
idation at C(l) already carrying a carbon substituent in these com­
pounds ; 15,16-dihydro-1,11 -methanocyclopenta[a]phenanthren- 
17-one is also metabolised to form a 1,2-diol, but here the diol 
is <7«a.«-diaxial due to constraint by the 1,11-methylene bridge 
in the plane of the aromatic rings.
No evidence of a prominent 3,4-dihydrodiol or further 
hydroxylated derivative, characteristic of compounds (I) and
(III) —(V), was observed among the metabolites (k —x) of the
1-methyl-17-ketone (II). However peak (k) exhibits chromophores 
which strongly suggest a 1,2,3,4-tetrahydro-tetraol structure; this 
could of course have arisen by further metabolism of either a 
(diequatorial) 1,2-dihydrodiol or a transient 3, 4-dihydrodiol. A 
clue to the apparent absence of 3,4-diols comes from identifica­
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tion of the least polar phenol (x) as the 4-phenol (15,16-dihydro-4- 
hydroxy-l-methylcyclopenta[a]phenanthren-17-one, VI). Both the 
elution time and the u.v. spectra (neutral, alkaline, and reduc­
ed) of this metabolite were indistinguishable from those of the 
synthetic 4-phenol. Presumably (x) arises from facile isomerisa- 
tion of the initially formed 3,4-epoxide of (II) before it can 
undergo enzymic hydration. Isomerisation is probably promoted 
by electron release by the /?-methyl group because the reverse, 
stabilisation of epoxides towards isomerisation, known to be 
favoured by electron withdrawal (17). Of the other phenols, (q) 
and (r) have u.v. spectra similar to that of the 4-phenol (x), but 
have the polarity of diols and are therefore probably the 15- and
16-hydroxy derivatives of (VI). Peaks (n, probably a triol) and 
(s, probably a diol) are similar, but somewhat different from (q) 
and (r) in that their anions lack the strong absorption at — 325 nm. 
They could possibly be 4-phenols additionally hydroxylated at 
the methyl group (r), and also in the D ring (n). Finally the phenol 
(t) shows general similarity to both sets of phenols.
In summary, the l-methyl-17-ketone (II) appears to be 
metabolised at the A and D rings, like the other four compounds, 
but differs from them in that the 3,4-epoxide rapidly isomerises 
to the 4-phenol (VI) which itself gives rise to a range of hydroxy 
phenols. The C(l)-methyl group is also extensively hydroxylated, 
and despite its presence the C(l), C(2) double bond is attacked 
to yield a 1,2-dihydrodiol. The lack of a 3,4-dihydrodiol for con­
version to a bay-region diol epoxide appears to offer a satisfac­
tory reason for the non-carcinogenicity of 15,16-dihydro-1- 
methylcyclopenta[a]phenanthren- 17-one (II).
By contrast, the non-carcinogens (I) and (IV) form trans-
3,4-dihydrodiols in amounts commensurate with those given by 
the two carcinogens (HI) and (V). Thus the general conclusion 
to be drawn from this study is that although correct initial 
metabolism is obviously necessary, other factors, among which 
are the necessity for further metabolism to a diol epoxide of the 
right stereochemistry and stability, are also essential in causing 
these compounds to be carcinogenic.
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The biological activity and activation of 15,16-dihydro-l, 11- 
methanocyclopenta[a]penanthren-17-one, a carcinogen with an 
obstructed bay region
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The proposal that an unobstructed bay region is a pre­
requisite for tumorigenic activity in cyclopenta[a]phenan- 
threne-17-ones is not supported by the observation of the 
tumorigenicity of 15,16-dihydro-l, 1 l-methanocyclopenta[a]- 
phenanthrene-17-one towards the skin of T.O. mice. The title 
compound is oxidised in vitro by a mixed function oxidase to 
produce, inter alia, a (r<ms-3,4-dihydrodiol, postulated as the 
proximate tumorigen. Unequivocal identification of a second 
metabolite as a /Tw7S-l,2-dihydrodiol derivative demonstrates 
the potential for enzymatic oxidation within the obstructed 
bay region and supports the proposal that the ultimate 
tumorigen is a (ra«5-3,4-dihydrodiol-c/7(/-l,2-oxide. This is 
further substantiated by the chromatographic behaviour of 
the major hydrocarbon-nucleoside adduct derived from 
mouse skin treated with the parent compound in vivo. The 
structures of certain others of the metabolites produced in 
vitro are also considered.
Introduction
Extensive studies on members of the cyclopenta[a]phenan- 
thren-17-one series (Figure 1 ,1) have shown that tumorigenic 
activity is critically dependent upon both the position and 
nature of substituents within the aromatic nucleus (1). Table I 
illustrates that small electron-releasing groups at C-7 or C-ll 
potentiate activity in the otherwise inactive series, while ter­
minal ring substituents (C-l — C-4) fail to do so. Furthermore 
the tumorigenic activity of C-l 1 substituted analogues 
diminishes rapidly as a function of increasing chain length, as 
demonstrated by both the 11-alkyl and 11-alkoxy series (1,2). 
The most active cyclopenta[a]phenanthren-17-one (IB) is 
metabolised to a /ram'-[3R],[4R]-dihydrodiol-««(/-l,2-oxide
(II) (3,4), and the binding to DNA of this species is believed 
to be responsible for the observed biological activity (5).
Recognition that the terminal benzo ring is the principal 
site of activation within this series as it is with many other 
polycyclic compounds (6), taken in conjunction with the 
observed structure-activity relationships, prompts this study 
of 15,16-dihydro-l, 11 -methanocyclopenta[a]phenanthren-l 7- 
one (III). This compound retains an essential electron-releas­
ing substituent at C-l 1 but also has a rigidly obstructed bay 
region and a terminal ring substituent, both latter features 
postulated as being deleterious to biological activity. The aim 
of this study is to evaluate the relative importance and possi­
ble roles of such structural modifications in determining 
activity.
Materials and methods
Chemistry
The title compound (III), the synthesis of which has been reported (7), was 
labelled with tritium by catalytic exchange at the Radiochemical Centre, 
Amersham, UK, and purified here (8 ) to a final specific activity of 1.935 
Ci/mmol.
Skin tumour induction
The title compound (III) was tested twice in both the initiation promotion and 
repeated application assays, using formally randomised T.O. mice in groups 
of 20 (10 male and 10 female). Conditions were generally as described 
previously (9). Mice in group 1 received twice-weekly applications to their dor­
sal skin of a toluene solution of the compound (in) (50 ^g in 10 /d) for 
50 weeks; group 2 received similar treatment for 39 weeks. Mice in groups 3 
and 4 were treated topically with a single dorsal dose of the compound (400 fig 
in 40 ix 1 toluene). After one week, twice-weekly applications of croton oil in 
toluene (1:99 v/v; 10 /d) were undertaken and continued for the two year 
duration of the experiment. Groups 5 —7 were controls: 5, toluene twice 
weekly; 6 , croton oil twice weekly; 7, clipped and otherwise untreated. 
Animals in all groups were observed for two years.
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Fig. 1. Structures of isomeric cyclopenta[a]phenanthren-17-ones mentioned 
in the text (I); the ultimate active form of 15,16-dihydro-l 1- 
methylcyclopenta[a]phenanthren-17-one (II); 15,16-dihydro-l,11- 
methanocyclopenta[a]phenanthren-17-one (III), and 4,5-methylene- 
phenanthrene (IV).
Table I. Carcinogenicity of isomeric methyl cyclopenta[a]phenanthren-17- 
ones (see Figure 1)
Compound Carcinogenicity3,15^
IA < 1
IB 46
IC < 1
ID 1 0
IE (all isomers) < 1
aExpressed as Iball index.
bTested as complete carcinogens by skin-painting.
cSee reference (1).
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Table II .  Skin tumour incidences of formally randomised TO mice treated with 15,16-dihydro-l,ll-methanocyclopenta[a]phenanthren-17-one
Group
( 1 0  o* + 10 9 
per group)
Treatment No. of tumourless survivors at (months)
6  12 18 24
No of mice with squamous 
papillomas carcinomas
Total no. of 
mice with 
tumours
Mean latent
period
(weeks)
1 a 18 11 8 2 6 2 8 39
2 b 19 14 7 1 6 3 1 1® 45
3 c 14 1 0 4 4 7 4 1 2 h 29
4 c 14 3 1 0 8 6 14 27
5 d 19 17 15 8 0 0 0 -
6 e 19 18 15 5 0 0 0 -
7 f 2 0 19 16 6 0 0 0 -
aMice received 50 fig of (ID) in 10 fil toluene twice weekly for 50 weeks. 
bMice received 50 fig of (III) in 10 fil toluene twice weekly for 39 weeks.
cMice received 400 fig of (III) in 40 fil toluene once, then 10 fil of a 1% v/v solution of croton oil in toluene twice weekly for 50 weeks.
dMice received 10 fi\ of toluene twice weekly for .50 weeks.
eMice received 1 0  p\ of a 1 % v/v solution of croton oil twice weekly for 50 weeks.
fMice were clipped but otherwise untreated.
8Histology unavailable for two mice. 
hOne animal had a spindle cell sarcoma.
Preparation o f  metabolites and their reaction with DNA in vitro
The title compound (III), labelled with tritium at 0.74 mCi/mmol, was 
metabolised using hepatic microsomes prepared as described previously (5) 
from male Sprague-Dawley rats (-200  g) induced with a solution of Aroclor 
1254 in com oil (120 mg in 3 ml; i.p., 4 days before sacrifice). Details of in­
cubation procedures, isolation of metablites by h.p.l.c., and methods used to 
study binding to exogenous DNA in vitro have been described (5).
Binding to DNA in vivo
Male T.O. mice, 7 —9 weeks old, were used in groups of 20. All protocols in­
volved closely followed those previously described (5).
Mutagenicity assays
Metabolites were tested for mutagenicity towards Salmonella typhimurium 
TA 100 using a standard plate incorporation assay (10) with a rat liver 
homogenate supplement. Adenosine-5'-triphosphate (ATP, 20 mmol/ml; 
Sigma Chemical Co., London, UK) was added to the supplement on occa­
sions as specified in the text.
Analysis o f metabolites
Isolated metabolites were purified to homogeneity by further reverse-phase 
h.p.l.c. prior to analysis. Proton magnetic resonance (p.m.r.) spectra were 
recorded on a Bruker WH 400 spectrometer (Queen Mary College, London, 
UK) in CD3OD using tetramethylsilane as the internal standard. U.v. spectra 
were recorded for solutions in methanol on a Perkin-Elmer Coleman 572 
spectrophotometer, using 1 cm path length cells. Electron-impact mass spec­
tra were measured at 70 eV by direct insertion into an AEI MS 902 mass 
spectrometer coupled to a MSS data acquisition unit (Queen Mary College).
Results
Skin tumour induction by compound III 
The results of the duplicate experiments (Table II) indicate 
That the title compound (HI) is substantially active in both the 
initiation-promotion and repeated application assay, ap­
proaching the activity of 15,16-dihydro-11-methylcyclopenta- 
[a]phenanthren-17-one (IB) as a tumour initiator but being 
considerably less active as a complete tumorigen.
Bacterial mutagenicity o f  compound III 
In contrast to its behaviour as a relatively strong tumorigen, 
the title compound (III) elicits only a very low mutation fre­
quency in S. typhimurium TA 100 (Table III). Although 
showing dose-response behaviour the mutation frequency is 
only approximately twice background at its optimum. This 
contrasts strongly to compound IB which produces over 25 
times the background number of revertant colonies at an op­
timum dose of 10 jig/plate when employed as a positive con­
trol. Addition of ATP to the activating system, stimulating 
sulphotransferase activity and facilitating conjugation of
Table III. Mutagenicity of (III) towards S. typhimurium TA 100 using a rat 
liver homogenate activating system additionally fortified with ATP
Number of revertant colonies/platea’b
-A T P + ATP
Test 1 (20 fig) 205 ± 22 
Test t (20 fig) 273 ± 18.2
236 ± 13.3 p  >0.9 (t-test) 
297 ± 2 5  p  >0.9 (t-test)
background, not subtracted, was unaffected by ATP: 116± 2.5, test 1; 
114 ± 20.2, test 2. 
bMean of 5 plates ±  1 SD.
putative hydroxyl functions (11), fails to enhance the muta­
tion frequency. This result offers no support to the postulate 
that the activity of the title compound (III) in vivo relies upon 
an activation pathway normally redundant in vitro leading to, 
for example, a reactive benzylic carbonium ion intermediate 
(12).
The profile of the ethyl acetate-extractable metabolites 
formed by incubation of compound (III) with rat liver 
microsomes in vitro, and separated by reverse phase h.p.l.c. is 
shown in Figure 2. When equivalent amounts of fractions
(i)—(x), based on radioactivity, are examined for their muta­
genicity, only fraction (iv) elicits a higher reversion rate than 
the parent compound (III, fraction x). Relative average rever­
sion rates are: (i) 18, (ii) 24, (iii) 23, (iv) 160, (v) 44, (vi) 28, 
(vii) 80, (viii) 59, (ix) 43 and (x) 100%. Fraction (iv) apparent­
ly consists of a single metabolite (b) with a retention time ex­
pected for a diol derived from (III).
DNA binding in vivo and in vitro
Treatment of mouse skin with high specific activity [ ^ c o m ­
pound (III) and subsequent isolation and hydrolysis of DNA 
gives a peak of radioactivity eluting from Sephadex LH 20 
later than the least mobile unmodified nucleoside, adenosine. 
Further examination of this fraction by h.p.l.c. discloses a 
pattern of adducts as shown in Figure 3. In keeping with
15,16-dihydro-11 -methylcyclopenta[a]phenanthren-17-one 
(IB) a single adduct accounts for over 80% of the radio­
activity bound (5). The pattern of adducts obtained from in 
vitro microsomal oxidation of compound (III) in the presence 
of exogenous DNA proves essentially identical: this is verified
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Fig. 2. Separation of metabolites of the 1,11-methano-17-ketone (III) by 
reverse-phase h.p.l.c. Conditions used: Whatman Partisil M9 10/50 ODS 
column eluted with a linear gradient of methanol in water commencing at 
15% and increasing at a rate of 1%/min.
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Fig. 3. Separation by h.p.l.c. of deoxynucleoside adducts of compound 
(III) derived in vivo. Conditions used: Whatman Partisil 10/25 ODS 
column equilibrated in 1 0 % methanol in water and eluted with an 
increasing methanol gradient of 0 .2 %/min.
by the observation that equal amounts of the major in vivo 
and in vitro adducts co-elute, giving rise to a single sharp 
peak. Incubation of metabolite b (Figure 2) with microsomes 
in the presence of DNA generates a single adduct chromato- 
graphically indistinguishable from the major adduct derived 
from the parent compound (III) and eluting slightly ahead of
250 273270
x4
330
257
•371
2
298
321 328
348
359 375
Wavelength (nm)
270
270
260
338
323
374
Wavelength (nm)
Fig. 4. U.v. spectra of metabolites a and b. Broken lines refer to spectra of 
metabolites after in situ reduction with sodium borohydride. Inserts refer 
to spectra of 1,2-dihydrodiol (a) and 3,4-dihydrodiol (B) derivatives of the 
11-methyl-17-ketone (IB).
the major adduct derived from compound IB. On the basis of 
the high level and identity of binding to DNA both in vivo 
and in vitro, metabolite b is proposed as the proximate 
tumorigen/mutagen.
Analysis o f  metabolites
Metabolite b. The u.v. spectra of this metabolite specifically 
resemble the corresponding spectra of the trans-3,4-dihydro­
diol derivative of the 15,16-dihydro-ll-methylcyclopenta[a]- 
phenanthren-17-one (IB) (Figure 4). The hypsochromic shift 
upon in situ reduction with sodium borohydride indicates an 
intact, conjugated carbonyl function.
The mass spectrum (Table V) has an apparent molecular 
ion at m/z 260.0711 (C18Hi20 2 requires m /z 260.0837). The 
trans-3,4-dihydrodiol function is clearly identified by other 
means (vide infra) therefore this ion is believed to arise 
through facile loss of the elements of water from the true 
molecular ion, as can be seen to occur with analogous trans-
3,4-dihydrodiols leading in each case to the base peak (3,4).
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Table IV. Electron impact mass spectra of metabolites a and b, and of com­
pounds II and IV. Fragment ions >  10% abundance of base peak reported
Metabolite b Metabolite a III IV
mass intensity mass intensity mass intensity mass intensity
261 14.6 279 15.3 245 11.3 191 1 0
260 58.6 278 69.2 244 57.3 190 1 0 0
258 1 0 .6 261 23.0 216 1 2 .1 189 80
232 13.3 260 1 0 0 .0 215 2 2 . 6 187 1 0
231 13.3 259 11.5 213 16.5
219 13.3 251 11.5 203 17.3
218 58.6 250 46.1 2 0 2 1 0 0
213 1 2 .0 249 50.0 189 17.3
(204 9.3) 244 17.3 188 17.8
2 0 2 14.6 235 11.5
232 23.0
231 15.3
219 21.1
218 80.7
217 13.4
Table V. Partial p.m.r. spectra of metabolites a and b
Metabolite Chemical shift (p.p.m.) and Assignment'
coupling constants (Hz)
8.14-7.67 Ar-H (3H)
7.00; d, J3j4 = 9.5 H-4 (1H)
6.46; d.d, j 3>4 = 9.5, J2>3 = 5.5 H-3 (1H)
4.48; d, J2 3 ’= 5.5 H-2 (1H)
4.18 s (broad) H-18 (2H)
8.47; d, J6 7  = 9 H - 6  or H-7 (1H)
8.14; d, J6 ’7 = 9 H - 6  or H-7 (1H)
7.64; s ’ H-12 (1H)
6.14; m, J2 3  — 3.5, J2 jg = 2.0 H-2 (1H)
6.02; d, J3 4 = 5.5 H-4 (1H)
a4.78; m, j 3 4 = 5.5, J2;3 3.5 H-3 (1H)
4.15; d, (unresolved) H-18 (2H)
irradiation of this signal causes the signal at 6  = 6 . 0 2  to collapse to a 
singlet while the signal at 8 = 6.14 collapses to a partially resolved triplet.
Available evidence does not distinguish between an authentic 
fragmentation of the molecular ion and thermal dehydration 
within the probe of the spectrometer. Subsequent fragmenta­
tion: m/z 258, [M-H20-H 2] t ;  232 [M-H20-C0] t  or [M- 
H20-C 2H4] t , and 204, [M-H20-C2H4-C0] i  are those ex­
pected from breakdown of the unmodified five-membered 
ring (13). In addition, a major fragment ion occurs at m/z 
218. Predominant loss of 42 atomic mass units from either 
the molecular ion or base peak appears exclusive to the title 
compound (III) and certain of its metabolites and is not com­
monly observed among other cyclopenta[a]phenanthren-17- 
ones (3,4,13). No corresponding fragment occurs in the mass 
spectrum of 4,5-methylenephenanthrene (IV) (Table IV). 
Therefore this peak may represent loss of a ketene moiety 
from the cyclopentenone ring in a process facilitated by the 
presence of the methylene bridge and concomitant introduc­
tion of strain into the molecule.
The partial proton magnetic resonance spectrum of 
metabolite b (Table V) is consistent with the putative trans-
3,4-dihydrodiol structure, assignments being substantiated by 
selective proton spin-decoupling experiments. The coupling 
constant between the carbinol protons, ^ 4  = 5.5 Hz, is 
significantly smaller than analogous coupling constants
CO
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Fig. 5. Elution of the major deoxynucleoside adduct of compound (III) 
from a Sephadex LH 20 column equilibrated with 20% methanol in buffer 
and eluted with an increasing gradient of methanol in 0.05 M Tris-HCl, 
pH 8.7 (broken line) or in 0.05 M borate, pH 8.7 (solid line).
found for trans-3,4-dihydrodiols derived from other cyclo- 
penta[a]phenanthren-17-ones. These lie typically in the range 
of 10—12 Hz (1A — C) (4) indicating that in each case the 
hydroxyl functions are in a predominantly gMtfsf-diequatorial 
conformation. In this instance, however, the average dihedral 
angle between the hydroxyl groups is larger leading to a loss 
of hydrogen bonding and a consequent increase in polarity.
This is reflected in the smaller elution volumes (reverse-phase 
h.p.l.c.) of both the metabolite itself and the derived nucleo­
side adduct as compared to the respective species generated 
from 15,16-dihydro-11 -methylcyclopenta[a]phenanthren-
17-one (IB). It is interesting to speculate that the weak 
mutagenicity of the title compound (III), mediated via a fur­
ther derivative of metabolite b, may also reflect the increase 
in polarity, since the test relies upon the ability of metabolites ( 
generated extracellularly to permeate the lipophilic bacterial 
cell wall prior to expression of mutagenicity.
Metabolite a. Evidence for metabolic epoxidation of the 
C-l,2 double bond in the title compound (III) follows from 
identification of metabolite a as a fra«5- l,2-dihydrodiol 
derivative. The ultraviolet spectra resemble those reported for 
a 1,2-dihydrodiol derivative of compound IB (Figure 4). The 
mass spectrum has a molecular ion at m/z 278.0954 
(C18H 140 3 requires 278.0943) and fragment ions consistent
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Table VI. Comparison of the predominant fragmentations observed in the electron impact mass spectra of metabolites c—g and the synthetic compounds, 
15-hydroxy and 16-hydroxy-15,16-dihydro-l l-methylcyclopenta[a]phenanthren-17-one
°7o Intensity
c
Found 276.079400 
Ci8H 120 3 requires 
276.078642
d
Found 258 
Ci8H 10O2
e
Found 260 
Ci8H 120 2
f
Found 260 
C18H 120 2
g
Found 258.068078 
C 18H 10O2 requires 
258.067699
15-OH-(IB) 
Found 262 
Ci8H u0 2
16-OH-(IB) 
Found 262
Ci8H 140 2
M + l 13 _ 2 1 2 0 2 1 2 0 19
M 62 33 1 0 0 1 0 0 1 0 0 1 0 0 1 0 0
M - l 11 - 16 1 0 15 4 3
M -2 16 - 2 1 5 - - -
M - 16 40 - 7 6 - 4 3
M -  17 2 2 - 7 9 - 14 7
M - 18 1 0 0 - 7 1 2 - 40 1
M -28 - - 39 1 2 28 8 27
M -29 - 17 2 0 11 1 0 9 32
M -42 38 - 70 17 - 5 2
M -45 2 2 - 2 2 30 - 38 28
M -47 18 - 16 2 1 - 34 1 0
M -55 11 - 7 3 19 - -
M -56 13 - 11 6 91 - 4
M -58 24 - 39 2 2 31 6 11
M -71 29 - 26 32 14 15 14
275
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1257 g
262
275
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Fig. 6 . U.v. spectra of metabolites c - g  and the parent compound (III). 
Broken lines refer to spectra of metabolites after in situ reduction with 
sodium borohydride. The spectrum of metabolite d after treatment with 
base is also shown (Xmax 262, 310 nm).
with the proposed /ra/?s-l,2-dihydrodiol structure (Table IV). 
The p.m.r. spectrum (Table V) confirms this assignment. In 
the absence of a benzylic carbinol proton, the conformation
of the dihydrodiol system is inferred from a comparison of 
the other available coupling constants with those reported for 
trans-3,4-dihydroxy-3,4-dihydrophenanthrene in which the 
bay region hydroxyl groups adopt a quasi-diaxial conforma­
tion (14). The close agreement of the two sets of coupling 
constants indicates that the hydroxyl groups of metabolite a 
have the expected quasi-d\ax\a\ conformation.
Further metabolism o f  metabolite b
The implication of a trans-3,4-dihydrodiol as the promuta- 
genic/protumorigenic form of the title compound (III) and 
identification of a trans-1,2-dihydrodiol derivative suggest 
that the ultimate form of compound (III) is probably a bay 
region diol-epoxide by comparison with the established route 
of activation of the carcinogen IB. This idea is supported by 
the chromatographic behaviour of the major nucleoside ad­
duct. The elution volume of this species from Sephadex LH20 
is reduced specifically by addition of a borate buffer to the 
eluent (Figure 5). This is consistent with formation of a cyclic 
borate complex involving a vicinal ds-diol system as would be 
produced at C-2/C-3 by nucleophilic attack at C-l of an anti- 
diol-epoxide (15). Since there is insufficient material to allow 
direct use of the appropriate spectrometric methods, confir­
mation of this finding awaits synthesis of the pertinent inter­
mediates.
Other metabolites o f  15,16-dihydro-l,11-methanocyclo- 
penta[a\phenanthren-17-one
U.v. and mass spectral data for metabolites c-g are presented 
in Figure 6 and Table VI, respectively. The u.v. spectra of 
metabolites c, e, and f (Figure 6) are closely similar and 
resemble that of the parent compound (III); these metabolites 
therefore appear to retain the intact methanophenanthrene 
system conjugated to a C-l7 carbonyl group. After in situ 
treatment with sodium borohydride the ultraviolet spectra of 
metabolites e and g become identical and very closely resem­
ble that of similarly reduced metabolite c. Reduction of 
metabolite f leads to a spectrum resembling that of the reduc­
ed parent, i.e., 15,16-dihydro-l,ll-methanocyclopenta[a]- 
phenanthrene-17-ol. The observation of bathochromic shift
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Fig. 7. Proposed structures of principal metabolites of compound (III) 
found in vitro; c is probably the 15,18-diol, and f the I6 -0 I (see text).
in the ultraviolet spectrum of metabolite d upon treatment 
with base suggests the presence of a potentially acidic func­
tion.
The mass spectra (Table VI) suggest that metabolites d and 
g are diketone derivatives of the title compound (III), while e 
and f are monohydroxylated derivates and c a dihydroxylated 
derivative. The uncharacteristically long wavelength absor­
bance and red shift (u.v.), and relatively short retention time 
(h.p.l.c.) for an alleged diketone suggest that the second car­
bonyl function of metabolite d may be situated at C-l5. These 
observations may then by rationalised in terms of a preferred 
enol tautomer. Metabolite g, also a diketone, shows none of 
the anomalies associated with d. Therefore, the second car­
bonyl function is assigned to the C-l 8 position.
On the basis of these deductions, the hydroxyl function in e 
is assigned to the C-l8 position (congruence of reduced u.v. 
spectra of e and g). The similarity of the reduced spectrum of 
metabolite c with that of e and g suggests that one hydroxyl 
group in c is at C-l8; the second must therefore be at C-l5 or 
C-16. Further information comes from a comparison of the 
fragmentation patterns of metabolites c and f with those of 
synthetic 15- and 16-hydroxy derivatives of the 11-methyl-17- 
ketone (IB). Loss of the elements of water from the former is 
a major fragmentation pathway, but this is not so for the lat­
ter. By analogy therefore, metabolite c is the 15,18-diol 
whereas metabolite f is the I6-0I. The same conclusion is 
reached concerning the latter by consideration of the non­
identity of the reduced spectra of metabolites d and f. The 
proposed structures are summarised in Figure 7.
Discussion
The tumorigenicity of the title compound (III) is not entirely 
without precedent. Dunlap and Warren (16) found that the 
corresponding methano- analogue of dimethylbenz[a]anthra- 
cene, l,12-methano-7-methylbenz[a]anthracene, elicited 
tumours in mice after a single subcutaneous injection in 
tricaprylin. Furthermore, recent reports have also described 
metabolic oxidation at substituted aromatic double bonds in 
both 7-methylbenzo[a]pyrene (17) and 8-methylbenz[a]- 
anthracene (18).
The evidence presented strongly implicates a trans-3,4- 
dihydrodiol-awfr- 1,2-oxide analogous to structure (II) as the 
acti^p form of 15,16-dihydro-l, 1 l-methanocyclopenta[a]- 
phenanthren-17-one (III). This result emphasises the role of 
C -ll substituents in endowing cyclopenta[a]phenanthren-17-
ones with carcinogenic activity and further demonstrates that 
substitution at an aromatic double bond is not sufficient to 
prevent metabolic oxidation.
The obstruction to the bay-region provided by the 
methylene bridge is mainly within the plane of the molecule. 
It is probable that the active oxygen species is inserted from 
either above or below this plane in the active site of the en­
zyme; this would help to explain the inhibitory effect of in­
creasing size and chain length of C-ll substituents which are 
not confined to this plane. Finally, bay-region dihydrodiol- 
epoxides of terminal ring methyl-substituted (inactive) cyclo- 
penta[a]phenanthren-17-ones would experience different con­
formational constraints to those of the title compound (III). 
Work in progress is exploring the role of such conformational 
differences in determining carcinogenic potential.
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Abstract
Eight main metabolites of the parent carcinogen 15,16-di­
hydro-1 l-methylcyclopenta[a]phenanthrene-17-one (I) were 
assayed for their ability to initiate skin tumours in T.O. mice 
after topical application in two-stage experiments with croton 
oil used as the promoter. All were less active than I with the 
exception of the /ra/Ls-3,4-dihydro-3,4-diol which was more 
than ten times as active. This diol is therefore confirmed as 
the proximate carcinogen, a conclusion reached previously on 
different evidence.
Introduction
We have previously (1) identified a tAms-3,4-dihydro-3,4- 
diol as the probable proximate form of the carcinogen
15,16-dihydro-1 l-methylcyclopenta[a]phenanthren-17-one (I) 
(Figure 1), which is itself similar in potency to benzo[a]pyrene 
in inducing skin tumours in mice (2). Of the eight main 
metabolites of I isolated after in vitro metabolism with rat 
liver microsomal preparations (1,3,4) this 3,4-diol reacted the 
most extensively with DNA; moreover it was the only 
metabolite to yield the main nucleotide adduct isolated from 
the DNA of the skin of mice following topical application of I 
in vivo (1,5). It was also more mutagenic towards Salmonella 
typhimurium TA100 than the carcinogen itself or any of the 
other metabolites (1). It was therefore of interest to in­
vestigate the skin tumour initiating potential of this com­
pound in comparison with that of the carcinogen I and its 
other metabolites, employing T.O. mice known to be suscep­
tible to I.
Materials and Methods
Chemicals
Compounds I - IV  (Figure 2) were prepared here as previously described
(6), and their purity was established by standard methods. 14C-methyl-labelled 
carcinogen I (7) with a specific activity of 9.34 mCi/mmol was used in the 
metabolic experiments to facilitate quantitation of the metabolites. Acetone 
and toluene were Analar grade from Fisons Ltd., Loughborough, croton oil 
was obtained from Sigma Chemical Co., St. Louis, and NADPH from 
B.D.H. Chemicals Ltd., Poole.
Metabolic preparation
Metabolites were prepared as follows: to 20 ml of Tris buffer (pH 7.2,
0.1 M) contained in a 250 ml conical flask and pre-warmed to 37°C was add­
ed, in order [14C](I) (5 //mol in 200 //l dimethyl sulphoxide), NADPH (100 mg), 
and microsomes [prepared from 12 g of liver from methylcholanthrene- 
induced rats (3)] suspended in 5 ml of buffer. The mixture was shaken, open 
to air, at 37°C for 30 min then cooled in ice. The cold mixture was extracted 3 
times with ethyl acetate (25 ml), and the extracts were pooled and 
dried over anhydrous sodium sulphate. Extracts from four such preparations 
were together evaporated to dryness in vacuo, redissolved in methanol/water 
(95:5 v/v) (400 /d), and fat was removed from this solution by one extraction
with an equal volume of hexane. The clear yellow methanol solution was in­
jected on to a Whatman Partisil M9 10/50 ODS column (Whatman Ltd., 
Maidstone) fitted to standard Waters Associates h.p.l.c. equipment, and 
eluted with methanol/water (15:85 v/v) changing to methanol alone in a linear 
gradient at 1%/min at a flow rate of 120 ml/h. The major metabolites and 
unchanged ketone (I) were collected separately; they amounted to 73% of the 
radioactivity used. From a total of 85 //mol of I processed in this manner were 
obtained the 1,2,15-triol (9.06//mol, 10.7% yield), 3,4,16-triol (5.2, 6.1%), 
3,4,15-triol (2.99, 3.5%), 11-hydroxymethyl-15-ol (3.27, 3.8%), 3,4-diol 
(2.53, 3.0%), monohydroxy compounds (6.78, 9%), and unchanged I (4.22, 
5.0%) after purification by further h.p.l.c. The five polyhydroxy metabolites 
and recovered carcinogen (I) were dissolved in toluene/acetone (1:1 v/v) at 5 
//mol/ml for skin painting.
Skin painting experiments
Randomly bred Theiler’s Original (T.O.) Swiss mice from a closed colony 
maintained in these laboratories were divided by a formal randomisation pro­
cedure into groups of 10 mice of either sex for each experiment shown in 
Tables I - I I I .  Animals were maintained and treated essentially as previously 
described (8), and as indicated in these tables. Mice were killed when their 
largest skin tumour reached 1 cm in diameter, or when they died naturally; a 
few sick animals were killed earlier in order to avoid loss of material. 
Tumours were examined histologically, and those that involved the pan- 
niculus carnosus muscle were classified as carcinomas whilst those which did 
not were classified as papillomas.
Results and Discussion
As a preliminary to this comparative experiment a dose 
response study with the carcinogen (I) was undertaken in 
order to judge the minimum dose of the metabolically derived 
compounds that would be needed to give a meaningful result.
CH- 1600 nmol
-15
400 nmol
-1 0
SI
200 nmol
- 5
6020 80
Latent period (w eek s)
Fig. 1. The initiating dose of the carcinogen (I) shown was administered in 
40 fil of toluene to groups of 20 mice, and this was followed by twice-weekly 
promotion with toluene/croton oil (99:1 v/v, 10 //I). The curves represent the 
first appearance of the first skin tumour/mouse in Figures 1 -3 .
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Figure 1 and Table I show the time of first appearance of skin 
tumours in groups of 20 mice initiated with either 1600, 400, 
or 200 nmol of I dissolved in toluene, followed by twice- 
weekly promotion with croton oil. Even at the lowest dose the 
tumour incidence reached 50% with a mean latent period of
31.4 weeks. It was therefore considered that a dose of about 
this value would be suitable for the proposed comparison of 
metabolites.
All three mono-hydroxy derivatives of I [i.e., the 15-ol (II),
16-ol (III), and 11-hydroxymethyl compound (IV)] occur as 
microsomal metabolites in the approximate ratio 12:1:3 (4). 
However, these are difficult to separate by h.p.l.c., especially 
on a large scale as required here. It was therefore decided to 
test the three synthetic mono-ols (II, III and IV), although it 
was appreciated that the two former were racemic whereas 
the corresponding metabolites themselves were probably op­
tically active. Compounds II —IV, together with the parent 
carcinogen (I), were tested in groups of 20 mice with an in­
itiating dose of 1600 nmol/mouse (Figure 2 and Table II). For 
solubility reasons the solvent employed was acetone/toluene 
(1:1 v/v), and as before promotion was carried out twice 
weekly with croton oil. The initiating potential of the I6-0I
(III) (100% tumour incidence, mean latent period 26.6 weeks) 
was found to be not far short of that of the carcinogen (I) 
(95%, 21.4 weeks). The two other mono-ols II and IV were 
less active as demonstrated both by their tumour incidences 
(40% and 50%) and their longer mean latent periods (45 and 
41 weeks, respectively). The use of acetone/toluene (1:1 v/v) 
in place of toluene alone had the unexpected effect of 
shortening the mean latent period: 21.4 weeks for 1600 nmol
Table I. Dose response in the two-stage system with the carcinogen (I).
Initiating No. of tumourless No. of squamous Total no.
dose survivors at (months) papillomas carcinomas of mice
(nmol) 6 12 18 24 with < 
turn
1600 1 2 5 1 0 13 3 18
400 14 8 3 1 1 0 2 14
2 0 0 19 1 2 5 2 6 3 1 0
Croton oil
control 19 18 15 5 0 0 0
Toluene
control 2 0 18 16 7 0 0 0
The initiating dose in each case was administered to the shaved dorsal skin in 
40 /il of toluene. Twice-weekly promotion was begun one week later using 
10 /d of toluene/croton oil (99:1 v/v)/mouse. The initiating dose of car­
cinogen was omitted with the croton oil control mice, and both carcinogen 
and promoter were omitted with the toluene control animals.
of I in acetone/toluene (Figure 2) compared with 30.3 weeks 
for the same dose in toluene (Figure 1).
For comparison of the polyhydroxy metabolites it was 
finally decided to use a dose of 100 nmol/mouse because this 
required < 1  mg of each metabolite, an amount conveniently 
obtainable from several in vitro metabolic preparations and 
h.p.l.c. separations. The carcinogen (I) recovered from these 
preparations was used as a standard, and the solvent was 
again acetone/toluene followed by twice-weekly promotion 
as before. The results of this comparison (Figure 3 and Table 
III) are readily appreciated; the 3,4-diol is highly carcino­
genic. Both on the basis of tumour incidence (90%) and mean 
latent period (24.0 weeks) it is clearly much more active than 
the parent compound (I) (60%, 33.8 weeks); in fact its activi­
ty approaches that of I at 16 times the dose (Figure 2, 95%,
21.4 weeks). By contrast none of the other polyhydroxy 
metabolites is as active as I. The 3,4,16-triol produced five 
skin tumours (one regressed) with a mean latent period of 
53.6 weeks, while the 3,4,15-triol gave two papillomas (66 
weeks) and the 11,15-diol only one (38 weeks).
It is therefore clear that all the metabolites of the carcino­
CH.
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Fig. 2. First appearance of skin tumours after an initiating dose of 1600 
nmol of compounds I —III in 40 /xl toluene/acetone (1:1 v/v) followed by 
twice-weekly promotion with toluene/croton oil (99:1 v/v, 10 /il).
Table II. Skin tumour initiation with the ketone (I) and three synthetic monohydroxy derivatives (II—IV).
Compound3 No. of tumourless survivors at 
(months)
6  ' 12 18 24
No. of mice with 
papillomas
squamous
carcinomas
Total no. mice 
with dorsal tumours
Mean latent period 
(weeks)
Ketone (I) 5 0 0 0 13 6 19 21.4
15-ol (II) 2 0 17 1 0 3 6 2 8 45
I6 -0 I (III) 9 0 0 0 11 6 2 0 b 21
11-CHpH (IV) 17 13 5 2 6 2 10= 41
toluene/acetone control 19 19 11 4 0 0 0 -
aThe initiating dose in each case was 1600 nmol administered once in 40 /d of toluene/acetone (1:1 v/v). Twice-weekly promotion was begun one week later using 
10 fd of toluene/croton oil (99:1 v/v) for each mouse. Control mice received 40 /d of toluene/acetone initially. 'T’hree tumours were unavailable for histology. cOne 
tumour was unavailable for histology, and one tumour ( 2  mm) regressed.
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gen (I) are less active than the parent compound with the ex­
ception of the trans-3,4-dihydro-3,4-diol, which at a conser­
vative estimate is >  10 times as active. Thus, this diol is con­
firmed as the proximate carcinogen, a conclusion reached 
earlier on different grounds (1). The ultimate carcinogen, the 
a n ti-3 ,4-d ihyd ro-3 ,4-fra /75-d ihyd roxy-l ,2 -d ih y d ro -l ,2- 
ep oxide has not been isolated, but its structure has also been 
previously suggested (1), and recently confirmed by a mass 
spectral examination o f the adduct it forms with D N A  (9). 
The carcinogen 15,16-dihydro-l 1-methylcyclopenta[a]-phen- 
anthren-17-one (I) is therefore metabolically activated via a 
bay-region diol epoxide, like a number o f  related hydrocar-
- 1 0
3,4,16-Triol
- 5
3,4,15-Triol
80604020
Latent period (w eeks)
Fig. 3. First appearance of skin tumours after initiation with 100 nmol of I, 
the 3,4-diol, the 3,4,16-triol and the 3,4,15-triol, followed by twice-weekly 
promotion with toluene/croton oil (99:1 v/v, lOftl). The 15-hydroxy-l 1- 
hydroxymethyl derivative of I gave rise to one papilloma at 38 weeks; the 
1,2,15-triol was inactive.
Table m . Skin tumour initiation with the ketone (I) and its main 
microsomal metabolites.
Compound3 No. of tumourless No. of mice with Total no. of
survivors at squamous mice with
(months) papillomas carcinomas dorsal
6 12 18 tumours
1,2,15-triol 20 19 11 0 0 0
3,4,16-triol 20 18 12 3 0 5b,c
3,4,15-triol 19 18 11 1 1 2
11-hydroxy- 20 19 9 0 0 lb
methyl-15-ol
3,4-diol 6 1 1 13 2 18b
recovered I 17 8 5 5 1 12b
aThe initiating dose in each case was 100 nmol/mouse administered once in 
20 fil of toluene/acetone (1:1 v/v). Twice weekly promotion was begun one 
week later using 10^1 of toluene/croton oil (99:1 v/v) for each mouse. 
'Tumours were unavailable for histology (because death occurred and 
autolysis was too far advanced) as follows: 3,4,16-triol, 1; 11-hydroxymethyl- 
15-ol, 1; 3,4-diol, 3; I, 6; cOne tumour regressed after it had reached 3 mm 
diam.
bons ( 1 0 ) including those with a methyl group at an 
analogous position in the bay (1 1 -1 3 ) .
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liquid chromatographic separation and partial characterization
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A bstract
The 11-methyl derivative (11-methyl ketone) is the m ost 
carcinogenic of the series of methylated derivatives bas­
ed on 15,16-dihydro-cyclopenta[a]phenanthren-17-one. 
The nucleoside adducts derived from  [3H ]-ll-m ethyI 
ketone-m odified mouse skin D NA have been separated 
by both Sephadex LH -20 chrom atography and reverse- 
phase h .p .l.c . and com pared to those derived from  
D N A  modified in vitro with the [14C ]-ll-m ethy l ketone 
using rat liver m icrosom es. The in vivo modified DNA 
separated to give 6 adducts (designated I - V I )  on 
h .p .l.c . The m ajor in vivo adduct (80% total adducts) 
co-chrom atographed with the m ajor in vitro adduct. 
The m etabolites o f the 11-methyl ketone (designated 
a - g ) have been separated by h .p .l.c ., and the adducts 
derived from  each o f these individual m etabolites deter­
mined by fu rther m etabolism  in the presence of DNA. 
H .p .l.c . separation of these adducts has allowed 
characterization of the in vivo adducts. The m ajor ad ­
duct (V) and possibly one of the m inor adducts (IV) 
were derived from  the 3,4-dihydro-3,4-diol o f the 
11-methyl ketone (m etabolite e). A dducts II and III 
were derived from  the 16- and 15-monohydroxylated 
derivatives o f the 11-methyl ketone and also from  their 
corresponding 3,4-diols and therefore are likely to be 
the 16- and 15-hydroxy derivatives, respectively, of a d ­
duct V. A dduct VI, however, although derived from  the
15-hydroxy-3,4-diol had a late retention time on 
h .p .l.c ., suggesting either a non-diol-epoxide adduct or 
a deoxyadenosine adduct. The use of [3H-G ]D N A  has 
established that the m ajor adduct (V) and the
16-hydroxy-derived adduct (II) contain deox- 
yguanosine. Reaction of the carcinogen with [3H- 
A]poIy(dA-dT) gave adduct VI which was the only ad ­
duct peak shown to contain [3H ]deoxyadenosine.
In troduction
T he reaction o f  chemical carcinogens with cellular 
m acrom olecules, especially D N A , seems to be an im por­
tant step in the initiation o f  carcinogenesis. The iden­
tification o f  the adducts formed between the carcinogen
*Abbreviations: 11-methyl ketone, 15,16-dihydro-l 1-methyl-
cyclopenta[a]phenanthren-17-one; poly (dA-dT), alternating co­
polymer o f deoxyadenylic and deoxythymidylic acids.
and D N A , therefore, is im portant for a fuller 
understanding o f  their m ode o f  action. The com pound,
15,16-d ih ydro-11 -m ethylcyclopenta[a]phenanthren-l 7- 
one (11-methyl ketone*, Figure 1, structure II) is the
Fig. 1. The parent compound, 15,16-dihydro-cyclopenta[a]- 
phenanthren-17-one (I) and its carcinogenic 11-methyl analog (II).
m ost carcinogenic member o f  the series o f  m ono- 
m ethylated derivatives based on the com pound,
15,16-dihydro-cyclopenta [alphenanthren-17-one (Fig­
ure 1, structure I). The series contains com pounds with  
a gradation o f  carcinogenic effectiveness resulting only  
from  altering the position o f  the m ethyl group (1). The 
11-methyl ketone is carcinogenic on m ouse skin after 
topical application o f  a low dose or after i.m . injection  
o f  a higher dose (2). It is o f  equivalent carcinogenicity to 
benzo[a]pyrene on topical application to m ouse skin (2) 
and is m utagenic to Salmonella typhimurium T A  100 
(3). It is activated via a vicinal diol-epoxide in the bay- 
region (4) although hydroxylation can also occur in the 
11 -, 15- and 16-positions o f  the m olecule (5). A  covalent 
bond with D N A  is form ed both in vitro after m etabolic 
activation (6) and in vivo on m ouse skin (4). Partial 
separation o f  the D N A  adducts has been achieved on  
Sephadex LH -20 allow ing quantitation o f  the extent o f  
total carcinogen binding (4, 6).
In this paper, we present the separation by h .p .l.c . o f  
the carcinogen -  D N A  adducts form ed both in vivo and 
in vitro. The pattern o f  adducts form ed in vitro, using 
rat liver m icrosom es, resembles that found in vivo from  
m ouse skin. By analysis o f  the D N A  adducts form ed  
from  individual m etabolites o f  the 11-m ethyl ketone the 
origin o f  specific adducts has been elucidated and a bet­
ter understanding o f  the m etabolism  o f  the carcinogen  
has been achieved. The m ajor adducts form ed in vivo 
involve covalent attachm ent o f  the carcinogen to  either 
deoxyguanosine or deoxyadenosine.
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Materials and Methods
R a d i o c h e m i c a l s  a n d  e n z y m e s
The 1 l-raef/2j>/-14C-labelled carcinogen (Figure 1; 9.3 
m C i/m m ol) was prepared in these laboratories (7). 
General tritium labelling o f  the carcinogen (4.63 C i/  
m m ol) was performed by the R adiochem ical Centre, 
Am ersham , UK, follow ed by purification in these 
laboratories (8). Tritium-labelled deoxynucleoside 
triphosphates were obtained from the Radiochem ical 
Centre. Specific base-labelled D N A  was prepared accor­
ding to Kelly e t  a l .  (9), using the appropriate tritium- 
labelled triphosphates and E .  c o l i  D N A  polymerase I. 
The [3H -A -]poly(dA -dT) was prepared according to 
Schachman e t  a l .  (10), using [3H ]dA T P, dTTP and E .  
c o l i  D N A  polym erase I.
Pancreatic D N ase I (type 1, E .C .3 .1 .45 ), snake 
venom  phosphodiesterase (type II, E .C .3 .1 .4 .1), E .  c o l i  
alkaline phosphatase (type II, E .C .3 .1 .3.1), and pan­
creatic RNase (type III-A , E .C .3 .1 .4.22) were obtained  
from Sigm a, L ondon, UK. E .  c o l i  D N A  polym erase I 
(E .C .2 .7 .7 .7 ) was obtained from Boehringer, Lewes, 
UK.
I n  v i t r o  m e t a b o l i s m  a n d  s e p a r a t i o n  o f  m e t a b o l i t e s
The general procedure for the isolation o f  m etabolites 
has been described previously (4, 5). For the large scale 
preparation o f m etabolites required in these ex­
perim ents, the follow ing incubation mixture was used: 
10 ix mol [14C]-11-m ethyl ketone, 125 mg N A D P H , 
m icrosom es from 40 g rat liver in 0.1 M Tris-H Cl, pH
7.2 , in a total volum e o f  25 ml. The mixture was in­
cubated at 37°C  for 30 min before ethyl acetate extrac­
tion and separation o f  the m etabolites on a W hatman  
Partisil M9 10/50  ODS colum n (W hatman Ltd., 
M aidstone, UK) using a Waters h .p .l.c . system (Waters 
A ssociates, M A , U SA ).
I n  v i t r o  r e a c t i o n  o f  1 1 - m e t h y l  k e t o n e  a n d  i t s  m e t a b o l i t e s  
w i t h  D N A
The preparation o f  m icrosom es and their use in i n  
v i t r o  studies on the binding o f  the 11-methyl ketone to 
D N A  have been previously described (6). A  normal 
reaction mixture contained the follow ing: 2 mg labelled 
or unlabelled D N A , 0.4 / x mol [14C ]-11-methyl ketone, or 
one o f  its m etabolites in DM SO , m icrosom es from 2 g 
rat liver, 6 mg N A D P H , in total volum e o f  2 ml o f  0.1 
M Tris-H C l, pH 7.2 , 0.04%  agar. Incubation was car­
ried out at 37°C  for 1 - 2  h before extraction with 
chloroform -saturated 0.1 M Tris-phenol, pH 7.2 The 
sam ple was dialysed extensively before enzym atic 
hydrolysis (M ethod 1).
In the analysis o f  D N A  bases associated with the ad­
ducts, the labelled D N A  was contained in a small 
dialysis sac which was placed in the flask containing the 
m icrosom al enzym es and the carcinogen. Follow ing in­
cubation, the dialysis sac was transferred to a large flask 
o f  distilled water for several hours before enzymatic 
hydrolysis (M ethod 2).
[3H -A ]P oly(dA -dT ), after m odification with the 
11-methyl ketone by M ethod 1 was separated from any
endogenous D N A  associated with the m icrosom es by 
CsCl density gradient centrifugation. Solutions o f  CsCl 
containing m odified [3H -A ]poly(dA -dT) were prepared 
in 0.01 M potassium  phosphate buffer, pH 7.4, to a 
density o f  1.600 g /c m 3. Centrifugation was carried out 
at 45,000 r.p .m . in a M SE Superspeed 65 centrifuge for 
40 h at 25°C  and the position o f  the poly(dA -dT) was 
m onitored by both acid-insoluble radioactivity and ab­
sorbance at 254 nm. Poly(dA -dT)-containing fractions 
were collected, dialysed and enzym atically hydrolysed.
C a r c i n o g e n  t r e a t m e n t  o f  m o u s e  s k i n  a n d  i s o l a t i o n  o f  
D N A
Male T .O . M ice (Theiler’s Original, derived from  
Swiss), 7 - 9  weeks old were used in groups o f  10. For 
the analysis o f  carcinogen — D N A  adducts in m ouse 
skin, the dorsal skin o f  the mice was shaved with electric 
clippers (approx. area, 2.5 cm x 2.5 cm) and [G-3H ]-1 1- 
m ethyl ketone (4.63 C i/m m ol, 400 g g  in 40 g \  toluene) 
applied to the shaved area o f  each m ouse (2, 4). Three 
days after treatm ent, the shaved section o f  dorsal skin 
was removed and frozen in liquid nitrogen.
Frozen tissue was hom ogenized in cold 5% p -  
am inosalicyclic acid, 1% NaCl using a Polytron P-20  
(Northern M edia Supplies, N . Hum berside, UK), and 
D N A  isolated by repeated extraction with phenol m ix­
ture (500 g  phenol, 70 g  m -cresol, 0.5 g  8 hydroxy- 
quinoline, 50 ml water) follow ed by exhaustive dialysis. 
The dialysate was reduced to 5 m l, made 0.4%  in 
sodium  acetate, 1 mg heat-treated RNase added, and in­
cubated at 37°C  to remove contam inating R N A . After 2 
h, the mixture was again extracted with phenol mixture, 
follow ed by dialysis before enzymatic hydrolysis.
E n z y m a t i c  h y d r o l y s i s  a n d  S e p h a d e x  L H - 2 0  
c h  r o  m a  t o g  r a p h y
M odified D N A  was hydrolysed in 0.01 M Tris-HCl 
buffer, pH 7 .2 , 0.01 M M gC l2, with 1000 units o f  pan­
creatic DN ase I for 2 h at 37°C , follow ed by hydrolysis 
in 0.1 M Tris HC1, pH 9 .0 , with 0.05 units o f  snake 
venom  phosphodiesterase and 10 units o f  alkaline 
phosphatase for 16 h. Carcinogen — D N A  adduct 
separation was essentially according to the m ethod o f  
Baird and Brookes (11). The hydrolysed D N A  solution  
was made 20% in m ethanol and applied to a Sephadex 
LH-20 colum n (90 x 1.5 cm) (Pharm acia, Sweden). The 
colum n was eluted with a gradient o f  20% to 100% 
m ethanol and 5 ml fractions collected. The positions o f  
the four deoxynucleosides, which elute early, were 
m onitored at 254 mn while the carcinogen adducts, 
eluting after approximately 40 fractions, were 
m onitored by sampling the fractions for radioactivity. 
The am ount o f  D N A  hydrolysed was determined from  
the absorbance o f  the deoxyadenosine peak which is the 
last deoxynucleoside to elute. Fractions corresponding 
to carcinogen — D N A  adducts were pooled and reduced 
in volum e before further analysis by h .p .l.c .
H . p . l . c .  s e p a r a t i o n  o f  c a r c i n o g e n  — D N A  a d d u c t s
Analysis o f  the carcinogen — D N A  adducts by 
analytical h .p .l.c . was performed on Waters Associates
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(M A , U SA ) equipm ent fitted with a Partisil 10/25 ODS  
colum n (25 cm x 4 .6  mm) from W hatman Ltd., 
(M aidstone, UK). The colum n was equilibrated in 10% 
methanol -  water and elution o f  adducts at a constant 
flow rate o f  1 m l/m in  was achieved with an increasing 
m ethanol gradient (0 .2% /m in ). One ml fractions were 
collected directly into scintillation vials, 5 ml o f  A quasol 
scintillation fluid (New England Nuclear, M A , USA) 
added and the radioactivity determined in a LKB 1215 
Rackbeta liquid scintillation counter.
Results and Discussion
The carcinogenicity o f  11-methyl ketone on m ouse 
skin has been well established. It is effective by single 
dose follow ed by croton oil prom otion as well as by 
repeated adm inistration and appears to have equivalent 
potency to the ubiquitous carcinogen, benzo[a]pyrene
(2). A lthough binding o f  this carcinogen to D N A  has 
been reported previously, a more detailed analysis o f  in­
dividual adducts separated by both Sephadex LH-20 
and h .p .l.c . has now been achieved.
S e p h a d e x  L H - 2 0  s e p a r a t i o n  a n d  a n a l y s i s  o f  r a d i o a c t i v e  
p e a k s
The separation o f  the D N A  adducts o f  the car­
cinogen, 11-methyl ketone, on Sephadex LH-20 has 
been described previously (4, 6). I n  v i t r o ,  tw o peaks o f  
radioactivity corresponding to carcinogen — nucleotide 
adducts were consistently eluted follow ing the four nor­
mal deoxynucleosides (peaks A and B, Figure 2). In 
som e cases, a third radioactive peak (peak C, Figure 2) 
was found when the D N A  was directly in contact with 
the m icrosom e mixture (M ethod I). When the D N A  was 
separated by a dialysis sac (M ethod 2), this peak was 
never present. I n  v i v o ,  peak C has never been found and 
peak A was greatly reduced (4). These peaks have been 
collected and further analysed by h .p .l.c . (see later).
Three other peaks o f  radioactivity which eluted 
before the normal deoxynucleosides have been observed  
after reaction o f  the carcinogen with D N A  both i n  v i v o  
and i n  v i t r o .  Early eluting peaks have been reported in 
the analysis o f  several hydrocarbons (11, 12, 13, 14, 15). 
The first peak, eluting after approxim ately 45 ml, was 
observed only in the case o f  incom plete enzymatic 
hydrolysis and represents m odified polymer or 
nucleoside m onophosphates. The second, eluting after 
approxim ately 70 ml, contained only a very small 
am ount o f  u .v. absorbing material and co-eluted with 
small oligonucleotide markers o f  2-4 nucleotides which 
lack a terminal phosphate. The radioactive counts may 
be derived from intercalated carcinogen or from  
carcinogen-bound protein associated with these 
oligom ers. The third peak o f  radioactivity, the X peak 
(Figure 2) eluting after approximately 90 m l, contained  
a sharp peak o f  u .v. absorbing material and a variable 
but high proportion o f  radioactive counts. This material 
was resistant to further hydrolysis by either 
phosphodiesterase or proteinase K and was com pletely  
dialysable. The u .v . spectra suggested that it contained  
largely thymidine which was confirm ed by the use o f
30
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Fig. 2. Sephadex LH-20 profile of in vitro modified calf thymus
DNA treated with [14Cl-l 1-methyl k e to n e__________  , radioactivity
in each of the fractions; ............. , u.v. absorption by continuous moni­
toring. The positions of the X peak and the four deoxynucleosides as 
well as the adduct peaks A, B and C are shown.
J \
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Fig. 3. H.p.l.c. profile o f X peak of mouse skin DNA. Separation 
was on a reverse-phase Partisil 10/25 ODS column, eluted with 10°/o 
m ethano l-w ater. The position of the normal deoxynucleosides is 
shown.
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Fig. 4 . H.p.l.c. profile of radioactive 11-methyl ketone —DNA ad­
ducts derived from mouse skin. Separation was on a reverse-phase 
Partisil 10/25 ODS column eluted with an aqueous methanol gradient. 
The relative percentage of each of the peaks is shown.
specific base-labelled DNA. The peak was further 
analysed on reverse-phase h.p.l.c. using a Partisil 10/25 
ODS (25 cm x 4.6 mm) column which was eluted with 
10% methanol —water. The X peak derived from 
carcinogen-modified mouse skin DNA separated into 
three components as shown in Figure 3. The major peak 
(retention time 7.4 min) co-eluted with thymidine, while 
the second largest (retention time 5.4 min) co-eluted 
with deoxycytidine. The radioactivity eluted as a diffuse 
band not associated with any of the u.v. peaks (Figure 
3). This is consistent with the fact that the X peak can be 
observed after hydrolysis of normal DNA which has not 
been modified with carcinogen. The early elution of the 
thymidine and deoxycytidine appears to be associated 
with a specific interaction with the Tris buffer used in 
the hydrolysis of the DNA. Separate chromatographic 
analysis of thymidine in 0.1 M Tris buffer, pH 9, led to 
the appearance of an X peak. Similar chromatographic 
analysis in the absence of Tris buffer or in the presence 
of MgCl2 did not produce an X peak. The radioactivity 
associated with this peak may be non-covalently bound 
carcinogen co-eluting at the same position. The 
possibility of non-covalent interaction of the 11-methyl
In vitro add ucts  
M ethod 1.
20
o
In vitro adducts  
_  M ethod 2.20
10
ir 1-------- 1--------- 1---------1--------- 1 r
20 60  100 140
R eten tion  tim e (m in s)
Fig. 5. H.p.l.c. profile of radioactive 11-methyl ketone —DNA ad­
ducts derived in vitro using rat liver microsomes. Separation was on a 
reverse-phase Partisil 10/25 ODS column eluted with an aqueous 
methanol gradient. A. DNA free in reaction mixture; B. DNA enclos­
ed in a dialysis sac. Co-chromatography with in v/vo-derived adducts 
has allowed the assignment of the peak numbers shown.
m
0 6020 40
Retention time (min.!
80
Fig. 6. H.p.l.c. profile o f 11-methyl ketone metabolites derived in
vitro using rat liver microsomes______  , u.v. absorption at 254 nm.
Separation was on a reverse-phase Partisil M9 10/50 ODS column 
eluted with an aqueous methanol gradient.
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Fig. 7. H .p.l.c. profile of radioactive 11-methyl ketone -  DNA adducts derived in vitro from individual metabolites of 11-methyl ketone. Separa­
tion was on a reverse-phase Partisil 10/25 ODS column eluted with an aqueous methanol gradient. The structures o f the proposed metabolites are 
shown. The adducts shown have been co-chromatographed with in v/vo-derived adducts.
ketone with D N A  was tested by the incubation o f  [14C]- 
11-methyl ketone in the absence o f  m icrosom es. A fter 
phenol extraction o f  the D N A , enzym atic hydrolysis 
and Sephadex L H -20 chrom atography, as described in 
M ethods, radioactive counts were found under the X  
peak only. A lthough the radioactive counts in peak X  
were not as high as would be found after m etabolic ac­
tivation, non-covalent interaction with the D N A  does 
take place. These observations suggest that the early 
eluting peaks contain only a very m inor am ount, if  any, 
o f  covalently bound carcinogen. Our major effort, 
therefore, has concentrated on the separation and iden­
tification o f  the adduct peaks eluting after the norm al 
deoxynucleosides on  Sephadex LH -20.
In v ivo , a sm all am ount o f  m etabolic incorporation  
o f  tritium was found in the norm al deoxynucleosides, 
especially deoxyadenosine and deoxyguanosine. N o  
such incorporation was found using 14C-labelled car­
cinogen.
H .p .l.c . analysis o f  addu cts
Figure 4 shows the h .p .l.c . pattern o f  adducts derived  
from  the D N A  o f  carcinogen-treated m ouse skin. The 
two peaks derived from  Sephadex L H -20
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Fig. 8. H.p.l.c. profiles of [14C]-11-methyl ketone- DNA adducts derived in vitro from [3H-G]DNA using Method 2 (see Methods) and of [,4C]- 
11-methyl ketone-D N A  adducts derived in vitro from [3H-A]poly(dA-dT) using Method 1 (see Methods). 14C d.p.m.; • ,  3H d.p.m.
chromatography each separated into several adducts. 
Peak A gave rise to peaks I, II and III (retention times 
54, 68 and 75 min) on h.p.l.c. while peak B separated to 
peaks, IV, V and VI (92, 105 and 115 min). The h.p.l.c. 
pattern of adducts derived from DNA treated in vitro 
with carcinogen in the presence of rat liver microsomes 
is shown in Figure 5A. Figure 5B shows the pattern of 
adducts derived from DNA which had been separated 
from the microsomes by a dialysis sac (Method 2, see 
Methods); both peaks IV and VI have been greatly 
reduced or eliminated. Generally the pattern of adducts 
for in vitro modified DNA is essentially the same as for 
in vivo modified DNA, with the addition of some very 
minor adduct peaks. The major adducts from both in 
vivo and in vitro modified DNA have been shown to co­
chromatograph.
Adducts derived from  carcinogen metabolites
The origin of the individual adduct peaks was deter­
mined by incubating each of the metabolites derived 
from the 11-methyl ketone (Figure 6) with DNA in the 
presence of rat liver microsomes. Metabolite peak g has 
been previously shown to co-chromatograph with an 
authentic marker compound, the 16-hydroxy-11-methyl 
ketone (5), while metabolite peak /  co-chromatographs 
with both marker compounds, the 15-hydroxy-l 1- 
methyl and the 11-hydroxymethyl ketones (5). 
Metabolite e has been shown by u.v. and mass spec­
troscopy to be the 3,4-diol of the 11-methyl ketone (4). 
As previously observed only metabolites b, c, e, f  and g
covalently bind to DNA upon re-incubation in the 
presence of microsomes (4). H.p.l.c. of the DNA ad­
ducts derived separately from each of these metabolites 
is shown in Figure 7. In each case, the major adducts co­
chromatograph with adducts derived from in vivo 
carcinogen-modified DNA.
Metabolite e, the 3,4-dihydroxy-11-methyl ketone, 
gave rise to an adduct with a retention time of 105 min 
which corresponded to the major DNA adduct derived 
from the 11-methyl ketone (4) both in vivo (Figure 4) 
and in vitro (Figure 5). A small adduct peak with a 
retention time of 92 min corresponded to peak IV found 
in vivo (Figure 4) and appears to be derived only from 
this 3,4 diol (e). Metaboliteg, the 16-hydroxy-l 1-methyl 
ketone, and metabolite b both gave rise to an adduct 
with retention time 68 min, corresponding to peak II in 
vivo (Figure 4). Metabolite b is known to be a 3,4,x-triol 
(5) and therefore is most likely to be the 3,4,16- 
trihydroxy-11-methyl ketone. Similarly, metabolites /  
and c both gave rise to peaks with retention times of ap­
proximately 30 min, 75 min and 115 min (Figure 7). 
Metabolite / i s  known to consist of the 15-hydroxy-11- 
methyl ketone mixed with a small proportion of its 
11 -hydroxymethyl isomer (5). Metabolite c is a 3,4,x- 
triol (5) and, therefore, likely to be the 3,4,15- 
trihydroxy-11-methyl ketone. The structure of the ad­
duct in the first peak (retention time, 30 min; Figure 7) 
is unknown but chromatographic behaviour suggests a 
higher degree of hydroxylation; it is not found in vivo.
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Fig. 9. Proposed metabolic pathways o f the carcinogen, 11-methyl ketone, leading to the metabolites shown. Upon further metabolism in the 
presence o f DNA, the individual metabolites gave rise to adducts which correspond to the in v/vo-derived adducts shown.
The second peak (retention time, 75 min; Figure 7) is 
probably derived from the 3 ,4 ,15-hydroxy-1,2-epoxide 
and corresponds to peak III after i n  v i v o  reaction o f  the 
11-methyl ketone (Figure 4). The third peak (retention  
time, 115 min; Figure 7) is unexpected since it cannot be 
a deoxyguanosine adduct derived from the 15-hydroxy- 
diol-epoxide due to its late retention time. It is retained 
longer than the adduct derived from  the m etabolite e  
(3 ,4-diol). Tw o explanations are possible: firstly, it 
could be derived from a non-diol-epoxide leading to an 
adduct containing 3 or less hydroxyl groups in its 
polycyclic m oiety; or secondly, it could represent a 
deoxyadenosine adduct, which are known to elute more 
slowly from reverse-phase h .p .l.c . colum ns (16). Base 
analysis o f  the adducts supports the latter explanation  
(see later). Figure 9 shows the m etabolic pathways 
which lead to the form ation o f  the adducts described.
B a s e  a n a l y s i s  o f  a d d u c t s
The analysis o f  the bases associated with the major 
adducts was attempted by em ploying specific base 
labelled D N A  or polynucleotides. The use o f  labelled 
D N A  in direct contact with the m icrosom al mixture 
m ade interpretation o f  the data difficult, but by placing 
the labelled D N A  within a dialysis sac floating in the 
m icrosom al mixture (see M ethods) identification o f  the 
guanine adducts could be achieved (Figure 8). The m a­
jor adduct (peak V) and the 16-hydroxylated adduct 
(peak II) were both found to contain a guanine base 
(Figure 8). This procedure, however, as noted above, 
leads to the loss o f  peaks IV and VI and identification o f  
the bases associated with these peaks could not be 
achieved in this way. No m eaningful inform ation could  
be obtained using [3H -adenine]D N A  or [3H- 
cytosineJDNA owing to the presence o f  endogenous 
D N A  within the m icrosom al preparation leading to con ­
tam ination. The lower buoyant density o f  [3H-
AJpoly(dA-dT), however, allowed separation o f  this 
polymer from  contam inating D N A  by CsCl density gra­
dient centrifugation. Subsequent hydrolysis and separa­
tion o f  adducts by h .p .l.c . led to the identification o f  a 
deoxyadenosine-containing adduct peak (Figure 8) cor­
responding to peak VI from i n  v i v o  m odified  D N A  
(Figure 4). M inor contam ination o f  the polym er by 
D N A  was seen by a m inor peak at retention tim e 105 
m in, the position o f  the major guanine adduct. The 
bases associated with the m ouse skin D N A  adduct peaks 
I, III and IV remain unknow n.
C onclusion
The carcinogen, 11-methyl ketone, reacts with m ouse  
skin D N A  i n  v i v o  to produce six distinct adduct peaks 
which can be separated by h .p .l.c . Figure 9 show s the 
probable m etabolic pathways which lead to the form a­
tion o f  these adducts. The m ajor pathway is via a
3.4-d iol which leads to both the m ajor i n  v i v o  and i n  
v i t r o  adducts, through the form ation o f  a
3 .4-dihydroxy-1,2-epoxide (4). M etabolic activation  
through a vicinal d iol-epoxide appears to be a com m on  
pathway for a number o f  carcinogenic polycyclic com ­
pounds (15, 17, 18, 19, 20, 21). H ydroxylation o f  the
11-methyl ketone at either the 11-, 15- or 16-positions in 
addition to the form ation o f  the 3,4-d iol leads to the 
form ation o f  the m inor adducts, peaks II and III, which  
represent approxim ately 4 and 1%, respectively, o f  the 
total i n  v i v o  adducts. A t least 2 o f  the adducts, the m a­
jor adduct (peak V) and the 16-hydroxy adduct (peak II) 
have been shown to contain deoxyguanosine, while the 
last adduct to elute (peak VI) contains deoxyadenosine. 
This adduct, which represents approxim ately 9 ° I o  o f  the 
total i n  v i v o  adducts, is derived from  the 15-hydroxy-
3.4-d iol. No corresponding deoxyadenosine adduct 
derived from  the 3,4-d iol has been found. The im por­
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tance of these adducts in carcinogenic transformation 
has yet to be resolved.
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Covalent binding of poly cyclic 
aromatic compounds 
to mitochondrial and nuclear DNA
J. A. Allen* & M. M. Coombs
Chemistry Laboratory, Imperial Cancer Research Fund, Lincoln’s Inn 
Fields, London WC2A 3PX, UK
Since the pioneering work of the Millers1 it has become clear 
that most chemical carcinogens require metabolism to reactive 
electrophiles and then exhibit their carcinogenic potential by 
reacting chemically with, and modifying, cellular macromole­
cules. At first modification of proteins was considered most 
likely to be of importance in carcinogenesis. Later, Brookes and 
Lawley2 demonstrated that the extent of binding of several 
polycyclic hydrocarbons to DNA, but not to RNA or protein 
isolated from the skin of mice treated topically with these 
compounds, correlated with their known carcinogenic potency 
to this tissue. Mammalian cells, particularly mouse embryo cells, 
treated with chemical carcinogens have often been used, and 
DNA has been involved almost exclusively from whole cells. 
However, mitochondria possess unique DNA which accounts 
for 0.1-1% of the total DNA present in mammalian cells3, and 
three studies have shown that carcinogenic alkylating agents 
modify the mitochondrial DNA by a factor about five times 
greater than the nuclear DNA from the same cells4-6. We 
demonstrate here that with six polycyclic aromatic compounds, 
all of which require metabolic activation and bind to DNA to a 
much smaller extent than direct-acting alkylating agents, the 
binding to mitochondrial relative to DNA is dramatically 
increased by a factor of nearly 50 to over 500.
Whole mouse embryo cells in their third passage from specific 
pathogen-free Tyler’s Original (TO) mice were labelled in
* Present address: Huntingdon Research C entre, Huntingdon, Cambridgeshire, UK.
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Fig. 1 LH20 chromatography of hydrolysates of nuclear (a) and 
mitochondrial (b) DNA from mouse cells treated in culture with 
benzo[a]pyrene. Hydrolysates were run on Sephadex LH20 
columns of 90 x 1.5 cm with a linear gradient of 30% methanol in 
water increasing to 100% methanol. Fractions (5 ml) were collec­
ted and aliquots (1.5 ml) were counted for 14C and 3H activities in a 
LKB Wallac 1215 Rackbeta liquid scintillation counter. The 
amounts of the nucleosides were corrected for the efficiency of the 
hydrolysis, calculated from the total 14C in the DNA hydrolysed 
and the 14C in the thymidine peak. The large amount of tritium 
eluted in the first 100 ml of the mitochondrial DNA hydolysate 
arises from the tritiated hydrocarbon bound to the RNA and
residual pro tein . , UV absorption at 254 nm; • —9 —• ,
3H d.p.m.;  ----- , 14C d p.m.
culture with [2-14C]thymidine (60 mCi mmol-1) and grown to 
confluency. Tritium-labelled polycyclic compounds (0.16-
1.25 p,gml-1, depending on toxicity) were added as shown in 
Table 1 and 24-48 h later the cells were collected, washed, and 
gently disrupted mechanically by hand using a Potter-Elvehjem  
homogenizer. Nuclei and mitochondria were isolated by the 
methods of Prescott et al.7 and Miyaki et al.8, respectively, and 
their purity was checked by light and electron microscopy. 
Nuclear DNA was extracted using Diamond’s modification of 
the Kirby method9 which involves isolation of the D N A  from 
SDS lysates by phenol extraction, subsequent treatment with 
RNase, and a second isolation by phenol extraction. Mitochon­
drial DNA was obtained basically by the method of Hirt10; 
because mitochondrial DNA was lost during phenol extraction, 
the latter step and RNase treatment were omitted. The resultant 
solution of mitochondrial D N A  therefore still contained mito­
chondrial RNA and residual protein which were also labelled 
with tritium through binding to the hydrocarbons to these 
macromolecules.
The amount of nuclear DNA (usually 1-2 mg) was deter­
mined by UV spectrophotometry, having calibrated this by 
phosphorous analysis using the colorimetric method of King and 
Wotton11. Mitochondrial DNA was estimated, following 
enzymatic hydrolysis and separation of the deoxynucleosides, by 
relating the 14C d.p.m. in the thymidine peak to the specific 14C 
activity of the nuclear DNA, and was found to fall into the 
expected range (about 2 p,g). On one occasion this was 
confirmed by direct estimation of the mitochondrial D N A  by the 
fluorimetric micro method of Hill and Whatley12 using 
mithramycin, thus establishing that the 14C specific activities of 
the nuclear and mitochondrial D N A  were similar. After dilution 
with carrier calf thymus DNA, both samples were hydrolysed 
enzymatically with DNase which had been carefully checked 
for absence of RNase activity, and the liberated 
deoxyribonucleosides were separated by Sephadex LH20 
chromatography (Fig. 1). The binding index (p,mol of compound 
bound per mol of DNA phosphorous) was calculated from the 
total amount of tritium in the modified deoxyribonucleoside 
peaks which elute after the natural deoxyribonucleosides, 
assuming the specific activity of the bound compound was 
unaltered. As Phillips et al.13 have shown, residual protein and 
RNA do not interfere with this separation because they are 
eluted in the first 100 ml, immediately before the natural 
nucleosides. Six polycyclic aromatic compounds were examined 
in this way, the results of which are summarized in Table 1.
All six compounds modified both nuclear and mitochondrial 
DNA, and in each case the binding index for the latter was 
considerably higher than for the former. Although experimental 
difficulties made the precision of the values rather uncertain, the 
large differences observed cannot be explained by the small 
deviations in purine and pyrimidine base ratios known to exist 
between mammalian nuclear and mitochondrial DNA. These 
differences in binding index may occur because both the mito­
chondrial inner14 and outer15 membranes contain the enzymes 
required to metabolize polycyclic aromatic compounds which 
probably tend to accumulate in these lipophilic membranes16. 
Furthermore, mitochondrial DNA is ‘naked’, being devoid of 
the histone and non-histone proteins that are intimately asso­
ciated with DNA in the nucleus. The highest DNA-binding 
indices, both nuclear and mitochondrial, are shown by the two 
most potent carcinogens: 7,12-dimethylbenz[a Janthracene 
(DMBA) and 3-methylcholanthrene (MCA). Benzo[a]pyrene 
and 15,16-dihydro-11 -methylcyclopenta[a Jphenanthren-17- 
one(ll-M eCPP) are similar to each other in potencies17, but are 
less active as carcinogens than DM BA and MCA; 
benz[fl]anthracene is an extremely weak carcinogen whereas
12-MeCPP is inactive18. The nuclear DNA-binding indices of 
these last four compounds do not reflect this, whereas there is 
good correspondence with the mitochondrial binding indices. In 
all cases, the nucleoside adducts seen in the nuclear DNA  
hydrolysates are also present in the hydrolysates of the mito-
Table 1 Binding of polycyclic aromatic compounds to nuclear and mitochondrial D N A
Binding index (p.mol of compound bound
Specific per mol DNA phosphorous)
activity Dose Incubation Nuclear DNA Mitochondrial Ratio
Compound (Ci mmol-1) (ixg ml-1) time (h) (nuc) . DNA (mt) mt/nuc
DMBA 19.6 0.212 24 12.1±2.0 897 ±63.5 78± 18.5*
MCA 9.0 0.496 24 21.9±0.3 1,024 ±20 47±0.3*
B[a]P 18.0,27.0 0.235 24 7.5 ±1.9 413± 164 53±8.7*
11-MeCPP 13.9 1.250 48 0.53 312 589t
B[a]A 5.9 0.644 24 0.44 ±0.11 104±40.2 230±51.5*
12-MeCPP 27.5 1.250 48 0.28 ±0.03 26.3 ±16.2 98±65.5*
All compounds were generally labelled with tritium. DMBA, 7,12-dimethylbenz[a]anthracene; MCA, 3-methylcholanthrene; B[a]P, 
benzo[a]pyrene; 11-MeCPP, 15,16-dihydro-l l-methylcyclopenta[a]phenanthren-17-one 4; B[a]A, benz[a]anthracene; 12-MeCPP, 15,16-dihy- 
dro-12-methylcyclopenta[a]phenanthren-17-one24.
* Duplicate experiments ±s.d. 
t  Single experiment.
chondrial D N A , but in addition the latter also exhibit substantial 
amounts of slower-running adducts. In the case of 
benzo[n]pyrene19 (shown in Fig. 1) and 11-M eCPP20, the major 
nuclear adduct peak is known to represent the compound 
formed by reaction of the bay-region dihydrodiol epoxide with 
deoxyguanosine. The slower-running, less polar adducts there­
fore probably result from reaction of simple non-hydroxylated 
epoxides, such as K-region or non-K-region epoxides, with a 
D N A  base.
The significance of these findings is not clear. As these cells 
contain about 1,000 times more nuclear than mitochondrial 
D N A , the actual amount of compound bound to the former is
2 -2 0  times that bound to the latter. This does not imply that 
damage caused by this modification will also be in this ratio, 
because the efficiency of D N A  repair may be different at these 
two sites. However, mitochondrial D N A  codes for several 
essential subunits of ATPase, cytochrome bcx and cytochrome c 
oxidase21, and it is therefore interesting that derangements of 
energy metabolism often characterize tumours (see ref. 22). 
Recently W ilkie et al.23 found that most carcinogens they tested 
caused the cytoplasmic ‘petite’ mutation in the yeast 
Saccharomyces cerevisiae. Moreover, effects on the cell surface 
were observed in non-fermentable conditions where mito­
chondrial function is required for growth. These authors suggest
a possible role for mitochondrial mutations in cancer through a 
heritable disturbance either directly or by modulation of a 
nuclear gene.
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Mutagenic and Carcinogenic Metabolites of the Carcinogen 15,16-Dihydro-
11-methylcyclopenta[a]phenanthren-17-one1
Maurice M. Coombs,2 Tarlochan S. Bhatt, Anna-Maija Kissonerghis, and Colin W. Vose
Chemistry Laboratory, Imperial Cancer Research Fund, Lincoln’s  Inn Fields, London WC2A 3PX, England [M. M. C., T. S. B., A-M. K.], and Departm ent of 
Metabolic Studies, G. D. Searle and Co., Ltd., Lane End Road, High W ycom be HP12 4HL, Buckinghamshire, England [C. W. V.]
ABSTRACT
M icrosom al m etabo lites of th e  ca rc in o g en  15 ,16-d ihyd ro -
1 1-m ethy lcyclopen ta[a]phenan th ren -17 -one (S tru c tu re  I) w ere  
s e p a ra te d  by h ig h -p ressu re  liquid ch rom atog raphy , an d  their 
s tru c tu res  w ere  e stab lish ed  on th e  b a s is  of the ir ultraviolet and  
m ass  sp e c tra , to g e th e r with co n sid e ra tio n s  of their g en era l 
chem ical p ropertie s . This w as  a ss is te d  by co m p ariso n s  with 
m etabolites form ed in th e  sam e  w ay from th e  syn thetic  15- 
hydroxy (S truc tu re  III), 1 6-hydroxy (S tru c tu re  II), an d  11 -hy- 
droxym ethyl (S truc tu re  IV) derivatives, w hich th em selv es o ccu r 
a s  m etabo lites of S tru c tu re  I. P ro d u c ts  derived  from a ttack  a t 
th e  tw o benzo-ring  doub le  b o n d s  o ccu rred , bu t no K-region 
p ro d u c ts  w ere  found. Only m etabo lites having a  non-bay  region
3,4-dihydrodiol system  w ere  m utagen ic  an d  bound  to  DNA 
after in vitro m icrosom al activation, an d  it w as co n c lu d ed  th a t 
th e  3 ,4-d ihydro-3 ,4-d io l (M etabolite e) w as th e  main form and  
tha t th e  3 ,4 -d io ls of th e  m onools (S tru c tu re s  II to  IV) w ere  minor 
proxim ate form s of th is ca rc inogen .
In a  tw o -s tag e  experim en t, th e  syn thetic  1 6-ol (S truc tu re  II) 
w as show n to be  alm ost a s  ca rc in o g en ic  a s  w as S tru c tu re  I 
itself in mice; th e  15-ol (S truc tu re  III) and  1 1-hydroxym ethyl 
derivative (S tructu re  IV) w ere  m uch le s s  active. T he sam e  o rd e r 
w as a lso  o b se rv ed  in th e  m utagenicity  of th e s e  co m p o u n d s in 
th e  A m es tes t.
INTRODUCTION
R ecently , w e (9) d esc rib ed  th e  sep a ra tio n  of m icrosom al 
m etabo lites of th e  s trong  carc in o g en  1 5 ,1 6 -d ihyd ro -11 -m ethyl- 
cyclop en ta [a ]p h en an th ren -1 7 -o n e  (S tru c tu re  I) by HPLC3 
(C hart 1); th e  7 main m etabo lites (a to  g) w ere  exam ined  for 
m utagenicity  in th e  A m es te s t and  for their ability to  bind to  
DNA on reincubation  with rat liver m icrosom es and  NADPH. Of 
th e  7, M etabolite e  w as th e  m ost m utagen ic , being 2 to  3  tim es 
m ore active than  the  carc in o g en  itself. M oreover, it w as the  
only m etabolite to give rise in vitro to th e  m ajor DNA A dduct B 
ob ta ined  from th e  skin of m ice tre a te d  in vivo with th e  ca rc in ­
ogen . M etabolite e  w as identified on th e  b a s is  of its m a ss  and  
UV sp ec tra , to g e th e r with its g en e ra l chem ical p ropertie s , a s  
th e  frans-3 ,4 -d ihydro -3 ,4 -d ihydroxy  derivative of S tru c tu re  I 
and  w as p ro p o sed  a s  th e  proxim ate ca rc inogen . Of th e  o th e r 
m etabolites, M etabolites a  and  d  w ere  biologically inert, but 
M etabolites b, c, f, and  g w ere  all m utagen ic , and  all gav e  rise  
to  the  m ore polar, m inor DNA A dduct A, but not to  A dduct B. 
This p ap e r is co n ce rn ed  with th e  n a tu re  of th e se  m etabo lites 
and  co n seq u en tly  su p p lem en ts  ou r original com m unication .
1 This work w as supported  by the Imperial C ancer R esearch  Fund.
2 To whom requests  for reprints should be ad d ressed .
3 The abbreviation used  is: HPLC, h igh-pressure liquid chrom atography.
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MATERIALS AND METHODS
T h ese  w ere  generally  a s  d e sc r ib ed  recen tly  (9); th e  11 - 
methyl-'4C -labeled  carc in o g en  (S tru c tu re  I) w as u sed  to  allow 
quantitation . T he un labeled  syn thetic  m onools, S tru c tu re  II (2), 
S tru c tu re  III, and  S tru c tu re  IV (7), w ere  m etabolized , an d  th e  
m etabo lites w ere  se p a ra te d  by HPLC essen tia lly  a s  a lready  
d esc rib ed  for S tru c tu re  I (9).
T he com pound  (5 0 0  jug) w as in cuba ted  for 3 0  min a t 3 7 °  
under gen tle  shak ing  in air with 0.1 m Tris buffer ( 1 0  ml), pH
7 .2 , contain ing  NADPH (3 7 .5  mg) an d  m icro som es equ ivalen t 
to  10  g of liver ob ta ined  from ra ts  previously induced  by i.p. 
injection of 20 -m ethy lcho lan th rene  (15). T he solu tion  w as  ex ­
tra c ted  5 tim es with ethyl a c e ta te  (1 0  ml each ); th e  la tte r w as 
dried  over an h y d ro u s sodium  su lfa te  an d  ev ap o ra ted  to  d ry n e s s  
u nder red u ced  p re ssu re . T he re s id u e  w as red isso lved  in 2 5 0  
jul of m ethanokw ater (95 :5 , v /v ), an d  fat w as rem oved  by 2 
ex trac tio n s with h ex an e  (2 5 0  jul each ); negligible radioactiv ity  
w as  lost from th e  a q u e o u s  m ethanolic  p h a se  w hich now  form ed 
a  c lea r pale  yellow liquid. This so lu tion  (10 0  jul) w as  in jec ted  on 
to a  W hatm an Partisil M9 1 0 /5 0  ODS colum n (W hatm an Ltd., 
M aidstone, E ngland) fitted to a  V arian 4 2 0 0  liquid ch ro m ato g ­
raphy  sy s tem  and  w as elu ted  with 15%  m ethanol in w a te r 
chang ing  to m ethanol a lone  in a  linear g rad ien t a t 1 % /m in  a t 
a  flow ra te  of 1 2 0  m l/h r  (C hart 3).
Owing to slight varia tions in reten tion  tim es in individual 
HPLC runs, the  identity of certa in  m etabo lites of th e s e  m onools 
with m etabo lites of th e  14C -labeled  ca rc in o g en  of sim ilar re te n ­
tion tim e w as ch e c k e d  by co ch ro m ato g rap h y  of th e  c o rre ­
spond ing  un labeled  and  rad ioactive  frac tions. In p rac tice , it 
w as not difficult to  a ss ig n  p e a k s  a s  show n in C hart 3  with 
certain ty . T he UV sp e c tra  of ce rta in  m etabo lites w ere  found  to  
a lter on s to rag e , th e  ex ten t of th e  c h a n g e  being d e p e n d e n t on 
both s to ra g e  tim e and  conditions. T he UV d a ta  in T able  2 w ere  
ob ta ined  within 2 to  3  hr of th e  m etabo lites having b een  
ex trac ted  from th e  incubation  an d  s e p a ra te d  by HPLC. R ed u c ­
tion with sodium  borohydride  and  dehyd ra tion  with h o t 5 n  
sulfuric ac id  w as ca rried  o u t a s  d e sc r ib e d  (9).
Anim al E xp erim en t. O ne hund red  formally random ized  TO 
m ice w ere  divided into 5 g ro u p s  e a c h  consisting  of 10  m ales  
and  10  fem ales, 3  m onths old. O ne w eek  a fte r  the ir b a c k s  
w ere  sh av ed  with e lec tric  c lippers, e a c h  of th e  m ice in G ro u p s 
1 to  4  w as tre a te d  with 4 0 0  jug of th e  te s t com pound  d isso lved  
in 8 0  jul of to lu en e :ace to n e  (1 :1 , v /v ) . T he co m p o u n d s  u se d  
w ere: G roup 1, S tru c tu re  I; G roup 2 , S tru c tu re  II; G roup  3 , 
S tru c tu re  III; and  G roup  4 , S tru c tu re  IV. T w ice-w eekly p rom o­
tion with 10 jul of cro ton  o ik to luene (1 :9 9  v /v )  w as  b eg u n  8 
d ay s a fte r initiation. Mice in G roup 5 w ere  tre a te d  with to luene : 
a c e to n e  alone; no tum ors w ere  p ro d u ced  by th is trea tm en t; 
ne ither w ere  tum ors induced  previously  w hen  con tro l m ice 
w ere  trea ted  a s  ab o v e  with c ro ton  o ik to luene . G en era l co n d i­
tions w ere  a s  d e sc r ib ed  previously (3).
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Chart 1 . Separation of in vitro microsomal m etabolites a  to g  of ,4C-labeled 
Structure I by HPLC; UV trace  a t 254  nm. Peak m  contained no radioactivity and 
is therefore of microsomal origin; for column conditions, s ee  “ M aterials and 
M ethods.”
A m es T e s t. T he syn thetic  co m p o u n d s I to IV w ere  te s te d  for 
m utagenic activity in Salmonella typhimurium T A 100 a s  d e ­
scribed  previously (6 ). T he num ber of revertan t co lon ies p e r 
jug of te s t com pound  is ca lcu la ted  from th e  slo p e  of th e  initially 
stra igh t part of th e  d o se - re sp o n se  cu rve  and  is ne t of b ack ­
g round revertan t co lon ies (usually  70  p e r plate).
RESULTS
A typical HPLC sep ara tio n  of m etabo lites p ro d u ced  by in­
cubation  of S truc tu re  I with a  m icrosom al sy s tem  is show n in 
C hart 1 a s  a  UV tra c e  (2 5 4  nm); th e  14C tra c e  w as  alm ost 
identical ex cep t th a t th e  p eak  m arked  m w as a b se n t. This is 
the re fo re  d u e  to  m aterial of m icrosom al origin. U nder th e se  
conditions, ab o u t 75%  of th e  radioactivity  w as ex trac ted  from 
th e  incubation m ixture with ethyl a c e ta te , and  M etabolites a  to  
g p lus un ch an g ed  S tru c tu re  I a cco u n ted  for ab o u t 85%  of this. 
The leas t polar m aterial w as readily  show n to b e  u n ch an g ed  
(S tructu re  I) by its elution volum e and  UV spec trum . In a  sim ilar 
m anner, the  minor M etabolite g w as  identified a s  th e  16-hy- 
droxy derivative of S tru c tu re  I by com parison  with the  syn thetic  
ketol (S tructu re  II) (2). T he m ajor P eak  f  had  th e  sam e  elution 
volum e a s  do  both the  syn thetic  15-hydroxy and  11 -hydroxy- 
methyl derivatives (7) of S tru c tu re  I, w hich a re  not reso lved  on 
this colum n. T he m olecular ion (m /e  2 62 ) w as the  b a s e  p eak  
in the  m ass  spec trum  of M etabolite f, and  an  a c c u ra te  m ass  
determ ination  gave  its form ula a s  C18H1402 , a  monool (Table 
1). The UV d a ta  for M etabolite f  (T able 2) w ere  alm ost identical 
with th o se  of th e  syn thetic  15-ol (S truc tu re  III), in line with the  
expecta tion  th a t this would be  th e  m ajor m onool form ed (8 ).
M etabolites a  to e w ere  sep a ra te ly  purified by fu rther HPLC, 
and  their m ass  sp e c tra  e stab lish ed  th a t M etabolites a , b, and  
c w ere  triols (C i8H160 4) and  th a t M etabolites d  and  e  w ere  diols 
(C i8Hi40 3). All with th e  excep tion  of M etabolite d  exhibited  
prom inent M— H20  ions, su g g es tin g  th a t they  con ta ined  vicinal 
diol sy s tem s cap ab le  of being readily  deh y d ra ted . In co n tra s t, 
th e  m olecular ion w as th e  only m ajor ion in th e  m ass  spec trum  
of M etabolite d, behavior ch a rac te ris tic  of cyclopen ta[a]phen- 
an th ren es  retaining an  in tact p h en an th ren e  ring system  (17). 
This conclusion  w as su p p o rted  by its UV sp ec tra l d a ta  (C hart 
2; T able 2) which show ed  a  con ju g a ted  p h en an th ren e  ch ro - 
m ophore sim ilar to th a t of th e  15-ol (S truc tu re  III). M etabolite
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Table 1
M ass spectra  o f M etabolites a to f 
Only ions with m /e  above 20 0  of 1 0% or m ore relative abundance  com pared 
with the b a se  peak  are  listed.
M etabolite M ass sp ec tra
a
C 18H16O4
Found: M+ 
Requires:
296 .1043
2 96 .1049
298  (21), 297  (26), 2 9 6 (1 0 0 , M+), 2 8 0 (1 6 ) , 279 
(16), 278  (61, M— H20 ), 262  (13), 254  (24), 253 
(13), 252  (6 8 ), 251 (11), 2 50  (16, M— CO— H20 ), 
2 49  (21), 232 (11), 21 9  (21), 21 8  (11), 207 (16), 
2 0 2 ( 1 1 )
b
C 18H16O4
2 9 6 (1 3 , M+), 280  (22), 279  (21), 2 7 8 (1 0 0 ,
M— H20 ), 2 63  (1 1 ), 262  (33), 261 (1 1 ), 26 0  (44,
M— 2H20 ), 25 0  (1 1, M—CO— H20 ), 246  (11), 220 
(11), 219  (33), 20 3  (11), 2 02  (22)
c
C 18H16O4
2 9 6  (25, M+), 280  (21), 2 79  (21), 278  (100,
M— H20 ), 263  (14), 262 (36), 261 (11), 26 0  (39, 
M—2H20 ), 250  (14, M—CO— H20 ), 235  (14, 
M—C O —H20 —CH3), 23 4  (1 0 ), 23 3  (29), 219  
(21), 218  (13), 20 7  (14), 205  (13), 202  (18)
d
C 18H14O3
Found: M+ 
Requires:
2 78 .0948
2 78 .0943
2 8 0  (18), 279  (19), 2 7 8  (100, M+), 2 6 0  (15,
M—H20 ), 231 (12, M— H20 — CHO), 203  (16), 202 
(1 1 ) '
e
C 18H16O3
Found: M+ 
Requires:
280 .1 1 0 9
2 80 .1100
2 8 0  (28, M+), 279  (12), 264  (19), 263  (22), 262 
(100 , M— H20 ), 2 34  (25, M—CO— H20 ), 219  (16, 
M— H20 —CO—CH3), 20 2  (10)
f
C 18H14O2 
Found: M + 
Requires:
2 62 .0995
262 .0994
2 64  (19), 263  (20), 26 2  (100, M+), 2 45  (17), 244 
(31, M—H20 ), 2 33  (11), 231 (11), 22 3  (17), 219 
(22), 218  (15), 21 7  (31), 21 6  ( 1 1), 215  (26), 204 
(10), 2 0 3 (2 9 )
a  had  a  UV spec trum  alm ost identical with th a t of th e  m ajor 
urinary m etabolite  (S truc tu re  V) of th e  ca rc in o g en  an d  g av e  th e  
know n 1 5-hydroxy-2-phenol on  acid  d ehyd ra tion  (4). This M e­
tabo lite  a  w as the re fo re  th e  1 ,2 -d ihyd ro -1 ,2 ,1 5-triol (C hart 5).
The UV sp e c tra  of M etabolites b an d  c w ere  a lm ost identical 
and  w ere  sim ilar to th a t of M etabolite e; th e s e  m etabo lites w ere  
th ere fo re  3 ,4 ,x-trio ls, w here  x d e n o te s  a tta ch m en t of th e  third 
hydroxyl g roup  a t C -15, a t C -16, o r to  th e  11 -m ethyl g roup . 
Information on th e  position of th e  third hydroxyl g ro u p  in 
M etabolites b and  c  w as provided by a  s tudy  of th e  m etabo lites 
form ed by m icrosom al incubation  of th e  3 sy n th e tic  m onools, 
S tru c tu re s  II to IV, u n d e r identical cond itions (C hart 3). S in ce  
th e  syn thetic  15- and  16-o ls a re  racem ic  m ix tures w h e re a s  th e  
co rrespond ing  biologically derived  m onools a re  p robab ly  op ti­
cally active, introduction of a  se c o n d  chiral c e n te r  in th e  
racem ic  m onools, su ch  a s  an  optically  ac tive  trans-3,4-dio l 
system , will then  resu lt in 2 ch rom atog raph ica lly  d is tinc t en - 
an tiom ers. It should  a lso  b e  b o rne  in mind th a t prev iously  it 
w as found th a t m icrosom al m etabolism  of th e  ca rc in o g en  
(S truc tu re  I) gave  rise  to  th e  1 6-ol (S tru c tu re  II), 1 5-ol (S tru c tu re  
III), and  11 -hydroxym ethylketone (S tru c tu re  IV) in th e  ap p ro x ­
im ate ratio 1 :12 :3  (8 ).
R eferring to  C hart 3 , /, it is s e e n  th a t m etabolism  of th e  16-ol 
p ro d u ces  equal am oun ts of 2 m etabo lites , th e  re ten tion  tim e of 
th e  m ore polar being identical with th a t of M etabolite  c . T he UV 
sp e c tra  of th e s e  2 m etabo lites w ere  identical with th a t of 
M etabolite c and  sim ilar to  th a t of th e  3 ,4 -d io r(M etab o lite  e); 
they  a re  there fo re  probably  3 ,4 ,1 6-triols, en an tio m eric  a t C- 
16. T he 15-ol (C hart 3 , ii) y ielded unequal am o u n ts  of 2 
m etabo lites ch rom atograph ically  an d  spec tra lly  ind istingu ish ­
ab le  from M etabolites b an d  c . T h e se  a re  th e re fo re  p robab ly  
th e  2 enan tiom eric  3 ,4 ,1 5-triols, th e  re a so n  for the ir inequality
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Table 2
UV spectra  o f M etabolites a to f and their chemical transformation products
Amax (mm)
Dehydration product
M etabolite NaBH4 reduction product Neutral Alkaline
a 265  (4.60), 322 (4.10),
334  (4.14), 354 (3.71), 
37 3  (3.68)
b  27 3  (4.70), 327 shfa (3.83),
335  (3.84), 370 sh 
(3.54)
c  272  (4.70), 3 2 7  sh (3.89), 
33 3  (3.90), 37 0  sh
259 (4.65), 267 (4.69), 
320  (3.80)
248  (4.74), 327  (3.97), 
347  (3.85)
24 8  (4.76), 32 6  (4.03), 
347  (3.90)
278  (4.71 f
269  sh (4.61), 274 
(4.62), 3 0 1 .5  (4.48)
26 9  (4.68), 274 (4.67), 
301 (4.57)
2 5 0  (4.53), 301 (4.55)
261 (4.70), 3 27  (4.37)
262  (4.76), 32 8  (4.46)
(3.61)
of 269  (4.78), 30 0  (4.27),
35 8  (3.26), 376  (3.24)
e  273 (4.71), 33 2  sh (3.84), 
35 7  (3.57), 371 (3.55) 
fc 265 (4.83), 300 .5  (4.29),
35 9  (3.00), 374  (3.02)
25 5  (4.82), 279  (4.09),
290  (4.05), 301 (4.09), 
334  (3.06), 3 5 0  (2.93)
25 0  (4.70), 306  (3.58), 
33 0  (3.63), 34 9  (3.59)
256  (4.82), 28 0  (4.07),
291 (4.06), 30 3  (4.13), 
337  (3.11), 352  (3.04)
271 (4.66), 301 (4.45) 261 (4.64), 3 25  (4.32)
Literature value for 15 ,16-dihydro-2,15-dihydroxy-11 -m ethylcyclopenta[a]phenanthren-17-one: Amax 276  (neutral); 
250, 30 0  (alkaline) (4). 
b sh, shoulder.
0 Literature values: 15,16-dihydro-15-hydroxy-11-m ethylcyc!openta[a]phenanthren-17-one, Amax 265  (4.84), 300 
(4.53), 356  (3.29), 374  (3.21) (7); 15 ,16-dihydro-l 1-hydroxym ethylcyclopenta[a]phenanthren-17-one, Amax 264 .5  
(4.85), 285  (4.51), 300  (4.32), 356  (3.29), 3 7 2 .5  (3.41) (7).
being th a t o n e  of th e  optically active 1 5-o ls is a  b e tte r  su b s tra te  
for th e  enzym e(s) leading to 3 ,4-diol form ation. T he m ajor 
m etabolite  of th e  11 -hydroxym ethylketone (C hart 3, Hi) w as 
a lso  ch rom atograph ically  and  spectra lly  identical with m e tab ­
olite to; a s  ex p ec ted , th is optically inactive su b s tra te  gave  a  
sing le  peak  which is m ost probably  th e  11 -hydroxym ethyl-3 ,4 - 
diol. To sum m arize, M etabolite  b (C hart 1) m ay b e  co m p o sed  
of th e  3 ,4 ,1 5-triol and  1 1 -hydroxy-3 ,4-diol, while M etabolite c 
m ay be  a  mixture of 3 ,4 ,1 5 -  and  3 ,4 ,16 -trio ls.
Of th e  m onools, th e  1 5-ol (S truc tu re  III) is th e  b e s t su b s tra te , 
an d  its m ajor m etabolite is th e  1 ,2 ,1 5-triol (M etabolite  a ) which 
o c c u rs  a s  a  single p eak , aga in  p robably  d u e  to optical se le c ­
tivity. In ag reem en t with this a ss ig n m en t of M etabolites a , 
ne ither th e  16-ol (S truc tu re  II) or 11 -hydroxym ethyl com pound 
(S truc tu re  IV) g ives a  m etabolite  with th e  reten tion  tim e of 
M etabolite a. T he 16-ol (S truc tu re  II) g ives a  m inor m etabolite  
with a  slightly longer re ten tion  time, w hich p robably  a c c o u n ts  
for th e  sh ou lder on th e  trailing ed g e  of M etabolite  a  (C hart 1). 
M etabolite d is form ed from both th e  15-ol and  11-hydroxy­
m ethy lketone but no t from th e  16-ol. This diol h a s  a  UV s p e c ­
trum  sim ilar to  th a t of th e  15-ol and  is th e re fo re  th e  11 -hydrox- 
ym ethyl-15-ol. As ex p ec ted , none  of th e  3  m onools gave  rise 
to  M etabolite e. T he main in vitro m etabolic  pa thw ays for th e  
ca rc in o g en  (S truc tu re  I) an d  th e  s tru c tu re s  of th e  m etabo lites 
a re  sum m arized  in C hart 5.
T he re su lts  of testing  th e  syn thetic  m onools for ca rc in o g en ic  
activity in a  2 -s ta g e  experim en t is show n in C hart 4 , which 
in d ica te s  th e  tim e of first a p p e a ra n c e  of th e  first skin tum or on 
ea c h  anim al in G roups 1 to  4  up to 1 y ear; this experim en t is 
still in p ro g re ss , and  full de ta ils  will b e  pub lished  later. T he 16- 
ol (S truc tu re  II) p ro v es to be  a lm ost a s  ca rc in o g en ic  a s  is 
S tru c tu re  I; a t 5 0  w eek s , tum or inc idence  for S tru c tu re  I is 
95% , and  for S tru c tu re  II it is 100% ; m ean  la ten t pe rio d s a re  
2 1 .2  and  2 6 .8  w eek s, respectively . By c o n tra s t, th e  15-ol 
(S tru c tu re  III) (24% , 3 5 .8  w eeks) and  1 1 -hydroxym ethylketone 
(S tru c tu re  IV) (35% , 3 4 .5  w eeks) a re  m uch le ss  active. The 
m u tagen ic  activity of th e s e  co m p o u n d s to w ard s S . typhimurium
TA10 0  with m etabolic activation is show n in T able 3. The 16-0 I 
is tw o-thirds a s  ac tive  a s  is S tru c tu re  I, while th e  15-ol and  11- 
hydroxym ethylketone a re  only 15 and  7%  a s  active, re s p e c ­
tively.
DISCUSSION
T he carc in o g en  (S truc tu re  I) is m etabolized  by 2 main rou tes  
a s  show n in C hart 5. Aliphatic hydroxylation a t th e  15- and  16- 
m ethylene g ro u p s  and  a t th e  11-m ethyl g roup  g ives the  m on­
ools II to IV (M etabolites f  and  g) and  th e  diol d. E poxidation of 
the  non-bay-reg ion  doub le  bond in th e  benzo  ring of S tru c tu re  
I, followed by enzym atic opening , le ad s  to  th e  3 ,4-diol (M etab­
olite e) which is th e  proxim ate c a rc in o g en  (9). S eco n d ary  
m etabolism  of th e  m onools yields th e  1 ,2 ,1 5-triol (M etabolite 
a) and  the  3 ,4 ,x-trio ls (M etabolites b an d  c). T he m etabolism  of 
S truc tu re  I th ere fo re  re sem b le s  tha t of o th e r purely polycyclic 
h yd rocarbons in th a t both th e  benzo-ring  doub le  b o n d s  a re  
a ttack ed , while K-region (C -6,7) p ro d u c ts  a re  no t found. As 
with o th e r p h en an th ren e -b ased  c a rc in o g e n s .(1 , 1 0 , 1 1 , 1 3 -  
1 6 ,1 9 ) ,  th e  3 ,4-diol sy s tem  g ives rise  to m utagen ic  and  c a r­
cinogenic  activity. P resum ably , th e  3 ,4 ,x -trio ls, like th e  3,4-diol 
(M etabolite e) (9), a re  further oxidized a t th e  1 ,2 -doub le  bond 
to ep o x id es which a re  th ere fo re  th e  ultim ate form s of the  
carc inogen ic  m onools (S tru c tu res  II to  IV).
T he m uch h igher ca rc inogen ic  and  m utagenic  activity of 
S truc tu re  II com pared  with S tru c tu re  III a p p e a rs  to  b e  c a u se d  
by th e  16-hydroxyl g roup  in the  form er com pound  directing  
aryl oxidation to  th e  non-bay-reg ion  doub le  bond . T he 15-ol 
(S tructu re  III), on th e  o th e r hand , is largely  co nverted  into the  
1 ,2 ,1 5-triol (M etabolite a). Like th e  bay-reg ion  diol of benzo- 
[a jpy rene  (18), M etabolite a  is biologically inert and  its 3 ,4 - 
double bond is not apparen tly  oxidized fu rther in vitro. How­
ever, in th e  in tact ra t it s e e m s  likely th a t M etabolite a  is 
converted  into the  oxepin (S tructu re  V) b e c a u se  th is is a  m ajor 
m etabolite in th e  urine of th e  an im als given in jections of the  
ca rc inogen  (S truc tu re  I) (5). The com paratively  low biological
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i267
327
273
334
322
370
'320 354 373
358 375
359 376
Chart 2. UV absorption sp ec tra  of M etabolites a , b, d, and f (see  Chart 1);
 , m etabolite in aqueous m e th an o l; , the  sam e after reduction by the
addition of sodium borohydride. The sp ec tra  of M etabolite c, both before and 
after reduction, w ere alm ost identical to those  of M etabolite b (see  Table 2). For 
the spec tra  of M etabolite e, s ee  Table 2 and Ref. 9.
Table 3
M utagenicity of Structures I to IV in the Am es te s t with S. typhimurium TA100  
and microsomal activation 
For details, s e e  “ M aterials and M ethods.”
M utagenicity
Structure R evertants/A g R evertan ts/nm ol
I 167 41
II 1 0 1 26
III 25 6.5
IV 1 1 2.9
activity of th e  11 -hydroxym ethylketone (S truc tu re  IV) is anom ­
alous b e c a u se  th e  main m icrosom al m etabolite of th is com ­
pound is th e  3 ,4 -d ihydroxy-11 -hydroxym ethyl ke to n e  (M etab­
olite b). After fu rther m etabolic activation , th is m etabolite b inds 
very strongly  to DNA in vitro (9), su g g es tin g  th a t epoxidation  of 
its bay-reg ion  doub le  bond o ccu rs  norm ally. T he rea so n  for its 
low m utagenicity  and  carc inogenicity  m ay be  tha t th e  a d jac en t 
hydroxym ethyl g roup  is stra teg ically  p laced  to  open  the  1 ,2 - 
epox ide  by rea r a ttack  a t C -1 , th e reb y  reducing  the  half-life of 
this ultim ate carc inogen .
In addition to th e s e  main m etabolic transfo rm ations, it is 
c lea r from th e  num ber of minor m etabo lites tha t severa l o th e r 
pa thw ays a re  a lso  operative. Thus, the  fac t th a t M etabolite e, 
on fu rther m etabolism  in th e  p re s e n c e  of DNA, g ives a  small 
am ount of th e  faster-running  DNA A dduct A in addition to  the
CH-
•OH
CH-
Chart 3. Separation of in vitro m icrosomal m etabolites of the synthetic  mon­
ools by HPLC; conditions sam e a s  in Chart 1.
CH:
•OH
-1 5
v> 
o
E3
C
at
_c
-10
HOCH-
a>u
E
- 5o
20 Weeks 30
Chart 4. Time of first ap p ea ran ce  of skin tum ors after an  initiating d o se  of 
40 0  /ng of S tructures I to IV, followed by twice-weekly promotion with croton oil.
main A dduct B (9), sh o w s th a t M etabolite e  is hydroxy la ted  to  
o n e  o r m ore of th e  triols b and  c  w hich a re  know n to  give rise  
so lely  to A dduct A (9). Exam ination of th e  m inor m etabo lites 
m ore polar than  M etabolite a  (C harts 1 an d  3) rev ea ls  th a t they  
all p o s s e s s  UV sp e c tra  ch a rac te ris tic  of th e  1 ,2 ,3 ,4 -te trahyd ro
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h o c h 2 t^
CH:CH; OH
OH
n,(g)
H O C H 2-
CH. ‘OH
*OH
HOH0‘ OHOHOH
Chart 5. P roposed m etabolic pathw ays of the  carcinogen (S tructure I) leading
to M etabolites a  to g. M etabolite e  is the main proxim ate carcinogen, and 
M etabolites b  and c  a re  minor proxim ate carcinogens of S tructure I. S tructure V 
is the structure of a  major urinary metabolite and is not found am ong the  products 
of microsomal metabolism of Structure I.
derivative of S tru c tu re  I and  a re  probably  th e re fo re  1 ,2 ,3 ,4 - 
te trao ls  and  1 ,2 ,3 ,4 ,x -p en tao ls  derived from hydrolytic c leav ­
a g e  of th e  postu la ted  1 ,2 -ep o x id es of M etabolites b, c, and  e.
In sum m ary, w e c o n sid e r th a t th e  3,4-diol e  is th e  main 
proxim ate form and  th a t th e  3 ,4 ,x-trio ls b and  c  a re  minor 
proxim ate form s of th e  ca rc in o g en  (S truc tu re  I). All a re  p ro b a ­
bly converted  to  ultim ate form s by fu rther m etabolism  to  1 ,2- 
ep ox ides . This work th ere fo re  fully su p p o rts  th e  bay  region 
theory  of biological activation of polycyclic arom atic  c a rc in o ­
g e n s  (12).
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ABSTRACT
Enzym atic hydrolysis of calf thym us DNA trea ted  in vitro with 
th e  ca rc in o g en  15 ,16 -d ih y d ro -l 1-m ethy lcyclopenta[a]phen- 
an th ren -1 7 -o n e  and  a  m icrosom al enzym e system  followed by 
colum n ch rom atog raphy  d isc lo sed  two ad d u c t fractions, A and  
B, eluting afte r th e  natural n u c leo s id es. Isolation and  hydrolysis 
of th e  DNA from th e  skin of m ice tre a ted  topically with 1 5 ,1 6 - 
d ihyd ro -11 -m ethy lcyc lopen ta [a ]phenan th ren -17 -one  o r from 
m ouse  em bryo  cells ex p o sed  to 15 ,1 6 -d ih y d ro -l 1-m ethylcy- 
c lo p en ta [a ]p h en a th ren -1 7 -o n e  in cu ltu re  gave  mainly A dduct 
B identical with th a t ob ta ined  in vitro. T he sev en  main m etab ­
olites form ed from 15 ,1 6 -d ih y d ro -l 1-m ethylcycIopenta[a] 
p h en an th ren -1 7 -o n e  with th e  m icrosom al sy s tem  w ere  iso lated  
by h ig h -p ressu re  liquid ch rom atog raphy  and  w ere  individually 
incuba ted  with DNA and  th e  activating system ; th e  DNA w as 
su b seq u en tly  recovered  and  analyzed . A dduct B a ro s e  from a 
single m etabolite  identified on th e  b a s is  of its ultraviolet and 
m ass  sp e c tra  to g e th e r with its gen e ra l chem ical behavior a s  a
3 .4 -d ihydro -frans-3 ,4 -d ihydroxy  derivative of 15 ,16-d ihydro- 
1 1 -m ethy lcyclopen ta[a]phenan th ren -17 -one. In addition, this 
m etabolite w as th e  m ost m utagenic  in th e  A m es te s t, being 
m ore active than  th e  carc in o g en  itself. This m etabolite  is th e re ­
fore th e  proxim ate form of th e  carc inogen .
The ultraviolet sp ec tru m  of A dduct B resem b led  th a t of a
1 .2 .3 .4 -te trah y d ro  derivative of 1 5 ,1 6-d ihydro-11-m ethylcy- 
c lo p en ta [a ]p h en an th ren -1 7 -o n e , while th e  ch rom atog raph ic  
mobility of th e  ad d u c t on S e p h a d e x  LH-20 w as m arkedly 
in c rea sed  by inclusion of b o ra te  in th e  eluant, indicating a  c/'s- 
diol sy s tem . S in ce  th e  3 ,4-diol is trans, th is su g g e s ts  further 
m etabolism  of th e  benzo  ring. It is there fo re  p ro p o sed  tha t th e  
ultim ate carc in o g en  is a  1 ,2 -d ihydro -1 ,2 -epoxy-3 ,4 -d ihydro - 
fran s-3 ,4 -diol of 15 ,16 -d ih y d ro -l 1-m ethy lcyclopenta[a]phen- 
an th ren -1 7 -o n e .
INTRODUCTION
After m etabolic activation, th e  strong  carc in o g en  1 5 ,1 6 -d i­
hydro -l 1 -m ethy lcyc lopen ta [a ]phenan th ren -17 -one  (S truc tu re  
I) (9) (C hart 1) b inds to DNA in vitro (16) and  is m utagenic  to 
Salmonella typhimurium T A 100 (13). Both th e se  activities a re  
su p p re sse d  by th e  aryl hydrocarbon  hydroxylase inhibitor 7 ,8 - 
benzoflavone, which strongly  inhibits form ation of m etabolites 
derived from enzym atic  a ttack  on th e  arom atic  rings, but not 
th o se  p ro d u ced  by hydroxylation a t sa tu ra te d  ca rb o n  a tom s 
(C -15 and  C -16 m ethylene g ro u p s  and  11-m ethyl g roup) (16). 
Skin tum or production  by topical application  of this carc in o g en  
(S tructu re  I) is a lso  red u ced  by a  coadm inistra tion  of 7 ,8 -
1 To whom req u ests  for reprints should be add ressed .
2 Recipient of a  bursary  aw ard from the Imperial C ancer R esearch  Fund.
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benzoflavone (11). T aken  to g e th e r with th e  o b se rv ed  co rre la ­
tion be tw een  m utagenicity  and  carc inogen ic ity  in th e  cyclo- 
p en ta [a ]p h en an th ren e  s e r ie s  (13), th is su g g e s ts  th a t th e  m e­
tabo lite  re sp o n sib le  for th e  ca rc in o g en ic  activity of S tru c tu re  I 
Is derived from th e  arom atic  part of th is m olecule. T he ability of 
S tru c tu re  I to bind to  DNA in vitro a fter m etabolic activation 
d e c re a s e s  rapidly u n d e r am bien t cond itions and  is lost im m e­
diately  on acidification, su g g es tin g  th a t th e  active m etabolite  is 
p robably  an  aryl ox ide (16). This p a p e r  d e sc r ib e s  exp erim en ts  
w hich have led to  its identification a s  a  3 ,4-d ihydroxy-1 ,2 - 
epox ide  of S tru c tu re  I. A prelim inary report h a s  a p p e a re d  (10).
MATERIALS AND METHODS
L ab e led  C o m p o u n d s . 1 1 -m efhy/-14C -labeled  ca rc in o g en  
(S truc tu re  I) (9 .3  m C i/m m ol) w as sy n th esized  by th e  m ethod 
d e sc rib ed  previously (15). G enerally  tritiated  S tru c tu re  I (1 3 .9  
C i/m m ol) w as p rep a red  by platinum  m eta l-ca ta lyzed  e x c h a n g e  
in 70%  [3H ]acetic ac id  (6 ). Tritium n uc lea r m agnetic  re s o n a n c e  
revealed  that, with th e  ex cep tion  of C-1 and  C -16, all positions 
w ere  labeled  a s  follows: C-2 and  C-3, to g e th e r, 2 3 .6 ; C-4, 
18 .2 ; C -6 , 8 .2 ; C-7, 4 .5 ; C -12, 3 .1 ; C -15 , 16 .4 ; 11 -m ethyl, 
2 5 .5% . T he s tru c tu re s  of th e s e  co m p o u n d s a re  show n in C hart 
1 .
E n zy m es. D N ase I (DN-CL), sn a k e  venom  p h o sp h o d ie s te r­
a s e  type  II (P -6877 ), alkaline p h o sp h a ta se  (Escherichia coli) 
type III (P -4252 ), an d  R N ase A (R 5125) w ere  o b ta ined  from 
Sigm a, London, E ngland. P ro te in a se  K (fungal) and  NADPH 
w ere  from British Drug H ouses, Poole, D orset, E ngland.
In Vitro E x p e rim e n ts  w ith DNA. Binding of th e  ca rc in o g en  
(S truc tu re  I) and  its iso lated  m etabo lites to DNA in vitro and  
enzym atic hydrolysis of th e  DNA followed by sep a ra tio n  of its 
co n stitu en ts  by ch ro m ato g rap h y  on S e p h a d e x  LH-20 w as  c a r­
ried ou t a s  d e sc rib ed  previously (16).
Iso la tion  o f DNA from  M ouse  S k in . Male TO (T yler’s  O rigi­
nal) m ice, 7 to 9  w eek s  old, w ere  u sed  in g ro u p s  of 15 . Their 
b a c k s  w ere  sh av ed  with e lec tric  c lippers, and  24  hr la te r G-3H- 
labeled  S tru c tu re  I (4 0 0  jug in 4 0  jul to luene) w as  app lied  to 
e a c h  m ouse; th e  a re a  co v ered  w as approx im ately  2 .5  x 2 .5  
cm . G roups of m ice w ere  killed by cervical d is location  at 
se le c te d  tim es a fte r trea tm en t (C hart 3); th e  tre a te d  a re a  of 
skin w as rem oved an d  frozen in liquid n itrogen  in an  e a r th e n ­
w are  m ortar. T he frozen  skin fragm en ts w ere  g round  to  a  
pow der by hand , using a  pestle , and  ad d ed  in sm all po rtions to 
a  lysing solution of p ro te in a se  K a t 5 0 °  acco rd in g  to  th e  g en e ra l 
m ethod of Blin an d  S tafford  (2) for isolation of DNA. This 
co n s is ts  of solubilization of th e  tissu e , isolation of th e  nucleic  
a c id s  by phenol ex trac tions, re incubation  with R N ase , and  
reisolation  of th e  DNA by fu rther phenol ex trac tio n s . T he DNA 
solution th u s  o b ta ined  w as exhaustively  d ialyzed  ag a in s t tap  
w ate r and  finally ag a in s t distilled w ate r befo re  co n cen tra tio n  
for enzym atic  hydrolysis.
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Chart 1. S tructu res of the  labeled forms of the carcinogen (S tructure I) used.
Isolation of DNA from Mouse Embryo Cells. S eco n d ary  
w hole-m ouse-em bryo  cells w ere  se e d e d  a t 5 x  1 0 6 c e l l s /1 50 - 
mm tissu e  cu ltu re  dish (Falcon P lastics, O xnard , Calif.) in 
D u lbecco’s  m odification of E ag le ’s  m edium  contain ing  10%  
fetal calf serum  (G ibco Bio-cult, Paisley , S co tland ) and  grow n 
to confluency  over 3 days. E ach of 15  d ish es  (total 4  x  10 8 
cells) w as tre a ted  with 5 0  jug of th e  G-3H -labeled carc in o g en  
(S truc tu re  I) in 5 0  jul of dim ethyl su lfoxide to give a  final 
concen tra tion  of 1 .2 5  jug/ml, and  incubation  w as con tinued  for 
a  fu rther 4 8  hr. T he m edium  w as rem oved, th e  d ish e s  w ere 
w ash ed  tw ice with phosph a te -b u ffe red  sa line  [containing NaCI 
(10 g), KCI (0 .2 5  g), N a2H P 0 4 (1 .4 4  g), KH2P 0 4 (0 .2 5  g), 
CaCI2, 2H 20  (0 .1 7  g), and  MgCI2, 6H 20  (0 .1 3  g) p e r liter of 
sterile  distilled w ater, pH 7 .2], and  th e  ce lls  w ere  s c ra p e d  off, 
su sp e n d e d  in pho sp h a te -b u ffe red  sa line, and  cen trifuged  a t 
9 0 0  x  g for 5 min. T he cell pellet w as w ash ed  tw ice with 
p ho sp h a te -b u ffe red  sa line  by re su sp en sio n  and  recen trifuga­
tion; it w as  finally ad d ed  to th e  p ro te in ase  K lysing solution, 
and  th e  DNA w as iso lated  a s  a lready  d esc rib ed .
In Vitro Metabolism and Separation of Metabolites. 11- 
/77efhy/-14C -labeled  S tru c tu re  I (5 0 0  jug), m icrosom es from 10 
g of rat liver, and  NADPH (3 7 .5  mg) in 0.1 m Tris buffer (10  
ml), pH 7 .2 , w ere  sh ak en  gently  in air a t 3 7 °  for 3 0  min, and 
the  m etabo lites form ed w ere  ex trac ted  with ethyl a c e ta te  e s ­
sentially  a s  a lready  d esc rib ed  (16).
M etabolites w ere  se p a ra te d  by HPLC3 a s  d esc rib ed  previ­
ously (16) ex c e p t th a t a  W hatm an Partisil M9 1 0 /5 0  ODS 
colum n (W hatm an Ltd., M aidstone, E ngland) w as u sed  with a  
g rad ien t initially of 15%  m ethanol in w ate r chang ing  to m etha­
nol a lone  a t 1% /m in  and  a  flow ra te  of 12 0  m l/h r  (C hart 4).
Identification of Metabolite (e). HPLC frac tions contain ing  
M etabolite e  w ere  pooled  and  rerun , collecting only th e  cen tra l 
part of th e  peak . T he a q u e o u s  m ethanolic solution th u s  o b ­
ta ined  w as ev ap o ra ted  to  d ry n ess  in a  vacuum  a t 3 5 ° , and  th e  
res idue  w as d isso lved  in a  sm all volum e of m ethanol. An aliquot 
contain ing ab o u t 5 0  jug (b a sed  on its radioactivity) w as ev ap o ­
ra ted  in a  small capillary tu b e  for d irec t insertion into th e  inlet 
of a  A.E.I. MS 9 0 2  instrum ent, and  th e  m ass  spec trum  w as 
reco rd ed  a t 70  eV and  1 5 0 0  (10%  valley) resolving pow er 
(Table 2).
An aliquot w as diluted with m ethanol for UV sp e c tro sc o p y  
(Table 2; C hart 5), sodium  borohydride (10  mg) w as ad d ed , 
and  th e  sp ec tru m  w as re reco rd ed  after 3 0  min. For d eh y d ra ­
tion, an o th e r aliquot (1 ml, 10  a b so rb a n c e  units) w as h ea te d  in 
a  boiling w ater bath  for 3 0  min with 5 n  sulfuric acid  (4 ml). 
The coo led  solution w as ex trac ted  3 tim es with ethyl a c e ta te , 
and  th e  la tter w as w ash ed  with sa tu ra te d  sodium  hydrogen  
c a rb o n a te  solution and  with w ate r and  dried over an h y d ro u s
3 The abbreviation used  is: HPLC, high-pressure liquid chrom atography.
sodium  su lfa te . After evapora tion  to d ry n ess  in a  vacuum , th e  
res id u e  w as red isso lved  in neu tral m ethanol, and  its UV s p e c ­
trum  w as reco rd ed  befo re  and  a fte r addition of n  sodium  
hydroxide (0.1 ml). A fu rther aliquot (2 ml, 10  a b so rb a n c e  
units) w as stirred  with 5%  pallad ium -on-charcoal ca ta ly s t (1 
mg) in an  a tm o sp h e re  of hydrogen  for 1 hr, and  th e  UV 
sp ec tru m  w as  reco rd ed  after rem oval of th e  ca ta ly s t by c e n ­
trifugation. This solution w as fu rther red u ced  with sodium  bo­
rohydride a s  a lready  d esc rib ed , and  its sp ec tru m  w as re­
co rd ed .
The elution volum e of M etabolite e  (4 2 8  ml) run on a  S e p h ­
ad ex  LH-20 colum n with Tris buffer (pH 8 .7 ) w as u n ch an g ed  
w hen th e  eluting so lven t w as rep laced  by sodium  b o ra te  buffer 
(pH 8 .7).
Determination of Mutagenicity of Metabolites a to g. Me­
tabo lites a  to g (C hart 4) w ere  iso lated  by HPLC, and  their 
ability to c a u s e  reversion  to  p ro to trophy  in S. typhimurium 
TA 100 grow n on a  h istid ine-deficient m edium  w as  exam ined  
essen tia lly  a s  d e sc r ib ed  previously (13).
Characterization of Adduct B. LH-20 frac tions contain ing  
th is ad d u c t (C hart 2 ) w ere  pooled  and  c o n c e n tra te d  in a  
vacuum  to 2 ml. T he a q u e o u s  solution, Amax2 6 0 , 281 nm, w as 
red u ced  v/ith sodium  borohydride, Amax 2 4 0 , 2 8 5  nm; intensity  
a t 2 6 0  nm w as m uch d e c re a s e d  (for UV sp e c tra  of 1 ,2 ,3 ,4 - 
te trahyd ro  derivatives of S tru c tu re  I, s e e  T able  2 an d  C hart 5).
The elution volum e of A dduct B on a  colum n of S e p h a d e x  
LH-20 equilib rated  with Tris buffer, pH 8 .7 , w as 2 5 6  ml. W hen 
the  buffer w as rep laced  by sodium  b o ra te  buffer, pH 8 .7 , this 
volum e w as red u ced  to  2 0 5  ml (C hart 6 ).
RESULTS
Binding of Structure I to DNA in Vitro and in Vivo. As show n 
previously (16), th e  14C -labeled  ca rc in o g en  (S tru c tu re  I) b inds 
to  DNA w hen the  la tter is p re se n t during th e  incubation  with rat 
liver m icrosom es and  NADPH. Enzym atic hydro lysis of th is 
DNA followed by ch ro m ato g rap h y  of th e  resu lting  n u c leo s id e s  
on S e p h a d e x  LH-20 co lum ns g ives 2 rad ioactive  p e a k s , A and  
B, eluting a fte r th e  natural n u c leo s id e s  (UV trace ) a s  show n in 
C hart 2 a . T he sa m e  pa tte rn  w as o b se rv ed  with calf thym us, 
salm on sperm , an d  E. coli DNA an d  with DNA p re p a re d  from 
m ouse  skin, provided in vitro incubations w ere  u sed . In addition  
to  A dducts A and  B, a  sh a rp  co inciden t p eak  (P eak  X) of 
radioactivity  and  UV abso rp tion  alw ays a p p e a re d  a t ab o u t 8 5  
ml, th e  approx im ate  elution volum e of po lydeoxyribonucleo - 
tides. T he s ize  of th is p eak  w as not a lte red  by fu rth er incubation  
with th e  various en zy m es u sed  in th e  isolation an d  hydro lysis 
of th e  DNA.
In o rd e r to investiga te  th e  pa tte rn  of DNA binding in vivo, 
m ice w ere  tre a te d , e a c h  on its do rsa l region, with 4 0 0  jug of 
th e  h igh-specific-activ ity  3H -labeled ca rc in o g en . T his is know n 
to  b e  a  pow erful initiating d o se  w hich, w hen follow ed by tw ice- 
w eekly  prom otion with c ro ton  oil, g av e  rise  to  tu m o rs in 90%  
of th e  an im als with a  m ean  la ten t period of 3 5  w e e k s  (8 ). After 
2 4  hr and  a t s u b s e q u e n t tim es up to 3 6  d a y s  m ice w ere  killed, 
DNA w as iso la ted  from th e  tre a te d  skin an d  w as  hydro lyzed  
and  ch ro m ato g rap h ed  a s  befo re . In e a c h  c a s e , a  p a tte rn  sim ilar 
to  th a t show n in C hart 2b w as found, co nsis ting  of A dduct B 
and  a  tra c e  of A dduct A. Identity of th is in vivo 3H -labeled  
A dduct B with th e  14C -labeled  A dduct B form ed in vitro w as 
e s tab lish ed  by co ch ro m ato g rap h y , w hen both  is o to p e s  e lu ted
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C hart 2. Sephadex  LH-20 profiles of DNA hydrolysates, a , profile from calf
thym us DNA trea ted  in vitro with the  14C-labeled ketone (S tructure I ) ; ......... , UV
absorption  of the continuously monitored e lu a te ;  , radioactivity in individual
fractions collected, to, profile from DNA isolated from the skin of mice treated  
topically with G-3H-labeled S tructure  I; note the  radioactive labeling of the 
individual nucleoside b a se s  by 3H20  liberated by oxidative metabolism  of the 
carcinogen , c, cochrom atography of 14C-labeled in vitro Adduct B and 3H-labeled 
in vivo Adduct B.
to g e th e r  (C hart 2c). In addition  to  th e s e  ad d u c ts , C hart 2b a lso  
sh o w s th e  p re s e n c e  of th e  early  P eak  X and  an  even  fa s te r- 
running p eak . T he latter, but not P eak  X, w as d e c re a s e d  w hen 
th e  DNA w as iso la ted  by precip itation  befo re  hydrolysis; how ­
ever, th is s te p  w as  usually  om itted to e n su re  th a t no lo ss of 
DNA o ccu rred . T he faster-runn ing  p eak  m ay th e re fo re  co n sis t 
of nondialyzab le , carcinogen-Y nodified p ep tid e s  not am enab le  
to  com p le te  d igestion  with th e  p ro te a se  u sed . A sm all am ount 
of labeling of the  natural n u c leo s id es  is a lso  ev iden t in C hart 
2b. This a r ise s  by m etabolic  incorporation  of tritium d isp laced  
from th e  3H -labeled ca rc in o g en  during oxidative m etabolism . 
This in vivo p a tte rn  of radioactivity  bound  to DNA is sim ilar to 
th o se  rep o rted  for o th e r c a rc in o g e n s  (28).
C hart 3  sh o w s th e  tim e c o u rse  of binding of th e  3H -labeled 
ca rc in o g en  (S tru c tu re  I) to  m o u se  skin DNA in vivo. Maximum 
radioactiv ity  in P e a k s  A, B, an d  X o ccu rred  a t 4 8  hr. P eak  X 
dec lin ed  rapidly during th e  su b s e q u e n t w eek , th en  m ore slowly 
an d  w as  bare ly  p re s e n t a t 3 6  d ay s . By c o n tra s t, th e  am ount of 
A dduct B rem ained  co n s ta n t until th e  fifth day  and  th en  d e ­
c re a s e d , rapidly a t first, to  a b o u t 10%  of its original value a t 3 6  
d ay s .
Binding of th e  3H -labeled  ca rc in o g en  to  th e  DNA of m ouse  
em bryo  ce lls  in cu ltu re  w as  a lso  stud ied . Again, maximum 
binding w as  found a t 4 8  hr; th e  pa tte rn  of radioactivity  in th e  
hydro lysis p ro d u c ts  w as th e  sa m e  a s  th a t for m ouse  skin show n 
in C hart 2b.
Mutagenicity and Binding to DNA of Metabolites. M etabo­
lites a  to  g (C hart 4) form ed from 14C -labeled  S tru c tu re  I by
incubation  with ra t liver m icrosom es and  NADPH w ere  s e p a ­
ra ted  by HPLC and  exam ined  for biological activity by m ean s 
of th e  A m es te s t. Previously, w e have  dem o n stra ted  (13) tha t 
th e re  is a  good  correlation  be tw een  m utagenicity , a s  m easu red  
by th e  reversion  to  p ro to trophy  in S. typhimurium TA 100, and 
carc inogen ic ity  am ong 29  cy c lo p en ta [a ]p h en an th ren es which 
had  a lso  b een  te s te d  for their ability to  elicit skin tum ors in 
m ice. Like th e  ca rc in o g en  itself, none  of th e  m etabolites w as 
ac tive  in th e  a b se n c e  of fu rther m etabolism ; m utagenicity  in its 
p re s e n c e  is sum m arized  in T able  1 . M etabolite e  w as th e  m ost 
active, being  m ore than  tw ice a s  active a s  th e  carc in o g en  
(S tru c tu re  I). M etabolites b, c, f, and  g w ere  a lso  m utagenic, 
but le s s  so  than  S tru c tu re  I, while M etabolites a  and  d w ere 
inert.
Binding of th e s e  14C -labeled  m etabo lites to DNA in vitro by 
th e  m ethod a lready  d e sc rib ed  is a lso  show n in T able 1. M etab­
olite e  w as  un ique in tha t it w as th e  only m etabolite to  give rise 
to th e  n u c leo s id e  A dduct B, th e  main a d d u c t p ro d u ced  by th e  
ca rc in o g en  in vivo. Its ex ten t of binding w as a lso  severa l tim es
< 2 0 0
8 ioo-
5 1
800200 400
h o u rs
600
Chart 3. Variation in am ounts of carcinogen (S tructure I) bound to A dducts A, 
B, and X (Chart 2b)  derived from the  DNA isolated from the skin of mice at 
various tim es after topical treatm ent with G-3H-labeled S tructure I (400  fig).
20 retention tim e,m in 60 80o
Chart 4. UV absorption (254  nm) trace  of S tructure I and its in vitro m etabo­
lites eluted from a  reverse-phase  h igh-pressure liquid chrom atograph column 
with an aqueous methanol gradient. For details, s e e  the text.
Table 1
M utagenicity and binding o f 'AC-iabeied M etabolites a t o g  to DNA in vitro
M etabolite
M utagenicity
(rev e rtan ts /
nmol)
DNA-binding index (fimol m etabolite/m ol 
DNA phosphorus)
Adduct A Adduct B Total
a 0 0 0 0
b 8.9 347 0 347
c 14.8 74 0 74
d 0 0 0 0
e 45 .6 56 541 597
f 6.6 58 0 58
g 13.6 31 0 31
I 17.5 30 127 157
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g re a te r  than  th a t of S tru c tu re  I. Of th e  o th e r m etabolites, 
M etabolites b, c, f, and  g all g ave  only A dduct A, while M etab­
olites a  and  d did not bind to  DNA. T he parallelism  betw een  
m utagenicity  an d  total am ount of the  m etabolite  bound  to DNA 
is no ticeab le . T he na tu re  of th e s e  o th e r m etabo lites is u nder 
investigation and  will form th e  su b jec t of a  s e p a ra te  com m uni­
cation .
T h e  S tru c tu re  o f M etab o lite  e  (T ab le  2; C h a rt 5). The
reten tion  volum e of m etabolite  e  su g g e s te d  a  diol, and  th is w as 
confirm ed by an  a c c u ra te  m ass  determ ination  which show ed  
its com position  to  b e  Ci8H160 3. T he third oxygen  atom  is 
p re sen t a s  th e  original k e to n e  function b e c a u se  mild reduction  
c a u se d  a  shift in th e  UV maximum from 2 7 3  to  2 5 0  nm. T h ese  
sp e c tra  a re  unlike th e  s p e c tra  of S tru c tu re  I and  its reduction
239
260
2 97 -5
287xIO
288
358
358 3? 334.
338
250 273
271
261
330
X4
301
,357 371
2 8 5
C hart 5. UV absorption spec tra , i, C arcinogen I ( ) and its borohydride re­
duction product, the  corresponding 17-ol (--------- ); ii, 1 ,2 ,3 ,4-te trahydro  deriva­
tive of S tructure  I (------ ) and  its borohydride reduction product, the corresponding
17-ol (------- -) ; //'/, M etabolite e  (------ ) and its borohydride reduction product
(--------- ); /V, product of acid-catalyzed dehydration of M etabolite e  in neutral
methanol (------ ) and in alkaline m ethanol (--------- ); v, DNA Adduct B (— -) and  its
borohydride reduction product (--------- ).
Proximate-Ultimate Forms of a Cyclopenta[a]phenanthrene 
Table 2
Characterization of the proximate carcinogen (M etabolite e)
M ass spectrum  (only p eak s  g rea te r than 10% of the  b a se  peak  are  listed)
m /e  (relative abundance  and  tentative assignm ent)
C18H160 3 requires: M+2 8 0 .1 109
M olecular ion, found: M+2 8 0 .1 100 (28% )
279 (12% )
264 (19% )
263 (22% )
B ase peak: 262 (100% , M -H 20 )
234 (25% , M -H zO -C O )
219 (16% , M -H 2O - C O - C H 3)
191 (16% , M -H 20 - C 0 - C H 3- '
UV sp ec tra  (for experim ental details, s e e  text; s ee  a lso Chart 5)
Amax (log e)
M etabolite e; 273  (4.68), 35 7  (3.39), 371 nm (3.40).
NaBH4 reduction product; 250 , 33 0  nm.
Acid dehydration product; neutral, 271 .5 , 301 nm.
Acid dehydration product; alkaline, 261, 325  nm.
Hydrogenation product; 259  nm [cf. 1 ,2 ,3 ,4 ,15 ,16-hexahydro-11-m ethylcy- 
clopenta[a]phenanthren-17-one, 260  (4.77), 287  (3.97), 2 9 7 .5  nm (4.02) 
(7)].
NaBH4 .reduction product of hydrogenation product; 239 , 279 , 33 0  nm [cf.
1 ,2 ,3 ,4 ,1 5 ,1 6-hexahydro-17-hydroxy-11 -m ethylcyclopenta[a]phenan- 
threne; 239, 288 , 334  nm].
p ro d u c t ( \ max 2 6 4  and  2 5 5  nm, respectively), indicating th a t 
th e  diol o x y g en s a re  situ a ted  in a  co n ju g a ted  ring. T he in ten se  
ion in th e  m ass  spec trum  of m etabolite  e  a t m /e  2 6 2 , c o rre ­
spond ing  to  a  lo ss of w a te r from th e  m olecu lar ion, confirm s 
th e  p re s e n c e  of a  readily  d eh y d ra ted  vicinal diol sy s tem . T he 
UV sp ec tru m  of M etabolite e  w as d ifferent from th o s e  of th e  
know n 1 ,2 - (12), 6 ,7 - (5), 1 1 ,1 2 -, o r 1 3 ,14 -d ihyd ro  (4) deriv­
atives of 1 5 ,1 6 -d ihyd ro cy c lo p en ta [a ]p h en an th ren -1 7 -o n e ; it 
th e re fo re  p robably  re p re se n ts  th e  unknow n 3 ,4 -d ihyd ro  ch ro - 
m ophore. A cid-catalyzed  dehydra tion  of M etabolite e  g av e  a  
phenol, th e  UV sp ec tru m  of w hich w as  no t th e  sa m e  a s  th o se  
of th e  know n 2 - (14), 3-, 6 -, an d  7 -p h en o ls  (5) of th is  se r ie s ; 
th e  4 -pheno l is the  ex p ec ted  p ro d u c t from dehyd ra tion  of th e
3 ,4 -d ihydro-3 ,4 -d io l, by com parison  with th e  p ro d u c t (1 -naph - 
thol) of dehydration  of 1 ,2 -d ihyd ro -1 ,2 -d ihyd roxynaph tha lene  
(17 , 19). T he p re s e n c e  of th e  3 ,4 -d ihyd ro  sy s tem  in M etabolite  
e  w as confirm ed by ca ta ly tic  hydrogenation , th e  p ro d u c t of 
w hich had  th e  know n ch rom ophore  of a  1 ,2 ,3 ,4 -te tra h y d ro  
com pound  (7). T he trans s te reo ch em is try  e x p e c te d  of a  diol 
form ed m etabolically  with m am m alian en zy m es w as  a lso  su g ­
g e s te d  by th e  failure to  d e c re a s e  th e  elution volum e of th is 
m etabolite  by addition  of sodium  b o ra te  to  th e  elu ting  buffer. 
M etabolite e  is th e re fo re  th e  3 ,4 -d ihyd ro -3 ,4 -frans-d ihyd roxy  
derivative and  is th e  prox im ate ca rc in o g en  (C hart 7); th e  a b ­
so lu te  s te reo ch em istry , o r indeed  w h e th e r it is a  sing le  e n an - 
tiom orph, is not know n a t p re sen t.
Id en tifica tio n  o f th e  U ltim ate  C a rc in o g e n . T he n a tu re  of th e  
reac tive  m etabolite  form ed from th e  3 ,4 -d ihyd ro -3 ,4 -d io l (M e­
tabo lite  e ) is su g g e s te d  by con sid era tio n  of th e  n u c leo s id e  
A dduct B w hich a r ise s  from it. T he UV sp ec tru m  of th is m aterial 
is th a t ex p e c te d  of an  ad d u c t consisting  of a  1 ,2 ,3 ,4 -te tra h y d ro  
derivative of S tru c tu re  I a tta c h e d  to  a  n u c leo s id e  b a s e  w ithout 
con jugation  of e ither ch rom ophore . A dduct B e lu ted  from a  
S e p h a d e x  LH-20 colum n earlie r and  a s  a  s ing le  p e a k  w hen  
b o ra te  buffer (23 ) w as u sed  in p lace  of Tris buffer (C hart 6 ). 
This is indicative of a  c/s-diol sy s tem , and  b e c a u s e  th e  3 ,4-d io l 
is trans th e  im plication is th a t th e  a d d u c t co n ta in s  a  third 
hydroxyl g roup  a t C-2, cis with re s p e c t to  th a t a t C -3. T his in
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Chart 6. Effect of sodium borate  on the  elution volume of the  nucleoside 
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Chart 7. P roposed  s tructu res of the proxim ate and ultimate forms of the 
carcinogen (S tructure I).
turn  im plies m etabolism  of th e  1 ,2 -doub le  bond in M etabolite 
e.
In view of th is ev id en ce  and  th a t for th e  involvem ent of an 
aryl ox ide m entioned in th e  introduction, it s e e m s  m ost p ro b a ­
ble th a t th e  reactive  m etabolite is an  anf/'-3 ,4 -d ihydro-3 ,4-frans- 
d ihydroxy l-1 ,2 -d ihydro-1 ,2 -epox ide  of S tru c tu re  I, an a lo g o u s 
to th e  d io l-epoxide now though t to be  th e  active form of 
ben zo (a)p y ren e  (29 , 37). In th e  p re sen t c a s e , th e  c o rre sp o n d ­
ing syn-diol ep o x id e  is excluded  b e c a u se  if ad d u c t form ation 
o c c u rs  by nucleophilic  a ttack  a t th e  benzylic C-1 position 
acco m p an ied  by inversion, but with reten tion  of configuration 
a t C-2 (23), th is would lead  to an  all-trans s tru c tu re . In the  
p re se n t a b s e n c e  of know ledge of th e  ab so lu te  ste reo ch em istry  
of th e  3 ,4-diol (M etabolite e), w e p ro p o se  th a t th e  ultim ate form 
of S tru c tu re  I is one , or both, of th e  optical isom ers (C hart 7). 
U nequivocal proof of th e s e  s tru c tu re s  aw aits sy n th es is  of the
3 ,4-d io l (M etabolite e) and  its 1 ,2 -ox ide, w ork w hich is at 
p re se n t in hand .
DISCUSSION
Of th e  m icrosom al m etabo lites of 15 ,16-d ihydro -11-m ethy l- 
cy c lo p en ta [a ]p h en an th ren -1 7 -o n e  (S truc tu re  I), th e  3 ,4-d ihy- 
d ro -3 ,4 -d io l (M etabolite e) is th e  m ost active, being m ore 
m u tagen ic  an d  binding to  DNA m ore strongly  than  d o e s  th e  
p a re n t ca rc in o g en  and  being th e  only m etabolite  to give rise to 
th e  in vivo A dduct B. A nalogous activation of o th e r p h en an ­
th re n e  derivatives, namjely, b enzo (a)py rene  (26 , 29 , 37), 
b en z (a )a n th ra c e n e  (24 , 30 , 34 , 35), 7-m ethy lbenz(a)-
a n th ra c e n e  (1, 2 6 , 32), 7 ,1 2-d im ethy lbenz(a)an th racene  
(18 , 21 , 2 6 , 27 , 33), 3 -m ethy lcho lan th rene  (22 , 3 1 , 33), di-
b en z (a ,h )an th racen e  (36), ch ry sen e  (25), and  5-m ethylchry- 
s e n e  (20), h a s  recen tly  b een  rep o rted . Further oxidation of the  
bay-reg ion  doub le  bond in th e  3 ,4-diol (M etabolite e) to a  3 ,4 - 
d io l-1 ,2 -epox ide  (S truc tu re  III) g ives th e  ultim ate ca rc inogen , 
a s  in th e s e  o th e r sy s tem s . In th e  c a s e  of th e  b e s t stud ied  
hyd rocarbon , b enzo (a)py rene  (23 , 37), both syn- and  anf/'-diol 
ep o x id es  a re  found; only th e  anti-d io l-epoxide (S truc tu re  III) is 
form ed from th e  ca rc in o g en  (S truc tu re  I). 7 ,1 2-D im ethylbenz[a] 
a n th racen e , with an  an a lo g o u s  methyl g roup  in th e  bay  region, 
s e e m s  a lso  to  give mainly th e  anti-isom er (18). While S tru c tu re  
I an d  th e  co rre sp o n d in g  1 1 -m ethoxy-17-ketone  a re  strong  
ca rc in o g en s , th e  11 -e thy l-17 -ke tone  is m uch le ss  active, and 
th e  11 -bu ty l-17 -ketone  is inactive a s  a  carc in o g en  (9) and  a s  
a  m utagen  (16). P ossib ly , th e s e  larger g ro u p s  h inder ap p ro ach  
of th e  o x id ase  to  th e  1 ,2-doub le  bond and  h en ce  inhibit epox- 
idation.
In th e  p re se n t experim en ts, binding to  DNA h as  been  esti­
m ated  from th e  sum  of th e  radioactivity in A dducts A and  B. 
H ow ever, th e re  is ev id en ce  th a t th e  early  P eak  X a lso  c o n sis ts  
a t leas t partly of carc inogen-m odified  nucleo tides (18 , 28). 
A lthough this p eak  is sm all in vitro (C hart 2a), in vivo it is 
ap p rec iab le , especia lly  a t early  tim es (C hart 3). P eak  X from 
th e  DNA of th e  skin of tre a ted  m ice d is a p p e a rs  m ore quickly 
and  com pletely  than  d o e s  A dduct B which is still easily  dem on­
strab le  even a fte r 3 6  days. In studying the  binding of tritiated 
7 ,1 2 -d im ethy lbenz[a]an th racene  to th e  DNA of m ouse  em bryo 
cells in cultu re , Dipple and  N ebzydoski (18) a lso  o b serv ed  tha t 
th e  p eak  eluting a t 8 5  ml and  th e  la ter ad d u c t p e a k s  w ere 
sim ilar in am oun t a t 24  hr bu t w ere  a t a  ratio of 1 :10  a t 4 8  hr.
N early all p o ten t polycyclic ca rc in o g en s  p o s s e s s  a  p h en an ­
th ren e  ring sy s tem  to g e th e r with additional, fu sed  arom atic  
ring(s). 15 ,16-D ihydro -11-m ethy lcyclopen ta[a]phenan th ren- 
1 7-one, with p o tency  sim ilar to  tha t of benzo (a)py rene , is 
th ere fo re  one  of th e  sim plest m olecu les c a p ab le  of being 
ac tiva ted  th rough  a  bay-reg ion  dio l-epoxide to display  high 
carc in o g en ic  activity. The im portance  of th e  carbonyl g roup  at 
C -17 lies in its con jugation  with th e  p h en an th ren e  system , for 
it m ay be  rep laced  by a  ca rb o n -ca rb o n  doub le  bond a t C- 
16(17) with reten tion  of strong  activity, while th e  hydrocarbon  
with a  sa tu ra te d  5 -m em bered  ring is only a  w eak  carc inogen
(9). T he 11 -m ethyl ke tone  (S truc tu re  I) is th e  m ost active of its 
positional methyl isom ers; th e  7-m ethyl ke tone  is le ss  active, 
and  th e  2-, 3-, 4-, 6-, and  1 2-m ethyl k e to n es , like th e  pa ren t 
k e to n e  1 5 ,1 6 -d ihyd rocyc lopen ta [a ]phenan th ren -17 -one , a re  
not ca rc in o g en s . S in ce  all th e s e  co m p o u n d s have similar bay 
reg ions, th is of itself is not sufficient to  e n su re  carcinogenicity ; 
co rrec t positional substitu tion  by a  sm all e lec tron -re leas ing  
g roup  is a lso  critical. T he sam e  pattern  of activation by methyl 
substitu tion  is a lso  se e n  am ong th e  m ethy lbenz[a]an th racenes 
and  m ethy lch rysenes, which m ay be  view ed a s  an a lo g s of 
S tru c tu re  I in w hich conjugation  by the  1 7-carbonyl g roup  is 
rep laced  by th e  conjugation  of a  further, fu sed  b en zen e  ring. 
C om parison of th e  m etabolic p ro d u c ts  form ed from S truc tu re  
I with th o se  from its inactive isom ers may lead to  a  b e tte r 
un d ers tand ing  of th e  role of th e  11 -m ethyl g roup  in inducing 
carc in o g en ic  p ro p ertie s  in th e s e  com pounds .
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THE CARCINOGENICITY OF 
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Summary.—Direct comparison of skin-tumour induction by 15,16-dihydro-11- 
methylcyclopenta[a]phenanthren-17-one (I) and by benzo[a]pyrene on mouse skin, 
both by repeated application or by initiation with a single dose followed by promotion 
with croton oil, demonstrated that these two carcinogens have similar potency. After 
repeated application of (I) the mean latent period for skin-tumour induction was 
linearly related to the logarithm of the dose over a 10-fold dose range. Under these 
conditions, application of the aryl-hydrocarbon-hydroxylase inhibitor 7,8-benzo- 
flavone together with (I) inhibited tumour induction by about 40%. By contrast, in 
the 2 -stage experiment, little effect on tumour incidence or latent period was observed 
when this inhibitor was applied with the single initiating dose of (I). Co-administra­
tion of the epoxide-hydratase inhibitor 1,1,1-trichloropropene oxide caused enhance­
ment by shortening the latent period.
After s.c. injection of (I) into mice, a similar number of tumours was induced on 
skin remote from the site of injection by promotion with croton oil begun either one 
week or 6 months after initiation. Gastric instillation of (I) into female rats induced 
mammary adenocarcinomas.
W e h a v e  p r e v i o u s l y  o u t l i n e d  our 
interest in compounds of the cyclopenta- 
[a]phenanthrene series as aromatic ana­
logues of steroids (Coombs & Croft, 1969). 
Comparisons of the carcinogenicity of 
some 40 closely related members of this 
series have revealed th a t the title com­
pound (I) (see Fig. 1) is the most active, 
and th a t its activity depends upon 2 
structural features: the presence of a small 
electron-releasing group a t C -ll, and 
further conjugation of the phenanthrene 
ring system a t C-17. Of the monomethyl 
isomers, only the 11-methyl-17-ketone 
(I) is strongly carcinogenic; the 7-methyl-
17-ketone is a weak carcinogen whilst the
2-, 3-, 4-, 6-, and 12-methyl isomers are 
inactive, as is the unsubstituted parent 
ketone (V) (Coombs et al., 1973). The 
11-methoxy-17-ketone (II) is almost as 
active as (I), bu t other methoxy isomers
lack activity. Strong carcinogenicity is 
also associated with the 11,17-dimethyl- 
16(17)-ene (III), in which conjugation 
by the 17-carbonyl group is replaced by 
conjugation by the 16(17)-double bond; 
the corresponding hydrocarbon with a 
saturated 5-membered ring is much less 
active, as are ring-methyl isomers of 
(III) (Coombs & Croft, 1969).
These comparisons were all made by the 
same method: groups of 20 mice were 
treated topically with 50 /xg of the com­
pound twice weekly for one year, and 
observed for a second year. F irst appear­
ance of skin tumours a t the site of applica­
tion (dorsal region) was scored, and 
tumours were subsequently classified his­
tologically. In  this paper, the carcino­
genicity of (I) is compared with th a t of the 
classical carcinogen benzo[a]pyrene, both 
by this method and by the 2-stage system.
C orresp on d en ce  to  D r . M . M . C oom b s, C h em istry  L a b o r a to r y , Im p e r ia l C ancer R e se a r ch  F u n d , L in c o ln ’s 
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The original method is also used to test 
the 1,2,3,4-tetrahydro derivative (IV) for 
carcinogenicity, and to investigate the 
effect of the dose of (I) on latent period. 
The effects of the enzyme modifiers 7,8- 
benzoflavone (BF) and 1,1,1-trichloro- 
propene oxide (TCPO) on its carcino­
genicity are presented, as is the production 
of mammary tumours in rat-feeding ex­
periments with (I).
M A T E R IA L S  A N D  M E T H O D S
Chemicals. — The cyclopenta [a] phenan- 
threnes (I), (IV) and (V) were synthesized 
here, as already described (Coombs, 1966; 
Coombs & Bhatt, 1973); their structures are 
shown in Fig. 1. Benzo[a]pyrene, 7,8-benzo-
I I  n
F ig . 1.— S tru ctu res  o f  c y c lo p e n ta [a ]p h e n a n -  
th re n es  m e n t io n e d  in  th e  t e x t .
flavone and 1,1,1-trichloropropene oxide were 
obtained from the Aldrich Chemical Co., 
Milwaukee, and croton oil from the Sigma 
Chemical Co., St Louis. Toluene was Analar 
grade from Fisons Ltd., Loughborough, and 
was used throughout as the vehicle.
Mouse experiments.—Formally randomized 
TO (Tyler’s Original) albino mice (10 males 
and 10 females) were used for each group, 
1-3 and 6-26; Groups 4 and 5 each consisted 
of 20 males and 20 females. Conditions were 
generally as previously described (Coombs & 
Croft, 1969).
In Groups 1-10 (Table I) compounds or 
mixtures were applied to the shaved dorsal 
skin twice weekly as toluene solutions (10 yu.1 
at each administration) for 50 weeks, and the 
mice were observed for up to 100 weeks. Mice 
in Groups 11-16 (Table II) each received
400 jug of carcinogen in 80 /zl of toluene; in 
addition, mice in Group 13 each received BF 
(1,200 fxg) dissolved in the carcinogen solu­
tion. Twice-weekly promotion with croton 
oil (10 pi of a 1% v/v solution in toluene) as 
indicated in the Table was begun 8 days later. 
Animals in Group 14 were treated topically 
with TCPO (10 fx\ of a 10% v/v solution in 
toluene) at 30 min before and again imme­
diately before the initiating dose of carcino­
gen. Negative control Groups 17 and 18 were 
each treated initially with toluene (800 pi); 
mice in Group 17 were subsequently treated 
twice weekly with this solvent (10 pi), 
whereas those in Group 18 were “promoted” 
with croton oil in the usual way.
Mice in Groups 19-23 (Table III) were 
injected, each in the right shoulder with the 
carcinogen (I) in olive oil (0-2 ml); Groups 
24 and 25 were similarly injected with the 
ketone (V) (3 mg), while Group 26 was in­
jected with olive oil alone. Promotion of the 
shaved dorsal region as already described was 
started 8 days later (Groups 20, 22, and 25) 
and 6 months later (Groups 21 and 23). In 
all cases promotion was continued for the 
whole experiment, up to 2 years.
Animals were killed when their skin tumour 
reached 1 cm in diameter; a few sick mice were 
killed earlier to avoid loss of material. All 
animals were opened and examined macro- 
scopically for abnormal tissues; tumours 
other than those appearing on promoted skin 
for mice injected with (I) (Groups 19-21) are 
shown in Table IV. All tumours were exam­
ined histologically except in a few cases, as 
noted in the Tables, when they were unavail­
able because the animal had died, and auto­
lysis was too far advanced, and also when more 
than one skin tumour per animal was ob­
tained. In the latter case only the first- 
appearing tumour, which was usually also 
the first to reach 1 cm in diameter, was 
examined histologically. Classification of 
skin tumours as papillomas or carcinomas 
was carried out as previously described 
(Coombs et al., 1973). Usually 1cm tumours 
were carcinomas when induced by repeated 
application of the carcinogen (Table I), but 
papillomas were more common when pro­
duced by initiation and promotion (Tables 
II  and III). A complete list of experimental 
and control groups appears in Tables I-III , 
which also show the rate of tumourless sur­
vival.
Rat experiment.—Virgin Sprague-Dawley
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rats, random-bred in this Institute, were 
divided into 2 groups by a formal randomiza­
tion procedure. They were housed 3-4 to a 
cage, fed on pelleted GR 3 diet (Dixon and 
Son, Ware, Herts) and allowed free access to 
water. At 50 days of age, 30 mg of carcinogen 
(I), suspended and partly dissolved in corn 
oil (2 ml), was given intragastrically to each 
of 27 rats; a further 96 rats were left un­
treated. From the fourth week of treatment 
all rats were examined weekly to detect 
developing tumours. These were removed 
surgically when they had grown to about 1 cm 
in diameter, and were classified histologically 
(Table V) as malignant adenocarcinomas or 
benign fibroadenomas (Young & Hallowes, 
1973).
Statistical methods.—Latent periods shown 
in Figs. 2-4 refer to the first appearance of 
the first skin tumour on each animal. Mean 
latent periods are listed in Tables I-I II  
together with their standard deviations. 
Estimation of the probability of the curves of 
latent period for Groups 4 and 5, 12 and 13, 
and 12 and 14 (Figs. 2 and 3) being different is 
made by the summary chi-square procedure 
advocated by Mantel (1966) for comparing 
2 sets of life tables in their entirety. This 
statistical method takes both differences in 
latent period and tumour incidence into con­
sideration over the whole experimental period, 
rather than at any single time. The test tends 
to be conservative, in that the latent periods 
are considered only as the order in which the 
first tumour on each animal appears in time, 
and not as actual time values. The probabili­
ties of the number of rat mammary tumours 
being significant (Table V) are calculated by 
the exact method of Yates (Fisher, 1954).
R E S U L T S
Direct comparison of the tumour inci­
dence and mean latent period of skin 
tumours produced by the carcinogen (I) 
a t its lowest dose (Group 4, 34*7 weeks, 
45%) with benzo[a]pyrene a t the same 
dose (Group 8, 37-5 weeks, 50%) (Fig. 2) 
demonstrates th a t they are similar as 
complete carcinogens on mouse skin. Also 
shown in Fig. 2 are curves formed by 
plotting the time of first appearance of 
skin tumours with (I) a t 50, 25, 10, and 
5 p,g twice weekly. Using the well known
-75 1-5-IQpg
-50 1-0 -
5pgl
-25 0-5-
MEAN LATENT
LATENT PERIOD P E R IO D(weeks)
F ig . 2 .— I n d u c t io n  o f  d orsa l sk in  tu m o u rs  in  
m ic e  b y  tw ic e -w e e k ly  a p p lic a tio n  o f  b en zo -
[a ]p y ren e  ( +  - + )  a n d  th e  k e to n e  (I)
( O —  O ) a t  d o se s  s ta te d . T u m o u rs p ro d u ced  
w ith  (I) (5 jag) to g e th e r  w ith  7 ,8 -b en zo -  
fla v o n e  (15  /ag) are sh o w n  b y  so lid  c ircles  
( 0 — 0 ) .  F o r  th is  a n d  F ig s . 3 a n d  4, 
“ la te n t  p er io d ” m e a n s  t im e s  fro m  b e g in ­
n in g  o f  tr e a tm e n t .
empirical relationship between mean latent 
period (L, in weeks) and dose (d , in jag),
L = a  — h (logio d  -f c),
where a , 6, and c  are constants (Bryan & 
Shimkin, 1941), the plot of L against 
— logio d  approximates to the straight 
line, and the mean latent period = 29-40- 
10-803(logio^ —1-199) with a correlation 
coefficient, r =  0-96. Also shown are the 
6 tumours induced by twice-weekly appli­
cations of (I) (5 jag) plus 7,8-benzoflavone 
(15 jag), with a mean latent period of 
36-2 weeks. When this latent period is 
fitted on an extrapolation of the dose- 
response curve, it appears th a t under these 
conditions the inhibitor effectively reduces 
the administered dose to about 3 jag. 
Finally, Table I  shows no evidence for 
carcinogenicity for the 1,2,3,4-tetrahydro 
derivative (IV) in this test involving re­
peated applications.
Fig. 3 and Table I I  illustrate the results 
of the initiation-promotion experiments. 
A single application of 400 jag of (I) per 
mouse followed by twice-weekly promo­
tion with croton oil (Group 12, 30-0 weeks,
CARCINOGENESIS BY A CYCLOPENTA[a ]P!IENANTHRENE 917
T a b l e  I.— Skin-tumour production in mice by repented topical application
N o . o f  tu m o u r-free  
su r v iv o rs  a t N o . o f  N o . o f  sq u a m o u s  M ean
G roup C om p ou n d (s)
D o s e  
(/Tg, 2 x  
w eek ) 6
(m o n th s)
A
12 18 20
m ice
w ith
tu m o u rs
A
p a p il­
lo m a s
ca rc i­
n o m a s
la te n t  
p er io d  +  
s .d .
1 I 50 8 1 0 0 17 0 17 23-3  +  8-1
2 I 25 15 0 0 0 18 2 16 28-4  +  7-7
3 I 10 18 2 • 1 0 16 1 15 31-2  +  6-8
4 I 5 37 18 12 . 6 18* 3 13 34-7  +  8 -2 f
5 I  +  B F 5 + 1 5 38 31 20 8 6 3 3 36-2  +  8 -6 |
6 B F 15 19 18 12 5 0 - —
7 I V 50 20 20 13 6 0 - _ —
8 B [a ]P 5 16 9 5 0 10* 3 5 37-5  +  11-2
9 to lu en e — 18 14 9 3 0 - _ —
10 — — 19 18 10 4 0 - - —
* T w o  tu m o u r s  w ere  u n a v a ila b le  for  h is to lo g y  in  e a ch  o f  G roups 4 , a n d  8.
P  A vs 5 <  0 -01 , e s t im a te d  b y  th e  m e th o d  o f  M a n te l (1 9 6 6 )— see  M ateria ls  a n d  M eth od s.
90%) gave a result similar to th a t ob­
served recently (Coombs & Bhatt, 1978) 
when the initiating dose was subdivided 
and given on 4 subsequent days (35 weeks, 
90%). Comparison of Groups 12 and 16 
reveals th a t (I) is somewhat more active 
than benzo[a]pyrene as an initiator (Group 
16, 33 weeks, 65%). Both carcinogens a t 
this dose gave some skin tumours without
>~II & TCPO
I&BF
promoted
B aP
-1 0
BaP
Li_
31 not 
promoted
LU
3
LATENT PERIOD (weeks)
F ig . 3 .— In d u c t io n  o f  d orsa l sk in  tu m o u r s  in  
m ice  in  th e  tw o -s ta g e  s y s te m . I n it ia t io n  w a s
w ith  4 0 0  fig o f  b e n zo [a ]p y ren e  ( -I h ),
k e to n e  (I) ( O — 0 )>  k e to n e  (I) p lu s  7,8- 
b en z o fla v o n e  (1-2 m g ) ( 0 — 0 ) ,  or k e to n e  
(I) +  T C PO  (see  t e x t )  ( ® — @ ). P r o m o te d  
w ith  cro to n  o il, or n o t ,  a s  sh o w n .
promotion (Groups 11 and 15) after com­
paratively long latent periods.
Unexpectedly, topical application of 
7,8-benzoflavone (1,200 /xg/mouse) to ­
gether with the initiating dose (400 /xg) 
of (I) (Group 13) appears to have no effect 
on latent period or tumour incidence. This 
is in marked contrast to the result with 
repeated twice-weekly administration, al­
ready discussed. Application of the 
epoxide-hydratase inhibitor TCPO before 
the initiating dose of (I) (Group 14) caused 
enhancement, evident as shortening of the 
latent period.
After i.m. injection of (I) (3 mg/ 
mouse), this carcinogen initiated skin 
tumours remote from the site of injection. 
As shown in Fig. 4 and Table III , promo­
tion by croton oil started 8 days after 
initiation led to skin tumours in 65% of 
the mice, with a mean latent period of 33 
weeks (Group 20). When promotion was 
delayed for 6 months, 50% of the mice 
developed skin tumours, with a mean 
latent period of 24 weeks from the start of 
croton-oil treatm ent (Group 21). No 
tumours appeared on the dorsal skin 
without promotion (Group 19); however, 
other tumours were found in animals of 
all 3 groups (Table IV). Injection of 300 /xg 
of (I) (Groups 22 and 23) was ineffective, 
as was injection of 3 mg of the unsubsti­
tu ted  ketone (V) (Groups 24 and 25, 
Table III).
Mammary adenocarcinomas were de-
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T a b l e  II.—Skin-tumour production in  mice in  the initiation-promotion experiments
P r o m o t io n N o . o f  tu m o u r-free M ean
(tw ice su r v iv o rs  a t N o . o f N o . o f  sq u a m o u s la te n t
w e e k ly (m o n th s) m ice ( A p er io d
cro to n  r- A v w ith p a p il­ ca rc i­ ± s .d .
G roup C om p ou n d (s)J oil) 6 12 18 24 tu m o u r s lo m a s n o m a s (w eek s)
11 I _ 18 17 10 6 5 4 1 4 6 -0 + 1 0 - 7
12 I + 12 5 1 0 1 8 f* 13 3 29-9  +  13-9 §
13 I  +  B F + 15 1 1 0 16 12 4 30-6  +  9-5§
14 I  +  T C PO + 9 2 1 0 19* 16 2 23-6  +  9-7§
15 B [a ]P — 19 15 12 10 7 5 2 42-9  +  17-7
16 B [a ]P + 14 13 4 4 13* 9 3 3 3 - 5 ±  17-3
17 to lu en e — 20 18 16 7 0 - - —
18 to lu en e + 19 18 15 5 0 - - —
* H is to lo g y  u n a v a ila b le  for  o n e  a n im a l, 
f  O ne tu m o u r  w a s  a  sp in d le -ce ll sarcom a.
% T h e  in it ia t in g  d o se  o f  (I) a n d  B [a ]P  w a s  40 0  /x g /m o u se ; in  G roup  13, 7 ,8 -b en zo fla v o n e  (B F ) (1 ,2 0 0  /xg/  
m o u se ) w a s  a p p lie d  s im u lta n e o u s ly ;  m ic e  in  G roup  14 r e c e iv e d  1 ,1 ,1 -tr ich lo ro p ro p en e  o x id e  (T C PO ) (10  /xl 
o f  a  10%  v /v  so lu tio n ) a t  30  m in  b efo re  a n d  a g a in  im m e d ia te ly  b e fo re  th e  in it ia t in g  d ose  o f  (I).
§ P 1 2  vs 13 =  0-62 ; P 1 2  vs 14 =  0 -17 , e s t im a te d  b y  th e  m e th o d  o f  M a n te l (1 9 6 6 )— see  M ateria ls  a n d  M eth o d s.
-15
Gp 20
-10
Gp 21
LATENT PERIOD (w e ek s)
F ig . 4.— Induction o f dorsal skin tumours 
after injection o f the ketone (I) (3 mg/ 
mouse) followed by promotion with croton 
oil 8 days (O — 0)> or 6 months ( ® — # )  
later.
tected during the 18th week after intra- 
gastric treatm ent of rats with 30 mg of the 
carcinogen (I), bu t the single spontaneous 
tumour did not appear in the untreated 
group until the 42nd week. Differences in 
tumour incidence between the two groups 
was significant a t 20 weeks and highly 
significant a t 50 weeks (Table V). By
contrast, benign fibroadenomas occurred 
later, and to a similar extent in both 
groups.
D IS C U S S IO N
In  both the repeated-application and 
initiation-promotion experiments 15,16- 
dihydro- 11 -methylcyclopenta[a] phenan- 
thren-17-one (I) is comparable with benzo-
[a]pyrene as a carcinogen, despite the 
former having only 3 fused aromatic 
rings. Practically all known carcinogenic 
polycyclic hydrocarbons have 4 or more 
fused aromatic rings, 3 of which form a 
phenanthrene ring system. The ketone 
(I), in common with a number of other 
phenanthrene-derived carcinogens (Jerina 
et al., 1978) is metabolically activated by 
conversion to its bay-region, 3,4-dihydro-
3,4- dihydroxy -1,2- dihydro -1,2- epoxide 
(Coombs et al., 1979). I t  therefore seems 
probable th a t (I) represents the smallest 
conjugated system th a t can be activated 
by this mechanism to display strong car­
cinogenic activity. No evidence for car­
cinogenicity was found for its 1,2,3,4- 
tetrahydro derivative (IV), in keeping 
with the proposed activation mechanism, 
for this compound lacks the necessary 
double bonds for metabolic formation of a 
bay-region diol-epoxide.
At the lowest dose (5 fxg twice weekly) 
co-administration of the aryl-hydrocarbon-
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T a b l e  I I I .— Skin tumours appearing on promoted skin following injection of (I) into mice
G roup
C o m ­
p o u n d
I n je c ­
t e d
d o se
(mg)
P r o m o tio n
(tw ice
w e e k ly
cro to n
oil)
N o . o f  tu m o u r-free  
su rv iv o rs  a t  (m o n th s)
,------------------ »------------------ ,
6 12 18 24
N o . o f  
m ice  
w ith  
d orsa l 
tu m o u rs
N o . o f  sq u a m o u s
p a p il- carci- 
lo m a s  n o m a s
M ean  
la te n t  
p eriod  
+  s .d . 
(w eek s)
19 I 3 n o n e 20 16 5 0 0 _ - —
20 I 3 8 d a y s  la ter 18 13 0 0 13 9 4 33 ±  11-3
21 I 3 6 m o n th s  la te r 18 11 7 2 9 8 ■ 1 4 9*  ± 7 - 0
22 I 0-3 8 d a y s  la te r 19 18 10 5 0 - —
23 I 0-3 6 m o n th s  la te r 19 19 14 11 0 - - —
24 Y 3 n o n e 19 19 14 8 0 - - .— .
25 y 3 8 d a y s  la te r 19 18 16 12 0 - - —
26 o liv e  o il n o n e 20 19 18 14 0 - - —
* 24 w e ek s  fro m  b e g in n in g  o f  p r o m o tio n .
T a b l e  IV.— Tumours other than those appearing on promoted skin, after injection of (I)
into mice
M ice w ith
G roup E y e lid E a r H e a d V e n tr a l su rface lu n g  a d e n o m a sj
19 4 (2 p a .)* — 2 sq . p a . 2 f  (1 m a m m a r y  ca .) 4
20 4 sq . p a .
2 a n a p la st ic  sq . ca .
1 seb a ceo u s  a d en o m a
1 sq . ca . 1 sq . p a . 7
21 1 sq . p a . 1 sq . ca. 
1 sq . ca .
* H is to lo g y  n o t  a v a ila b le  for  2 tu m o u r s.
1 sq . p a . 8
f  H is to lo g y  n o t  a v a ila b le  for  1 tu m o u r , 
sq . pa. =  sq u a m o u s  p a p illo m a , 
sq . c a .=  sq u a m o u s  ca rc in o m a .
|  N o  lu n g  a d e n o m a s  a m o n g  a n im a ls  in  th e  o liv e -o il co n tr o l (G roup  26).
T a b l e  V . — Mammary tumours induced in  rats after intragastric instillation of (I)
(30 mgjrat)
A d en o ca rcin o m a s  
I n  ra ts  a fter  I  
I n  u n tr ea ted  ra ts
p *
F  ibr o a d en o m a s  
I n  ra ts  a fter  I  
I n  u n tr ea ted  ra ts
p *
N o . o f  ra ts  
a t  t im e  o f  
tr e a tm e n t
27
96
27
96
N o . o f  r a ts
________A___________^
w ith
N o . o f  r a ts
________ A
w ith
N o . o f  r a ts___ A____
w ith
N o . o f  r a ts  
w ith
tu m o u r  a liv e  tu m o u r  a liv e  tu m o u r  a liv e  tu m o u r  a liv e
a t  20  w e ek s
2 26
0  94
0-455
a t  30  w eek s
4  26
0  92
0 -0019
26
94
26
92
a t  50  w eek s
6 20
1 85
0-0001
0 20
3 85
0 -5270
a t  75 w e ek s
2 13
7 70
0-2845
* E x a c t  v a lu e  o f  P  c a lc u la te d  b y  m e th o d  o f  Y a te s  (F ish er , 1954).
hydroxylase inhibitor, 7,8-benzoflavone 
(15 /xg) reduced the carcinogenicity of (I), 
in agreement with previous observations 
(Coombs et al., 1975). Using the dose- 
response curve shown in Fig. 2, BF 
apparently causes about 40% inhibition 
of tumour production under these condi­
tions. I t  was therefore surprising th a t 
inhibition was lacking when BF (1,200 /xg) 
was given together with the initiating 
dose of I  (400 /xg) in the two-stage experi­
ment. The reason for this difference is not 
clear. Several workers have shown th a t 
BF inhibits hydrocarbon-induced aryl
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hydrocarbon hydroxylase more than  the 
constitutive enzyme (Grundin et al., 1973; 
Hill & Shih, 1975; Wiebel et al., 1971). 
I t  seems possible th a t promotion experi­
ments using a relatively large single dose, 
as described here, might differ from experi­
ments in which a small dose is adminis­
tered repeatedly, in th a t the majority of 
the dose would be activated by the con­
stitutive enzyme in the first situation, but 
not in the second.
Shortening of the mean latent period 
was obtained when the epoxide-hydratase 
inhibitor TCPO was given topically to ­
gether with the initiation dose of (I). 
Enhancement of tumour production with 
TCPO has also been reported for 3- 
methylcholanthrene (Berry et al., 1977; 
Burki et al., 1974) and benzo[a]pyrene 
(Berry et al., 1977). W ith the latter, the 
inhibitor in  vitro prevents hydration of the 
initially formed 7,8-oxide to the 7,8-diol 
(Selkirk et al., 1974) but the ultimate car­
cinogen, the 7,8-dihydroxy-9,10-epoxide, 
is apparently not a substrate for this 
enzyme (Wood et al., 1976). The carcinogen 
(I) is activated in a manner analogous to 
th a t of benzo[a]pyrene, so it seems prob­
able th a t the mechanism by which TCPO 
causes enhancement is the same in both 
cases. Possibly, by inhibiting cytoplasmic 
epoxide hydratase, TCPO allows the 
initially-formed non-bay region oxide to 
escape to a site where it can be more 
advantageously further converted into the 
ultimate carcinogen.
In  the experiments so far described in­
volving topical application of (I), tumour 
formation is confined to the treated skin. 
The injection (mouse) and feeding (rat) 
experiments demonstrate th a t this car­
cinogen is also active systemically, and 
in more than  one animal species. P re­
viously, injection of (I) (8 and 50 mg) into 
mice led to ventral skin tumours as well 
as sarcomas a t the site of injection 
(Coombs & Croft, 1969). Tumours at 
several sites, including the ventral sur­
faces, were seen in the present experiment 
(Table IV). Injection of 3 mg per mouse, 
but not one tenth  of this dose, was suffi­
cient to initiate the dorsal skin (Fig. 4 and 
Table III)  so th a t subsequent promotion 
yielded a skin-tumour incidence of 65% 
and a mean latent period of 33 weeks. 
After injection initiation persisted, for 
when promotion was started 6 months 
later skin tumours occurred in 50% of the 
mice, bu t with a shorter mean latent period 
of 24 weeks (calculated from the beginning 
of promotion). No tumours were induced 
with the parent unsubstituted ketone (V) 
when injection of this compound (3 mg) 
was followed by topical treatm ent with 
croton oil. This agrees with the failure to 
induce tumours in mice by injection (50 
mg) or by skin painting (50 pg twice 
weekly) (Coombs & Croft, 1969) or in the 
two-stage system with an “initiating” dose 
of 400 iug (Coombs & Bhatt, 1978).
In  its ability to induce mammary car­
cinomas after a single intragastric instil­
lation of 30 mg, compound (I) resembles 
other known potent carcinogens such as
3-methylcholanthrene (Shay et al., 1949) 
and 7, 12 - dimethylbenz [a] anthracene 
(Huggins, 1961). However, it is less potent 
than either of these, both in this regard and 
also as judged by their relative mean 
latent periods for induction of skin 
tumours in mice (Coombs & Croft, 1969). 
The suggestion th a t the carcinogenicity of 
aromatic hydrocarbons increases as their 
structure approaches th a t of the steroids 
(Yang et al., 1961) is therefore not sub­
stantiated. The ketone (I) not only pos­
sesses the same carbon-ring system as the 
steroids, bu t also bears an oxygen atom 
at C-17, a position which is oxygenated in 
virtually all natural Cis and C19 steroids. 
This carcinogen, with potency similar to 
th a t of benzo[a]pyrene, is best considered 
as a simple member of the large group of 
polycyclic hydrocarbon carcinogens whose 
structures are based on phenanthrene.
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SUMMARY C -
Fifty-four p o lycyc lic  c o m p o u n d s , 29  of th e  cy c lo - 
p e n ta [a ]p h e n a n th re n e  s e r ie s ,  11 c h ry s e n e s ,  a n d  14 
b e n z [a ]a n th ra c e n e s , have  b e e n  te s te d  fo r m u ta g e n ic ity  by 
A m es’s  m e th o d , u s in g  Salmonella typhimurium  TA100. 
W ithout e x c e p tio n  all 37 c a rc in o g e n s  a n d  a  k n o w n  in itia to r 
were m u ta g e n s . Of th e  16 n o n c a rc in o g e n s  7 w ere  m u ta - 
; gen ic , b u t n o n e  of th e s e  h a s  y e t b e e n  te s te d  fo r in i tia tin g , a s  
o p p o sed  to  c a rc in o g e n ic ,  ac tiv ity . T h e re  a p p e a re d  to  b e  
i little q u a n ti ta t iv e  c o r r e s p o n d e n c e  b e tw e e n  c a rc in o g e n ic  
an d .m u ta g e n ic  p o te n c y , h o w ev e r, an d  p o s s ib le  r e a s o n s  fo r 
■ this a re  d is c u s s e d .  T he aryl h y d ro c a rb o n  h y d ro x y la se  inh ib - 
, itor 7 ,8-b e n z o f la v o n e  s tro n g ly  in h ib ited  th e  m u ta g e n ic ity  of 
; certain c o m p o u n d s  w h en  it w as  a d d e d  to  th e  in c u b a tio n s .
I »i . *
| INTRODUCTION
!
I The s o m a tic  m u ta tio n  th e o ry  o f c a n c e r  re q u ire s  c a rc in o -  
l gens to  b e  m u ta g e n s . A lth o u g h  p rev io u sly  m o s t p o lycyc lic  
? hydrocarbon  c a rc in o g e n s  a p p e a re d  to  b e  in ac tiv e  w h en  
\ tested in s ta n d a rd  m u ta g e n e s is  a s s a y s , it is n o w  e s ta b lis h e d  
| that the  b io lo g ica l activ ity  o f th e s e  m o le c u le s  is m e d ia te d  by 
; oxidative m e ta b o lism , a  fa c t th a t  h ad  n o t b e e n  ta k e n  in to  
| considera tion  h ith e r to . U sing  h is tid in e -d e f ic ie n t m u ta n ts  of 
S Salmonella typhimurium  in a  b a c k -m u ta tio n  sy s te m  w ith  
? mam malian liver p re p a ra tio n s  to  p ro v id e  m e ta b o lic  ac tiv a - 
f tion, A m es (12) h a s  re cen tly  c la im ed  a  90%  c o r r e s p o n d e n c e  
| between c a rc in o g e n ic ity  a n d  m u ta g e n ic ity  in o v e r 300  co m - 
|  pounds of w idely, d iv e rse  c h e m ic a l ty p e s . T h e se  in c lu d e d  a 
| series of 38 po lycyc lic  a ro m a tic  c o m p o u n d s  w h ich  w e re  
|  mostly te s te d  a g a in s t  a  new  s tra in , S . typhimurium  TA100.
| The latter w as  d e riv ed  from  an  e a rl ie r  s tra in  (TA 1535, his~,
I excision re p a ir  d e f ic ie n t, d e e p  ro u g h ) by in c lu s io n  of an  R- 
[ factor p lasm id  (pK M 101, c a rry in g  am p ic illin  re s is ta n c e )  
|  v/hich m ak es th e  b a c te r ia  m o re  se n s itiv e  to  m u ta g e n e s is  by 
I polycyclic c o m p o u n d s  (13). A m ong  th is  s e r ie s  o f 38  co m - 
f pounds, th e  c o rre la tio n  b e tw e e n  c a rc in o g e n ic ity  a n d  m u ta - 
I genicity w as b e tte r  th a n  90% .
r  Our in te re s t in th is  a re a  a ro s e  from  th e  n e e d  to  d is tin ­
i\ Received June 8, 1976; accep ted  August 30. 1976.
g u ish  th e  b io lo g ica lly  a c tiv e  from  th e  in e r t m e ta b o li te s  
o f th e  c a rc in o g e n  1 5 ,1 6 -d ih y d ro -l 1 -m e th y lc y c lo p e n ta [a ]-  
p h e n a n th re n -1 7 -o n e  (7 ).1 O f th e  p o s itio n a l m eth y l is o m e rs  
(2 to  8), on ly  th is  k e to n e  (7) is a  s t ro n g  c a rc in o g e n ;  w ith  th e  
e x c e p tio n  o f th e  7 -m e th y l-1 7 -k e to n e  (6) w h ich  is m o d e ra te ly  
ac tiv e , th e  re s t a re  w ith o u t ac tiv ity , a s  is th e  u n s u b s t i tu te d  
p a re n t k e to n e  (7) (3). In a t te m p ts  to  u n d e rs ta n d  how  m ethy l 
s u b s ti tu tio n  a t C -11 in th is  s e r ie s  in d u c e s  c a rc in o g e n ic i ty , 
m e ta b o lism  of k e to n e s  1 an d  7 h a s  b e e n  c o m p a re d  b o th  in 
vivo (6 ) a n d  in vitro  (8), a n d  re c e n tly  h ig h -p re s s u re  liqu id  
c h ro m a to g ra p h y  h a s  b e e n  u se d  fo r  rap id  a n d  e ff ic ie n t s e p a ­
ra tio n  of th e  c o m p le x  m e ta b o lite  m ix tu re s . U sing  th is  
m e th o d , it h a s  p ro v e d  p o s s ib le  to  d e m o n s tr a te  d is c re te  
f ra c tio n s  th a t  c o n ta in  m e ta b o li te s  th a t  a re  lab ile  a n d  th a t  
b ind  co v a le n tly  to  DNA in vitro  (9). It is n o t n o w  k n o w n  
w h e th e r  th e s e  m e ta b o li te s  a ls o  p o s s e s s  b io lo g ic a l ac tiv ity , 
b u t A m es’s  m e th o d  sh o u ld  b e  c a p a b le  o f p ro v id in g  th is  
in fo rm a tio n .
A s a  firs t s te p  to  u s in g  A m e s’s  te s t ,  it s e e m e d  p ru d e n t  to  
e x p lo re  th e  c o rre la tio n  b e tw e e n  m u ta g e n ic i ty  a n d  c a rc in o ­
g en ic ity  in th e  c y c lo p e n ta [a ]p h e n a n th re n e  s e r ie s .  A c c o rd ­
ingly , k e to n e s  7 to  8 h av e  b e e n  te s te d  a g a in s t  TA 100, a s  
h av e  21 o th e r  c y c lo p e n ta [a ] p h e n a n th re n e  d e riv a tiv e s  (9 to  
29) a n d  5 s tru c tu ra lly  re la te d  c h ry s e n e s  (30 to  34). All th e s e  
c o m p o u n d s  w e re  s y n th e s is e d  in th e s e  la b o r a to r ie s  an d  
h av e  b e e n  te s te d  h e re  fo r c a rc in o g e n ic  ac tiv ity  by m e a n s  of 
a  s ta n d a rd iz e d  sk in  p a in tin g  m e th o d  u s in g  m ic e  (3, 4 , 7). 
W e h av e  a ls o  e x a m in e d  th e  6 iso m e ric  m o n o m e th y l c h ry ­
s e n e s  (35 to  40) a n d  all 12 m e th y lb e n z [a ]a n th ra c e n e s  (42 to  
53) fo r m u ta g e n ic ity ; c a rc in o g e n ic i ty  d a ta  fo r th e s e  c o m ­
p o u n d s  a re  ta k e n  from  th e  l i te ra tu re  (9, 10). C h a r t  1 illu s­
t r a te s  th e s e  ring  s y s te m s  a n d  th e  c o n v e n tio n s  u s e d  fo r 
n u m b e r in g  th e m .
M ATERIALS AND M ETHODS *
S . typhimurium  TA100 w a s  o b ta in e d  from  D r. B. N. A m es. 
N u trien t b ro th  c u ltu re s  w e re  g ro w n , s to c k s  w e re  k e p t f ro zen  
a t - 8 0 °  a s  h e  d e s c r ib e d  (2), a n d  th e  a s s a y s  w e re  c a r r ie d  o u t
1 Numbers in ita lics  refer to com pounds listed in Table 1.
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cyclopenta[a]phenanthrene chrysene benz[a]anthracene
(W )
C h art 1. R ing sy stem s  an d  th e ir  n u m b erin g  u sed  in th e  tex t.
fo llow ing  th is  p u b lis h e d  p ro c e d u re  c lo se ly . L iver “ S -9 ” w a s  
p re p a re d  from  th e  livers o f 150-g m ale  S p ra g u e -D a w le y  ra ts , 
ra n d o m  b re d  in th e  L C .R .F . c lo s e d  c o lo n y  a n d  m a in ta in e d  
o n  D iet G R3EK  (E. D ixon a n d  S o n s , W are , H e rtfo rd sh ire , 
E n g lan d ) a n d  w a te r  ad lib itum . T h e  ra ts  w e re  in d u c e d  w ith  
A ro c lo r 1254 a s  d e s c r ib e d  (2).
C o m p o u n d s  w e re  a d d e d  in 100 /xl of d im e th y l su lfo x id e . 
T hey  w e re  first s c r e e n e d  at 2 o r  3 d o s e  levels w ith  20 , 50 , o r 
100 /xI o f S-9 p e r  p la te . W hen  m u ta g e n ic  ac tiv ity  w a s  o b ­
se rv e d , a d o s e - r e s p o n s e  cu rv e  w a s  o b ta in e d , u s in g  th e  
o p tim u m  a m o u n t of liver p re p a ra tio n  an d  th e  c o m p o u n d s  a t 
d o s e s  u p  to  100 /x g /p la te . All c o m p o u n d s  w e re  a ls o  te s te d  
in th e  a b s e n c e  of liver e n z y m e s . C o n tro ls  in c lu d e d  d im ethy l 
su lfo x id e  a lo n e  (100 /x\) to  p ro v id e  th e  s p o n ta n e o u s  b a c k ­
g ro u n d  m u ta tio n  ra te  a n d  3 p o sitiv e  c o n tro ls , 
b e n z o (a )p y re n e  (5 /ig ) , a c e ta m id o f lu o re n e  (10 /xg), an d  th e  
k e to n e  (7) (10 /x g /p la te ) . T h e  b a c te r ia  w e re  ro u tin e ly  
c h e c k e d  fo r am p ic illin  r e s is ta n c e , a n d  th e  s te rility  of th e  S-9 
w a s  a lso  te s te d .  All e x p e r im e n ts  w ere  c a rr ie d  o u t in d u p li­
c a te ,  a n d  m u ta g e n e s is  w a s  m e a s u re d  a s  th e  a v e ra g e  n u m ­
b e r  of re v e r ta n t TA100 c o lo n ie s  p e r  p la te  le s s  th e  a v e ra g e  
s p o n ta n e o u s  m u ta tio n  ra te  (u su a lly  a b o u t 7 0 /p la te ) . In th e  
in h ib itio n  e x p e r im e n ts  (C h art 3), 7 ,8 -b e n z o f la v o n e  (300 /xg) 
in d im e th y l su lfo x id e  (50 /il) w a s  a d d e d  to  e a c h  p la te  to ­
g e th e r  w ith  th e  c a rc in o g e n , a ls o  in d im ethy l su lfo x id e  (50 
/x l) .
R ESU L TS
T h e  c a rc in o g e n ic  a n d  m u ta g e n ic  a c tiv itie s  of th e  54 c o m ­
p o u n d s  te s te d  a re  p re s e n te d  in T ab le  1. F o r C o m p o u n d s  1 
to  34, fo r w h ich  c o m p a ra b le  m o u s e  d a ta  o b ta in e d  h e re  by 
sk in  p a in tin g  a re  a v a ilab le , c a rc in o g e n ic ity  is e x p re s s e d  a s  
a  s in g le  f ig u re  (Iball index ) e m b ra c in g  b o th  tu m o r  inc i­
d e n c e ,  in c lu d in g  p a p il lo m a s  a n d  c a rc in o m a s , a n d  la ten t 
p e r io d  (T ab le  1). C o m p o u n d s  m a rk e d  <1 w e re  n o n c a rc in o ­
g e n s ,  i.e., th e  tu m o r  in c id e n c e  w a s  le s s  th a n  5%  (1 in 20 
a n im a ls )  in 700  d a y s  (3, 4 , 7). S p o n ta n e o u s  sk in  tu m o rs  
h av e  n e v e r  b e e n  o b s e rv e d , ev en  a m o n g  c o n tro l an im a ls  
p a in te d  w ith  to lu e n e . T h e  c a rc in o g e n ic i ty  d a ta  fo r th e  m eth - 
y lc h ry s e n e s  (35 to  40) r e p re s e n t  th e  re s u lts  of a  re c e n t s tu d y  
of b o th  th e  c a rc in o g e n ic  a n d  in itia tin g  a c tiv itie s  of th e s e  
h y d ro c a rb o n s  to  m o u s e  sk in  (11). T h e  d a ta  fo r th e  
b e n z [a ] a n th ra c e n e s  {41 to  54) a re  ta k e n  from  su m m a rie s
(10) o f b o th  sk in  p a in tin g  (m o u se )  an d  in jec tio n  (rat) e x p e r i­
m e n ts .  T h e se  b e n z [a ] a n th ra c e n e s  have  n o t b e e n  te s te d  s y s ­
te m a tic a lly  fo r in itia tin g  ac tiv ity  n o r  have  C o m p o u n d s  1 to  
34.
M u tag en ic ity  is e x p re s s e d  b o th  a s  th e  n u m b e r  of revert­
a n t TA100 c o lo n ie s  p e r  /xg of c o m p o u n d  in c o rp o ra te d  in the 
p la te  a n d  a s  th e  n u m b e r  o f re v e r ta n t c o lo n ie s  p e r  nm ole
(12). C o m p o u n d s  e x h ib itin g  le s s  th a n  0.2 co lo n y /n m o le  
w e re  c la s s e d  a s  n o n m u ta g e n s ;  th is  n u m b e r  is ap p ro x i­
m a te ly  e q u iv a le n t to  th e  s p o n ta n e o u s  m u ta tio n  ra te . C hart 2 
sh o w s  ty p ica l d o s e - r e s p o n s e  c u rv e s  fo r th e  k e to n e  (6 ) ob­
ta in e d  w ith  v a rio u s  a m o u n ts  o f liver e n z y m e s  (S-9) in the 
s a m e  e x p e r im e n t . M u ta g e n ic ity  f ig u re s  in T ab le  1 a re  ca lcu ­
la te d  from  th e  initially  s t ra ig h t p a r ts  o f th e  d o se - re sp o n se  
c u rv e s , u s in g  th e  o p tim u m  a m o u n t of S -9 ; ./ .e  , fo r C om ­
p o u n d  6 m u ta g e n ic ity  is g iv en  a s  th e  n u m b e r  o f revertan t 
c o lo n ie s  w ith  a d o s e  o f 10 /x g /p la te , u s in g  50 /xl o f S-9. At 
th e s e  low  d o s e s  o f te s t  c o m p o u n d s , c y to to x ic ity  is neglig i­
b le  a s  e v id e n c e d  by th e  a p p e a ra n c e  o f a  n o rm a l back­
g ro u n d  “ law n ” of u n re v e r te d  b a c te r ia .  T h is  g ro w s  by utiliz­
ing  th e  t r a c e  of h is tid in e  a d d e d  to  th e  p la te  to  a llow  the 
se v e ra l ro u n d s  o f re p lic a tio n  n e c e s s a ry  to  “ fix” m u ta tions 
in d u c e d  by th e  c o m p o u n d s .  M u tag en ic ity  is th e re fo re  given 
by th e  s lo p e  o f th e  initially s t ra ig h t p a rt of th e  d o se -re ­
s p o n s e  c u rv e  a n d , a s  c a n  b e  s e e n  from  C h a rt 2 , th is  slope 
b e c o m e s  le s s  {i.e., a p p a re n t  m u ta g e n ic ity  is d im in ished) 
w h en  to o  m u c h  e n zy m e  is u s e d . A lth o u g h  w e have at­
te m p te d  to  u s e  th e  o p tim u m  a m o u n ts  of S-9 fo r e a c h  com ­
p o u n d , it is o b v io u s  th a t  th e  p re c is io n  of th e s e  d a ta  is open 
to  so m e  q u e s t io n . A lso th e  n u m b e r  of re v e r ta n t c o lo n ie s  in 
th e  p o sitiv e  c o n tro ls  v a ried  s o m e w h a t (±  10 to  20%) from 
d ay  to  d ay , ev en  w h e n  th e  s a m e  b a c te r ia l s u s p e n s io n  was 
u s e d . W e have  te s te d  a  n u m b e r  of c o m p o u n d s  th a t  ap p ea r 
in A m e s’s ta b le , n am e ly  th e  p o sitiv e  con tro ls 
b e n z o (a )p y re n e  a n d  a c e ta m id o f lu o re n e  a n d  C o m p o u n d s  3 , 
7, 40, a n d  54. In all c a s e s  o u r  re s u lts  a re  qu a lita tiv e ly  sim ilar 
to  th o s e  of A m es, b u t w e reg u la rly  o b se rv e  le s s  th a n  one- 
half th e  n u m b e r  o f c o lo n ie s  re p o r te d  by h im . W e attribu te  
th is  to  a  d if fe re n c e  in th e  s tra in  o f ra ts  u se d  o r  to  th e  effect 
o f th e  d if fe re n t d ie t. T h e se  p ro b le m s  d o  n o t, h o w ev e r, inval­
id a te  th e  c o n c lu s io n s  d is c u s s e d  b e lo w . S ev e ra l re p re se n ta ­
tive c y c io p e n ta [a ]p h e n a n th re n e s  w e re  a lso  te s te d  with 
o th e r  s tra in s  of S . typhimurium  d e v e lo p e d  by A m es. The 
m u ta g e n ic ity  o f th e s e  c a r c in o g e n s  w a s  d e te c te d  w ith  much 
re d u c e d  sen s itiv ity  w ith  TA98, a n d  n o t a t all w ith  strains 
TA1535 to  1538 w h ich  la c k e d  th e  R fa c to r .
C h a rt 3 illu s tra te s  th e  e ffe c t of th e  aryl h y d ro c a rb o n  hy­
d ro x y la se  in h ib ito r, 7 ,8 -b e n z o f la v o n e , on  th e  m utagen ic ity  
of th e  c a rc in o g e n  (7); a t a  d o s e  o f 10 /x g /p la te  a b o u t 95% 
in h ib itio n  is o b s e rv e d .
D ISC U SSIO N
•E xam ina tion  o f T ab le  1 d is c lo s e s  th a t  w ith o u t excep tion  
all 37 c a rc in o g e n s  an d  th e  k n o w n  in itia to r (35) a re  m uta­
g e n s . T h e  7 n o n c a rc in o g e n s  m a rk e d  w ith  a s te r is k s  a re  also 
m u ta g e n ic , w h e re a s  th e  re m a in in g  9 n o n c a rc in o g e n s  are 
in ac tiv e . T h e re  a re  n o  c a rc in o g e n s  th a t  a re  n o t m u tagens; 
ev en  th e  very w e a k  c a rc in o g e n s ,  c h a ra c te r iz e d  by low tu­
m o r in c id e n c e  a n d  long  la te n t p e rio d  {e.g., h y d ro ca rb o n s  
28 a n d  34), a re  read ily  d e te c te d  a s  m u ta g e n s .
O n th e  o th e r  h a n d  it is d is a p p o in t in g  th a t  th e re  is little 
e v id e n c e  of c o rre la t io n  b e tw e e n  c a rc in o g e n ic  a n d  muta-
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gen ic  p o te n c y , e x c e p t p e rh a p s  in th e  2 iso m eric  s e r ie s  (2 to  w e a k e r  c a rc in o g e n s  of th e  s a m e  s t ru c tu r a l  ty p e , e.g., co m -
8 an d  35 to  40). C o rre la tio n  w a s  no  b e t te r  th a n  w h e n  pap il- p a re  7 ,1 2 -d im e th y lb e n z [a ]a n th ra c e n e  (54) w ith  th e  le s s  ac -
lom as a n d  c a rc in o m a s  w ere  c o n s id e re d  s e p a ra te ly  fo r C om - tive 7 -m ethy l c o m p o u n d  (48) o r  th e  2 k e to n e s  (7 a n d  76).
p o u n d s  7 -to 34. A d e c re a s e  in th e  n u m b e r  of re v e r ta n t S p e c ie s  an d  o rg a n  variab ility  m ay  c o n tr ib u te  to  th e  la ck  of
c o lo n ie s  is co m m o n ly  s e e n  w ith  in c re a s e  in d o s e  (C h a rts  2 q u a n ti ta tiv e  c o r r e s p o n d e n c e  b e tw e e n  c a rc in o g e n ic i ty  a n d
and  3), a n d  th is  is a s c r ib e d  to  to x ic ity  (1): B o th  in A m e s’s  m u ta g e n ic ity , fo r w h e re a s  ra t liver w a s  u s e d  a s  th e  s o u r c e
tab le  (12) a n d  in th is  w o rk , it is n o tic e a b le  th a t  s t ro n g  of m ic ro so m e s  fo r th e  b a c te r ia l m u ta g e n ic i ty  te s t s  c a rc in o -
i c a rc in o g e n s  o ften  a p p e a r  to  b e  le s s  m u ta g e n ic  th a n  a re  g e n ic  ac tiv ity  w a s  m e a s u re d  by tu m o r  in d u c tio n  o n  m o u s e
i  '
j. . Table 1 .
; Carcinogenicity and mutagenicity (to S. typhimurium TA100) of polycyclic compounds  'v
For Compounds 7 to 34 for which strictly comparable skin painting results using mice are available (3, 4, 6):
! * _ . .. 100 x % tum or incidence
• .. C arcinogenicity— --------- - ----- —— r ~ r .— —• !. mean latent period in days
For the other compounds (35 to 54) a qualitative estimate of their activity has been made from published data, as 
shown. All compounds were tested for mutagenicity at 1, 5, 10, 20, 50, and 100 /i.g/plate as shown in Chart 2. Ratios 
refer to the initial straight parts of the dose-response curves where cytotoxicity is negligible (see text). Mutagenicity is
• given as (A) number of revertant colonies per /ig of compound incorporated in the plate and (B) number of revertant
colonies per nmole. Numbers of colonies are net of background reversions, which were usually about 70/plate, 
equivalent approximately to 0.2 colony/nmole for compounds with a molecular weight of approximately 250.
I M
Compound Ca A B Ref.
Cyclopenta[a]phenanthrenes 
(1) 15,16-Dihydro-17-one <1 820/20 9.5* 7
(2) 2-Methy!-15,16-dihydro-17-one <1 23/100 <0.2 3
(3) 3-Methy!-15,16-dihydro-17-one <1 69/100 <0.2 3
(4) 4-Methyl-15,16-dihydro-17-one <1 82/100 <0.2 3
(5) 6-MethyI-15,16-dihydro-17-one <1 44/100 <0.2 3
(6) 7-Methyl-15,16-dihydro-17-one 10 1000/20 12.3 3 -
(7) 11-Methyl-15,16-dihydro-17-one 46 1760/20 21.7 3 .7
(8) 12-Methyl-15,16-dihydro-17-one <1 72/100 . <0.2 7
(9) 3-Methoxy-15,16-dihydro-17-one <1 71/100 0.2 7
(10) 11 -Methyl-15,16-dihydro-17-one 25 240/20 3.1 7
(11) 11-Ethyl-15,16-dihydro-17-one 8 350/50 1.8 3
(12) 11-n-Butyl-15,16-dihydro-17-one <1 4/100 < 0.2 - 3
(13) 1 1 ,12-Dimethyl-15,16-dihydro-17-one 30 220/50 1.1 7
(14) 11-Methyl-16-hydroxy-15,16-dihydro-17-one 11 700/10 18.3 3
(15) 11 -Met hyl-6-methoxy-15,16-dihydro-17-one 14 310/50 1.7 3
(16) 7-Methyl-11-methoxy-15,16-dihydro-17-one 17 2500/20 34.5 3
(17) 11-Meth,y!-11,12,15,16-tetrahydro-17-one <1 80/100 <0.2 3
(78) 16,17-Dihydro-15-one <1 290/10 ' 6.7* 7
(19) 11-Methyl-16,17-dihydro-15-one -  ^.... 5 750/50 3.7 3
(20) 17-Methyi-15H- 6 350/50 1.6 7
(21) 11,17-Dimethyl-15tt- 27 200/50 1.0/ •7
(22) 12,17-Dimethyl-15H- 7 250/50 1.0 7
(23) 11,12,17-Trimethyl-15 H- 23 90/20 1.2 7
(24) 3-Methoxy-17-methyl-15H- <1 140/50 0.7* 7
(25) 11-Methoxy-17-methyl-15H- 12 170/50 0.9 7
(26) 17/7- <1 930/50 4.0* 7
(27) 17-Methyl-15,16-dihydro- (Diels’ hydrocar- <1 150/50 0.71 7
.bon)
(28) 11,17-Dimethyl-15,16-dihydro 3 125/20 1.5 7
(29) 3-Methoxy-17-methyl-15,16-dihydro <1 34/100 <0.2 7
Chrysenes 
(30) 1 ,2,3,4-Tetrahydro-1-one <1 1460/50. 7.2* 4
(31) 11-Methyl-1,2,3,4-tetrahydro-1-one 45 1370/50' 7.1 4
(32) 1,11-Dimethyl 23 160/20 2.1 4
(33) 3,4-Dihydro-1,11-dimethyl 10 210/20 2.7 4
(34) 1,2,3,4-Tetrahydro-1,11-Dimethyl 4 55/20 0.7 4
(35) 1-Methyl Initiator 285/10 6.9 11
(36) 2-Methyl Weak 155/10 3.7 11
(37) 3-Methyl Weak 340/20 4.1 11
(38) 4-Methyl Weak 445/10 10.8 11
- (39) 5-Methyl Moderate 1245/10 30.1 11
(40) 6-Methyl Weak 92/10 2.2 11
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Table 1 -C ontinued
M !i
Compound C° A B Ref.
Benz[a]anthracenes 
(41) Benz[a]anthracene Weak 994/20 11.3 10
(42) 1-Methylbenz[a]anthracene ± 500/20 6.0 10
(43) 2-Methylbenz[a]anthracene ± 313/10 7.6 10 '
(44) 3-Methylbenz[ajanthracene Inactive 194/5 9.4 10
(45) 4-Methylbenz[a]anthracene Weak 2492/20 30.2 • 10
(46) 5-Methylbenz[a]anthracene Weak 699/10 16.9 1 0 " ^
(47) 6-Methylbenz[ajanthracene Weak 318/10 7.7 10 '
(48) 7-Methylbenz[a]anthracene Strong 1275/20 15.4 io
(49) 8-Methylbenz[ajanthracene Moderate 330/20 4.0 10
(50) 9-Methylbenz[a]anthracene Weak 348/20 4.4 10
(51) 10-Methylbenz[a]anthracene Weak 122/10 3.0 10
(52) 11-Methylbenz[ajanthracene Weak 464/50 2.3 10
- (53) 12-Methylbenz[a]anthracene Moderate 460/20 5.7 10
(54) 7,12-Dimethyibenz[a]anthracene Very strong 437/20 ' 5.6 10
° C, carcinogenicity; M, mutagenicity; *, compoundsthat are mutagens, but not known carcinogens; ± , compounds 
for which evidence of carcinogenicity rests on the observation of single papillomas.
2 0 0 0 ’
CH. lOOpI
<u
n
Cl
lOOOl 50 pi
*co
100
pg of compound /  plate
C h art 2 . D o se -resp o n se  cu rv es  for th e  ca rc in o g en  (6) a t 3 liver enzym e 
levels (vo lum es of S-9). For d e ta ils  s e e  tex t.
sk in . E x p e r im e n ts  a re  in p ro g r e s s  to  e x a m in e  th is  p o s s ib il­
ity. H ow ever, a  m o re  fu n d a m e n ta l , re a s o n  fo r th e s e  d is ­
c r e p a n c ie s  m ay  b e  c o n n e c te d  w ith  th e  sp e c ific ity  s h o w n  by 
c a r c in o g e n s  fo r th e  ta rg e t  s e q u e n c e  in th e  b a c te r ia l DNA, a 
m u ta tio n  th a t  c a u s e s  re v e rs io n  to  p ro to tro p h y . A m es (13) 
h a s  sh o w n  th a t  c e r ta in  c la s s e s  o f c h e m ic a l c a r c in o g e n s  a re  
e sp e c ia lly  e ffec tiv e  in c a u s in g  re v e r s io n s  in p a r tic u la r  
s t r a in s  o f S . typhimurium, w h e re a s  th e y  a re  m u c h  le s s  
ac tiv e  in o th e r  s t r a in s .  In th is .w o rk  it w a s  fo u n d  th a t  a c e ta m - 
id o f lu o re n e  w a s  very  e ff ic ien t in C ausing  fram e-sh ift m u ta ­
t io n s  in b o th  TA98 a n d  TA1538 b u t w a s  m ark ed ly  le s s  a b le  to  
re v e r t TA100 by b a s e -p a ir  s u b s t i tu t io n . T h e  o p p o s i te  b e h a v ­
io r w a s  n o te d  fo r a n u m b e r  of c y c lo p e n ta [a ]p h e n a n th re n e s , 
w h e re a s  b e n z o (a )p y re rie  sh o w e d  le s s  sp e c if ic ity . It s e e m s  
th a t  e a c h  c a rc in o g e n  h a s  its ow n  in h e re n t sp e c ific ity  fo r th e  
d if fe re n t b a s e  s e q u e n c e s  invo lved  in th e s e  m u ta tio n s , a n d  
h e n c e  it is un like ly  th a t  a q u a n ti ta tiv e  re la tio n sh ip  b e tw e e n  
m u ta g e n ic ity  a n d  c a rc in o g e n ic i ty  w o u ld  h o ld  a m o n g  a  s e ­
rie s  o f d if fe re n t c o m p o u n d s  te s te d  w ith  a p a r t ic u la r  b a c te ­
rial s tra in .
A m ong  th e  6 m o n o m e th y l c h ry s e n e s ,  all o f w h ich  h a v e -
2000
CH,
o
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pg of (7)/plate
C h art 3 . Inhib ition  of th e  m u tag en ic ity  o f the  k e to n e  (7) (E2) w ith the  aryl 
h y d ro c a rb o n  hydroxy lase  in h ib ito r 7 ,8 -b en zo flav o n e . E ach p la te  contained  
th e  inh ib ito r (300 /i'g) an d  S-9 (100 /d ). S im ilar re su lts  w ere  a lso  o b ta in ed  with 
th e  c h ry sen o n e  (37), b en zo (a )p y ren e , a n d  d ib e n z [a ,/)]an th ra ce n e . .
b e e n  ca re fu lly  te s te d  b o th  a s  in itia to rs  a n d  a s  co m p le te  
c a rc in o g e n s  (11), th e  1-, 2-* 3-, 4-, a n d  6- iso m e rs  (35 to  38, 
a n d  40) a re  c o m p a ra b le  m u ta g e n s , all p o s s e s s  s im ila r initi­
a tin g  ac tiv ity , a n d  all a re  c o m p le te  c a r c in o g e n s  e x c e p t 1- 
m e th y lc h ry se n e  (35). O n th is  b a s is  o n e  m ig h t e x p e c t  1-, 2-, 
a n d  3 -m e th y lb e n z [a ]a n th ra c e n e s  (42 to  44) to  b e  in itia to rs; 
e v id e n c e  fo r th e  c a rc in o g e n ic i ty  o f C o m p o u n d s  42 a n d  43 is 
m e a g e r  a n d  it is n e g a tiv e  fo r th a t  of 44, b u t all th e  other 
iso m e rs  a p p e a r  to  b e  c a rc in o g e n ic  to  vary ing  e x te n ts  (10). 
Of th e  o th e r  6 m u ta g e n s  th a t  a re  n o t c a r c in o g e n s ,  4 (Com­
p o u n d s  1,18, 27, a n d  30) a re  p a re n t  m o le c u le s , w h ich  are 
u n s u b s ti tu te d  in th e  p h e n a n th r e n e  ring  sy s te m  b u t which 
b e c o m e  c a rc in o g e n ic  w h e n  s u b s t i tu te d  w ith  a  m ethy l group 
a t C -11. In S e r ie s  1 to  8 it a p p e a r s  th a t  a m ethy l g ro u p  can 
e ith e r  e n h a n c e  o r  d im in ish  m u ta g e n ic ity , d e p e n d in g  upon 
th e  p o s itio n  of its  s u b s ti tu tio n . It is n o t k n o w n  w h e th e r  the  7 
n o n c a rc in o g e n ic  m u ta g e n s  a re  in itia to rs . An e x p e r im e n t is 
in h an d  to  te s t  c e r ta in  of th e m  by th e  c la s s ic a l sk in  painting 
m e th o d , u s in g  c ro to n  oil a s  th e  p ro m o tin g  a g e n t .
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T he m a rk e d  inh ib itio n  of th e  m u ta g e n ic ity  of th e  c a rc in o ­
gen  (7) in th e  p re s e n c e  of 7 ,8 -b e n z o f la v o n e  (C hart 3) is in 
line w ith  th e  s tro n g  inh ib itio n  a lso  o b se rv e d  in th e  c o v a le n t 
b ind ing  o f th is  k e to n e  to  DNA in vitro, a f te r  m e ta b o lism  in 
the  p r e s e n c e  o f th e  flav o n e  (5). T h is  in h ib ito r a lso  s u p ­
p re s se d  tu m o r  fo rm a tio n  by C o m p o u n d  7 w h en  b o th  w ere  
p a in te d  to g e th e r  on  to  th e  b a c k s  of m ice  (5). W e h av e  a lso  
fo und  m a rk e d  inh ib itio n  of m u ta g e n ic ity  w ith th e  c h ry s e n -  
one  (37), b e n z o (a )p y re n e , an d  d ib e n z [a ,/7]a n th ra c e n e . S k in  
tu m o r p ro d u c tio n  is s u p p r e s s e d  to  vary ing  e x te n ts  w h en  
th is  in h ib ito r is re p e a te d ly  p a in te d  to g e th e r  w ith  th e s e  c a r ­
c in o g e n s  (u n p u b lis h e d  o b se rv a tio n s ) .
In su m m a ry , A m es’s  te s t ,  u s in g  S . typhimurium  TA 100, is 
fo und  to  p ro v id e  a se n s itiv e  a n d  c o n v e n ie n t q u a lita tiv e  
m e th o d  fo r th e  d e te c tio n  of c a rc in o g e n s  a m o n g  p o lycyc lic  
c o m p o u n d s  b y 'v ir tu e  of th e ir  m u ta g e n ic  ac tiv ity .
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The Relative Carcinogenic Activities of a Series of 5-Methylchrysene 
Derivatives
Maurice M. Coombs, Tarlochan S. Bhatt, Maureen Hall, and Charles J. Croft
Chemistry Department, Imperial Cancer Research Fund, Lincoln's Inn Fields, London WC2A 3PX [M. M. C., T. S. B., M. H.\, and the National 
Institute fo r Medical Research, Mill Hill, London, N W 7 IAA [C. J. C.], England
SUMMARY
The carcinogenicity of 1 ,1 1-dimethylchrysene (= 5 ,7 -  
dimethylchrysene) and its 1,2,3,4-tetrahydro-, 3,4-dihy­
dro-, and 1 ,2 ,3,4-tetrahydro-l-oxo derivatives was tested 
by mouse skin painting. Each mouse received 30 pg of the 
chrysene on the dorsal skin twice weekly for one year, and 
the animals were observed for a second year.
The 1-ketone was much more active than any of the 
hydrocarbons. Of the latter, the fully aromatic 1 ,11-di­
methylchrysene was fairly active, the 3,4-dihydro deriva­
tive was less so, while the 1,2,3,4-tetrahydro compound 
was a weak carcinogen.
These results are discussed in connection with the carci­
nogenicity of the corresponding cyclopenta[a]phenan- 
threnes, which exhibit a similar structure-activity relation­
ship.
INTRODUCTION
The polycyclic hydrocarbon chrysene (I), like its isomer 
benz[tf]anthracene (II), has generally been found to lack or 
to possess at most marginal carcinogenic activity (14a, 16). 
However, methyl substitution in the latter at certain, 
specific ring positions, particularly C-7 (14b) and C 12 (14c), 
promotes activity so that 7 , 12-dimethylbenz[a]anthracene 
is one of the most potent carcinogens known (Chart 1).
The methyl derivatives of chrysene have been less exten­
sively studied. Like the parent hydrocarbon the 1-methyl
(13), the 4- and 6-methyl (12), the 2,3-dimethyl (15), and 
the 4,5-dimethyl derivatives (12) either lack or possess very 
weak carcinogenic activity. By contrast, the 5-methyl (12) 
and 5,6-dimethyl derivatives (1, 12) of chrysene are moder­
ately strong carcinogens. C-5 ( =C -11) in chrysenes is in the 
same position relative to the 3 rings comprising the 
phenanthrene system as is C-12 in benz[a]anthracenes.
A similar situation exists with regard to the associated 
structure 1 5 ,16-dihydrocyclopenta[a]phenanthrene (Ilia), 
which is of interest because it possesses the same ring system 
as do the natural steroids. Both the parent hydrocarbon 
(Ilia) and its 17-methyl derivative (Diel’s hydrocarbon, 
Illb) are without activity, as are the majority of the 
isomeric methyl and dimethyl derivatives. Weak carcinoge-
Received D ecem ber 11, 1973; accepted February  7, 1974.
nicity is conferred by methyl substitution at C -ll (5, 7) to 
give I lie  and X  in which the aryl methyl groups are 
positionally equivalent to C-5 in chrysenes and C-12 in 
benz[a]anthracenes. It seems probable that the correlation 
between carcinogenicity and methyl substitution at these 
equivalent ring positions is not fortuitous and that these 
methyl groups therefore exert some common effect that 
endows these hydrocarbons with activity.
Introduction of a conjugated A16-double bond into Diel’s 
hydrocarbon also confers weak activity (7, 11), and it 
reinforces the effect of 11-methyl substitution so that I X  is a 
much stronger carcinogen than either IIIc or X.  Thus, with 
the use of the same strain of mice and the same skin painting 
technique used in the experiment described in this paper, I X  
induced skin tumors at the site of application in 17 of 18 
animals (based on the number of animals alive at the ap­
pearance of the 1st tumor), with a mean latent period of 48 
weeks (7). More interesting was the discovery that introduc­
tion of a carbonyl group at C-17 also greatly augments the 
activity conferred by 11-methyl substitution, so that 15,16- 
dihydro-1 l-methylcyclopenta[a]phenanthren-17-one VIHb) 
(100% tumor incidence, 31 weeks, compared with 21 weeks 
for 20-methyl-cholanthrene used as a positive control in the 
same experiment) (6) is more active than the most active 
hydrocarbon (IX). The parent ketone (Vi lla)  was without 
activity. On exploration of the consequences of structural 
alterations of VIHb  on its carcinogenicity, it was found that 
the homolog with 1 extra methylene group in the nonaro- 
matic ring, namely 11-methyl-1 ,2 ,3 ,4-tetrahydrochry- 
sen-l-one (IVb), retained the high potency of VIHb.  This 
methylchrysenone induced skin tumors in 17 of 18 mice 
with a mean latent period of 30 weeks. As in the cyclopenta- 
[ojphenanthrene series, the parent, unsubstituted ketone
( IVa) was devoid of activity. __
With this methylchrysenone (IVb) to hand, 1 ,1 1-dimeth- 
ylchrysene (VII) and the 3,4-dihydro (V), and 1,2,3,4-  
tetrahydro (VI) derivatives were readily available (Chart 2). 
It was of interest to determine whether the carcinogenic 
potency of these compounds would fall into the order TVb 
> V > VI, i.e., the same order as_ their cyclopental[a]- 
phenanthrene counterparts VIHb, IX,  and X . The relative 
activity of the fully aromatic analog (VII)  was also of 
interest for, of course, this can have no counterpart in the 
series bearing a 5-membered ring. This paper describes the 
preparation and testing of these compounds by our standard 
skin painting technique.
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Chart 1. Chemical structures mentioned in the text.
Chart 2. Chrysenes tested by skin painting {IVb to VII), and their 
cyclopenta[a]phenanthrene analogs {VIHb to X).
MATERIALS AND METHODS 
Chemistry
The preparation of the methylchrysenone (/Lb) has been 
reported previously (10). Equipment and general methods 
used are as recently described (6). Woelm Grade I alumina 
(Koch-Light Laboratories Ltd., Colnbrook, SL3 OBZ, 
Buckinghamshire, England) was used for the purification of 
hydrocarbons. _
Preparation of 3 ,4 -Dihydro-1,11-dimethylchrysene (V). 
The ketone (/7b ) (2.60 g) in benzene (26 ml) was added 
gradually to a solution of methyl magnesium iodide [from 
magnesium turnings (2.0 g), methyl iodide (3.0 ml), and dry 
ether (50 ml)], and the mixture was heated under reflux for 1 
hr. The ether was removed by distillation while more 
benzene (50 ml) was added, and heating was continued for a
further 2 hr. The cooled reaction mixture was poured into 
aqueous ammonium chloride (10%, w/v) (125 ml) contain­
ing 5 n  HC1 (2.5 ml), more benzene was added, and the 
whole was shaken vigorously. The organic layer was 
separated without delay, washed with aqueous N aH C 03, 
and dried over anhydrous N a2S 0 4. The residue left on 
removal of the solvent was purified by chromatography on a 
column of alumina (100 g) using hexane as the eluant. 
Fractions homogeneous by thin-layer chromatography were 
combined to yield a cream-colored solid (1.46 g). Recrys­
tallization from methanol gave 3 ,4-dihydro-1 ,11-dimethyl­
chrysene ( V ) ,  m.p. 104-104.5°.
C2 0 H 18
Required: C 93.0; H 7.0
Found: C 92.8; H 6.85
A » 01 223.5 (log € 4.33), 272 (4.70), 284.5 (4.70), 298 sh 
(4.28), 308 sh (4.13), 321 sh (3.72), 355 (2.89), and 372 nm 
(2.87); j f e o1 874, 822, 749 cm’ 1.
Preparation of 1,11-Dimethylchrysene (VII). The above 
dihydro compound (345 mg) in dry benzene (135 ml) was 
treated with 2 ,3-dichloro-5, 6-dicyano-1,4-benzoquinone 
(335 mg) at room temperature for 24 hr. Precipitated 
hydroquinone was collected, and the filtrate was evaporated 
to leave a brown solid (431 mg). Chromatography on a 
column of alumina (100 g) with hexane gave a white solid 
(270 mg) which on recrystallization from methanol yielded 
1 ,1 1-dimethylchrysene (VII)  (150 mg), m.p. 168.5-169°.
C20H 16
Required: C93.7; H 6.3
Found: C93.6; H 6.4
X#£xano1 225 (4.43), 265 sh (4.84), 272 (4.96), 304 (3.97), 317 
(4.10), 330.5 (4.10), 350 (3.99), and 369 nm (3.79);
864, 798, and 778 cm -1.
Preparation of 1, ll-Dimethyl-l,2,3,4-tetrajiydro- 
chrysene ( V I ) .  A solution of the dihydro compound (L) (305 
mg) in ethanol (150 ml) was stirred with 5% palladium-on- 
charcoal catalyst (150 mg) in an atmosphere of hydrogen for 
90 min. After removal of the catalyst by filtration, the 
solution was evaporated to leave a white solid. Recrystalli­
zation from methanol (50 ml) gave 1,11 -dimethyl-1 ,2 ,3 ,4 -  
tetrahydrochrysene ( V I )  (170 mg), m.p. 69-69.5°.
C20H20
Required: C 92.3; H 7.7
Found: C92.5; H 7.5
Amafno1 229 (4.30), 256.5 (4.80), 282 (4.00), 294.5 (4.02), 306 
(4.09), 338.5 (2.76), and 354 nm (2.69); v S 1 813 and 748 
cm '1.
Skin Painting Experiment
This was carried out as previously described (6). Groups 
of 10 male and 10 female mice were used for each 
compound, 30 jug of which were applied as a 0.5% w/v 
solution in toluene twice weekly for 50 weeks. The animals
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were observed for a 2nd year or killed when their induced 
tumor had reached 8 to 10 mm in diameter. Tumors were 
examined histologically except in 8 cases in which tissue was 
unavailable because death had occurred and autolysis was 
too far advanced. The results of this experiment are 
summarized in'Table 1 and in Chart 3.
RESULTS
Of the 4 chrysenes tested, the 1-ketone ( T V b) was by far 
the most active, producing tumors in 17 of the 20 mice alive 
at the appearance of the 1st tumor. The mean latent period, 
27 weeks, was similar to that (31 weeks) previously reported
(6) (the mean latent for the control, 20-methylcholanthrene, 
was 22 weeks compared with 21 weeks found previously). 
The least active chrysene was the tetrahydro hydrocarbon 
(F7) (3 of 18 mice, 55 weeks). In both respects, these 
chrysenes are similar to the corresponding cyclopenta[«]- 
phenanthrenes. However, the dihydrochrysene ( V )  was 
distinctly less active (8 of 20, 57 weeks) than the hydrocar­
bon (IX)  (7) (17 of 18, 48 weeks), with regard to both the 
tumor incidence and latent period. Indeed, it was the fully 
aromatic chrysene (VII)  (15 of 19, 50 weeks) that had 
activity similar to that of IX.
DISCUSSION
These results indicate that the size of the 4th, partially 
saturated ring has little influence on_the relative carcinoge­
nicity of the ketones Vll l b  and IV b, and of the tetrahy- 
drohydrocarbons X  and V T .  This is not the case with the 
dihydrohydrocarbons I X  and V. Here the sterically 
strained, 5-membered cyclopentadiene ring in T X  induces 
carcinogenic activity to an extent similar to that induced by 
the fully aromatic, 6-membered ring in the chrysene (VII), 
whereas the corresponding dihydrochrysene ( V )  resembles 
the less active tetrahydrochrysene ( V T )  in latent period, 
although its tumor incidence was higher. The electrons
associated with the partially unsaturated ring in I X  are less 
localized than those in V. In certain chemical reactions (8, 
9), cyclopenta[a]phenanthrenes react with bond migration 
as shown in Chart 4A,  whereas this does not occur with
3 ,4-dihydrochrysenes (for example, V). The fused cyclopen­
tadiene ring therefore resembles, in some respects, an 
aromatic ring, and this seems to be reflected in the similar 
carcinogenic activity possessed by I X  and VII.
CH,
MC
-15
I
-10s
8£
100W e ek s
Chart 3. Skin tumor production by chrysenes (/Kb to VII) and 
methylcholanthrene (M C ). Experimental details are given in “Materials 
and Methods.” The unsubstituted chrysenone Via. was inactive in this 
system (6). All visible skin tumors grew progressively.
18
H,C
xi b xn
Chart 4. A, bond migration in cyclopenta[a]phenanthrenes; B, possible 
incorporation of the angular 18-methyl group into the D-ring in plant 
steroids from N. physaloides.
Table 1
Number o f  mice surviving without tumors and histology o f  induced tumors at site o f  application in the skin
painting experiment
Compounds tested
No. of tumorless survivors at No. of mice with
6 mo. 12 mo. 18 mo. 24 mo.
Squa­
mous
papil­
loma
Squa­
mous
carci­
noma
11 -Methyl-1 -oxo-1 ,2 ,3 ,4-tetrahydro-(/ Tb) 11 0 0 0 1 16
1,11-Dimethyl-1 ,2 ,3 ,4-tetrahydro-( VI) 20 18 11 5 “
3 ,4-Dihydro-1,11 -dimethyl-( V) 20 18 6 3 2 4°
1,1 l-Dimethylchrysene-(K/7) 19 15 3 0 6 5a> b
Methylcholanthrene 9 0 0 0 4 15
Toluene control 19 18 14 4 0 0
Clipping control 20 18 18 10 0 0
“ Tumors were unavailable for histology for these compounds as follows: VI, 3; V, 2; VTl, 3. 
6 An additional animal had a tumor (spindle-cell sarcoma) at the site of application.
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In both the cyclopenta[a]phenanthrene and chrysene 
series, introduction of a doubly bonded ketone oxygen atom 
at the benzylic position equivalent to C-17 in a steroid 
augments the activity of the hydrocarbon, Again, the effect 
is similar to the effect of fusion of an additional aromatic 
ring, now at C-12 and C-17. In the case of cyclopenta[a]- 
phenanthrene, this would lead to cholanthrene which is a 
strong carcinogen, somewhat less active than its well-known 
20-methyl homolog (14d). Since both the ketone and fused 
aromatic ring can be regarded as electron-withdrawing 
substituents, it seems probable that both function by 
altering the electron distribution in the phenanthrene sys­
tem.
Formally, the chrysene ring system can be derived from a 
C 1 8 steroid by incorporation of the carbon of the 18-methyl 
group into the D-ring, as indicated in Chart 4B, X I  —► XII .  
A particularly clear indication that this may occur naturally 
is afforded by recent investigations (2-4) on the family of 
insect-repellent plant steroids isolated from Nicandra 
physaloides. Certain of these are normal steroids bearing a
18-methyl group and having a side chain at C-17. Others 
lack the 18-methyl group and possess an aromatic 6-mem- 
bered D-ring bearing the same side chain, but now situated 
at C-2 in this ring, C-l having presumably been supplied by 
incorporation of the methyl group.
The isolation of naturally occurring derivatives of chry­
sene adds interest and importance to the examination of the 
relationship between structure and carcinogenic activity in 
the chrysene series.
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I. Introduction
Interest in a possible relationship between carcinogenic poly- 
cyclic hydrocarbons and the natural steroids originated from the 
early work on chemical carcinogenesis [ C o o k , 1933]. Following the 
dram atic chemical transformation of the bile acid derivative, 
dcoxycholic acid, into the potent carcinogen 20-methylchoianthrene 
(20-MC) independently by W ie l a n d  and D a n e  [1933] and C o o k  
and H a s l e w o o d  [1933], speculation in this field centered upon the 
possibility of in vivo .production of cholanthrcncs and this w-as 
extensively reviewed by I n h o f f e n  [1953] and by H a d b o w  [1958]. 
The early concepts were extended by F ie s e r  [1941] who suggested 
that if endogenous carcinogens do arise as a result of abnorm al 
steroid metabolism, the process might be closely related to the bio­
synthesis of the partially aromatic steroids,, the oestrogens. In  order
1 Present address: National Institute for Medical Research, Mill Hill, London, 
N.W. 7 (England).
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to provide a fifth fused ring, at that time-considered essential for 
'carcinogenic activity, he suggested that such steroids might condense 
with pyruvic acid and subsequently undergo cvclization to com­
pounds o fth e  cholanthrcne scries.
Subsequent work revealed that carcinogenic properties are 
associated with a great num ber of poly cyclic hydrocarbons, and 
these results tended to overshadow the earlier interest in cholan- 
! hr cries. Jt was noted that the majority of these hydrocarbons were 
derivatives of phenanthrenc having additional, fused aromatic 
rings and much effort was expended in attempts to correlate 
chemical structure and reactivity with the carcinogenic activity 
shown by these compounds. In  particular, attempts to use quantum  
mechanical indices of electron density of the so-called K-rcgions as 
a measure of carcinogenic potency met with success for certain 
limited series of closely related hydrocarbons [DAUDEL'and D a u d e l , 
1966], but failed to account for the effects of alkyl substitution. 
Thus, in the bcnzanthracenc series, methyl substitution at C-l to 
C-'l- has little effect on the marginal activity of the parent hydro­
carbon, whereas methyl substitution at Cl-7 and C-12 produces 
extremely active carcinogens. In  the chokmthrcne series, lengthening 
or branching the hydrocarbon substituent at C-20 drastically 
lowers activity. Neither of these effects can be accounted for on 
purely electron density grounds, and the unavoidable conclusion 
is that while high electron density in the K-region is of undoubted 
importance in conferring carcinogenic properties, its action rnay 
be cancelled by steric effects o fthe  ring substituents. This has been 
'emphasized by Y a n g , C a s t r o , L e w is  and W o n g  [1961], who 
pointed out the close spacial relationship between several classes of 
steroid hormones and some of the strongest polycyclic hydrocarbon 
carcinogens. They suggested that the latter might act by occupying 
the same receptor sites as these hormones.
S e n ;  (a ) a n lh r a c e " ?  C hO 'anihrcriD
While considerable knowledge of the carcinogenicity of poly­
cyclic hydrocarbons containing four or more condensed aromatic
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rings has been gained, less attention has been paid to members of 
the 9 tf/openta[a]phcnanthrene2 scries having the same ring system 
as the steroids, with only three fused arom atic rings. The lack of 
activity of the parent hydrocarbon (I) and its 17-mcthyl homologuc 
(Diels’ hydrocarbon), both of which were isolated from the prod­
ucts of dchydrogenation of a num ber of steroids a t an early stage 
[F ie s e r  and F ie s e r , 1959], is probably a factor which diverted interest 
from the 9 'r/openta[a]phcnanthrcnes as potential endogenous carcin­
ogens. Also, the large num ber of different chemical types now 
known to possess carcinogenic properties has tended to diminish 
interest in polycyclic hydrocarbon carcinogenesis. However, in a 
systematic study of the methyl homologues of (I), B u t e n a n d t  and 
D a n n e n b e r g  [1953] established that* while the 1-, 2-, 4- and 
6-monomcthyl, the 4,17-, 6,17-, 2,12-, 4,12- and 6; 7-dimethyl, and 
6,17, 17-trimethyl derivatives of (I) were inactive, weak carcinogen­
ic activity was conferred by methyl substitution at C-7 and C - ll.  
In  later work on the nature of the carcinogenic constituent of the 
hydrocarbon mixture obtained by chloranil dehydrogenation of 
cholesterol, D a n n e n b e r g  [1960] showed that the 17-mcthyl 
derivative of the A 1G-hydrocarbon (II) and its 15-methyl- A 15 
isomer also possessed weak carcinogenic activity. In  view of the 
results of his previous work mentioned above, he suggested that 
11-methyl substitution might increase the activity of these com­
pounds.
II. Biosynthetic Considerations
The earlier search for endogenous carcinogens related to the 
steroids was carried out at a time when little was known about the 
biosynthesis of the latter. In  particular, a difficulty encountered in
2 Note on chemical nomenclature. The term £>'c/opcnta[a]phenanthrcnc is properly 
reserved for the fully unsaturated hydrocarbon of which (II) is the 15-r/-isomer; (I) is 
therefore its 16,17-dihydro derivative. The term will be employed loosely in this paper 
to imply both types of structure. These compounds arc numbered according to the 
steroid convention, as shown.
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effecting the in vivo transform:',linn of a C3S or CJ9 steroid into a 
9 r/cpenla[a]phonanthrene was the presence of the singular 13- 
and 19-methyl groups, which block aromatization. Recent work 
on the metabolism and biosynthesis of steroids has largely removed 
these difficulties, so that in vivo formation of cjclopcrdv. [a] phenan- 
thrcne derivatives now appears distinctly feasible.
Complete aromatization of a typical G1& steroid such as andros- 
terone requires removal of the two angular m ethyl'groups and 
would lead to the phenolic ketone ( I I I) ;  simultaneous elimination 
of the 3-oxygcn function would give the corresponding 3-deoxy- 
kclone (IV).
no
A n d ro ste rcn -;
Ecfnenir j -O e o x y e q u i le n f iOostror’e
Precedents for loss o fth e  19-mcthyl group and arom atization of 
rings A and B arc provided by the well-known, partially aromatic 
steroids such as ocstrone and cquilenin, while a precedent for the 
additional loss of the 3-oxygen function is afforded by 3-dcoxy- 
equilcnin. This compound was isolated by two groups of workers, 
M a r k e r  and R o iir m a n n  [1939] and P r e l o g  and T u i i r e r  [1945], 
from marc's pregnancy urine under conditions which preclude its 
formation as an artefact. The biosynthetic derivation of this com­
pound is not known. If  it is formed in common with the 3-oxygcnatcd 
steroids by way of Ianostcrol, elimination of the 3-oxygcn atom 
must occur before the final aromatization step. However, another 
possibility exists, because B a r t o n  and Moss [196G] have recently 
indicated that in yeast, squalcnc cyclization follows the route; 
squalcne ~>~ lanosta-8,2-:-dicnc (enzyme bound) *->- ianostcrol. I f  the 
enzyme-bound hydrocarbon became free, presumably it could lead 
to a scries of 3-dcoxy steroids. In  this connection it is interesting 
that many tritcrpcnoids lack oxygen at G-3, although they arc also 
derived'from squalcnc.
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All C18 oestrogens lack the 19-methyl group and it is now firmly 
established that they are biosynthcsizcd from C19 androgens by 
oxidative elimination of this methyl group followed by aromatiza- 
•tion of ring-A [ T a l a l a y , 1965], Recent work suggests that the 
18-methyl group may also be eliminated by a similar mechanism. 
Thus, the biosynthesis of aldosterone is now known to involve 
hydroxylation of the 18-methyl group, probably of corticosterone 
[ E is e n s t e in , 1967], so that 18-hydroxylation is established as a 
normal adrenal function, at least for C21 steroids. In  1958, M a r r ia n  
isolated a new oestrogen metabolite, 18-hydroxyoestrone, from 
hum an pregnancy urine and showed that under mild conditions 
in vitro it readily underwent ^-elimination of formaldehyde to yield 
18-norocstrone. The way for complete arom atization to the cyclo- 
penta[a]phenanthrene analogue (III) by straightforward biological 
dehydrogenation is thus theoretically open. In  order to establish 
whether compounds of this type are carcinogenic, and if  so, what 
the structural requirements for such action are, the r)’c/opcnta[a]- 
phenanthrcnes shown in figure 1 were synthesized and tested for 
carcinogenicity in mice.
13 -H y d ro x y o e s tro n e  IS -N o ro es-tro n e
III. Methods 
A. Chemistry
The 9 ^openta[a]phcnanthrenes used in this study are shown 
in figure 1. They include compounds bearing oxygen substituents 
at the biologically interesting 3-, 11- and 17-positions, as well as 
methyl at G -ll which, on the basis of B u t e n a n d t  and D a n n e n - 
b e r g ’s results [1953], was expected to confer carcinogenicity in 
certain derivatives.
The ketones 2 a -f  were prepared by variations on the general 
route devised by R o b in s o n  [1938] for the construction of the 
steroid skeleton. The ketones were converted by means of the
C oO M B s/C uO F T
methyl Grigrinrd reagent to the 17-mcthyl- / P  hydrocarbons l a - f  
which were hydrogenated ■ to the 17-mcthyl saturated D-ring 
derivatives 3a~f. Details of the synthesis o f tliese compounds and of 
c o m p o u n d s h a v e  been published [C o o m b s , 1 9 6 6 ] .
. a ?
ch3
{ A
0
{ C
Substitution 
j 1,12-diMi; in 2a
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Fig.], Compounds tested by skin painting
33, Animal experiments
Two skin-painting experiments were performed. The methods 
and preliminary results o f th e  first experiment have been reported 
previously [ C oo m bs  and .C r o f t , 1966]. The final results of this 
experiment arc included in table I, where they arc indicated by an 
asterisk*. The second experiment was performed in an identical 
m anner to the first, except that toluene was used as the solvent 
instead of benzene. As in the first experiment, one drop (6 //I) of a 
0.5% (w/v) solution of each chemical was applied twice a week for 
52 weeks to the dorsal skin of 20 T.O . random -bred mice, and they 
were observed for a second year. Two negative control groups 
consisted of animals painted with the solvent (toluene) only, and 
animals which were clipped but otherwise untreated. In  addition, 
two positive control groups consisting of animals painted with
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Table I. Number of mice surviving without tumours and histology of induced tumours 
at site of application in the skin painting experiments
Number of tumourlcss survivors at: Number o f mice with:
£
o£.EoU G 
mo
nt
hs
12 
m
on
th
s
18 
m
on
th
s
24 
m
on
th
s
Sq
ua
m
ou
s
pa
pi
llo
m
a
Sq
ua
m
ou
s
ca
rc
in
om
a "cujy 5 
*5 o
la 17 10 5 0 1 14 0
lb 18 9 0 0 1 16 0
lc 18 15 10 2 .1 "4 0
Id* 19 13 10 0 3 ? 0
lc 19 16 12 2 .1 2 0
I f 19 19 18 . 7 0 0 1
6 18 16 13 • 4 0 0 0
7* 17 11 . 4 ' 0 1 4 0
8 16 16 14 5 0 0 0
2a . 14 6 0 0 2 11 0
2b 17 2 0 ' 0 l' 13 0
2b* 18 0 0 • 0 8 5 2
2c 17 8- 3 O' 2 9 0
2d* 18 9 6 4 0 . 0 0
2c* 18 ’ 7 6 3 0 0 0
2f* 20 15. 4 1 0 0 0
4 15 14 13 3 0 I 0
5 20 17 15 6 0 0 0
3a 18 13 9 2 0 6 0
3b 15 13 8 2 0 « 0
3c 14 13 9 0 . xJ 0 0 0
3d 17 17 12 5 0 0 0
3d* 20 13 7 3 0 0 0
3c 16 15 ■ 13 7 0 0 0
3 f 19 19 17 7 0 0 0
DMBA 0 0 0 0 2 12 1
MC 9 0 0 0 0 12 2
Solvent (toluene) 20 20 18 8 0 0 0
Clipping 20 20 17 6 0 0 0
Solvent* (benzene) 17 13 8 3 0 0 0
Clipping* 20 18 16 13 0 0 0
* Results of first experiment (see page 74).
7,12-dimcthylbcnz [a] anthracene (DMBA) and 20-methylcholan- 
threne (MG) were included.
Compounds 2a, 2b and 2d were also tested by subcutaneous in­
jection into formally randomized groups of T .O . mice from the
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same source as those used in the skin-painting experiments. The 
compounds were suspended in olive oil and injected in the region of 
the right scapula. Control groups were injected with the olive oil 
only. The dosages and num ber of animals injected are indicated 
in table II.
The size and position of all skin tumours were recorded when the 
animals were painted (i.e., twice a week) during the first year of 
both skin-painting experiments, and fortnightly during the second 
year. The animals which had been injected subcutaneously were 
observed fortnightly.
In  the first skin-painting experiment tumours were biopsied for 
histology, but this procedure was not followed in the second ex­
perim ent in which the tumours were-allowed to grow until they 
were about 1 cm in diameter,- when the animals were killed and 
autopsies performed.
W henever possible, autopsies were performed on dead animals, 
and sick animals were killed and autopsied. In  the skin-painting 
experiments, at the end of two years, surviving animals were killed 
and autopsied. Because o f the high m ortality of thc'subcutancously 
injected animals, all survivors were killed after one year in the case 
of the 8 mg dosage, and after 9 months in the case of the 50 mg 
dosage.
Tumours arising at the application site in the skin-painting 
experiments were examined histologically, and those which in­
volved the panniculus carnosus muscle were classified as carcinomas. 
I f  the latter muscle was intact they were classified as papillomas. In  
25 cases no skin tumours were available for histology (in 10 of these 
cases, because the tumours had regressed; in 15, because the animals 
had died and autolysis was too far advanced). Regressions occurred 
only with tumours less than 4 mm in diameter.
In  the subcutaneous experiments the largest skin tum our and the 
subcutaneous tumours at the site of injection were examined 
histologically.
IV. Results
A. Hydrocarbons
In  the series of hydrocarbons possessing a 17-mcthyl-saturated 
D-ring (compounds 3a~f), Diels’ hydrocarbon {3d) was inactive, in
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agreement with several previous groups c f workers [ H a r t w e l l , 
1953], as were the 3--ruethoxy, 11-rricthoxy and 12-methyl deriva­
tives. The 13-methyl derivative gave 2 tumours, thus confirming 
B u t p n a n d t  and D a.n n e n b e r g ?s result [1953] that 1.1-methyl sub­
stitution gave rise to very weak activity in the parent hydrocarbon. 
The 13,12-dimet.hyI homologue was rather more active, producing 
four tumours during the period of painting and three more sub­
sequently. I t  is interesting to note that B a d g e r  [1942] demonstrated 
weak carcinogenicity with the related, tricyclic hydrocarbon, 1,2,3, 
d-tet rarncthylphcnmivhrene.
The results of this test are presented diagrammatically in figure 
2, where the num ber of animals with tumours arc plotted against 
time in weeks; la  a l l ’s [1939] indices, calculated from these 
results, are shown in parentheses. Histology of induced tumours and 
the survival of tumour-free mice are shown in table I.
The 17-mcthyl-id:,'hydrocarbons (compounds la - f)  displayed 
higher carcinogenic activity, as demonstrated in figure 3. Again in 
agreement with D a n n e n b e r g  [I960], the unsubstitutcd compound 
produced several tumours after a long latent period, as did its 
17-methylene isomer (7). The li-m cthoxy and 12-methyl deriva­
tives had similar activity, but tumours tended to appear earlier. 
Distinctly higher activity was observed with the 11-methyl and
11,12-dimethyl derivatives [la and lb), which produced tumours
1
3j
Fig. 2. Turn ja r  production by the 17-mcthyl saturated D-ring compounds. The 
unsiibstitutcd hydrocarbon and its 3-mcthoxy, 11-incthoxy and 12-mcthyl derivatives 
were inactive.
□  11,12-dimcthyl (3a)
"* ’ o 11-methyl (5b)
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1 1 -M e 11.12-diM e
,^ -Q  tf"1'  /“ (2?) JJV
10 2 0  3 0  <0 5 0  5 0  70 8 0  9 0  100
W e ek s
Fig. 3. Tumour production by the 17-metliyl-J10 compounds. 3-OMc (If)  produced 
one tumour at 99 weeks. The 17-methyienc isomer (7) produced 6 tumours (63, 67, 83, 
102, 102 and 102 weeks).
□ methylcholanthrene (MC)
O 11-methyl (lb)
Q 11,12-dimcthyl (la)
A  11-methoxy (lc)
V 12-methyl (le) 
o unsubstitutcd (Id) ’
earlier and in a larger proportion of the animals. Thus, the effects 
of 11-mcthyl substitution and a double bond in the 5-membered 
D-ring arc additive, and give rise to hydrocarbons with about half 
the activity of 20-methylcholanthrene, on the basis of the I e a l l ’s 
indices. All the compounds in this series showed activity, for even 
the 3-mcthoxy compound ( I f )  produced one tum our towards the 
end of the experiment.
The lack of activity in 17//-<y^/openta[a]phenanthrene itself 
(6) is surprising because D a n n e n b e r g  [1960] found activity in the
15-mcthyl derivative of this hydrocarbon (as well as in its zl1G-17- 
methyl isomer I d ) .  A possible reason may be that the presence 
of a methyl group adjacent to the double bond prevents partial 
delocalization of th e ' double bond over the 5-mcmbcrcd ring 
[C o o m b s , 1966]. This would result in m aintenance of the high 
electron density at the double bond, presumably of im portance if, 
as D a n n e n b e r g  [1960] suggested, this is the K-region in these 
molecules. Alternatively, a methyl group attached to the unsaturated 
D-ring may confer activity by some other mechanism. Similar 
considerations may explain the inactivity of the zl15-17-isopro- 
pylidene compound 8.
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B. Ketones
Since the introduction of oxygen substituents into carcinogenic 
hydrocarbons usually diminishes their activity, the high level of 
carcinogenicity exhibited by both the 11-methyl and 11-methoxy 
substituted 17-ketones (2a, b and c), summarized in figure 4, was 
unexpected. The 11-methyl .ketone (2b) appeared to be the most 
active compound tested in the present work. In  two independent 
experiments ail the survivors at one year had tumours, giving
Idm,V8 i w l t a  of SI nn& M  and a rnoan Intaav period of about .35
weeks, compared with an index of 48 and a mean latent period of 
about 25 weeks for 20-mcthylcholar; throne, tested at the same time. 
The 11,12-cIimethyl ketone displayed similar carcinogenicity, while 
the 11-methoxy ketone had a somewhat longer mean latent period, 
but still produced tumours in the majority of the animals and was 
as active as the most active zl1G-hydrocarbon. In  this scries carcino­
genicity appeared to be confined to these 11-substituted derivatives. 
Even the ll-acetoxy-17-.ket.onc (4) produced tumours in two ani­
mals, whereas the unsubstituted ketone and its 15-isomer (5) were
Weeks
Fig.4. Tumour production by the 17-ketone:;. Tiic unsubstituted {2d), 12-Mc {2c)
and 3-Oivli: {2f) -17-ketones and the l.r)-ketone (5) wore all inactive. The 11-acctoxv-
i7-kctone ('/) produced 2 tumour:: (42 and 03 weeks).
□ m ethylcholanthrene (MG)
O 11-m ethy l {20)
(Z) 11-methyl {20)*
H 11,12-dimethyl {2a)
. ... A 1 1-rnethoxy {2c)
X 11-acctoxy {4)
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Tabic HI. I e a l l ’s indices
Yt} ch3 ch3 0fd d d
11-Mc 3 27 31,36
11,12-diMc 12 23 30,
11^0 Me 0 11 25
Unsubst. 0 8 0
12-Me 0 7 0
3-OMe 0 2 0
11-OAc - - 3
20-MC 48
devoid of activity, as were the 12-methyl- and the 3-methoxy-17- 
ketones.
These skin painting results were confirmed by subcutaneous ' 
injection of three of the ketones into mice. In  the two experiments 
shown in table I I , the 11-methyl ketone .yielded local sarcomas and 
multiple skin tumours remote from the injection site, and the latter 
were also given by the 11,12-dimcthyl ketone. No skin tumours 
were produced by the unsubstituted ketone, which was also in­
active by skin painting. Histologically, some of these remote skin 
tumours were mixtures of squamous papillomas and sebaceous 
adenomas which appear to be similar to those observed by K l e i - 
n e n b e r g , N e u f a c h  and S h a b a d  [1940] following subcutaneous 
injection of hum an liver extracts into mice, and by R o e , R o w s o n  
and S a l a m a n  [1961] after injection of newborn mice with dimcthyl- 
bcnzanthraccnc.
Discussion
In  table I I I  I b a l l ’s indices, derived from the skin-painting 
experiments, clearly demonstrate that 11-mcthyl substitution 
promotes carcinogenicity in all three series of c>'drcpcnta[a]phenan- 
tbrcncs. In  the ketone scries only 11-substituted compounds arc 
active, whereas all the 17-mcthyl- J 1G hydrocarbons possess carcino­
genic properties to some extent. I t  is tem pling to suggest that 
possibly these two scries of compounds exert their biological action 
in different ways. D a n n e n b e r g  [1960] has proposed that in these 
hydrocarbons the double bond in the five-mcmbered ring should
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be designated the K-region, .since it is chemically the most reactive 
double bond, undergoing preferential reaction with oxidizing agents 
such as osmium tetroxidc and chromic acid. The 17-ketones, on the 
other hand, . interact with these reagents mainly at the A5 
‘phcminlhrene* doable bond3, which might therefore be considered 
as the K-region in 17-oxo-15,1 G-dihydronr/opcn ta[a]phcnan- 
threncs. It is hoped that, metabolic studies now in progress will help 
to illuminate these problems, since B o y l a n d  [19G4] has shown that, 
contrary to previously held opinion, polycyclic hydrocarbons 
appear to suffer preferential biological oxidation a t their K-rcgions.
Recently, Sim s [1967] reported that the 15- and 16-kctoncs 
derived from 20-methylc.hoIanthrene were strong carcinogens, 
although not as potent as the hydrocarbon itself. He suggested that 
these ketones might well be carcinogens in their own right, with 
their activity unrelated to that of the parent hydrocarbon. In the 
present work the 11-substitutcd-l7-ketones in the structurally 
related rnApentn [a]phenarithrenc series arc much more active 
than the hydrocarbons from which they are derived.
Although carcinogenic activity has been demonstrated in certain 
mcthoxy derivatives of several polycyclic hydrocarbon carcinogens 
(e.g., 12-meihoxydibenz[a,h]anthracene [B a r r y . C o o k , H a s l e - 
w o o d , H ik g e r . H e w e t t  and K e n n a w a y , 1935];8-mcthoxybcnzo- 
[ajpyrcne [ C o o k  and S c h o e n t a l , 1952]), in the present case, 
11-methoxy substitution induces carcinogenicity in an otherwise 
inactive ketone; moreover, the 11-acetoxy ketone 4 is also weakly 
active. Steroid-like compounds bearing an additional methyl group 
at C-l 1 are unknown as natural products and biosynthetic pathways 
leading to such compounds, for instance by abnorm al cvclization 
of squalcnc or by one-carbon methylation of a preformed tetracyclic 
structure, are without precedent. On the other hand, 11-oxygenatcd 
steroids are of widespread occurrence, and our attention is focussed 
upon the 11-mcthoxy- and 11-acetoxy- 17-kctoncs which not only 
possess the steroid ring system, but also bear oxygen atoms at two 
of the positions commonly oxygenated in several classes of steroid 
hormones. I t  would seem quite possible, on the basis of the bio­
synthetic scheme outlined above, that such 1 i-oxygenated steroids 
might give rise to 11-oxygcnalcd or/pen ta[a]phonanthrcnes in vivo.
3 Gookbs: U npublished observations.
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I t  is now well established that chemical carcinogens are produced 
by a variety of plants and microorganisms [ R o e  and L a n c a s t e r , 
1964], and it seems possible that a  similar state of affairs may also 
exist in animals. This could explain the carcinogenicity shown by 
extracts of various animal and hum an tissues [see, for example, 
H ig g in s o n , D u n n  and S u t t o n , 1964]. The hypothesis advanced 
by C o o k  [1933], that endogenous carcinogens produced by abnor­
mal steroid metabolism could explain the occurrence of spontaneous 
anim al neoplasms, is still valid. I f  such an abnorm ality were under 
genetic control like other inborn errors of metabolism, it could 
account for the strong genetic influence found in inbred strains of 
mice on spontaneous tumour production, a fact which cannot be 
entirely accounted for on the basis of known environmental, 
hormonal or viral factors. The present work clearly shows that 
strong carcinogenic properties are associated with relatively simple 
arom atic compounds which are closely related in chemical structure 
to the natural steroids; moreover, m odern steroid biochemistry 
indicates possible pathways by which such compounds could arise 
in vivo. While g)>r/opcnta[a]phenanthrenes from natural sources have 
so far not been identified, it seems im portant to enlarge our knowl­
edge of the structural limits associated with carcinogenicity in 
this field as a first step towards ascertaining whether compounds 
of this type have significance in spontaneous m alignant disease.
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Potentially Carcinogenic C yclopenta[a]phenanthrenes (1,2-Cyclopenteno- 
phenanthrenes). Part I. A New Synthesis o f 15,16-Dihydro-17-oxo- 
cyclopenta[a]phenanthrene and th e  P henanthrene Analogue o f 18- 
Norcestrone M ethyl Ether
By M. M. Coombs
1 5 ,1 6 -D ih y d ro -1 7 -o x o cy clo p en ta [a]p h en an th ren e  and  its 3 -m ethoxy . 11 - an d  12-m ethy l, and 11 .1 2 -d im eth y l 
derivatives have been syn thesised  by arom atisation  of th e  3 -u n su b stitu ted  and  3 -m eth o x y -1 1 .17 -d ik e to n es  in 
w h ich  rings c  and o are bo th  sa tu ra ted ; the  m echanism  of th e  arom atisation  is d iscu ssed .
R e n e w ed  interest in 1,2-cyclopentenophenanthrene 
(16,17-dihydro-15//-cyclopenta[a]phenanthrene) (IX) 
has arisen in connection with the carcinogenic properties 
of certain members of this series structurally related to 
the natural steroids,1*2 and it became of interest to 
devise syntheses of derivatives oxygenated at positions 
3 and 17 (steroid numbering). Although several syn­
• The trans configuration of the c /d  ring junction is assumed 
throughout (see Chinn el al.u).
theses of the 17-oxo-derivative (Via) have been de­
scribed, they are not readily adapted to the preparation 
of nuclear-substituted derivatives. It has now been 
found that the diketones (la) and (lb),* obtained by
1 H. Dannenberg, D. von Dresler, and H.-G. Neumann. 
Annalen, 1960, 636. 74.
* H. Dannenberg. Z. Krebsforsch., 1960, 63. 623.
* (a) A. Koebner and R. Robinson, J . Chem. Soc., 1938, 
1994; (b) A. J. Birch, R. Jaeger, and R. Robinson, ibid., 1945, 
582; see also (c) L. J. Chinn. E. A. Brown, R. A. Mikulec, and 
R. B. Garland. J . Org. Chem., 1962, 47. 1733.
Robinson from furfuraldehyde and 2-acetyl- and 
2-acetyl-7-methoxy-naphthalene, respectively, can be 
employed with advantage for the preparation of the 
required 17-oxo-derivative. _A_preliminary report- of 
this work has appeared.4
Selective ketalisation of the 17-carbonyl group in the 
diketone (la) was achieved by acid-catalysed exchange 
with ethylmethyldioxolan to give the oxo-ketal (Ila) in 
good yield. Under comparable conditions the 3-meth- 
oxy-diketone (lb) was converted into a mixture of the 
17-monoketal (lib) and the 11,17-diketal (IVb); the 
corresponding diketal (IVa) was also obtained from (la) 
by prolonged exchange. These diketals were readily 
partially hydrolysed to the 17-monoketals with chloro­
form containing a trace of hydrochloric acid. The 
monoketals (Ila) and (lib) exhibit typical aryl ketone
R2 ° ^ °
(la: R - H )  
(lb: R -  OMe)
(Ila: R1 -  R2 -  H)
(l ib: R1 -  OMe, R2 -  H)
( l ie :  R1 -  H, R2 -  Me)
(lid: R1 -  H, R2 •= CHO) 
( l ie :  R1 -  H, R2 -  CH2-OH)
(I lia :  R' -  R * H)
(111b: R1 -  OMe, R2 * H)
(I I Ic : R* -  H ,R 2 -  Me)
(H id : R1-  H ,R 2 = CH2*OH).
(Va: X -  O)
(IVa: R 
(IVb R
<Vb: X < H ) OH '
O
VI) R1 R2 R1
a: H H H
b: OMe H H
c: H Me H
d: H H Me
e: H Me Me
f: H H OMe
(Vc: X
(Vd: X -  H2)
infrared absorption at 6*0 ^ and have ultraviolet spectra 
closely similar to those of the parent diketones. The 
diketals (IVa) and (IVb), on the other hand, lack infra­
red carbonyl absorption, while (IVa) has 229 and 
280 mu, characteristic of the unconjugated naphthalene 
chromophore in cyclopenta[a]phenanthrenes having
4 M. M. Coombs, Chem. and Ind., 1965, 270.
* W. S. Johnson and J. W. Peterson, J . Amer. Chem. Soc., 
1945, 67. 1366.
rings c and d saturated. Reduction of the oxo-ketals 
(Ila) and (lib) with sodium borohydride furnished the 
corresponding 11-hydroxy-17-ketals (I I la) and (Illb) as 
epimeric mixtures-which were-not further separated.
When (Ilia) was boiled with acetic acid containing 
hydrochloric acid, instead of the expected product of 
dehydration and deketalisation, namely (Va), a mixture 
of (Via) and its tetrahydro-derivative (VII) was ob­
tained. Since this result pointed to the mutual oxidation- 
reduction of a common intermediate, the dehydration 
was repeated in the presence of a large excess of nitro­
benzene; as expected, the fully oxidised product (Via) 
was now obtained as the sole isolated product, in 86% 
yield. Under these conditions, with nitrobenzene and 
acid, the ll-hydroxy-3-methoxy-compound (Illb) gave 
the ketone (VIb), the phenanthrene analogue of 18-nor- 
cestrone methyl ether, in 84% yield.
The diketone (la) was reduced with borohydride 
to the corresponding diol which was then heated with 
nitrobenzene and acid, as above. The product, however, 
was a complex mixture, chromatography of which 
yielded the unsaturated alcohol (Vb) as the main com­
ponent (approximately 30% yield). A small amount of 
(IX) contaminated with the corresponding 15,16-de­
hydro-compound was also isolated, but only a trace of 
the expected 15,16-dihydro-17-hydroxycyclopenta[a]- 
phenanthrene was detected. Compound (Vb) had 
239 and 315 mji, characteristic of structure (IX) having 
additional hydrogen atoms at the c/ d  ring fusion 
positions (13;14); on catalytic reduction, followed by 
reoxidation of the saturated alcohol with the Jones re­
agent, the ketone (VII) was isolated, identical with that 
obtained above. Oxidation of the alcohol (Vb) with the 
Jones reagent gave the ketone (Va) in low yield, while 
oxidation with an excess of chromium trioxide in 
pyridine did not afford (Va), but (Via) was readily 
isolated (68%). The unsaturated ketone (Va) was better 
prepared from the hydroxy-ketal (I I la) through its 
tosylate which, on elimination, gave the ketal (Vc). 
Mild acid hydrolysis of the latter then led to (Va). This 
compound was very sensitive to acids and disproportion- 
ated completely to (Via) and other products when the 
mild acid hydrolysis was prolonged. When the un­
saturated ketal (Vc) was heated with nitrobenzene and 
acid, as described above, the sole product was (Via) 
(91% yield); in the absence of nitrobenzene the yield 
was 43%. The compound (VII) was isolated (36%), 
together with its 13,14-dehydro-derivatives’6 (22%), 
presumably formed by acid-catalysed isomerisation of 
the 13,14-dihydro-17-ketone to the fully conjugated
11,12-dihydro structure.
I t therefore appears that a 17-carbonyl group is 
necessary for the easy dehydrogenation of the 13,14-di- 
hydro-compounds. In order to investigate this further, 
compound (Villa) 7 was prepared and reduced to the
• A. L. Wilds, L. W. Beck, W. J. Close, C. Djerassi, J. A. 
Johnson, T. L. Johnson, and C. H. Shunk, J . Amer. Chem. Soc., 
1947. 69. 1985.
7 A. Butenandt, H. Dannenbcrg. and D. von Dresler, Z. 
Naturforsch., 1946, 1, 151.
corresponding alcohol. The latter was then heated with 
acid, both with and without added nitrobenzene. The 
products from both reactions were similar complex, 
mixtures consisting of about ten separate compounds as 
judged by thin-layer chromatography. The three least 
polar compounds were isolated and identified; from both
(V II )
X*
/ / V  
f III '1
(Villa : X -  O)
(VIII b :
\/»X
(VIIIc : X II X
Me Me 1 • Nv/ O O
O H /
Me Q
(X a :  X «  O ) 
M .
( X b : x = <  >
O H /
Me Me
(XII)
experiments these were (VIIIc), (Vd), and (IX), in 
yields of 14, 3, and 20% (from reaction with PhN 02), 
and 14, 10, and 20% (without PhN02). Thus, although 
limited aromatisation occurs, the extent to which it 
does so is not influenced by the addition of nitrobenzene, 
as is the case with the ketone (Va). With this compound 
it is suggested that dehydrogenation is initiated by ab­
straction of a hydride ion from C-14 in the enol (XIII), 
followed by bond rearrangement and the eventual loss 
of the second hydrogen atom as a proton. Further 
evidence for this mechanism is presented below.
-H
(XIII)
-H
(Via)
Methylation of the oxo-ketal (Ila) with methyl iodide 
and potassium t-butoxide gave mixtures of the 12-methyl 
(lie) and 12,12-dimethyl (Xa) derivative depending on 
the ratios of reagents employed; methylation with 3 
equivalents was most satisfactory, producing (lie) in 
62% yield. The ultraviolet spectra of (lie) and (Xa) 
closely resembled that of the unsubstituted compound 
(Ila). The structure of (Xa) was further substantiated 
by the presence of its nuclear magnetic resonance
(n.m.r.) spectrum of two unsplit methyl signals at 
t 8-64 and 8-82. Both 12-methyl derivatives exhibited 
ja marked tendency, probably associated with their cage­
like structures, to occlude solvents, and reproducible 
analytical figures were obtained only after sublimation. 
These ketones also resisted reduction by borohydride, 
but were smoothly reduced to the corresponding 
alcohols (IIIc) and (Xb) with lithium aluminium hy­
dride. In line with previous results, when (IIIc) was 
heated with nitrobenzene and a mixture of acetic and 
hydrochloric acids, the ketone (VIc) was produced in 
76% yield.
Condensation of the oxo-ketal (Ila) with ethyl 
formate in the presence of sodium ethoxide afforded the 
formyl compound (IId) in high yield. This bright 
yellow substance behaved as a typical 0-dicarbonyl 
compound, dissolving readily in aqueous sodium 
hydroxide and exhibiting infrared carbonyl absorption 
at 6*24 and 6*3 |i. Attempted 12-methylation of its 
potassium salt with methyl iodide was unsuccessful, 
giving only the retro-aldol product (Ila). Reduction 
with lithium aluminium hydride gave the diol (Hid), 
while catalytic hydrogenation stopped after the uptake 
of 1 mol. of hydrogen, with the formation of the 12-hydr- 
oxymethyl-11-ketone (He). The reaction of the diol 
(Hid) with acids was studied in the expectation that 
double dehydration would occur to provide an altern­
ative route to (Vic). When the diol was boiled with 
acetic and hydrochloric acids this compound was indeed 
formed as the main product (45%). However, when the 
reaction was conducted in the presence of an excess of 
nitrobenzene, a second major product, C^H^C^, was 
isolated in addition to (VIc). This showed a single aryl 
ketone infrared band, and its ultraviolet spectrum was 
almost identical with that of (VIc). It is therefore 
assigned the dimeric ether structure (XVI), and its 
formation is considered to involve the carbonium ion 
(XV). In the absence of an oxidising agent, a  proto­
tropic shift from C-14 in the initially formed ion (XIV), 
followed by bond rearrangement and the expulsion of a 
proton, leads to (VIc). In the presence of nitrobenzene, 
rapid abstraction of a hydride ion from C-14 in (XIV) 
leads, by the previously discussed mechanism, to the 
relatively stable ion (XV) which then attacks a second 
molecule of hydroxymethyl compound to give (XVI).
Treatment of the oxo-ketal (Ila) with an excess of 
methylmagnesium iodide, followed by chromatography 
of the product on alumina, gave two substances, identified 
by spectroscopy as the ll-methyl-ll-en-17-one and its 
ethylenedioxy-derivative. By heating these with nitro­
benzene and acid as usual, the ketone (VId) was formed 
in 69% yield.
For the preparation of the dimethyl compound (Vie), 
the methyl-oxo-ketal (lie) was treated with methyl- 
lithium, and the crude product heated with nitrobenzene 
and acid. Chromatography of the reaction product then 
furnished the ketone (Vie) in 72% yield, together with a 
small amount of a compound C19H180 . The structure
(XI) is assigned to the latter on the following grounds.
The ultraviolet spectrum showed, in addition to maxima 
at 271 and 281 mu characteristic of the unconjugated 
naphthalene chromophore, strong absorption at 255 mp. 
The latter was attributed to the a(J-unsaturated ketone 
which was also indicated by strong infrared bands at
H2C OH
(XIV) CH:
(XV)
CH;
01
(XVI)
5*88 (conjugated C=0) and 6-1 p (conjugated double bond, 
intensity enhanced by cis configuration). The n.m.r. 
spectrum confirmed this structure, with two 3-proton 
doublets at * 8*63 ( /  =  8 c./sec.; secondary 11-methyl 
group), and at 7-55 (7 =  3 c./sec.; 12-methyl group, 
adjacent to double bond). As expected, (XI) resisted 
hydrogenation over palladised charcoal; with Adams 
catalyst, rapid reduction of the ketone was accompanied 
by disappearance of the 255 mp absorption band and 
followed by very slow saturation of the tetrasubstituted 
double bond without further change in the ultraviolet 
spectrum.
The ketal (Xb) was also treated with nitrobenzene and 
acetic-hydrochloric acid in the expectation that (Vie) 
would be formed through dehydration accompanied by a
I,2-shift of a methyl group to C-ll. Compound (Vie) 
was, in fact, obtained in low yield on prolonged heating, 
but a product formed in larger amount was a ketone 
(XII), CjgHjgO, isomeric with (XI). The ultraviolet 
spectrum of this compound was closely similar to that of
II,12-dihydro-(IX). In addition, the non-aromatic 
region of the n.m.r. spectrum consisted of a 6-proton 
singlet at t 8*68 (two geminal methyl groups) and a
2-proton singlet at 6*86 (benzylic methylene group 
adjacent to a quaternary carbon atom), together with 
asymmetrical multiplets at approximately 7*1 and 7-3 
arising from the C-15 and C-16 methylene groups, 
respectively. The equivalence of the two methyl 
groups indicates that rapid inversion occurs at C-ll and 
a t C-12. The fact that the dihydro-ketones (XI) and
(XII), in which enolisation cannot occur towards the 
C-13 bridgehead, are not further dehydrogenated by 
nitrobenzene in acetic-hydrochloric acid provides further 
support for the mechanism proposed above for this 
aromatisation. The formation of these compounds as 
by-products in reactions leading to (Vie) probably 
reflects the strain introduced by steric compression of 
the methyl groups in the intermediate 11,12-dimethyl- 
11-ene. That this strain persists in (Vie) is demonstrated
by the relative shielding of the methyl resonance in this 
compound with that in both the 11- and 12-methyl 
compounds. Cross and Durham 8 recently reported 
that in 15,16-dihydro-3-hydroxy-l,17,17-trimethylcyclo- 
penta[a]phenanthrene absorption of the protons of the
I-methyl group, which is sterically equivalent to the
II-methyl group in (Vld), also occurs at x 7*00, and they 
attribute this low-field absorption to strong deshielding 
by all three proximate aromatic rings. The methylene
Table 1
N.m.r. spectra (x-values) of 17-oxocyclopenta- 
[o]phenanthrenes (VI)
CH, protons Me
C-16 C-16 protons
: (Via) 6-72t 7-3m —
<1 '~t_ (VIc) , 6-72t 7-3m • 7-18s(3H)
I f  -  ^ ( V ld )  . . . 6-77t 7-32m 7-00s(3H)
/  - - ( V i e )  .... .. 6-83t 7-3m • 7-25s(6H)
s =  singlet, t =  triplet, m =  multiplet. 
* Partly obscured by methyl singlet.
T able 2
Infrared and ultraviolet absorption maxima of 
17-oxocyclopenta[a]phenanthrenes (VI)
vm«. (p)
(Via) 6-92 (C=0). 11-48, 11-82, 12-40, 12-86, 13-22, 14-18
(VIb) 6-92 (C=0), 11-42, 12-38, 13-04
(VIc) ‘ 6-92 (C=0). 11-36, 12-32, 12-70, 13-20
(Vld) 5-92 (C=0). 11-40, 12-28, 13-34, 14-00, 14-62
(Vie) 6-94 (C=0), 11-40, 12-38, 13-26, 14-00
(Vlf) * 6-88 (C=0), 11-30, 12-30, 13-32
^ox>. (mp) (log c)
(Via) 218(4-18), 266(4-89), 284(4-62), 296(4-38), 334(3-24),
350(3-40), 367(3-44)
(VIb) 218-220(4-21), 269sh(4-78), 277(4-83), 319(4-22), 
347sh(3-62). 366(3-28),
(VIc) 219(4-18), 268(4-85), 286(4-42), 299(4-36), 340(2-96),
355(3-22), 373(3-28)
(Vld) 222(4-11), 264(4-83), 288(4-49), 301(4-32), 342(3-11),
358(3-38), 376(3-43)
(Vie) 218(4-09), 268(4-88), 292(4-45), 304(4-32), 349(3-05),
366(3-34), 383(3-40)
(Vlf) * 214(4-21), 261(4-86), 292(4-42), 303(4-29), 346(3-42),
363(3-72), 381(3-82)
* M. p. 184°; prepared according to R. Robinson, J .
Chem. Soc., 1938, 1390.
protons are assigned to the 15- and 16-positions as shown 
by analogy with those in (IX). This compound exhibits 
two multiplets in the methylene region, at x 6-85 and 
7*75, the areas of which are in the ratio 2 :1 . It there­
fore follows that the lower figure is associated with the 
magnetically near-equivalent C-15 and C-17 protons, 
while the C-16 protons absorb at x 7*75.
The ultraviolet and infrared absorption maxima of 
the ketones (Via—e) and the 11-methoxy-derivative 
(Vlf) are in Table 2. Introduction of a 12-methyl 
group produces the expected small bathochromic shift 
of the maximum, but the 11-methyl and 11-methoxy- 
ketones appear to be anomalous in this respect.
EXPERIMENTAL
Thin-layer chromatograpny (t.l.c.) was carried out using 
plates coated with silica gel (Merck, Kieselgel G) and dried
• A. D. Cross and L. J. Durham, J . Org. Chem., 1965, 30, 
3199.
overnight in air. Melting points were determined mostly 
on a hot-stage apparatus. Solutions were dried over 
anhydrous sodium sulphate. Ether refers to AnalaR 
diethyl ether, and silica gel was the MFC grade supplied 
by Hopkin and'W illiam s. Ultraviolet spectra (log c in 
parentheses) were recorded for ethanol solutions using a 
Perkin-Elmer 137UV instrument. Infrared spectra were 
recorded on a Perkin-Elmer 137 Infnicord, and refer to 
Nujol mulls unless otherwise stated. N.m.r. spectra were 
recorded on a Varian A60 spectrometer for deuterio- 
chloroform solutions with tetramethylsilane as internal 
standard.
17.11-E thylenedioxy-11,12.13,14,15,1 G-hexahydro-11 -oxo- 
cyclopenta[a.]phenanthrene (Ila).—The diketone (la) (46-1 g.), 
m. p. 120° (lit.,’ 116°), 216 (4-61), 248 (4-33), 315 (3-82) 
mF. W  6’78' 6’98 t1* was heated under reflux with ethyl- 
methyldioxolan (220 ml.; b. p. 117— 118°) and toluene- 
/>-sulphonic acid (100 mg.) using a short fractionating 
column equipped with a take-off head. The volatile pro­
ducts were very slowly distilled off through the side-arm, 
and small amounts of fresh catalyst were added from time to 
time. After about 20 hr. the temperature of the vapour 
was constant at 117°. The reaction mixture was cooled, 
extracted with sodium hydrogen carbonate solution, 
washed with water, and dried. After removal of the excess 
of the dioxolan in  vacuo, the brown gum was crystallised 
from benzene (60 ml.) and hexane (60 ml.), giving a first 
crop of crystals (31-9 g.), m. p. 93— 95°, and a second crop 
(11*3 g.), m. p. 84— 90°, of less pure material. The com- 
po u n d  (Ila) crystallised from ethanol in prisms, m. p. 98° 
(Found: C, 77*85; H, 6*25. CxtH wO requires C, 77*5; 
H. 6-15%). X ^  216 (4*58), 245 (4*31), 313 (3*81) mp,
6*05 |i. The bisethylenedioxy-com pound  (IVa) was also 
isolated b y fractional crystallisation from the products of a 
reaction in which the heating had been prolonged. This 
compound, m. p. 170° (from ethanol) (Found: C, 74*5; 
H, 6-8. C,0H tlO4 requires C, 74*35; H, 6*55%), X ^  
229 (4*92), 280 (3*75) mp, showed no carbonyl absorption 
in the infrared. When (IVa) (3*5 g.) was shaken for 3 min. 
with chloroform (50 ml.) containing 5 drops of conc. hydro­
chloric acid and worked up as before, (Ila) (1*95 g.), m. p. 
95°, was recovered.
17.11-E thylcnedioxy-11,12,13,14,15,IG-hcxahy dro-Z-meth- 
oxy-ll-oxocyclopenta[a.]phenanthrenc ( lib ).—The diketone 
(lb) (10*8 g.). m. p. 133° (lit.,3 126— 127°), Xmi30 221 (4*60), 
249 (4*32), 315 (3*72) mp, vw l  5*8, 6*0 p, was treated with 
ethylmethyldioxolan as described above. Fractional 
crystallisation of the product from ethanol-ether afforded 
the derivative (lib ) (4*0 g.), m. p. 114° (from ethanol) 
(Found: C, 74*3; H, 6*1. Cl0H MO4 requires C, 74*0;
H* 6*2%). W  221 (4’65)* 246 (4‘49)* 310 (3‘76) Vma*. 
6*0 p, together with the bisetkylenedioxy-com pound  (IVb)
(3*8 g.), m. p. 174° (Found: C, 71*35; H, 6*7. CltH ,40 8
requires C. 71*7; H, 6*55%). When (IVb) (2*68 g.) was
shaken with chloroform containing hydrochloric acid
as before, crystallisation of the crude product from ethanol
furnished (lib ) (1*96 g.), m. p. 108°.
M ethyla tion  o f  the Oxo-ketal (Ila).—The oxo-ketal (Ila) 
(20*25 g.) was boiled under reflux for 15 min. with t-butyl 
alcohol (640 ml.) containing potassium (8 06 g., 3 equiv.) 
under an atmosphere of pure, dry nitrogen. After being 
cooled to 25°, methyl iodide (13 ml., 3 mol.) was added 
in one lot with vigorous stirring, and cooling was maintained 
so that the temperature of the mixture did not rise above 
27°. After being kept at room temp, for 5 hr., the mixture
was poured into water (1*5 1.) and extracted with ether 
(total, 1 1.). The extracts were washed with water, dried, 
and evaporated, to give a brown syrup (22 g.) which was 
chromatographed on a column of alumina (1 kg.); 100-ml. 
fractions were collected. Fractions 17— 41 (ether) were 
combined (14*56 g.); crystallisation from a mixture of 
benzene (20 ml.) and hexane (30 ml.) yielded the m ethyl- 
oxo-ketal (lie ) (11 g.), m. p. 120— 121°. A specimen sub­
limed at 120°/10'* mm. had m. p. 123— 124° (Found: 
C. 77*6; H, 6*5. C ^ o O ,  requires C, 77*9; H, 6*55%), 
X ^  217 (4*61), 240sh (4*32), 310 (3*81) mp, 6*0 p. 
Fractions 46— 78 (ether) (2*3 g.), on recrystallisation from 
hexane, gave the starting material (Ila) (2 g.), m. p. 93— 
94°. Fractions 11— 15 (1 :1  ether-hexane) crystallised 
from hexane to yield the dim ethyl-oxo-ketal (Xa) (1*45 g.), 
m. p. 162— 164°. After two recrystallisations this sub­
stance had m. p. 167°, X ^  217 (4*35), 244 (4*14), 306 (3*59) 
mp, vm l 5*94 p; a correct analysis was obtained only after 
sublimation at 150°/10*4 mm. although this did not alter 
this m. p. (Found: C, 78*2; H, 6*85. C^H^O, requires 
C, 78*2; H, 6*9%). Rechromatographv of fraction 16 
(0*93 g.) and various mother-liquor residues (3*58 g.) 
afforded additional (lie) (2*1 g.) and (Xa) (0*24 g.). The 
yield of (lie )  (61*7%) was lower when less than 3 mol. of 
potassium butoxide and m ethyl iodide were employed; 
correspondingly more starting material was recovered. 
The amount of (Xa) increased at the expense of (lie) with  
molar ratios greater than 3.
17,11-E thylenedioxy-12-form yl-11,12,13,14,15,16-hexa- 
hydro-1 l-oxocyclopenta[a!\phenanthrenc (lid ).—To methanol- 
free sodium methoxide (from 0*5 g. of sodium) was added the 
oxo-ketal (Ila) (2*94 g.), ethyl formate (1*61 ml.), and dry 
benzene (15 ml.). The flask was filled with dry nitrogen, 
sealed, and set aside at room temperature for 48 hr. W ater 
was added to dissolve the yellow solid which filled the liquid, 
and the deep yellow aqueous solution was extracted 
once with ether. The solution was brought to pH 7*5 by 
the cautious addition of dilute acetic acid, and the yellow  
precipitate was collected, dried, and crystallised from hot 
n-butanol. The fo rm y l derivative  (lid ) was obtained as 
large yellow prisms (2*74 g.)# m. p. 144— 145° (Found: 
C, 74*45; H, 5*75. C,0H lgO4 requires C, 74*5; H, 5*65%), 
Xm»x. 218 (4‘54)« 254'5 (4‘13)- 362 (3*87) m F . W  6*24. 6*3 p.
For attempted methylation, ( lid ) (1*07 g., 3 mmoles) 
was heated with t-butyl alcohol (30 ml.) containing potas­
sium (0*375 g.). To the bright yellow suspension of the 
potassium salt was added m ethyl iodide (1*42 g., 10 mmoles), 
and the mixture was boiled gently for 22 hr. The almost 
colourless solution containing pale fawn solid was poured 
into water and extracted with ether. Evaporation of the 
dried extract left a brown syrup (1 g.) which on crystall­
isation from hexane (30 ml.) gave the unmethylated oxo- 
ketal (Ila) (0*68 g.), m. p. and mixed m. p. 96— 98°.
\5 ,\G -D ihydro-\l-oxocyclopenta\& \phenanthrene  (Via).—  
B y  the general procedure. The oxo-ketal (Ila) (6*2 g.), 
tetrahydrofuran (40 ml.), water (10 ml.), and sodium  
borohydride (2 g.) were heated under reflux w ith stirring 
for 5 hr., then left at room temp, for 20 hr. The excess of 
reducing agent was destroyed by the careful addition of 
dilute acetic acid to bring the pH to 6*5, and, after the 
addition of more water, the mixture was extracted with  
ether, the extract was washed with sodium hydrogen 
carbonate solution and water, and dried. ‘ Removal of the 
solvent left a semi-crystalline mass (6*15 g.) which showed 
no infrared carbonyl absorption.
This material was dissolved in a mixture of glacial 
acetic acid (120 ml.) and nitrobenzene (30 ml.); addition 
of conc. hydrochloric acid (30 ml.) produced a green 
coloration which became yellow-brown after being 
heated for a few minutes." Heating under reflux was con­
tinued for 30 min., the mixture was diluted with water, 
and the nitrobenzene was removed by distillation in steam. 
When cold, the brown solid was dried (4-2 g., 85- 8%),.m. p. 
197°. Recrystallisation from benzene (150 ml.; charcoal) 
yielded the ketone (Via) as very pale yellow needles (3-6 g.), 
m. p. 203—204° (lit.,* 200—201°) (Found: C, 87-8; H. 5*2. 
Calc, for C17H n O: C, 87*9; H, 5*2%).
B y  the general procedure, but with om ission o f  nitrobenzene. 
The oxo-ketal (Ila) (1-0 g.) was reduced with sodium 
borohydride as described above. The product was dissolved 
in acetic acid (80 ml.) and boiled for 1 hr. with conc. 
hydrochloric acid (20 ml.), to give a yellow solution. After 
removal of the solvent in  vacuo the residue was dissolved 
in benzene (20 ml.) and chromatographed on alumina 
(90 g.). The initial fractions, eluted with 0-1% methanol in 
benzene and together weighing 148 mg., were recrystall­
ised from light petroleum (b. p. 60—80°) (20 ml.), to give 
the ketone (VII) (88 m g.),m .p. 115° (lit.,* I l l — 112°) (Found: 
C. 86*45; H. 6*85. Calc, for C17H uO: C. 86*4; H, 6*85%). 
Xnmx. 228 (5*92), 2®0 (3*82) mp, 5*8 p. Later fractions 
(513 mg., eluted with 0*3% methanol in benzene) were 
recrystallised from benzene, to furnish (Via) (273 mg.), 
fn. p. 201—202°.
\5,lG -D ihydro-Z-m ethoxy-\l-oxocyclopcnta\a)phenanihrcne  • 
(VIb).—The methoxy-oxo-ketal (lib ) (5*65 g.) was sub­
mitted to the general procedure described above. The 
crude product (4*8 g.). m. p. 192— 197°, crystallised from 
benzene (200 ml., charcoal), to give the methoxy-ketone 
(VIb) (3*83 g., 83*7%), m. p. 208—214°; the analytical 
sample showed a double m. p. at 209 and 230° (Found: 
C, 82*7; H, 5*2. CwH uO, requires C, 82*5; H, 5*4%).
Treatm ent o f  \ \ , \2 ,\Z ,\ \ , \5 ,\G -H c x a h y d r o - \ \ ,n -d ih y d r -  
oxy-\5H-cyclopenta[sC\phenanthrene with Nitrobenzene and  
A c id .—The dikctone (la) (5*0 g.) was reduced with sodium  
borohydride (5*0 g.) in tetrahydrofuran (100 ml.) and water 
(20 ml.) for 17 hr. under reflux. The pale yellow solution 
was poured into water (600 ml.), acidified with 2N-hydro- 
chloric acid, and the gum extracted with ether. On evapor­
ation, the dried solution yielded a glassy solid (5*1 g.) which 
lacked infrared carbonyl absorption.
This diol was treated with nitrobenzene and acid by the 
general procedure. After removal of the nitrobenzene by  
distillation in steam, the brown oil was extracted with ether, 
and the solution washed, dried, and evaporated, to give an 
oil which exhibited strong infrared ester absorption at 
6*8 and 8*1 p. It was saponified with sodium hydroxide 
(5*0 g.), in methanol (150 ml.) and water (10 ml.), for 45 min. 
under reflux. The hot solution was decanted from some dark 
resinous material (0*5 g.), poured into water (500 ml.), and 
extracted with ether. The dark gum, obtained on removal 
of the solvent from the dried extract, was chromatographed 
on alumina (Woelm, Brockmann Grade 1; 300 g.) with 
benzene containing increasing proportions of methanol. 
The first few fractions yielded an oil which crystallised . 
.(320 mg.) (A). A small amount of a mixture consisting of 
two substances (t.l.c.) was eluted with 1% methanol in 
benzene, but was not further investigated. The main 
fraction, a brown gum (3*455 g.) (B), was eluted with
1— 1*5% methanol in benzene; only a trace of material 
was obtained on further elution (up to 2% of methanol).
Fraction A was shown by t.l.c. (4 : 1 hexane-benzene) to 
consist of two substances, R v  0*85 and 0*77, both of which 
gave blue spots after being heated with sulphuric acid. 
Identical spots were given by compound (IX) and the 
”-15,16-dehydro-derivative,* respectively. Recrystallisation 
of A from methanol (16 ml.) gave crystals (85 mg.), m. p. 
127— 130°, of (IX) contaminated with a small amount of 
the 15-ene (t.l.c.). Fraction B was crystallised from 
ethanol (10 ml.) from which separated the hydroxy-com pound  
(Vb) (1*468 g.). m. p. 117— 118° (Found: C. 86*1; H, 7*0. 
C17H u O requires C. 86*4; H, 6*85%), X ^  239 (4*75), 301*5 
(3*85), 315 (3*95), 330 (3*79), 336 (3*69) mp, 3*0 and 
9*35 p (OH). T.l.c. (dichloromethane) of the mother- 
liquor revealed four spots, R P 0*60, 0*44, 0*31 (Vb), and 
0*21; the last, blue with sulphuric acid, was identical with 
that given by a sample of 15,16-dihydro-17-hydroxycyclo- 
pcnta[a]phenanthrcne * prepared by reduction of the 
17-ketone with sodium borohydride.
The unsaturatcd alcohol (Vb) (229 mg.) was hydrogen­
ated in ethyl acetate with Adams catalyst (10 m g.). When 
the calculated volume of hydrogen had been consumed 
(15 min.), the solution was filtered free from catalyst and 
evaporated to give a crystalline mass, X,  ^ 280 mp. The 
crystals were dissolved in acetone (10 ml.), and an aqueous 
solution (0*5 ml.) of chromic acid [from potassium dichrom- 
ate (5*0 g.) and 96% sulphuric acid (3*76 ml.) made up to 
25 ml. with water] was added dropwise. After 15 min. at 
room temperature, the mixture was diluted with water and 
extracted with ether, and the solution was washed, dried, 
and evaporated, to leave a crystalline residue (220 mg.). 
Recrystallisation from hexane (40 ml.) afforded the ketone 
(VII) as rosettes of needles, m. p. 114— 114*5° alone and 
when mixed with the analytical specimen.
The unsaturated alcohol (Vb) (1*10 g.) was kept a t 40° 
with a mixture of chromium trioxide (3*0 g.) and pyridine 
(90 ml.) for'22 hr. After dilution with water and addition of 
an excess of sodium pyrosulphite, the solution was extracted  
with dichloromethane. The extract was washed w ith  
dilute sulphuric acid, aqueous sodium hydrogen carbonate, 
and water, and dried. Evaporation of the solvent left a 
pale brown solid which was recrystallised from benzene to 
afford (Via) (0*74 g., 68%), m. p. and mixed m. p. 202°. 
T.l.c. revealed minor amounts of several other substances 
in the mother-liquor.
Oxidation of (Vb) (240 mg.) with chromic acid in acetone, 
essentially as described above for the saturated alcohol, 
gave a product which was shown to consist of at least eight 
substances by t.l.c. Careful column chromatography on  
silica gel with hexane-dichloromethane (2 :1 )  gave a  
chromatographically homogeneous fraction (42 mg.),
Xm, T 316 mp, which, on crystallisation from hexane, yielded  
(Va) (10 mg.), m. p. 96— 98°, the infrared and ultraviolet 
spectra of which were identical w ith those of the analytical 
sample described below.
13, l4 ,l5 ,l6-Telrahydro-n-oxocyclopcnta[a .]phcnanthrene  
(Va).—The hydroxy-ketal (I lia ) (2*5 g.) in dry pyridine 
(6 ml.) was allowed to stand a t room temp, for 72 hr. 
with toluene-/>-sulphonyl chloride (1*8 g.). After dilution  
with saturated sodium chloride solution (200 ml.) and ex­
traction with dichloromethane, the crude tosylate was ob­
tained as a brown gum (3*7 g.) by evaporation of the solvents. 
This material was boiled for 1 hr. with redistilled collidine
* See Part II (following Paper).
• D. Nasipuri and D. N. Roy, J .  Chem. Soc., 1961, 3361.
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(10 ml.). The cooled solution was diluted with ether 
(200 ml.) and quickly extracted with N-hydrochloric acid 
(200 ml.) and with sodium hydrogen carbonate solution, 
and dried. Removal of the solvent under reduced pressure 
left a crystalline solid (2-2 g.) which on recrystallisation 
from ethanol furnished cream prisms (1*12 g.). m. p. 92— 
95°. The ethylencdioxy-com pound  (Vc) formed leaflets 
(from ethanol), m. p. 90° (Found: C, 82*0; H, 6*65. 
C^HjjOj requires C, 82-0: H, 6-5%), 239 (4-81),
302 (3-89), 314 (4-00), 319 (3-84), and 336 (3*72) mp.
This ketal (250 mg.) was dissolved in tetrahydrofuran 
(25 ml.) containing 5N-hydrochloric acid (0*8 ml.). After 
8 hr. at room temp, the mixture was diluted with water 
(100 ml.), extracted with ether, and the extract washed 
with aqueous sodium hydrogen carbonate. Chromato­
graphy of the semi-solid residue (obtained by concentration 
of the dried extract) on silica gel with hexane-dichloro- 
methane (2 : 1) gave a crystalline solid (144 mg.), m. p. 85—  
90°, recrystallisation of which from hexane afforded the 
ketone (Va) (48 mg.), m. p. 95— 96° (Found: C, 87*35; H, 
6*45. C „H u O requires C, 87*15; H, 6*0%), Xma]C 239 (4*73),
303 (3*88), 316 (4 01), 330 (3*88), and 336 (3*86) mp, V|nat 
6*75 p (unconjugated C=0). In preliminary small-scale 
experiments this hydrolysis was monitored by t.l.c. When 
hydrolysis of the ketal was almost complete (about 8 hr.) 
formation of (Via) was already appreciable, and after 30 hr. 
the ketone (Va) was practically all converted into (Via) 
and two other substances less polar than (Via).
Treatm ent o f  the U nsaturated K eta l (Vc) with A cetic  and  
H ydrochloric A c id s.— I n  the presence o f  nitrobenzene. The 
unsaturated ketal (Vc) (278 mg.) was dissolved in a mixture 
of acetic acid (5 ml.) and nitrobenzene (1 ml.), and boiled 
for 30 min. with concentrated hydrochloric acid (1 ml.). 
The mixture was diluted with water, the nitrobenzene re­
moved in steam, and, when cold, the pale brown crystalline 
deposit of pure (Via) (211 mg., 91%), m. p. 202— 204°, 
collected and dried.
I n  the absence o f  nitrobenzene. The above experiment was 
repeated without the addition of nitrobenzene. The deep 
orange solution was diluted with water, extracted with  
dichloromethane, and the extracts were washed with  
sodium hydrogen carbonate solution and dried. Evapor­
ation left a yellow gum (236 mg.) which was chromato­
graphed on silica gel in dichloromethane. The first fractions 
yielded (VII) (85 mg.), m. p. 103— 108° (109— 112° when 
mixed with an authentic specimen of m. p. 114— 115°). 
Further elution gave (Via) (100 mg.), m. p. 198— 201°. 
Elution of the column with 1% ethanol in dichloromethane 
then afforded pale yellow leaflets (50 mg.) of the 11,12-di- 
hydro-derivative of (Via), m. p. 219— 221° (lit.,6 222*5—  
223*3°) (Found: C, 87*35; H, 6*15. Calc, for C17H u O: 
C, 87*15; H, 6*0%), X ^  219 (4*59), 242 (3*80), 251sh 
(4*25), 271 (4*59), 281 (4*69), 326 (4*10), 338 (4*14), and 
362sh (3*93) mp (lit.,6), vmIi 5*92 (conjugated C=0), 6*1 p 
(conjugated C=C).
D ehydration-dehydrogenation E xperim ents w ith the 
ll-H yd ro xy -co m p o u n d  (VHIb).—  The ketone (V illa )  
(1*0 g.), m. p. 115— 117°, prepared according to Dannen- 
berg,7 was reduced with sodium borohydride in the usual 
way to form the l l-o l  (VHIb) (0*98 g.). X^^ 229 and 283 mp, 
no carbonyl absorption in the infrared.
This alcohol (0*50 g.), in glacial acetic acid (10 ml.) and 
nitrobenzene (2*5 ml.), was boiled for 30 min. with concen­
trated hydrochloric acid (2*5 ml.). After dilution with  
water the nitrobenzene was removed in steam, and the gum
which had separated was extracted with ether. Evaporation 
of the washed and dried extracts gave an amber gum which 
showed 10 spots on a thin-film plate. The gum was placed 
on a column of alumina (80 gTfW oelm , Grade I, neutral), 
and the following were eluted, in this order, with hexane: 
compound (VIIIc) (73 mg.), m. p. 85— 87°; com pound  
(Vd) (14 mg.), m. p. 73— 75°; compound (IX) (100 mg.), 
m. p. 108— 117°.
When this reaction was repeated (0*48 g. of VIHb) with­
out nitrobenzene, the product appeared identical with that 
above by t.l.c., and the same three compounds were obtained: 
(VIIIc) (68 mg.), m. p. 87— 89°; (Vd) (46 mg.), m. p. 
72— 75°; (IX) (103 mg.), m. p. 110— 120°.
Recrystallisation of (VIIIc) (from both experiments, 
total was 141 mg.) from ethanol gave needles (84 mg.), 
m. p. 91— 92°, not raised by further recrystallisation 
(lit.,10 85— 87°) (Found: C, 91*65; H, 8*25. Calc, for 
Cn H u : C. 91*85; H. 8*15%), X ^  230 (4*28), 275 (3*63), 
285 (3*76), and 292 (3*54) mp.
Recrystallisation of (Vd) (total, 60 mg.) from ethanol 
followed by sublimation at 100°/10"6 mm. yielded the 
hydrocarbon, m. p. 79— 80° (Found: C, 92*5; H, 7*5. 
C17H 16 requires C, 92*7; H. 7*3%). X ^  239 (4*76), 303 
(3*84), 315 (3-91), and 337 (3-63) mp, 10*55, 11*54, 
12*15, 12*42, 13*25, 13*5, and 13*8 p.
The infrared and ultraviolet spectra of (IX) from both 
experiments were identical with those of a pure sample.
\5 ,\6-D ihydro-\2 -m ethyl-Y l-oxocyclopenta \z\phenanthrene  
(VIc).— B y  the general procedure. The methyl-oxo-ketal (lie)  
(3*0 g.) in tetrahydrofuran (90 ml.) was reduced by the 
addition of lithium aluminium hydride (3*0 g.) in small 
portions with stirring during 3 hr. at room temperature, 
and the mixture was left overnight. Excess of hydride 
was destroyed by the cautious addition of ethyl acetate, and 
the mixture was diluted with water and brought to pH 7 
with 2N-acetic acid. The reduction product was extracted 
with ether and the extract was washed and dried. Evapor­
ation of the solvent left a gum (2*37 g.) devoid of infrared 
carbonyl absorption. Treatment of this with nitrobenzene 
and acid by the general procedure gave the methyl-ketone  
(VIc) (1-80 g., 75%), m. p. 233° (from benzene) (Found: 
C, 88*1; H, 5*65. C „H u O requires C, 87*75; H, 5*75%).
F rom  the \2 -fo rm yl com pound  ( lid ), (a) The formyl 
compound (966 mg.) was suspended in ethanol (40 ml.) 
and shaken in hydrogen w ith Adams catalyst (100 mg.). 
Uptake of hydrogen was rapid at first, but became very  
slow. After filtration from the catalyst, the solution was 
evaporated, leaving a pale yellow gum, X^^ 307 (3*93) mp, 
2*94 (OH) and 5*96 p (11-carbonyl), which was reduced 
with lithium aluminium hydride (500 mg.) in tetrahydro­
furan (10 ml.) as previously described. Infrared carbonyl 
absorption was virtually absent from the spectrum of the 
product (842 mg.). Treatment of the latter with nitro­
benzene and acid by the general procedure gave a dark 
brown solid (656 mg.), t.l.c. (1: 1 dichloromethane-benzene) 
of which revealed (VIc) (R P 0*44) and a second major 
product (R P 0*50), together with several less polar spots. 
Fractional crystallisation from benzene afforded (VIc) 
(51 mg.), m. p. 208— 213° (infrared spectrum identical 
with that of the authentic material) and the R P 0*5 material, 
di-( 15,16-dihydro-\l-oxocyclopenta[di]phenanthr- 12 -ylm ethyl) 
ether (XVI) (70 mg.), m. p. 229— 233° (Found: C, 85*55; 
H, 5*15%; M , 510. C^HmC^requitesC. 85*35; H,5*15% ;
10 E. Bucha and H. Ziemer, Annalen, 1956, 601, 155.
M, 506-6), XmRX 219, 267-5, 286, 298, 338, 353, 371 m p ,  
W  6’92 (O O ),'12-32, 13-36, 13-68, 14-50 p .
(6) The formyl compound (500 mg.) was reduced with 
lithium aluminium hydride (500 mg.) in tetrahydrofuran 
(10 ml.) under gentle reflux for 8 hr. and worked up as 
before to give an amber gum (377 mg.), the infrared spectrum 
of which was identical with that of the 842 mg. (above). 
This gum was dissolved in glacial acetic acid (10 ml.) and 
boiled with conc. hydrochloric acid (2-5 ml.) for 30 min. 
After dilution with water, the mixture was extracted with 
dichloromethane, and the extract washed and dried as 
' usual, and evaporated; t.l.c. demonstrated the absence of 
products less polar than (VIc) in the residue. Chromato­
graphy of the resinous product on alumina (50 g.) with 
2 : 1  dichloromethane-benzene, furnished (VIc) (171 mg., 
45%), m. p. 230°.
\b ,\5-D ihydro~\\-m ethyl-\l-oxocyclopenta[z]phenanthrene  
(Vld).—To a solution of methylmagnesium iodide [from 
magnesium (0-61 g.), methyl iodide (4 g.), and ether (60 ml.)] 
was added a solution of the oxo-ketal (Ila) (5-88 g.) in ether 
(120 ml.) and benzene (20 ml.) under nitrogen. The mix­
ture was stirred and boiled gently under reflux for 4 hr., 
then set aside at room temperature overnight. The re­
action mixture was shaken with ice-cold ammonium chloride 
solution, and the organic layer separated, washed with 
water, and dried. The residue (6-1 g.), obtained on evapor­
ation of the solvents and still containing some unchanged
11-ketone (weak vmax 6-0 p), was chromatographed on 
alumina. Two main fractions, together weighing 3-54 g. 
and probably consisting of the An-ll-m ethyl-17-ketone (X„, 
318 mp, 5-8 p) and the corresponding 17,17-ethylene- 
dioxy-compound ( 1 ^  318 mp, no infrared carbonyl 
absorption), were elu.ted with benzene containing 0-1—  
0*6% of ethanol. This material (3*64 g.) was treated with 
nitrobenzene and acid by the general procedure, to  afford 
the meihyl-ketone (VId) as pale yellow needles (from ethyl 
acetate) (2-32 g., 69-2% based on the isolated intermediates; 
47*2% overall), m. p. 171— 172° (Found: C, 88-0; H. 
6-55%). The overall yield was 50% when the crude product 
of the Grignard reaction was heated with nitrobenzene and 
acid without previous purification.
15,lb -D ihydro-l 1 ,\2-dim ethyl-\l-oxocyclopenta[a]phcn- 
anthrene (Vie).— From  the \2-m elhyl-oxo-ketal (lie ). To a 
freshly prepared solution of methyl-lithium [from lithium  
chips (3-6 g.), methyl iodide (20 ml.), and ether (600 ml.)] 
was added a solution of (lie ) (4*20 g.) in benzene (20 ml.), 
with stirring under nitrogen. When the addition was 
complete, the mixture was boiled under reflux for 6 hr., 
and left at room temperature overnight. The mixture 
was decomposed with ice, and the organic layer dried 
and evaporated, to yield a brown gum which exhibited 
weak 11-ketone absorption at 5-95 p. This was heated 
with nitrobenzene and acid by the general procedure; 
the initial deep green coloration gradually became dark 
brown, and heating was continued for 1 hr. The brown 
oil which remained after steam-distillation was extracted 
with dichloromethane, the extract was washed with 5% 
sodium hydroxide solution, dried, and evaporated, and the 
residue was chromatographed on alumina (150 g.) with 
mixtures of hexane and benzene containing increasing
proportions of the latter. Later fractions were combined 
and evaporated, to yield the dim cthyl-ketone  (Vie) (2-57 g., 
72%), m. p. 148— 149°, raised to 149— 150° by one re- 
crystallisation from methanol (360 ml.) (Found: C, 87*65; 
H, 6-0. C19H j,0  requires C, 87-65; H, 6-2%). Earlier frac­
tions from the column were combined and crystallised from 
ethanol, to furnish cream needles of the unsaturated d im ethyl- 
ketone (XI) (424 mg.), m. p. 178° (Found: C, 87-3; H, 7-2. 
C „H lgO requires C, 87-0; H, 6-9%), X ^  228 (5-01), 255 
(4-07), 271 (3-86). 281 (3-78) mp, 5-88 (0=0), 6*1 (C=C), 
11*6, 11*8, 12-3, 13-0, 13-4, 13-6 p. This compound (40 mg.), 
in ethyl acetate (20 ml.), was not reduced when shaken with  
5% palladium-charcoal in an atmosphere of hydrogen. 
W ith Adams catalyst (6 mg.), approximately 1 mol. of 
hydrogen was absorbed in 1 h r.; a portion of the solution, 
on dilution with ethanol, then showed ^  281 mp. A 
further 70 hr. was required to complete the uptake of the 
second mol. of hydrogen, and the ultraviolet spectrum of 
the product was identical with that of the partially re­
duced material.
F rom  the dim ethyl-oxo-ketal (Xa). This compound 
(1*33 g.) was reduced with lithium aluminium hydride 
(0*75 g.) in boiling tetrahydrofuran (20 ml.) for 1*6 hr. and 
then left at room temperature overnight. The product 
obtained on working up the solution in the usual way was a 
yellow resin (1*31 g.), 2*9 p (OH); no carbonyl
absorption.
This alcohol was dissolved in a mixture of acetic acid 
(40 ml.) and nitrobenzene (10 ml.). Addition of conc. 
hydrochloric acid (10 ml.) produced a brilliant emerald 
green solution, the appearance of which was unchanged 
after being boiled for 0*5 hr. On further heating, the colour 
gradually became brown, and after 22 hr. a portion showed 
strong infrared absorption a t 6*9 p (conjugated C=0). 
The solution was diluted with water, and the brown oil 
which remained after removal of the nitrobenzene in steam  
was chromatographed on a column of silica gel (200 g.) 
with hexane containing increasing concentrations of di- 
chlor'omethane; 60-ml, fractions were collected. T.l.c. 
revealed that fractions 76— 85 contained almost pure di- 
methyl-ketone (Vie); evaporation yielded fawn needles 
(101 mg.) which, after one recrystallisation from ethanol, 
had m. p. 148— 149°. Fractions 86— 95 were mixtures 
and were not further investigated. On evaporation, frac­
tions 96— 127 gave brown crystals (180 mg.) which were 
recrystallised from ethanol to yield 11,12,15,16-tetrahydro- 
\2 ,\2 -d im e th y l-17-oxocyclopenta[a.]phenanthrene (XII) as 
prisms (112 mg.), m. p. 186— 187° (Found: C, 86*9; H, 
6*8%; M ,  252. C19H wO requires C, 87*0; H, 6-9%; 
M ,  262-3), X ^  219 (4-87), 241 (4*11), 251sh (4*16), 262sh 
(4*57), 270 (4*89), 281 (5-00), 324 (4*48), 336 (4*51), 362sh 
(4*25) m p ,  5*90 (C=0). 10*1, 12*3, 12*78, 13*22 p .
The author thanks Dr. G. F. Marrian, F .R .S., for his 
interest, and T. S. Bhatt and D . M. Carr for skilful technical 
assistance.
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'Pbtentially  Carcinogehic C yclopentafdlphenanthrenes^C T^-C ycIo-^ 
pentenophenanthrenes). Part 'II.1 Derivatives Containing Further 
U nsaturation in Ring d
By M. M. Coom bs
Substitu ted  17 -m ethy l-1 5 //-cy c lo p en ta[aJp h en an th ren es have been prepared from the  corresponding 15 .16 - 
d ihydro-17-ketones by the  Grignard reaction, and reduced to  the analogues of the  Diels hydrocarbon. The
15.16-dihydro-17-m ethylene-deriv5tive (unsubstitu ted) w as ob tained by th e  W ittig reaction. Elimination from 
th e  17 -to Iuene-p-su lphonyloxy-com pound  a t 170* gave th e  A16 -  17/7-com pound  (A), but at 100* the  A1* -  1 5/7- 
isomer w as form ed. B ase-catalysed  condensation  of (A) w ith ace tone  and aryl aldehydes yielded 17 -su b stitu ted - 
m ethylene derivatives. The chem ical shifts of pro tons a ttached  to  ring D in th ese  com pounds are listed.
A l t h o u g h  1,2-cyclopentenophenanthrene (16,17-di- 
hydro-15//-cyclopenta[a]phenanthrene) (I) is not itself 
carcinogenic, weak activity has been reported for the
11-methyl and 11,12-dimethyl com pounds1 and for 
derivatives of (I) containing further unsaturation in the 
D-ring.2 It was therefore of interest to  investigate  
whether carcinogenic potency would be enhanced b y  the 
presence of both of these structural features in the same 
molecule. The recent demonstration 3 of the presence 
of 16,17-dihydro-3-hydroxy-15//-cyclopenta[rt]phen- 
anthrepe in the pyrolysis products of natural fats makes 
the study of compounds oxygenated at positions 17, 
11, and 3 of particular relevance. The availability of a 
number of the m ethyl and m ethoxy-17-ketones b y  a 
new route 4 prompted the present investigation.
R2 Me
R1 R2 R3
a : H H H
b: OMe H H
c « H Me H
d • H H Me
e t H Me Me
f * H H OMe
Dannenberg cl al.h obtained the 17-methyl compound 
(Ilia) from the 17-ketone (Ila) by a Grignard reaction 
followed by chromatography of the crude tertiary alcohol 
on alumina, and reported the concomitant formation 
of a dimer, CggHgg. This has now been confirmed, 
and the method applied to the ketones (lib—f) to 
prepare the corresponding 17-methyl-lG-enes (Illb—f).
* P art 1, M. M. Coombs, preceding Paper.
1 A. Butenandt, H. Dannenberg, and D. von Dreslcr, Z. 
Naturforsch., 1940, 1, 153.
1 H. Dannenberg, Z. Krebsforsch., 1900, 63, 523.
The yields of the latter varied considerably (see Table 
3); since no attempt was made to isolate the dimers 
[except from the reactions with (Ila) and (Ilf)], these 
yields probably provide a rough indication of the amount 
of dimer formed. In the case of (Ilf), crystallisation of 
the crude Grignard reaction product from boiling alcohol 
gave the 11-methoxy-monomcr (Illf) in 86% yield, 
whereas the yield was only 18% when the crude product 
was chromatographed in the usual way, and much 
11 -methoxy-dimer was also isolated. It therefore appears 
that dimerisation accompanied dehydration on the 
chromatographic column, although neutral alumina 
was employed. The structure (V) suggested by Dannen­
berg for the unsubstituted dimer was confirmed by its 
nuclear magnetic resonance (n.m.r.) spectrum, which 
exhibited methyl absorption (total of 6 protons) at t  
8*23 (singlet) and 8*12 (closely spaced doublet, J  — 2 
c./sec.) together with a well-resolved 2-proton multiplet 
at 6*2 assigned to the C-15 methylene protons adjacent 
to the 16-double bond. In addition, absence of absorp­
tion in the olefinic proton region and absorption in the 
aromatic proton region closely similar to that of the 
monomer (Ilia) strengthened this evidence. Hydro­
genation of the monomers (Illb—f) furnished the 17- 
methyl compounds (IVb—f), derivatives of the Diels 
hydrocarbon (IVa); the dimer (V) resisted hydrogenation, 
as expected from the sterically hindered nature of its
16-double bond.
The ultraviolet absorption maxima of these compounds 
are summarised in Table 1. Conjugation of the 16- 
double bond causes a bathochromic shift of about 15 mix 
in the main peak, and further small shifts are caused by 
the introduction of methyl substituents into the phen- 
anthrene nucleus. Methyl and methoxy substitution 
at C-ll is anomalous as noted 4 for the ketones (lid) 
and (Ilf). The moderate-to-weak absorption bands in 
the 280—380 mjx region are particularly useful for the 
identification of the compounds in these various series. 
The strong infrared bands in the 10—15 fx region are 
also listed in Table 1.
Dannenberg et al.h reported that, when using the methyl 
Wittig reagent, the ketone (Ila) gave the 16-ene (Ilia).
8 K. Hoffclner, H. Libct, and L. Schmidt', Z. Ernaehrungswiss., 
19G4, 5 (I). 16.
4 P art 1; also M. M. Coombs, Chem. and Ind., 1965, 270.
* H. Dannenberg, D. Dannenberg-von Dresler, and H.-G. 
Neumann, Annalen, 1960, 636, 74.
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Table 1
Ultraviolet and infrared absorption maxima of cyclopenta- 
—  -"^fljphenanthreneff^IIIJandjlV) ‘
(mil) (log t)
(Ilia) .......223(4-30), 270(4-70), 276(4-73), 293-6(4-14), 316(3-74),
331(2-71), 348(2-69), 366(2-46)
(Illb) .......223(4-28), 273(4-84), 294(4-22), 304sh(4-16), 318(4-10),
338(2-92), 365(3-04), 374(3-03)
(IIIc) .......222-6(4-38). 272(4-808), 276sh(4-807), 290(4-27),
318(3-88), 349(2-71), 367(2-43)
(Illd) ......222(4-32), 270(4-70). 276-6(4-81), 295sh(4-13), 306sh
(4-13). 317(3-69), 350(2-93), 368(2-83)
(Ille) ......219(4-35), 280(4-93), 311(4-14), 355sh(2-78)
(Illf)  221(4-37), 272(4-70), 280(4-74), 287(4-63), 324(3-69).
339(3-29), 366(3-49), 374(3-57)
(IVa)  .218(4-39), 259(4-69), 280(4-07), 288(3-99), 300(4-05),
320(2-76). 336(2-86), 352(2-87)
(IVb)  212(4-42), 225(4-30), 236(4-36), 261(4-82), 282(4-20),
291(4-12), 302(3-95), 326(2-83), 341(3-16), 358(3-28)
(IVc)  217(4-63), 261(4-83), 290(4-06). 303(4-13). 321(2-57).
337(2-64), 363(2-41)
(IVd)  .219(4-45), 227(4-19), 257(4-80). 294(4-02), 306(4-07),
324(2-85), 339(3-00). 365(3-03)
(IVe)  218(4-33), 224-9(26), 261(4-71), 287(3-98), 301(3-97),
312(4-01), 343(3-17), 360(3-07)
(IVf) .......218—220sh(4-42), 228(4-45), 246-5(4-60), 252-6(4-59).
276(4-44), 298(3-96),'330(3-26). 345(3-55), 362(3-65)
n^uuc. (|^ ) >.
(Ilia) .......11-0, 11-55, 12-0, 12-3, 12-8, 13-4, 13-82
(Illb) .......10-94. 11-64, 12-22, 13-1, 13-82
(IIIc) .......10-96, 11-44, 12-28, 12-34, 13-15, 13-34
(Illd) .......‘10-9, 11-62, 12-2, 13-06, 13-32, 13-86
(Ille) .......10-9, 12-3, 13-18, 13-34, 13-64, 14-9
(Illf) .......10-92. 11-95, 12-1, 12-2, 12-55, 13-1, 13-35, 13-9
(IVa) .......11-6, 12-06. 12-36, 13-06. 13-4, 13-9
(IVb) .......11-64, 12-28, 12-46, 13-84
(IVc) .......11-6, 12-22, 13-42
(IVd) . . . . . .1L4, 12-02, 12-24, 13-28‘ 13-4, 13-94. 14-6
(IVe) ...... .11-5, 12-12, 12-66, 13-3, 13-86
(IV f)*  11-92, 12-26, 12-56, 13-3, 13-96
* Liquid film
However, in our hands the 17-m ethylene com pound (VI)
w as isolated w ithout difficulty, b ut it  isomerised to
(I lia )  in the presence of traces of acid. The ultraviolet
absorption m aximum  of (VI) (273*5 mji) was near that
of (I lia )  (276 m u), b ut in  addition (VI) also exhibited a
series of weak bands of increasing intensity at 333, 349,
and 367 mjx, unlike (I lia )  b ut similar to  those of the
ketone (Ila) which also has an exocyclic double bond at
C-17. In addition, (VI) showed the expected infrared
exocyclic m ethylene absorption at 3*25 and 6-18 jx,
absent from the spectrum  of (I lia ) . In the n.m.r.
spectrum  of (VI) signals due to  the olefinic protons
appeared at r 4*44 and 4*87 while the C-15 and C-16
m ethylene protons were represented b y m ultiplets at
6-95 and 6*75. W hen the spectrum was determined in
deuteriochloroform which had not been purified from
traces of acid, the spectrum of (I lia )  was observed. This
consisted of m ethyl absorption, a 3-proton doublet
( J  =  2 c./sec., further split) at 7*7, a 1-proton olefinic
peak at 3*55, and a well-resolved 2-proton triplet at
6-34 derived from the C-15 m ethylene group.
In order to prepare the unknown 15//-cyclopenta[a]-
* H. Dannenberg and W. Steidle, Z. Naturforsch., 1954, 9b, 
294.
7 O. SOss, Annalen, 1953, 579, 133.
8 W. E. Bachmann and M. C. Kloetzel, J . Amer. Chem. Soc., 
1937, 59. 2207.
phenanthrene, compound (Ila) was reduced with sodium 
borohydride to the 17-ol (Vila) and converted into the 
tosylat"e”(VIIb). Base-catalysed elimination with boiling 
collidine then afforded a compound, m. p. 164—165°, 
in high yield, having the same ultraviolet absorption 
characteristics as 17/f-cyclopenta[a]phenanthrene re­
ported6 for a sample of the same m. p. prepared 7
OR,
(VI)
a :
(VIII)
R -  H 
R = CHMej
c r 'r2
(VII)
R ** Tos
b :  R «  CHMez
T  1 ril i|
(X) u
H, R2 ■ Ph : as r ' - h ,
• R2 = Me bs r ’« r :
R2 «f>-NMez - c *h4
C(Me) *CHZ
Me
through decarboxylation of the 17-carboxylic acid. 
In particular, it showed the small peak-at 240 mp 
which was claimed 8 to be diagnostic of the A18 system. 
In order to confirm the identity of our compound, 16,17- 
dihydro-15-oxocyclopenta[a]phenanthrene8 was pre­
pared and reduced with borohydride. Conversion of 
the 15-ol into its tosylate, and elimination from the 
latter as before, then furnished the A18-compound (Villa) 
identical with this compound derived from the 17-ketone.
An isomeric compound, m. p. 182—183°, obtained by 
Kon 9 by selenium dehydrogenation of the phosphoric 
acid cyclisation product of 2-(2-2'-naphthylethyl)cyclo- 
pentanol and claimed to be the 15 H- or 17/f-compound 
was shown by Cook and H ew ett10 to be chrysofluorene. 
Recently Kotlyarevskii and Zanina11 isolated a 
compound, m. p. 182—182-5°, from the products of
• G. A. R. Kon, J . Chem. Soc., 1933, 1081. ‘
10 J. W. Cook and C. I. Hewett, J .  Chem. Soc., 1934, 365.
11 L. Kotlyarevskii and A. S. Zanina, Zhur. obshchei K him ., 
1961, 31, 3206.
pyrolysis of 1-(1,2,3,4-tetrahydro-l-hydroxy-l-naph- 
thyl)-2-(l-hydroxycyclopentyl)acetylene at 400—500° 
o^yer.. a^magnesia-chromia-ralumina^talyst^^hisjwas- 
claimed to be a 1,2-cyclopentadicnophenanthrene by 
reference to Kon's original Paper and by the fact that 
on hydrogenation it consumed 2 atoms of hydrogen to 
give (I). However, these authors make no reference to 
the later work of Cook and Hewett. The 15-ene (V illa), 
m. p. 164— 165°, obtained in the present work also ab­
sorbed 2 atoms of hydrogen to yield (I), but its ultra­
violet and infrared spectra differed from those of the 
Russian compound. It appeared unlikely that the latter 
was the unkown A16-isomer because this must have been 
formed initially during the elimination of the 17-tosylate, 
but apparently rearranged even at 170° to the 15-ene. 
In order to effect this elimination under milder conditions, 
use was made of dimethyl sulphoxide.12 The hydro­
carbon, isolated in very low yield after the 17-
tosylate had been heated at 100° in this solvent for a 
short time, exhibited an ultraviolet spectrum (see 
Figure) very similar to that of the 17-methyl-16-ene
•VJ.
C \
oo
a
220 240 260 280 300 320
A(njy)
Ultraviolet spectra. A, (IXa); B, (Ilia); C, (V illa)
(Ilia), but different from that pf (Villa) by the absence 
of the 240 mp peak and by the reversal of the intensities 
of the maxima at 269 and 273 mp. Moreover, judging 
from the ultraviolet spectrum of the product, this com­
pound was isomerised to (Villa) when heated at 180°. 
The same result was also observed when the elimination 
in dimethyl sulphoxide at 100° was prolonged. It is 
therefore concluded that the new hydrocarbon is the 
previously unknown (IXa). The infrared spectra of 
(Villa) and (IXa) differed only in minor details (see 
Experimental section).
Condensation of the 15-ene (Villa) with benzal- 
dehyde in ethanol containing potassium hydroxide gave 
the 17-benzylidene-15-ene (Xa). On hydrogenation, 
this compound, which showed strong light absorption 
at 328 and 383 mp, absorbed 2 mol. of hydrogen, to 
yield (XIa), the ultraviolet spectrum of which closely 
resembled that of the Diels hydrocarbon. Condensation 
of (Villa) with />-dimethylaminobenzaldehyde likewise
afforded the />-dimethylaminobenzylidene compound 
(Xc), of interest because the corresponding l-/>-dimethyl- 
^aminoindene is claimed to^xhibit:marked anti-tumour- 
activity. Condensation of (Villa) with acetone in the 
presence of potassium hydroxide did not lead to the 
isopropylidene derivative (Xb), but this substance was 
readily secured as a yellow compound (Xmfc 310 mp) 
when the condensation was catalysed by piperidine. 
A colourless isomer isolated from the potassium hydroxide 
catalysed reaction had ultraviolet absorption very simi­
lar to that of the 17-methyl-16-ene (Ilia) and is con­
sequently assigned the structure (XII). Presumably 
rotation of the isopropenyl group about the 17-single 
bond relieves steric compression with the C-12 hydrogen 
atom and deconjugates the terminal double bond from 
the ring-system chromophore. The structures proposed 
for (Xb) and (XII) were confirmed by their n.m.r. 
spectra; in the methyl and methylene regions the former 
consisted of two proton singlets at t 7*52 and 7*69 arising 
from the two non-equivalent methyl groups/ while the 
latter revealed the presence of one methyl group adjacent 
to a double bond (3-proton singlet at 8T) and the C-15 
methylene group (2-proton multiplet at 6*18). Hydro­
genation of (Xb) readily gave (Xlb), but when the 
reduction was interrupted after the uptake of 2 atoms of 
hydrogen the expected 17-isopropylidene analogue of 
(VI) was not obtained. The product instead consisted 
of a mixture of four compounds, present in comparable 
amounts. After chromatographic separation these 
proved to be starting material (Xb), the tetrahydfo- 
derivative (Xlb), and two dihydro-compounds. One 
of the latter was (IXb), from its ultraviolet absorption
Table 2
N .m .r. absorptions (t) of protons attached to the D-ring in  
cyclopenta[o]phenanthrenes
Compound C-17 C-16 C-16
(I)   6-85m(2H) 7-75m(2H) 6-85m(2H)
(V illa) 6-35m(2H) (~3-3 *)
(IVa) ... [7-0—8-6(3H) *] 6-78m(2H)
(Ilia) ... —  3-55s 6-33t(2H)
(VI) ............  — 6-95m(2H) 6-75m(2H)
(Ila)
(Xb)
7-3m(2H) 6-7m(2H)
(3-Os, 3-Is)
(XII) ...
* Unresolved;
— 3-25s 6-18d(2H)
Other protons
Me, 8-63d(3H) 
Me, 7-76d(3H) 
CH, protons 
4-44s, 4*87s
Me groups 
7-62s(3H), 
7-69s(3H)
Me, 8*ls(3H)
s =  singlet, d =  doublet, m =  multiplet.
characteristics and melting point.5 The ultraviolet 
spectrum of the other was similar to that of (V illa), 
with X^ ,* 269 and a small maximum at 240 mp, and 
it must therefore have the A16-17-isopropyl structure 
(VHIb). The ease of reduction of the tetrasubstituted 
16-double bond suggests that this also is a result of the 
relief of steric strain.
Chemical shifts of the D-ring protons in representatives 
of the various classes of compound encountered in the  
present work are summarised in Table 2.
11 H. R. Nace, J . Amer. Chem. Soc., 1959, 81, 5428.
18 C. T. Bahner, H. Kinder, D. Brotherton, J. Spiggle, and 
L. Gutman, J . M edicin. Chem., 1965, 8, 390.
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phonium bromide (14*28 g.) in tetrahydrofuran (200 ml.), 
EXPERIMENTAL and the m ixture was boiled under nitrogen for 30 min., to
Experim ental conditions are generally as described in give a clear orange solution. A fter addition of the ketone
Part I (preceding Paper). (Ila ) (4*64 g.), the m ixture was boiled underreflux in nitrogen
G rignard R eactions w ith  17-K eton es.— To a solution for 4 hr. and left overnight a t room temperature. Most
of methylm agnesium  iodide [from magnesium turnings of the so lvent (150 ml.) w as rem oved in  vacuo, the residue
(0-8 g.), m ethyl iodide (1*2 ml.), and dry ether (20 ml.)] was treated w ith water (700 ml.), the dark oil was extracted
was added the ketone (1-0 g.) in dry benzene, and the w ith  chloroform, and the solution was dried and evaporated,
m ixture was heated under reflux for 1 hr. The ether was The residual gum  was rapidly chromatographed on alum ina
then removed by  distillation, more benzene (20 ml.) w as (200 g.) w ith  benzene (1 l.j; on evaporation, the eluate
T able  3
17-M ethyl-15H -cyclopenta[a]phenanthrenes (III) prepared b y  Grignard reactions.
Yield Found (%) H Required (%)
(III) R1 R* R* M. p. (%) C H Formula C H
a  .................  H H H 209—212°* 60 — — CUH U — —
b . . . . . . . . . . . . . ......... OMe H H 204—205 J 55 87-5 6-2 C1#HuO 87*65 6*2
c  ............  H Me H 161— 162 f  28 93*15 7*05 C „H „ 93*4 6*6
d  .............. H H Me 149— 150 f 74 93*6 7*0 C „H „ 93*4 6*6
e . . . . . . . . . ................ H Me Me 126— 126*5 1 32 92*75 6*95 Ci0Hlt 93*0 7*0
f  ..................  H H OMe 159—1601 18 § 87*45 5*85 C„HuO 87*65 6*2
* From carbon tetrachloride (Found: M , 236. Calc, for ClgHu : Af, 230*3); lit.,‘ m. p. 207— 209°. The dimer was also isolated, 
m. p. 203—204° (from benzene) (lit., 192— 194°) (Found: M , 455), 261*5(4*76), 273(4*80), 283*5(4*92), 300*5(4*44), 324(4*13,
m^, Vnux.11-6, 12*32, 13*4, 13*88 p. f From ethanol. J From benzene. § (Ilf) prepared according to R. Robinson, J . Chem. Soc., 
1938, 1395, was employed. A considerable amount of dimer, m. p. 210—212° (from ethanol), was also isolated in this experiment 
(Found: C, 87*44; H, 6*25%; M , 526. CggHggOg requires C, 87*65; H, 6*2%; M , 520*6), J w  255(4*69), 274(4*87), 289(4*95), 
330(4*11), 344(3*92), 361(3*97), 377(3*72) mp. 11*6, 12*0, 12*1, 12*22, 12*54, 13*18, 13*3, 13*9 p. In a similar experiment, in 
which chromatography was omitted, the crude product crystallised from ethanol to give (Illf) (85%), m. p. 155— 168°. ^ Analytical 
samples were sublimed at 130— 160°/1 O'4 mm.
T able  4
15,16-Dihydro- 17-m ethylcyclopenta[a]phenanthrenes (IV) prepared b y  hydrogenation.
F oun d(%) J Required (%)
(IV) R* R* R* M .p . C H Formula C H
a    H H H 126*6— 127*5° * 92*95 6*95 C„HU 93*05 6*95
b ....'...... . . ...............   OMe H H 149— 160 § 87*1 6*76 ClfHuO 87*0 .6*9
c     H Me H 66—57 92*4 7*46 , CltH w 92*65 7*35
d      H H Me 6 5 -  92*65 7*6 C„Hlg 92*65 7*35
e.... ................................    H  Me Me 75—77 92*7 8*0 Cf0HM 92*3 .7*75
f...............................    H  H OMe — t 86*4 6*9 C „H „ 87*0 6*9
* Diels hydrocarbon, m. p. 125° (Harper, Kon, and Ruzicka, J . Chem. Soc., 1934, 124). f Analysed as a viscous syrup after 
molecular distillation at 80°/10** mm. J Analytical samples were sublimed at 70—80°/10'4 mm. § Lit., m. p. 146*5— 148*5 
(Cohen, Cook, and Hewett, J . Chem. Soc., 1935, 445).
added, and heating was continued for 1 hr. further. The 
cooled reaction mixture was poured into 10% aqueous 
ammonium chloride solution (50 ml.) containing 5N-hydro- 
chloric acid (1 ml.), shaken thoroughly with more benzene, 
separated without delay, and washed with sodium hydrogen 
carbonate solution. After being dried, the solvent was 
removed in vacuo, and the residue was redissolved in the 
minimum of dry benzene and chromatographed on a column 
of alumina (Woelm, neutral, Brockmann Grade I ; 100 g.) 
using a linear gradient made by continuously mixing 
benzene (1 1.) with hexane (1 1.). The 17-methyl-16-ene 
was eluted first, followed by the dimer. The compounds 
prepared in this way are summarised in Table 3.
Hydrogenation of &}*-Compounds.—  The unsaturated
compound (600 mg.) in ethanol (100 ml.) was shaken with 
Adams catalyst (50 mg.) in an atmosphere of hydrogen 
until the calculated volume of hydrogen had been absorbed. 
The catalyst was removed by filtration and washed with 
ethanol, the solution was evaporated to dryness and the 
residue was recrystallised from ethanol or otherwise as 
specified in Table 4.
15,16-Dihydro-17-methylenecyclopenta[di]phenanthrenes 
(VI).—A solution of the methyl Wittig reagent was pre­
pared as follows. A 3*4N-solution of butyl-lithium (12*0 
ml.) was added to a suspension of methyltriphenylphos-
fumished the VI-methylene compound (VI) (2*05 g.) as a 
cream solid which crystallised from ethanol (350 ml.) 
as large pale amber leaflets (1*7 g.), m. p. 217— 218° (sealed, 
evacuated capillary tube) (Found: C, 93*65; H, 6*3%; 
M, 240. C18H m requires C, 93*9; H, 6*1%; M, 230*3), 
215(4*22), 273*5(4*69), 287(4*44), 299(4*34), 307(4*09), 
333(3*08), 349(3*28), 367(3*34) mp, (CHC1,) 3*25 (exo­
cyclic CHj), 6*18, 10*62, 11*6, 12*04, 12*42, 13*42, 13*9 p.
To a hot solution of (VI) (120 mg.) in ethanol (20 ml.) 
was added 2 drops of conc. hydrochloric acid. After 1 min. 
the solution was cooled; there separated cream needles 
(62 mg.) of (Ilia ), the infrared spectrum of which was identi­
cal with that of this compound prepared by the Grignard 
reaction from (Ila).
Hydrogenation of (VI) (100 mg.) with Adams catalyst 
(10 mg.) in ethanol (25 ml.) occurred smoothly. Recrystal­
lisation from ethanol afforded Diels hydrocarbon (IVa) 
(76 mg.), m. p. 126°.
15,16 -Dihydro- 17 -hydroxycylopenta [a.]phenanthrene 
(V ila).—The 17-ketone (Ila) (2*0 g.), tetrahydrofuran 
(120 ml.), water (8 ml.), and sodium borohydride (2*0 g.) 
were heated under reflux for 5 hr., the solution was poured 
into water (1 1.), and the cream precipitate was dried in 
vacuo. The alcohol (V ila) (1*91 g.), m. p. 183— 184°, was 
dried at room temperature over phosphorus pentoxide for
2 days (Found: C, 87*0; H, 6*1. C17H l40 .  requires C,
87* 16; H, 6*0%), 269(4-77), 280(4-09), 288(3*98),
300(4-12) mp, vniax 3-15 and 9-55 (OH), 11-5, 12-28, 12-92, 
13*4, 13-85 p.
The above alcohol (1-9 g.), toluene-/>-sulphonyl chloride 
(1-7 g.), and dry pyridine (25 ml.) were kept at room temper­
ature for 24 hr. The mixture was diluted w ith . water 
(250 ml.), and the pale brown precipitate was washed with 
water and dried (2-01 g.), m. p. 167— 168°. The tosyl 
derivative (Vllb) formed leaflets (from ethanol), m. p. 178—  
179° (Found: ~ C, 74-4; H, 6-35. CMH t0OsS requires C, 
74-2; H, 6*2%), X ^  220(4-48), 259(4-83), 279(4-23), 
288(4*09). 300(4-15) mp. vM  11*4, 12-24, 12*8, 12-95, 
14*0, 14-3, 14*68 p.
17H-Cyclopenta[a.]phenanihrene (V illa ).—From the 17- 
tosylate. This compound (V llb) (440 mg.) was boiled under 
reflux with redistilled collidine (10 ml.) for 30 min. After 
dilution with chloroform (30 ml.), the solution was washed 
with N-sulphuric acid (90 ml.), sodium hydrogen carbonate 
solution, and water. Evaporation of the dried solution 
left (V illa ) (202 mg.), m. p. 159— 163°; an analytical 
sample crystallised from ethanol as pale pink needles, 
m. p. 164— 165° (Found: C, 94-55; H, 5*5. Calc, for 
C„H U: C. 94*5; H, 6*6%), Xmax 224(4-41), 239(4-24), 
269(4*72), 273*5(4*70), 292(4-17), 302-5(4-16), 314-5(4-04) 
mp1vw l 10'6, 11*0, 11*65, 12*28, 12-8, 13*36, 13*66, 14*4 p, 
(CS,) 695, 746, 762, 810 cm.-1 (measured as a 2% 
solution on a Perkin-Elmer 237 grating spectrometer).
Hydrogenation of this compound afforded (I), m. p. 134—  
135° (lit.,* 134— 135°), X ^  216(4*48), 259(4-77), 280(4*16), 
288(4*07), 300(4*17) mp, 10*62, 11*56, 12*3, 12*95, 
13*4, 14*08 p.
From IB,l7-dihydro-l5-oxocyclopenia[!L]phenanthrene. 
This ketone was prepared by cyclisation of phenanthrene-
2-propionic acid according to Bachmann and Kloetzel; 8 
it was obtained as pale yellow needles, m. p. 184— 186°, 
X ^  216(4*41), 251*5(4*68), 288(4*06), 319(4*08), 344sh(3*65), 
362(3*49) mp, 6*9 (conjugated C=0) 10*32, 10*4, 11*4, 
11*76, 11*9, 12*26, 12*92, 13*2, 13*94 p.
Reduction of this ketone (5*0 g.) with sodium borohydride 
as described above gave the 16-alcohol (4*85 g.), m. p. 
164— 165° (lit.,14 166— 167°). This alcohol was converted 
into its tosylate, and the crude material was heated with 
collidine, as described above. Chromatography of the 
elimination product on alumina with hexane-benzene (1: 1) 
then afforded (V illa ) as needles (1*08 g.), m. p. 161 and 
161— 164° when mixed with the analytical specimen derived 
from the 17-ketone. The ultraviolet and infrared spectra 
of the two specimens were superimposable.
15H-Cyclopenta[a.]phenanthrene (IXa).—The 17-tosylate 
(V llb) (5*0 g.) was kept at 100° with dimethyl sulphoxide 
(25 ml.) for 30 min. The temperature of the bath was then 
lowered to 60° and the solution was evaporated to dryness 
on an oil pump to give a solid which was triturated with 
hexane-dichloromethane (9 :1 ;  100 ml.). Chromato­
graphy of the extract on silica gel (100 g.) using this solvent 
mixture as eluant yielded crystals (149 mg.), X ^  273*5 mp, 
no maximum at 240 mp. This material was crystallised 
rapidly from warm ethanol, to give the product (IXa) 
(63 mg.), m. p. 165— 167° (with change of crystal form at 
150°) (Found: C. 94*35; H, 6*0%), X ^  220(4*45), 269 
(4*795), 273(4*81), 292(4*23), 302(4*17), 314(3*96) mp, 
W (CS2) 698, 748, 814 cm.-1 (measured as a 2% solution
14 G. M. Badger, W. Carruthers, and J. W. Cook, J. Chem. 
Soc., 1952, 4996.
on a Perkin-Elm er 237 grating spectrometer);... ;.V£hten. 
the reaction was'-lallowed to proceed a t 1 0 0 ° for 6  hr.? the 
material recovered exhibited X ^^  239 and 269 mp. The 
same result was observed when a small sample of ( IX a )  
was heated at 180° in a sealed, evacuated glas. tube for 
30 min.
17-1 sopropenyl-15H.-cyclopenta[a.]phenanthrene ( X I I ) . —
The compound (V i l la )  (100 mg.) was dissolved in acetone 
(2*0 ml.) and treated w ith  a solution (0*001 m l.) containing 
potassium hydroxide (250 mg.) in methanol ( 1*0 m l.). 
An orange colour rapidly developed, and w ith in  2 hr. 
crystals filled the liquid. The crystals (40 mg.), m. p. 
250— 266°), were recrystallised from benzene (2 m l.), to 
furnish the isopropenyl compound ( X I I )  as needles, m. p. 
255° (Found: C, 93*95; H , 6*35. C10H 1# requires C. 93*7;
H . 6*3%), X ^  223(4*40), 271(4*74), 276(4*76), 295(4*30), 
316(3*40) mp. 10*2, 10*9, 12*08, 12*38, 12*86, 13*48,
14*6 p .  .
17-Isopropylidenecyclopenta[v]phenanthrene (X b ) .—  The
15-olefin ( V i l la )  (250 mg.) was dissolved in  acetone (6*5 
ml.) containing piperidine (1 0 0  mg.) and le ft a t  room tem ­
perature in a sealed flask for 2 days. The solution became 
yellow and yellow crystals separated. The solvent was 
evaporated in vacuo and the residue was recrystallised from  
n-butanol. The isopropylidene compound (X b ) formed 
bright yellow leaflets (251 mg.), m. p. 188—-189° (Found: 
C, 93*6; H , 6*4%), X ^  214(4*44), 228(4*50), 270(4*63), 
302(4*67), 310(4*77), 346— 349sh(3*61), 364— 369sh(3*50) 
m P, vmax 6-1 (conjugated C=C) 11*66,12*0,12*14, 12*6,13*2 p.
The isopropylidene compound (23*8 mg.) in ethyl acetate 
(6  m l.) was hydrogenated using 6 %  palladium-charcoal 
(21 mg.). Uptake of 2 mol. of hydrogen was complete 
w ith in  15 min. Evaporation of the colourless, filtered  
solution, and recrystallisation of the residue from  methanol 
(1 m l.), g ive  needles (15 mg.), m. p. 97— 98° ( l it . ,18 97— 98°) 
of (X lb )  (Found: C, 92*6; H , 8*0. Calc, for Ct0H t0: 
C, 92*25; H , 7*75%), X ^  216(4*51), 259(4*79), 281(4*17), 
288(3*86), 300(4*14) mp, W  11*54, 12*38, 13*0, 13*34 p.
The isopropylidene compound (25* 1 g.) was hydrogenated 
as above w ith  2  mg. of catalyst, and shaking was interrupted  
when 1 mol. of hydrogen had been absorbed (17 m in .). 
The filtered solution was evaporated, and the pale yellow  
residue was chromatographed on a column of silica gel 
(29 x  1 cm .; 10  g.) w ith  hexane, collecting 10-m i. fractions. 
Fractions 10— 16 gave crystals (4*2 mg.), m . p. 85— 93°, 
of the saturated compound (X lb ) .  Fractions 17— 23 were 
combined, and yielded crystals (7*1 mg.), m. p. 105— 107°, 
raised to 106— 107° after one crystallisation from  methanol, 
of the isopropyl compound (V H Ib )  (Found: 93*2; H , 6*9. 
C20H 18 requires C, 93*0; H , 7*0%), X ^  221(4*66), 240(4*33), 
269(4*65). 274(4*60), 292*5(4*07), 303(4*075), 317(3*95) mp, 
W  10*30- 10'52' 10'76> 10"9» 11>5. 12*3, 13*0, 13*26, 13*65, 
14*0 p. Further elution w ith  hexane (fractions 24— 40) 
gave crystals (6*0 mg.), m . p. 135— 142°, raised to 160—  
153° (lit . ,8 164— 165°) by recrystallisation from  methanol, 
of ( IX b ), X ^  224(4*31), 271(4*70), 275(4*71), 316(4*02) mp, 
W  10,2°* 10  9' 12*22* 12‘9. I3 3 4 . 13 ' 6 9  {i* F inally ,
elution of the yellow band w ith  benzene-hexane ( 1 : 1) 
gave yellow crystals (4*0 mg.), m. p. 172— 176°, of the start­
ing material (X b ).
17-Benzylidenecyclopenta[a.]phenanthrene (X a ).— To a solu­
tion of the 15-olefin ( V i l la )  (210 mg.) in ethanol (15 m l.) 
containing benzaldehyde (1 2 0  mg.) was. added a saturated
14 B. Riegel, M. H. Gold, and M. A. Kubico, J . Amer. Chem. 
Soc., 1943. 65, 1772.
968 J. Chem. Soc. (C), 11)00
solution (0*5 ml.) of potassium hydroxide in ethanol. An 
^orange crystalline solid rapidly separated; after 30 min. 
on a  steam -bath, the solution was cooled and the solid was 
dried (231 mg.), in. p. 257— 259°. The benzylidene com­
pou n d  (Xa) formed orange, feathery needles (from toluene,) 
m. p. 202— 203° (Found: C, 94-9; H , 5-55. C21H 16
requires C, 94-7; H , 5-3%). \ mx 249(4-52), 328(4-05), 
and 384(4-07) mp, 12-05, 12-47, 13-12, 13-38, and
14*44 p.
H ydrogenation of this compound (100 mg.) in ethyl 
acetate (20 ml.) over 5% palladium -charcoal (100 mg.) 
stopped w ith the uptake of 2 mol. of hydrogen. After 
filtration, the colourless solution was evaporated, and the  
residue was recrystallised from ethanol, to  furnish the  
benzyl com pound  (XIa) (73 mg.), m. p. 156— 157° (Found: 
C, 93-4; H , 6-7. C24H 20 requires C, 93-45; H . 6-55%), 
216(4-46), 260(4-81), 281(4-20), 289(4-08), 301(4-14), 
320(2-77), 336(2-98), 352(3-00) mp, vmax 12-1, 12-36, 12-96,
13-3, 13-48, 14-28 p.
\l-\>-D im ethylam inobenzylidenccyclopenta\\\)phenan1hrcne  
(X c).— Condensation of (V IIla) (170 mg.) with />-dimethyl- 
am inobenzaldehyde (117 mg.) in the presence of potassium  
hydroxide as described above gave the com pound  (Xc) 
(165 mg.) as a bright yellow m icrocrystalline solid, m. p. 
248— 250° (Found: C. 90-05; H , 6-25. C,„H2lN requires 
C, 89-9; H, 6-1%), Xmax 371(4-18), 434(4-58) mp. vnu3,  . 
12-15, 12-32, 12-58, 13-24, 13-5 p.
The author thanks Dr. G. F . Marrian, F .R .S ., for his 
interest, and Dr. C. J. Croft of the P athology U nit for test­
ing m any of the compounds described in Parts I and II 
for carcinogenic activ ity , the results of which will be pub­
lished elsewhere. I t  is also a pleasure to  acknowledge the  
valuable technical assistance of T. S. B h att and D. M. Carr.
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Oxidation of 15,16-dihydrocyclopenta[a]phenanthren-17-one and of its strongly carcinogenic 11-methyl homo- 
logue with chromic acid, osmium tetroxide, lead tetra-acetate, and ammonium cerium(lV) nitrate was studied. 
The position of attack, either on the phenanthrene nucleus or on the five-membered ring D, depended mainly 
upon the oxidising agent and only to a minor extent upon the substrate. Both the biologically inactive hydro­
carbon. 16,17-dihydro-15//-cyclopenta[a]phenanthrene, and its weakly carcinogenic 11-methyl homologue 
gave the corresponding 15-ketones as the main products on chromic acid oxidation.
S k i n - p a i n t i n g  experiments have revealed the surprising 
fact that 15,16-dihydro-ll-methylcyclopenta[a]phen- 
anthren-17-one (lb) possesses strong carcinogenic 
properties whereas as expected the unsubstituted ketone 
(la) is devoid of such activity.2 The chemical re­
activities of these two compounds have therefore been 
compared, and various oxygenated derivatives which 
might be expected to be encountered in metabolic work 
now in progress have been synthesised.
Oxidation of the parent hydrocarbon 16,17-dihydro- 
15J/-cyclopenta[a] phenanthrene (Ila) with chromic 
acid3’4 was found to give mainly the 15-ketone (Xa), 
together with a trace of the 6,7-quinone 4 The weakly 
carcinogenic 11-methyl hydrocarbon (lib),5 conveniently 
prepared by hydrogenolysis of the 11-methyl ketone 
(lb), on similar oxidation gave the 11-methyl-15-ketone 
(Illb) (37%) with recovery of starting material (lib) 
(12%). In contrast to these results, similar oxidation 
of the 17-ketone (la) resulted in an almost quantitative 
yield of the bright yellow 17-oxo-6,7-quinone (IVa), 
while oxidation of the ll-methyl-17-ketone (lb) under 
these conditions gave several products. The major 
compound (51%) was the ll-methyl-17-oxo-6,7-quinone
1 Part II, M. M. Coombs, J . Chem. Soc., 1966, 963.
2 M. M. Coombs and C. J. Croft, Progr. Experimental Tumor 
Research, 1969, II , 69.
3 A. Butenandt, H. Dannenberg, and D. von Dresler, Z.
Naiurforsch., 1946, 1, 222.
(IVd), but starting material (16%) was also recovered 
and t.l.c. disclosed three other minor oxidation products.
Addition of osmium tetroxide across the 6,7-double 
bond in the hydrocarbon (Ila) was investigated by 
Dannenberg and his co-workers 5 who isolated the 6,7-diol 
(XIa) after treatment in benzene solution containing 
pyridine. The ketones (la) and (lb) under these con­
ditions, or better in pyridine solution without added 
benzene, gave the corresponding keto-diols (Va) and (Vb) 
in good yield. These compounds exhibited strong, broad 
u.v. absorption bands around 310 mp. which shifted on 
borohydride reduction to maxima around 275 mp, similar 
to that of the diol (XIa). A notable feature in the i.r. 
spectra of the keto-diols (Va and b) was enhanced absorp­
tion at 1600 cm.-1; this was not observed with the diol 
(XIa). Oxidation of the keto-diols with chromic acid 
afforded high yields of the keto-quinones (IVa and b), 
thus confirming the structure of the latter. The keto-diol 
(Va) was dehydrated smoothly when heated with sul­
phuric acid, but the 11-methyl keto-diol (Vb) was de­
hydrated less readily. The main product from (Va) was 
the 6-ol' (VI; R' =  H ); the derived methyl ether (V ia; 
R1 =  Me) was identical with a specimen synthesised 
from 1-methoxy naphthalene.6 A minor phenolic
4 G. M. Badger, W. Carruthers, and J. W. Cook, J . Chem. 
Soc., 1952, 4996.
5 A. Butenandt and H, Dannenberg, Arch. Geschwulstforsch., 
1953, 6, 1.
6 M. M. Coombs and S. B. Jaitly, unpublished work.
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product was probably the isomeric 7-hydroxy-l7-ketone  
(V II); it  possessed an increased Rp  value, as did also the  
ll-hydroxy-17-ketone in which the hydroxy-group is 
sterically hindered (see Experim ental section). B y
(V) OH
'OH
(VII)
OAc
( I X )
r v i)  OR
( VIII )
0  ( X
a;  R = H 
b; R = Me
(XI)
analogy, the dehydration product from (Vb) was assumed 
to  be the 6-ol (V lb; R' =  H), and this was supported  
b y  its Rp value. Moreover, in the n.m.r. spectrum of 
the derived acetate (V Ib; R' =  Ac) the chem ical shift 
of the m ultiplet ascribed to  the C-15 m ethylene protons 
was the same as that of the C-15 m ethylene protons in the 
unsubstituted ketone (la), whereas distinct alterations 
in  the position of this signal are noted w ith  7-substituted  
derivatives.7
O xidation of the ketones (la  and b) w ith lead tetra­
acetate was also studied, because the potent carcinogen
7 M. M. Coombs, unpublished work.
8 G. M. Badger and J. W. Cook, / .  Chem. Soc., 1939, 801; E. 
Boyland and P. Sims, Biochem. J ., 1965, 95, 780.
9,10-dimethylbenzanthracene is oxidised to the 9,10-bis- 
acetoxymethyl derivative by this reagent,8 and it was 
hoped that the ll-acetoxymethyl-17-ketone could be 
obtained in this way. Little reaction was observed when 
the unsubstituted ketone (la) was stirred with the 
reagent in glacial acetic acid at room temperature, but 
irradiation of a boiling mixture gave the 16-acetoxy- 
ketone (V illa ; R' =  Ac) in moderate yield. This 
acetoxy-ketone was better prepared from the enol 
acetate (IXa), itself obtained in high yield from (la) with 
isopropenyl acetate and toluene-^>-sulphonic acid, by 
oxidation with lead tetra-acetate at room temperature. 
The 17-oxo-group in (V illa; R' =  Ac) absorbs at 
1720 cm.-1, 30 cm.-1 to higher frequency than in the 
parent ketone, probably as a result of interaction with 
the acetate carbonyl group. Many instances of elevation 
of normal carbonyl frequencies in 21-acetoxy-20-keto- 
and 12-acetoxy-ll-keto-steroids are recorded.9 Acid 
hydrolysis of (V illa; R' =  Ac) furnished the 16- 
hydroxy-17-ketone (V illa; R' =  H), which had 
‘ normal ’ carbonyl absorption at 1690 cm.-1. The u.v. 
spectra of (V illa; R' =  H or Ac) were identical and 
closely resembled that of the ketone (la), with the 
difference that all the maxima were shifted 2—4 mp to 
longer wavelengths.
The 11-methyl-16-hydroxy-l7-ketone (VHIb; R' =  
H) was also readily prepared by oxidation of the enol 
acetate (IXb) with lead tetra-acetate as already described, 
and had properties similar to (Villa). Treatment of the 
11-methyl ketone (lb) with this reagent at room tem­
perature caused little reaction, but in boiling, irradiated 
acetic acid it gave as main product the ll-methyl-16- 
acetoxyketone (VHIb; R' =  Ac); no evidence for 
appreciable oxidation of the 11-methyl group was found.
Conversion of the aromatic methyl group in 1-methyl- 
oestrone methyl ether into a formyl group, by oxidation 
with cerium(iv) ammonium nitrate in 90% acetic acid at 
room temperature, has recently been reported10 to occur 
smoothly without concomitant attack at the aliphatic 
(C-18) or O-methyl groups, or at the activated methylene 
groups at C-6 and C-16. However, under these 
conditions the unsubstituted ketone (la) was rapidly 
oxidised, and the keto-quinone (IVa) was isolated in 
28% yield; unchanged (la) was also recovered (23%). 
A third substance (ca. 15%) was not obtained pure, but 
possessed spectral properties suggesting the enolic 
(3-diketone structure, cyclopenta[«]phenanthrene- 
15(16H),17-dione. The several minor oxidation pro­
ducts included an acidic fraction (10%) which appeared 
to consist of a mixture of phenanthrenecarboxylic acids 
produced by cleavage of the 5-membered ring d .  
Oxidation of the 11-methyl ketone (lb) with cerium(iv) 
ammonium nitrate followed by t.l.c. of the reaction 
mixture disclosed a similar variety of products, although 
the amount of quinone was considerably less, as also 
noted in the chromic acid oxidation of this ketone. The
9 L. J. Bellamy, ‘ The Infra-red Spectra of Complex Mole­
cules,’ Methuen, London, 2nd edn., 1958, p. 146.
10 S. B. Laing and P. J. Sykes, J . Chem. S oc., 1968, 2915.
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cyclopenta[a] phenanthrene ring system  is thus markedly 
more susceptible to  oxidation b y  cerium (iv) ions than is 
the oestrane system , and these experim ents were dis­
continued.
EXPERIMENTAL
R e a g e n t s  a n d  a p p a r a t u s  w e r e  g e n e r a l l y  a s  d e s c r i b e d  i n  
P a r t  I . 11 T h e  m e d i u m - t o - s t r o n g  i . r .  b a n d s  i n  t h e  1 0 — 15  p. 
r e g i o n  a r e  q u o t e d  i n  a d d i t i o n  t o  o t h e r  s a l i e n t  b a n d s  o f  
d i a g n o s t i c  r e l e v a n c e .
15 , l(3-Dihydro-ll-methylcyclopenta[a.]pJienanthrene ( l i b ) . 
— T h e  1 1 - m e t h y l  k e t o n e  ( l b ) , 11 g l a c i a l  a c e t i c  a c i d  ( 1 0 0  m l . )  
c o n t a i n i n g  c o n c .  h y d r o c h l o r i c  a c i d  (4  m l . ) ,  a n d  a  m i x t u r e  o f  
A d a m s  c a t a l y s t  (5 0  m g .)  a n d  5 %  p a l l a d i u m - c h a r c o a l  
(1 0 0  m g .)  w e r e  s h a k e n  i n  h y d r o g e n .  A b s o r p t i o n  o f  g a s  
c e a s e d  w h e n  t h e  c a l c u l a t e d  v o l u m e  h a d  b e e n  c o n s u m e d  
(6 0  h r . ) .  T h e  c a t a l y s t  w a s  f i l t e r e d  o f f  a n d  t h e  s o l u t i o n  
f u r n i s h e d  a n  o i l  w h i c h  w a s  c h r o m a t o g r a p h e d  o n  a l u m i n a  i n  
b e n z e n e - h e x a n e  (1 : 1). T h e  h y d r o c a r b o n  ( l i b )  w a s  o b ­
t a i n e d  a s  a  c o lo u r l e s s  o i l  (1 -1 3  g .)  w h i c h  c r y s t a l l i s e d  a n d  
g a v e  n e e d l e s  (5 1 0  m g . ) ,  m . p .  8 1 — 8 2 °  ( f r o m  e t h a n o l )  ( l i t . , 12 
8 0 — 8 1 °).
16 , \l-Dihydro-\l-methylcyclopenta[y.]p]ienanthren-1 5 -one 
( I l l b ) . — T h e  h y d r o c a r b o n  ( l i b )  (1 -2 6  g .)  w a s  s t i r r e d  w i t h  
g l a c i a l  a c e t i c  a c i d  (1 4  m l . )  w h i l e  a  s o l u t i o n  o f  c h r o m i u m  
t r i o x i d e  (0 -8 8 2  g .)  i n  8 0 %  a c e t i c  a c i d  (2 -2  m l . )  w a s  a d d e d  
d u r i n g  5  m i n .  S t i r r i n g  w a s  c o n t i n u e d  a t  r o o m  t e m p e r a t u r e  
f o r  4 0  h r . ,  a t  t h e  e n d  o f  w h i c h  t h e  b r o w n  s u s p e n s i o n  w a s  
p o u r e d  i n t o  wTa t e r  a n d  e x t r a c t e d  w i t h  c h lo r o f o r m .  T h e  
e x t r a c t  w a s  w a s h e d  w i t h  s o d i u m  h y d r o g e n  c a r b o n a t e  
s o l u t i o n  a n d  w a t e r ,  a n d  d r i e d .  E v a p o r a t i o n  l e f t  a  y e l lo w  
s o l id  w h i c h  w a s  r e d i s s o l v e d  i n  b e n z e n e  a n d  c h r o m a t o g r a p h e d  
o n  a  c o l u m n  o f  a l u m i n a .  E l u t i o n  w i t h  b e n z e n e - c y c l o -  
h e x a n e  ( 1 : 1 )  g a v e  t h e  s t a r t i n g  m a t e r i a l  ( l i b )  ( 1 5 0  m g . ) .  
F u r t h e r  e l u t i o n  w i t h  b e n z e n e  y i e l d e d  t h e  ketone ( I l l b )  
4 9 5  m g . ,  3 7 % ) ,  w h i c h  g a v e  p a l e  y e l lo w  n e e d l e s ,  m . p .  1 8 2 —  
1 8 3 °  ( f r o m  h o t  e t h a n o l )  ( F o u n d :  C , 8 8 -0 ;  H ,  5*7. C 18H 140  
r e q u i r e s  C , 8 7 -8 ;  H ,  5 - 7 5 % ) ,  \ nx 2 1 7  ( lo g  e 4 -5 7 ) ,  2 5 3  (4 -6 3 ) ,  
2 8 4  (4 -1 5 ) ,  3 2 3  (4 -1 4 ) , a n d  3 6 3  (3 -4 1 ) m p ,  vffl3X 5 -9 4  (1 5 -C O ) ,
1 1 -6 0 , 1 1 -9 0 , 1 2 -2 2 , 1 3 -2 8 , 1 3 -7 2 , a n d  1 4 -0 2  p . ‘
1 5 -1  (i-Dihydrocyclopenta [&\phenanthrene- 6 ,7 ,1 1-trione 
( I V a ) . — T h e  u n s u b s t i t u t e d  k e t o n e  ( l a )  (9 2  m g . )  i n  g l a c i a l  
a c e t i c  a c i d  (1 0  m l . )  w a s  s t i r r e d  w i t h  c h r o m i u m  t r i o x i d e  
( 1 5 0  m g . )  a t  r o o m  t e m p e r a t u r e  f o r  2 4  h r . ;  t . l . c .  t h e n  
s h o w e d  t h e  a b s e n c e  o f  s t a r t i n g  m a t e r i a l .  T h e  y e l lo w  s o l id  
A vhich  h a d  s e p a r a t e d  w a s  c o l l e c t e d ,  w a s h e d  w i t h  a  l i t t l e  
a c e t i c  a c i d ,  t h e n  w i t h  w a t e r ,  a n d  d r i e d ,  g i v i n g  t h e  keto- 
quinone ( I V a )  (6 7  m g . ) ,  m . p .  2 4 5 — 2 4 7 °  ( d e c o m p .)  [ m .p .  2 5 0 °  
( d e c o m p .)  ( f r o m  t o l u e n e ) ]  ( F o u n d :  C , 7 7 -7 ;  H ,  4 -2 .
C 17H 10O 3 r e q u i r e s  C , 7 7 -8 5 ;  H ,  3 - 8 5 % ) ,  vmax 5 -8 4  (1 7 -C O ) , 
5 -9 7  a n d  6 -3 0  ( q u in o n e ) ,  1 0 -4 5 , 1 1 -6 3 , 1 1 -9 0 , a n d  1 2 -9 0  p .  
T h e  a c e t i c  a c i d  m o t h e r  l i q u o r s  w e r e  d i l u t e d  w i t h  w a t e r  a n d  
t h e  g r e e n  s o l u t i o n  w a s  e x t r a c t e d  w i t h  c h l o r o f o r m  t o  y i e l d  
y e l lo w  c r y s t a l s  (2 0  m g . )  s h o w n  b y  t . l . c .  t o  b e  ( I V a )  c o n ­
t a m i n a t e d  w i t h  t r a c e s  o f  f o u r  o t h e r  s u b s t a n c e s .
T h i s  k e t o - q u i n o n e  w a s  a l s o  o b t a i n e d  b y  o x i d a t i o n  o f  t h e  
k e t o - d i o l  (V a )  (2 0  m g . )  w i t h  c h r o m i u m  t r i o x i d e  (1 0  m g . )  i n  
a c e t i c  a c i d  (4  m l . )  f o r  2  h r .  a t  r o o m  t e m p e r a t u r e .  T h e  
m i x t u r e  w a s  t r e a t e d  a s  b e f o r e  t o  g iv e  y e l lo w  c r y s t a l s  (1 6  m g . ) ,  
m . p .  2 4 6 — 2 4 9 ° ,  i . r .  s p e c t r u m  i d e n t i c a l  w i t h  t h a t  o f  t h e  
a n a l y t i c a l  s p e c i m e n  o f  ( I V a ) .
11 M. M. Coombs, J . Chem. Soc., 1966, 955.
12 A. Butenandt, H. Dannenberg, E . Bieneck, and W. Steidle, 
Z. Nalurforsch., 1950, 5b, 405.
1 5 ,1  Q-Dihydro-ll-methylcyclopenta[a.]phenanthrene-6,7 ,1 7 -  
trione ( I V b ) .— T h e  1 1 - m e t h y l  k e t o n e  ( l b )  (4 9 2  m g . )  w a s  
o x i d i s e d  a s  a l r e a d y  d e s c r i b e d ; a f t e r  2 4  h r .  t h e  p r e s e n c e  o f  
s o m e  u n c h a n g e d  ( l b )  t o g e t h e r  w i t h  o n e  m a j o r  a n d  t h r e e  
m i n o r  p r o d u c t s  w a s  d e m o n s t r a t e d  b y  t . l . c .  T h e  y e l lo w  
s o l u t i o n  w a s  d i l u t e d  w i t h  w a t e r  a n d  e x t r a c t e d  w i t h  c h l o r o -  
f o r m - e t h y l  a c e t a t e  t o  y i e l d  a n  o r a n g e  g u m ,  t r i t u r a t i o n  o f  
w h i c h  w i t h  a  f e w  d r o p s  o f  e t h y l  a c e t a t e  g a v e  t h e  1 1 -  
methyl keto-quinone ( I V b )  (1 9 1  m g . ) ,  w h i c h  y i e l d e d  s m a l l  
o r a n g e  p r i s m s ,  m . p .  2 3 0 °  ( d e c o m p .)  ( f r o m  b e n z e n e - h e x a n e )  
( F o u n d ;  C , 7 7 -9 5 ;  H ,  4 -2 . C 18H 120 3 r e q u i r e s  C , 7 8 -2 5 ;
H ,  4 - 4 % ) ,  5 -8 0  (1 7 - C O ) ,  6 -0  a n d  6 -2 4  ( q u i n o n e ) ,  1 0 -3 0 ,
1 1 -9 1 , 1 2 -8 0 , 1 3 -7 0 , a n d  1 3 -8 6  p .
C o l u m n  c h r o m a t o g r a p h y  o f  t h e  e t h y l  a c e t a t e  s o l u t i o n  o n  
s i l i c a  g e l  i n  t o l u e n e  g a v e  t h e  s t a r t i n g  m a t e r i a l  (8 1  m g . )  a n d  a  
s e c o n d  m a t e r i a l  (3 8  m g . ) .  E l u t i o n  w i t h  d i c h l o r o m e t h a n e  
g a v e  m o r e  q u i n o n e  ( I V b )  (9 0  m g . ) .
O x i d a t i o n  o f  t h e  1 1 - m e t h y l  d i o l  (V b )  ( 1 0 0  m g .)  w i t h  
c h r o m i u m  t r i o x i d e  a s  b e f o r e  g a v e  t h e  q u i n o n e  ( I V b )  a s  a  
y e l lo w  s o l id  (1 0 6  m g . ) ,  i . r .  s p e c t r u m  i d e n t i c a l  w i t h  t h a t  o f  
t h e  a n a l y s e d  m a t e r i a l .
6 .7 .1 5 .1 6-TeiraIiydro-6,l-diIiydroxycyclopenta [ a ]phen- 
anthren-ll-one  ( V a ) .— T h e  u n s u b s t i t u t e d  k e t o n e  ( l a )  ( 4 6 4  
m g . ) ,  o s m i u m  t e t r o x i d e  ( 5 1 0  m g . ) ,  a n d  p y r i d i n e  (1 0  m l . )  
w e r e  s t i r r e d  t o g e t h e r  i n  a  d r y  a t m o s p h e r e  a t  r o o m  t e m ­
p e r a t u r e  f o r  8  d a y s ;  t . l . c .  ( e t h a n o l - t o l u e n e ,  1 : 4 )  t h e n  
s h o w e d  t h a t  m o s t  o f  t h e  k e t o n e  h a d  b e e n  c o n s u m e d .  
W a t e r  (2  m l . )  a n d  s o d i u m  p y r o s u l p h i t e  (2  g .)  w e r e  a d d e d  
a n d  s t i r r i n g  w a s  c o n t i n u e d  f o r  5  h r .  T h e  d a r k  m i x t u r e  w a s  
p o u r e d  i n t o  w a t e r  ( 2 0 0  m l . )  a n d  t h e  l i g h t - c o l o u r e d  s o l id  w a s  
c o l l e c t e d ,  w a s h e d  w i t h  w a t e r ,  d r i e d ,  a n d  s t i r r e d  w i t h  c h l o r o ­
f o r m  (1 0  m l . )  t o  r e m o v e  u n c h a n g e d  k e t o n e .  T h e  r e s i d u e  
( 4 3 8  m g . )  w a s  b o i l e d  w i t h  n - b u t a n o l  (3 0  m l . )  a n d  t h e  
s o l u t i o n ,  a f t e r  r e m o v a l  o f  a  s m a l l  a m o u n t  o f  i n s o l u b l e  s o l id ,  
d e p o s i t e d  p r i s m s  o f  t h e  k e t o - d i o l  (V a ) ,  m . p .  2 3 2 — 2 3 4 °  
[ m .p .  2 4 7 — 2 4 9 °  ( f r o m  n - b u t a n o l ) ]  ( F o u n d :  C , 7 6 -5 ;  H ,  
5 -1 . C 17H 140 4 r e q u i r e s  C , 7 6 - 6 5 ;  H ,  5 - 3 % ) ,  vm x  2 -8 7  
a n d  2 -9 6  ( O H ) ,  5 -9 0  (1 7 -C O ) , 1 0 -2 8 , 1 2 -1 6 , 1 2 -8 0 , a n d ‘l 3 - 5 0 p .
1 5 .1 6-Dihydro-f)-Jiydroxycyclopenta[a,]phenanthren-1 7 -one 
( V i a ;  R '  =  H ) . — T h e  k e t o - d i o l  (V a )  ( 1 6 §  m g . )  w a s  h e a t e d  
a t  1 0 0 °  w i t h  5 N - s u lp h u r i c  a c i d  (1 0  m l . )  i n  a  s e a l e d  t u b e  f o r  
1 h r . ; t h e  l i q u i d  b e c a m e  f i l l e d  w i t h  a  f l o c c u l e n t  y e l l o w  s o l id .  
W h e n  c o ld ,  t h e  s o l i d  w a s  c o l l e c t e d ,  w a s h e d  w i t h  w a t e r ,  a n d  
d r i e d .  T h i s  s o l id  (1 5 0  m g . ) ,  w h i c h  s h o w e d  t w o  s p o t s  o n  
t . l . c .  ( s e e  l a t e r ) ,  g a v e  g o l d e n - y e l l o w  n e e d l e s  o f  t h e phenol 
( V i a ;  R '  =  H )  (1 4 1  m g  ), m . p .  2 8 0 °  [ f r o m  n - b u t a n o l  ( 6 m l . ) ] ,  
w h i c h  c o n s i s t e d  e n t i r e l y  o f  t h e  s l o w e r  r u n n i n g  m a t e r i a l  
( F o u n d :  C , 8 2 -0 5 ;  H ,  4 -8 . C 17H 120 2 r e q u i r e s  C , 8 2 -2 5 ;  
H ,  4 - 8 5 % ) ,  vnnx 3 -2 0  ( O H ) ,  5 -9 6  (1 7 - C O ) ,  1 1 -5 4 , 1 1 -8 0 ,
1 2 -1 8 , 1 2 -2 6 , a n d  1 3 -0 8  p .
R e l a t i v e  v a l u e s  a n d  c o l o u r s  d e v e l o p e d  w i t h  G i b b s  
r e a g e n t  *
R y t Colour
Dehydration of (Va):
main product......................................... 0-69 Turquoise-green
minor product ..................................... 0-72 Mauve
Dehydration of (Vb) ................................. 0-69 Blue-violet
15,16-Dihydro-3-hydroxycyclopenta-
[a]phenanthren-17-one ........................ 0-69 Fawn
15,16-Dihydro-11-hydroxycyclopenta-
[a]phenanthren-17-one J .................... 0-75 Mauve
9-Phenanthrol ......................................... Turquoise-green
* Solution (0-5%) of 2,6-dichloro-/>-benzoquinone 4-chloro- 
imine in ethanol, followed by 10% aqueous sodium carbonate, 
f Silica gel plates; ethanol-toluene, 1 : 5. J R. Robinson, 
J . Chem. Soc., 1938, 1390.
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M ethylation of the phenol (V ia; R 7 =  H) (150 mg.) under 
nitrogen w ith 10% aqueous sodium hydroxide (50 ml.) and 
dim ethyl sulphate (10 ml.) gave a solid (125 mg.) w hich gave 
pale yellow  needles of th e  m ethyl ether (V ia; R 7 =  Me) 
(55 m g .), m.p. 193— 195° (from ethanol) (Found: C, 82-7; 
H, 5-3. C18H 140 2 requires C, 82-4; H , 5-4%), 5-90
(17-CO), 10-12, 12-22, 12-74, 13-02, and 13-76 p; m ixed  
m .p. w ith  a sam ple (m.p. 196— 197°) synthesised from 1- 
m ethoxynaphthalene showed no depression.
6.7.15.1 6-Tetrahydro-G ,1-d ih yd ro x y-11-nietJiylcyclopenta [a] - 
phenanthren-Y l-one  (Vb).— The 11-m ethyl ketone (lb) 
(2-0 g.) was oxidised w ith  osm ium tetroxide (2-05 g.) in  
pyridine (30 ml.) as already described. The crude grey  
solid was boiled w ith ethanol (100 ml.), filtered w hile hot, 
and concentrated to yield  discoloured crystals (1-37 g.); 
these gave the 11 -m ethyl keto-diol (Vb) as prisms, m .p. 244—  
245° (from ethanol) (Found: C, 76-9; H , 5-7. C18H 160 3 
requires C, 77-1; H , 5-75%), vmax 2-90 and 3-05 (OH), 5-96 
(17-CO), 10-20, 10-38, 11-12, 12-04,' 12-78, 13-10, 13-40, 13-80, 
and 14-46 p.
15.1 G -D ihydro-G -hydroxy-1\-m eth y l cyclop enta\jx\phen- 
a n th ren -ll-o n e  (VIb; R 7 — H ).— The diol (Vb) (1-16 g.) 
was heated in a sealed tube w ith  5N-sulphuric acid (50 ml.) 
for 2 hr. The yellow  solid was collected and washed w ith  
aqueous x-sodium  hydroxide, leaving a grey solid (0-73 g.) 
which proved to  be starting material, m.p. 245— 247°. The 
alkaline solution w as acidified and the yellow  precipitate 
w as collected, washed w ith  water, and dried. The crude 
solid gave golden-yellow needles (172 mg.), m.p. 335° 
(decomp.) [from hot octan-2-ol (50 m l.)], of the 11 -m ethyl 
phenol (V Ib; R 7 -  H) (Found: C, 82-0; H , 5-25. C18H 140 2
requires C, 82-4; H , 5-4%), 3-08 (OH), 5-95 (17-CO),
11-46, 12-05, 12-86, 13-04, 13-74,'and 14-50 p.
W hen the tim e of heating was extended to  17 hr., the diol 
(Vb) (0-94 g.) gave the phenol (VIb; R 7 =  H) (0-76 g.) to ­
gether w ith  only a trace of alkali-insoluble material. B oth  
this phenol and the crude phenol from the 2 hr. heating  
gave only one spot on t.l.c.
A cetylation of the pure phenol (200 mg.) w ith  acetic  
anhydride-pyridine gave the acetate (VIb; R 7 =  Ac) 
(158 mg.), m.p. 225— 227° [from n-butanol (20m l.)] (Found: 
C, 78-85; H, 5-0. C20H 16O3 requires C, 78-95; H , 5-3%).
M ethylation of the phenol (560 mg.) as before gave the  
m eth yl ether (VTb; R 7 =  Me) (564 mg.) w hich separated  
from ethanol as prisms, m.p. 203— 205° (Found: C, 82-65; 
H , 5-75. C19H X60 2 requires C, 82-6; H , 5-85%), vm, x 5-86
(17-CO), 12-26, 13-18, and 13-78 p.
1 o ,\G -D ih ydro-‘S-hydroxycyclopenta\y]phenanthren-\'l-one. 
— 15,16-Dihydro-3-m ethoxycyclopenta[a]phenanthren-17- 
one 11 (0-80 g.) was heated w ith freshly distilled pyridine 
hydrochloride (10 g.) at 220° to yield a red liquid. After 
3 min. cold water (50 ml.) was added. Trituration gave a 
yellow  powdery solid which was stirred and warmed w ith
0-lN-sodium hydroxide (600 ml.). After an insoluble 
orange-coloured solid had been filtered off, the alkaline 
solution was acidified and the flocculent yellow  precipitate 
was collected, washed w ith  water, and dried (0-25 g.). R e­
crystallisation from n-butanol gave the phenol as sm all 
yellow  rosettes of needles (Found: C, 81-85; H , 5-1.
Ci7H 120 2 requires C, 82-25; H , 4-85%), Xmax 270sh (log e
4-94), 277-5 (5-02), 292infl (4-30), 324 (4-08), *366 (3-28), and  
396— 403 (2-91) mp, vmax 3-20 (OH), 5-98 (17-CO), 10-50,
11-52, 12-36, 12-60, and 14-15 p.
A cetylation as before gave 3-acetoxy-15,16-dihydrocyclo- 
penta \a]ph en anthren -\7-on e, pale yellow  needles from n-
butanol, m.p. 209— 213° (Found: C, 78-85; H , 5-2.
C19H u 0 2 requires C, 78-6; H , 4-85%).
17-A cetoxy-15H -cyclopenta[&]phenanthrene (IX a).— The
unsubstituted ketone (la) (3-30 g.) was heated under reflux 
w ith  isopropenyl acetate (250 ml.) and toluene-^-sulphonic 
acid (20 mg.) during 6 hr. w hile the solvent (200 ml.) was 
slow ly distilled off.  D ichlorom ethane (100 ml.) was added 
and the solution was washed w ith  aqueous sodium  hydrogen  
carbonate and water, and dried. The pale fawn crystals 
obtained on rem oval of the solvent yielded the enol acetate 
(IXa) (3-23 g.), m .p. 210— 211° [from benzene (30 ml.)] 
(Found: C, 83-25; H , 5-05. C19H 140 2 requires C, 83-2; 
H , 5-15%), Xmx 222 (log s 4-48), 269 (4-91), 273 (4-92), 291 
(4-28), 312 (3-89), 312 (3-89), 329 (2-91), 345 (2-83), and  
363 (2-66) mp, 5-72 and 8-24 (enol acetate), 11-00, 12-02,
12-28, 12-85, 13-34, and 13-88 p.
16-A  cetoxy-15,16-dihydrocyclopenta[& ]phenanthren-17-one 
(V il la ;  R 7 =  A c).— The enol acetate (IXa) (3-53 g.) was 
stirred in  glacial acetic acid (115 ml.) and acetic anhydride 
(15 ml.) w ith  lead tetra-acetate (6-3 g.; m oist w ith  acetic 
acid), and the flask w as irradiated w ith  a 60 w  tungsten  
filam ent lamp. After 3 hr., more lead tetra-acetate (1-0 g.) 
w as added, and stirring and irradiation were continued  
overnight (17 hr.). After dilution w ith  dichloromethane 
(500 ml.) the yellow  solution w as washed successively w ith  
5% aqueous sodium  thiosulphate (2 x 500 ml.), saturated  
sodium hydrogen carbonate solution (2 x 500 ml.), and 
water, and w as dried. Evaporation left an orange syrup  
which crystallised; th is m aterial had i.r. bands at 5-75m, 
5-81s, 8-10s, and 8-23m p (16,17,17-triacetate?). I t  crystal­
lised from benzene (20 ml.), after rem oval of a little  in­
soluble material, as pale yellow  leaflets (2-48 g.) of the 16- 
acetoxy-ketone  (V il la ;  R 7 =  Ac), m .p. 178° (Found: C, 
78-8; H , 4-65. C19H 140 3 requires C, 78-6; H , 4-85%),
vmaX 5'70 and 8’16 (acetate), 5-81 (17-CO), 12-14, 12-40,
12-92, and 13-16 p.
H ydrolysis of th is acetoxy-ketone (500 mg.) in m ethanol 
(25 ml.) w ith 5N-sulphuric acid (10 ml.) under reflux for 
2 hr. gave a solution w hich was cooled to yield pale yellow  
prisms of the hydroxy-ketone  (V il la ;  R 7 =  H) (342 mg.) 
m .p. 186— 187°. Recrystallisation from ethanol-chloro- 
form (2: 1; 30 ml.) gave a sample, m.p. 195° (decomp.) 
(Found: C, 82-1; H , 4-55. C17H 120 2 requires C, 82-24;
H , 4-85%), vmax 2-96 (16-OH), 5-92 (17-CO), 12-16, 12-44, 
and 13-30 p. A ttem pted alkaline hydrolysis led to  a 
m ixture of products.
16-A cetoxy-15,16-dihydro-ll-m ethylcyclopen ta[a .]phen- 
anthren-17-one  (V H Ib; R 7 =  Ac).— The 11-m ethyl ketone 
(lb) (6-65 g.) was treated w ith  isopropenyl acetate and 
toluene-/>-sulphonic acid as already described to  give the  
crude enol acetate (IXb) as a brown crystalline mass. 
O xidation of th is m aterial w ith  lead tetra-acetate and 
precipitation from benzene (60 ml.) w ith  hexane (30 ml.) 
yielded the 11 -m ethyl 16-acetoxy-ketone (V H Ib; R 7 =  Ac) 
(1-94 g.), w hich (from the sam e solvent mixture) gave silky  
needles, m .p. 156— 157° (Found: C, 78-9; H , 5-2. C20H 16O3
requires C, 78-95; H , 5-35%), vm!t 5-72 and 8-10 (acetate),
5-81 (17-CO), 12-02, 12-14, 12-90, 13-18, 13-30, and 13-96 p.
Acid hydrolysis of th is acetoxy-ketone (1-79 g.) as before 
yielded the 11 -m ethyl 16-Ay droxy-ketone  (V H Ib; R 7 =  H) 
(1-44 g.), w hich gave pale yellow  needles, m.p. 205— 207° 
(from n-butanol) (Found: C, 82-45; H , 5-3. C18H 140 2
requires C, 82-4; H, 5-25%), vmx 3-00 (16-OH) 5-92 (17- 
CO), 11-44, 11-62, 12-06, 12-28, 12-55, 12-80, 13-56, and
14-10 p.
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O xidation  o f  the 17-K etones w ith L ead  Tetra-acetate .—  
U n substitu ted  ketone (la). This ketone (230 mg.) was boiled  
under reflux w ith acetic acid (10 ml.) and lead tetra-acetate  
(500 mg.) w ith  irradiation for 16 hr. The brown solution  
w as diluted w ith chloroform and treated as in the similar 
oxidation of the enol acetate to afford a yellow  gum, t.l.c. 
(dichloromethane) of w hich disclosed the presence of starting  
material (la), the 16-acetoxy-ketone (V il la ;  R ' =  Ac), and  
sm all am ounts of several other products more polar than the  
latter. T his gum  was absorbed on a sm all colum n of silica  
gel. E lution w ith  hexane-dichlorom ethane (4: 1) gave 
m aterial (93 mg.) w hich yielded (la), m .p. 199— 201° 
(30 mg.) (from benzene). Later fractions contained the  
acetoxy-ketone, m.p. 178— 180° (55 m g.). The i.r. and  
u.v. spectra of this m aterial were identical w ith  those of the  
sam ple prepared from the enol acetate.
11 -M eth y l ketone (lb). Treatm ent of th is ketone (25 mg.) 
w ith  lead tetra-acetate as already described gave a brown 
gum, preparative t.l.c. (dichloromethane) of w hich yielded  
crystals of the m ain product w ith  i.r. and u.v. spectra  
identical w ith  those of the 11-m ethyl 16-acetoxy-ketone 
(V H Ib; R ' — Ac) derived from the corresponding enol 
acetate. The presence of starting m aterial (lb) was also 
demonstrated, and the t.l.c. pattern of minor oxidation  
products was similar to  th at exhibited b y  the crude lead 
tetra-acetate oxidation product of (la).
O xidation  o f 17-K etones w ith C eriu m {iv) A m m on iu m  
N itra te .— U nsubstitu ted ketone (la). The ketone (2-32 g.) 
was stirred at room tem perature w ith  acetic acid (50 ml.) 
while a solution of cerium(iv) am m onium  nitrate (22-42 g.) 
in acetic acid (200 ml.) and water (15 ml.) w as added. 
After a further 3 hr. stirring all the solid had dissolved to  
give a clear yellow  solution w hich was poured into water 
(2 1.) and extracted w ith  dichloromethane. The extract 
was washed w ith sodium hydrogen carbonate solution and  
w ith water, and dried; evaporation left a yellow  gum  
(2-40 g.). The alkaline washings were acidified and ex ­
tracted to  yield a yellow  resinous solid (0-26 g.), Xmax 265 mp, 
vmax 2-85 and 3-78, and 5-92— 5-78 p (C 02H). The neutral 
material, shown by  t.l.c. (dichloromethane) to  consist of at 
least ten  compounds, was chromatographed on a colum n of 
silica gel, w ith  toluene containing increasing proportions 
(1— 20%) of ethyl acetate as eluant. Later fractions 
yielded crystalline keto-quinone (IVa) (710 m g.); un­
changed ketone (la) (609 mg.) was eluted w ith 3% ethyl 
acetate. Fractions eluted w ith 5% ethyl acetate gave a 
yellow  gum (475 mg.) which was rechromatographed to
yield  an amorphous solid (235 mg.), not obtained crystalline  
although it  appeared to  consist of a single substance (t.l.c.). 
This solid had i.r. bands a t 6-10, 5-83, and 5-75 p (CO), 
suggesting a partially enolised (3-diketone system , and this 
w as confirmed by the production of a green colour when a
U .v . and visible absorption m axim a of 15,16-dihydrocyclo- 
penta[a] phenanthren-17-one derivatives 
X max. (mp) (log e)
(IVa) 271—279 (4-03), 331 (3-31), 406 (3-21) 
(IVb) 263 (4-15), 345 (3-44), 410infl (2-94)
(Va) 245 (4-02), 309—317 (4-43)
(Vb) 232infl (4-13), 308—314 (4-22)
(Via) 274 (4-79), 285sh (4-54), 386 (3-45)
(VIb) 270 (4-70), 289sh (4-58), 378 (3-32), 390 
(3-35)
(Via) 270 (4-81), 287 (4-48), 302 (4-28), 361 
(3-37), 378 (3-42)
(VIb) 265 (4-76), 289sh (4-51), 306sh (4-27), 
368 (3-37), 384 (3-41)
(V illa) 265 (4-95), 284 (4-49), 296 (4-39), 335 
(3-15), 351 (3-32), 369 (3-33)
(VHIb) 264 (4-88), 288 (4-52), 301 (4-35), 345 
(3-14), 361 (3-36), 379 (3-39)
(V illa) 266 (4-92), 284 (4-50), 297 (4-39), 352 
(3-31), 370 (3-32)
(VHIb) 263 (4-87), 288 (4-52), 301 (4-35), 342 
(3-12), 357 (3-37), 375 (3-42)
dilute ethanolic solution of the m aterial w as m ixed w ith  
ethanolic copper(n) acetate. The u.v. spectrum [Xmax 
268 mp w ith  broad shoulders a t 285 and 295 mp] altered to  
Xmax 291 mp on addition of x-sodium  hydroxide and to  
Xmax 269— 272 mp on addition of x-hydrochloric acid; 
these changes were reversible. After addition of sodium  
borohydride the solution had Xmax 260 mp, sim ilar to  both
15- and 17-hydroxy-15,16-dihydrocyclopenta[a]phenan- 
threnes.
The 11-m ethyl ketone (lb). The ketone (25 mg.) was 
oxidised as already described. The dichlorom ethane extract 
of the m ixed oxidation products w as noticeably less yellow  
than th at from the sim ilar oxidation of (la). T .l.c. d is­
closed a similar range of products, but the am ount of 
quinone was considerably less.
I thank T. S. B h att and Miss J. Y . Comben for technical 
assistance, and J. F . Richards and D . W . Thom as for the  
microanalyses.
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Potentially Carcinogenic Cyclopenta[a]phenanthrenes. Part IV .1 Syn­
thesis o f 17-Ketones by the Stobbe Condensation
By M. M. Coom bs,* (Mrs.) S . B. Jaitly , and F. E. H. C raw ley, Chemistry Department, Imperial Cancer Research 
Fund, Lincoln's Inn Fields, London W.C.2
2-. 3-. 4-. and 6-Methyl- and 6-methoxycyclopenta[a]phenanthren-17-ones were prepared from appropriately 
substituted naphthalenes or tetralones, through Stobbe condensation of the corresponding 1.2,3,4-tetrahydro- 
phenanthren-1 -ones. The synthesis of ketones labelled with 14C in ring D and in the 11 -methyl group is also de­
scribed.
I n  Part I 2 w e described the use of the interm ediate
ll,12,13,14,15,16-hexahydrocyclopenta[«]phenanthrene- 
11,17-d ione3 in a sim ple synthesis of 15,16-dihydro- 
cy clopenta [a] phenanthren-17-ones. However, this 
scheme was not suitable for providing 14C-labelled 
ketones for biochem ical studies, nor did it  offer a con­
venient route to  several m ethyl homologues required to  
extend  our skin-painting experim ents.4 W e have 
therefore used the schem e described b y  Johnson and 
Peterson 5 in which an appropriate 1,2,3,4-tetrahydro- 
phenanthren-l-one is condensed b y the Stobbe reaction  
w ith  d iethyl sodiosuccinate to  provide the extra carbon 
atom s w ith  which to  construct the five-membered ring d .  
W e now describe the synthesis of a number of cyclo- 
penta[a]phenanthren-17-ones b y  this m ethod.
1,2,3,4-Tetrahydrophenanthren-l-ones were prepared 
b y  tw o general routes. In  the first, the 1-bromo- 
naphthalenes (la— c) were converted into the l-(2-hydr- 
oxyethyl) derivatives (I la — c; X  =  OH) b y  condensa­
tion  of the derived Grignard reagents w ith  ethylene 
oxide.6 The alcohols were treated w ith  phosphorus tri-
1 Part III, M. M. Coombs, J . Chem. Soc., 1969, 2484.
2 Part I, M. M. Coombs, J . Chem. Soc., 1966, 955.
3 A. Koebner and R. Robinson, J . Chem. Soc., 1938, 1994; 
A. J. Birch, R. Jaeger, and R. Robinson, ibid., 1945, 582.
4 M. M. Coombs and C. J. Croft, Progr. Experimental Tumor 
Research, 1969, 11, 69.
bromide to yield the bromides (Ila—c; X  =  Br) from 
which the diesters [Ila—c; X  =  CHJCOgEt)  ^ were 
obtained by condensation with sodiomalonic ester.
cn)
a; R =  H  
b; R =  Me 
c; R =  OMe
R
(IV )
Saponification followed by decarboxylation gave the 
acids (Ilia—c), which were cyclised with tin(iv) chloride7 
to give the tricyclic ketones (IVa—c).
In the second method the readily available 1-tetralones 
(Va—d) reacted with methyl y-bromocrotonate under
B W. S. Johnson and J. W. Peterson, J . Amer. Chem. Soc., 
1945, 67, 1366.
6 W. E. Bachmann and W. L. Wilds, J . Amer. Chem. Soc., 
1942, 64, 1424.
7 W. E. Bachmann and W. L. Wilds, J . Amer. Chem. Soc., 
1940, 62, 2084.
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Reform atsky conditions 8 to  yield the 2,4-dienoic esters 
(V ia— d). Isomerisation of the latter b y  heating w ith  
palladium  black followed b y  saponification gave the  
acids (V ila — d), which were cyclised as before to give the 
ketones (V il la — d). The m .p.s of 1,2,3,4-tetrahydro- 
7-m ethylphenanthren-l-one (VIIIc) (70-5— 71°) and its 
precursor, the acid (VIIc) (134— 135°), differed appreci­
ably from those reported by Orcutt and B o g ert9 (92— 94 
and 116— 118°, respectively), who obtained these com ­
pounds from a Friedel-Crafts succinoylation of 2-m ethyl- 
naphthalene. However, the m .p. of (VIIc) agreed with  
that quoted b y  Nasipuri and R oy,10 who made this 
compound b y  the route we used. Since the starting
C02Me
R (VI) R
R1 R2 R3
a; H H H
b; Me H H
c; H Me H
d; H H Me
(VII)
(Yin)
material for this synthesis, 3,4-dihydro-6-methylnaph- 
th a len -l(2#)-on e (Vc), was prepared b y  cyclisation of 
4 -(w-tolyl(butyric acid, evidence was sought to dem on­
strate that cyclisation had not led to the isomeric 
8-m ethyltetralone. The n.m.r. spectra of each of the 
m ethyltetralones (Vb— d) in the aromatic proton region 
exhibited a one-proton signal at t 2-0— 2-2, ascribed to  
the C-8 proton, downfield from those of the other two  
aromatic protons (2*8— 3-0). Moreover, similar de­
shielding of the protons of an 8-m ethyl group is to be 
expected in view  of the m agnetic anisotropy induced  
by the carbonyl group,11 but the m ethyl signals of 
(Vb— d) all had similar t values (7-66, 7-65, and 7*75, 
respectively). The structure of (Vc), and thus that of 
(VIIIc), is therefore assured. Since Friedel-Crafts 
acetylation of 2-m ethylnaphthalene gives m ixtures of the 
6- and 8-acetyl d erivatives12 it seem s possible that the 
minor isomer used b y  Orcutt and Bogert was 2-methyl-
8-succinoylnaphthalene, not the 5-succinoyl compound 
as claimed. This would have led * to  the naphthyl- 
butyric acid (V llb ) and tetrahydrophenanthren-l-one 
(VH Ib), both of which have been synthesised during the 
present work and which have m .p.s 125— 126 and 89—  
90°, respectively, similar to those reported b y the 
American workers.
* We thank a Referee for this suggestion.
8 K. von Ziegler, A. Spath, E. Schaaf, W. Schumann, and E. 
Winkelmann, Annalen, 1942, 80, 551; R. C. Fuson, R. I. Arnold, 
and H. G. Cooke, J . Amer. Chem. Soc., 1938, 60, 2272; W. Cook 
and R. Schoental, J . Chem. Soc., 1945, 288; W. C. J. Ross, 
ibid., 1947, 1364.
8 R. B. Orcutt and M. T. Bogert, J . Amer. Chem. Soc., 1941, 
63, 127.
10 D. Nasipuri and D. N. Roy, J . Sci. Ind. Res. India, 1961, 
21B, 60.
1,2,3,4-Tetrahydro-4-m ethylphenanthren-l-one (X I), 
previously prepared13 from l-(l-n ap h th y l)eth y l bromide 
(IXa) b y  a procedure involving A rndt-E istert chain  
extension of the derived acid (IXb) to  (X), was obtained  
b y  either of the following routes. Condensation of 
2-(l-naphthyl)propionaldehyde ( I X c )14 w ith  malonic 
acid led to  4-(l-naphthyl)pent-2-enoic acid (IXd) in high  
yield. Catalytic hydrogenation followed b y  cyclisation  
gave the required ketone (XI). A lternatively, 2 -(l-  
naphthyl) propionic acid ( I X e )15 was esterified and  
reduced to  the alcohol (IX f). Conversion into the  
bromide and chain extension as before yielded the inter­
m ediate acid (X).
Condensation of the tricyclic ketones (IVa— c), 
(V il la — d), and (XI) w ith  d iethyl succinate was readily  
accomplished in 40— 50% yield  b y  the Stobbe procedure; 
potassium  t-butoxide was used, w ith  a ketone-d iester  
ratio of 1 : 1-5— 1*7. Since it was intended to  label the
CHMeR
(IX )
a; R =  Br
b; R =  CH2-C02H
c; R =  CHO
d; R =  CH:CH-C02H
e; R =  C 02H
f; R =  CH2-OH
g; R — CH2Br
Me, Me,
ca,H
(X) (X I)
15.16-dihydrocyclopenta[a]phenanthren-l 7-ones (X IV a  
and f) a t the 15- and 16-positions by use of diethyl- 
[2,3-14C2]succinate, this reaction was studied in som e 
detail w ith the unlabelled diester. Based on the am ount 
of the latter em ployed, the yield of 3-(3,4-dihydro- 
4-m ethyl-l-phenanthryl)-3-ethoxycarbonylpropionic acid  
(X llf)  from (XI) was not appreciably dim inished b y  
increasing the ketone-d iester ratio to  1 : 1, but an 
inferior yield was obtained when the ketone was in  
excess. Cyclisation of the half esters (X l la — g) w ith  
zinc chloride in acetic anhydride-acetic acid proceeded  
sm oothly provided that m oisture was carefully exclu ded ; 
subsequent saponification and decarboxylation then  
afforded the 11,12,15,16-tetrahydrocyclopenta[a]phen- 
anthren-17-ones (X H Ia— g) in good yields.
The final step in this synthesis, dehydrogenation of the
11.12.15.16-tetrahydro-ketones (X III) to  the 15,16-di- 
hydro-derivatives (X IV ), was exam ined in the case of 
(XIVa) b y Dannenberg,16 who achieved good results by
11 L. M. Jackman, ‘ Applications of NMR Spectroscopy in 
Organic Chemistry,’ Pergamon, London, 1959, pp. 112— 124.
12 G. A. R. Kon and W. T. Weller, J . Chem. Soc., 1939, 792.
13 W. E. Bachmann and R. O. Edgerton, J . Am er. Chem. Soc., 
1940, 62, 2221.
14 L. F. Fieser, L. M. Joshel, and A. M. Seligman, J . Am er. 
Chem. Soc., 1939, 61, 2134.
15 F. F. Bincke and R. F. Feldkamp, J . Am er. Chem. Soc., 
1944, 66, 1087.
16 H. Dannenberg, Annalen, 1950, 568, 105.
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catalytic dehydrogenation under controlled conditions. 
H ydrogenolysis to  the hydrocarbon, 15,16-dihydro-17H- 
cyclopenta[a]phenanthrene, was encountered as a side- 
reaction. D espite considerable experim entation we 
have been unable to  secure satisfactory results w ith  
either 20% platinum  on charcoal,17 as used b y  this author, 
or w ith  a commercially available 10% sample. Al­
though conditions were varied w idely, the reaction at 
best led to  (X lV a) in about 25% yield  w ith  considerable 
recovery of starting material. The 11-m ethyl homo- 
logue (XIVf) w as sim ilarly prepared (see Experim ental 
section). B etter yields were obtained b y  dehydrogen­
ation of the tetrahydro-compounds w ith  2,3-dichloro- 
5,6-dicyano-l,4-benzoquinone (DDQ), and this m ethod  
w as adopted for the m ajority of the reactions. The
0
(xn) 0 (xm i
W  R (xnn
R 1 R 2 R3 R 4 R6
a; H H H H H
b; Me H H H H
c; H Me H H H
d; H H Me H ' H
e; H H H Me H
f ; H H H H Me
g; H H H OMe H
11-m ethyl com pound (X lV f) was not obtained from  
(X H If) and DDQ. Presum ably steric factors ensure 
that (X H If) ex ists largely as the isomer in which the  
11-m ethyl group is axial; consequently it  does not 
possess a pair of tfnms-diaxial protons, a stereochemical 
requirement for quinone dehydrogenation.18 [15,16-14C2]- 
Labelled ketones (X lV a  and f) were also obtained by  
slight m odifications of the m ethod described, and the 
11 -[methyl-u C] ketone was prepared from the keto- 
acetal (XV) 2 w ith  [14C]methylmagnesium iodide.
Spectral data for the 15,16-dihydrocyclopenta[a] - 
phenanthren-17-ones (X lV a— g) are collected in Table 4. 
Introduction of a m ethyl substituent at position 2, 3, 4, 
or 6 in the parent ketone (XIVa) caused a bathochromic 
shift of the m ain u .v . absorption band of 1— 2 nm ., but 
the 11-m ethyl ketone (XIVf) was anomalous in this 
respect, as previously observed.2 The 6-m ethoxy- 
ketone (XIVg) was identical w ith  that derived from the 
acid-catalysed dehydration of 6,7,15,16-tetrahydro-6,7- 
dihydroxycyclopenta[a] phenanthren-17-one.1
17 R. P. Linstead and S. L. S. Thomas, J . Chem. Soc., 1940, 
1127.
18 A. B. Turner and H. J. Ringold, J . Chem. Soc., 1967, 1720.
19 W. E. Bachmann and R. C. Edgerton, J . Amer. Chem. Soc., 
1940, 62, 2550.
The six-m embered ring d  homologue of the carcinogen  
(X lV f), nam ely 1,2,3,4-tetrahydro-ll-m ethylchrysen- 
1-one (X V III), was readily prepared from the ketone 
(XI) b y  application of the Reform atsky reaction w ith
(XY)
Me,
(XYT)
,H
Me.
(X Y m )
m ethyl y-bromocrotonate, following the m ethod of Cook 
and Schoental8 for the unsubstituted ketone. The 
resulting ester (XVI) was isomerised and saponified to  
yield the m ethylphenanthrylbutyric acid (X V II), which  
on cyclisation gave (X V III), identical w ith  this ketone 
previously prepared b y  a less convenient route.19
EXPERIMENTAL
Reagents and apparatus were generally as described in 
previous Parts of this series. Alumina used for column 
chromatography was Woelm, grade I, unless otherwise 
specified. Radioactivity was determined with a Nuclear 
Chicago Liquid Scintillation System, Mark I, or by counting 
thin films with a Nuclear Chicago Cl 16 gas-flow counter.
l-{2-Hydroxyethyl)naphthalenes (Ila—c; X  =  OH).—  
These alcohols were prepared by the general method of 
Bachmann and W ilds:8 l-(2-hydroxyethyl)naphthalene 
(Ila) (85%), m.p. 62°, b.p. 140— 141°/2 mm. (lit.,8b.p. 140—  
150°/0'2 m m .); l-(2-hydroxyethyl)-4-methylnaphthalene 
(lib) (80%), b.p. 152— 153°/l-6 mm. (lit.,20 b.p. 135°/0-5 
m m .); l-(2-hydroxyethyl)-4-methoxynaphthalene (lie) 
(90%), m.p. 84— 86°, b.p. 190°/2 mm. (lit.,21 m.p. 87°).
l-(2-Bromoethyl)naphthalenes (Ila—c; X  =  Br).—The 
alcohol (25 g.) and redistilled phosphorus tribromide (10 
ml.) were heated together on a steam-bath for 2 hr. After 
dilution with benzene the solutions were washed with  
2N-sodium carbonate and with water. Evaporation of the 
dried solutions gave oils which were distilled under reduced 
pressure: l-(2-bromoethyl)naphthalene (Ila) (71-5%), b.p. 
160°/5 mm. (lit.,8 172°/20 m m .); l-(2-bromoethyl)-4-methyl- 
naphthalene (lib) (42%), b.p. 152— 153°/1*6 mm. (lit.,20 
b.p. 142°/0*5 mm.); l-(2-bromoethyl)-4-methoxynaphthal- 
ene (lie) (43%), b.p. 161°/l-5 mm. (lit.,21 b.p. 161°/1*2 mm.).
4-(l-Naphthyl)butyric acids (I lia—c).—The bromides 
(Ila—c) were condensed with sodiomalonic ester by the 
procedure of Bachmann and Wilds 7 to yield the acids 
(I lia—c) as follows: 4-(1-naphthyl)butyric acid (Ilia)
(77%), m.p. 109— 110° (lit.,7 m.p. 109— 110°); 4-(4-methyl- 
l-naphthyl)butyric acid (Illb ) (63%), m.p. 148— 149°
20 D. J. C. Gamble and G. A. R. Kon, J. Chem. Soc., 1935, 
444.
21 G. A. R. Kon and F. C. J. Ruzicka, J. Chem. Soc., 1936,187.
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(Found: C, 78*7; H, 6*8. ClsH ieOa requires C, 78*9; H, 
7*05%); 4- (4-methoxy-1 -naphthyl)butyric acid (IIIc)
(70%), m.p. 129— 130° (lit.," m.p. 131°).
4t-{\-Naphthyl)butyric acids (VIla—d) from Tetralones (V). 
—These compounds were all prepared as described here for 
(V illa ).
A mixture of 1-tetralone (9*4 g.), zinc wool (3*5 g.), 
methyl y-bromocrotonate (10 g.), absolute ether (40 ml.), 
and dry benzene (40 ml.), containing a small crystal of 
iodine, was heated under reflux. Fresh zinc wool (0-5 g.) 
was added four times during 2 hr.; more methyl y-bromo­
crotonate (2 ml.) was then added and heating was continued 
for 4 hr. The cooled mixture containing much yellow solid 
was poured into 2N-hydrochloric acid and was shaken with 
more benzene. The organic layer was evaporated and the 
residue was hydrolysed by boiling with methanol (50 ml.), 
potassium hydroxide (5 g.), and water (10 ml.) for 2 hr. 
After dilution with water the solution was acidified and 
extracted with benzene. The extract was shaken with 
saturated sodium hydrogen carbonate solution and the 
aqueous layer was acidified to give the crude dienoic acid as 
a gum. This was re-esterified by heating for 1 hr. with  
methanol (80 ml.) to which acetyl chloride (10 ml.) had been 
cautiously added. After removal of the solvents under re­
duced pressure the methyl 2,4-dienoate (Via) was obtained 
as a brown syrup (9-68 g.), vm<nr 5-85s (conj. C=0) and 6-2s 
(conj. diene) p, (strong, broad) 330 nm.
This ester was isomerised with palladium black (0*5 g.) 
at 280— 300° for 1 hr. The product was dissolved in 
methanol, filtered from catalyst, and saponified as before.
4-(l-Naphthyl)butyric acid (V ila), m.p. 109— 110° (47*5% 
overall yield from 1-tetralone), was identical with the sample 
prepared by the first route \i.e. (Ilia)].
In a similar way 7-methyl-1-tetralone22 gave 4-(7-methyl- 
l-naphthyl)butyric acid (Vllb) (70%), m.p. 126— 126° 
(Found: C, 78*4; H, 6*85. C1BH 160 2 requires C, 78*9; 
7*05%); 6-methyl-l-tetralone 10 gave 4-(6-methyl-1-naph- 
thyl)butyric acid (VIIc) (56%), m.p. 134— 135° (lit.,10 
136°); .5-methyl-1-tetralone 23 led to 4-(5-methyl- 1-naph- 
thyl)butyric acid (VTId) (50%), m.p. 128— 129° (lit.,24 m.p. 
127— 129°).
4-(l-Naphthyl)pent-2-enoic Acid  (IXd).—Malonic acid 
(31 g.), pyridine (64 ml.), and 2-(l-naphthyl)propionalde- 
hyde (25 g.), prepared 14 in three steps from 1-naphthyl- 
magnesium bromide, were heated with piperidine (2 ml.) 
at 80° for 1 hr., then under reflux for 5 hr. The crystalline 
solid which separated when the mixture was diluted with 
water and acidified, gave the acid (IXd), m.p. 114— 115° 
(from acetic acid) (Found: C, 79-4; H, 6*25. C15H 14Oa 
requires C, 79*6; H, 6-25%).
4 -(l-Naphthyl)valeric Acid  (X).13—From (IXd). The 
enoic acid (IXd) (10 g.) was hydrogenated over 5% pallad­
ium-charcoal (0-5 g.) in ethanol (200 m l.); the theoretical 
volume of hydrogen was absorbed in 2 days. After removal 
of the catalyst the solution was evaporated and the residue 
was crystallised to yield the saturated acid (X) (9 g.), m.p. 
76— 77° (lit.,12 78—80°).
From ethyl 2-(l-naphthyl)propionate. This ester18 (24 g.) 
was reduced with lithium aluminium hydride (3 g.) in dry 
ether (100 ml.) to yield the alcohol (IXf) (17 g.), b.p. 160°/5 
mm. (lit.,14 130—132°/2 mm.). Treatment with phosphorus 
tribromide as already described gave 2-(l-naphthyl)propyl
23 F. Krollpfeiffer and W. Schafer, Ber., 1923, 56, 620.
23 J. Harvey, I. M. Heilbron, and D. G. Wilkinson, J. Chem, 
Soc., 1930, 423.
brom ide (IXg) (72%), b.p. 160— 162°/10 mm . (Found: Br, 
32*2. C18H 13Br requires Br, 32*1%). This bromide (47*5 
g.) was condensed w ith d iethyl sodiom alonate and the pro­
duct was decarboxylated as described before to  afford (X) 
(12-8 g.), m.p. 76°. A  R eform atsky reaction between
1-tetralone and m ethyl 4-brom opent-2-enoate25 followed  
b y  heating w ith palladium  black failed to  yield the acid (X).
1,2,3,i-T etrahydroph en an thren -l-on es  (IVa— c), (V H Ib—  
d), and (X I).— These ketones were obtained from the corre­
sponding naphthylbutyric acids ( I l ia — c), (V llb — d), and
(X) b y  cyclisation w ith  th ionyl chloride and tin(iv) 
ch lorid e;13 redistillation of the latter im m ediately before 
use improved yields. W hen necessary the crude product 
was chromatographed over alum ina w ith  toluene-dichloro- 
m ethane to  purify it  before recrystallisation from m ethanol. 
Yields, m .p.s, and spectroscopic data are collected in Table 1.
3-(3,4:-D ihydro-l-phenanthryl)-3-ethoxycarbonylpropion ic  
A c id s  (X H a— g) p rep a red  by  the Stobbe R eaction .— General 
procedure. The ketone (IVa) (17*8 g.) and diethyl succinate 
(30 g., 1*5 mol.) were heated under reflux for 1 hr. w ith  a 
solution of potassium  (5 g.) in dry t-butanol (80 ml.) under 
dry nitrogen. The cooled solution w as acidified w ith  
2N-hydrochloric acid and extracted w ith  ether, w hich was 
then  re-extracted w ith  N-ammonium hydroxide. The half-
Table 1
1,2,3,4-T etrahydrophenanthren-1 -ones
(Found: C, 85-85;
H, 6-6%) * 
(Found: C, 85-65; 
H, 6-6%) *
* C15H140  requires C, 85-7; H, 6-6%.
0 Ref. 6. 8 R. D. Haworth and C. R. Mavin, J . Chem. Soc., 
1932, 2720. « Ref. 21. <* Ref. 24.
Xmax. (nm.) (log e)
(IVa) 254 (4-82), 289 (3-95), 298 (3-92), 348 (3-30)
(IVb) 257 (4-72), 293 (3-96), 302 (3-92), 350 (3-41)
(IVc) 254 (4-58), 302 (3-77), 360 (3-62)
(VIHb) 255 (4-84), 289 (3-15), 298 (3-11), 350 (3-37)
(VIIIc) 257 (4-82), 294 (3-95), 302 (3-95), 350 (3-28)
(VUId) 257 (4-79), 294 (3-94), 302 (3-90), 350 (3-33)
(XI) 255 (4*76), 289 (3-92), 298 (3-91), 350 (3-30)
>Wx. in)
(IVa) 6-0 (C=0), 11-18, 11-40, 11-75, 12-14, 13-3, 13-98, 14-5 
(IVb) 6-0 (C=0), 11-06, 11-22, 11-60, 13-05, 13-30, 13-85 
(IVc) 6-0 (C=0), 11-0, 11-84, 13-0, 13-84, 14-40 
(VIHb) 5-98 (C=0), 11-24, 11-36, 11-90, 13-44, 14-02, 14-54 
(VIIIc) 6-0 (C=0), 11-25, 11-68, 12-20, 12-88, 14-08, 14-5 
(V llld) 5-98 (C=0), 11-32, 12-14, 12-40, 13-50, 14-20
(XI) 5-98 (0=0), 11-42, 12-08, 13-30, 14-40
ester which precipitated on acidification of th e alkaline 
extract was collected, washed w ith  w ater, and dried to  g ive  
a brown solid (22-7 g., 77% based on th e ketone). This
yield was raised to  97% b y  tw ice recycling th e  ketone re­
covered from the original ether extracts. W hen th e
24 R. B. Woodward, H. H. Inhoffen, H. O. Larson, and K. H. 
Menzel, Chem. Ber., 1953, 86, 594.
88 E. Buchta and K. Burger, Annalen, 1952, 576, 155.
Yield
(%) M.p. Lit. m.p.
(IVa) 85 95—96° 94—96° »
(IVb) 51 76 74—75 8
(IVc) 84 93—94 88—8 9 e
(VHIb) 63 89—90
(VIIIc) 78 70-6—71
(VUId) 82 167— 168 166— 167 «*
(XI) 91 79—81 81—83 a
1270 J. Chem. Soc. (C), 1970
ketone-ester ratio was varied the following yields were 
obtained:
Molar ratio % Product based on
Table 3
11,12,15,16-Tetrahydrocyclopenta[a]phenanthren-17-ones
ketone ester ketone ester
1-3 : 1 19 25
1 1 37 37
1 : 1-4 84 40'
1 1-9 77 43
H alf-esters prepared as described here are shown in Table 2; 
analytical sam ples were purified by recrystallisation from  
m ethanol.
Table 2
H alf-esters (X H a— g) prepared by the Stobbe reaction
Half- 
Ketone ester 
(IVa) (XIIa)« 
(VIHb) (X llb) 
(VIIIc) (XIIc) 
(VHId) (X lld )8 
(IVb) (X lle) 
(XI) (XHf) 
(IVc) (XHg)
° Lit.,8 m.p.
Found (%) Reqd. (%)
M.p.
148— 149°
123— 125
120— 122
154—155
C
74-2
74-3
74-35
74-4
H
6-35
6-5
6-4
6-5
^ 20^ 2 0 ^ 4
C
74-05
H
6-2
C21H 220 4 74-55 6-55
Not obtained crystalline
47—50
Not obtained crystalline 
148-2— 149-3°. 8 Lit.,24 m.p. 154-5— 155°
11,12,15,1 G-Tetrahydrocyclopenta[a]phenanthren-ll-ones 
(X H Ia— g).— The half-ester (X H a) (6-3 g.), acetic anhydride 
(64 ml.), and a solution (32 ml.) made b y  dissolving freshly  
fused zinc chloride in  glacial acetic acid (20 g./l.) w ithout 
exposure to  atm ospheric moisture were heated under reflux 
for 5 hr. under dry nitrogen. After cautious treatm ent w ith  
w ater (64 ml.) and concentrated hydrochloric acid (38 ml.), 
boiling was continued for 1 h r .; the solvents were then re­
m oved under reduced pressure. The residue was heated  
on a steam -bath for 30 min. w ith 5% potassium  hydroxide 
in  order to  hydrolyse any lactone. The crude product was 
collected, washed w ith  water, and dried; it  formed brown 
crystals (3-0 g., 63%) w hich were sufficiently pure for use in 
the n ext stage. Purification by chromatography on alumina 
w ith  toluene-dichlorom ethane gave analytically pure, pale 
yellow  crystals w ith  little  loss.
The compounds (X H Ib — g) were prepared in  a similar 
manner. A nalytical and spectroscopic data are collected  
in Table 3.
15,lQ-Dihydrocyclopenta\a]phenanthren-ll-ones (X lV a—  
g).— B y dehydrogenation with 2,3-dichloro-5,6-dicyano-1,4- 
henzoquinone (DDQ). The tetrahydro-ketone (0-5 g.) and 
D D Q  (0-7 g.) were heated under reflux in anhydrous benzene 
(80 ml.) under dry nitrogen for 70 hr. A fter rem oval of the  
solvent, the residue was chromatographed on alum ina as 
before. The fractions containing the dihydro-ketone gave 
pale yellow  crystals of the pure dihydro-compound. U n­
changed tetrahydro-ketones could also be recovered from  
th e  appropriate fractions and recycled to  increase the total 
yields, but product thus obtained is not included in  the  
yields given in Table 4.
W hen the 11-m ethyltetrahydro-ketone (X IH f) was 
treated w ith  D DQ  only a m inute quantity of the dihydro- 
ketone (X lV f) w as isolated.
B y dehydrogenation with platinum-charcoal. The ketone 
(X H Ia) (50 mg.) and catalyst (20% Pt~C 17 or 10% Pt~C; 
K och-Light) were heated together in a sm all hard glass 
test tube in a m etal bath. The cooled mass was dissolved  
in  toluene-dichlorom ethane, filtered from catalyst, and 
chromatographed on alumina.
Yield Found (%) Reqd. (%)
(%) M.p. C H C H
(XIHa) ■ 63 218—220° 86-9 6-0 C17H 140  87-2 6-0
(XIHb) 69 139— 140 87-5 6-451
(XIIIc) 61 222—223 86-8 6-4
(X llld ) 8 82 245—246 ■C18H 1#0  87-0 6-5
(X llle) 55* 180-5— 181-5 87-1 6-35
(XIHf) 87 177— 178 87-2 6-3
(XIHg) 30* 175— 176 81-45 6-05 C48H480 2 81-8 6-1
« Lit ,8 m.p 217-5—220-5°. 8 Lit.,24 m.p. 237-5—241-5°.
* From the crude half-esters.
W .  (nm.) (log ej 
(XIHa) 272 (4-61), 282 (4-70), 325 (3-18), 337 (3-21), 367 (2-97)
(XIHb) 272-5 (4-56), 283 (4-68), 327 (3-29), 338 (3-31), 370 (2-94)
(XIIIc) 272 (4-61), 283 (4-70), 327 (3-25), 340 (3-31), 368 (3-12)
(XHId) 276 (4-50), 288 (4-59), 327 (3-07), 342 (3-11), 372 (2-89)
(X llle ) 276 (4-50), 287 (4-65), 327 (3-06), 342 (3-12), 375 (2-99)
(XHIf) 271 (4-58), 282 (4-68), 327 (3-14), 341 (3-19), 368 (3-00)
(XHIg) 280 (4-53), 290 (4-64), 327 (2-92), 342 (2-94), 375 (2-99)
m^ax. [(A
(XIHa) 11-50, 11-94, 12-14, 13-24, 13-85
(XIHb) 10-25, 11-80, 12-10
(XIIIc) 11-16, 12-24, 12-98, 13-78, 14-10
(XHId) 12-20, 12-44, 13-18
(X llle ) 11-42, 12-15, 13-10
(XIHf) 11-52, 12-10, 12-28, 13-26
(XIHg) 11-70, 12-20, 13-15
Table 4
15,16-Dihy drocyclopenta [a] phenanthren-17-ones prepared 
b y dehydrogenation of the 11,12,15,16-tetrahydro- 
ketones w ith  DDQ
(XlVa) •
(XlVb)
(XIVc)
(XlVd)
(XlVe)
(XIYg)
-^max. (nm.) (log e)
(XIVa) 265 (4-89), 284 (4-52), 296 (4-38), 334 (3-24), 350 (3-40), 
367 (3-44)
(XlVb) 267 (5-05), 284 (4-22), 298 (4-12), 336 (3-11), 352 (3-34), 
370 (3-37)
(XIVc) 267 (5-02), 285 (4-67), 298 (4-41), 344 (3-28), 366 (3-25) 
(XlVd) 266 (4-98), 284 (4-67), 300 (4-36), 336 (3-06), 352 (3-22), 
370 (3-23)
(XIVe) 266 (5-06), 284 (4-69), 298 (4-45), 336 (3-10), 352 (3-32), 
370 (3-33)
(XlVf) * 264 (4-83), 288 (4-49), 301 (4-32), 342 (3-11), 358 (3-38), 
376 (3-43)
(XlVg) 270 (4-98), 287 (4-69), 302 (4-37), 361 (3-36), 378 (3-33) 
Vmax. (lA
(XlVa) 5-92 (C=0), 11-48, 11-82, 12-40, 12-86, 13-22, 14-18
(XlVb) 5-85 (0=0), 11-72, 11-90, 12-10, 12-50, 12-95, 14-08
(XIVc) 5-88 (C=0), 11-10, 11-60, 11-90, 12-36, 13-05, 13-90, 
14-10
(XlVd) 5-92 (C=0), 11-10,11-88, 12-05,12-34,12-60,13-85,14-15 
(XlVe) 5-86 (C=0), 11-44, 12-12, 13-00, 14-25
(X lV f)* 5-92 (C=0), 11-40, 12-38, 13-26, 14-00
(XlVg) 5-90 (C=0). 11-86, 12-24, 12-76, 13-04, 13-78, 14-12
* Prepared by catalytic dehydrogenation; m.p. 171— 172° 
(lit.,2 171— 172°).
The experim ents listed in Table 5 are representative of a 
number performed.
Yield Found (%) Reqd. (%)
(%) M.p. C H C H
34 203—204° 87-8 5-2 87-9 5-2
32 221—222 87-75 5-801
30
10
203—204
265—266
87-45
87-55
5-65
5-75 "C18H140 87-75 5-75
29 210-5—212 87-7 5-7 J
10 196— 197 82-65 5-75 ^ 1 8 ^ 1 4 ^ 2 ,82-6 5-85
° Lit.,2 m,.p. 203-—204‘>
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T a b l e  5
Products (%)
Time Catalyst Dihydro- Tetrahydro-
Temp. (min.) (mg-) (XlVa) (XHIa)
220—225° 3 9 (10%) 10 85
250—255 15 9 (10%) 20 75
250—255 60 10 (10%) 25 65
220—225 3 5 (20%) * 15 70
220—225 3 5 (20%) f 10 85
250—255 15 10(20%) 20 70
* Heated under dry nitrogen. f Heated under carbon
dioxide.
Similar results were obtained w ith the 11-m ethyl tetra- 
hydro-ketone (X IH f).
15,16 -D ihydro  [15,16-14C2] cyclopenta  [ai]phenanthren- 17-one. 
D iethyl [2,3-14C2]succinate {5-72 g., 1 mCi) was condensed  
w ith  (V illa ) (3-92 g.) and the product w as cyclised and 
dehydrogenated w ith  DDQ  as already described. The 
ketone, [15,16-14C2]-(X IV a) (1*54 g., 24 p Ci/mmole, 33%  
overall chem ical yield), m .p. 205— 206°, ran as a single 
spot on t.l.c . and had u.v. and i.r. spectra identical w ith  
those of an authentic specimen. Radiochem ical purity  
determ ined b y  dilution analysis was 98*6%.
15 ,16-D ihydro-ll-\}*C ]m ethylcyclopenta[a]phenanthren-
17-one. W ith use of a  vacuum -line technique to  exclude 
atm ospheric moisture and oxygen, the Grignard reagent 
prepared from [14C]methyl iodide (0*71 g., 1 mCi) was 
treated w ith  the k eto a ceta l2 (XV) (1*47 g.), and the  
product was dehydrated and dehydrogenated b y  boiling  
w ith nitrobenzene and acetic and hydrochloric acids as 
previously described.2 After chromatography of the crude 
product [me/Ay/-14C]-(XIVf) (0*66 g., 208 p. Ci/mmole, 55% 
overall chem ical yield) w as obtained as pale yellow  needles, 
m.p. 175— 177°, the i.r. and u.v. spectra of which were
identical w ith  those of an analytical sample. The radio­
chemical purity was determ ined b y  dilution analysis to  be 
98%.
4i-{4:-M ethyl-l-phenanthryl)butyric A c id  (X V II).— 1,2,3,4- 
Tetrahydro-4:-m ethylphenanthren-l-one (XI) (1*72 g.) was 
treated w ith  zinc wool and m ethyl y-brom ocrotonate as 
described for the tetralones. The crude ester (XVI) was 
isomerised w ith palladium  black (200 mg.) a t 240— 260° for 
2 hr. under dry nitrogen. A fter separation from the cata­
ly st the saturated ester w as saponified to  yield  4-(4-m ethyl-
1-phenanthryl)butyric acid (X V II) (800 m g.), m.p. 150—  
152° (from benzene) (lit.,13 152— 152-5°).
1 ,2 ,3 ,4-T etrah y d r  o -ll-m e th y lch rysen -l-o n e  (X V III).— A
m ixture of the acid (X V II) (500 mg.) and th ionyl chloride 
(0-3 ml.) in anhydrous ether (5 ml.) containing 2 drops of 
pyridine was left for 1 hr., then evaporated under reduced 
pressure. The residue was dissolved in dry benzene (10 
ml.) and treated w ith  cooling in an ice-bath w ith  redistilled  
tin(iv) chloride (0-5 m l.). A fter 20 min. a t room tem pera­
ture the m ixture w as hydrolysed w ith  ice-cold hydrochloric 
acid and the benzene layer was washed w ith  aqueous sodium  
carbonate and water, dried, and evaporated. The residue 
gave 1,2,3,4-tetrahydro-ll-m ethylchrysen-l-one (X V III) 
(195 mg.), m .p. 139-5— 140° (from ethanol-acetone) (lit.,19 
138— 140°), X ^  267 (log e 5-32), 288 (4-84), 302 (4-64), 344 
(2-73), 363 (3-06), and 380 (3-10) nm.
W e thank the Im perial Cancer Research Fund for a  
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also thank T. S. B hatt and Miss J. Y . Comben for technical 
assistance, and J. F. Richards and D. W . Thom as for th e  
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Potentially Carcinogenic Cyclopenta[a]phenanthrenes. Part V.1 Syn­
thesis of 15,16-Dihydro-7-methylcyclopenta[a]phenanthren-l7-one
By M. M. C oom bs and (Mrs.) S. B. Jaitly , Chemistry Department, Imperial Cancer Research Fund, Lincoln's 
Inn Fields, London WC2A 3PX
15,16-Dihydro-7-methyIcyclopenta[a]phenanthren-17-one has been prepared by sodium and liquid ammonia 
reduction of the diethyl phosphate of its readily available 11-hydroxy-derivative.
A m ong the m onom ethyl derivatives of the hydrocarbon
15,16-dihydrocyclopenta[a]phenanthrene, of interest on 
account of its structural resemblance to  the natural 
steroidal sex hormones, the 7- and 11-m ethyl derivatives 
were found b y  Butenandt and Dannenberg 2 to  display  
weak carcinogenic activity. In more recent work in the 
17-ketone series we have sh ow n 3 that 11-m ethylcyclo- 
penta[a]phenanthren-17-one is a potent carcinogen, 
while the unsubstituted ketone and its 12-methyl and
6-m eth y l4 derivatives are w ithout activity. I t  was, 
therefore, of interest to synthesise and test the 7-m ethyl- 
17-ketone, but a number of unexpected difficulties were 
encountered when this was attem pted, apparently 
resulting from the strategic position occupied b y  the  
m ethyl group in relation to the five-membered ring in 
these compounds.
Em ploying the scheme described in Part I,5 2-acetyl- 
3-m ethylnaphthalene was converted into the furfuryl- 
idene derivative (I; R  =  Me). Treatm ent of the latter 
w ith acid gave the expected dioxoheptanoic acid (III; 
R =  Me) together w ith  considerable am ounts of a 
non-ketonic acid, C18H 160 3, to which the naphthylfuran  
structure (II) was assigned. The n.m.r. spectrum of 
(II) consisted of six  aromatic protons ( t  1-9—2-8), four 
m ethylene protons (m ultiplet centred at 7-05), an aryl 
m ethyl singlet (7-38), and a pair of one-proton doublets 
(3-47 and 3-82, each w ith J  7 Hz), assigned to the two  
furan hydrogen atoms. Although this compound was 
stable to hot hydrochloric acid, treatm ent w ith nitric 
acid in cold acetic acid cleaved the furan ring to give the  
dioxoheptanoic acid (III; R  =  Me), together w ith  a 
second acid w ith similar chromatographic properties. 
Since these conditions are those under which 2,5-diaryl- 
furans are oxidised to cis-l ,2-diaroylethylenes,6 the crude 
reaction m ixture was shaken w ith hydrogen in the 
presence of palladium on charcoal. No gas was absorbed, 
however, and t.l.c. showed that the com position of the 
m ixture was unchanged. The structure of this second  
compound was not pursued; nevertheless, the formation  
of (III; R  =  Me) from (II) adds support to the furan 
structure proposed for the latter.
In the unsubstituted series treatm ent of the fur- 
furylidene compound ( I ; R  =  H) w ith acid gives the 
dioxo-acid (III; R  =  H) as the only isolated product. 
In the present case conjugation of the carbonyl group
1 P a r t  IV , M . M . C o o m b s , S . B . J a i t l y ,  a n d  F .  E . H .  C ra w le y , 
/ .  Chem. Soc. (C ), 1970, 1266.
2 A . B u t e n a n d t  a n d  H . D a n n e n b e rg ,  Arch. Geschwulstfor-sch., 
1953, 6 , 1.
3 M . M . C o o m b s  a n d  C. J .  C ro f t ,  Progr. Exp. Tumor Res., 
1969, 11, 69.
w ith  the aryl rings is sterically inhibited b y the m ethyl 
group and, as Butenandt et a l?  have dem onstrated for 
the tetrahydro-analogue, th is favours cyclisation in­
volving this carbonyl group leading to the furan-acid.
CH:CH
'Me (U)
C0,H
JR (HT)
0
Treatm ent of the dioxoheptanoic acid ( I I I ; R  =  Me) 
with base afforded the cyclopentenone (IV ; R  =  Me) in  
high yield.
The German authors carried out a series of reactions 
similar to those described above, starting w ith  6-acetyl-
1,2,3,4-tetrahydro-7-m ethylnaphthalene. T hey reported  
that acid treatm ent of the furfurylidene derivative (V) 
led to  one product, the tetrahydroheptanoic acid (VI), 
while on cyclisation of the latter w ith  base tw o com ­
pounds, the cyclopentenone (VII) and the furan (VIII), 
were isolated. Since th is seem ed improbable on the  
basis of our results w ith  the naphthyl analogues, th is  
work was repeated. In  our hands acid treatm ent of (V) 
gave both (VI) and (VII) as expected, while w ith  base 
the dioxo-acid (VI) gave only the cyclopentenone (VII). 
W e are unable to account for th is discrepancy.
The cyclopentenone acid (IV ; R  =  Me) absorbed at 
259 nm. compared w ith  268 and 306 nm. for the un­
substituted acid (IV ; R  =  H) showing that, as in  
B utenandt’s com pound (VII), resonance of the enone 
m oiety w ith the naphthalene rings is inhibited. H ydro­
genation of the double bond in (IV ; R  =  Me) did  not 
occur sm oothly, as it did with the unsubstituted hom o- 
logue (IV; R  =  H ). More than the calculated volum e  
of hydrogen was absorbed and the product consisted of 
six  compounds, as judged b y  t.l.c. The com pound
4 U n p u b l is h e d  w o rk .
6 M. M. C o o m b s , J . Chem. Soc. (C ), 1966 , 9 5 5 .
6 R .  E .  L u t z  a n d  F .  N. W ild e r ,  J . Amer. Chem. Soc., 1934 , 
56, 978 .
7 A . B u te n a n d t ,  H .  D a n n e n b e r g ,  a n d  D . v o n  D re s lc r ,  Z. 
Naturforsch., 1948 , 4b, 69.
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present in  the largest am ount proved to  be the desired 
cyclopentanone acid (IX) required for cyclisation to  the  
11,17-diketone in order to com plete the synthesis b y the  
previously described m ethod. Unfortunately, separ­
ation of (IX) from the hydrogenation m ixture proved  
im practicable except on a sm all scale b y  t.l.c.
As in the unsubstituted series,8 the acid (IV ; R  =  Me) 
readily underwent cyclisation when boiled w ith  acetic 
anhydride to  give a high yield of ll-acetoxy-15 ,16- 
dihydro-7-m ethylcyclopenta[a]phenanthren-17-one ( X : 
R  =  Ac), from which the parent phenol (X ; R  =  H) 
and m ethyl ether (X ; R  =  Me) were prepared. The 
availability of th is phenol encouraged attem pts to  
rem ove the 11-oxygen function from it  in order to  arrive 
at the title  compound.
'Me
0(V)(IV)
HO-C0
Me Me
'Me ^ M e
(IX)
(XI)
( X I I )
addition, a benzylic ketone function. Difficulty was 
experienced in preparing the phenyltetrazoyl ether, 
probably as a result of the steric overcrowding, but the  
benzoxazolyl ether (XII) was obtained under rather 
vigorous conditions. Hydrogenation of th is ether 
occurred sluggishly at a pressure of 6 atmospheres over 
5% palladium -charcoal to  give only a trace of the  
required ketone (X I; R  =  H). The major product 
was chromatographically and spectroscopically distinct 
from the latter and was not the urethane (X I ; R  =  
PhNH*COO) which would have arisen through cleavage 
of the benzoxazoyl aryl-oxygen bond. The failure of 
th is reaction can probably also be attributed to steric 
factors.
A ttention was therefore directed towards reducing 
agents w ith  low steric requirements. Reduction w ith  
sodium in  liquid ammonia has this characteristic11 and  
was em p loyed 12 to  reduce aryl d iethyl phosphates to  
hydrocarbons b y  Kenner and W illiams. These authors 
reported that m ethyl benzoate could be obtained in 20%  
yield from the d iethyl phosphate of m ethyl salicylate 
b y  this m ethod, and this encouraged us to  attem pt to  
reduce [X I; R  =  O P O (O E t)2] w ithout prior protection  
of the ketone group. This phosphate was secured in  
good yield b y  prolonged treatm ent of a suspension of the  
phenol (X I; R  =  OH) in carbon tetrachloride w ith  
diethyl phosphite and triethylam ine.12 Reduction w ith  
two atom s of sodium  per molecule of phosphate in  a 
m ixture of liquid am monia and tetrahydrofuran led to  a  
m ixture of products from which the required ketone  
(X I; R  =  H) was readily isolated b y  column chromato­
graphy in  27% yield. Although th is yield  was low, the  
overall yield  from the acid (IV ; R  =  H) was 18%, 
similar to  the overall yield obtained in  the seven-stage 
synthesis partially described in Part I.5
This scheme was applied to  the 7-m ethyl-l 1-phenol 
(X ; R  =  H). Reduction of the derived diethyl 
phosphate [X ; R  =  PO^OEt)^ w ith  sodium in  liquid  
am m onia-tetrahydrofuran occurred sm oothly to furnish 
the required 15,16-dihydro-7-methylcyclopenta[a]phen- 
anthren-17-one (X III) in 43% yield. The u.v. absorp­
tion spectrum of th is ketone closely resembled those of
N .m .r. spectra (r-values) of 15,16-dihydro-7-m ethylcyclo- 
penta[a]phenanthren-17-ones 
CH2 protons
C-15
6-24t
6-42t
6-3t
6-72t
D eoxygenation was first investigated w ith  the easily  
ava ilab le8 unsubstituted phenol (X I; R  =  OH). Of 
th e m ethods for replacing phenolic hydroxy-groups b y  
hydrogen described in  the literature,9'10 the latter, 
involving catalytic hydrogenolysis of tetrazoyl or benz­
oxazolyl ethers under m ild  conditions, appeared to  be 
suitable for phenols such as (X ; R  =  H) bearing, in
8 R. Robinson, J . Chem. Soc., 1938, 1390.
9 W. H. Pirkle and J. L. Zabriskie, J . Org. Chem., 1964, 29, 
3124, and references cited therein.
(X; R =  Ac)
(X; R =  Me)
(XIII)
[Unsubstituted 
(XI; R =  H)
s =  Singlet, t  =  triplet, m =  multiplet. 
* Partly obscured by methyl singlet.
C-16
7-2m*
7-35m
7-28m
7-3m
Me protons t 
7-08s, 7-51s (Ac) 
7*18s, 5-9s (OMe) 
7-08s
]
its positional isomers, particularly that of the strongly  
carcinogenic ll-m ethyl-17-ketone,5 w ith  the exception
10 W. J. Musliner and J. W. Gates, J . Amer. Chem. Soc., 1966, 
88, 4271.
11 M. Smith in ‘ Reduction: Techniques and Applications in 
Organic Synthesis,' Marcel Dekker, Inc., New York, 1968, p. 96.
12 G. W. Kenner and N. R. Williams, J . Chem. Soc., 1955, 522.
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that the main band absorbed at a slightly higher w ave­
length. The n.m.r. spectra of the 7-m ethyl-17-ketones 
(X III) and ( X ; R  =  Ac, Me) differed from those of 
other cyclopenta [a] phen anthren-17-ones 5 not bearing a
7-m ethyl group, in dem onstrating that the 15-methylene 
protons were deshielded.
EXPERIMENTAL
R e a g e n t s  a n d  a p p a r a t u s  w e r e  g e n e r a l l y  a s  d e s c r i b e d  i n  
p r e v i o u s  P a r t s  o f  t h i s  s e r i e s  e x c e p t  t h a t  m o s t  o f  t h e  u . v .  
s p e c t r a  w e r e  r e c o r d e d  f o r  e t h a n o l  s o l u t i o n s  o n  a  P e r k i n -  
E l m e r  M o d e l  4 0 2  s p e c t r o p h o t o m e t e r .
A c id  T reatm ent o f  1 -F urfu rylid in eacety l-1 ,2 ,3 ,4-tetrahydro- 
Q-methylnaphthalene ( V ) .— T h i s  c o m p o u n d  (8 -9  g . ) ,  p r e p a r e d  
a c c o r d i n g  t o  B u t e n a n d t , 7 b . p .  1 8 0 ° / l - 5  m m . ,  m . p .  7 5 — 7 7 °  
( l i t . , 7 6 9 — 7 2 ° ) ,  w a s  b o i l e d  w i t h  e t h a n o l  (3 3  m l . )  a n d  c o n c .  
h y d r o c h l o r i c  a c i d  (8 -5  m l . )  f o r  9  h r . ,  w h e n  t h e  a l c o h o l  w a s  
r e m o v e d  u n d e r  r e d u c e d  p r e s s u r e .  T h e  d a r k  g u m  w a s  a g a i n  
b o i l e d  f o r  2  h r .  w i t h  a  m i x t u r e  o f  w a t e r  (4 7  m l . ) ,  g l a c i a l  
a c e t i c  a c i d  (4 7  m l . ) ,  a n d  c o n c .  h y d r o c h l o r i c  a c i d  (1 9  m l . ) ,  
t h e n  d e c a n t e d  w h i l e  h o t  f r o m  t h e  i n s o l u b l e  t a r  t h r o u g h  a  
p a d  o f  g l a s s  w o o l .  T h e  c r y s t a l s  w h i c h  s e p a r a t e d  w h e n  t h e  
f i l t r a t e  w a s  c o o le d  w e r e  c o l l e c t e d ,  t h e  m o t h e r  l i q u o r  w a s  
r e t u r n e d  t o  t h e  f l a s k ,  a g a i n  b o i l e d  f o r  2  h r . ,  a n d  t h e  w h o le  
p r o c e d u r e  w a s  r e p e a t e d  n i n e  t i m e s  u n t i l  o n l y  a  t r a c e  o f  
f u r t h e r  c r y s t a l s  w a s  o b t a i n e d  f r o m  t h e  c o o le d  e x t r a c t .  
E a c h  o f  t h e  1 0  c r o p s  ( t o t a l ,  4 -4 3  g .)  h a d  m . p .  1 1 0 — 1 1 5 °  
a n d  w a s  s h o w n  b y  t . l . c .  ( t o l u e n e - e t h a n o l ,  5 : 1 )  t o  c o n s i s t  
o f  t w o  c o m p o u n d s ,  p r e s e n t  i n  s i m i l a r  a m o u n t s .  R e ­
c r y s t a l l i s a t i o n  o f  a  p o r t i o n  (0 -5  g .)  f r o m  8 0 %  a q u e o u s  a c e t i c  
a c i d  g a v e  t h e  f u r y l n a p h t h y l  a c i d  ( V I I I )  ( 0 T  g . ) ,  m . p .  1 4 4 —  
1 4 5 °  ( l i t . , 7 1 4 3 ° ) .  A f t e r  d i l u t i o n  o f  t h e  m o t h e r  l i q u o r  w i t h  
a n  e q u a l  v o l u m e  o f  w a t e r  t h e r e  c r y s t a l l i s e d  t h e  d i o x o - a c i d  
( V I )  (0 -2  g . ) ,  m . p .  1 1 5 — 1 1 8 ° , w h i c h  a f t e r  t w o  r e c r y s t a l l i s ­
a t i o n s  f r o m  e t h a n o l  h a d  m . p .  1 2 3 — 1 2 4 °  ( l i t . , 7 1 2 0 — 1 2 2 °) 
( F o u n d :  C , 7 1 -6 ;  H ,  7 -4 5 . C a lc ,  f o r  C 18H 220 4 : C , 7 1 -5 ;  
H ,  7 -3 5 ) .  T h i s  a c i d  (0 -1 9  g .)  w a s  h e a t e d  u n d e r  r e f l u x  w i t h  
T 9 %  a q u e o u s  p o t a s s i u m  h y d r o x i d e  (1 9 -5  m l . )  f o r  3  h r .  
T h e  c o o le d  s o l u t i o n  w a s  a c i d i f i e d ,  e x t r a c t e d  w i t h  e t h e r ,  a n d  
t h e  e t h e r  w a s  w a s h e d  w i t h  w a t e r  a n d  d r i e d .  O n  e v a p o r ­
a t i o n  i t  y i e l d e d  c r y s t a l s  (0 -1 9  g . ) ,  t . l . c .  o f  w h i c h  s h o w e d  t h e  
p r e s e n c e  o f  s o m e  s t a r t i n g  m a t e r i a l  ( V I ) ,  i ? p  0 -5 0 , a n d  a  n e w  
a c i d  ( V I I ) ,  7?p  0 -5 8 , b u t  n o  t r a c e  o f  t h e  f u r y l - a c i d  ( V I I I ) ,  
i ? p  0 -6 6 . R e c r y s t a l l i s a t i o n  f r o m  a c e t o n e - l i g h t  p e t r o l e u m  
a f f o r d e d  ( V I I )  (4 0  m g . ) ,  m . p .  1 2 8 — 1 3 0 °  ( l i t . 7, 1 3 0 — 1 3 2 ° ) .
3-F urfurylideneacetyl-2-m ethylnaphthalene  ( I ;  R  =  M e ) .  
— C o n t r a r y  t o  a  p u b l i s h e d  r e p o r t , 13 h y d r o g e n a t i o n  o f  2 -  
m e t h y l n a p h t h a l e n e  o v e r  W 2  R a n e y  n i c k e l  a t  1 3 0  a t m . / 1 3 0 °  
g a v e  a  m i x t u r e  o f  l , 2 , 3 , 4 - t e t r a h y d r o - 6 - m e t h y l -  a n d  1 ,2 ,3 ,4 -  
t e t r a h y d r o - 2 - m e t h y l - n a p h t h a l e n e s  [ n .m . r .  M e  s ig n a l s ,  r 
7 -7 9  s  a n d  8 -9 9  d  ( /  5  H z ) ,  r e s p e c t i v e l y ]  w h i c h  w a s  c o m ­
p l e t e l y  s e p a r a b l e  o n l y  b y  g . l .c .  A  p u r e  s a m p l e  o f  t h e  
f o r m e r  w a s  t h e r e f o r e  p r e p a r e d  b y  C le m m e n s e n  r e d u c t i o n  14 
o f  1 ,2 ,3 , 4 - t e t r a h y d r o - 7 - m e t h y l n a p h t h a l e n -  1 -o n e  a n d  s u b ­
m i t t e d  t o  a  F r i e d e l - C r a f t s  r e a c t i o n  15 w i t h  a c e t y l  c h l o r i d e  t o  
y i e l d  6 - a c e t y l - l , 2 , 3 , 4 - t e t r a h y d r o - 7 - m e t h y l n a p h t h a l e n e ,  b .p .  
1 4 2 — 1 4 4 ° /4  m m . ,  m . p .  3 1 — 3 2 °  ( l i t . , 16 o i l  b .p .  1 5 6 — 1 5 7 ° /1 1  
m m . ) .  D e h y d r o g e n a t i o n  w i t h  s u l p h u r  15 a f f o r d e d  2 - a c e t y l -
3 - m e t h y l n a p h t h a l e n e ,  b . p .  1 8 4 — 1 8 8 ° /2 3  m m . ,  m . p .  8 2 — 8 3 °  
( l i t . , 15 o i l  b . p .  1 6 4 ° /1 1  m m . )  ( f r o m  l i g h t  p e t r o l e u m ,  t h e n  
e t h a n o l )  ( F o u n d :  C , 8 5 -0 ;  H ,  6 -7 . C a lc ,  f o r  C 13H 120 :  
C , 8 4 -7 5 ;  H ,  6 - 6 % ) ,  m e t h y l  s i n g l e t s  t  7 -3 0  a n d  7 -3 3 .
13 L . F .  F ie s e r  a n d  R .  N . J o n e s ,  J. Amer. Chem. Soc., 1938, 
60, 1940.
T h i s  k e t o n e  (4 6 -1  g .)  w a s  d i s s o l v e d  i n  a  s o l u t i o n  c o n t a i n ­
i n g  f u r f u r a l d e h y d e  (1 7 -1  m l . ) ,  e t h a n o l  (1 2 5  m l . ) ,  a n d  
2 N - s o d iu m  h y d r o x i d e  s o l u t i o n  (5  m l . )  a n d  l e f t  a t  r o o m  t e m p ,  
f o r  18  h r .  T h e  y e l l o w  c r y s t a l s  w e r e  c o l l e c t e d  a n d  w a s h e d  
w i t h  c o l d  e t h a n o l .  T h e  fu rfu ry lid en e  com pound  ( I ;  R  =  
M e) (4 1 -1  g .)  h a d  m . p .  1 0 3 — 1 0 5 ° , r a i s e d  t o  1 0 9 — 1 1 0 °  b y  
f o u r  r e c r y s t a l l i s a t i o n s  f r o m  m e t h a n o l  ( F o u n d :  C , 8 2 -7 ;  
H ,  5 -7 5 . C 18H 14O a r e q u i r e s  C , 8 2 - 4 ;  H ,  5 - 4 % ) ,  Xm!tY ( lo g  s) 
2 2 3 -5  (4 -8 4 ) ,  2 5 5  (4 -3 8 )  n m .  (4 -1 3 ) ,  3 3 3 .
A c id  T reatm ent o f  3 -F u r fu ry lideneacety l-2-m ethylnaphtha- 
lene ( I ;  R  =  M e ) .— T h e  f u r f u r y l i d e n e  c o m p o u n d  ( I ;  
R  =  M e) (4 7  g .)  w a s  h e a t e d  u n d e r  r e f l u x  f o r  9  h r .  w i t h  
e t h a n o l  ( 1 7 5  m l . )  c o n t a i n i n g  c o n c e n t r a t e d  h y d r o c h l o r i c  a c i d  
(4 5  m l . ) .  T h e  e t h a n o l  w a s  r e m o v e d  u n d e r  r e d u c e d  p r e s s u r e  
a n d  t h e  r e s u l t i n g  b l a c k  g u m  w a s  e x t r a c t e d  r e p e a t e d l y  b y  
b o i l i n g  w i t h  a  m i x t u r e  o f  g l a c i a l  a c e t i c  a c i d  ( 2 5 0  m l . ) ,  
w a t e r  ( 2 5 0  m l . )  a n d  c o n c e n t r a t e d  h y d r o c h l o r i c  a c i d  ( 1 0 0  
m l . ) ,  a s  d e s c r i b e d  f o r  t h e  t e t r a h y d r o - a n a l o g u e .  T h e  
p r o d u c t ,  o b t a i n e d  i n  1 0  c r o p s  ( t o t a l ,  2 2 -7  g .)  a l l  o f  w h i c h  
h a d  m . p .  1 0 5 — 1 3 0 °  a n d  c o n s i s t e d  o f  t w o  c o m p o u n d s  a s  
j u d g e d  b y  t . l . c . ,  w a s  d i s s o l v e d  i n  h o t  8 0 %  a c e t i c  a c i d  
(1 8 0  m l . ) .  B r o w n  c r y s t a l s  (9 -5 7  g . ) ,  m . p .  1 4 5 — 1 5 3 ° , 
s e p a r a t e d  w h i c h  a f t e r  f u r t h e r  r e c r y s t a l l i s a t i o n  f r o m  e t h y l  
a c e t a t e  a n d  t h e n  n - b u t a n o l  g a v e  5 - [ 2 - ( 3 -m ethylnaphthyl)']- 
fu ra n -2 -p ro p io n ic  acid  ( I I ) ,  m . p .  1 5 7 — 1 5 8 °  ( F o u n d :  C , 
7 6 -9 5 ;  H ,  5 -9 5 . C 18H 160 3 r e q u i r e s  C , 7 7 -1 ;  H ,  5 - 7 5 % ) ,
Xmax. 2 5 5  (4 -4 9 )> 2 7 4  (4 ,5 6 )> 3 1 0  (4 ' 2 2 )> 3 4 8  n m - (3 '2 9 ) .  T h e  
m o t h e r  l i q u o r  w a s  h e a t e d  a n d  d i l u t e d  w i t h  h o t  w a t e r  
( 1 0 0  m l . ) ;  o n  c o o l i n g  7-[2-(3-m ethyln aphthyl)]-4 ,7 -d ioxo- 
heptoic acid  ( I I I ;  R  =  M e) (1 0 -1  g . ) ,  m . p .  1 1 6 — 1 2 0 ° , 
s e p a r a t e d  a s  f a w n  n e e d l e s .  R e c r y s t a l l i s a t i o n  f r o m  a q u e o u s  
m e t h a n o l  g a v e  a  s a m p l e  m . p .  1 2 3 — 1 2 4 °  ( F o u n d :  C , 7 2 - 6 5 ;  
H ,  6 -0 . C 18H 180 4 r e q u i r e s  C , 7 2 - 4 5 ;  H ,  6 - 1 % ) ,  X , ^  2 4 1
(4 -6 3 ) ,  2 4 8  (4 -6 2 ), 2 8 3  (3 -8 8 ) ,  3 3 2  n m .  ( 3 - 1 3 ) ;  5 -8 8 ,
5 -9 0 , 5 -9 7  p ;  t  7 -4 2  (s , M e ) .
T h e  f u r a n  ( I I )  (1 2  g .)  w a s  s u s p e n d e d  i n  a c e t i c  a c i d  ( 1 0 0  
m l . )  w h i l e  c o n c e n t r a t e d  n i t r i c  a c i d  (5  m l . )  w a s  a d d e d  d r o p -  
w is e  w i t h  c o o l in g  s o  t h a t  t h e  t e m p ,  o f  t h e  m i x t u r e  d i d  n o t  
e x c e e d  2 0 ° . A f t e r  5  m i n .  t h e  c l e a r ,  p a l e  o r a n g e  s o l u t i o n  
w a s  p o u r e d  i n t o  w a t e r  (5 0 0  m l . ) ,  a n d  t h e  p r e c i p i t a t e  w a s  
c r y s t a l l i s e d  f r o m  e t h a n o l  (5 0  m l . ) .  T h e  f i r s t  c r o p  (5 -7 2  g .)  
w a s  s h o w n  b y  t . l . c .  ( t o l u e n e - e t h a n o l ,  1 :  5) t o  c o n s i s t  o f  t h e  
d i o x o h e p t a n o i c  a c i d  ( I I I ; R  =  M e )  t o g e t h e r  w i t h  a  s e c o n d ,  
s l i g h t l y  m o r e - p o l a r  c o m p o u n d ;  t h e  s e c o n d  c r o p  (0 - 4 0  g .)  
w a s  a l m o s t  p u r e  ( I I I ;  R  =  M e ) .  R e c r y s t a l l i s a t i o n  o f  a  
s p e c i m e n  f r o m  e t h a n o l  g a v e  n e e d l e s ,  m . p .  1 2 5 — 1 2 6 ° , n o t  
d e p r e s s e d  o n  a d m i x t u r e  w i t h  p u r e  ( I I I ;  R  =  M e ) ,  m . p .  
1 2 3 — 1 2 4 ° , d e s c r i b e d  a b o v e .  A  p o r t i o n  (0 -5  g .)  o f  t h e  f i r s t  
c r o p  w a s  d i s s o l v e d  i n  e t h y l  a c e t a t e  (2 0  m l . )  a n d  s h a k e n  w i t h  
5 %  p a l l a d i u m - c h a r c o a l  i n  a n  a t m o s p h e r e  o f  h y d r o g e n .  
N o  u p t a k e  o f  g a s  w a s  o b s e r v e d  a n d  t . l . c .  d e m o n s t r a t e d  t h a t  
t h e  m i x t u r e  w a s  u n c h a n g e d .
[2-(3-M ethylnaphthyl)~ \-2-oxo-5-cyclopent-l(5)-eneacetic acid  
( I V ;  R  =  M e ) .— T h e  d i o x o - a c i d  ( I I I ;  R  =  M e )  (5 -0  g .)  
d i s s o l v e d  i n  2 %  a q u e o u s  s o d i u m  h y d r o x i d e  s o l u t i o n  (5 0 0  
m l . )  w a s  k e p t  a t  9 5 °  f o r  8 0  m i n .  T h e  g u m  w h i c h  s e p a r a t e d  
w h e n  t h e  c o o le d  s o l u t i o n  w a s  a c i d i f i e d  w a s  e x t r a c t e d  w i t h  
d i c h l o r o m e t h a n e  a n d  t h e  e x t r a c t  w a s  w a s h e d  w i t h  w a t e r ,  
a n d  d r i e d .  E v a p o r a t i o n  y i e l d e d  a  g u m  (4 -0  g .)  w h i c h  w a s  
c r y s t a l l i s e d  f r o m  n - b u t a n o l  (8  m l . )  t o  g i v e  t h e  a cid  ( I V ; 
R  =  M e) (2 -4  g . ) ,  m . p .  1 8 2 — 1 8 4 °  r a i s e d  t o  1 8 5 — 1 8 6 °  b y  
t h r e e  r e c r y s t a l l i s a t i o n s  f r o m  e t h a n o l  ( F o u n d :  C , 7 6 - 9 ;
14 F .  K ro llp fe i f fe r  a n d  W . S c h a fe r ,  Ber., 1 9 2 3 , 5 6 B, 6 2 0 .
15 P .  K a r r e r  a n d  A . E p p r e c h t ,  Helv. Chim. Acta, 1 9 4 0 , 23, 
272 .
Org. 233
H, 5-65. C18H 160 3 requires C, 77-1; H, 5-75%), 222
(4*78), 259 (4-21), 321 nm. (3-00), 5-85 (carboxyl and
ketone C=0) and 6*04 jje. (C=C). The methyl ester, prepared 
from the acid with methanol and dry hydrogen chloride, 
formed an oil vm!1Y 5-77 (ester G=0), 5-88 (ketone C=0), 
and 6-10 p, (C=C).
{2-{3-Methylnaphthyl)~\-2-oxo-5-cyclopentaneacetic Acid  
(IX).—The above ester (3*76 g.) in methanol (20 ml.) was 
shaken with 5% palladium-charcoal (1 g.) in hydrogen. 
After 165 hr. the calculated volume of hydrogen had been 
taken up, but gas was still being absorbed. T.l.c. (dichloro- 
methane) showed the presence of starting material and one 
major and 5 minor products. Attempts to separate this 
mixture by chromatography on silica-gel columns with 
several solvent systems failed, and a portion was finally 
resolved by preparative t.l.c. The zone bearing the major 
product was eluted to give an oil, Xmax 273 nm., which was 
saponified with 10% aqueous sodium hydroxide containing 
some ethanol at the boil for 30 min. Acidification gave a 
solid which was crystallised from ethanol to form prisms of 
the saturated acid (IX), m.p. 140° (Found: C, 76-65; H, 6-3. 
C18H 180 3 requires C, 76-55; H, 6-45%), Xmx 229 (4-96), 
272-5 (3-66), 280-5 (3-65), 309 (2-71), 323 nm. '(2-60); vmax_
5-72 (saturated 5-membered ring CO), 5-85 p (carboxyl CO).
15,10-Dihydrocyclopenta[a\phenanthren-17-one (XI; R  =  
H) from the 11-Diethyl Phosphate.—The unsaturated acid 
(IV; R  =  H) (6-00 g.) was converted into the phenol (XI; 
R  =  H) (4-77 g.) according to Robinson.8 This phenol 
(4-77 g.) was stirred with carbon tetrachloride (20 ml.) and 
diethyl phosphite (2-58 ml.) while triethylamine (2-8 ml.) 
was added drop wise. The mixture became warm. After 
being allowed to stand at room temp, for 6 days protected 
from moisture, the paste was dissolved by the addition of 
dichloromethane and extracted with 0-lN-sodium hydroxide. 
The organic layer was washed with water, dried, and 
evaporated to give a brown solid which was crystallised 
from ethanol (50 ml.). There separated fawn needles 
(5-97 g.) of diethyl ll-{15,10-dihydro-17-oxocyclopenta{a\- 
phenanthryl) phosphate [XI; R =  OPO(OEt)2], m.p. 144—  
145° (Found: C, 65-85; H, 5-4; P, 7-8. C21H210 5P
requires C, 65-65; H, 5-5; P, 8-3%), Xmax 262 (4-83), 288-5 
(4-48), 302 (4-32), 340 (3-27), 357 (3-52), 375 nm. (3-59), 
vmax (aryl ketone), 7-9 (P-O-aryl), 9-8 p (P-O-alkyl).
This phosphate (5-97 g.) was suspended in liquid ammonia 
(300 ml.) and sodium-dried tetrahydrofuran (100 ml.) in a 
flask fitted with a solid carbon-dioxide cold-finger condenser 
and sodalime drying tube. Sodium (0-69 g., 2 atom per 
molecule of phosphate) cut into ca. 50 pieces, was added 
slowly with magnetic stirring during 1 hr. so that the blue 
colour from each fresh addition was discharged before the 
next addition was made. A clear, dark brown solution was 
formed when ca. 20%  of the sodium had been added. When 
addition was complete the solution was stirred for a further 
15 min. after which the ammonia was evaporated in a 
stream of nitrogen using a warm water-bath. Water was 
added and the mixture was extracted with dichloromethane. 
The organic solution was washed with water until the 
washings were neutral and evaporated to give a brown gum 
shown by t.l.c. to  contain the required product (XI; 
R  =  H), a small quantity of the starting material, and 
several other compounds more polar than the former. This 
gum, dissolved in toluene-ethyl acetate was added to a 
column of alumina (Woelm Grade II, 250 g.). Elution with 
toluene containing 5% ethyl acetate gave fractions which 
on evaporation furnished 15,16-dihydrocyclopenta[a]phen- 
I
anthren-17-one (XI; R  =  H) as pale yellow needles 
(0-945 g.), m.p. 202—204°, with i.r. and u.v. spectra 
identical with those of an authentic specimen. The 
overall yield from the unsaturated acid (IV; R  =  H) was 
18%.
15,16-Dihydro-l l-hydroxy-7-methylcyclopenta[a]phen- 
anthren-Yl-one (X ; R  =  H).—The unsaturated acid (IV; 
R  =  Me) (5-95 g.) was heated under reflux with acetic 
anhydride (45 ml.) for 3-5 hr. The solution was cooled and 
crystals separated and were collected and dried (5-37 g.), 
m.p. 238—240°; a further quantity (0-77 g.) was obtained 
by hydrolysis of the mother liquor. ll-Acetoxy-15,10- 
dihy dr o-7-met hy Icy clopent a[a]phenant hren-17 -one (X; R  =  
Ac) formed straw-coloured laths (from n-butanol), m.p. 
243— 244° (Found: C, 78-8; H, 5-4. C20H 16O3 requires C, 
78-95; H, 5-3%).
This acetate (6-14 g.) was hydrolysed by heating it under 
reflux with ethanol (240 ml.), water (5 ml.), and sodium 
hydroxide (2-5 g.) for 1-5 hr. Acidification with 2 n -  
hydrochloric acid gave a yellow precipitate which was 
collected, washed with water, and dried in vacuo (4-52 g.). 
An analytical sample of the phenol (X ; R  =  H) was 
prepared, by crystallisation from n-butanol, as pale yellow 
prisms, m.p. 335—340° (decomp.) (Found: C, 82-9; H, 5-4. 
C18H 140 2 requires C, 82-4; H, 5-4%), X ^  230-5 (4-24), 
267 (4-79), 295-5 (4-38), 360sh (3-47), 378 (3-77), 398 nm. 
(3-86). The methyl ether (X ; R  =  Me), prepared by methyl- 
ation of the phenol with dimethyl sulphate and sodium 
hydroxide in ethanol, formed needles (from ethanol), m.p. 
215—216° (Found: C, 82-65; H, 5-85. C19H 160 2 requires 
C, 82-6; H, 5-85%), Xmax 267 (4-81), 293-5 (4-37), 321 (3-92), 
355 (3-44), 373 (3-74), 393 nm. (3-81).
1 l-Benzoxazol-2-yloxy-15,16-dihydrocyclopenta[a]phen- 
anthren-17-one (X II).—To the sodium salt from the phenol 
(X I; R  =  OH) (2-32 g.), dried for 7 days over phosphorus 
pentoxide, was added sodium-dry toluene (25 ml.) contain­
ing 2-chlorobenzoxazole (1-54 g.) (b.p. 77— 78°/17 mm., 
lit.,18 92° in vacuo) and the mixture was heated under reflux 
for 70 hr. in the absence of moisture. The cooled mixture 
was diluted with dichloromethane, extracted with 0-1 n -  
sodium hydroxide, and the solution was finally washed with 
water and dried. Evaporation gave a brown solid (0-975 g.) 
which was crystallised from ethyl acetate to yield golden 
needles of the benzoxazoyl ether (XV), m.p. 237— 238°. A 
sample was sublimed for analysis at 180°/10“5 mm. (Found: 
C, 78-6; H, 3-9; N, 3-85. C24H 15N 0 3 requires C, 78-9; 
H, 4-15; N, 3-85%), X ^  229, 263, 285sh, 300, 338, 355, 
373 nm.
The above ether (100 mg.) and 5% palladium-charcoal 
(50 mg.) in ethyl acetate (25 ml.) was shaken in hydrogen at 
6 atm. and 30— 35° for 24 hr. (the starting material was 
largely recovered after less drastic treatment). T.l.c. 
(dichloromethane) revealed some starting material (R-p 0-22) 
and a trace of the expected ketone (Rp 0-34) together with 
a slightly less-polar material (RF 0-30). After elution with 
ethanol this material had X^ ^ 261 nm. and no sharp peaks 
in the 300—400 nm. region characteristic of a cyclo- 
penta[a]phenanthrene.
The phenol (X I; R  =  OH) (1-0 g.) was heated with 
isocyanatobenzene (1 ml.) and dry pyridine (5 ml.) in a 
sealed tube at 100° for 18 hr. The crystals which filled the 
dark liquid were filtered off and recrystallised from n- 
butanol. The urethane (X I; R  =  PhNH*CO*0) formed
18 Neth. Pat. Appl. 6,505,511 {Chem. Abs., 1966, 64, 12,679h).
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cream needles, ^  263, 288, 301-5, 339, 353, 375 nm.; 
vmar. (NH), 5-86 (amide I), 5-90 (aryl ketone), 6-51 {x 
(amide II); I?F 0-14 (dichloromethane).
15,1 Q-Dihydro-7-methylcyclopenta [&]phenanthren-17-one 
(XIII).—The phenol (X; R  =  OH) (4-52 g.) was suspended 
in carbon tetrachloride (20 ml.) and treated with diethyl 
phosphite (3-25 ml.) and triethylamine (3-55 ml.) at room 
temperature for 13 days. Work-up as before yielded brown 
crystals of the diethyl phosphate [X; R  =  PO (O Et)2] 
(3-02 g.), m.p. 140— 142°, 266, 291, 305, 350, 368, and
396 nm.; vm,T 5-88 (aryl ketone), 7-82 (P-O-aryl), and
9-70 [x (P-O-alkyl).
This phosphate (3-00 g.) in liquid ammonia (150 ml.) and 
tetrahydrofuran (50 ml.) was reduced with sodium (0-36 g.) 
as described above. Chromatography of the crude product
on alumina gave fractions, homogeneous by t.l.c., which 
were combined and evaporated to yield pale yellow crystals 
(0-822 g.). Recrystallisation from ethanol gave 15,16- 
dihydro-7-methylcyclopenta[cL]phenanthren-17-one (XIII)
(0-665 g.), m.p. 198— 199° (Found: C, 88-05; H, 5-85. 
C18H 140  requires C, 87-75; H, 5-75%), X ^  268 (4-79), 286 
(4-42), 301 (4-28), 343 (3-23), 360 (3-41), 378 nm. (3-42); 
vmax 591 ketone)> n ’3' H -98, 12-92, 13-34 px.
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Potentially Carcinogenic Cyclopenta[a]phenanthrenes. Part V I.1 
1,2,3,4-Tetrahydro-17-ketones
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Cyclisation of 2-oxo-5*(5.6,7.8-tetrahydro-2-naphthyl)cyclopentaneacetic acid led to both angular and linear 
ring-fused products from which were derived 1,2,3,4,15,16-hexahydrocyclopenta[a]phenanthren-17-ones and
1.2,7,8,9,10-hexahydrocyclopent[a]anthracen-3-ones.
E s s e n t i a l  structural features associated with a high 
degree of carcinogenicity in compounds of the cyclo- 
penta[a]phenanthrene series appear to be the presence 
of a methyl substituent at C-ll and a C=C or C=0 
double bond at C-17.2 Reduction of the 11,12-double 
bond in the potent carcinogen ll-methyl-15,16-di- 
hydrocyclopenta[a]phenanthren-17-one (I) abolishes 
activity, but the effect of reduction elsewhere in this 
molecule has not been studied. 1,2,3,4-Tetrahydro- 
dibenz[a,A]anthracene retains carcinogenic activity com­
parable with that of the fully aromatic hydrocarbon,3 
and it was therefore of interest to prepare the 1,2,3,4- 
tetrahydro-derivative of compound (I), namely the 
ketone (lib). Additionally, knowledge of the u.v. 
absorption of this ketone was of importance in con­
nection with the structural elucidation of a major 
metabolite of the carcinogen (I) in the rat.4
The syntheses of the ketones (Ha and b) followed
1 Part V, M. M. Coombs and S. B. Jaitly, J . Chem. Soc. (C), 
1971, 230.
1 M. M. Coombs and C. J. Croft, Progr. E xp. Tumor Res., 
1969, 11, 69; also unpublished observations.
the general scheme employed in Part I.6 6-Acetyl-
1,2,3,4-tetrahydronaphthalene6 was converted into its 
furfurylidene derivative (III), which with hot acid 
gave the dioxoheptanoic acid (IV). Cyclisation of the 
latter under alkaline conditions led to the cyclopentenone 
acid (Va), which was reduced with lithium in liquid 
ammonia to the cyclopentanone acid (Via). Over- 
reduction was difficult to avoid when catalytic hydro­
genation over palladium was employed to reduce this 
tetrasubstituted double bond, and the cyclopentane 
acid (VIb) was isolated as a by-product.
In the naphthalene series, phosphoric acid-catalysed 
cyclisation of the analogue of (Via) occurs exclusive^ 
in the angular sense to yield a phenanthrene derivative. 
In the present case lack of the strongly directing, fused 
aromatic ring led to a 1 :4  mixture of the angular
* W. Lijinsky, H. Garcia, B. Tcrracini, and U. Saffiotti, 
J . N at. Cancer Inst., 1965, 84, 1.
4 F. E. H. Crawley, unpublished work.'
* M. M. Coombs, J . Chem. Soc. (C), 1966, 955.
* M. S. Newman and H. V. Zalin, J . Amer. Chem. Soc., 1943, 
65, 1097.
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(Vila) and linear (Villa) diketones. Each selectively 
gave a monoacetal [(Vllb) and (VUIb)] on acid- 
catalysed exchange with 2-ethyl-2-methyl-l,3-dioxolan.
Me
2
3
O j R  * H  
bj R = Me
( H I )
( n r )
I T )
a ; R = H 
bj  R = Me
a; X s 0  
bi X = H
The structures of these compounds followed from their 
i.r. spectra, which in both cases indicated a conjugated 
carbonyl group, and from the characteristic n.m.r. 
signals of their aromatic protons. Those of (Vllb) 
consisted of an AB quartet centred at t  2*88, whereas 
those of (VUIb) formed two rather broad ‘ singlets ’ 
at t  2-22 and 2*98. Ring closure of the cyclopentane 
acid (VIb) with phosphoric acid gave mainly the linear 
monoketone (VIIIc), with evidence of a second ketone, 
probably the angular isomer (VIIc).
Cyclisation of (Va) by heating with acetic anhydride 
led to a mixture of two isomeric acetoxy-ketones, (IX) 
and (Xa), readily distinguished by their n.m.r. spectra, 
the aromatic region of the latter consisting of three well 
resolved one proton singlets. In confirmation, dehydro­
genation of (IX) with 2,3-dichloro-5,6-dicyanobenzo-
1,4-quinone (DDQ) yielded the known 11-acetoxy-
15,16-dihydrocyclopenta[a]phenanthren-17-one,7 and 
similar dehydrogenation of the tetrahydroanthracen-3- 
one (Xa) gave 6-acetoxy-l,2-dihydrocyclopent[a]- 
anthracen-3-one (XIa). The u.v. absorption of this 
compound was similar to that of its 5-deacetyl derivative 
(Xlb) described later.
The acetal (Vllb) was converted into the ketone 
(lib) by reaction with methylmagnesium iodide followed 
by treatment with acid in the presence of nitrobenzene.5 
The unsubstituted tetrahydro-ketone (Ha) was prepared
from (Vllb) by reduction with sodium borohydride 
and subsequent treatment with acid and nitrobenzene. 
In contrast to the high yields of phenanthrenes pre­
viously obtained with this dehydration-dehydrogenation 
reaction,6 the yields of naphthalenes obtained in the 
present work were poor. Since it was essential to 
conserve for biological evaluation the small quantity 
of (lib) obtained, this ketone was characterised by mass 
spectrometry. The base peak was the molecular ion, 
mje 250. The next most abundant ion was at tnje 222 
(13-5%), corresponding to M  — CO, and for which a 
metastable peak at tn/e 197-3 was observed.
In a similar manner the linear acetal (Vllb) furnished
l,2,7,8,9,10-hexahydrocyclopent[a]anthracen-3-one (Xb). 
Dehydrogenation with DDQ gave the corresponding
9
8
(TXT)
AcO
( I X )
(X)
0 ; R = OAc 
bj R s H
( X I )
1,2-dihydro-compound (Xlb), with u.v. absorption 
characteristics almost identical with those of 2-acetyl- 
anthracene.8
EX PERIM EN TA L
Reagents and apparatus were generally as described in  
previous Parts of this series.
Q-Furfurylideneacetyl-1,2,3,4-tetrahydronaphthalene ( I I I ) . 
— To a solution of 6-acetyl-l,2,3,4-tetrahydronaphthalene • 
(202 g; b.p. 146° a t 10 m m Hg) in 2-furaldehyde (99 g) 
and ethanol (720 ml) was added aqueous sodium hydroxide 
(8 %  w /v ; 2 ml) dropwise during 20 min. A fte r 18 h a t 
room temperature the pale yellow crystals were collected 
and recrystallised from ethanol to  yield the furfurylidene 
compound ( I I I ) ,  m.p. 68— 69° (Found:' C, 80*8; H , 6-35. 
C i7H ieO , requires C, 80-9; H , 6-4% ), X ^ ( E t O H )  238-5
7 R. Robinson, / .  Chem. Soc., 1938, 1395.
• R. A. Friedel and M. Orchin, ' Ultraviolet Spectra of Aro­
matic Compounds,' Chapman and Hall, London, 1951, spectrum 
No. 393.
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(log e 3-60) and 342 nm (4-23), vffla3C(Nnjol) 1670 (CO), 
1015, 980, 886, 820, 808, 730, and 700 cm"1.
4,1-Dioxo-l- (5,6,7,8~tetrahydro-2-naphthyl) heptanoic A cid
(IV).—The furfurylidene compound (III) (210 g) was 
heated under reflux with conc. hydrochloric acid (195 ml) 
and ethanol (750 ml) for 9 h. The ethanol was removed 
under diminished pressure, and the dark gum which 
remained was boiled with a mixture of conc. hydrochloric 
acid (432 ml), glacial acetic acid (1073 ml) and water 
(1073 ml) for 2 h. The hot solution was decanted from the 
tar through a pad of glass wool and the crystals which 
separated on cooling were collected. The mother liquor was 
returned to the flask and boiled with the tar for 2 h. After 
seven repetitions of this cycle the crystalline material 
amounted to 165 g; recrystallisation from ethyl acetate 
gave the diketo-acid (IV) as needles, m.p. 115— 116° (Found: 
C, 70-75; H, 6-8. C17H 20O4 requires C, 70-8; H, 7-0%),
W ( E t0 H ) 215-5 (loe e 4‘14) and 258 nm (4-06)' W
(Xujol) 1680— 1740 (CO), 918, and 802 cm"1.
5-Oxo-2- (5,6,7,8-telrahydro-2-naphthyl)cyclopeni-l-ene- 
acetic Acid (Va).—A solution of the diketo-acid (IV) (10 g) 
in water (900 ml) containing potassium hydroxide (20 g) 
was maintained at 95° for 1 h. Charcoal was added and 
the hot solution was filtered, cooled, and acidified with 
conc. hydrochloric acid (128 ml). The precipitated acid
(V) was collected, washed writh water, and dried (9-7 g) ; 
it  was sufficiently pure for the next stage. A sample 
crystallised from n-butanol had m.p. 133— 134° (Found: 
C, 75-35; H, 6-65. C17H 180  requires C, 75-55; H, 6-7%),
vmax.(N u i o1) 1 7 3 0 ’ 1 6 7 5  (C ° )>  9 5 7 ' 8 2 2 « a n d  8 1 0  Cm_1- T h e  methyl ester (Vb) formed pale yellow needles (from ethanol),
m.p. 93—94° (Found: C, 76-3; H, 6-75. C18H 20O3 requires
C, 76-05; H, 7-1%), X^JEtO H ) 225-5 (loge 3-39) and
284 nm (3-60).
Reduction of the Unsaturated Acid (Va).— (a) With 
lithium in liquid ammonia. The acid (Va) (1-0 g) in dry 
tetrahydrofuran (10 ml) was added to a solution of lithium  
(400 mg) in liquid ammonia (375 ml) during 5 min, with 
cooling in acetone-solid carbon dioxide. Ammonium 
chloride (40 g) was then added during 20 min, followed by 
tetrahydrofuran (50 ml), and the mixture was stirred at 
room temperature for 14 h. Water was added and the 
aqueous layer was acidified and extracted with ether. 
Removal of the solvent left 2-oxo-5-(5,6,7,8-tetrahydro-2- 
naphthyl)cyclopentaneacetic acid (Via) (1-0 g) as brown 
gum which ran as a single spot, RF 0-20, on t.l.c. (5% 
ethyl acetate-dichloromethane); ?Virtv (EtOH) 273 and 
279 nm, vm i 1750 (five-membered ring ketone), 1710 
(COjH), 910, 827, and 810 cm*1.
(b) By hydrogenation over palladium. The acid (Va) 
(24-2 g, 0-1 mol), dissolved in ethanol (150 ml), was shaken 
with 5% palladium-charcoal in hydrogen. After 10 days
1-5 times the calculated amount of gas had been consumed, 
and the majority of the starting material had been reduced. 
Filtration and evaporation left a pale brown gum (20-4 g), 
which crystallised from ethanol to yield 2-(5,6,7,8-tetra- 
hydro-2-naphthyl)cyclopentaneacetic acid (Vlb) (8-5 g), 
m.p. 116— 117° (Found: C, 78-7; H, 8-4. C17H „ 0 2
requires C, 79-05; H, 8-6%), X^JEtO H ) 208 (loge 3-98), 
217 (3-83), 270 (2-90), and 279 nm (2-97), v ^ N u jo l)  1710 
(COtH), 916,830, and 812 cm-1. On t.l.c. (5% ethyl acetate- 
dichloromethane) the brown gum revealed three spots, 
RF 0-12 (Va), 0-20 (Via), and 0-53 (Vlb). A similar result 
was obtained when palladium-calcium carbonate was 
employed.
(c) Hydrogenation of the methyl ester (Vb). This ester 
(29-4 g) was reduced over palladium-charcoal as in (b) 
until t.l.c. showed absence of the starting material. The 
product was saponified to yield a brown gum (27-5 g), 
t.l.c. (dichloromethane) of which showed the presence of the 
cyclopentanone acid (Via), i?P 0-65, accompanied by the 
cyclopentane acid (Vlb), J?P 0-85.
11- 4^ cetoxy-1,2,3,4,15,16-hexahydrocyclopenta[a.]phenan- 
tkren-17-one (IX) and 5-acetoxy-1,2,7,8 ,9,10-hexahydrocyclo- 
pent[si}anthracen-3-one (Xa).—The cyclopentenone acid 
(Va) (5 g) was heated under reflux with acetic anhydride 
(40 ml) for 1 h. The needles (1-5 g) which separated on 
cooling were collected and crystallised repeatedly from 
benzene and from n-butanol to give the acetoxyanthracenone 
(Xa), m.p. 228— 229° (Found: C, 77-45; H, 6-0. C„H180 8 
requires C, 77-55; H, 6-15%), X ^ (EtOH) 263 (loge 4-57), 
287 (3-91), 297-5 (3-96), 308 (3-86), 338 (3-67), and 352 nm, 
(3-69), vmajo(Nujol) 1765 and 1190 (acetate), 1695 (conj. 
CO), 1050, and 908 cm*1, t 2-31, 2-40, and 2-62 (each 1H, s, 
aromatic).
The acetic anhydride mother liquor was poured into 
water (500 ml) and extracted with dichloromethane; the 
extract was washed with water, dried, and evaporated. 
The crystalline residue (3-4 g) was recrystallised from 
benzene and sublimed to yield the aceioxyphenanthrenone 
(IX), m.p. 207—208° (Found: C, 77-1; H, 5-95. C„H 180 3 
requires C, 77-55; H, 6-15%), Xma3L(EtOH) 222 (log e 4-27), 
257-5 (4-84), 286 (4-00), 296 (4-04), 307 (3-91), 340 (3-72), 
and 352 nm (3-81), vmaT(Nujol) 1760, 1206 (acetate), 1700 
(conj. CO), 1040, 907, and 810 cm-1.
The acetoxy-ketone (IX) (73 mg), DDQ (141 mg), and 
dry benzene (4 ml) were boiled together for 21 h. The 
solution, containing precipitated hydroquinone, was diluted 
with ether (10 ml) and filtered. Removal of solvent from 
the washed filtrate and sublimation of the residue gave
11-acetoxy-15,16-dihy drocyclopenta[o]phenanthren-17-one, 
m.p. and mixed m.p. 215— 216°.
The acetoxy-ketone (Xa) (290 mg) and DDQ (567 mg) 
were boiled together in dry benzene (8 ml) for 24 h. The 
product, isolated as already described, was chromato­
graphed on silica gel, with ethyl acetate-dichloromethane 
(1: 20) as eluant. Fractions homogeneous by t.l.c. were 
pooled and sublimed to yield 5-acetoxy-1,2-dihydrocyclo- 
pent[a]anthracen-3-one (Xla), m.p. 231—233°, Xmai^ (EtOH) 
264-5 (log e 4-48), 277 (4-45), 329 (3-53), 347 (3-58), 364 
(3-61), 378 (3-55), and 398 nm (3-47).
1,2,3,4,13,14,15,1 &-Octahydrocyclopenta[ai]phenanthrene- 
11(12H),17-dione (Vila) and 1,3a,4,7,8,9,10,l ib -Octahydro- 
cyclopent[a]anthraccne-Z(21l),5-dione (V illa ).—Phosphoric 
acid (20 g) and phosphorus pentoxide (20 g) were heated 
together at 120° for 2-5 h to give a clear solution. The 
keto-acid (Via) (5-4 g) was added during 15 s; the mixture 
was stirred at 120— 125° for a further 2-5 min, poured 
onto ice, and extracted with ethyl acetate. The extract 
was washed with sodium hydrogen carbonate solution, 
and dried. The products from three cyclisations (14-7 g) 
were together chromatographed on a column of silica gel 
(2-5 kg) with ethyl acetate-dichloromethane (1:19); 
50 ml fractions were collected. Fractions 114— 122 were 
evaporated and the product (2-2 g) was crystallised from 
ethanol to afford the phenanthrenedione (Vila), m.p. I l l —  
113° (Found: C, 80-25; H, 7-2. C17H 180 2 requires C, 80-3; 
H, 7-15%), Xmai(EtOH) 200 (log e 4-25), 257 (3-91), and 308 
nm (3-33), vjnax(Nujol) 1740 (five-membered ring ketone), 
1680 (conj. CO), 990, 930, and 838 cm-1. Fractions 123—
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163 were combined and the product (6*4 g) was recry sta l­
lised twice from ethanol to  yield the anthracenedione 
(V i l la ) ,  m.p. 102— 103° (Found: C, 80-45; H , 6-95%),
* w ( E t0 H ) 221 (l0S e 4*36)« 264 (4'12)« ^  302 nm (3'35)-
v (Nujol) 1733 (five-membered ring ketone), 1675 (conj. 
ketone), 1605 (strong, aromatic C=C), 935, and 841 cm-1, 
t  2-30 and 2-89 (aromatic singlets).
17, 11-Ethylenedioxy-1,2,3,4,12,13,14,15,16,11-decahydro- 
cyclopenta[a]phenanthren-ll-one (V llb )  and 3,3-Ethylene- 
rfto.ry-l,2,3,3a,4,7,8,9,10,11 b-decahydrocyclopcnt[&] anthracen-
5-one (V U Ib ).— A  crude m ixture of the diketones (V ila )  
and (V i l la )  (7-0 g) was heated w ith  2-ethyl-2-m ethyl-1,3- 
dioxolan (42 ml) and toluene-/>-sulphonic acid (20 mg) 
while the more volatile products (1 0  ml) were slowly 
removed by distillation. A fter 5 h the solution was 
diluted w ith  ether, washed w ith  sodium hydrogen carbonate 
solution and w ith  water, and dried. The gum (7-0 g) 
le ft on evaporation was chromatographed on a column of 
alumina (Woelm, grade I I )  w ith  hexane-ether (1 : 1); 
150 m l fractions were collected. Fractions 24— 50 yielded 
material (1*7 g) which was crystallised repeatedly from  
methanol to yield the phenanthrene acetal (V llb ) , m.p. 
82— 83° (Found: C, 76-65; H , 7-4. C19H 2jO s requires 
C, 76-5; H , 7-45% ), X ^ J E tO H ) 218 (loge 4-29), 256 
(3-88), and 309 nm (3-33), vM T (Nujol) 1680 (conj. ketone), 
950, 910, 840, and 812 cm-1. Fractions 51— 89 gave 
material (2-4 g) which crystallised from methanol to give 
the anthracene acetal (V U Ib ), m.p. I l l — 114° (Found: 
C, 76-5; H , 7-1% ), X ^ E t O H )  217 (loge 4-59), 262 (4-30), 
and 304 nm (3-58), v^^JNujol) 1680 (conj. CO), 1610s 
(aromatic C=C), 1050, 1020, 950, and 915 cm-1.
1,2,3,4,15,16-Hexahydrocyclopenla[a]phenanthren-17-one 
( I la ) .— The oxo-acetal (V llb ) (800 mg), tetrahydrofuran  
(5-3 m l), water (13 ml), and sodium borohydride (0-26 g) 
were stirred under reflux for 8  h, after which the p H  was 
brought to 6-5 by careful addition of dilute acetic acid. 
The m ixture was diluted w ith  water and extracted w ith  
dichloromethane; removal of the solvent gave a gum 
(0-60 g) which showed no i.r. carbonyl absorption. This 
material was dissolved in glacial acetic acid (15 ml) and 
nitrobenzene (4 m l); addition of conc. hydrochloric acid 
(4 ml) produced a green colouration. A fte r 30 m in under 
reflux the solution was diluted w ith  water and the nitro­
benzene was removed in steam. The p artly  crystalline 
residue was extracted w ith  dichloromethane to give a gum 
(0-40 g) which was chromatographed on a column of silica 
gel (100 g) in ethyl acetate-toluene (1 :2 0 ). Fractions 
homogeneous by t.l.c. were combined (80 mg), recrystallised 
from ethanol, and finally sublimation gave the hexahydro- 
phenanthren-Yl-one ( I la ) , m.p. 145— 146° (Found: C, 86-05; 
H , 6-5. C „ H x#0  requires C, 86-4; H , 6 -8 % ), ^  (E tO H ) 
256-5 (loge 3-96), 282 (3-25), 292-5 (3-27), 333-5 (2-86), and 
348 nm (2-91), v ^ J N u jo l)  1700 (conj. CO), 1048, 847, 
830, and 800 cm-1.
1,2,7,8 ,9 ,\0-Hexahydrocyclopent[si\anthracen-Z-one (X b ).—  
The linear oxo-acetal (V U Ib ) (600 mg) was reduced and 
treated w ith  nitrobenzene and acid as already described 
fo r the angular isomer. The hexahydroanthracen-3-one 
(X b) (115 mg), m.p. 158— 159°, crystallised from ethanol
(Found: C, 86-0; H, 6-50%), X ^  (EtOH) 245-5 (log e 4-67), 
261 (4-74), 284 (3-92), 295 (4-01), 305 (3-90), 337 (3-48), and 
351 nm (3-45), v ^ N u jo l)  1695 (conj. CO), 917, 870, 820, 
757 cm-1. Treatment of this ketone with DDQ as already 
described gave yellow crystals of l,2-dihydrocyclopent[uj- 
anthracen-3-one (Xlb), Xmtt(EtOH) 271 (loge 4-30), 
323 (3-44), 342 (3-26), 360 (3-21), 378 (3-06), and 396 nm 
(3-14). 2-Acetylanthracene8 has X^^EtOH) 270, 326, 
341, 360, 380, and 398 nm.
1,2,3,4,15,16-Hexahydro-1 \-methylcyclopenta\yCyphenan- 
thren-ll-one (lib ).—The oxo-acetal (Vllb) (300 mg), 
dissolved in dry benzene (5 ml), was added to a solution of 
methylmagnesium iodide [from magnesium turnings (120 
mg), methyl iodide (0-30 ml), and dry ether (5 ml)] under 
dry nitrogen. The mixture was boiled under reflux for 6 h, 
cooled, poured into a saturated solution of ammonium 
chloride containing a few drops of conc. hydrochloric acid, 
and extracted with benzene. The organic layer was 
washed with sodium hydrogen carbonate solution, and 
dried. Evaporation left a gum (320 mg) which showed 
only weak i.r. carbonyl absorption.
This material v-as treated with acid in the presence of 
nitrobenzene as described above to give a gum (300 mg). 
The products from two reactions were combined (620 mg) 
and chromatographed twice on columns of silica gel in 
dichloromethane containing 1% v/v  ethyl acetate. Frac­
tions containing the desired \l-methylphenanthren-\l-one 
(lib ), readily detected by its strong purple fluorescence 
in u.v. light, were homogeneous by t.l.c., but still deeply 
coloured. Evaporation gave a brown crystalline solid 
(110 mg) which on sublimation gave colourless material, 
m.p. 150—152°, Xmax(EtOH) 223 (loge 4-23), 261 (4-77), 
287 (3-97), 297-5 (4-02), 308 (3-87), 344 (3-69), and 354 nm 
(3-74), vjna!C(Nujol) 1690 (conj. CO), 867, and 808 cm-1, 
m\e 250-13574 (M+) (C18H lsO requires 250-13576), 235, 
222, 207, 194, and 179.
Cyclisation of the Cyclopeniane Acid (Vlb).—This acid 
(900 mg) was added to a solution of phosphorus pentoxide 
(3 g) in phosphoric acid (3 ml) which had been equilibrated 
at 120° for 2-5 h. After 6 min the solution was poured into 
ice and the green gum wTas extracted writh ethyl acetate. 
The extract was washed with sodium hydrogen carbonate 
solution and dried; removal of the solvent left a gum 
which crystallised. Repeated recrystallisation from ethanol 
yielded 1,2,3,3a,4,7,8,9,10,1 lb-decahydrocyclopent[&^an-
thracen-5-one (VIIIc), m.p. 76— 77° (Found: C, 85-2;
H, 8-35. C^HjoO requires C, 84-95; H, 8-4%), X ^ E tO H )  
219 (loge 4-24), 262 (3-98), and 306 nm (3-72), vmai(Nujol) 
1670 (conj. CO), 1605s (aromatic C=C), 912, 872, 862, and 
818 cm-1, t 2-32 and 3-02 (one-proton singlets). T.l.c. 
(dichloromethane) of the mother liquors revealed a second 
spot just ahead of (VUIb). Elution with ethanol gave a 
solution with X ^  258 and 300 nm, sliow-ing that this was 
probably the angular isomer (VIIc).
We thank D. W. Thomas for the microanalyses and 
C. W. Vose for the mass spectrum of (lib).
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Potentially Carcinogenic Cyclopenta[a]phenanthrenes. 
Diols and Related Compounds
Part VII.1 Ring-D
By Maurice M . Coombs * and (Mrs.) Maureen Hall, Chemis try  D epa r tm en t ,  Imperial C a n c e r  R e sea rch  Fund, 
Lincoln's jnn Fields, London WC2A 3PX
Eliminat ion f r o m 1 6 .1 7 -d ih y d ro - 1 7 - to s y lo x y -1 5 / / - c y c lo p e n ta |> ] p h e n a n th re n e  a n d  from its 1 5 - to s y io x y - is o m e r  
in d im ethyl su lp h o x id e  a t  100° gave ,  respectively ,  1 5 / / -  a n d  1 7 / 7 - c y c lo p e n ta [ a ]p h e n a n th r e n e s  w h e re a s ,  co n t ra ry  
to  a p rev ious report ,  e l im ination  f rom th e  fo rm er  in boiling co llidine led to  a 1 :1 mixture  of  th e  t w o  olefins.  D e h y d r o ­
g e n a t io n  o f  1 6 ,1 7 - d ih y d ro - 1 5 / / - c y c lo p e n ta [ a ] p h e n a n th r e n e  w i th  DD Q  a lso  led to  a mixture of  t h e  1 5 7 / -  a n d  
1 7 / / -o le f in s .  Elimination from 1 6 ,1 7 - d ih y d ro - 1 1 -m e th y l - 1 7 - to s y lo x y - 1 5 / / - c y c lo p e n ta [ a ] p h e n a n th r e n e  in boil ing  
collidine y ie lded  on ly  t h e  11 V m ethyI-15 / / -o lefin .  Oxidation  of  t h e s e  olefins w i th  o sm iu m  te t ro x id e  g a v e  cis- 
diols, w h e r e a s  trans-diols w e r e  o b ta in e d  by  reduc t ion  of  t h e  co r re sp o n d in g  1 6 -h y d ro x y - 1 7 -k e to n e s  w i th  so d iu m  
borohydride .  U n c b n ju g a te d  1 6 -k e to n e s  resulted  f rom a c id -ca ta ly se d  d e h y d ra t io n  o f  t h e s e  diols.
Metabolic studies on the potent, carcinogen 15,16-di- 
hydro-ll-methylcyclopenta[a]phenanthren-17-one 2 (lb) 
have implicated attack at the five-membered ring and 
prompted the work on synthetic ring-D oxygenated 
compounds described here.
In Part I I 3 we claimed the synthesis of 15/7-cyclo- 
penta[a]phenanthrene (Ila) and the 1777-isomer (III), 
the former from the. 17-tosylate in dimethyl sulphoxide 
at 100°, and the latter by elimination under more 
vigorous conditions in boiling collidine. The latter 
olefin was also prepared3 by elimination from the 15- 
tosylate in boiling collidine. Both samples of olefins had 
the same m.p. and u.v. absorption characteristics as 
177/-cyclopenta[a]phenanthrene reported by Siis4 from
2
3
c j R = H
(H)
b ; R = Me
( i n )
OR
OR
(Y
□ j R H
-OR
(YT)
the decarboxylation of the 17-carboxylic acid. The 
former olefin (Ila) had u.v. absorption similar to that 
of the related 17-methyl-16(17)-ene.3 In order to pre­
pare the 16,17- and 15,16-diols these olefins were treated
f Unpublished work.
1 Part VI, M. M. Coombs and T. S. Bhatt, preceding paper.
2 M. M. Coombs and C. J. Croft, Progr. Exp. Tumor Res., 
1969, 11, 69.
with osmium tetroxide. As expected, (Ila) gave the 
c/s-16,17-diol (IVa) as sole product, but the supposed 
1777-isomer yielded roughly equal amounts of two diols, 
one of which was identical with (IVa). The second 
compound was formulated as the cis-15,16-diol (Va), 
since its u.v. spectrum bore a strong resemblance to 
that of 15-hydroxy-16,17-dihydro-15//-cyclopenta[a]- 
phenanthrene.f The identity of (Va) was confirmed 
by the preparation of a specimen of 17/7-cyclopenta- 
[ajphenanthrene by elimination from the tosylate in 
dimethyl sulphoxide at 100°. Addition of osmium 
tetroxide to this olefin gave a diol characterised as (Va) 
on the basis of mixed m.p. determinations of the derived 
diacetates. The u.v. spectra of the 1577- and 1771- 
isomers of cyclopenta[a]phenanthrene differ as pre­
viously described,3 but the purer sample of the latter 
displays more intense absorption at 239 and 269 nm 
than reported.3 I t is therefore apparent that boiling 
either 1571- or 1777-cyclopenta[a]phenanthrene in colli­
dine (b.p. 175°) leads to an equilibrium mixture contain­
ing roughly equal proportions of the two isomers and 
that the compound described previously as (III) was 
in reality a mixture of the two olefins. Dehydrogen­
ation of 16,17-dihydro-15/7-cyclopenta[a]phenanthrene 
with 2,3-dichloro-5,6-dicyanobenzo-l,4-quinone (DDQ) 
in boiling benzene also gave a mixture of the two olefins 
in good yield, but in this case the 15/7-isomer pre­
dominated.
Reduction of 16-hydroxy-15,16-dihydrocyclopenta- 
[a]phenanthren-l 7-one5 with sodium borohydride in 
methanol led to a high yield of a third diol, more polar 
and less soluble than (IVa). This was therefore assigned 
the /raws-16,17-diol structure (Via). A small quantity 
of the c/s-diol (IVa) was identified cliromatographically 
in the crude reduction products. Presumably co­
ordination of the 16-hydroxy-group in the a-ketol with 
the borohydride directs attack by the latter on the 
carbonyl group from the side of the ring bearing the
16-oxygen atom, thus leading to a ira n s  product. •
16,17-Dihydro-ll-methyl-15/7-cyclopenta[a]phen- 
anthren-17-ol (Vila) was prepared by borohydride 
reduction of the ketone (lb). Elimination from the
3 Part II, M. M. Coombs, J . Chem. Soc. (C), 1966, 963.
4 O. Siis, Annalen, 1953, 579, 133.
3 Part III, M. M. Coombs, J . Chem. Soc. (C), 1969, 2484.
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derived 17-tosylate (Vllb) in boiling collidine gave an 
olefin which displayed no u.v. absorption at 238 nm; 
the ispectrum was similar to that of the known 11,17- 
dimethyl-16(17)-ene.8 That this olefin was 11-methyl-
OR
Me
H
OR
ORMe
dj R = H
b ; R = Ac
OR
Me
( I X )
a ;  R = H
b ;  R = Ac
15-frT-cyclopenta[a]phenanthrene (lib), unaccompanied 
by its 17/f-isomer, was established by oxidation with 
osmium tetroxide to yield a single as-diol (Villa).
is substantially smaller for the a's-diacetates than for 
the frvws-isomers.
Acid catalysed dehydration of the mixture of 15,16- 
and 16,17-a's-diols (IVa) and (Va) furnished a single 
product, the 16-ketone (Xa), analogous to the. uncon­
jugated ketone formed on similar dehydration of indane-
1,2-diol.6 The structure of (Xa) follows from its u.v. 
absorption characteristics, which are similar to those of
16,17-dihydro-15i/-cyclopenta[a]phenanthrene. In ad­
dition, the i.r. stretching frequency of the 16-carbonyl 
double bond occurs at 1750 cm-1, similar to that of the
16-carbonyl group in the 17-methyl-16-ketone (XI) 
prepared by dehydration of the 17-methyl-16,17-diol.7 
Dehydration of the ll-methyl-16,17-diol (IXa) gave the
ll-methyl-16-ketone (Xb), a positional isomer of the 
potent carcinogen (lb).
EXPERIMENTAL
Reagents and apparatus were generally as described 
in previous Parts of this series. T.l.c. was performed on 
plates coated with Kieselgel G (Merck) and dried overnight 
in air. Solutions in organic solvents .were dried over an­
hydrous sodium sulphate.
R eactions o f  15H- a n d  lT R -C yclopenta\a]phenanthrenes  
w ith O sm ium  T etroxide.— C om parative experim ent. Samples 
(10 mg) of 15H-cyclopenta[«]phenanthrene and the olefin 
designated as the ‘ 17H-isomer ’ in P art I I  were separately 
dissolved in portions (0-5 ml) of a solution in benzene of 
Os04,2py [containing osmium tetroxide (254 mg, 1 mmol) 
and pyridine (160 mg, 2 mmol) in 10-0 ml]. After 20 h
N.m.r. chemical shifts ( t )  and coupling constants (Hz) of protons attached to the D-ring in 16,17-diacetates
R
cis-Diacetate (IVb) H
cis-Diacetate (VUIb) Me
Oaws-Diacetate (Vlb) H
/raws-Diacetate (IXb) Me {
AcO u
JL^n Y OAc
H x
l Y V h b
C-15
/■'
H a - H b
C-16 C-17
H A H b H x H y OAc
6-58(q) 6*30(q) 0-28 4-28(q) 3-58(d) 7-91(s), 7*89(s)
J a b  16 / ax 5 J a b  16 / bx 7 / xy 6
6-65(q) 6-36(q) 0-29 4-31(q) 3-61(d) 7-92(s), 7-88(s)
J a b  16 / ax 4 J a b  16 / bx 6 / xy 6
6-78(q) 6*07(q) 0-71 4-39(quint) 3-54(d) 7-90(s), 7*86(s)
J a b  16 / ax 4 J a b  16 / bx 8 / xy 4
6-84(q) 6T0(q) 0-74 4-42 (quint) 3-58(d) 7-92(s), 7-87(s)
J a b  17 / ax 4 J a b  17 / bx 8 / xy 4
Thus the presence of the 11-methyl group appears 
to fix the position of the ring-D double bond in this olefin 
(lib). The more polar and higher melting 11-methyl- 
trans-lQ,ll-6iol (IXa) was obtained as before by boro­
hydride reduction of 15,16-dihydro-16-hydroxy-ll- 
methylcyclopenta[a]phenanthren-l7-one.5 In this case 
also the as-diol (Villa) was a minor reduction product.
The two pairs of cis- and fows-16,17-diols are readily 
distinguished by comparison of the n.m.r. spectra of 
their diacetates, as shown in the Table. In particular, 
separation of the chemical shifts between the two 
quartets due to the two non-equivalent C-15 protons
the supernatant liquids were pipetted off and the brown 
precipitates were heated for 1*5 h on a steam-bath, each 
with pyridine (0*5 ml), water (0-2 ml), and sodium pyro- 
sulphite (0-2 g). Addition of more water (15 ml) gaVe 
grey suspensions which were extracted with ether, yielding, 
in both cases, white solids. That from the 15H-olefin 
gave, on t.l.c. (ethanol-toluene, 1 :5), one spot, R p  0-43; 
the solid from the 17H-olefin exhibited two spots, R p  043 
and 0*46, of similar intensity. These solids were separ­
ately acetylated with acetic anhydride (TO  ml) in pyridine
6 C. W. J. Brooks and L. Young, Biochem. J ., 1956, 63, 264.
7 H. Dannenberg, D. Dannenberg-von Dresler, and H.-G. 
Neumann, Annalen, 1960, 636, 74.
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(TO ml) for 18 h a t room temperature. After addition of 
water (10 ml) and refrigeration for 3 h the precipitates were 
collected, washed with water, and dried. Each weighed 
8 mg. That from the 15.H-olefi.n had m.p. 167—172° and 
its i.r. spectrum was identical with th a t of the «'s-16,17-di- 
acetate, m.p. 173— 175° (see later). The solid from the 
‘ 17/f-olefin ’ melted between 140 and 155°.
P rep a ra tive  experim ent. Osmium tetroxide (540 mg) 
was added to the ‘ 17H-olefin ’ (454 mg) (Part II) dissolved 
in pyridine (5-0 m l); the solution became dark and a 
solid separated. After 2 h sodium pyrosulphite (1-0 g) 
in water (5-0 ml) was added, and the mixture was kept 
for a further 30 min with frequent shaking. Addition of 
water (200 ml) gave an orange solution containing cream- 
coloured solid which was filtered off, washed with water, 
and dried (465 mg). This mixture of diols (two adjacent 
spots on t.l.c.) was acetylated as already described yielding 
a crystalline solid (567 mg), m.p. 143—150°. Chromato­
graphy on a column of silica gel (60 X 2 cm diam.) with 
hexane containing increasing proportions of dichlorometh­
ane led to the separation of two compounds. The faster- 
running (125 mg), m.p. 188—189°, was recrystallised from 
ethanol to furnish cis-15,16-diacetoxy-16,17-d ih ydro -15H- 
cyclopenta[a]phenanthrene (Vb), m.p. 189—191° (Found: 
C-, 75-3; H, 5-5. C21H 180 4 requires C, 75-45; H, 5-45%),
Xmax (EtOH) 223 (log s 4-29), 255 (4-76), 279 (4-13), 287-5 
(4-06), 299-5 (4-11), 319 (2-58), 325-5 (2-49), 334 (2-59), 
340 (2-35), and 350 nm (2-23), (Nujol) 1730 (Ac), 
820, and 755 cm-1. In the same way the slower-running 
material (144 mg) gave cis-16,11-diacetoxy-16,11-dihydro- 
15H -cyclopenta[a]phenanthrene (IVb), m.p. 173—175° 
(Found: C, 75-4; H, 5-3%), (EtOH) 249-5 (log s
4-74), 256-5 (4-87), 278-5 (4-20), 286 (4-09), 298 (4-18), 
319-5 (2-63), 327-5 (2-48), 334-5 (2-82), 343 (2-43), and 350 
nm (2-82), (Nujol) 1738 (Ac) 817, and 754 cm-1.
16,17-D ih yd ro -15H -cyclopenta[a]phenanthrene-cis-16,17- 
d io l (IVa).—The ezs-diacetate (IVb) (105 mg), m.p. 160— 
165°, contaminated with a small quantity of the cfs-15,16- 
isomer, was dissolved in ethanol (5 ml) and water (0-5 ml) 
and kept a t ambient temperature for 20 h with potassium 
hydroxide (100 mg). Addition of more water (10 ml) 
gave a crystalline precipitate of the cis-16,17-<A'o/ (IVa), 
m.p. 226—228° (Found: C, 81-3; H, 5-25. C17H 140 2 
requires C, 81-6; H, 5-65%), R p  0-50 (ethanol-toluene, 
1 : 4)> Xmax (EtOH) 250-5 (log e 4-71), 257 (4-83), 279 (4-16), 
287 (4-06),' 299 (4-16), 320 (2-71), 327-5 (2-56), 334-5 (2-87), 
343 (2-49), and 350 nm (2-86), (Nujol) 3285 (OH), 
823, 817, 750, and 742 cm"1.
16,11-D ih yd ro -15H -cyclopenta[a]phenanthrene-trans-16,17- 
d io l (Via).—15,16-Dihydro-16-hydroxycyclopenta[a]phen-. 
anthren-17-one (1-20 g) was stirred in methanol (40 ml) 
during the addition of sodium borohydride (1 g). After 
1 h, more sodium borohydride (1 g) was added and stirring 
was continued for a further 2 h. Dilution with water (60 
ml) gave a precipitate which was collected, washed with 
water, and dried. The cream solid (0-951 g) was shown 
by t.l.c. (ethanol-toluene, 1 :4) to consist mainly of a 
substance with R p  0-44, together with a small amount 
of the efs-16,17-diol, R p  0-50. Crystallisation of this solid 
from n-butanol gave the trans-16,17-dio/ (Via), m.p.
277—278° (Found: C, 81-2; H, 5-55. C17H 140 2 requires
C, 81-6; H, 5-65), X ^  (EtOH) 250-5 (log e 4-71), 257 
(4-82), 279 (4-16), 287 (4-05), 299 (4-17), 320 (2-65), 327-5 
(2-49), 335 (2-84), 343 (2-44), and 350 nm (2-84), (Nujol) 
3260 (OH), 824, and 744 cm-1. The trans-16,17-diacetate
(Vlb), prepared by treatm ent with acetic anhydride- 
pyridine a t room temperature for 20 h, crystallised 
from ethanol in prisms, m.p. 159—160° (Found: C, 75-3; 
H, 5-1. C21H 180 4 requires C, 75-45; H, 5-45%), Xmg,
(EtOH) 249-5 (log e 4-74), 256-5 (4-88), 278-5 (4-17), 286-5 
(4-06), 298-5 (4-18), 319 (2-64), 327 (2-51), 334 (2-83), 342 
(2-45), and 350 nm (2-80), vmx (Nujol) 1730 (Ac), 825, 
and 757 cm-1.
lTH .-Cyclopenta[a]phenanthrene (III).— 16,17-Dihydro- 
15 H -c y c lopenta[a]phenanthren-15-ol 8 (175 mg), dissolved 
in dry pyridine (3 ml), was kept with toluene-^-sulphonyl 
chloride (142 mg) for 3 h. After dilution with water (50 ml), 
the mixture was extracted with dichloromethane and the 
extract was washed successively with 2N-sulphuric acid, 
aqueous sodium hydrogen carbonate, and water, and dried. 
Removal of the solvent gave the crude tosylate as a gum 
(137 mg) which was dissolved in dimethyl sulphoxide 
(0-2 ml) and heated on a steam-bath for 1 h. The solvent 
was removed in  vacuo, and the residual gum was triturated 
with hexane-dichloromethane (10:1). The extract (46 
mg) was purified by preparative t.l.c. (hexane-benzene, 
4 :1 ) on three 20 X 20 cm plates to furnish 17H-cyclo- 
penta[a]phenanthrene (III) (12 mg) as a white solid, 
Xmax (EtOH) 238 (log e 4-11), 268-5 (4-46), 273 (4-42), 
291-5 (3-93), 302 (3-91), 314-5 (2-82), 343 (2-45), and 360 
nm (2-44). Repetition of the dimethyl sulphoxide trea t­
ment with the hexane-dichloromethane-insoluble material 
gave a further quantity of (III) (5 mg).
This olefin (12 mg) was treated with osmium tetroxide as 
already described. The product was a cream solid (11-5 
mg) which had the same R p  as (Va). Acetylation gave 
crystals, m.p. 168— 171°, with the same R p  as (Vb). Mixed 
m.p. with a sample of (Vb) (m.p. 189—191°) was 182— 
185°, and with a sample of (IV) (m.p. 173—175°) was 
149—160°.
D ehydrogenation o f  16,17-D ih ydro -1 SH -cyclopen ta\a \ -
phenanthrene w ith 2,3-D ichloro-5 ,6-dicyano-l,A -benzoquinone. 
—The dihydro-compound (80 mg) was heated under reflux 
with a solution of DDQ (100 mg) in dry benzene (10 ml) for 
20 h. The precipitate was filtered off and the filtrate 
was evaporated to dryness. The resulting solid was 
chromatographed on a column of alumina (Woelm, grade 
IV; 5 g.) with hexane-benzene (4 : 1) to yield 15H-(and 
17H-)cyclopenta[a]phenanthrene (53-3 mg), X^^ (EtOH) 
239 (log s 4-026), 269 (4-798), and 273-5 nm (4-803).
A sample (10 mg) of this olefin was treated with osmium 
tetroxide as described in the comparative experiment. 
The isolated diol (8 mg) gave a major spot, R p  0-43, and a 
minor spot a t R p  0-46, on t.l.c. as already described. 
After acetylation the product (6 mg) melted a t 155—* 
165° (cf. with mixed m.p.s in the previous section).
16,17-D ihydro-1  l-m ethyl-15i¥L-cyclopenta\a\phenanthren• 
l l - o l  (Vila).— 15,16-Dihydro-1 l-methylcyclopenta[a]pheiT 
anthren-17-one (0-50 g), sodium borohydride (0-50 g), 
tetrahydrofuran (30 ml), and water (2 ml) were boiled 
together under reflux for 18 h. Dilution with water gave 
a precipitate which was collected and dried (380 mg). 
Crystallisation from dichloromethane-hexane (1 : 1) afforded 
the 17-0/ (Vila) (220 mg), m.p. 140—141° (Found: C, 
86-9; H, 6-8. C18H 160  requires C, 87-1; H, 6-5%), Xmax 
(EtOH) 227 (log e 4-22), 255 (4-78), 281 (4-02), 293 (4-02)*’ 
304-5 (4-10), 323 (2-79), 338-5 (2-96), and 354 nm (2-98), 
W  (Nuio1) 3245 (OH), 825, 817, and 750 cm '1.
8 G. M. Badger, W. Carruthers, and J. W. Cook, T. Chem. Soc., 
1952, 4996.
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1 l-M ethyl-15H -cyclopen ta\si\phenan threne  (Hb).—The
17-ol (Vila) (424 mg), toluene-/-sulphonyl chloride (330 
mg), and dry pyridine were kept together a t room tem­
perature for 2 h. After dilution with chloroform (30 ml) 
the solution was washed as already described to yield the 
tosylate (Vllb) as a  resinous brown solid (335 mg), vmftT 
(Nujol) 1030 and 1010 cm-1, characteristic of tosylates. 
This derivative, dissolved in collidine (5-0 ml), was boiled 
under reflux for 30 min, and worked up as already described 
to  give an oil (360 mg) showing no u.v. absorption a t 238 
nm. After filtration through a short column of alumina 
(Woelm, grade II) in benzene-hexane (1: 1) the product 
(275 mg) was an almost colourless oil which readily crystall­
ised. A sample was sublimed a t 100° and 10“3 mmHg, 
giving the olefin (Hb), m.p. 87—89° (Found: C, 93-6; 
H, 6-3. C18H 14 requires C, 93-85; H, 6-15%), (EtOH) 
221-5 (log e 4-47), 267 (4-65), 274 (4-65), 294 (4-08), 306 
(4-08), 317 (2-83), 348 (2-85), and 364 nm (2-74), vmaT 
(Nujol) 815, 751, and 701 cm-1.
16.1 7 -D ih yd ro -l l-m ethyl-lSH .-cyclopen ta[a]phenanthrene- 
cis-16,17-cZioZ (V illa).—A solution of the 15H-olefin (Hb) 
(115 mg, 0-5 mmol) in benzene (11-5 ml) was treated with 
osmium tetroxide (0-55 mmol) by the usual method; no 
solid separated from the brown solution. After 2 h, 
when t.l.c. demonstrated absence of olefin, the solvent was 
removed under diminished pressure and the residue was 
treated with sodium pyrosulphite as already described to 
yield a crystalline solid (135 mg) which ran as one spot, 
R p  0-59 (toluene-ethanol, 4 :1 ) [the 11-methyl-fnms-
16,17-diol (IXa) had R p  0-55 when run alongside]. Re­
peated crystallisation from ethanol gave the diol (V illa), 
m.p. 181—182°, X ^  (EtOH) 227 (log e 4-19), 255 (4-83), 
281 (4-07), 292-5 (4-03), 304 (4-11), 323-5 (2-80), 338-5 
<2-96), and 354 nm (2-94), (Nujol) 3310 (OH), 1098, 
820 , and 743 cm-1. Acetylation with pyridine-acetic 
anhydride a t room temperature for 20 h gave the cis-diace- 
tate  (VIHb), m.p. 192-5—193°, X ^  (EtOH)'226 (log s 4-15), 
254-5 (4-88), 281 (4-11), 292 (4-06), 303-5 (4-14), 323-5 
(2-81), 338-5 (2-97), and 354 nm (2-98), (Nujol) 1740, 
1255, 1237, and 818 c m m /e 348-1366 (M+) (C22H 20O4 
requires 348-1362).
16.17-D ihydro-11-m eth yl- 15H -cyclopenta[a}phenanthrene- 
trans-16,17-d io l (IXa).—15,16-Dihydro-16-hydroxy-11- 
methylcyclopenta[a]phenanthren-17-one (TOO g) was re­
duced with sodium borohydride as already described. The 
precipitate (0-59 g) formed on addition of water (60 ml) to 
the mixture consisted mostly of a substance, R p  0-46 
(ethanol-toluene, 1 :4). Crystallisation from ethanol 
yielded the H -m ethyTtvaxiS-16,17-diol (IXa), m.p. 224— 
226° (Found: C, 81-5; H, 6-05. C18H 160 2 requires C, 
81-8; H, 6-1%), Xmax, (EtOH) 227 (log e 4-22), 256 (4-85), 
281 (4-07), 292-5 (4-04), 305 (4-13), 323 (2-82), 338-5 (2-97),
and 354 nm (2-98), (Nujol) 3275 (OH), 1068, 825, 
and 745 cm-1. Acetylation gave the diacetate (IXb), 
m.p. 156—157°, X ^  (EtOH) 224 (log e 4-14), 254 (4-88), 
280-5 (4-09) 292 (4-05), 304 (4-15), 323 (2-80), 338 (2-97), 
and 354 nm (2-97), vmaT (Nujol) 1730, 1258, and 1240 cm-1 
(acetate). The material in the original mother liquor 
was shown by t.l.c. to  consist of similar amounts of (IXa) 
and the cis-diol (V illa).
15,17-D ihydro-17-m ethylcyclopenta[a]phenanthren-16-one  
(XI).— 16,17-Dihydro-17-methyl-15H-cyclopenta[a]phen-
anthrene-16,17-diol7 (235 mg) was heated on a steam-bath 
with 5N-sulphuric acid (10 ml) for 3 h. The solid was 
collected, washed with water, dried, and crystallised from 
benzene-hexane to furnish the 17-m ethyl-16-one (XI) as 
rosettes (80 mg), m.p. 184— 185° (Found: C, 87-6; H,
6-1. C18H 140  requires C, 87-75; H, 5-75%). X ^. (EtOH) 
259 (log e  4-80), 278 (4-23), 288 (4-10), 300 (4-14), 319 
(3-06), 334 (3-03), and 350 nm (2-96), (Nujol) 1740 
(CO), 818, and 748 cm"1.
15.17 -D ihydrocyclopenta[a]phenanthren-16-one (Xa).—A 
mixture (107 mg) of the 15,16-diacetoxy- and 16,17-diacet- 
oxy-compounds from the osmium tetroxide oxidation 
was dissolved in methanol (10 ml) and water (2 ml) and 
heated on a steam-bath with potassium hydroxide (200 mg). 
After 75 min, 5N-sulphuric acid (50 ml) was added and 
heating was continued for 6 h. The cooled mixture was 
extracted with chloroform and the solid left on removal 
of the solvent was recrystallised twice from benzene with 
the addition of hexane to yield the ketone (Xa) as pale 
yellow rosettes of needles (10 mg), m.p. 172—174° (Found: 
C, 87-65; H, 5-1. C17HiaO requires C, 87-9; H, 5-2%), 
x j ^  (EtOH) 258 (log e  4-77), 269 (4-21), 278 (4-11), 300 
(4-21), 319 (3-14), 335 (3-10), and 350 nm (3-03), vmj. 
(Nujol) 1750 (CO), 833, 802, 768, and 748 cm '1.
15.17 -D ih ydro -1 l-m ethylcyclopen ta[a]phenanthren-16-one 
(Xb).—The ll-methyl-16,17-/mns-diol (IXa) (203 mg) was 
boiled under reflux with tetrahydrofuran (10 ml) and 
5N-sulphuric acid (10 ml) for 17 h. The cooled solution 
was extracted with benzene; the extract was washed with 
sodium hydrogen carbonate and dried. Evaporation gave 
a yellow gum (201 mg) which was purified by elution from 
a column of silica gel with dichloromethane. The ketone 
(Xb) (57 mg) formed pale yellow needles, m.p. 152-5—153°, 
Xm„  (EtOH) 256-5 (log e 4-77), 282 (4-06), 295 (4-08), 307 
(4-16), 324 (2-99), 339 (3-06), and 355 nm (3-04), 
(Nujol) 1740 (CO), 828, 795, and 743 cm '1, m fe 264-1041 
(M +) (C18H u O requires 246-1045).
We thank C. W. Vose for discussions, and D. W. Thomas 
for the microanalyses.
[2/2652 Received, 23rd November, 1972]
Potentially Carcinogenic Cyclopenta[a]phenanthrenes. Part VIII.1
Bromination of 17-Ketones
By M a u r i c e  M .  C o o m b s , *  (Mrs.)  M a u r e e n  H a l l ,  a n d  C o l i n  W .  V o s e ,  Chem is try  D ep a r tm en t ,  Imperial  C a n c e r  
R e sea rch  F und ,  Lincoln 's  Inn Fields, L o n d o n  W C 2 A  3PX
R e p r in te d  f ro m
J O U R N A L
OF
THE C HEM ICA L SOCIETY
PERKIN TRANSACTIONS I
2236 J.C.S. Perkin I
Potentially Carcinogenic Cyclopenta[a]phenanthrenes. Part VIII.1 
Bromination of 17-Ketones
By M aurice M. Coombs,* (Mrs.) M aureen Hali, and Colin W. Vose, Chemistry Department, Imperial Cancer 
Research Fund, Lincoln's Inn Fields, London WC2A 3PX
Brom ination  of  1 5 ,1 6 -d ih y d ro c y c lo p e n ta  [a] p h e n a n t h r e n - 1 7 - o n e  an d  its 11 -m ethy l  h o m o lo g u e  g a v e  th e  1 5 - b ro m o -  
a n d  1 5 ,1 5 -d ib rom o-de r iva t ives ,  even  u n d e r  co n d i t io n s  favouring  a ro m at ic  b rom ina tion .  /V -B rom osucc in im ide  
in t roduc ed  b rom ine  a d ja c e n t  to  t h e  carbonyl  g roup .  R educ t ive  tr it iation of  t h e  1 5 - b ro m o - k e to n e  g a v e  th e  
[ 1 5 -3H ]-der iva tive ,  b u t  nuc leoph i l ic  d i sp la c e m e n t  of  t h e  b rom ine  a to m  w i th  so d iu m  a c e t a t e  in a c e t i c  ac id  led 
u n e x p e c te d ly  to  t h e  1 6 - a c e t o x y - 1 7 - ke tone .  A c id -c a ta ly se d  hydration  of  t h e  1 5 ( 1 6 ) - e n - 1 7 - o n e ,  readily  p rep a red  
by deh y d ro b ro m in a t io n  of  t h e  1 6 - b r o m o - 1 7 - k e to n e  w i th  tr ie thylamine,  y ie lded  th e  1 5 -h y d ro x y k e to n e .  T h e  
a c e ta te  o f  th e  latter  w a s  t h e  major p ro d u c t  from a t t e m p te d  b rom ina tion  of  t h e  1 7 - k e t o n e  in t h e  p r e s e n c e  of  tha ll ium  
tr iace ta te .
B ro m in a tio n  of phenanthrene under a variety of condi­
tions leads to substitution at the 9- and 10-positions.2 
We considered that, by analogy, bromination of 15,16- 
dihydrocyclopenta[n]phenanthren-l 7-one (la) would
yield 6- or 7-bromo derivatives, especially since these 
positions (as in phenanthrene) are attacked by reagents 
such as osmium tetroxide and chromic acid.3 It was 
hoped that the expected 6- and 7-bromo derivatives, by 
reductive debromination in tritium gas, would furnish 
these ketones labelled specifically with tritium at very 
high specific activity,4 making them available for bio­
logical experiments in connection with the high carcino­
genic activity of the 11-methyl-17-ketone (lb).5 In the 
event this aim was not achieved, and the results de­
scribed in this paper emphasize the substantial reactivity 
of the five-membered ring in compounds of this series.
Treatment of the unsubstituted ketone (la) with 
1 equiv. of bromine in chloroform or acetic acid gave a 
mono- and a dibromo-derivative. The former proved 
to be the 15-bromo-17-ketone (Ila) since its n.m.r. 
spectrum exhibited signals of an ABX system, corre­
sponding to two non-equivalent methylene protons 
coupled to a strongly deshielded methine proton (see 
Table). Moreover, reductive debromination in a mix-
1 Part VII, M. M. Coombs and M. Hall, J.C .S . Perkin I, 1973, 
1255.
2 C. A. Dornfeld, J. E. Callan, and G. H. Coleman, Org. 
Synth., Coll. Vol. I ll, 1955, 134.
ture of tritium and hydrogen gas gave the [15-3H]-17- 
ketone (Vc) which retained its label both on treatment 
with alkali and on oxidation to the 6,7-quinone,3 proving 
that the tritium was not at C-6, -7, or -16.
Bromination of the ketone (la) with iV-bromosuccin- 
imide gave a different monobromo-derivative in high 
yield. This bromo-ketone also exhibited an ABX 
system in its n.m.r. spectrum and is thus the 16-bromo- 
17-ketone (III). Reduction of this compound with 
sodium borohydride gave the cis-bromohydrin, since the 
product was stable to alkali. Dehydrobromination of 
(III) occurred readily, being essentially complete within 
10 min at room temperature on treatment with triethyl­
amine in tetrahydrofuran, or with 2 equiv. of aqueous 
sodium hydroxide in dioxan. Cyclopenta[a]phenan- 
thren-17-one (IV) formed bright orange crystals with 
characteristic u.v. absorption, but purification was 
complicated by the ease with which it gave rise to 
insoluble material on storage or attempted recrystallisa­
tion. In this respect it resembles the analogous system 
indenone.6 Treatment of the 16-bromide (III) with 
sodium acetate in acetic acid also gave insoluble, intract-
3 M. M. Coombs, J . Chem. Soc. (C), 1969, 2484.
4 M. M. Coombs and H. R. Roderick, Steroids, 1968, 925.
5 M. M. Coombs and C. J. Croft, Progr. Experimental Tumor 
Research, 1969,11, 69.
6 C. S. Marvel and C. W. Hinman, J . Amer. Chem. Soc., 1954, 
76, 5435.
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able material, presumably through prior elimination to 
the enone (IV).
Similar attempted displacement of bromine from the 
15-bromo-17-ketone (Ila) led smoothly, not to the
( I )
a ;  R=H
b;  R=Me
(IY)
(Y ) a ;  R=OH 
b; R=OAc
(VI)
C ;  R = H
(Vm)a;R=H
b; R=Me
the 15-ketone of this series.3 A substantial quantity 
of insoluble pink solid precipitated out during this re­
action, and a minor reaction product was the ketone 
(la). This compound was also formed when the elimina­
tion of the 16-bromide with triethylamine was carried 
out in boiling benzene. It would therefore appear that 
(la) is produced from the enone (IV) by abstraction of
N.m.r. chemical shifts (t) and coupling constants (Hz) of 
ring-D protons in bromo- and acetoxy-17-ketones 
measured in deuteriochloroform
C( 16)-P ro to n s  C( 15)-P ro to n s
C o m p ou n d • h a H b H 0 h d
(I la ) 6-32q 5-81q 5-17q
J ab 18, J ac 3 J ab 18, J bc7 J ac 3, J bc 7
(H b ) 6-28q 6-77q 5-15q
J ab 18, J ac 3 J ab 18, J bc ^ J ac 3, J bc 7
(V ila ) -<------ 5-31s -------> -
( V llb ) - < -------5* 34s ------ > -
(V I) 3-90s 4-95s
(I II ) 4-04q 6-80q 6-52q
J ad 6, J ac 2 Jco 18, J ac 2 J cd 18, J ad 6
(Vb) 7-29q 6-65q 3-17q
J ab 18, J ac 2 J ab 18, J bc 6 J ac 2, J bc 6
( V i l l a ) 4-37q 6-75q 5-87q
J ad 7-5, J cd 17, J cd 17,
J ac 4 J ac 4 J ad 7-5
(V U I b ) 4-52q 6-83q 6-01q
J ad 8, J ac 4 J cd 18, J  ac 4 J cd 18, J ad 8
OAc
i v n )  Q; R = H  
b; R = Me
expected 15-acetoxy-compound, but to the 16-acetoxy-
17-ketone (Villa) identical with the compound pre­
viously obtained by oxidation of the parent ketone (la) 
with lead tetra-acetate.3 Formation of this compound 
probably occurs by nucleophilic attack by an acetate 
anion at C-16 in the enol with concomitant expulsion of 
bromide from C-15 (Scheme 1), since the 15-bromide 
(Ila) showed no evidence of rearrangement to the iso­
meric 16-bromide (III) under the reaction conditions 
employed, but without potassium acetate. The 15- 
acetoxy-17-ketone (Vb) was prepared, again by analogy 
with indenone,7 by acid-catalysed hydration of the 
15(16)-double bond in the enone (IV) using aqueous 
sulphuric acid in tetrahydrofuran at room temperature, 
followed by acetylation. The structure (Vb), rather 
than the isomeric 17-acetoxy-15-ketone structure, was 
assigned to this compound on the basis of its u.v. absorp­
tion characteristics which are very similar to those of the
17-ketones (la and b) and quite different from those of
hydrogen, presumably from the solvent or a second 
molecule of the phenanthrene.
Bromination of the 15-bromo-17-ketone (Ila) with 
iV-bromosuccinimide led to a dibromo-compound which 
was different from that obtained by bromination of (la) 
with molecular bromine. The n.m.r. spectrum of the 
former showed two one-proton singlets arising from two 
chemically and magnetically different protons, and was 
therefore the 15,16-dibromide (VI). The product from
^~OAc‘
OAc
(YEOa
Scheme 1
the reaction with bromine was assigned as the 15,15-di­
bromide (Vila) because it had a two-proton singlet at 
t 5-31 in its n.m.r. spectrum.
Bromination of the carcinogenic ketone (lb) with
7 P . H . L a c e y  a n d  D . C. C. S m ith , J .  Chem. Soc. (C), 1971 , 41 .
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bromine in chloroform also gave mono- and di-bromo- 
derivatives, the structures of which were readily estab­
lished as the 15-bromo- and 15,15-dibromo-17-ketones, 
(lib) and (Vllb), by n.m.r. spectroscopy.
In an attempt to direct bromination of (la) to the 
aromatic rings, the reaction with bromine in acetic acid 
was carried out with complete exclusion of light, but the 
same mixture of 15-bromo- and 15,15-dibromo-deriva- 
tives was isolated. Bromination with bromine in the 
presence of silver nitrate and acid,8 a method reported to 
favour electrophilic bromination owing to the liberation 
of Br+ cations, also gave the same mixture of bromo- 
ketones together with a variety of other products which 
was not investigated.
Recently thallium triacetate has been recommended 9 
as a good catalyst for aromatic bromination. Treatment 
of the ketone (la) with one equivalent of bromine in 
carbon tetrachloride in the presence of thallium triacetate 
gave small amounts of the usual bromoketones, together 
with a compound ^19^14^3 as major product. The 
latter was characterised as the 15-acetoxy-17-ketone 
(Vb), identical with the product of acetylation of the 
15-alcohol, described above. It was not formed when 
either the ketone (la) or the 15-bromoketone (Ila) was 
treated with thallium triacetate in carbon tetrachloride, 
and the best yield of (Vb) was secured when the bromine 
was added in one lot to the mixture of (la) and thallium 
triacetate. It therefore seems probable that a bromo- 
derivative of T l111 is involved, possibly allowing 
nucleophilic attack of acetate at C-15 by a mechanism 
involving an enolic thallic ester (Scheme 2), similar to 
that recently proposed to account for the formation of 
10p-trifluoroacetoxy-19-norandrosta-l,4-diene-3,17-dione 
by the action of thallium tris(trifluoroacetate) on 
oestrone.10
(0 2C-CF3
COCF,
^COCF,
COCH
OCOCH3
O-COCH
Scheme 2
EXPERIMENTAL
Materials and methods were generally as described in 
previous parts of this series.
15-B rom o- a n d  15,15-D ibrom o-15,1 Q-dihydrocyclopenta[ai]- 
p h en a n th ren -ll-o n es, (Ila) an d  (Vila).—A solution of 
bromine (2-09 g) in dry chloroform (50 ml) was added drop- 
wise with stirring during 2 h to a solution of 15,16-dihydro- 
cyclopenta[a]phenanthren-17-one (3-00 g) in chloroform 
(200 ml), and after stirring a t room temp, for 20 h, the 
solvent was removed under reduced pressure to leave a 
brown solid (3-58 g). Chromatography on Woelm Grade II  
alumina using toluene gave two substances, from first
8 D. H. Derbyshire and W. A. Waters, J . Chem. Soc., 1950,
573.
fractions an orange solid (0-597 g) and from later fractions 
a cream solid (1-603 g). Crystallisation of the latter from 
n-butanol gave l5-brom o-15,16-dihydrocyclopenta[sL]phen- 
a n th ren -ll-o n e  (Ila) (1-455 g), m.p. 196—197° (Found: 
C, 65-35; H, 3-35; Br, 25-4. C17Hn BrO requires C, 65-6; 
H, 3-55; Br, 25-7%), (EtOH) 267-5 (log e 4-78),
286-5 (4-41), 298-5 (4-36), 310 (4-13), 354 (3-32), and 372 nm 
(3-31), vmaT (Nujol) 1711 (C=0), 820, and 757 cm-1. Several 
crystallisations of the orange solid from n-butanol gave
15,15-dibrom o-15 ,1 & -dihydrocyclopenta{a]phenanthren-11-one 
(Vila) (0-428 g), m.p. 213—213-5° (Found: C, 52-25; H, 
2-25; Br, 41-2. C17H 10Br2O requires C, 52-35; H, 2-3; Br, 
41-0%), Xmax (EtOH) 279 (log e 4-70), 298 (4-24), 314-5 
(4-18), 360 (3-30), and 377 nm (3-27), vniax (Nujol) 1710 
(C=0), 816, and 716 cm-1.
Use of glacial acetic acid in place of chloroform in this 
bromination gave the same two products in a similar ratio, 
even when light was carefully excluded.
Bromination in the presence of silver ions was carried out 
as follows. To a stirred solution of the ketone (la) (116 mg) 
in a mixture of glacial acetic acid (30 ml) and water (10 ml) 
containing silver nitrate (85 mg) was added a solution of 
bromine (80 mg) in glacial acetic acid (0-57 ml) dropwise 
with exclusion of light. After 5 h  water was added and the 
mixture was extracted with dichloromethane. T.l.c. dis­
closed a t least five products, prominent among which was 
the 15-bromoketone (Ila).
B rom ination  o f the 15-Brom oketone (Ila) w ith  N -B rom o- 
su ccin im ide .—The 15-bromoketone (Ila) (200 mg) in carbon 
tetrachloride (10 ml) was boiled with V-bromosuccinimide 
(114 mg) for 1 li adjacent to a 150 W lamp. After dilution 
with more carbon tetrachloride, the cooled solution was 
washed with water, dried, and evaporated to  yield an 
orange solid (235 mg). Recrystallisation from carbon 
tetrachloride gave 15,16-dibrom o-15 ,1 6-dihydrocyclopenta- 
SjC\phenanthren-ll-one (VI), m.p. 179—180°; the mixed 
m.p. with the 15,15-dibromoketone (m.p. 213—213-5°) was 
165—175° (Found: C, 52-65; H, 2-3; Br, 41-35%), XmaT 
(EtOH) 283 (log e 4-60), 311-5 (4-33), 361 (3-19), and 380 nm, 
(3-18), (Nujol) 1717 (OO), 831, and 760 cm"1.
B rom ination  o f 1 5 ,lG -D ihydro-ll-m ethylcyclopen ta[ai]phen-  
a n th ren -ll-o n e .—This ketone (lb) (436 mg) in chloroform 
(15 ml) was treated with a solution of bromine (279 mg) in 
chloroform (20 ml) as already described. After 20 h the 
solvent was removed to leave a brown solid (603 mg), 
chromatography of which on silica gel (100 g) with toluene- 
dichloromethane (3 : 1) gave two substances. From the 
first fractions was obtained an orange solid (134 mg) and 
from later fractions a yellow solid (395 mg). Several re­
crystallisations of the former from n-butanol gave orange 
crystals (38-5 mg) of 15,15-dibrom o-15,15 -d ih yd ro -l 1-m ethyl- 
cyclopenta[ai]phenanthren-ll-one  (Vllb), m.p. 206—207° 
(Found: C, 53-6; H, 2-8; Br, 39-1. C18H 12Br20  requires
C, 53-5; H, 3-0; Br, 39-55%), \ aLX (EtOH) 267-5 (log e 
4-68), 302-5 (4-32), 315sh (4-12), 369 (3-29), and 384 nm 
(3-3i) , vmax (Nujol) 1712 (OO), 823, 744, 718, and 708 cm"1. 
Recrystallisation of the yellow solid from the same solvent 
furnished yellow needles (247 mg) of 15-brom o-15,16-di- 
h yd ro -11 -m ethylcyclopenta\zC]phenanihren-11-one (Hb), m.p. 
211-5—212° (Found: 0 ,66-8; H, 4-0; Br, 24-45. C18H 13- 
BrO requires C, 66-5; H, 4-05; Br, 24-55%), X ^  (EtOH) 
267-5 (log e 4-68), 290 (4-37), 303 (4-29), 363 (3-31), and
9 A. McKillop, D. Bromley, and E. C. Taylor, f .  Org. Chem., 
1972, 37, 88.
10 M. M. Coombs and M. B. Jones, Chem. and Ind., 1972, 169.
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381 nm (3-35), v___ (Nujol) 1700 (C=0), 820, 759, 722, and 
700 cm-1.
16 -B rom o-15,1G-dihydrocyclopenta\a]phenanthren-17-one 
(III).—The ketone (la) (2*320 g, 10 mmol) and JV-bromo- 
succinimide (1*850 g, 10*5 mmol) in carbon tetrachloride 
(100 ml) were boiled under reflux with illumination from an 
adjacent 150 W  lamp. After 2 h  the yellow solution con­
taining precipitated succinimide was cooled, diluted with 
carbon tetrachloride, extracted with water, dried, and 
evaporated to give a pale brown crystalline solid. Re­
crystallisation from benzene gave the \G -b ro m o -\l-ketone
(III) as golden laths (1*950 g), m.p. 175° (decomp.) (Found: 
C, 65*3; H, 3*4; Br, 26*3%), X ^  (EtOH) 230*5 (log e 4*28), 
273 (4*73), 300*5sh (4*27), 335sh (3*00), 354 (3*13), and 371 
nm (3*13), vm3C (Nujol) 1700 (C=0), 816, and 756 cm"1.
The bromoketone (III) (100 mg) was treated with sodium 
borohydride (15 mg) in a mixture of dioxan (2*0 ml) and 
ethanol (1*0 ml) for 40 h a t room temp. Addition of water 
precipitated the cis-bromohydrin as a white solid (48 mg), 
X^y (EtOH) 256*5, 278, and 299 nm,vm i (Nujol) 3320 cm-1 
(OH). This material was recovered unchanged after it had 
been left for 20 h dissolved in ethanol containing 1 equiv. 
of potassium hydroxide.
D ehydrobrom ination  o f  the 16-B rom o-ll-ke ton e  (III).— 
W ith  aqueous p o ta ssiu m  hydroxide in  d ioxan . The bromo­
ketone (III) (30 mg), dissolved in dioxan (1 ml), was treated 
with 10% (w/v) aqueous potassium hydroxide (0*1 ml). 
The solution became orange, and after 15 min was warmed 
gently. Addition of water precipitated an orange solid 
which was collected, washed with water, and dried in  vacuo. 
This material (20 mg) was warmed with hexane (10 ml), 
and the solution was filtered. On concentration and cooling 
bright orange prisms of cyclopenta\y]phenanthren-Yi-one
(IV) separated, m.p. 202—208° (Found: C, 89*3; H, 4*2; 
M +, 230*0735. C17H 10O requires C, 88*7; H, 4*4%; M ,  
230*0732), (Nujol) 1710 (conjugated O O ), 810, 770, 
and 756 cm-1, Xmax^ (EtOH) 253, 286, 298, and 310 nm, 
rapidly giving the chromophore X^ aT 242, 270, and 290 nm 
characteristic of the 17H-15(16)-ene system,11 on addition 
of sodium borohydride. The crystals of (IV) became in­
soluble in hexane on storage a t room temp, or on attem pted 
recrystallisation.
W ith  triethylam ine in  tetrahydrofuran. The bromoketone 
(III) (100 mg) was dissolved in dry tetrahydrofuran (5 ml) 
and treated with triethylamine (0*1 ml); the solution be­
came orange and crystalline solid separated. The u.v. 
spectra of aliquot portions of the solution, removed a t 
intervals and diluted with ethanol, indicated th a t after 10 
min, conversion into the enone (IV) was complete. The 
reaction mixture was diluted with benzene, washed with 
ice-cold water, filtered, and dried. Evaporation below 40° 
under reduced pressure gave an orange crystalline solid, the 
i.r. spectrum of which was identical with th a t of the sample 
of (IV) already described.
W ith  trie th y lam in e  in  boiling benzene. The bromoketone 
(III) (575 mg) was heated under reflux with a mixture of 
triethylamine (10 ml) and dry benzene (10 ml) for 30 min, 
giving a deep red solution and a brick-red solid. After 
addition of further benzene the solid was filtered off, and 
the solution was washed with water and dried. Removal 
of the solvent left a deep orange syrup (264 mg) which 
crystallised, m.p. 175—190°, XmaY (EtOH) 250infl., 265, 284, 
297, and 310 nm. Attempts to purify this material by 
recrystallisation or chromatography led to further quantities 
of insoluble red solid, and the only pure compound isolated
was a small amount of the ketone (la), m.p. 198—199°, 
u.v. spectrum identical with th a t of authentic (la).
W ith  p o ta ssiu m  acetate in  acetic acid. The bromoketone 
(III) (1*0 g) in acetic acid (20 ml) was heated on a steam- 
bath  with potassium acetate (2*0 g) for 6 min to give a deep 
red solution filled with flocculent solid. The mixture was 
diluted with ethyl acetate, insoluble material (283 mg) was 
collected, and the solution was washed with water, and 
dried. The orange oil obtained on evaporation no longer 
dissolved completely in ethyl acetate. Filtration of the 
solution and re-evaporation left an orange gum, XmaY 
(EtOH) 269, 297, and 310 nm, which on storage in the 
refrigerator became partly insoluble in this solvent.
R eaction  o f  the \5 -B ro m o -Y l-ketone (Ila) with P o tassiu m  
A cetate in  A cetic  A c id .—The 15-bromoketone (Ila) (200 mg), 
acetic acid (20 ml), and potassium acetate (1*0 g) were 
heated under reflux for 20 h. The acetic acid was removed 
under reduced pressure, the residue was shaken with satu­
rated sodium chloride solution and ethyl acetate, and the 
latter was washed with aqueous sodium hydrogen carbonate, 
and dried. Evaporation left a buff solid (183 mg), re­
crystallisation of which from benzene gave 16-acetoxy-15,16- 
dihydrocyclopenta[o]phenanthren-l 7-one (V illa), m.p.
177*5—178°, mixed m.p. 178—179° with an authentic 
sample. 3 The i.r. and u.v. spectra of this material were also 
identical with those of the authentic material. The 15- 
bromoketone (Ila), m.p. and mixed m.p. 192—193°, was 
unchanged when a sample (20 mg) was boiled under reflux 
with glacial acetic acid (2*0 ml) for 20 h and worked up as 
described above. The u.v. spectrum of the recovered 
material was identical with th a t of (Ila).
[ 15-3H] -15,16-D ihydrocyclopen ta  [a] phenanthren- Yl-one 
(Vc).—The 15-bromo-17-ketone (Ila) (3*1 mg) and 5% 
Pd-CaC03 (3*5 mg) in ethanol (1*5 ml) were stirred together 
in an atmosphere of hydrogen containing ca. 0*5% v/v of 
tritium  gas. After 30 min, when absorption of gas had 
ceased, the mixture was added to water (10 ml) and ex­
tracted with benzene ( 2 x 5  ml). The benzene extract 
was washed with 5% (w/v) aqueous sodium hydroxide 
( 5 x 5  ml), then twice with water, and finally diluted to 
100*0 ml with benzene. This solution contained 840 pCi 
of tritium  and on t.l.c. ran as a single spot with values, 
u.v. absorption, and fluorescence under u.v. light indis­
tinguishable from those of authentic (la). Further ex­
traction of the benzene solution with aqueous alkali re­
moved no radioactivity.
Radioinactive ketone (la) was added to a portion of the 
benzene solution to give a sample of (Vc) with a specific 
activity of 78*6 pCi mmol-1. This ketone (92 mg) was 
stirred with a solution of chromium trioxide (150 mg) in 
glacial acetic acid (10 ml). After 24 h the yellow precipitate 
of the 6,7-quinone 3 was collected, washed with water, and 
dried. Recrystallisation from boiling toluene gave golden 
yellow leaflets, specific activity 72*3 pCi mmol-1.
15-A  cetoxy-15,1 G-dihydrocyclopenta[a.]phenanthren-17-one 
(Vb).—The 16-bromoketone (III) (620 mg) in tetrahydro­
furan (50 ml) was stirred with triethylamine for 15 min. 
5n-H2S04 (50 ml) was added and the deep orange solution 
was stirred a t room temp, for 24 h, when the reaction 
mixture consisted of a pink solid suspended in an orange 
solution. W ater (200 ml) was added and the mixture was 
shaken with an equal volume of ethyl acetate. The solid 
was filtered off, washed with water and ethyl acetate, and 
dried (216 mg). The ethyl acetate layer was separated,
11 M. M. Coombs, J . Chem. Soc. (C), 1966, 963.
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washed with water, dried, and evaporated to yield a partly 
solid orange gum (187 mg). This material was acetylated 
with acetic anhydride (2 ml) in dry pyridine (2 ml) over­
night. After addition of water, the mixture was extracted 
with dichloromethane and the extract was washed with 
2n-H2S04, then with water until neutral, and dried. Evap­
oration gave a dark brown gum (188 mg) which was chroma­
tographed on silica gel (60 g).' Fractions eluted with di­
chloromethane containing 2% v/v ethyl acetate and shown 
by t.l.c. to contain the 15-acetate were combined (55 mg). 
Two recrystallisations of this solid from hot n-butanol gave 
the 15-acetoxy-17-ketone (Vb) as cream needles, m.p. 
197—198°, and 197—199° when mixed with a sample of 
this compound obtained by treatm ent of (la) with thallium 
triacetate and bromine (see below).
T reatm ent o f  the K etone (la) w ith  T hallium  T riacetate and  
B ro m in e .—The ketone (la) (464 mg, 2 mmol) and thallium 
triacetate (763 mg, 2 mmol) were stirred together in carbon 
tetrachloride (100 ml), a solution of bromine (320 mg, 2 
mmol) in carbon tetrachloride was added, and the mixture 
was stirred a t room temp, for 22 h. The solid was collected 
and washed with the same solvent. The solution and 
washings were shaken with aqueous sodium hydrogen 
carbonate solution and with water, and dried; evaporation 
of the solvent left a yellow gum (297 mg).
This gum and material from a similar experiment (total,
615 mg) were chromatographed on a column of silica gel 
(60 g), eluting with dichloromethane. The first fractions 
contained a mixture (62 mg) of the bromoketones (Ila) and 
(Vila), identified by their values and u.v. light absorp­
tion characteristics. Subsequent fractions consisted of the 
starting material (la) and the product (Vb) (together, 236 
mg) in the approximate ratio 1:2.  Rechromatography 
of this material gave the \5 -a ce to x y-Y l-ketone (Vb) which 
after repeated recrystallisation from n-butanol, then 
ethanol, had m.p. 198-5—199° (Found: C, 78-9; H, 4-6; 
M +, 290-0949. C19H 140 3 requires C, 78-6; H, 4-85%; M
290-0943), (Nujol) 1740 (acetate), 1710 (ketone), 1022, 
855, 820, and 757 cm-1, ^  (EtOH) 269 (log e 4-76), 
297 (4-26), 330sh (3-10), 349 (3-09), 366 (3-07) nm.
When this procedure was repeated, but with omission of 
bromine, or when the 15-bromoketone (Ila) (10 mg) and 
thallium triacetate (12-5 mg) were stirred together in carbon 
tetrachloride (2 ml) for 22 h, the starting materials appeared 
unchanged and no new compounds had appeared, as 
judged by t.l.c.
We thank the Imperial Cancer Research Fund for a 
Bursary (to C. W. V.). We are indebted to Dr. R. B. Boar 
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phenanthren-17-one
By M a u r ice  M . C o o m b s * and F ran cis E. H. C ra w ley , Department of Chemistry, Imperial Cancer Research 
Fund Laboratories, Lincoln's Inn Fields, London WC2A 3PX
T h e  m ajor  urinary m e tabo l i te  of  t h e  ca rc in o g e n  1 5 .1 6 -d ih y d ro - 1 1 -m e th y lc y c lo p e n ta [ a ] p h e n a n th r e n -1 7 - o n e  ( l b )  
p r o d u c e d  by  th e  rat  is s h o w n  by  ch em ica l  an d  spectral  e xam ina t ion  to  p o s s e s s  t h e  novel  s t ruc tu re  8 ,9 - e p o x y -  
1 a ,2 (3 ,15£-tr ihydroxy-11 - m e t h y l - 8 ,9 - s e c o g o n a - 3 ,5 ,7 ,9 ,1 1 ,1 3 - h e x a e n - 1 7 - o n e  ( I I ) .
the extract from the urine of rats which had been 
administered the carcinogen (lb) contained a metabolite 
which accounted for ca. 50% of the radioactivity in this 
extract, whereas only a trace of material with a similar 
R-p value, u.v. absorption, and fluorescence was present 
in the extract from rats which had received the non-
2 M. M. Coombs and F. E. Crawley, in preparation.
8 M. M. Coombs and C. J. Croft, Progr. Experimental Tumor 
Research, 1969, 11, 69.
T h e r e  is a marked difference 2  in the urinary metabolism 
of 15,16-dihydrocyclopenta[a] phenanthren-17-one (la) 
and its strongly carcinogenic 3  1 1 -methyl homologue (lb) 
in the rat. In both cases, after injection of the [^C]- 
labelled ketones, 40—50% of the radioactivity present 
in the urine was extractable by ethyl acetate, and t.l.c. 
disclosed the presence of ca. 12 metabolites. However,
1 Part VIII, M. M. Coombs, M. Hall, and C. W. Vose, J.C .S . 
Perkin I , 1973, 2236.
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carcinogenic parent ketone (la). This paper describes 
the chemical identification of this major metabolite.
On acetylation this metabolite (C1 8 H1 6 0 6) yielded a tri­
acetate (HI), C2 4 H2 2 O7 , indicating that acetylation was 
accompanied by the loss of an oxygen atom. Hydrogen­
ation of the metabolite occurred with the uptake of 2  
moles of hydrogen to give the dihydrotriol (IVa), 
C1 8 H1 8 0 4, again with loss of an oxygen atom. Acetyl­
ation of (IVa) gave the dihydrotriacetate (IVb) (Cg^g^,) 
identical with the product of hydrogenation of the tri­
acetate (III). Treatment of the metabolite with hot 
mineral acid did not result in loss of oxygen, but gave
each of these ketones the carbonyl group in conjugated, 
absorbing at 1690 cm- 1  in the hydroxy-ketones (II) and 
(Va) and at 1720 cm' 1  in the acetates (III) and (Vb). A 
similar difference in the carbonyl frequency has been 
observed between the 15-hydroxy-ketone (Vila) and its 
acetate (Vllb ) . 1  That one hydroxy-group in these 
compounds is at C-15, rather than at C-16, is demon­
strated by the very similar chemical shifts and coupling 
constants of the 15- and 16-protons in the n.m.r. spectra 
of the acetates (III) and (Vb) when compared with those 
of the synthetic 15-acetoxy-17-ketone (Vllb), in contrast 
to those of the 16-acetoxy-l7-ketone (VIII) (Table 1).
R = H
AcO
m )
OAc
inn
R = Me
(Itf)  a  ; R = H 
b ; R  = Ac
Me, Me,
ROi 'OR RO 'OR
R = HR = H
b-.R = Ac b •, R = A c
'OR
Me. OAc Me
(DC)
b ; R  = Ac
dehydration to the mono-phenolic diol (Va) (C1 8 H1 4 0 4), 
acetylation of which gave the diacetate (Vb) (C2 2 H1 8 0 6). 
Both (Va) and (Vb) retain a non-funtional oxygen atom, 
whereas the oxygen atoms in the metabolite triacetate 
(III) are present in functional groups only. The presence 
of a thermally labile oxygen atom in both the metabolite
(II) and its dehydration product (Va) is clearly demon­
strated by the mass spectral fragmentation patterns of 
these two compounds [(Va), m/e 278 (M — O); (II), m/e 
278 (M  — H20  — O)]. Examination by t.l.c. of material 
recovered from the mass spectrometer inlet after intro­
duction of (II) showed the presence of only one com­
pound with the same R value and colour reactions as the 
dehydration product (Va). No ions corresponding to 
loss of oxygen appear in the mass spectrum of the metabo­
lite triacetate (III) or in that of the diol (Via), formed 
from (III) by deacetylation and dehydration with acid.
Ring c in the metabolite (II) and in its transformation 
products (III) and (V) is aromatic because in each the 11- 
methyl group has an n.m.r. absorption near t 7, and in
The u.v. spectra of (II) and (III) are very similar, 
despite the loss of the non-functional oxygen atom in the 
latter, but they differ from those of the other chromo- 
phores so far encountered with these metabolites. The 
u.v. spectra of the compounds formed on reduction with 
borohydride resemble that of 3,4-dihydro- (but not 1,2- 
dihydro-)phenanthrene. Thus ring B must also be 
aromatic and the conjugated ethylenic double bond must 
be between C-3 and C-4. The second and third OH 
groups are, therefore, attached at C-l and C-2. Selective 
hydrogenation of the 3,4-double bond in (III) and in (II) 
(accompanied in this case by loss of the extra oxygen 
atom), gave products with u.v. spectra very similar to 
that of the synthetic ketone (IX) , 4  thus confirming that 
ring a  is partially unsaturated.
The position and conformation of the secondary 
hydroxy-groups at C-l and C-2 are further established by 
consideration of the CHOH n.m.r. signals for C-l and C-2 
(Table 2). H-2 in metabolite (II) resonates at t  5*64 and
4 M. M. Coombs and T. S. Bhatt, J .C .S . Perkin I , 1973, 1261.
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is deshielded by 1*1 p.p.m. in the triacetate (III); it thus 
behaves as a typical secondary alcohol.5 H-l resonates 
1*5 p.p.m. lower in (II), at t 4*15, and is deshielded by 
1*26 p.p.m. on passing to (III). The environment of H-l 
is similar to that experienced by H-l in the cyclopentaja]- 
phenanthrene (lb), in which H-l resonates at 1—1*5
only as an internal epoxy-bridge, since treatment with 
acid does not open the ring to give a diol, as would be 
expected if a 1,2-epoxide were present. Several pieces 
of evidence suggest that (II) contains an internal epoxy­
bridge. The presence of ions showing the loss of an 
oxygen atom in the mass spectrum of (II) is the most
Proton
11-Me
AcO
H-16
H-16
H-16
H-16
H-l
H-2
H -ll
Other protons 
attached to 
conjugated C 
atoms
T a b l e  1
N.m.r. data ( t  values, /  in Hz) for compounds (Vila), 
15-Acetoxyketone (Vila) 16-Acetoxyketone (VIII) 
6-97 (3H)
7-86 (3H)
3-17 ( /15>18 2, / 15.16 6)
7*29 (/i5,ie 2, /xe.ij 18) 
6-65 ( / i 5,i8 6 , 7is.is 18)
1-32 (Jo 8, J m 2)
M 6 (J ii.it 9)
2-0—2-6 (6 H)
7-75 (3H)
6-85 ( /„ ,„  4, / UtU 18) 
6*02 ( / 15. 16 8 , / 15>16 18) 
4-50 (/is.is 4, 7i5.i8 8 )
M 8  (J0 7, J m 3)
2-0—2-6 (6 H)
(VIII), (III), and (Vb) in CDC1S 
(III)
7-02 (3H)
7-86 (3H)
7-98 (3H)
8-01 (3H)
3-22 (J  15,18 2, / i 6.i8 6)
7*32 (/i5,ie 2, /is.is 19) 
6*65 (J  15,18 6 , /18.18 19) 
2-87 U i .m 2)
4-52 ( /i . 2 2, / 2>8 6 )
1-92—3-66 (6 H)
(Vb)
6-84 (3H)
7-61 (3H)
7-88 (3H)
3d6 ( /i5.i8 2, J ig,i8 7)
7-30 ( /u .i, 2, / i 5.i8 19) 
6-65 (7i6.i8 7, 7i8.i5 19) 
1-33 (Jm 2)
2-0—2-85 (5H)
p.p.m. to lower field than the rest of the aromatic protons 
in this molecule. H-l in (II) and (III) is therefore 
equatorial, in almost the same plane as the aromatic 
rings, and within the deshielding zone of the aromatic
T a b l e  2
N.m.r. data * (t values, J  in Hz) for compounds (II) 
and (III) in CD3OD
t(II) -  t(III)
Proton (II) (III) /p.p.m.
H-l 4*15 (Ju t 2) 2-89 (7i>2 2) 1-26
H-2 6-64 (7i., 2, 7m  6 ) 4-53 (7i.2 2.73.s6) 1 -11
H-3 3-70 (72.3 6,73.4 9) 3-72 (72.3 6,73 4 9) - 0 -0 2
H-4 3-15(7s.4 9) 3-05 (7 , . 4  9) 0 -0 1
H -6 2-48 (76.7 9) 2-45 (76.7 9) 0-03
H-7 1-62 (7,.t9) 1-89 (A t 9) -0-37
H-12 2-48 2-44 0-04
H-16 4*24 (7is.is 2, 3-30 (A .!, 1-5, 0 -8 6
/ 15.16 6) /is.is 6)
H-16 6-81 (7i5, 18 6 , 6-72 (715.is 6 , 0-09
J 15.15 19) J15.15 19)
H-16 7-40 (7i8.x6 2, 7-38 (7i5.ie 1“5. 0 -0 2
/is. 15 19) / 15.15 19)
11-Me 6-78 (3H) 7-07 (3H) -0-28
* Some assignments were checked by spin-spin decoupling 
experiments.
ring current. The small magnitude of the coupling 
between H-l and H-2 (2 Hz) indicates that these protons 
are equatorial-equatorial, and the OH groups are thus 
trans (la,2(3), as expected for a vicinal diol derived 
metabolically from an aromatic ring A , probably via the
1,2-epoxide. This evidence establishes the structure of 
the metabolite triacetate as (III).
The similarity of the u.v. spectra of (II) and (III), and 
of their borohydride reduced derivatives indicates that
(II) and (III) have the same overall structure. The 
‘ extra ’ oxygen atom in (II) can then be accommodated
8 N. S. Bhacca and D. H. Williams, ‘ Application of N.m.r. 
Spectroscopy in Organic Chemistry,’ Holden Day, San Francisco, 
1964, p. 77.
significant. The valence tautomer (X) of pyrene 15,16- 
epoxide gave the expected M + ion at m/e 218 and an even 
more intense signal at m/e 202 (M  — O).6 In strong acid 
this molecule is protonated at oxygen with formation of 
the stable 3-membered ring. Treatment of 1,6-epoxy-
[10]annulene (XI) with acid gave 1-benzoxepin (XII),
H*
(X)
H*
(XI) (XQ)
ixm)
while mild hydrogenation led to naphthalene by elimin­
ation of the epoxy-bridge.7 In a similar way treatment 
of (II) with acid yields (Va) with retention of the' extra ’ 
oxygen atom, while hydrogenation causes its elimination. 
An n.m.r. study of syw-l,6-epoxy-8,13-methano[14]- 
annulene (XIII) led to the conclusion that this molecule 
tolerates compression of the bridges rather than bending
6 B. A. Hess, A. S. Bailey, and V. Bockelheide, J . Amer. Chem. 
Soc., 1967, 89, 2746.
7 A. Shani and F. Sondheimer, J . Amer. Chem. Soc., 1967, 89, 
6310.
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of the ring.8 The close similarity of the u.v. spectra of
(II) and (III) indicates that here, also, the molecule of
(II) is not substantially bent by the oxygen bridge.
Consideration of the n.m.r. spectra of (II) and (III) 
obtained under identical conditions (Table 2) shows that 
H-l, -2, and -16 in (III) are deshielded, as expected, by 
ca. 1 p.p.m. The chemical shifts of H-3, -4, -6, -12, and 
-15 are similar in (II) and (III), indicating that these 
protons occupy very similar conformations in the two 
molecules. The slight deshielding of H-4, -6, and -12 
probably results from the greater coplanarity, and hence 
greater ring current, associated with the aromatic rings 
B and c in (III). By contrast, H-7 and the protons of the 
11-methyl group are substantially shielded in (III). 
This suggests loss of an electronegative substituent from 
the adjacent 8- and 9-positions on passing from (II) to
CXDO
(III), and therefore that the epoxy-bridge is 8 — ►- 9. 
The structure of the metabolite is therefore as shown in 
<n ) ;
Since the ready loss of the epoxy-bridge on acetylation 
under mild conditions was unexpected, the acetylation 
conditions were investigated. Omission of the acid wash 
of the ether extract or examination of the reaction mix­
ture before addition of water gave products indistinguish­
able by t.l.c. from (III); also the metabolite (II) was 
recovered unchanged after dissolution in dry pyridine. 
It was therefore concluded that elimination of the 
oxygen occtirred during th« acetylation reaction itself. 
This may involve rear-side attack by the carbonyl oxygen 
of the C-l acetyl group at C-9, since a model demon­
strates that these two atoms can approach one another 
closely. Also the 8 —► 9 epoxy-bridge in the dehydr­
ation product (Va) is stable to acetylation, and the pro­
duct does not possess a la-acetoxy-group. The n.m.r. 
chemical shifts and coupling constants (Table 1) of H-15 
and -16 of this acetate (Vb) are very similar to those of
(III). The low field region of this spectrum includes a 
one-proton doublet at t  1*33 (J 2 Hz) while the rest of the 
aromatic protons resonate in the range t  2-0—2*85. 
This proton is therefore probably H-l, and in agreement 
with this it is not ortho-coupled since the phenolic OH 
group must then be at C-2. Two pairs of one-proton 
quartets at t  2-58 (J0 8, J m 2 Hz) and 2*04 (J0 8 Hz) can 
then be assigned to H-3 and -4, respectively. Signals due
8 E. Vogel, U. Haberland, and J. Ick, Angew. Chem. Internat. 
Edn., 1970, 9, 517.
9 M. M. Coombs, J . Chem. Soc. (C), 1969, 2484.
to the three protons in rings b and c occur between t  2*0 
and 2-4 as generally observed in cyclopenta[a]phenan- 
threnes. There is little evidence to suggest the position 
of the epoxy-bridge (Vb). However, the protons of the 
11-methyl group in this compound resonate at a lower 
field than those in 11 -methylcyclopenta [a] phenanthrenes 
( t  ca. 7-0), so that the bridge is probably 8 —► 9. If it 
were 8 —► 10, H-l would not be deshielded to the extent 
observed. The dehydration product therefore has 
structure (Va). The product of dehydration and de- 
acetylation of (III) with acid is similar to (Va) but con­
tains one less oxygen atom, and is therefore probably the 
corresponding cyclopenta[a]phenanthrene (Via).
It seems improbable that metabolism of the ketone 
(lb) could lead directly to insertion of the 8,9-epoxy­
bridge in the metabolite (II). This compound is more
OH
CO
(XV)
“CO
c m )
likely to have arisen by rearrangement of a reactive 
intermediate. Chemical oxidation of (la) and (lb) 
occurs at the if-region, osmium tetraoxide yielding the 
6,7-dihydro-6,7-diols and chromic acid giving the 6,7- 
quinones.9 It thus seems likely that this region will also 
be the site of major metabolic attack leading to 6,7- 
dihydro-6,7-epoxides.10 Rearrangement of the latter 
with migration of the oxygen atom at a position bridging 
C-8 and C-9 seems possible. Recently a rearrangement 
of this type has been proposed by Bruice11 to account for 
the formation of indan-4-ol (XV) and indan-5-ol (XVI) 
from 3a,7a-epoxy-3a,7a-dihydroindan (XIV). In this 
rearrangement the arene oxide opens to give a zwitterion 
which collapses to an isomeric oxide, resulting in move­
ment of the oxygen atom round the ring, finally to yield 
the two phenols. Possibly the marked difference in 
urinary metabolism between the carcinogenic 11-methyl- 
ketone (lb) which gives (II), and the inactive un­
substituted ketone (la) which gives only a trace of the 
unsubstituted homologue, is that the electron-releasing 
11-methyl group favours this type of rearrangement, or 
that oxepin formation allows release of the 1-H-ll-Me 
interaction.
EXPERIMENTAL
Procedures are generally as described in the preceding 
parts of this series. M.p.s were obtained using a Kofler hot
10 E. Boyland, in ' The Jerusalem Symposia o.n Quantum 
Chemistry and Biochemistry,’ eds. E. D. Bergmann and B. 
Pullman, vol. 1, Academic Press, Israel, 1969, p. 28.
11 P. Y. Bruice, G. J. Kasperek, T. C. Bruice, H. Yagi, and 
D. M. Jerina, J . Amer. Chem. Soc., 1973, 95, 1673.
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stage microscope (RCH, Reichert, Austria), or glass capillary 
tubes and an Electrothermal electrically heated block. 
I.r. spectra were recorded as mulls in Nujol on a Perkin- 
Eliner model 257 . spectrometer. N.m.r. spectra were 
measured on a Varian A60 (60 MHz) or a Perkin-Elmer R32 
(90 MHz, Me4Si lock) spectrometer. Mass spectra were ob­
tained using an A.E.I. MS902 instrument.
P r e p a r a t i o n  o f  1 5 , 1 6 - D i h y d r o - l l - [ 3H ] m e t h y l c y c l o p e n t a [ a . ' ] -  
p h e n a n t h r e n - Y l - o n e . —This compound was prepared from
17,17-ethylenedioxy-12,13,14,16,15,17-hexahydrocyclo- 
penta[a]phenanthren-ll-one (588 mg, 2 mmol) and [8H]- 
methyl iodide (282 mg, 2 mmol, 200 mCi) by a Grignard 
reaction as previously described 12 for the [14C] methyl com­
pound. The product (248 mg, 26-5 mCi) obtained after 
chromatography as fawn needles, m.p. 202°, ran as a single 
spot on t.l.c. (dichloromethane) and had u.v. and i.r. spectra 
identical with those of the authentic, unlabelled ketone.
C h a r a c t e r i s a t i o n  o f  t h e  M e t a b o l i t e  8 , 9 - E p o x y - \ a . , 2 $ , 1 5 '£ >-  
t r i h y d r o x y - 1  l - m e t h y l - 8 , 9 - s e c o g o n a - 3 , 5 , 7 , 9 , 11, l Z - h e x a e n - 1 7 -  
o n e  (II).—This material was soluble in ethanol and moder­
ately soluble in water, and was best purified by recrystallis­
ation from ethyl acetate with addition of a  little charcoal. 
After repeated recrystallisation from this solvent the 
m e t a b o l i t e  (II) was obtained as pale fawn needles which 
decomposed without melting a t 120° ( i n  v a c u o ) ,  [a]D26 
— 214° ( c  0T34, EtOH). For analysis, samples were dried 
a t 40° i n  v a c u o  after recrystallisation from ethanol (Found: 
C, 69*3; H, 5-7%), and from ethyl acetate (Found: C, 70’3; 
H, 5*2%; m / e  294-0893. C18H 160 6 requires C, 69-2; H, 
5*15%. M +  — H 20  requires m / e ,  294-0892), m / e  294 (6%), 
278 ( M  — H 20  -  O, 34), 277 (100), 261 (30), 260 (21), 259 
(20), 248 (20), 234 (36), and 232 (60), X ^  (EtOH) 267 (log e 
4-57), 320 (4-03), 332 (4-04), 352 (3-67), and 370 nm (3-61), 
unchanged by the addition of aqueous N aOH; treatm ent of 
the ethanolic solution with NaBH4 for 30 min gave 
X ^  (EtOH) 258 (log e 4-60), 267 (4-67), 3-18 (3-78) nm; W  
3400—3160 (O-H str., probably involving intermolecular 
hydrogen bonding), 1690 (ArCO), 1605 (conjugated C=C), 
and 1040 and 1005 cm-1 (possibly C-O-C), t  (CD3OD, 90 
MHz) in Table 2.
The metabolite (II) gave no immediate colour with Gibb’s 
reagent (not phenolic), nor did it liberate iodine from KI 
in 2m-H 2S04 (not a hydroperoxide).13 I t  did not liberate 
alkali from a solution of Na2S20 3 in 50% (v/v) aqueous 
acetone, a test considered specific for 1,2-dihydro-1,2- 
epoxides.14
1 a, 2(3,15£- T r i a c e t o x y - 1,2,15,16 - t e t r a h y d r o - 11 - m e t h y l c y c l o -  
p e n t a [ s i ] p h e n a n t h r e n - 1 7 - o n e  (III).—The metabolite (II) (40 
mg) was dissolved in a mixture of acetic anhydride (0-5 ml) 
and dry pyridine (0-5 ml) and kept a t room temperature for 
18 h. After addition of water (10 ml), the solution was 
extracted with ether, and the extract was washed succes­
sively with 2m-H2S04, saturated aqueous NaHCOs, and 
water. Evaporation of the dried solution left an orange 
gum which crystallised; after repeated recrystallisation 
from ethanol it gave pale fawn crystals of the t r i a c e t a t e  (III), 
m.p. 170— 171° (Found: C, 67-95, 68-3; H, 4-9; M + , 
422-1354. C24H 220 7 requires C, 68-25; H, 5-25%, M ,  
422-1361), (EtOH) 268 (log e 4-64), 322 (4-05), 333 
(4-07), and 370 nm (3-50), and after treatm ent with NaBH4, 
X ^  (EtOH) 264 (log e 4-62), 269 (4-66), and 323 nm (3-74), 
vjmi3c. (acetate CO) andl710 (ketone CO), and 1020 cm-1,
12 M. M. Coombs, S. B. Jaitly, and F. E. H. Crawley, J . Chem. 
Soc. (C), 1970, 1266.
t  (CD3OD) in Table 2, t  (CDC13) in Table 1, m / e  422 (M +), no 
M  —  O  peak.
1,2,3,4,15,16 - H e x a h y d r o - l a . ,  2(3,\ 5 \ - t r i h y d r o x y - 11 - m e t h y l -  
c y c l o p e n t a [ a . ] p h e n a n t h r e n - 17- o n e  (IVa).—The metabolite (II) 
(15 mg), dissolved in ethanol, was stirred in an atmosphere 
of hydrogen with 10% palladium-on-charcoal (Johnson- 
Matthey). Uptake of gas ceased after 80 min when 1-95 
mol. equiv. of hydrogen had been consumed. The catalyst 
was removed by filtration and the product was crystallised 
from ethanol to  yield cream needles of the h y d r o g e n a t e d  
d e r i v a t i v e  (IVa) (Found: M + , 298-1199. C18H180 4 requires
M ,  298-1205), m.p. 225—227° (from ethanol), X ^  (EtOH) 
260 (log s 4-70), 285 (3-89), 295 (3-94), 342 (3-46), and 354 nm 
(3-49) { c f .  1,2,3,4,15,16-hexahydro-1 l-methylcyclopenta[a] - 
phenanthren-17-one (IX),4 X^y (EtOH) 261 (logs 4-77), 287 
(3-97), 297-5 (4-02), 344 (3-69), and 354 nm (3-74)}. Acetyl­
ation of (IVa) as previously described gave a  triacetate, 
m.p. 123— 124°, identical with the triacetate obtained by 
hydrogenation of (III) (see below).
H y d r o g e n a t i o n  o f  t h e  T r i a c e t a t e  (III).—Hydrogenation of 
(III) (5 mg) as already described yielded crystalline 
la, 2p, 15 % , - t r i a c e t o x y - 1,2,3,4,15,16 - h e x a h y d r o - 11 - m e t h y l c y c l o -  
p e n t a [ s L ] p h e n a n t h r e n - 1 7 - o n e  (IVb) (Found: M + , 424-1523. 
C24H 210 7 requires M ,  424-1522), m.p. and mixed m.p. with 
the foregoing sample 123— 125°, X ^  as for (IVa), vmaY 
(CHC13) as for (III), with increased intensity a t 2925 and 
2850 cm-1 (aliphatic C-H).
8, 9 - E p o x y -2 ,15 % - d i h y d r o x y - 1 l - m e t h y l - 8 , 9 - s e c o g o n a -
l , 8 , 5 , 7 , 9 , l l , 1 8 - h e p t a e n - 1 7 - o n e  (Va).—The metabolite (II) 
(20 mg) was heated on a steam-bath with 5m-H2S 04 (10 m l); 
after 1 h  the yellow solid was collected, washed with water, 
and dried to give the p h e n o l  (Va), homogeneous by t.l.c. 
[toluene-ethyl acetate-methanol ( 2 : 1 : 1  and 15: 5 : 1, 
v/v), yellow fluorescence in u.v. light], m.p. 280—282° 
(Found: C, 73-25; H, 4-4%; m / e ,  278-0935. C18H 140 4 
requires C, 73-45; H, 4-8%. M + — O requires m / e ,
278-0943), m / e  294 (M+, 7%), 278 ( M  -  O, 22), 277 ( M  -  
OH, 8), 275 (8), 261 (100), 260 (10), 259 (29), 247 (10), 244 
(10), and 232 (14), vmaT (Nujol) 1690 (conjugated 0=0), 
3180-3265 (OH), and 1005 cm-1, X ^  (EtOH) 278 nm (log e 
4-55), X ^  [EtOH soln. (2-5 ml) +  2M-NaOH (0-1 ml)] 255 
(4-50) and 299 nm (4-50); after treatm ent with NaBH4, 
X^  (EtOH) 258, 310, 347, and 366 nm, ^  (EtOH +  
NaOH) 251 and 344 nm. The phenolic nature of (Va) was 
confirmed by the production of an immediate deep blue 
colour with Gibb’s reagent. Compound (Va) could not be 
hydrogenated under the conditions described for (II) and
(III).
Acetylation of (Va) by the method described previously 
gave cream crystals of the d i a c e t a t e  (Vb), m.p. 208—210° 
(from ethanol) (Found: C, 70-0; H, 4-6%; M + , 378-1008. 
C22H 18Oe requires C, 69-85; H, 4-8%; M ,  378-1103), 
X^x (EtOH), 267, 298sh, 356, and 374 nm, vma^ (Nujol) 1762, 
1734, and 1715 cm-1 (C=0 str.), no OH absorption, r  
(CDC13) in Table 1, m / e  [ c f .  (Va)] 378 ( M + , 1%) and 362 
( M  -  O, 48).
T r e a t m e n t  o f  t h e  T r i a c e t a t e  (III) w i t h  A c i d .— Compound
(III) (5 mg) was heated a t 100° with 5m-H2S04 for 2 h, 
cooled, and extracted with ethyl acetate. Evaporation of 
the washed and dried extract gave 15,16-dihydro-2,15£- 
dihydroxy-1 l-methylcyclopenta[a]phenanthren-17-one
18 S. N. Lewis, in ‘ Oxidation,' ed. R. L. Augustine, Marcel 
Dekker, New York, 1969, p. 213.
14 W. C. J. Ross, / .  Chem. Soc., 1950, 2267.
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(Via) as a yellow solid, XmttY (EtOH) 276 nm, Xmax. (EtOH +  
NaOH) 250 and 300 nm, X ^  (EtOH +  NaBH4) 260 and 315 
nm. This substance further resembled (Va) in its yellow 
fluorescence in u.v. light, blue colour with Gibb’s reagent, 
and similar value; tnje 278 (M +), 277, and 276.
Acetylation of this material in the usual way yielded the 
diacetate (VIb) (Found: M +, 362-1139. C22H 180 6 requires 
M ,  362-1154), X ^  (EtOH) 267 nm, Vmai (Nujol) 1735, 1720, 
and 1700 cm-1, no OH absorption.
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B hatt for assistance with the'anim al work, Mr. G. Coum- 
barides for n.m.r. spectra, and Mr. P. Cook for mass spectral 
measurements. We are indebted to Mrs. R. E. M. Jones and 
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Potentially Carcinogenic Cyclopenta[a]phenanthrenes. Part X.1 Oxy­
genated Derivatives of the Carcinogen 15,16-Dihydro-11-methylcyclo- 
penta[a]phenanthren-17-one of Metabolic Interest
By M aurice  M . C o o m b s /  M aureen  H all, V ero n ica  A. S id d le , and C olin  W . V o se , Chemistry Department, 
Imperial Cancer Research Fund Laboratories, Lincoln's Inn Fields, London WC2A 3PX
T w o  m e tabo l i te s  of  th e  title c o m p o u n d ,  nam e ly  th e  1 5 -h y d ro x y -  a n d  1 1 -h ydroxym ethy l  der iva t ives ,  a n d  a lso
1 5 ,1 6 - d i h y d r o - 2 -h y d r o x y c y c lo p e n ta [ a ] p h e n a n th r e n -1 7 - o n e  h a v e  b e e n  s y n th e s i se d  b y  a d a p ta t io n s  o f  rou te s  
previously  descr ibed  for c o m p o u n d s  of  this series.
A f t e r  injection of the carcinogen 15,16-dihydro-lI- 
methylcyclopenta[a]phenanthren-17-one (lb) 2 into rats, 
the major metabolite isolated from the urine was the 
epoxy trihydroxy benzocyclodecene (II),1 whereas the 
non-carcinogenic ketone (la) was not metabolised to a 
similar structure in significant amounts. The epoxy­
compound (II) was not found among the in vitro meta­
bolites when the carcinogen was incubated with various 
rat liver preparations in the presence of NADPH and 
oxygen, but here the major metabolite was the 15- 
hydroxy-derivative (Ilia), together with smaller amounts 
of the 16-hydroxy- (IVa) and 11-hydroxymethyl- (Va) 
ketones.3 This paper describes the chemical synthesis 
of (Ilia) and (Va), and of 15,16-dihydro-2-hydroxycyclo- 
penta[a]phenanthren-17-one (Vila) which was required 
as a model during the elucidation of the structure of the
1 P a r t  I X ,  M . M. C oom b s a n d  F . E . H . C raw ley , J.C.S.
Perkin I. 1974, 2330 .
* M . M . C oom b s a n d  F . E . H . C raw ley , in  p r ep a ra tio n .
phenolic epoxybenzocyclodecene (VI) formed on treat­
ment of the urinary metabolite with acid.
The 15-acetoxy-ketone (Illb) was readily obtained 
by either of the methods described for the corresponding 
derivative of the parent ketone.4 Treatment of (lb) 
with bromine and thallium(m) acetate led directly to the
15-acetate (IIlb), but isolation from the reaction mixture 
by chromatography was not readily accomplished. 
Attention was therefore directed towards the second 
method, acid-catalysed addition to the enone (Vlllb). 
The carcinogen was readily brominated in good yield 
with V-bromosuccinimide to give the 16-bromo-ketone 
(IX), the ring D protons of which possessed n.m.r. 
chemical shifts and coupling constants almost identical 
with those of 16-bromo-15,16-dihydrocyclopenta[a]- 
phenanthren-17-one, and different from those of the
* M . M. C oom b s, M . H a ll, V . A . S id d le , artd C. W . V o se , in  
p rep a ra tio n .
* M . M. C oom b s, M. H a ll, a n d  C. W . V o se , J.C.S. Perkin I, 
1973, 2 2 36 .
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known 15-bromo-derivative of (lb).* Dehydrobromin- 
ation with triethylamine readily generated the 15-en-17-
( I )  a ; R  = H
b ;  R = Me
OR
(HI) a  ;  R = H
ORMe
( Of J a  ; R :  H
b ; R * Ac b ; R = Ac
m
Me,
RO 'OR
( 2 3 ) a  r  R = H
b : R = Ac
RO
{2 H J a  ; R = H
b ; R = Ac
(2 H I ) a  ; R = H
Me
Me B r
one (VUIb). This compound was not isolated, but was 
identified by its characteristic four-banded u.v. spectrum 
which was very similar to that of the unsubstituted 
enone (Villa).4 It appeared to be appreciably more 
stable than the latter, giving rise to insoluble, pink 
decomposition products only slowly. Moreover, acid- 
catalysed addition of water to the double bond occurred 
very slowly, being still incomplete after 48 h at ambient
6 P. H. Lacey and D. C. C. Smith, J . Chem. Soc. (C). 1971, 41.
* G. M. Badger and J. W. Cook, J . Chem. Soc., 1939, 801; E. 
Boyland and P. Sims, Biochem. J ., 1966, 95, 780.
temperature. Recourse was therefore made to acid- 
catalysed addition of acetic acid to this double bond, for 
it is known that this occurs some 700 times faster than 
acid-catalysed hydration of the double bond in the 
analogous system indenone.6 By using acetic acid 
containing 5% of sulphuric acid, addition was essentially 
complete within 1 h and the 15-acetoxy-17-ketone (Illb) 
was obtained directly by crystallisation in about 40% 
yield. It was essential to remove the triethylamine 
hydrobromide before the addition of the acid; failure 
resulted in regeneration of the 16-bromoketone (IX). 
The reason for this surprising result is not clear, for 
acefate attacks as expected at C-15. There was 
evidence for a small proportion of the 15-bromide in the 
material recovered. Attempted alkaline hydrolysis of 
the acetate (Illb) led to degradation, but hydrolysis 
with sulphuric acid in tetrahydrofuran gave the 15- 
hydroxy-compound (Ilia) in moderate yield.
Hydroxymethyl derivatives of methyl substituted 
polycyclic aromatic hydrocarbons have been prepared 
directly by oxidation with lead tetra-acetate,® but under 
these conditions the carcinogen (lb) is converted largely 
into the 16-acetate (IVb).7 For synthesis of the 11- 
hydroxymethyl derivative (Va) we therefore used the 
convenient intermediate (X).8 Grignard reagents pre­
pared from benzyl chloromethyl ether and chloro- 
methyl methyl ether failed to react with this ketone, 
presumably owing to steric hindrance, but addition to 
the carbonyl group occurred in reasonable yield with the 
ylide from trimethylsulphonium iodide.9 The expected 
epoxide was not isolated, for when the reaction was 
worked up by acidification to pH 2—3 with dilute 
acetic acid the product obtained was the 11-hydroxy- 
11-hydroxymethyl acetal (XIa). Absence of i.r. carbonyl 
absorption and of a methyl singlet in its n.m.r. spectrum 
indicated this structure. In addition, the methylene
(X)
ROCH
(X I)  a  ; R = H
b *, R = Ac
A c O C H
( X H  )
protons of the hydroxymethyl group appeared as an 
AB quartet with geminal coupling of 11-5 Hz. The
7 M. M. Coombs, J . Chem. Soc. (C), 1969, 2484.
* M. M. Coombs, J . Chem. Soc. (C), 1966, 956.
• E. J. Corey and M. Chaykovsky, J . Amer. Chem. Soc., 1966, 
87, 1353.
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base peak in the mass spectrum, mfe 295, corresponds to 
the loss *CH2OH fronvthe-molecular ion.
Protection of the primary hydroxy-group by mild 
acetylation, followed by dehydration with phosphoryl 
chloride and pyridine gave the A11acetal (XII) in 
which the methylene protons of the acetoxymethyl 
group were equivalent, appearing as a singlet. Aro- 
matisation of ring c was completed by dehydrogenation 
with dichlorodicyanobenzoquinone (DDQ); removal of 
the acetal function with acid led to the fully aromatic 
acetoxymethyl ketone (Vb) with u.v. absorption very 
similar to that of the ketone (lb). Mild alkaline hydro­
lysis finally yielded the required 11-hydroxymethyl 
ketone (Va).
For the synthesis of the 2-phenolic-17-ketone (Vila) 
the route previously employed10 was followed, starting 
from the tricyclic ketone (XVI). The latter was 
prepared from anisole by a six-step sequence, after 
abandoning a potentially shorter route by way of 
Friedel-Crafts succinylation of 2-methoxynaphthalene. 
Although this reaction was sta ted11 to yield solely
3-(2-methoxy-l-naphthoyl)propionic acid (XHIa) in un­
stated yield when carbon disulphide was used, employ­
ing these conditions Bachmann and Horton 12 isolated 
the required 7-methoxy-l-naphthoyl isomer as the 
ethyl ester (XV) in ca. 10% yield, but obtained none of 
the 2-methoxy-isomer (Xllla). In our hands, repetition 
of the succinylation according to these authors led to a 
small amount of (XV) together with a much larger 
quantity of the phenolic ester (XlVb). The latter was 
readily methylated with diazomethane to the 2-methoxy-
1-naphthoyl ester (Xlllb), but attempted methylation 
with dimethyl sulphate and alkali failed, giving only the 
phenolic acid (XlVa). This partly explains the above 
discrepancy, for the former authors11 stated merely 
that the reaction was ‘ worked up in the usual way,' 
whereas the latter specify treatment of the crude 
Friedel-Crafts product with dimethyl sulphate and 
alkali before esterification and distillation. Neverthe­
less, it is not clear why the original authors did not also 
observe extensive demethylation with aluminium 
chloride in boiling carbon disulphide.
Stobbe condensation of the tricyclic ketone (XVI) 
with diethyl succinate yielded the half-ester (XVII) 
which was cyclised with acetic anhydride and anhydrous 
zinc chloride. The product (XVIII), readily identified 
by its u.v. spectrum characteristic of 11,12,15,16-tetra- 
hydro-17-ketones of this series,10 was dehydrogenated by 
prolonged heating with chloranil in toluene. The yield 
of the cyclopenta[«]phenanthrenone (XIX) was ca. 50%; 
reaction with DDQ occurred more quickly, but the yield 
was less. Demethylation with boron tribromide13 
below 0° yielded the 2-hydroxy-17-ketone (Vila), 
isolated as its more soluble acetate (Vllb). The free
2-phenol resembled in most respects the known 3-, 6-, 
and 7-phenols,7 except that with alkali the u.v. maximum
10 M. M. Coombs, S. B. Jaitly, and F. E. H. Crawley, J . Chem. 
Soc., (C). 1970, 1266.
11 W. F. Short, H. Stromberg, and A. E. Wilds, J . Chem. Soc., 
1936, 319.
at 274*5 nm gave place to two maxima of similar in­
tensity at 245 and 296 nm, instead,of .the simple batho- 
chromic shift shown by the maxima of these other 
phenols. This behaviour was also exhibited by the 
metabolite derivative (Via),1 with a transition from 
278 nm (neutral) to maxima of equal intensity at 255 
and 299 nm in alkaline solution. The n.m.r. signals due
MeO HO
a; R = H 
b; R = Et
a  ; R = H 
b ;  R= Et
C02Et
( X T ) ( X Z I )
COj H
MeO
MeO
to the aromatic protons in these two compounds are 
compared in the Table. Very similar chemical shifts are
N.m.r. chemical shifts (t) and coupling constants ( / /Hz) of 
aromatic protons in (VIb) and (Vllb) measured a t 100 
MHz in CDCl3
(VIb) (Vllb)
H-l 1-33 (A , 2) 1*62 Ux.» 2)
2*58 (7Xi, 2. A t  8) 2-59 (A* 2. A .4 8)
2-04 (A 4 8) 2-08 (A . 8)
tiling)
H-3
H-4
H-6
H-7
H -ll
H-12
1'48 ( / n , lt 8) 
2*11 [J n .it 8)2*16 (1H. s)
observed for H-3, -4, and -12, while the presence of the 
11-methyl group in (VIb) causes H-l to resonate at 
ca. 0*3 p.p.m. to lower field than that in (Vllb), as has 
been previously observed with similar compounds. 
However, H-6 and -7 in (Vllb) are accidentally equiva­
lent, appearing as a strong singlet at t  2*17 while in 
(VIb) they form an AB quartet. One proton, probably 
11 W. E. Bachmann and W. J. Horton, J . Amer. Chem. Soc., 
1949, 69, 58.
« J. F. W. McOmie and M. L. Watts, Chem. and Ind., 1963, 
1668.
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H-6, resonates at t  ca. 2-20 whereas the other (H-7) 
a p p e a r s  a t  ca. . 2 -02 indicating a t t a c h m e n t  o f  t h e e l e c t ro -  
negative" ring oxygen at the adjacent carbon” a t o m  
(C-8). A similar deshielding of H-7 in the metabolite
(II) was observed 1 when compared with its triacetate 
lacking this ring oxygen atom.
EXPERIMENTAL
Materials and methods were generally as described in 
previous parts of this series. I.r. spectral data for com­
pounds marked with an asterisk are listed in Supplementary 
Publication No. SUP 21216 (2 pp.).*
16-B rotno-16,16-d ihydro-1 \-m ethylcyclopenta[& \phen- 
a n th ren -ll-o n e  (IX).—The carcinogen (lb) (2-46 g,40 mmol) 
in carbon tetrachloride (100 ml) was boiled under reflux 
with IV-bromosuccinimide (2-14 g) for 3 h adjacent to a 
150 W lamp. After cooling, the precipitated succinimide 
was filtered off, and the orange solution was washed with 
water, dried, and evaporated to give a solid (2*21 g). 
Recrystallisation from benzene yielded the lQ -b ro m o -ll-  
m ethyl-ketone (IX) (1*65 g), m.p. 168° (unchanged by further 
recrystallisation) (Found: M +, 324-0141. C18H13BrO re­
quires M ,  324-0149); (Nujol) 1720 (OO), 870, 827, 
800, 770, 758, and 675 cm"1, X ^  (EtOH) 274-6, 359, and 
377 nm, t  (CDC1,) 4-06 (q. J  2 and 6 Hz, H-16), 6-7 (q, 
J  2 and 20 Hz, H-15), and 6-51 (q, J  6 and 20 Hz, H-15).
15-A  cetoxy-15,16-d ihydro-1 \-methylcyclopentaSjP\phen- 
anthren-Vl-one ( I llb ) .— F rom theen one  (VHIb). Thebromo- 
ketone (IX) (1-06 g) was dissolved in pure tetrahydrofuran 
(THF) (100 ml) and treated with triethylamine (2-0 ml). 
Aliquot portions were removed a t intervals and diluted 
with ethanol for u.v. spectrophotometry; after ca. 30 min, 
conversion into the enone (VHIb), Xmny 256, 288, 298, and 
312 nm, appeared to be complete. Dichloromethane 
(100 ml) was added and the solution was washed with 
water to remove triethylamine hydrobromide. After 
addition of a mixture of glacial acetic acid (180 ml) and 
conc. sulphuric acid (20 ml) aliquot portions were removed, 
diluted with acetic acid, and their u.v. spectra observed. 
After 1 h, when conversion into the product, X^^ 266 nm, 
was complete, more dichloromethane was added and the 
reaction mixture was washed several times with water, with 
sodium hydrogen carbonate solution, again with water, 
and dried. Evaporation and crystallisation of the residue 
from ethanol gave red needles (0-4 g), m.p. 196—204°. 
Several recrystallisations from this solvent with the 
addition of charcoal yielded the 1 5 -a c e to x y -ll-m e th y l-n -  
ketone (Illb)* as pale pink needles, m.p. 209—210° (Found: 
C, 78-85; H, 5-15. C20H1#O3 requires C, 78-95; H, 5-3%), 
(EtOH) 266 (log e 4-81), 301 (4-30), 356 (3-11), and 
374 nm (3-19).
In a preliminary experiment the bromo-ketone (IX) 
(50 mg) in TH F (1-0 ml) was treated with triethylamine 
(0-1 ml) for 30 min, when the above spectral change had 
occurred. Addition of 5% sulphuric acid in acetic acid 
caused an almost immediate change to X^^ (HOAc) 277 nm. 
After 30 min water was added and the product was ex­
tracted with dichloromethane as before to yield a pale 
brown crystalline solid (30 mg), m.p. 146— 155°,
(Nujol) as for (IX), with weak bands a t 820, 760, 722, and 
700 cm-1 possibly caused by the presence of a small quantity 
of the 15-bromo- 17-ketone.4
This acetate (Illb) (130 mg) was boiled for 20 h with 
2n-H2SO, (7-5 ml) ip THF (15 ml). The dark brown 
solution was diluted with water and extracted with ethyl
acetate. The crude product, which showed several spots 
on t .Lc., w as. purified by this method, recovering the 
rnaterial of R v  0-50 by elution of the silica gel with ethanol. 
Evaporation of the solvent under reduced pressure gave the
16-hydroxy-11-methyl-17-ketone (Ilia) as a  pale cream 
solid (20 mg), X ^  (EtOH) 265 (log e  4-84), 300 (4-63), 
356 (3-29), and 374 nm (3-21). This compound appeared 
to be rather unstable; rechromatography after keeping it 
a t ambient temperature again showed several spots, and 
for this reason no attem pt was made a t further purification.
F rom  (lb) with th a lliu m (u i) acetate and, brom ine. The 
carcinogen (lb) (150 mg) and thallium(in) acetate (234 mg) 
were stirred together in carbon tetrachloride (35 ml). 
Bromine (100 mg) in this solvent (2 ml) was added in one 
lot, and the mixture was stirred a t room temperature for 
23 h, when t.l.c. showed th a t most of the ketone (lb) had 
been consumed with the formation of a  more polar material 
identified as the 15-acetate (Illb) by its value and the 
greenish blue colour developed a t 100° after spraying with 
ethanolic H 2S 0 4. After filtration from the dark precipitate, 
removal of the solvent gave a bright yellow gum (194 mg) 
which was chromatographed on a column of silica gel 
(Hopkins and Williams M.F.C.) (20 g), eluting with dichloro­
methane containing increasing proportions of ethyl acetate. 
Fractions containing the acetate (Illb ), bu t still con­
taminated with starting material (lb) (60 mg) were purified 
further by preparative t.l.c. (silica gel, 1 mm layers; 
CH2C12) giving finally an orange solid (11 mg) with i.r. and 
u.v. spectra identical with those of the pure 15-acetate 
(Illb) described above. The chromatographic column 
remained strongly fluorescent when no more material 
could be eluted. r • :
\ l , \ l - E t h y l e n e d i o x y - l l - h y d r o x y - l \ - h y d r o x y m e t h y l -
11,12,13,14,15,16 - h e x a h y d r o c y c l o p e n t a [ a . ] p h e n a n t h r e n e  (XIa). 
—Sodium hydride (50% dispersion in oil; 0-36 g) was 
washed by decantation with light petroleum (b.p. 40—60°). 
Dry dimethyl sulphoxide (30 ml) was added under nitrogen 
and the mixture was stirred a t 70° until hydrogen evolution 
ceased. After cooling, dry tetrahydrofuran (30 ml) was 
added and the mixture was further cooled to —3° before 
trimethylsulphonium iodide (3-63 g) dissolved in dimethyl 
sulphoxide was added slowly with stirring, keeping the 
temperature below 0°. When the addition was complete 
the oxo-acetal (X) (3-5 g) in a mixture of dimethyl sulph­
oxide (15 ml) and TH F (15 ml) was run in slowly below 0°, 
and the solution was stirred a t this tem perature for 2 h. 
When the reaction mixture had attained room temperature 
it was poured into water (260 ml) and acidified to pH  2— 3 
with glacial acetic acid to facilitate extraction with di­
chloromethane. The extract was washed with water, 
saturated sodium hydrogen carbonate solution, water, 
and dried. The gum (3-4 g) left on removal of the solvent 
under reduced pressure crystallised from benzene-n-hexane 
as fawn needles (1-3 g); the mother liquor contained mostly 
starting material. Recrystallisation gave the 11 -hydroxy-  
W -h ydroxym eth yl acetal (XIa)* as needles (1-12 g), m.p. 
168-170-5° (Found: C, 73-3; H, 6-7%; M +, 326-1511. 
C20H 22O4 requires C, 73-6; H, 6-8%; M , 326-1518), m /e  326 
(M +, 35%), 380 (M + -  H 20 , 20), 295 (M + -  CH2OH, 
100), and 99 (acetal ion, 89); Xm ax  (EtOH) 230-5 (log e 4-92), 
272-5 (3-74), 282 (3-76), and 291 nm (3-62); t  (CDC13) 6-13 
(d, J  11-5 Hz, HaCHbOH), 5-67 (d, J  11-5 Hz, H AC //DOH), 
and 6-04 (s, 0CH 2CH20).
* For details of Supplementary Publications, see Notice to 
Authors No. 7 in J .C .S . Perkin I , 1974, Index issue.
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This diol (1*12 g) was acetylated with acetic anhydride 
-and  pyridine-overnight~at. roorcutemperature.— Chromato­
graphy of the product (1*1 g) on alumina (Merck grade 
II—III) with toluene-ethanol (200: 1 v/v) gave the 11- 
acetoxym ethyl-11 -hydroxy acetal (Xlb)* as a pale yellow glass 
(0-76 g) (Found: C, 71-8; H, 6-1%; M +, 368-1617.
C22H 240 6 requires C, 71-7; H, 6-6%; M , 368-1623), m /e 368 
(M+, 25%), 350 (M+ -  H tO, 45), 295 (M  -  CHtOAc, 15), 
and 99 (acetal ion, 100); 3 ^  230 (log e 4-96), 272 (3-74), 
282 (3-76), and 291 nm (3-62); t  7-95 (s, OAc), 6-05 (s, 
OCHtCHjO), 6-98 (d, /  11-5 Hz, HaCHbOAc), 4-92 (d, 
/  11-5 Hz, HaC //bOAc).
\ b , l Q - D i h y d r o - l l - h y d r o x y m e t h y l c y c l o p e n t a [ s i ] p h e n a n t h r e n -  
17- o n e  (Va).—Redistilled phosphoryl chloride (394 mg, 0-24 
ml) was added to a vigorously stirred solution of the 
acetoxymethyl acetal (Xlb) in pyridine (15 ml), cooled in 
ice. The solution was stirred a t 0° for 30 min and then 
a t 79° for 6 h in the absence of moisture. After addition 
of ice and extraction with ether, a pale orange-yellow gum 
(211 mg) was obtained which ran as one spot on t.l.c., R v
0-73 (ethyl acetate-dichloromethane, 1 : 9 v/v) and appeared 
to be the required ll-acetoxymethyl-All-acetal (XII),* ^  
(EtOH) 237-5 (log c 4-81), 303 (3-88), 315 (3-87), and 
336 nm (3-59), similar to the spectrum of the corresponding
ll-methyl-Au -acetal; t  7-90 (s, OAc), 7-32 (m, H -l3 and 
-14), 6-00 (s, OCHjCHjO), and 4-75 (s, C H t O A c ) .  Chro­
matography of a  sample of this A11-acetal on alumina 
(Grade III) resulted in decomposition to a number of 
products, and the acetal was therefore used without further 
purification.
This material (60 mg), dissolved in benzene (10 ml), was 
treated with dichlorodicyanoquinone (DDQ) (40 mg) a t 
room temperature -for 48 h. The precipitated hydro- 
quinone was collected, and the filtrate was washed with 
2N-sodium hydroxide to yield an orange glass (49 mg) 
which was dissolved in THF, acidified with 5N-hydrochloric 
acid, and stirred overnight a t room temperature. The 
solution was poured into saturated aqueous sodium hydrogen 
carbonate and extracted with ether; the product was 
reacetylated as already described. Chromatography of 
the product on a  column of silica gel (MFC) with toluene- 
ethanol (60 : 1 v/v) and crystallisation of fractions showing 
bright blue fluorescence in u.v. light from ethanol gave 
1 l - a c e t o x y - 1 5 , 16 - d i h y d r o c y c l o p e n t a [ a . ] p h e n a n t h r e n ~ 1 7 - o n e  
(Vb)* as needles (30 mg); m.p. 175— 176° (Found: M + , 
304-1093. Ct0H leOs requires M ,  304-1099), t n f e  304 (M+, 
100%), 245 (M+ -  CHjCOj, 20), and 231 (Af -  CH2OAc, 
30), X ^  (EtOH) 265 (log e 4-88), 285 (4-50), 300-5 (4-36), 
366 (3-32), and 373 nm (3-44); r  [(CD3)2SO] 7-92 (s, OAc),
7-18 (m, 16-H2), 6-88 (m, 15-H2), 4-68 (s, C H 2O A c ) ,  and
2-70—1-75 (7H, aromatic).
This compound (25 mg) in ethanol (8 ml) was hydrolysed 
with 6% sodium hydroxide solution (0-3 ml) at room 
temperature for 2 h. Addition of water and extraction 
with chloroform gave the 1 l - h y d r o x y m e t h y l -  \ 1 - k e t o n e  (Va)* 
crystallised from chloroform-n-hexane as fine, pale yellow 
needles (13 mg), m.p. 190— 192° (Found: M + , 262-0987. 
C,*H14Ot requires M ,  262-0993), m / e  262 (M+, 100%), 
234 ( M + -  CO, 20), 235 ( M + -  CHO, 45), and 233 (M + -  
CHjOH, 18), X ^  (EtOH) 264-5 (log e 4-85), 285 (4-51), 
300 (4-32), 356 (3-29), and 372-5 nm (3-41).
P r e p a r a t i o n  o f  6 - M e t h o x y - 3 l 4 - d i h y d r o p h e n a n t h r e n - \ ( 2 H ) -  
o n e  (XVI).—3-p-Anisoylpropionic acid14 (from anisole;
14 D. A. Hahn, J . Amer. Chem. Soc., 1916, 88, 1933.
“  E. L. Martin, Org. Synth., Coll. Vol. II, 1943, p. 500.
4®%) was reduced with amalgamated zinc and hydrochloric 
—acid - to -4-/>-methoxyphenylbutyric-acid “  (70 %). -Cyclis- 
ation with tin(iv) chloride gave 7-methoxytetralone 18 
(65%). A Reformatsky reaction with methyl 3-bromo- 
crotonate 14 followed by isomerisation of the product gave 
4-(7-methoxy-l-naphthyl)butyric acid (50%) which was 
cyclised to the methoxy-ketone (XVI), m.p. 104— 105° 
(lit.,1* 102— 103-5°) (62%).
S u c c i n y l a t i o n  o f  2 - M e t h o x y n a p h t h a l e n e . —2-Methoxy- 
naphthalene (79 g) was treated as described,12 giving a 
distillate (36-6 g), b.p. 178— 190° a t 0-4 mmHg. Dis­
solution in hot methanol and cooling gave the ethyl ester
(XV) as a finely divided, crystalline solid (3-2 g), m.p. 
72—74-6° (lit.,12 79-5—81°). Evaporation of the methanol 
and crystallisation of the residue from benzene yielded 
bright yellow prisms (20-6 g) of e t h y l  Z - { 2 - h y d r o x y - \ -  
n a p h t h o y l ) p r o p i o n a t e  (XlVb), m.p. 95—96° (Found: C, 
70-6; H, 6-05. C1#H160 4 requires C, 70-55; H, 5-9%), 
vm»x. (Nujol) 3295 (OH), 1729 (ester 0=0), and 1670 cm-1 
(aryl C=0). Methylation of (XIVb) (1-0 g) with an excess 
of diazomethane in ether gave an oil which rapidly crystal­
lised to yield the methoxy-ester (XHIb) (0-95 g), m.p. 
43—45° (lit.,11 41—42°), VniM, (Nujol) 1727 and 1700 cm"1. 
Saponification of (XlVb) (0-5 g) with warm 2N-NaOH gave 
the a c i d  (XlVa) (0-34 g), m.p. 105—-106° (Found: C, 68-65; 
H, 5-15. C14H 120 4 requires C, 68-85; H, 4-95%), vm.T 
(Nujol) 1700 and 1620— 1610s,br cm"1. The same product 
was also obtained when dimethyl sulphate was added to the 
alkaline solution of (XIVb).
2- M e t h o x y - 11,12,15,1 Q - t e i r a h y d r o c y c l o p e n t a [ a . ] p h e n a n i h r e n -  
17- o n e  (XVIII).—S t o b b e  r e a c t i o n .  The methoxy-ketone
(XVI) (7-60 g) and diethyl succinate (9 ml) were heated 
under reflux with potassium t-butoxide [from t-butyl 
alcohol (25 ml) and potassium (1-45 g)] for 90 min in an 
atmosphere of dry nitrogen. After being kept a t room 
temperature overnight, the reaction mixture was acidified 
to  pH 5—6 with 2N-hydrochloric acid and extracted with 
dichloromethane. The latter solution was thoroughly 
extracted with dilute aqueous ammonium hydroxide; 
acidification of the alkaline solution with 2N-hydrochloric 
acid liberated the half-ester (XVII) which formed a brown 
gum (9-56 g), not obtained crystalline, bu t which ran as a 
single spot on t.l.c.
C y c l i s a t i o n .  This half-ester (9-56 g) was dissolved in 
acetic anhydride (100 ml) and treated with a solution 
(50 ml) of freshly fused zinc chloride (3-0 g) in glacial 
acetic acid (150 ml) under reflux in dry nitrogen for 5 h. 
W ater (106 ml) was cautiously added to the cooled solution, 
followed by conc. HC1 (63 ml), and the mixture was boiled 
under reflux for a further hour. The residue left after 
removal of the solvents under reduced pressure was dis­
solved in aqueous 5% KOH (700 ml) and stirred vigorously 
with dimethyl sulphate (45 ml) for 20 h. The precipitate 
was collected, washed with water, and dried (5-00 g). 
Purification by chromatography on a column of alumina 
(100 g) with hexane-dichloromethane (1 :1  v/v) gave 
crystalline material (0-69 g), m.p. 152— 153°, and less pure 
solid (0-54 g). Recrystallisation of the purer sample from 
methanol yielded the t r i c y c l i c  k e t o n e  (XVIII),* m.p. 164— 
164-5° (Found: C, 81-6; H, 6-25. C18H 1#0 2 requires C,
81-8; H, 6-1%), X ^  (EtOH) 273-6 (log e 4-39), 284 (4-44), 
and 328 nm (4-30).
15,1 f i - D i h y d r o - 2 - m e t h o x y c y c l o p e n t a [ a . ' ] p h e n a n t h r e n - 17- o n e
14 H. Gilmore and W. J. Horton, J .  A m e r .  Chem. Soc., 1950, 72, 
733.
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(XIX).—The tctrahydro-ketone (XVIII) (0-88 g) and 
chloranil (1*20 g, 1*6 mol) were boiled together in dry 
toluene (100 ml) for 1 week when t.l.c. showed th a t little 
of the starting material remained. The dark crystalline 
precipitate of the hydroquinone was collected, washed with 
toluene, and the combined toluene solutions were evapor­
ated to a small volume, and placed on a column of silica 
gel (Hopkins and Williams, MFC). Elution with toluene 
containing increasing proportions of dichloromethane gave 
fractions (total 0-63 g) homogeneous by t.l.c. Crystallis­
ation from ethanol yielded the 2-m ethoxy-\l-ke ton e  (XIX) 
(0-40 g), m.p. 164— 165°, raised to 180— 180-6° by two 
more recrystallisations from this solvent (Found: C, 82-6; 
H, 5-5. C18H140 2 requires C, 82-4; H, 5-4%), )>tiT (EtOH)
271 (log E 4-81), 360 (3-45), and 377 nm (3-51); (Nujol) 
1705—1680 (aryl C=0), 1043, 955, 825, 790, 760, and 720 
cm-1.
15,1§-D ihydro-2-hydroxycyclopen ta[a]phenanthren-17-one 
(Vila).—The methoxy-ketone (XIX) (0-54 g) in dichloro­
methane (50 ml) was cooled to —80° and boron tribromide 
(5 ml) was added. After 1 h the solution was gradually 
warmed to 0° during 15 min, then poured into ice. The 
cream coloured precipitate was collected, washed with 
water, dried, and stirred with dichloromethane. After 
filtration, acetylation of the solid (0-38 g) gave a product
which was crystallised from benzene to yield pale fawn 
need 1 es of 2-acetoxy-15,1 Q-dihydrocyclopenta[si]phenanthren- 
n -o n e  (Vllb), m.p. 248—249° (Found: C, 78-65; H, 4-85. 
C1»H14Os requires C, 78-6; H, 4-85%), X ^, (EtOH) 265-5 
(log e  4-85), 282-5 (4-46), 296 (4-36), 352 (3-37), and 369 nm 
(3-39); (Nujol) 1755 (acetate C=0), 1695 (aryl C O ), 
1015, and 930 cm"»; t  (CDC1,) 6-56 (t, 15-H,), 7-17 ( t ,
16-H2), and 7-61 (CHsCOs).
This acetate (100 mg) was hydrolysed by boiling with 
ethanol (20 ml) containing aqueous 5% NaOH (2 ml) for 
1 h. Dilution with n-HCI (40 ml) gave a cream coloured 
precipitate which was washed with dichloromethane and 
recrystallised from butan-l-ol. The 2-hydroxy-17-ketone 
(Vila)* formed pale yellow needles (29 mg), m.p. 340° 
(decomp.; sealed, evacuated capillary), X^^ (EtOH) 274-5 
(log e 4-74), 366 (3-40), and 383 (3-45) (neutral); 245 (4-59) 
and 296 (4-62) (alkaline); 257 (4-69) and 310 (3-95) (neutral, 
after reduction with NaBH4) ; and 249 (4-73) and 334 nm 
(4-18) (alkaline, after reduction with NaBH4).
We thank Mr. D. Thomas for the microanalyses and 
Mr. P. Cook for the mass spectral measurements. C. W. V. 
thanks the Imperial Cancer Research Fund for a bursary.
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Potentially Carcinogenic CycIopenta[a]phenanthrenes. Part 11. Synthesis
of the 1-Methyl, 1,11 -Methano, and 7,11-Dimethyl Derivatives of
15,16-Dihydrocyclopenta[a]phenanthren-17-one
Odartey Ribeiro, Stephen T. Hadfield, Alexandra F. Clayton, Colin W. Vose, and Maurice M. Coombs,*
Chemistry Laboratory, Imperial Cancer Research Fund, Lincoln's Inn Fields, London WC2A 3PX
15,16-Dihydro-1-methylcyclopenta[a]phenanthren-17-one has been prepared starting from testos­
terone, and in addition by a multi-stage synthesis from a correctly substituted naphthalene. The latter 
route has also been employed for the synthesis of the 7,11 -dimethyl-17-ketone, and the 1,11 -methano- 
17-ketone containing a bridged bay region.
In previous parts of this series we have described the synthesis 
of the 2-, 3-, 4-, 6-,1 7-,2 11-, and 12-methyl3 derivatives of
15,16-dihydrocyclopenta[a]phenanthren-17-one (la), as well 
as numerous other compounds4 related to this parent poly- 
cyclic ketone. Of these monomethyl derivatives the 11-methyl-
17-ketone (lb) is a strong carcinogen,5 similar in potency to 
benzo[a]pyrene. The 7-methyl isomer is less active and all the 
other isomers are inactive, as is the parent ketone (la).6 The 
carcinogen (lb) is biologically activated to its onh-1,2,3,4- 
tetrahydro-fra/zs-3,4-dihydroxy-1,2-epoxide,7 and it was there­
fore anticipated that like the 2-, 3-, and 4-methyl isomers, the 
unknown 1-methyl-17-ketone would lack carcinogenic activity. 
The 1,11-methano-derivative (2) was also expected to be in­
active since, although it still retains a small electron-releasing 
substituent at C -ll, the bay region is apparently blocked by 
the 1,11-methylene group. This paper describes the syntheses 
of these two compounds, the former by two independent 
routes; a preliminary communication has appeared in connec­
tion with the latter (2).8 Also reported is the synthesis of the 
7,11-dimethyl-l7-ketone (Id); the potency of this compound 
was of interest because it bears methyl groups at both positions 
known to confer carcinogenic activity in this series.
Initially A-ring aromatisation of a suitable steroid via  the 
. dienone-phenol rearrangement9 seemed to offer a convenient 
means of placing the methyl group at C-l in a cyclopentafa]- 
phenanthrene. Dannenberg’s method 10 was selected, since 
ring-A aromatisation and removal of the 3-oxygen function 
are effected simultaneously. Thus testosterone acetate was 
converted by known methods in four steps into 1-methyl- 
oestra-l,3,5(10)-trien-17-one (3a).11 Several methods were 
considered for removal of the blocking 18-methyl group, but 
finally an adaption 12 of the method devised by Pinhey and his 
co-workers 13 for the removal of a 4-methyl group from a 
tetracyclic triterpenoid was chosen. An abnormal Beckmann 
rearrangement of the derived oxime (2b) yielded the methylene 
nitrile (4). Epoxidation with m-chloroperbenzoic acid led to 
the epimeric epoxynitriles (5) which, without separation, were 
cyclised with boron trifluoride to give the 18-norketone (6). 
The yield in the cyclisation step (14%) was much lower than 
that obtained by Pinhey and his co-workers for recyclisation of 
the six-membered ring a ,  and the overall yield of (6) from (2a) 
was only 8%. Unfortunately, complete dehydrogenation of the
18-norketone (6) to the desired cyclopenta[a]phenanthrenone 
also proved difficult, but as finally achieved, albeit in poor 
yield, by prolonged reaction with dichlorodicyanobenzo- 
quinone (DDQ) in boiling dioxan to furnish a small sample of
15,16-dihydro-1 -methylcyclopentaj>]phenanthren-17-one (lc) 
identical with the material from the second synthesis (see 
below). Although of no use practically, this route is never­
theless of interest as a new way of converting a natural steroid 
into a member of the cyclopenta[a]phenanthrene series.
A more practical synthesis of this compound was accom-
( 1 )
a ;  R 1 = r 2 = r 3 = h
b ;  R1 = Me, R2 = R 3 = H
o 33
.
II R3 = H, R 2 = Me
d ;  R2 = H, R 1 = R3 = Me
e ;  R1 = R2 = H, R 3 = Me
( 2 )
Me
( 3  )
(4  ) ( 5 )
a ;  X = 0  
b ;  X = N-OH
Me
( 6  )
( 1c)
Reagents-, i, DCC, CF3C02H, Me2SO; ii, w-C1C6H4C03H ; 
iii, BF3, toluene; iv, DDQ, dioxan
plished by adding rings c and d  sequentially to a suitable 
substituted naphthalene, a strategy previously adopted by us 
for the synthesis of cyclopenta[a]phenanthrenes. Treatment of 
the keto-ester (7 )14 with methyl bromoacetate in the presence 
of zinc gave the lactone (8), readily reduced by catalytic 
hydrogenolysis to the acid-ester (9). Cyclisation of the latter 
with stannic chloride was followed by borohydride reduction 
of the resulting tetralone (10); subsequent dehydration, and 
dehydrogenation of the product by heating with sulphur, 
yielded 8-methyl-1-naphthylacetic acid (11a). Chain extension 
was achieved by reduction to the corresponding naphthyl- 
ethanol, bromination, and application of the malonic acid 
synthesis. Cyclisation of the resulting naphthylbutyric acid 
(12a) gave the tricyclic ketone (13a) which was converted, via  
the Stobbe half-ester (14a) and further cyclisation with zinc 
chloride, into the 11,12-dihydro-compound (15a) by the 
previously described methods.1 Catalytic dehydrogenation
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C 0 2Me
CO 2 Me
(7  ) ( 8 )
CO?HMe
(9  )
V
(12 a . b )
( 13a ,b)
(11a,b )
IV,  V
V I .  VII
C 0 2Me
II
( 14a,b)
a ;  FT = Me , R1 = R = H 
b ;  R1 = R3 = Me, R 2 = H
( 15a,b)
^ ( x i i i )
( 1c ) a n d  ( 1d )
Reagents: i, BrCH^O^Me, Zn; ii, Pd/H2) AcOH, HCI04; iii, PC15 
SnCl4; iv, NaBH4; v, TosOH; vi, S; vii, NaOH; viii. LiAlH4; 
ix, Ph3PBr2; x, NaCH(C02Et)2; xi, Bu‘OK, (CH2C02Et)2; xii, ZnCl2; 
Ac20 , HC1; xiii, Pd, boiling p-cymene
C02H
C 0 2Et
(18 )
( 2 )
Reagents: i, LiAlH4; ii, PhPBr2; iii, KCN, then NaOH; iv, PC15, 
SnCl4; v, Bu'OK, (CH2C02Et)2; vi, Zn, Ac20, HQ;'.vii, Pd, 
boiling p-cymene
membered ring via the Stobbe half-ester (19) was carried out as 
before.
The cyclopenta[a]phenanthrenones (lc) and (Id) possessed 
spectral and other properties similar to those of the other 
positional isomers of this series. Noticeable differences in the 
u.v. spectrum of the methano-compound (2) probably reflect 
the considerable distortions of the phenanthrene system 
induced by bridging the bay region, as disclosed by the 
previous X -ra y  study.8 As expected, the 7,11-dimethyl-17- 
ketone is found to be a potent bacterial mutagen, whilst the 
l-methyl-17-ketone is essentially inactive; experiments to 
evaluate their carcinogenicity are in progress. The methano- 
ketone (2) proves to be both mutagenic to Salm onella typhi- 
murium  TA 100 (after biological activation) and a moderately 
strong skin tumour inducer in mice. An investigation of its 
metabolism is in hand to attempt to account for this.
with palladium in boiling p-cymene then led smoothly to the 
1-methyl-17-ketone (lc).
A similar sequence of reactions was employed in the syn­
thesis of the 7,11-dimethyl-17-ketone (Id). 2-(3-Methyl-l- 
naphthyl)propionic acid (lib ) (obtained via  Reformatsky 
reaction between 3-methyltetralone and ethyl 2-bromo- 
propionate) was chain-extended and cyclised as before to 
yield 4,10-dimethyl-l ,2,3,4-tetrahydrophenanthren-l-one
(13b) in good yield. Unfortunately the Stobbe reaction with 
this ketone and the subsequent cyclisation step occurred with 
difficulty, presumably as a result of steric hindrance by the 
adjacent methyl group. Similar problems were encountered 
in the synthesis of 15,16-dihydro-7-methylcyclopenta[a]- 
phenanthren-17-one (le).2 The final catalytic dehydrogenation, 
however, occurred in 85% yield despite the presence of the 
methyl group at C -ll. This dehydrogenation method with 
palladium in boiling p-cymene appears to be superior to the 
methods previously used (DDQ in boiling benzene, or fusion 
with palladium at 220 “C).1
Originally 8 in the synthesis of the 1,11-methano-compound 
(2), acenaphthen-l-ylacetic acid (16) was converted into the 
corresponding propionic acid (17) by the Arndt-Eistert reac­
tion.15 On a larger scale it was however found preferable to 
carry out this transformation in several stages, by reduction of 
the acid (17) and bromination of the resulting alcohol, con­
version into the nitrile and hydrolysis to (17). Cyclisation to 
the tetracyclic ketone (18) followed by elaboration of the five-
Experimental
Unless otherwise stated, m.p.s were determined for samples in 
open capillary tubes and are uncorrected, as are the b.p.s. I.r. 
spectra were recorded using either Nujol mulls or liquid 
films. N.m.r. data are for deuteriochloroform solutions with 
tetramethylsilane as internal reference and were recorded at 
60 MHz. U.v. spectra were recorded for solutions in 98% 
ethanol. ‘ Drying ’ refers to the use of magnesium sulphate; 
‘ evaporation ’ implies the use of reduced pressure.
\-M eth y l-\l-h yd ro x y im in o -o estra -\ ,3,5 (10)-trie ne (3b).—
l-Methyloestra-l,3,5(10)-trien-17-one 11 (2 g), hydroxylamine 
hydrochloride (1.04 g), sodium hydrogen carbonate (1.25 g), 
water (2.5 ml), and methanol (45 ml) were heated together 
under reflux for 1.5 h, and the mixture then cooled and poured 
into water (100 ml). The precipitate was collected by filtration, 
washed with water, and crystallised from ethanol to yield the 
oxim e  (3b) as needles (2.1 g), m.p. 96—98 °C, [a]D +178°;
265 nm; vmax 3 260, 945, 930, 767, and 740 cm"1; 8 1.02 
(3 H, s, 18-Me), 2.36 (3 H, s, ArMe), 2.80 (2 H, m, ArCH2),
7.00 (3 H, s, ArH), and 8.80 (1 H, broad s, NOH) (Found: C, 
80.0; H, 8.7; N, 4.8%. M + , 283.1936. C19H25NO requires C, 
80.5; H, 8.9; N, 4.9%; M, 283.1938).
\-M e th y l- \3 ,\ l- s e c o -o e s tr a - \ ,3,5(10),13(18 )-te tra e n e -\l-  
carbonitrile  (4).—The oxime (3b) (1.8 g) was added to a 
mixture of Me2SO and benzene (54 ml, 1 : 1 v/v) containing
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dicyclohexylcasbodi-imide (3.92 g) and trifluoroacetic acid 
(0.32 ml). After 3 h at room temperature the reaction mixture 
was added to water, the benzene layer was separated, and the 
aqueous layer was extracted with more benzene. The combined 
organic fractions were washed with saturated brine, dried, and 
evaporated to yield a honey-coloured oil (5 g). Chromato­
graphy on silica with benzene elution gave the seco-n itrile  (4) 
as an oil (1.2 g) which did not crystallise, 2,max 265 nm; [a]D 
+235° (EtOH); Vmax 2 246 (C=N), 1 645 OC=CH2), 1 580, 
895, 772, and 745 cm"1; 8 2.37 (3 H, s, ArMe), 4.72 (1 H, s, 
C=CH2), 4.96 (1 H, s, C=CH2), and 7.00 (3 H, s, ArH) 
(Found: N, 5.1. M +, 265.1834. C19H23N requires N, 5.3%; M  
265.1830).
13,18-^-E poxy-l-m eth yl-l 3 ,\l- se c o -o e s tra - \,3,5(10)-triene- 
Yl-carbonitrile  (5).—An ice-cold solution of m-chloroper- 
benzoic acid (1.45 mmol) in chloroform (3 ml) was added to a- 
vigorously stirred solution of the nitrile (4) (1.32 mmol) in 
chloroform (9 ml) at 0 °C. The stirred reaction mixture was 
maintained at this temperature for 15 h, after which it was 
added to ice-cold water. The chloroform layer was washed 
with cold aqueous 2M-sodium hydroxide and with water, and 
then dried and evaporated to yield the epoxyn itrile  as an oil 
(316 mg) which failed to crystallise, [a]D +119° (EtOH), Xmax 
265 nm; vmax 2 246 (C=N), 1 580, 1 220, 840, 772, and 745 
cm"1; 8 2.35 (3 H, s, ArMe), 2.70 (4 H, m, ArCH2), and 7.00 
(3 H, s, ArH) (Found: C, 80.6; H, 8.5; N, 4.65%; M +, 
281.1774. C19H23NO requires C, 81.1; H, 8.2; N, 5.0%; M, 
281.1780).
1 -M e th y l-18-no roes tra- I ,3 ,5 (l0 )-trien -l7 -o n e  (6).—The
epoxy-nitrile (5) (300 mg) and boron trifluoride-ether (0.75 
ml) were heated under reflux in toluene (145 ml) for 54 h. The 
cooled reaction mixture was washed with saturated aqueous 
sodium hydrogen carbonate, dried, and evaporated to give an 
orange gum (250 mg) which was chromatographed on silica 
with toluene containing increasing amounts of ethyl acetate. 
Material eluted with 1% ethyl acetate was crystallised from 
chloroform to give the trienone (6) as yellow needles (38 mg, 
14%), m.p. 85—88 °C, Xmax. 266 nm; vmax. 1 735 (C=0), 770, 
and 745 cm-1; 8 2.34 (3 H, s, ArMe), 2.80 (2 H, m, ArCH2), 
and 7.00 (3 H, s, ArH) (Found: M + 254.1665. C18H220  
requires M, 254.1671).
15,16-D ihydro-l-m ethylcyclopen  ta[a]phenanthren-11-one  
(lc).—The trienone (6) (95 mg), DDQ (474 mg), and dioxan 
(25 ml) were heated under reflux for 3 days after which the 
mixture was cooled and diluted with ether (25 ml). The hydro- 
quinone was removed by filtration and the filtrate was washed 
with aqueous sodium hydroxide and with water, dried, and 
evaporated to give a gum which was chromatographed on 
alumina. Elution with toluene yielded the 1-methyl-17-ketone 
(lc) (5 mg) as a semicrystalline material with u.v. and i.r. 
spectra, fluorescence, and R F values in several systems identical 
with those of the pure, analysed sample (see below).
4-M ethoxycarbonylm ethyl-4-{o-to lyl)-4-bu tanolide  (8).—
Methyl 4-oxo-4-o-tolylbutyrate (7 )16 (61 g), methyl bromo- 
acetate (52 ml), zinc fillings (36 g), and a small crystal of iodine 
were heated together in dry ether (200 ml) under reflux. A 
vigorous reaction took place, after which reflux was maintained 
for 6 h. The cooled reaction mixture was added to an excess of 
ice and hydrochloric acid; the organic layer was separated and 
the aqueous layer was extracted twice with ether. The com­
bined ether solutions were dried and evaporated to yield a 
mobile golden oil which was heated under reflux for 0.5 h 
with toluene-p-sulphonic acid (100 mg) in benzene (100 ml). 
The resulting solution was washed with water, dried, evapor­
ated, and distilled to give the lactone  (8) (52 g) as a viscous 
lime-coloured liquid, b.p. 188—190 °C/0.6 mmHg, \ mny. 175 
(lactone) and 1 730 cm-1 (ether); 8 2.44 (3 H, s, ArMe), 2.68 
and 3.03 (6 H, 3 X CH2), 3.60 (3 H, s, C 0 2Me), and 7.0—7.7 
(4 H, m, ArH) (Found: C, 67.7; H, 6.5. Ci4Hi60 4 requires C, 
67.7; H, 6.5%).
4-Q -Tolyl-S-m ethoxycarbonylpentanoic A c id  (9).—A stirred 
mixture of the lactone (8) (50 g) and palladium on charcoal 
(10%, 1 g) in acetic acid (200 ml) containing perchloric acid 
(10 ml) was hydrogenated at normal pressure for 48 h, during 
which time 4.8 1 of hydrogen were absorbed. The catalyst was 
removed by filtration and the solution was concentrated by 
evaporation to ca. 50 ml, diluted with water (300 ml), and 
extracted with ethyl acetate. The dried extract was evaporated 
to yield the a c id  (9) as a white solid (49 g), m.p. 95—97 °C 
(benzene-light petroleum), vmaY 1 735 and 1 710 cm-1; 8 2.1 
(4 H, 2 x  CH2), 2.35 (3 H, s, ArMe), 2.59 (2 H, CH2), 3.57 
(3 H, s, C 0 2CH3), and 7.14 (4 H, Ar) (Found: C, 67.5; H, 7.4. 
Ci4H 180 4 requires C, 67.2; H, 7.3%).
M e th y l 8-M eth y l-4 -o x o -1,2,3,4- tetrahydro-1 -naph thyl-
a ceta te  (10).—Phosphorus(v) chloride (30 g) was added in 
portions to a solution of the acid-ester (9) (25 g) in dichloro­
methane (200 ml) during 0.5 h at 0 °C. The reaction mixture 
was heated at 35 °C for a further 0.5 h, cooled to 0 °C, and 
tin(iv) chloride (50 ml) diluted with dichloromethane (50 ml) 
was then added dropwise. After being stirred at room temper­
ature for 2 h  the reaction mixture was poured onto an excess 
of ice and hydrochloric acid. Separation of the organic layer 
was followed by extraction of the aqueous layer with dichloro­
methane, and the combined extracts were washed with water, 
dried, evaporated, and distilled to yield m eth yl S-m ethyl-4- 
o xo-l,2 ,3 ,4 -te tra h yd ro -l-n a p h th y la ce ta te  (10) (15 g) as a mobile 
oil, b.p. 175 °C/1 mmHg, vmaY 1 730 (ester) and 1 685 cm-1 
(unsaturated ketone); 8 2.32 (3 H, s, ArMe), 1.8—2.8 (7 H, m, 
aliphatic H), 3.68 (3 H, s, C 0 2Me), 6.75—7.30 (2 H, m, 6-H 
and 7-H), and 7.75 (1 H, dd, Jortho 7 and J meta 2 Hz, 5-H) 
(Found: C, 72.2; H, 7.2. C14H 160 3 requires C, 72.4; H, 6.9%).
5-M ethyl-l-naph th ylacetic  A c id  (11a).—The tetralone (10) 
(20 g) was stirred with sodium borohydride (5 g) in ethanol 
(100 ml) overnight at room temperature. After dilution with 
water the organic material was extracted with ethyl acetate 
and the extract washed with water, dried, and evaporated to 
yield the hydroxy-ester (20 g), vmax 3 400v,br, and 1 735 cm-1.
A solution of this hydroxy-ester in benzene (50 ml) con­
taining a small quantity of toluene-p-sulphonic acid was 
heated under reflux for 0.5 h; the cooled solution was then 
washed with water, dried, and evaporated to leave an oil. 
Sulphur (3.0 g) was added and the resultant mixture was 
heated at 230—235 °C for 0.5 h. When cold, the reaction 
mixture was dissolved in ethanol (20 ml) and heated under 
reflux for 1 h with sodium hydroxide (10 g) and water (30 ml). 
After dilution with more water (200 ml), the solution was 
extracted once with ether and the clear aqueous layer acidified 
with concentrated hydrochloric acid and extracted several 
times with ethyl acetate. The combined extracts were dried 
and evaporated to give the naphthylacetic  a c id  (11a) as a 
slightly greenish solid (12.1 g), m.p. 173—174 °C (ligroin), vmgY 
1 710 cm"1; 8 2.95 (3 H, s, ArMe), 4.38 (2 H, s, CH2), and 
7.35—8.20 (6 H, m, ArH) (Found: C, 78.5; H, 6.1. C13Hi20 2 
requires C, 78.0; H, 6.0%).
% -M ethyl-\-naphthylbutyric A c id  (12a).—A solution of the 
acid (11a) (15 g) in dichloromethane (50 ml) was added drop- 
wise to a stirred suspension of lithium aluminium hydride (2 
g) in ether (200 ml); when the exothermic addition was com­
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plete the reaction mixture was heated under reflux for 1 h and 
then cooled in ice. Water was added, initially dropwise, 
followed by concentrated hydrochloric acid; the organic 
fraction was then separated and the aqueous layer extracted 
with ether. The combined organic solutions were washed with 
water, dried, evaporated, and the residue distilled at 130—132 
°C/0.9 mmHg to yield l-(8-m ethylnaphthyl)ethanol (12 g) as an 
oil which slowly crystallised, m.p. 57—58 °C, vmaY 3 200br 
cm"1; 5 2.83 (3 H, s, Me), 3.2—3.9 [4 H, m, (CH2)2], and 6.9— 
7.8 (6 H, m, ArH) (Found: C, 83.3; H, 7.8. C13Hi40  requires 
C, 83.8; H, 7.6%).
The naphthylethanol (10 g) in acetonitrile (50 ml) was 
added to a suspension of triphenylphosphine dibromide 17 
[from triphenylphosphine (21.12 g) and bromine (12.87 g)] in 
the same solvent (100 ml), and the mixture was maintained at 
60 °C for 2 h. After evaporation of the solvent, the solid residue 
was triturated with benzene and the solution filtered through a 
short column of silica. Removal of the benzene left the 
bromide as a mobile oil which, without further purification, 
was treated with diethyl sodiomalonate [from diethyl malonate 
(17 ml) and sodium hydride (50%) (3.8 g) in dry dimethyl- 
formamide (100 ml)]; the reaction mixture was stirred at 60 °C 
for 5 h. After evaporation, the residue was dissolved in 
ethanol (50 ml) and heated under reflux with sodium hydroxide 
(12 g) in water (100 ml) for 2 h. The cooled solution was further 
diluted with water (100 ml) and extracted with ether. The 
aqueous fraction was acidified with concentrated hydrochloric 
acid and the organic products were extracted into dichloro­
methane which was washed with water, dried, and evaporated. 
The residual gum was dissolved in pyridine (200 ml) and 
decarboxylation was effected by heating under reflux for 2 h. 
The pyridine was removed by evaporation to leave an oil, 
which on treatment with 2M-hydrochloric acid gave the 
naphthylbu tyric a c id  (12a) as a white solid (7.5 g, 61%), m.p. 
132—133 °C (toluene), v ^  1 705 cm"1; 8 2.05 (2 H, m, CH2), 
2.45 (2 H, t, J6 .5  Hz, CH2C 0 2H), 2.90 (3 H, s, Me), 3.32 (2 H, 
t, J  7 Hz, ArCH2), and 7.10—7.85 (6 H, m, ArH) (Found: C, 
78.8; H, 7.1. C15H 160 2 requires C, 78.9; H, 7.1%).
5-M ethyl-\,2,2>,4-tetrahydrophenanthren-\-one (13a).—
Cyclisation of the acid (12a) (7.0 g) was effected by the method 
used to prepare the tetralone (10), but employing phosphorus- 
(v) chloride (9.5 g) and tin(iv) chloride (7.0 ml). The phenan- 
threnone (13a) was obtained in 92% yield, m.p. 88—89 °C 
(benzene-light petroleum), vmax 1 675 cm-1; 8 2.50 (2 H, m, 
CH2), 3.14 (2 H, t, J  6 Hz, CH2CO), 3.37 (3 H, s, Me), 3.95 
(2 H, m, CH2Ar), 7.48—7.95 (4 H, m, ArH), and 8.37 (1 H, d, 
/ 9>io 8 Hz, 10-H) (Found: C, 86.1; H, 7.0. C15H140  requires C, 
85.7; H, 6.7%).
3-(3,'4-D ihydro-5 -m eth yl-\-ph en an thryl)-3 -eth oxy  carbonyl- 
propion ic  A c id  (14a).—To a stirred solution of potassium 
t-butoxide (1.6 g) in t-butyl alcohol (50 ml) was added the 
phenanthrenone (13a) (3.0 g) and diethyl succinate (5.0 ml); 
the mixture was then heated under reflux for 6 h. After 
dilution with water (200 ml), the solution was acidified with 
concentrated hydrochloric acid, extracted with ether, and the 
latter re-extracted with dilute aqueous ammonium hydroxide. 
Acidification of the alkaline solution was followed by extrac­
tion of the organic products into dichloromethane. Evapor­
ation of the dried extract yielded the half-ester (14a) as a 
golden coloured solid (1.5 g), m.p. 163—165 °C (ethanol), 
vmax. 1 728 and 1 702 cm-1 (Found: C, 74.6; H, 6.6. C2iH220 4 
requires C, 74.5; H, 6.6%). The n.m.r. spectrum was complex 
suggesting the presence of more than one isomer.
\ -M e th y l- \\,X l^ A b -te tra h yd ro cy c lo p e n ta \z \p h en a n th ren -  
Y l-one (15a).—A mixture containing the half-ester (14a) (1.5 g),
anhydrous zinc chloride (0.2 g), acetic acid (10 ml), and acetic 
anhydride (20 ml) was heated under reflux for 6 h. While still 
hot, water (10 ml) was added, initially dropwise, followed by 
concentrated hydrochloric acid (15 ml); heating under reflux 
was then continued for a further 2 h. After dilution of the 
cooled reaction mixture with water (200 ml) the products were 
extracted with ether, and the extracts were dried and evapor­
ated to leave an oil which was chromatographed on a column 
of silica gel, with chloroform-light petroleum as eluant.
l-M e th y l- l 1,12,15,16- tetrahydrocyclopen ta  [a]phenan thren-17- 
one (15a) was isolated as a buff solid (0.8 g), m.p. 138—140 °C 
(ethanol), ^  276 (4.55), 286 (4.62), 330 (4.09), 343 (4.11), 
and 376 (3.87) nm; vmax 1 685 (17=CO) and 1 650 cm"1 
[13(14) double bond] (Found: C, 87.6; H, 6.3. C18H lfiO 
requires C, 87.1; H, 6.5%).
' 15,16 -D ihydro-1 -m ethylcyclopen ta[a]phenan thren-11-one 
(lc).—The tetrahydro-ketone (15a) (0.7 g), 10% palladium-on- 
charcoal (0.1 g), and /?-cymene (50 ml) were vigorously heated 
under reflux for 0.5 h, filtered whilst hot, and evaporated to 
leave a light yellow solid. Trituration of the latter with a small 
volume of benzene gave 15,16-dihydro-1 -m ethylcyclopenta[di\- 
phenan thren-ll-one  (lc) as a white solid (0.55 g), m.p. 189— 
190 °C (ethanol), 266 (4.84), 288 (4.53), 303 (4.30), 359 
(3.77), and 375 (3.77) nm; v ^  1 690 cm"1; 8 2.73 (2 H, t, J 6  
Hz, 16-CH2), 3.08 (3 H, s, 1-Me), 3.38 (2 H, t, J 6  Hz, 15-CH2), 
7.27—7.84 (6 H, m, ArH), and 8.70 (1 H, d, J n ,u  9 Hz, 11-H) 
(Found: C, 87.8; H, 5.7. C18H 140  requires 87.7; H, 5.8%).
4-(3-M ethylnaphthyl)pentanoic A c id  (12b).—This acid was 
prepared by methods similar to those used to convert (11a) 
into (12a). The intermediate 2-(3-methyl-l-naphthyl)propionic 
acid ( l ib) 14 was reduced with lithium aluminium hydride to
4-(3-m ethylnaphthyl)propanol in 85% yield, b.p. 155—157 °C/ 
0.9 mmHg, v ^  3 560, 3 340, 1 660, and 1 608 cm"1; 8(D20) 
1.34 (3 H, d, CHMe), 2.44 (ArMe), 3.33—3.92 (3 H, m, CH- 
CH2), and 7.05—8.27 (6 H, m, ArH) (Found: C, 83.5; H, 8.2. 
Ci3H 160  requires C, 84.0; H, 8.1%). This alcohol was readily 
converted into 4-(3-m ethylnaphthyl)pen tyl brom ide (73%), b.p. 
166 °C/2.0 mmHg, v , ^  1 680 and 1 608 cm-1; 8 1.55 (2 H, d, 
J  6.5 Hz, CHMe), 2.46 (3 H, s, ArMe), 3.2—4.25 (3 H, m, 
CHCH2), and 7.00—8.23 (6 H, m, ArH) (Found: C, 63.9; H, 
6.0. CuHisBr requires C, 63.9; H, 5.8%). Conversion of the 
latter into the pentanoic a c id  (12b) (70%) was best conducted 
in absolute ethanol; the product was not obtained crystalline; 
vmx 1 703, 1 660, and 1 608 cm"1; 8 1.40 (3 H, d, J  6 Hz, 
CHMe), 1.90—2.33 [4 H, m; (CH2)2J, 2.98 (3 H, s, ArMe), 3.60 
(1 H, m, CH), and 7.10—8.20 (6 H, m, ArH) (Found: C, 79.2; 
H, 7.8. C16H 180 2 requires C, 79.3; H, 7.5%).
4,10-D im eth y l-1,2,3,4-tetrahydrophenanthren- l-one  (13b).— 
Cyclisation with tin(iv) chloride as for (13a) gave the phenan­
threnone (13b) (65%), m.p. 65 °C (light petroleum), v ^  1 670 
cm-1; 8 1.45 (3 H, d, J  7.5 Hz, CHMe), 1.95—3.00 [4 H, m, 
(CH2)2-], 3.92 (1 H, m, CH), and 7.23—8.17 (5 H, m, ArH) 
(Found: C, 85.3; H, 7.2. C16H 160  requires C, 85.7; H, 7.2%).
7,1 l-D im e th y l-l 1,12,15,16-tetrahydrocyclopenta[a.]phenan- 
th ren -ll-o n e  (15a).—The Stobbe reaction with the ketone 
(13b), carried out as for (13a), gave the half-ester (14b) (20%), 
as an oil, v ^  1 735 and 1 710 cm-1. Without further purifi­
cation this material was cyclised with zinc chloride as des­
cribed for (15a) to yield the ketone  (15b) (15%), m.p. 145—146 
°C (ethanol), ^  265sh (4.47), 274 (4.75), 285 (4.84), 335br 
(4.39) nm; v ^  1 685, 1 632, and 1.614 cm"1; 8 1.06 (3 H, 
d, J  7 Hz, CHMe), 2.68 (3 H, s, ArMe), and 7.15—8.17 (5 H, 
m, ArH) (Found: C, 87.2; H, 7.2. Ci9H 180  requires C, 87.0; H, 
6.9%).
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15.16 -D ihydro-1 ,1 \-d im eth ylcyclopenta[a]phenan th ren-ll- 
one (Id).—Dehydrogenation of (15b) was performed as in the 
preparation of the 1-methyl compound to yield 15,16-*//- 
hydro-l,ll-d im eth ylcyc lopen ta [a .]phenan th ren -ll-on e  (Id) 
(85%), m.p. 208—210 °C (ethanol); Xmax 275 (4.76), 293 (4.48), 
307 (4.29), 368 (3.46), and 389 nm (3.51); vmax 1 678 cm"1; 
8 2.65 (2 H, t, J  5 Hz, 16-CH2), 2.82 (3 H, s, ArMe), 2.98 (3 H, 
s, ArMe), 3.63 (2 H, t, J  5 Hz, 15-CH2), and 7.30—8.85 (6 H, 
m, ArH) (Found: C, 87.6; H, 6.2. CiyHi60  requires C, 87.7; 
H, 6.2%).
3-A cenaphthen-l-ylpropionic A c id  (17).—Acenaphthen-l-yl- 
acetic acid5 (16) (10 g) was reduced with LiAlH4 as already 
described to yield 2-acenaphthen-l-ylethanol (9.0 g) as a 
yellow oil, vm!,Y 3 330br cm-1 (OH); 8 1.9 (2 H, m, CHC H 2- 
CH2), 3.2 (6 H, m, ArCH2 and C H ~ C H 2- C H 2- O H ) ,  and 7.3 
(5 H, m, ArH). This alcohol was brominated with triphenyl­
phosphine dibromide in acetonitrile, and the bromide was 
purified by passage through a column of silica gel to give an 
oil (9.52 g), 8 2.1 (2 H, m, CHGtf2CH2), 3.2 (5 H, m, A tC H 2 
and C H C H 2C H 2), and 7.3 (5 H, m, ArH).
The bromide was stirred and heated under reflux with 
potassium cyanide (8.3 g) in methanol (150 ml) for 72 h and 
the nitrile, isolated as a red oil [vmax 2 250 cm"1 (C=N)], was 
heated under reflux with sodium hydroxide (10 g) in aqueous 
methanol (100 ml; 9 : 1 v/v) for 24 h. After extraction with 
ether, the solution was acidified and extracted with ethyl 
acetate. 3-Acenaphthen-l-ylpropionic acid (17) formed beige 
needles (6.81 g), m.p. 102—104 °C (lit.,15 m.p. 102.5—104.5 °C) 
from ethyl acetate-light petroleum, 8 2.8 (7 H, aliphatic H), 
7.55 (6 H, m, ArH), and lO.Obr (1 H, s, C 0 2H).
3-{3,4 -D ihydro-4 ,5-m ethylene-\-phenanthryl)-3-elhoxy- 
carbonylpropionic A c id  (18).—3-Acenaphthen-l-ylpropionic 
acid (17) (6.64 g) was cyclised with phosphorus(v) chloride and 
tin(iv) chloride as already described to yield 1,10-methano-l ,2- 
3,4-tetrahydrophenanthren-4-one (4.9 g), m.p. 119—120 °C 
(lit.,15 122—123 °C), vmax 1 670 cm '1 (C=0); 8 2.85 (7 H, m, 
alicyclic H), and 7.55 (5 H, m, ArH).
A Stobbe reaction with this ketone (0.7 g) as before gave the 
half-ester (18) as a beige solid (0.9 g), m.p. 160—162 °C (aq. 
methanol), ?iniax 251sh, 257 (4.60), 266 (4.64), 295sh, 310 
(3.71), 318 (3.75), 331 (3.67), and 347 nm (3.51); vmax 1 728 
(C 02Et), 1 702 (C 02H), 1 175, 1 040, and 1 040 cm"1; 8 1.2 
(3 H, t, CH2Me), 2.9 (8 H, m, aliphatic H), 4.05 (2 H, q, 
CZ/zMe), 5.8 (1 H, m, 2-H, and 7.35 (5 H, m, ArH) (Found: 
C, 75.3; H, 6.0. C2iH20O4 requires C, 75.0; H, 6.0%).
15.16 -D ihydro-1,11 -m ethanocyclopenta[a]phenanthren-17- 
one (2).—The above half-ester (18) (0.9 g) was cyclised with 
zinc chloride and acetic anhydride to give \ ,\ \-m e th a n o -  
l\,\2 ,\5 ,\6 -te tra h yd ro cyc lo p en ta [a )p h en a n th ren -\l-o n e  (19) 
as pale yellow crystals (0.2 g), m.p. 198—200 °C (methanol),
Xmax 267sh, 277 (4.52), 287 (4.59), 310 (2.83), 322 (3.92), 338 
(3.88), and 375 nm (3.92) (Found: C, 88.1; H, 5.9. C18H140  
requires C, 87.8; H, 5.7%).
Dehydrogenation of this tetrahydro-compound (0.76 g) 
with Pd/C in p-cymene under reflux for 0.5 h, and recrystal­
lisation of the product from methanol led to 15,16-dihydro- 
l ,l\-m e th an ocyclopen ta [a ]ph en an th ren -ll-on e  (2) as a pale 
yellow solid (0.64 g), m.p. 195 °C, 266.5 (4.77), 277 (4.76),
303 (3.34), 348 (3.03), and 365.5 nm (2.86); vmax 1 685 (CO), 
1 634, 1 400, 1 292, 820, and 805 cm"1; 8 2.8 (2 H, m, CH2C= 
O), 3.25 (2 H, m, CH2), 4.2 (2 H, s, ArCH2Ar), and 7.7 (6 H, 
m, ArH) (Found: C, 88.7; H, 5.1. Ci8H120  requires C, 88.5; 
H, 4.95%).
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